data_1qkh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1qkh _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.727 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.232 0.539 . . . . 0.0 109.858 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 70.4 t -105.55 117.56 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.727 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 37.1 t70 -44.45 112.71 0.45 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.403 0.621 . . . . 0.0 111.725 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.561 ' HA ' HD11 ' A' ' 16' ' ' LEU . 9.5 t70 -71.23 -21.97 62.05 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -70.11 -25.13 63.35 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.87 -0.519 . . . . 0.0 110.442 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.634 HD12 ' SD ' ' A' ' 44' ' ' MET . 0.6 OUTLIER -77.46 -37.47 51.38 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.658 ' HA ' HG11 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -62.5 -46.91 86.31 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.744 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.5 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -51.17 -23.47 3.34 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.311 179.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.465 ' HB2' HG22 ' A' ' 31' ' ' ILE . 14.3 mttm -106.06 -33.62 7.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.448 -0.782 . . . . 0.0 110.568 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.658 HG11 ' HA ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -73.3 -39.64 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.279 -0.888 . . . . 0.0 111.402 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.5 HD22 ' HA ' ' A' ' 17' ' ' GLU . 3.6 pp -63.13 -27.19 69.21 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.23 -32.67 64.88 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -77.99 -24.09 48.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.653 -0.654 . . . . 0.0 109.437 178.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -82.73 -11.63 58.16 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.392 -0.817 . . . . 0.0 109.635 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.66 -39.77 19.8 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 121.461 -0.774 . . . . 0.0 109.969 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.529 ' CD ' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -103.23 -23.37 13.62 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.459 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.414 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . 102.14 29.07 6.21 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.569 ' HB2' HD21 ' A' ' 22' ' ' LEU . 5.8 mt-10 -76.1 130.33 38.16 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.394 -1.062 . . . . 0.0 110.669 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.8 mtmm -107.3 59.68 0.62 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.569 -0.707 . . . . 0.0 109.285 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -102.88 -154.34 0.49 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.509 -0.744 . . . . 0.0 109.992 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.463 ' HB2' ' HB ' ' A' ' 48' ' ' THR . 0.0 OUTLIER -124.49 145.16 49.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.587 -0.695 . . . . 0.0 110.13 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.526 HD11 HG22 ' A' ' 19' ' ' VAL . 2.4 mp -114.65 119.83 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.615 -0.678 . . . . 0.0 109.47 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.421 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 20.5 mmtt -79.61 154.63 28.58 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.412 -0.805 . . . . 0.0 111.199 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.7 m -141.38 153.47 45.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.61 -0.681 . . . . 0.0 110.094 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.421 ' CH2' ' HB2' ' A' ' 32' ' ' LYS . 14.7 m-90 -144.49 35.01 1.17 Allowed 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.311 -0.868 . . . . 0.0 111.354 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.3 t -84.63 -96.03 0.07 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.893 -1.13 . . . . 0.0 110.586 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.6 mtm105 -171.81 -61.91 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.106 -0.996 . . . . 0.0 109.631 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.453 ' HG2' ' HD1' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -103.53 31.15 4.54 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.435 0.636 . . . . 0.0 109.399 178.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.4 m -44.74 130.9 7.08 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.439 0.637 . . . . 0.0 111.997 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 75.7 m -124.76 159.06 31.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.775 -0.578 . . . . 0.0 109.936 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.647 HG23 HG12 ' A' ' 62' ' ' ILE . 4.8 mp -79.56 169.48 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.389 -0.82 . . . . 0.0 111.237 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.567 HG22 ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -140.15 176.49 2.5 Favored Pre-proline 0 N--CA 1.5 2.056 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 43.2 Cg_endo -66.89 -29.85 40.89 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.006 1.53 . . . . 0.0 110.595 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -71.46 -3.63 22.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.444 -0.785 . . . . 0.0 111.061 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.634 ' SD ' HD12 ' A' ' 15' ' ' LEU . 1.4 mtp -98.24 7.21 46.57 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.988 -1.07 . . . . 0.0 112.143 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.629 HG23 ' HA ' ' A' ' 64' ' ' GLU . 89.6 t -57.5 -1.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.529 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.06 35.41 0.99 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.431 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 31.7 m-70 -142.48 146.34 34.66 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.41 -1.053 . . . . 0.0 111.117 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.585 HG22 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.7 83.95 2.85 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 178.023 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.564 ' HB ' ' HE1' ' A' ' 44' ' ' MET . 1.9 mt -86.97 120.63 36.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.139 -0.976 . . . . 0.0 110.924 -177.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.695 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -75.72 78.65 2.67 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.977 0.894 . . . . 0.0 109.152 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.3 m -59.9 131.11 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.534 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.455 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 26.8 t80 -78.06 105.01 8.99 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -75.09 7.91 2.97 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.317 -0.864 . . . . 0.0 111.055 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.26 -27.39 6.11 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.65 -24.9 0.77 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.821 -0.811 . . . . 0.0 111.495 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -132.65 154.49 50.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.134 -0.979 . . . . 0.0 112.244 -177.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.481 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . 0.8 OUTLIER -99.6 101.46 12.67 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.248 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.695 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 48.1 t -90.75 104.07 8.42 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.178 -0.951 . . . . 0.0 110.089 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.493 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.5 Cg_endo -66.08 87.37 0.24 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 O-C-N 123.899 1.473 . . . . 0.0 109.447 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.506 HG21 ' O ' ' A' ' 60' ' ' VAL . 15.1 m -92.72 112.59 26.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.464 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.585 ' HB2' HG22 ' A' ' 48' ' ' THR . 2.3 t80 -75.13 100.36 4.23 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.647 HG12 HG23 ' A' ' 40' ' ' ILE . 2.8 mp -81.57 135.29 25.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.564 -0.71 . . . . 0.0 111.144 -178.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.9 p -101.03 -155.47 0.52 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.629 ' HA ' HG23 ' A' ' 45' ' ' VAL . 1.3 tp10 -89.43 10.88 20.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.627 -1.295 . . . . 0.0 110.614 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.92 24.15 1.19 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.941 -1.099 . . . . 0.0 111.478 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 6.6 mmt -114.09 -27.95 7.5 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.039 -1.038 . . . . 0.0 110.216 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.455 ' CG2' HG21 ' A' ' 40' ' ' ILE . 7.5 p -63.02 164.87 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 O-C-N 121.585 -0.697 . . . . 0.0 111.822 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 123.35 -14.51 8.23 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.387 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.693 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 16.5 m-70 -122.03 -85.04 0.66 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 119.034 1.417 . . . . 0.0 111.21 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.65 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.68 -30.64 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.586 0.708 . . . . 0.0 110.42 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.515 ' HB3' ' O ' ' A' ' 70' ' ' LYS . 0.4 OUTLIER 174.46 -16.0 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.706 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.55 -16.4 75.8 Favored Glycine 0 N--CA 1.497 2.704 0 O-C-N 120.954 -1.091 . . . . 0.0 110.686 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.693 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 1.1 mm-40 . . . . . 0 N--CA 1.498 1.925 0 O-C-N 121.254 -1.145 . . . . 0.0 109.461 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.754 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.327 0.584 . . . . 0.0 110.03 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.8 p -106.06 116.92 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.754 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 35.9 t70 -47.93 108.7 0.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.437 -0.79 . . . . 0.0 111.266 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.77 -23.88 66.13 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -70.58 -20.54 62.77 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.976 -0.453 . . . . 0.0 110.071 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.629 ' HG ' HD11 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -88.54 -35.13 17.12 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.304 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.629 HD11 ' HG ' ' A' ' 15' ' ' LEU . 4.7 mp -69.52 -38.69 77.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.72 -0.612 . . . . 0.0 110.204 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.528 ' HA ' HD22 ' A' ' 20' ' ' LEU . 3.0 pt-20 -58.29 -20.69 44.76 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.439 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.474 ' HB2' HG22 ' A' ' 31' ' ' ILE . 41.7 mtpt -100.3 -29.56 12.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.387 -0.821 . . . . 0.0 110.394 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.618 HG13 ' HG3' ' A' ' 43' ' ' GLU . 1.5 p -76.19 -37.21 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.247 -0.908 . . . . 0.0 111.141 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.528 HD22 ' HA ' ' A' ' 17' ' ' GLU . 3.7 pp -61.8 -26.58 68.19 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.02 -33.97 70.86 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.19 -25.46 42.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.694 -0.629 . . . . 0.0 109.573 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -84.31 -12.91 53.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.509 -0.744 . . . . 0.0 109.592 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.87 -39.22 13.2 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 121.509 -0.745 . . . . 0.0 110.014 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 15.3 mmtt -94.77 -29.86 14.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.578 -0.701 . . . . 0.0 109.332 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.23 25.01 6.89 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -84.63 136.13 33.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.413 -1.051 . . . . 0.0 110.091 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -113.1 77.4 1.05 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.418 -0.801 . . . . 0.0 109.623 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.93 -154.85 0.57 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.496 -0.752 . . . . 0.0 110.363 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.507 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -112.85 155.36 24.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.412 -0.805 . . . . 0.0 110.545 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.515 HG23 HD11 ' A' ' 15' ' ' LEU . 2.7 mp -129.24 113.5 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.493 -0.755 . . . . 0.0 109.338 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.503 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -66.64 154.36 40.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.521 -0.737 . . . . 0.0 111.117 -179.062 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.509 HG22 ' CB ' ' A' ' 12' ' ' ASP . 9.1 m -143.06 135.83 27.75 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.696 -0.628 . . . . 0.0 109.997 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.651 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -152.46 75.71 1.12 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.259 -0.9 . . . . 0.0 111.25 -179.713 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.403 ' HB3' ' CE2' ' A' ' 10' ' ' PHE . 0.6 OUTLIER -123.28 -82.2 0.65 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.147 -0.97 . . . . 0.0 110.052 179.061 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.41 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 5.8 ttm180 -167.97 -64.17 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.314 -0.866 . . . . 0.0 109.727 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.41 ' HD2' ' HB3' ' A' ' 36' ' ' ARG . 0.4 OUTLIER -104.25 35.11 2.8 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.57 -0.706 . . . . 0.0 109.387 179.113 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.0 m -37.9 124.92 1.17 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.406 0.622 . . . . 0.0 111.991 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 34.4 m -130.57 159.08 38.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.788 -0.57 . . . . 0.0 110.183 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.632 HG22 HG12 ' A' ' 62' ' ' ILE . 5.1 mp -83.85 168.94 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.401 -0.812 . . . . 0.0 110.909 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.603 HG21 ' CG ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -138.43 176.9 2.36 Favored Pre-proline 0 N--CA 1.501 2.112 0 O-C-N 121.743 -0.598 . . . . 0.0 109.683 179.375 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.563 ' HD2' ' CG1' ' A' ' 41' ' ' VAL . 43.4 Cg_endo -66.93 -31.34 38.19 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.005 1.529 . . . . 0.0 111.276 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.618 ' HG3' HG13 ' A' ' 19' ' ' VAL . 2.5 pt-20 -72.27 -3.08 21.56 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.313 -0.867 . . . . 0.0 111.075 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.603 ' CG ' HG21 ' A' ' 41' ' ' VAL . 18.8 mmt -97.15 10.1 40.32 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.213 -0.929 . . . . 0.0 111.748 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.591 HG23 ' HA ' ' A' ' 64' ' ' GLU . 80.3 t -61.24 0.63 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 O-C-N 120.93 -1.106 . . . . 0.0 113.508 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.38 35.53 0.96 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.462 ' HB2' HD12 ' A' ' 49' ' ' ILE . 36.4 m-70 -141.68 150.24 41.62 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.484 -1.009 . . . . 0.0 111.041 -178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.555 HG22 ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -99.77 83.7 2.79 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.585 HG12 ' CD1' ' A' ' 15' ' ' LEU . 2.4 mp -83.56 121.39 36.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.398 -0.813 . . . . 0.0 110.885 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.736 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -77.23 79.49 3.75 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.695 0.76 . . . . 0.0 109.456 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.4 ' HA ' ' HB ' ' A' ' 33' ' ' THR . 19.4 m -58.16 135.0 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.385 0.612 . . . . 0.0 110.643 -179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.651 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 30.5 t80 -75.62 106.82 7.38 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.558 -0.714 . . . . 0.0 109.31 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -77.54 4.78 10.38 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.307 -0.871 . . . . 0.0 110.734 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.64 -30.17 4.98 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.87 -26.27 0.73 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.961 -0.729 . . . . 0.0 111.578 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.8 155.42 41.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.227 -0.92 . . . . 0.0 112.345 -177.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.472 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . 1.2 m-70 -97.77 104.81 16.87 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.736 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 48.6 t -93.51 101.49 5.93 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.228 -0.92 . . . . 0.0 110.108 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.52 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.7 Cg_endo -65.77 90.32 0.24 Allowed 'Trans proline' 0 N--CA 1.494 1.513 0 O-C-N 123.892 1.469 . . . . 0.0 109.712 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.7 t -96.04 113.96 31.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.123 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.555 ' HB2' HG22 ' A' ' 48' ' ' THR . 2.4 t80 -72.9 103.93 3.88 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.632 HG12 HG22 ' A' ' 40' ' ' ILE . 2.7 mp -84.81 132.04 32.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.638 -0.664 . . . . 0.0 111.105 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.0 p -94.92 -157.2 0.55 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 177.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.591 ' HA ' HG23 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -90.12 15.42 10.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.8 -1.188 . . . . 0.0 110.883 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.79 19.72 1.01 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.875 -1.141 . . . . 0.0 112.051 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 5.3 mmt -115.58 -18.19 10.97 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.834 -1.166 . . . . 0.0 110.502 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.538 HG22 ' C ' ' A' ' 41' ' ' VAL . 5.6 p -73.94 167.15 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.316 -0.865 . . . . 0.0 111.759 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.452 ' N ' HG23 ' A' ' 67' ' ' VAL . . . 121.28 -11.97 9.75 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.164 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.66 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 18.7 m-70 -128.13 -81.42 0.59 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.944 1.372 . . . . 0.0 111.257 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.6 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.76 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 121.714 0.768 . . . . 0.0 110.126 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.548 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 0.7 OUTLIER 173.73 -16.45 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.759 -179.641 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.1 -16.11 76.73 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.002 -1.061 . . . . 0.0 110.506 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.66 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 21.3 mm-40 . . . . . 0 N--CA 1.497 1.91 0 O-C-N 121.245 -1.15 . . . . 0.0 108.97 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.741 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.258 0.551 . . . . 0.0 110.189 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 p -105.17 112.86 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.741 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 38.9 t70 -41.38 111.8 0.25 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.468 0.651 . . . . 0.0 111.913 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.567 ' HA ' HD11 ' A' ' 16' ' ' LEU . 8.4 t70 -69.75 -23.99 63.47 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -67.4 -26.66 66.55 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.928 -0.483 . . . . 0.0 110.221 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.566 ' HG ' ' N ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -79.31 -36.11 40.14 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.621 ' HA ' HG11 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -64.57 -45.55 86.57 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.688 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.82 -22.69 2.29 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.148 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.443 ' HB2' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -103.59 -36.55 7.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.579 -0.701 . . . . 0.0 110.174 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.621 HG11 ' HA ' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -70.22 -40.67 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.281 -0.887 . . . . 0.0 110.872 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.466 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 10.9 mt -62.69 -37.26 85.79 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.57 -34.69 78.84 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.766 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -77.71 -27.78 50.76 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.345 -0.847 . . . . 0.0 109.515 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -82.51 -12.07 58.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.631 -0.668 . . . . 0.0 109.82 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.86 -35.22 20.74 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 121.385 -0.822 . . . . 0.0 109.867 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.474 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 11.3 mmtt -89.3 -16.05 32.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.61 -0.681 . . . . 0.0 109.816 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.35 26.52 27.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -109.44 137.89 46.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.587 -0.949 . . . . 0.0 110.489 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -110.63 87.78 2.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.49 -0.756 . . . . 0.0 109.644 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.44 -154.34 0.54 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.472 -0.767 . . . . 0.0 110.266 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -112.02 155.43 23.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -0.806 . . . . 0.0 110.589 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.485 HD11 HG22 ' A' ' 19' ' ' VAL . 3.3 mt -130.56 122.01 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.604 -0.685 . . . . 0.0 109.74 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 34' ' ' TRP . 0.1 OUTLIER -84.68 155.63 21.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.407 -0.808 . . . . 0.0 110.882 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.454 HG22 ' OG ' ' A' ' 38' ' ' SER . 19.4 m -137.17 158.19 44.99 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.582 -0.699 . . . . 0.0 110.466 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.479 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 19.8 m-90 -145.54 30.72 1.1 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.333 -0.855 . . . . 0.0 111.726 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 p -86.33 -96.91 0.08 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.847 -1.158 . . . . 0.0 110.606 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.27 -66.34 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.097 -1.002 . . . . 0.0 110.186 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.447 ' HG2' ' CD1' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -99.73 45.24 0.99 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.67 0.747 . . . . 0.0 109.6 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.454 ' OG ' HG22 ' A' ' 33' ' ' THR . 2.2 m -50.9 138.32 19.25 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.448 0.642 . . . . 0.0 112.371 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.742 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 57.0 m -132.0 159.17 39.54 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.644 HG22 ' CG2' ' A' ' 62' ' ' ILE . 5.2 mp -89.76 168.25 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.231 -0.918 . . . . 0.0 111.276 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.574 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -140.21 174.69 3.75 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.228 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.574 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 40.9 Cg_endo -64.86 -31.53 57.01 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.995 1.524 . . . . 0.0 110.194 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -65.93 -12.42 54.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.761 -0.587 . . . . 0.0 110.631 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.586 ' HE3' HD12 ' A' ' 62' ' ' ILE . 41.4 mtp -97.84 11.29 37.81 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.278 -0.888 . . . . 0.0 110.872 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 42' ' ' PRO . 7.5 p -62.14 5.03 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.339 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.28 33.05 1.03 Allowed Glycine 0 N--CA 1.493 2.475 0 O-C-N 120.311 -1.493 . . . . 0.0 109.976 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.536 ' HB2' HD12 ' A' ' 49' ' ' ILE . 45.9 m-70 -144.07 153.21 41.95 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.153 -1.204 . . . . 0.0 111.29 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.57 HG22 ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -100.01 83.92 2.78 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 178.255 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.573 ' CD1' ' HG2' ' A' ' 44' ' ' MET . 3.1 mp -86.61 118.13 32.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 111.281 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.713 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -76.77 80.26 3.38 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.922 0.868 . . . . 0.0 109.071 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.8 m -58.56 132.05 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.285 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.413 ' HB2' ' O ' ' A' ' 33' ' ' THR . 30.4 t80 -74.33 105.8 5.67 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -76.1 13.88 0.81 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.669 -0.644 . . . . 0.0 110.535 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.71 -27.72 12.8 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.5 pttp -140.48 -27.82 0.73 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.596 -0.943 . . . . 0.0 110.84 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -130.35 155.55 46.18 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.106 0.955 . . . . 0.0 113.546 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.621 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 50.8 m-70 -96.3 111.84 23.78 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.713 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 42.1 t -101.33 95.46 4.99 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.132 -0.98 . . . . 0.0 109.455 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.521 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.3 Cg_endo -65.09 87.51 0.18 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.939 1.494 . . . . 0.0 109.787 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 60' ' ' VAL . 10.4 m -94.77 114.67 31.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.208 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.57 ' HB2' HG22 ' A' ' 48' ' ' THR . 2.1 t80 -73.4 100.56 3.24 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.644 ' CG2' HG22 ' A' ' 40' ' ' ILE . 2.6 mp -83.9 138.43 19.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.594 0.711 . . . . 0.0 111.996 -177.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.406 ' C ' HG21 ' A' ' 45' ' ' VAL . 24.8 p -104.99 -153.98 0.5 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 176.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.407 ' HB2' HG22 ' A' ' 45' ' ' VAL . 4.7 tp10 -90.43 0.5 57.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.549 -1.344 . . . . 0.0 110.978 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -126.94 -8.9 6.02 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.014 -1.054 . . . . 0.0 112.191 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.6 mmt -86.96 -26.23 23.94 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.805 -1.184 . . . . 0.0 110.121 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.526 HG22 ' C ' ' A' ' 41' ' ' VAL . 5.5 p -66.91 164.31 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.377 -0.827 . . . . 0.0 111.827 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.416 ' N ' HG23 ' A' ' 67' ' ' VAL . . . 120.7 -11.89 10.19 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.52 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.69 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 16.3 m-70 -121.72 -84.99 0.66 Allowed 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 119.078 1.439 . . . . 0.0 111.074 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.742 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.1 OUTLIER 178.36 -30.54 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 CA-C-O 121.601 0.715 . . . . 0.0 110.328 -179.496 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.551 ' HB3' ' O ' ' A' ' 70' ' ' LYS . 1.2 pp 173.3 -15.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.703 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.71 -17.4 76.61 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.69 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 3.6 mm-40 . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.276 -1.132 . . . . 0.0 109.202 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.733 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 121.281 0.562 . . . . 0.0 109.951 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.5 p -114.43 121.02 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.733 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 30.9 t70 -48.93 102.88 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.502 -0.749 . . . . 0.0 111.043 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -63.89 -24.24 67.66 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.23 -33.86 76.25 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.617 ' HG ' HD11 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -77.39 -36.81 53.11 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.35 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.617 HD11 ' HG ' ' A' ' 15' ' ' LEU . 4.6 mp -62.38 -41.85 98.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.625 -0.672 . . . . 0.0 109.503 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.11 -23.17 19.51 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.647 -0.658 . . . . 0.0 109.993 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.442 ' HB2' HG22 ' A' ' 31' ' ' ILE . 21.4 mtmm -98.62 -33.13 11.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.431 -0.793 . . . . 0.0 110.489 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.482 HG13 ' HA ' ' A' ' 16' ' ' LEU . 1.5 p -69.73 -40.52 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.231 -0.918 . . . . 0.0 110.426 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.462 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 12.1 mt -63.22 -36.93 85.29 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 177.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.9 -34.04 72.65 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.627 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 29' ' ' ARG . 2.5 mm? -78.77 -26.99 44.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.347 -0.845 . . . . 0.0 109.435 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -81.48 -13.1 58.56 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.577 -0.702 . . . . 0.0 109.752 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.86 -35.39 24.21 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.447 -0.783 . . . . 0.0 109.702 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 17.1 mmtt -89.89 -15.09 32.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.724 -0.61 . . . . 0.0 109.826 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.55 26.25 36.32 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -111.0 144.6 39.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.539 -0.977 . . . . 0.0 110.497 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -111.27 92.99 4.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.502 -0.749 . . . . 0.0 109.611 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.412 ' HB2' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -115.84 -157.19 0.64 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.539 -0.725 . . . . 0.0 110.449 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -112.8 154.04 26.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.538 -0.726 . . . . 0.0 110.364 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.462 HD11 HG22 ' A' ' 19' ' ' VAL . 3.0 mt -131.49 121.84 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.498 -0.751 . . . . 0.0 109.873 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.39 160.02 24.18 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.287 -0.883 . . . . 0.0 110.816 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.508 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 16.5 m -137.31 158.39 44.53 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.659 -0.651 . . . . 0.0 110.181 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.434 ' CD1' ' HE1' ' A' ' 57' ' ' HIS . 20.0 m-90 -145.74 37.01 1.07 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.272 -0.893 . . . . 0.0 110.629 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.41 ' HB3' ' HE1' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -100.21 -155.45 0.51 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.168 -0.958 . . . . 0.0 110.687 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.74 -58.13 2.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.179 -0.95 . . . . 0.0 110.147 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.38 35.26 1.99 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.539 -0.726 . . . . 0.0 109.924 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.5 m -42.19 128.21 3.65 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.338 0.589 . . . . 0.0 111.839 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.654 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 23.7 m -136.94 163.46 30.65 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.674 -0.641 . . . . 0.0 110.308 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.692 HG23 HG12 ' A' ' 62' ' ' ILE . 5.1 mp -85.42 169.73 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.472 -0.768 . . . . 0.0 111.186 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.632 HG22 ' HG3' ' A' ' 44' ' ' MET . 0.1 OUTLIER -137.27 176.26 2.88 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 121.563 -0.711 . . . . 0.0 109.771 178.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.568 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 42.1 Cg_endo -66.57 -29.43 44.14 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.059 1.557 . . . . 0.0 111.334 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HG3' HG12 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -77.75 8.0 5.07 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.479 -0.763 . . . . 0.0 111.392 179.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.632 ' HG3' HG22 ' A' ' 41' ' ' VAL . 2.1 mtt -109.96 19.27 19.21 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.01 -1.056 . . . . 0.0 111.512 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.585 HG23 ' HA ' ' A' ' 64' ' ' GLU . 89.0 t -66.68 7.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 121.088 -1.007 . . . . 0.0 113.352 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.2 32.44 0.95 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 34.8 m-70 -138.78 147.36 42.49 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.277 -1.131 . . . . 0.0 111.243 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -99.63 82.0 2.57 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.604 HG12 ' CD1' ' A' ' 15' ' ' LEU . 2.6 mp -81.61 117.38 27.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.314 -0.866 . . . . 0.0 111.446 -177.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.693 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -76.67 78.01 3.32 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 122.094 0.949 . . . . 0.0 108.813 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.9 m -60.43 131.12 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.775 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.508 ' HB2' ' O ' ' A' ' 33' ' ' THR . 36.2 t80 -78.28 103.95 8.55 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -74.36 7.87 2.59 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.362 -0.836 . . . . 0.0 111.339 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.94 -27.31 5.94 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -140.71 -24.97 0.76 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.84 -0.8 . . . . 0.0 111.522 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -133.64 154.09 51.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.106 -0.996 . . . . 0.0 112.443 -177.668 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.466 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 22.3 m-70 -98.84 100.61 11.82 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.693 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 52.5 t -88.75 104.29 7.13 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.236 -0.915 . . . . 0.0 109.887 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.486 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.6 Cg_endo -66.65 88.75 0.28 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 O-C-N 123.912 1.48 . . . . 0.0 109.501 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.506 HG21 ' O ' ' A' ' 60' ' ' VAL . 13.7 m -94.31 112.44 27.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.327 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 5.9 t80 -72.9 100.0 2.82 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.692 HG12 HG23 ' A' ' 40' ' ' ILE . 2.7 mp -80.82 134.47 27.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.283 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.448 ' C ' HG11 ' A' ' 45' ' ' VAL . 1.9 m -105.19 -150.25 0.43 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 177.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.585 ' HA ' HG23 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -90.01 -3.66 57.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.341 -1.474 . . . . 0.0 111.247 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.4 24.41 4.45 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.917 -1.114 . . . . 0.0 111.44 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.1 mtt -114.82 -31.61 6.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.149 -0.97 . . . . 0.0 110.02 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.499 HG22 ' C ' ' A' ' 41' ' ' VAL . 6.0 p -62.07 163.29 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 O-C-N 121.453 -0.779 . . . . 0.0 111.925 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.449 ' N ' HG23 ' A' ' 67' ' ' VAL . . . 120.91 -9.55 10.42 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.323 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.678 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 17.1 m-70 -122.97 -86.29 0.65 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 119.101 1.45 . . . . 0.0 110.836 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.654 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.54 -30.43 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.495 0.664 . . . . 0.0 110.243 -179.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.534 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 1.4 pp 173.55 -14.05 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.273 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.805 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.37 -17.85 79.08 Favored Glycine 0 N--CA 1.493 2.454 0 O-C-N 120.927 -1.108 . . . . 0.0 110.627 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.678 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 16.7 mm-40 . . . . . 0 N--CA 1.497 1.905 0 O-C-N 121.251 -1.146 . . . . 0.0 109.352 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.702 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.17 0.51 . . . . 0.0 109.746 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.552 ' HA ' ' HB ' ' A' ' 39' ' ' THR . 13.5 p -92.11 108.4 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.702 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 36.2 t70 -48.31 115.74 1.32 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.457 0.646 . . . . 0.0 111.736 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.72 -25.07 62.78 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -63.78 -27.73 69.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.862 -0.524 . . . . 0.0 110.12 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.524 ' HG ' ' N ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -78.74 -36.73 42.77 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.712 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.596 ' HA ' HG11 ' A' ' 19' ' ' VAL . 4.0 mp -62.64 -43.79 97.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.853 -0.529 . . . . 0.0 109.919 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.32 -21.31 23.49 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.666 -0.646 . . . . 0.0 110.593 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -106.27 -23.81 12.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.4 -0.812 . . . . 0.0 111.164 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.596 HG11 ' HA ' ' A' ' 16' ' ' LEU . 1.4 p -86.26 -40.94 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.983 -1.073 . . . . 0.0 111.0 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.482 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 14.1 mt -65.34 -38.16 89.28 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -62.64 -33.84 75.84 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.539 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -78.0 -25.98 48.29 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.291 -0.881 . . . . 0.0 109.456 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -81.56 -12.4 58.8 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.586 -0.696 . . . . 0.0 109.682 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.91 -37.21 27.15 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 121.446 -0.784 . . . . 0.0 109.346 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -86.05 -22.55 27.15 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.64 15.71 51.76 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -95.68 145.03 25.6 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.534 -0.98 . . . . 0.0 110.388 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -110.15 89.39 3.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.517 -0.74 . . . . 0.0 109.557 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -111.77 -155.57 0.57 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.496 -0.752 . . . . 0.0 110.365 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.483 ' HB2' ' HB ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -119.2 154.09 33.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.412 -0.805 . . . . 0.0 110.319 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.52 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 2.7 mp -129.65 121.49 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.495 -0.753 . . . . 0.0 110.18 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.516 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -99.89 153.44 19.16 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.321 -0.862 . . . . 0.0 111.23 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -140.95 166.77 23.88 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.689 -0.632 . . . . 0.0 110.072 179.209 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.469 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 13.6 m-90 -144.89 43.16 1.34 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.639 -0.663 . . . . 0.0 110.508 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.26 -83.35 0.26 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.231 -0.918 . . . . 0.0 110.605 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -179.93 -63.68 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.422 -0.799 . . . . 0.0 110.155 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -101.89 35.94 2.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.466 -0.771 . . . . 0.0 109.616 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.2 m -42.16 113.22 0.41 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.442 0.639 . . . . 0.0 111.578 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.697 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 26.2 m -107.12 159.35 16.39 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.818 -0.551 . . . . 0.0 109.554 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.648 ' CG2' ' HG3' ' A' ' 44' ' ' MET . 1.1 mp -74.47 163.76 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.479 -0.763 . . . . 0.0 111.163 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.644 ' O ' ' SD ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -121.61 179.13 1.02 Allowed Pre-proline 0 N--CA 1.507 2.407 0 O-C-N 121.648 -0.658 . . . . 0.0 109.925 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 50.4 Cg_endo -71.44 -32.49 12.3 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 124.079 1.568 . . . . 0.0 111.346 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -83.98 15.27 3.48 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.445 -0.785 . . . . 0.0 110.573 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.701 ' HG2' ' CG2' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -82.92 -15.7 50.33 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.636 -0.665 . . . . 0.0 112.125 -179.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.501 ' HB ' ' HE3' ' A' ' 44' ' ' MET . 2.4 p -58.31 6.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.41 29.26 1.07 Allowed Glycine 0 N--CA 1.491 2.335 0 O-C-N 119.917 -1.739 . . . . 0.0 110.056 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.529 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 25.4 m-70 -145.93 156.6 43.63 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.998 -1.295 . . . . 0.0 111.539 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.483 ' HB ' ' HB2' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -99.03 78.86 2.3 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 177.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.507 HG12 ' HB ' ' A' ' 31' ' ' ILE . 78.8 mt -78.18 116.79 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.526 -0.734 . . . . 0.0 111.516 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.742 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.85 85.92 5.45 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.6 m -66.77 128.81 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.026 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.46 ' HB2' ' O ' ' A' ' 33' ' ' THR . 27.0 t80 -76.73 105.77 8.0 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.449 -0.782 . . . . 0.0 108.911 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -70.29 -0.85 8.82 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.679 -0.638 . . . . 0.0 110.679 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.9 -19.64 9.49 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -140.1 -28.68 0.73 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.933 -0.745 . . . . 0.0 110.898 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.68 155.2 50.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.187 -0.946 . . . . 0.0 111.977 -178.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.509 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -101.63 111.3 23.5 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.742 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 18.0 t -98.64 94.96 2.7 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.256 -0.902 . . . . 0.0 109.743 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.53 ' HA ' ' CA ' ' A' ' 50' ' ' ALA . 43.6 Cg_endo -69.37 94.9 0.5 Allowed 'Trans proline' 0 N--CA 1.487 1.137 0 O-C-N 123.847 1.446 . . . . 0.0 109.531 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 58' ' ' VAL . 48.6 t -111.93 127.89 68.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.062 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.529 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.9 t80 -72.19 102.34 3.03 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 176.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.701 ' CG2' ' HG2' ' A' ' 44' ' ' MET . 2.8 mp -65.54 -60.48 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -175.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' A' ' 62' ' ' ILE . 4.9 m 71.71 172.17 0.31 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -176.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.3 66.83 3.97 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.856 -1.152 . . . . 0.0 110.396 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -169.54 -24.17 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.398 -0.814 . . . . 0.0 112.625 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.431 ' HB2' HG21 ' A' ' 62' ' ' ILE . 11.0 mtt -110.15 9.12 24.01 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.613 -1.304 . . . . 0.0 112.544 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.617 ' HB ' ' HE1' ' A' ' 44' ' ' MET . 14.2 p -89.33 166.49 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 O-C-N 120.583 -1.323 . . . . 0.0 112.652 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.521 ' N ' HG21 ' A' ' 67' ' ' VAL . . . 105.17 -13.81 48.38 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.557 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 15.2 m-70 -113.43 -90.37 0.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 118.813 1.306 . . . . 0.0 110.478 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.86 -35.36 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 122.306 1.05 . . . . 0.0 109.106 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.539 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -178.67 -13.55 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.027 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.57 -15.64 80.44 Favored Glycine 0 N--CA 1.497 2.704 0 O-C-N 120.829 -1.17 . . . . 0.0 110.286 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.557 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 2.0 mm-40 . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.385 -1.067 . . . . 0.0 108.567 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.739 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.381 0.61 . . . . 0.0 110.293 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.463 HG13 HG12 ' A' ' 41' ' ' VAL . 77.7 t -105.14 114.48 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.739 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 1.8 t0 -44.58 106.29 0.07 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.448 0.642 . . . . 0.0 111.805 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -67.65 -23.35 65.32 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.7 t60 -67.32 -35.7 79.98 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.873 -0.517 . . . . 0.0 109.908 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.719 ' HG ' HD11 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -75.32 -38.24 60.33 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.29 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.719 HD11 ' HG ' ' A' ' 15' ' ' LEU . 2.6 mp -58.78 -43.58 90.45 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.299 0.571 . . . . 0.0 109.639 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.54 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -55.03 -25.75 32.56 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.065 179.315 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HB2' HG22 ' A' ' 31' ' ' ILE . 10.3 mmtm -97.12 -31.95 12.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.479 -0.763 . . . . 0.0 111.034 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.577 HG22 HD13 ' A' ' 49' ' ' ILE . 3.6 p -74.07 -38.03 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 120.997 -1.064 . . . . 0.0 111.271 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.54 HD22 ' HA ' ' A' ' 17' ' ' GLU . 3.6 pp -62.69 -25.03 67.95 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.75 -35.28 72.58 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.406 HD11 ' HA ' ' A' ' 22' ' ' LEU . 3.4 mm? -72.33 -27.49 62.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.623 -0.673 . . . . 0.0 109.585 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -83.17 -16.13 47.85 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.588 -0.695 . . . . 0.0 109.792 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.8 -36.99 23.12 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 121.577 -0.702 . . . . 0.0 109.57 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -88.03 -21.07 24.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.674 -0.641 . . . . 0.0 109.35 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.01 17.26 59.7 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -93.28 149.15 21.44 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.38 -1.071 . . . . 0.0 110.593 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -110.74 96.57 6.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.549 -0.72 . . . . 0.0 109.756 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 ttt85 -126.73 -155.53 0.69 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.532 -0.73 . . . . 0.0 110.353 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -116.99 155.79 28.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.5 -0.75 . . . . 0.0 110.469 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.512 ' HB ' HD12 ' A' ' 49' ' ' ILE . 3.2 mp -132.05 112.98 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.614 -0.679 . . . . 0.0 109.536 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.13 148.35 26.38 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.386 -0.821 . . . . 0.0 110.897 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 14.3 t -141.09 174.87 10.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.679 -0.638 . . . . 0.0 110.171 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.45 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 10.0 m-90 -143.8 47.13 1.45 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.145 -0.972 . . . . 0.0 111.666 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 t -88.96 -84.25 0.21 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.718 -1.239 . . . . 0.0 111.077 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.54 -88.83 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.02 -1.05 . . . . 0.0 111.36 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.547 ' HD2' ' HB3' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -97.4 52.83 1.13 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.209 -0.932 . . . . 0.0 109.975 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.499 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 0.4 OUTLIER -39.11 138.12 0.63 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.264 0.554 . . . . 0.0 112.363 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 24.4 m -129.2 159.21 36.76 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.529 -0.732 . . . . 0.0 110.133 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.682 HG22 ' SD ' ' A' ' 44' ' ' MET . 1.2 mp -78.99 159.55 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 121.541 -0.725 . . . . 0.0 111.604 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.491 HG23 ' HE2' ' A' ' 44' ' ' MET . 0.0 OUTLIER -133.64 171.23 9.46 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 42.6 Cg_endo -67.16 -31.79 35.42 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.133 1.596 . . . . 0.0 110.493 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.44 ' HG3' ' CG1' ' A' ' 19' ' ' VAL . 6.5 pt-20 -75.24 -1.97 25.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.53 -0.731 . . . . 0.0 111.025 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.682 ' SD ' HG22 ' A' ' 40' ' ' ILE . 1.4 ptp -114.98 16.7 17.11 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.897 -1.127 . . . . 0.0 110.886 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.57 ' CG1' ' HG3' ' A' ' 64' ' ' GLU . 2.6 t -68.27 6.5 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.358 -0.839 . . . . 0.0 112.782 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.77 35.79 0.92 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.518 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 54.2 m-70 -140.24 159.2 42.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.501 -0.999 . . . . 0.0 110.488 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.08 82.47 2.73 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 178.382 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.577 HD13 HG22 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -83.51 115.82 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.495 -0.753 . . . . 0.0 111.55 -176.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.735 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -77.99 81.6 4.38 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.499 ' HB ' ' HB3' ' A' ' 38' ' ' SER . 33.0 m -66.19 132.66 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.581 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 33' ' ' THR . 23.8 t80 -72.44 104.35 3.77 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -70.7 -0.23 8.39 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.51 -0.744 . . . . 0.0 110.488 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.6 -21.79 8.43 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.12 -30.0 0.69 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 122.009 -0.701 . . . . 0.0 110.633 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.89 156.47 48.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.309 -0.869 . . . . 0.0 111.737 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.433 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -102.41 101.74 12.0 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.178 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.735 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 14.6 m -91.39 105.56 13.26 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.152 -0.967 . . . . 0.0 110.335 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.501 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 43.0 Cg_endo -68.7 88.88 0.42 Allowed 'Trans proline' 0 N--CA 1.49 1.276 0 O-C-N 123.91 1.479 . . . . 0.0 109.163 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.493 HG21 ' O ' ' A' ' 58' ' ' VAL . 58.2 t -98.18 119.17 45.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.485 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 2.3 t80 -70.97 101.54 2.2 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 118.85 -1.14 . . . . 0.0 107.95 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.66 HD11 ' SD ' ' A' ' 44' ' ' MET . 3.2 mp -80.75 138.34 19.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.638 -0.664 . . . . 0.0 110.566 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.441 ' C ' HG11 ' A' ' 45' ' ' VAL . 60.8 p -98.71 -161.23 0.86 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 177.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.57 ' HG3' ' CG1' ' A' ' 45' ' ' VAL . 0.6 OUTLIER -85.29 5.79 28.98 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.823 -1.173 . . . . 0.0 111.081 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -128.57 -11.53 5.0 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.739 -1.226 . . . . 0.0 113.053 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.549 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 9.0 mtt -88.37 -5.59 58.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.519 -1.363 . . . . 0.0 110.618 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 68' ' ' GLY . 9.0 p -81.79 165.19 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.073 -1.017 . . . . 0.0 111.535 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.481 ' N ' HG23 ' A' ' 67' ' ' VAL . . . 109.05 -18.16 31.4 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.578 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 16.5 m-70 -115.89 -86.14 0.62 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -1.204 . . . . 0.0 110.695 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.37 -35.09 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 122.215 1.007 . . . . 0.0 109.291 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 179.63 -16.08 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.864 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.78 -15.1 73.43 Favored Glycine 0 N--CA 1.497 2.715 0 O-C-N 120.889 -1.132 . . . . 0.0 110.458 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.578 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 1.6 mm-40 . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.362 -1.081 . . . . 0.0 108.805 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.552 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 121.197 0.523 . . . . 0.0 109.964 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.434 HG13 HG12 ' A' ' 41' ' ' VAL . 56.0 t -110.22 124.19 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.617 ' HB2' HG22 ' A' ' 33' ' ' THR . 0.8 OUTLIER -45.1 107.14 0.09 Allowed 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.375 0.607 . . . . 0.0 111.427 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.78 -27.02 64.57 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.78 -15.81 63.62 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.943 -0.473 . . . . 0.0 110.171 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.609 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -84.36 -39.08 19.52 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.466 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.569 ' HA ' HG11 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -69.07 -43.79 73.9 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.605 -0.685 . . . . 0.0 110.714 179.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -53.93 -19.39 4.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.446 -0.784 . . . . 0.0 110.885 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HE3' HG21 ' A' ' 31' ' ' ILE . 2.1 mtmt -112.49 -33.6 6.11 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.261 -0.9 . . . . 0.0 111.134 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.628 HG13 ' CE ' ' A' ' 44' ' ' MET . 1.1 p -73.73 -39.69 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.081 -1.012 . . . . 0.0 111.591 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.498 HD13 ' HB3' ' A' ' 16' ' ' LEU . 18.1 mt -60.11 -37.88 81.33 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.07 -40.24 92.92 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.593 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.504 HD21 ' CB ' ' A' ' 27' ' ' GLU . 1.1 mt -71.92 -26.63 62.38 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.272 -0.892 . . . . 0.0 110.289 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -80.66 -10.75 59.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.558 -0.714 . . . . 0.0 109.636 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.98 -35.62 15.43 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.482 -0.761 . . . . 0.0 110.172 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.447 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -102.39 -25.89 13.48 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.547 -0.721 . . . . 0.0 109.793 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.55 29.49 12.06 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.504 ' CB ' HD21 ' A' ' 22' ' ' LEU . 5.0 mm-40 -80.14 149.37 30.58 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.446 -1.032 . . . . 0.0 110.351 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -111.8 86.0 2.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.579 -0.701 . . . . 0.0 109.953 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -136.34 -160.13 1.02 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.484 -0.76 . . . . 0.0 110.53 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -119.52 156.69 29.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.649 -0.657 . . . . 0.0 110.206 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.609 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 2.7 mp -124.79 123.39 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.37 -0.831 . . . . 0.0 109.75 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.402 ' HE3' HD12 ' A' ' 30' ' ' LEU . 1.1 mptt -98.28 151.15 20.79 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.246 -0.909 . . . . 0.0 111.137 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.617 HG22 ' HB2' ' A' ' 12' ' ' ASP . 18.4 m -136.15 162.47 32.86 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.652 -0.655 . . . . 0.0 109.584 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.428 ' CD1' ' NE2' ' A' ' 57' ' ' HIS . 27.9 m-90 -141.44 38.36 1.7 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.279 -0.888 . . . . 0.0 110.768 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.7 m -82.82 -101.23 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.208 -0.932 . . . . 0.0 110.566 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.43 -68.69 0.12 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.041 -1.037 . . . . 0.0 109.756 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.488 ' HG2' ' HD1' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -106.48 50.76 0.76 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.777 0.799 . . . . 0.0 108.857 178.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.429 ' OG ' ' HB3' ' A' ' 12' ' ' ASP . 22.4 m -47.86 111.01 0.37 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.302 0.572 . . . . 0.0 111.905 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 69' ' ' HIS . 28.7 m -105.43 155.84 18.76 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.693 -0.63 . . . . 0.0 109.597 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.607 HG22 HG12 ' A' ' 62' ' ' ILE . 4.4 mp -77.82 167.87 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.145 -0.972 . . . . 0.0 111.297 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.607 ' CG1' ' HD2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -137.5 176.73 2.53 Favored Pre-proline 0 N--CA 1.501 2.081 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.142 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.607 ' HD2' ' CG1' ' A' ' 41' ' ' VAL . 45.1 Cg_endo -68.42 -35.18 18.66 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.889 1.468 . . . . 0.0 111.335 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.504 ' HB2' ' HE3' ' A' ' 44' ' ' MET . 0.8 OUTLIER -66.0 -9.93 34.82 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.461 -0.775 . . . . 0.0 110.677 179.099 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.628 ' CE ' HG13 ' A' ' 19' ' ' VAL . 4.0 mmt -88.14 0.93 55.44 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.348 -0.845 . . . . 0.0 111.323 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 42' ' ' PRO . 5.6 p -54.98 -2.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.18 34.66 1.19 Allowed Glycine 0 N--CA 1.492 2.426 0 O-C-N 120.43 -1.419 . . . . 0.0 109.605 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.483 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 56.1 m-70 -142.54 150.94 41.09 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.304 -1.115 . . . . 0.0 111.127 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.553 HG22 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.75 81.41 2.46 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.15 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.58 HG12 ' CD1' ' A' ' 15' ' ' LEU . 3.0 mt -85.54 121.88 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 111.654 -176.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.734 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.85 82.48 5.05 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 122.102 0.953 . . . . 0.0 108.888 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.2 m -63.0 127.52 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.542 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.511 ' HB2' ' O ' ' A' ' 33' ' ' THR . 20.2 t80 -71.71 104.29 3.33 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -70.68 -1.43 11.32 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.557 -0.715 . . . . 0.0 110.553 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.29 -21.05 8.84 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -140.18 -29.75 0.69 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.882 -0.775 . . . . 0.0 110.82 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.41 155.67 49.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.332 -0.855 . . . . 0.0 111.928 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.428 ' NE2' ' CD1' ' A' ' 34' ' ' TRP . 6.0 m80 -102.51 103.99 14.38 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.734 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 28.7 t -93.55 102.78 8.28 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.3 -0.875 . . . . 0.0 110.106 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.501 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.5 Cg_endo -66.59 89.32 0.28 Allowed 'Trans proline' 0 N--CA 1.492 1.404 0 O-C-N 123.878 1.462 . . . . 0.0 109.195 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 58' ' ' VAL . 48.1 t -97.57 118.68 44.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.201 -178.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.553 ' HB2' HG22 ' A' ' 48' ' ' THR . 2.6 t80 -73.19 103.9 4.06 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.607 HG12 HG22 ' A' ' 40' ' ' ILE . 2.7 mp -84.45 144.82 9.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.675 0.75 . . . . 0.0 111.64 -178.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.9 p -111.03 -158.71 0.65 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -90.59 15.14 11.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.588 -1.32 . . . . 0.0 110.997 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -137.95 -13.47 1.43 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.919 -1.113 . . . . 0.0 112.527 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 28.3 mmt -88.04 -24.97 23.32 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.605 -1.309 . . . . 0.0 110.327 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.549 HG23 ' C ' ' A' ' 41' ' ' VAL . 4.2 p -66.61 163.45 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.388 -0.82 . . . . 0.0 111.437 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.539 ' N ' HG21 ' A' ' 67' ' ' VAL . . . 118.17 -14.79 12.23 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.113 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.635 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 21.5 m-70 -127.21 -81.14 0.6 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.965 -1.315 . . . . 0.0 111.497 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.559 ' HD2' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER 177.42 -31.97 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.717 0.77 . . . . 0.0 110.268 -179.264 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.559 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 0.7 OUTLIER 173.82 -16.0 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.757 -179.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.53 -18.02 73.29 Favored Glycine 0 N--CA 1.496 2.639 0 O-C-N 120.946 -1.096 . . . . 0.0 110.503 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.635 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 1.3 mt-10 . . . . . 0 N--CA 1.497 1.903 0 O-C-N 121.407 -1.054 . . . . 0.0 109.124 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.781 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.432 HG12 HG23 ' A' ' 41' ' ' VAL . 69.4 t -101.83 112.05 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.781 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 39.0 t70 -44.68 106.52 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.145 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -67.87 -24.2 65.21 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -66.22 -25.61 66.99 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.942 -0.474 . . . . 0.0 109.91 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.587 ' HG ' ' N ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -79.76 -38.16 33.81 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.587 ' N ' ' HG ' ' A' ' 15' ' ' LEU . 5.0 mp -62.58 -42.3 99.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.796 -0.565 . . . . 0.0 109.923 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.66 -30.76 22.98 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.136 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.57 ' HB2' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -91.77 -27.99 17.67 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.464 -0.772 . . . . 0.0 110.602 179.524 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.543 HG12 ' SD ' ' A' ' 44' ' ' MET . 93.9 t -73.62 -40.16 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.15 -0.969 . . . . 0.0 111.186 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 16' ' ' LEU . 10.9 mt -60.93 -36.43 79.29 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.18 -36.09 83.12 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.051 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.424 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 2.9 mm? -77.63 -26.57 50.65 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.258 -0.901 . . . . 0.0 109.666 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -81.96 -12.48 58.34 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.623 -0.673 . . . . 0.0 109.757 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.59 -34.53 27.65 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.417 -0.802 . . . . 0.0 109.512 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 25' ' ' LYS . 16.3 mmtt -93.11 -15.87 25.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.773 -0.579 . . . . 0.0 109.8 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.21 28.99 34.97 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -106.48 148.74 27.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.649 -0.912 . . . . 0.0 110.705 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 mtmm -113.36 90.81 3.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.586 -0.696 . . . . 0.0 109.97 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.9 ttt-85 -113.5 -158.32 0.65 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.459 -0.776 . . . . 0.0 110.305 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.0 OUTLIER -116.19 148.39 40.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.574 -0.704 . . . . 0.0 110.274 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.57 HG22 ' HB2' ' A' ' 18' ' ' LYS . 3.2 mp -121.83 118.75 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.594 -0.691 . . . . 0.0 109.552 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.502 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . 20.5 mmmt -78.9 152.93 30.89 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.453 -0.779 . . . . 0.0 111.029 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 24.1 m -139.69 153.16 47.18 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.589 -0.694 . . . . 0.0 109.778 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.426 ' CZ2' ' CB ' ' A' ' 32' ' ' LYS . 9.7 m-90 -145.3 36.44 1.1 Allowed 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.22 -0.925 . . . . 0.0 111.6 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 m -86.86 -95.97 0.08 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.764 -1.21 . . . . 0.0 110.361 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -173.99 -63.02 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.191 -0.943 . . . . 0.0 109.464 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.406 ' HG3' ' HB3' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -102.24 36.85 2.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.591 -0.693 . . . . 0.0 109.212 178.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.2 m -48.29 144.48 3.91 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.515 0.674 . . . . 0.0 111.77 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.679 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 52.3 m -133.81 160.19 38.36 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.273 0.558 . . . . 0.0 109.678 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.742 ' CG2' HG12 ' A' ' 62' ' ' ILE . 1.2 mp -83.41 164.78 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.632 -0.668 . . . . 0.0 111.846 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.638 HG21 ' CG ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -134.15 174.21 4.92 Favored Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.787 -0.57 . . . . 0.0 109.466 178.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.575 ' HD2' ' CG1' ' A' ' 41' ' ' VAL . 46.0 Cg_endo -68.92 -34.65 17.07 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 124.0 1.526 . . . . 0.0 111.581 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.518 ' HB3' HG13 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -68.42 -6.54 25.26 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.408 -0.808 . . . . 0.0 110.742 179.331 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.656 ' SD ' HD12 ' A' ' 49' ' ' ILE . 6.6 mmt -86.31 -6.29 58.99 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.365 -0.835 . . . . 0.0 111.658 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.447 ' HA ' HG23 ' A' ' 62' ' ' ILE . 6.0 p -51.51 1.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.406 ' C ' ' CG ' ' A' ' 47' ' ' HIS . . . -146.27 33.19 1.48 Allowed Glycine 0 N--CA 1.495 2.575 0 O-C-N 119.93 -1.731 . . . . 0.0 110.071 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.436 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 21.8 m-70 -147.66 153.98 40.03 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.106 -1.232 . . . . 0.0 111.181 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -99.64 88.76 3.92 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 177.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.656 HD12 ' SD ' ' A' ' 44' ' ' MET . 22.9 mt -86.24 121.94 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.565 -176.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.732 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.16 78.05 5.64 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.3 m -62.39 128.67 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.643 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 35.3 t80 -75.67 105.48 6.73 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -76.08 8.35 3.31 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.368 -0.833 . . . . 0.0 111.221 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.71 -27.11 6.06 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.49 -24.03 0.79 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.819 -0.812 . . . . 0.0 111.596 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -135.76 154.17 51.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.019 -1.051 . . . . 0.0 112.411 -177.655 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.453 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -100.19 105.2 16.77 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.732 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 23.4 t -94.1 101.26 6.04 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.146 -0.971 . . . . 0.0 109.935 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.516 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.8 Cg_endo -67.72 93.08 0.37 Allowed 'Trans proline' 0 N--CA 1.489 1.25 0 O-C-N 123.955 1.503 . . . . 0.0 109.697 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.517 ' O ' HD13 ' A' ' 62' ' ' ILE . 16.4 m -109.38 129.07 64.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.829 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 2.8 t80 -71.35 105.8 3.64 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.742 HG12 ' CG2' ' A' ' 40' ' ' ILE . 1.6 mp -57.97 -63.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 3.0 m 66.3 171.33 0.24 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -176.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -83.84 58.58 4.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.372 -1.455 . . . . 0.0 109.26 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -161.25 -36.86 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.306 -0.871 . . . . 0.0 112.181 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.478 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -88.24 -15.98 34.46 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.87 -1.144 . . . . 0.0 111.146 -179.087 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.603 HG21 ' N ' ' A' ' 68' ' ' GLY . 7.5 p -73.66 161.73 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.099 -1.0 . . . . 0.0 112.138 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.603 ' N ' HG21 ' A' ' 67' ' ' VAL . . . 113.56 -19.3 19.39 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.597 ' CG ' ' HG3' ' A' ' 73' ' ' GLU . 17.0 m-70 -114.9 -84.44 0.61 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.077 -1.249 . . . . 0.0 110.483 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.679 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.19 -34.67 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 122.042 0.925 . . . . 0.0 109.846 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.488 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 0.5 OUTLIER 176.88 -14.26 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.856 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.41 -15.58 72.89 Favored Glycine 0 N--CA 1.496 2.668 0 O-C-N 120.9 -1.125 . . . . 0.0 110.313 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.597 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 1.1 mt-10 . . . . . 0 N--CA 1.497 1.897 0 O-C-N 121.336 -1.097 . . . . 0.0 109.037 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.742 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.274 0.559 . . . . 0.0 109.888 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.456 HG23 HG12 ' A' ' 41' ' ' VAL . 7.2 p -108.8 113.98 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.742 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 38.8 t70 -41.96 109.23 0.12 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.716 -0.615 . . . . 0.0 111.682 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -68.52 -24.57 64.67 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.524 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 1.7 t-80 -65.57 -20.64 66.41 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.908 -0.495 . . . . 0.0 110.3 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HG ' ' N ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -85.32 -38.43 18.81 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.133 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.604 ' N ' ' HG ' ' A' ' 15' ' ' LEU . 4.7 mp -63.82 -43.13 97.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.83 -0.544 . . . . 0.0 110.26 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.601 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -57.31 -19.15 20.39 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.756 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.426 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 42.0 mttm -102.56 -29.02 11.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.356 -0.84 . . . . 0.0 110.657 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.661 HG23 ' SD ' ' A' ' 44' ' ' MET . 1.7 p -79.55 -36.21 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.154 -0.966 . . . . 0.0 111.479 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.601 HD22 ' HA ' ' A' ' 17' ' ' GLU . 3.8 pp -62.82 -25.66 68.36 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -34.34 63.36 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.674 HD21 ' HB2' ' A' ' 27' ' ' GLU . 1.2 mt -76.27 -27.43 56.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.796 -0.565 . . . . 0.0 109.567 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -84.16 -13.82 51.83 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.613 -0.679 . . . . 0.0 109.676 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.51 -37.94 15.35 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 121.55 -0.718 . . . . 0.0 109.955 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -97.01 -23.97 16.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.575 -0.703 . . . . 0.0 109.654 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.44 25.89 19.71 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.674 ' HB2' HD21 ' A' ' 22' ' ' LEU . 24.9 mt-10 -72.18 125.58 27.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.471 -1.017 . . . . 0.0 110.258 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.18 94.88 9.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.552 -0.717 . . . . 0.0 110.225 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.1 ttp85 -149.59 -160.93 1.24 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.519 -0.738 . . . . 0.0 110.312 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.596 ' HB2' ' HB ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -119.71 165.07 15.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.585 -0.697 . . . . 0.0 110.455 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.64 ' HB ' HG12 ' A' ' 49' ' ' ILE . 36.3 mm -112.57 159.92 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.321 -0.862 . . . . 0.0 109.026 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.48 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -125.5 153.41 43.61 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.288 -0.883 . . . . 0.0 110.839 -178.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.448 HG21 ' CG ' ' A' ' 12' ' ' ASP . 20.0 m -139.84 154.17 47.25 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.588 -0.695 . . . . 0.0 110.712 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.48 ' CH2' ' HB2' ' A' ' 32' ' ' LYS . 16.6 m-90 -146.49 34.19 0.96 Allowed 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.433 -0.792 . . . . 0.0 111.224 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.69 -93.56 0.11 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.864 -1.148 . . . . 0.0 110.989 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.5 ttp85 -170.02 -66.49 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.194 -0.941 . . . . 0.0 109.287 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.57 ' HD2' ' HB3' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -104.43 44.0 1.06 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.247 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.408 ' OG ' ' CG2' ' A' ' 33' ' ' THR . 19.5 m -56.21 153.08 9.86 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.555 0.693 . . . . 0.0 112.317 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.682 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 40.9 m -140.38 162.21 35.86 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.878 -0.514 . . . . 0.0 110.055 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.688 HG23 HG12 ' A' ' 62' ' ' ILE . 4.8 mp -81.81 170.29 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 O-C-N 121.291 -0.881 . . . . 0.0 111.094 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.659 HG21 ' CG ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -132.1 175.2 3.88 Favored Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.744 -0.597 . . . . 0.0 109.74 179.073 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.556 ' HD2' ' CG1' ' A' ' 41' ' ' VAL . 47.0 Cg_endo -70.17 -32.7 16.37 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 124.096 1.577 . . . . 0.0 111.539 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.578 ' HG3' ' CG1' ' A' ' 19' ' ' VAL . 2.0 pt-20 -72.33 -3.43 23.81 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.275 -0.891 . . . . 0.0 110.957 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.661 ' SD ' HG23 ' A' ' 19' ' ' VAL . 23.5 mmm -91.1 15.65 11.27 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.296 -0.878 . . . . 0.0 112.231 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.567 HG23 ' HA ' ' A' ' 64' ' ' GLU . 66.0 t -64.73 4.49 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 O-C-N 120.947 -1.096 . . . . 0.0 113.129 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.35 29.84 1.07 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.498 ' HB2' ' HE2' ' A' ' 44' ' ' MET . 20.0 m-70 -139.09 150.71 46.03 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.377 -1.072 . . . . 0.0 110.701 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.65 86.31 3.31 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.139 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.64 HG12 ' HB ' ' A' ' 31' ' ' ILE . 58.3 mt -72.53 117.79 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.17 -0.956 . . . . 0.0 111.298 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.651 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.91 73.99 6.66 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.2 m -56.27 126.29 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.305 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 29.0 t80 -76.93 101.99 6.19 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -74.55 9.97 1.54 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.485 -0.76 . . . . 0.0 111.065 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.67 -27.86 6.12 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.75 -25.85 0.75 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.837 -0.802 . . . . 0.0 111.602 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -130.74 153.89 48.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.149 -0.969 . . . . 0.0 112.377 -177.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.499 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 2.3 m80 -99.74 99.19 9.98 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.651 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 46.5 t -86.57 104.73 6.22 Favored Pre-proline 0 N--CA 1.501 2.102 0 O-C-N 121.215 -0.928 . . . . 0.0 109.505 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 57' ' ' HIS . 42.7 Cg_endo -67.08 90.68 0.31 Allowed 'Trans proline' 0 N--CA 1.489 1.258 0 O-C-N 123.892 1.47 . . . . 0.0 110.251 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.42 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 35.6 m -95.83 111.36 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.39 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 2.2 t80 -72.59 104.46 3.88 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.015 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.688 HG12 HG23 ' A' ' 40' ' ' ILE . 2.7 mp -85.59 127.98 39.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.578 -0.701 . . . . 0.0 111.324 -178.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.435 ' C ' HG11 ' A' ' 45' ' ' VAL . 46.3 p -92.71 -153.28 0.34 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.567 ' HA ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -87.97 8.0 28.44 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.711 -1.243 . . . . 0.0 111.196 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -147.64 21.11 1.16 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.959 -1.088 . . . . 0.0 111.775 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 7.8 mmt -107.61 -26.51 10.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.235 -0.916 . . . . 0.0 109.804 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.46 HG22 ' C ' ' A' ' 41' ' ' VAL . 6.8 p -65.36 163.7 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 121.469 -0.769 . . . . 0.0 111.691 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.436 ' N ' HG23 ' A' ' 67' ' ' VAL . . . 122.42 -10.2 9.28 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.397 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.668 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 17.4 m-70 -123.82 -86.26 0.64 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.128 1.464 . . . . 0.0 110.983 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.682 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.31 -30.29 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.556 0.693 . . . . 0.0 110.308 -179.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.524 ' HB3' ' O ' ' A' ' 70' ' ' LYS . 0.8 OUTLIER 174.27 -15.21 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.769 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.65 -18.46 78.65 Favored Glycine 0 N--CA 1.495 2.606 0 O-C-N 120.929 -1.107 . . . . 0.0 110.633 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.668 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 22.2 mm-40 . . . . . 0 N--CA 1.497 1.878 0 O-C-N 121.22 -1.165 . . . . 0.0 109.349 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.756 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.288 0.566 . . . . 0.0 110.075 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.46 ' HA ' ' HB ' ' A' ' 39' ' ' THR . 7.5 p -101.83 115.68 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 178.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.756 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 27.8 t70 -46.34 107.06 0.09 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.476 0.655 . . . . 0.0 111.303 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -69.6 -24.48 63.67 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -64.67 -28.45 69.61 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.809 -0.557 . . . . 0.0 109.841 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.577 ' HG ' HD13 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -77.25 -37.72 52.53 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.577 HD13 ' HG ' ' A' ' 15' ' ' LEU . 4.1 mp -60.47 -47.29 86.78 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.171 0.51 . . . . 0.0 109.736 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.1 -23.06 4.79 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.648 -0.657 . . . . 0.0 110.722 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.544 ' HB2' HG22 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -104.28 -25.27 12.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.331 -0.855 . . . . 0.0 110.679 179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.531 HG11 ' HA ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -79.81 -36.14 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.268 -0.895 . . . . 0.0 110.841 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 16' ' ' LEU . 9.2 mt -63.74 -36.53 84.17 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 178.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.93 -34.35 75.93 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.566 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.544 ' HG ' ' HB3' ' A' ' 27' ' ' GLU . 1.5 mp -79.0 -27.1 43.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.543 -0.723 . . . . 0.0 109.578 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -84.33 -11.22 56.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.567 -0.708 . . . . 0.0 109.408 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.73 -41.37 11.94 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.619 -0.676 . . . . 0.0 110.396 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -99.44 -27.06 13.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.371 -0.831 . . . . 0.0 110.076 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.455 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . 105.24 27.51 5.84 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.544 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -79.49 135.85 36.75 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.397 -1.06 . . . . 0.0 110.268 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -114.14 61.84 0.66 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.626 -0.671 . . . . 0.0 109.508 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -109.33 -154.8 0.54 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.504 -0.747 . . . . 0.0 110.187 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.514 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -117.59 156.43 28.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.453 -0.78 . . . . 0.0 110.637 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 18' ' ' LYS . 3.5 mt -127.71 114.5 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.44 153.04 25.56 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.293 -0.879 . . . . 0.0 111.203 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 15.3 t -144.75 -173.39 4.05 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.473 -0.767 . . . . 0.0 111.067 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.617 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 19.4 m-90 -139.68 39.33 2.02 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.182 -0.949 . . . . 0.0 111.633 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.01 -99.35 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.726 -1.234 . . . . 0.0 110.402 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.31 -62.41 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.935 -1.103 . . . . 0.0 109.684 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HG2' ' HD2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -106.19 38.35 2.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.541 -0.724 . . . . 0.0 109.242 178.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.506 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 1.1 m -41.5 114.97 0.57 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.335 0.588 . . . . 0.0 111.616 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 25.9 m -106.71 161.94 14.21 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.536 -0.728 . . . . 0.0 110.436 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.58 HG22 ' CG2' ' A' ' 62' ' ' ILE . 1.2 mp -83.91 168.06 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.472 -0.767 . . . . 0.0 111.904 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.618 HG22 ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -140.2 174.01 4.44 Favored Pre-proline 0 N--CA 1.501 2.109 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.301 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.507 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 42.3 Cg_endo -66.03 -30.61 47.52 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.923 1.486 . . . . 0.0 110.823 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -73.51 -4.68 35.37 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.584 -0.698 . . . . 0.0 110.948 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.618 ' SD ' HG22 ' A' ' 41' ' ' VAL . 51.4 mtp -97.27 2.53 50.91 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.115 -0.991 . . . . 0.0 111.033 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 42' ' ' PRO . 7.6 p -59.97 3.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.09 33.49 1.03 Allowed Glycine 0 N--CA 1.493 2.476 0 O-C-N 120.208 -1.558 . . . . 0.0 110.144 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.569 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 38.0 m-70 -145.51 156.34 43.65 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.219 -1.165 . . . . 0.0 111.048 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.549 HG22 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.87 86.25 3.25 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.514 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.592 ' CD1' ' HG2' ' A' ' 44' ' ' MET . 3.1 mp -91.87 117.84 36.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.18 -0.95 . . . . 0.0 111.556 -177.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.757 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.21 89.16 4.88 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 122.162 0.982 . . . . 0.0 109.311 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 38' ' ' SER . 26.2 m -66.39 127.43 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.131 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.617 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 26.1 t80 -70.01 108.49 4.07 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.174 -1.011 . . . . 0.0 108.911 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -75.92 16.57 0.4 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.666 -0.646 . . . . 0.0 110.322 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.93 -28.87 13.01 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -140.56 -26.76 0.74 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.528 -0.983 . . . . 0.0 111.14 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -127.74 156.52 42.29 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 76.8 m-70 -95.51 120.01 35.01 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.757 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 16.9 t -109.43 85.32 3.55 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.162 -0.961 . . . . 0.0 109.194 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.541 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.6 Cg_endo -67.6 85.57 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.348 0 O-C-N 123.852 1.448 . . . . 0.0 109.312 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 58' ' ' VAL . 50.5 t -99.46 123.12 51.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.844 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.549 ' HB2' HG22 ' A' ' 48' ' ' THR . 4.1 t80 -72.53 102.28 3.2 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.585 ' HB ' ' O ' ' A' ' 44' ' ' MET . 3.0 mp -80.87 140.76 16.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.843 0.83 . . . . 0.0 111.769 -177.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.5 p -105.51 -158.83 0.68 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.431 ' HB2' HG22 ' A' ' 45' ' ' VAL . 4.2 tp10 -90.55 7.43 39.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.708 -1.245 . . . . 0.0 111.244 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.423 ' ND2' ' HG3' ' A' ' 66' ' ' MET . 2.4 p-10 -127.33 -17.82 4.62 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.723 -1.235 . . . . 0.0 112.625 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.465 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 26.3 mtt -86.1 -17.95 33.69 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.625 -1.297 . . . . 0.0 110.399 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.565 HG21 ' N ' ' A' ' 68' ' ' GLY . 7.6 p -71.49 162.75 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.248 -0.908 . . . . 0.0 111.316 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.565 ' N ' HG21 ' A' ' 67' ' ' VAL . . . 114.31 -16.94 19.52 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.61 ' CG ' ' HG3' ' A' ' 73' ' ' GLU . 18.0 m-70 -120.5 -81.94 0.64 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.11 -1.229 . . . . 0.0 110.744 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.54 -34.72 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.03 0.919 . . . . 0.0 109.747 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.471 ' HB3' ' O ' ' A' ' 70' ' ' LYS . 0.7 OUTLIER 176.37 -15.29 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.195 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.926 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.52 -16.46 71.73 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 120.985 -1.072 . . . . 0.0 110.537 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.61 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 1.2 mt-10 . . . . . 0 N--CA 1.497 1.913 0 O-C-N 121.328 -1.101 . . . . 0.0 109.099 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.77 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 121.268 0.556 . . . . 0.0 109.849 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.556 ' CG2' HG23 ' A' ' 41' ' ' VAL . 12.5 p -111.71 117.15 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.536 -0.728 . . . . 0.0 109.052 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.77 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 37.2 t70 -46.43 105.2 0.06 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.507 -0.745 . . . . 0.0 111.422 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -67.1 -23.29 65.82 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -66.46 -26.67 67.31 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.899 -0.501 . . . . 0.0 109.955 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.677 HD13 HG22 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -81.37 -39.19 25.42 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.458 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.634 HD13 ' HG ' ' A' ' 15' ' ' LEU . 5.1 mp -62.22 -41.58 98.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.843 -0.536 . . . . 0.0 109.672 178.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.8 -30.88 6.2 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.741 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 0.9 OUTLIER -90.33 -30.89 17.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.529 -0.732 . . . . 0.0 110.327 179.058 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.677 HG22 HD13 ' A' ' 15' ' ' LEU . 71.8 t -72.63 -36.05 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.264 -0.897 . . . . 0.0 111.689 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 16' ' ' LEU . 12.2 mt -61.28 -37.66 83.96 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 18' ' ' LYS . 3.0 tm-20 -63.2 -39.74 95.51 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.322 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.55 HD11 ' HA ' ' A' ' 19' ' ' VAL . 3.6 mt -74.08 -22.08 59.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.274 -0.891 . . . . 0.0 110.091 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -83.43 -12.33 56.53 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.374 -0.829 . . . . 0.0 109.585 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.49 -39.18 16.53 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.447 -0.783 . . . . 0.0 109.757 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.424 ' HE3' ' HG2' ' A' ' 21' ' ' GLU . 65.3 mttt -97.52 -32.97 11.54 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.457 0.646 . . . . 0.0 109.325 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.74 19.53 19.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.527 ' CB ' HD21 ' A' ' 22' ' ' LEU . 28.8 mt-10 -71.22 140.36 50.42 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.509 -0.995 . . . . 0.0 110.351 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -110.73 76.84 1.0 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.475 -0.766 . . . . 0.0 109.762 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.83 -155.79 0.58 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.512 -0.742 . . . . 0.0 110.418 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -115.51 167.97 10.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.568 -0.707 . . . . 0.0 110.316 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.502 HG13 HG21 ' A' ' 19' ' ' VAL . 45.3 mm -126.72 157.99 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.438 -0.789 . . . . 0.0 109.79 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -120.74 130.67 54.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.548 -0.72 . . . . 0.0 110.319 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 18.2 m -119.54 159.82 23.6 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.572 -0.705 . . . . 0.0 110.318 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 19.3 m-90 -145.02 16.57 1.56 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.314 -0.866 . . . . 0.0 111.819 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.62 -152.72 0.07 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.918 -1.114 . . . . 0.0 110.785 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.78 -61.78 1.66 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.072 -1.018 . . . . 0.0 110.067 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.473 ' HG2' ' HD1' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -100.49 43.86 1.04 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.562 -0.711 . . . . 0.0 109.854 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.1 m -50.5 134.71 23.6 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.396 0.617 . . . . 0.0 111.606 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 27.1 m -130.18 161.95 29.98 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.811 -0.555 . . . . 0.0 109.748 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.733 ' CG2' HG12 ' A' ' 62' ' ' ILE . 5.0 mp -85.97 170.28 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.375 -0.828 . . . . 0.0 111.121 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.712 HG21 ' SD ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -135.84 175.45 3.57 Favored Pre-proline 0 N--CA 1.505 2.308 0 O-C-N 121.463 -0.773 . . . . 0.0 110.049 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.618 ' HD2' ' CG1' ' A' ' 41' ' ' VAL . 47.0 Cg_endo -69.43 -34.61 15.31 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 124.024 1.539 . . . . 0.0 111.719 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.709 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 0.7 OUTLIER -71.87 0.53 8.91 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.298 -0.876 . . . . 0.0 111.171 179.62 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.712 ' SD ' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -90.15 -3.86 57.63 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.15 -0.969 . . . . 0.0 111.224 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.592 ' HA ' HG23 ' A' ' 62' ' ' ILE . 4.4 p -49.1 2.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.6 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 44' ' ' MET . . . -146.15 30.02 1.63 Allowed Glycine 0 N--CA 1.496 2.634 0 O-C-N 119.798 -1.814 . . . . 0.0 110.292 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.457 ' CE1' ' HB3' ' A' ' 22' ' ' LEU . 8.1 m-70 -147.43 155.75 42.23 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.159 -1.201 . . . . 0.0 111.059 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.98 89.35 4.03 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.07 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.555 ' CD1' ' HG3' ' A' ' 44' ' ' MET . 2.3 mp -86.64 118.16 32.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.443 -0.786 . . . . 0.0 111.752 -176.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.734 ' HB3' ' HB3' ' A' ' 57' ' ' HIS . . . -78.91 84.85 4.91 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.973 0.892 . . . . 0.0 109.106 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.547 HG21 ' HB ' ' A' ' 58' ' ' VAL . 23.0 m -61.97 129.09 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.534 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.494 ' HB2' ' O ' ' A' ' 33' ' ' THR . 26.5 t80 -78.0 106.44 9.86 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.082 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -75.01 13.76 0.63 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.702 -0.624 . . . . 0.0 110.598 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.58 -25.74 20.29 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -140.51 -25.9 0.76 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.617 -0.931 . . . . 0.0 111.24 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -131.96 151.88 51.45 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.734 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 66.5 m80 -93.13 117.48 30.12 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.733 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 21.8 t -106.91 87.46 2.95 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.079 -1.013 . . . . 0.0 109.338 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.544 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.3 Cg_endo -65.69 93.04 0.25 Allowed 'Trans proline' 0 N--CA 1.489 1.254 0 O-C-N 123.952 1.501 . . . . 0.0 109.814 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.503 ' O ' HD13 ' A' ' 62' ' ' ILE . 12.4 m -107.05 125.97 63.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.655 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 2.8 t80 -71.64 103.52 3.06 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.733 HG12 ' CG2' ' A' ' 40' ' ' ILE . 1.6 mp -56.53 -56.74 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -176.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m 64.62 178.46 0.18 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -177.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.432 ' HB3' HG22 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -86.43 48.91 1.7 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.517 -1.364 . . . . 0.0 111.102 -179.314 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -171.81 -9.09 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.889 -1.132 . . . . 0.0 113.979 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 29.3 mtt -99.63 -23.48 15.04 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.203 -1.56 . . . . 0.0 111.202 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.551 HG23 ' C ' ' A' ' 41' ' ' VAL . 2.7 p -67.76 163.48 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.489 0 O-C-N 121.284 -0.885 . . . . 0.0 112.514 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.52 ' N ' HG21 ' A' ' 67' ' ' VAL . . . 122.75 -11.33 8.89 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.956 177.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.651 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 17.7 m-70 -125.14 -83.02 0.64 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.135 1.468 . . . . 0.0 110.77 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.67 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.34 -31.22 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.588 0.708 . . . . 0.0 110.258 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.543 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 1.0 OUTLIER 173.62 -15.94 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.709 -179.839 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.02 -18.19 76.19 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.651 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 23.1 mm-40 . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.291 -1.123 . . . . 0.0 109.184 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.744 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 121.194 0.521 . . . . 0.0 110.034 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.6 t -100.08 110.18 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.294 -0.879 . . . . 0.0 108.872 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.744 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 38.5 t70 -48.42 111.0 0.39 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.405 0.621 . . . . 0.0 111.306 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.35 -23.7 64.73 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -65.61 -28.58 69.22 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.92 -0.488 . . . . 0.0 110.493 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HG ' ' N ' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -77.57 -37.61 50.19 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.498 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.608 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 3.8 mp -60.96 -44.4 97.37 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 120.983 0.421 . . . . 0.0 109.946 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.554 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -53.9 -25.36 19.81 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.273 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.494 ' HE3' ' HG2' ' A' ' 17' ' ' GLU . 5.1 mtmt -101.77 -29.67 11.74 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.485 -0.759 . . . . 0.0 110.371 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.608 ' CG1' ' HA ' ' A' ' 16' ' ' LEU . 1.1 p -75.82 -35.93 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.366 -0.834 . . . . 0.0 111.37 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.554 HD22 ' HA ' ' A' ' 17' ' ' GLU . 3.8 pp -62.98 -28.68 70.26 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -71.91 -35.28 69.63 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.473 HD21 ' HB2' ' A' ' 27' ' ' GLU . 3.3 mt -73.57 -27.26 61.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.651 -0.656 . . . . 0.0 109.753 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -84.93 -17.82 36.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.596 -0.69 . . . . 0.0 109.374 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.33 -38.77 15.94 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.535 -0.728 . . . . 0.0 109.738 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.1 mttm -90.39 -26.34 19.95 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.08 15.14 49.55 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.473 ' HB2' HD21 ' A' ' 22' ' ' LEU . 20.7 mt-10 -80.95 124.93 29.54 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.382 -1.07 . . . . 0.0 110.364 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -98.87 74.15 2.02 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.574 -0.704 . . . . 0.0 109.517 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -108.15 -151.56 0.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.667 -0.645 . . . . 0.0 110.079 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -118.08 153.68 33.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 110.71 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.568 ' HB ' HD12 ' A' ' 49' ' ' ILE . 2.7 mp -127.26 119.08 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.516 -0.74 . . . . 0.0 109.186 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.525 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . 4.7 mptt -84.42 158.82 20.95 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.306 -0.871 . . . . 0.0 111.366 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 15.9 m -141.47 155.97 45.8 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.706 -0.622 . . . . 0.0 109.713 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.451 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 12.0 m-90 -145.76 36.54 1.06 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.225 -0.922 . . . . 0.0 111.404 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -91.91 -95.16 0.13 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.891 -1.131 . . . . 0.0 110.826 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.9 tpt85 -170.2 -63.5 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.084 -1.01 . . . . 0.0 110.514 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -99.27 37.52 1.55 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.267 -0.896 . . . . 0.0 110.007 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.0 m -40.91 133.74 2.08 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.473 0.654 . . . . 0.0 112.153 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 49.1 m -128.54 156.81 42.72 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.902 -0.499 . . . . 0.0 109.821 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.678 HG22 ' SD ' ' A' ' 44' ' ' MET . 1.3 mp -76.98 160.29 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.481 -0.762 . . . . 0.0 111.248 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.666 HG21 ' HG3' ' A' ' 44' ' ' MET . 0.0 OUTLIER -132.06 176.5 2.85 Favored Pre-proline 0 N--CA 1.502 2.158 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.158 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 41.7 Cg_endo -65.76 -29.5 50.88 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.906 1.477 . . . . 0.0 110.596 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -77.78 0.75 22.52 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.686 -0.634 . . . . 0.0 110.688 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.678 ' SD ' HG22 ' A' ' 40' ' ' ILE . 2.4 mtt -93.82 -11.62 30.84 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.072 -1.017 . . . . 0.0 111.644 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.539 HG21 ' N ' ' A' ' 64' ' ' GLU . 7.5 p -56.52 4.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.414 ' C ' ' CG ' ' A' ' 47' ' ' HIS . . . -150.29 29.74 1.08 Allowed Glycine 0 N--CA 1.495 2.601 0 O-C-N 119.953 -1.717 . . . . 0.0 110.088 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 21.8 m-70 -147.35 159.22 43.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.168 -1.195 . . . . 0.0 111.338 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.522 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.57 84.64 2.99 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 178.176 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.58 ' CD1' ' HG2' ' A' ' 44' ' ' MET . 1.0 OUTLIER -84.99 121.09 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.176 -0.953 . . . . 0.0 111.221 -177.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.758 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.61 84.17 4.74 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.832 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.0 m -64.83 130.08 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.4 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.468 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 30.1 t80 -75.34 107.14 7.25 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -84.34 28.01 0.66 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.461 -0.775 . . . . 0.0 110.92 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.11 -36.78 4.09 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -140.69 -20.35 0.82 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.443 -1.033 . . . . 0.0 111.721 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.468 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 2.2 mm100 -128.82 153.07 47.79 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -177.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.415 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . 2.1 m80 -98.7 108.16 20.78 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.758 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 21.8 t -100.86 95.61 4.72 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.144 -0.973 . . . . 0.0 109.469 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.536 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.0 Cg_endo -67.29 93.1 0.35 Allowed 'Trans proline' 0 N--CA 1.488 1.176 0 O-C-N 123.837 1.44 . . . . 0.0 109.423 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 58' ' ' VAL . 95.9 t -110.36 126.71 67.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.828 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.0 t80 -71.96 104.72 3.61 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.642 HG12 HG22 ' A' ' 40' ' ' ILE . 2.6 mp -67.37 -50.17 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 2.9 m 65.53 178.7 0.2 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.539 ' N ' HG21 ' A' ' 45' ' ' VAL . 1.1 tm-20 -86.17 61.58 6.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.506 -1.371 . . . . 0.0 109.323 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -162.28 -34.38 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.203 -0.935 . . . . 0.0 112.271 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.675 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 10.3 mtt -99.74 9.29 43.32 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.882 -1.136 . . . . 0.0 112.11 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.472 HG21 ' N ' ' A' ' 68' ' ' GLY . 8.3 p -90.04 162.02 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 120.736 -1.227 . . . . 0.0 112.461 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.472 ' N ' HG21 ' A' ' 67' ' ' VAL . . . 105.56 -16.0 44.98 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.552 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 16.2 m-70 -112.45 -88.89 0.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.015 -1.285 . . . . 0.0 110.792 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.3 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 122.437 1.113 . . . . 0.0 109.07 -179.663 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.547 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 0.8 OUTLIER -179.64 -13.85 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.938 -179.603 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.67 -15.17 77.77 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.675 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 1.5 mm-40 . . . . . 0 N--CA 1.495 1.825 0 O-C-N 121.36 -1.082 . . . . 0.0 108.824 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.714 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.12 0.486 . . . . 0.0 109.857 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.8 t -95.41 106.1 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 108.566 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.714 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 32.6 t70 -46.35 110.81 0.3 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.375 0.607 . . . . 0.0 111.404 -178.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -67.31 -23.1 65.61 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -63.56 -33.68 76.13 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.912 -0.492 . . . . 0.0 110.31 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.692 ' HG ' HD11 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -80.28 -38.1 31.49 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.692 HD11 ' HG ' ' A' ' 15' ' ' LEU . 4.0 mp -61.49 -40.8 95.88 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.61 -31.33 15.68 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.493 ' HB2' HG22 ' A' ' 31' ' ' ILE . 25.8 mmtt -89.13 -32.43 17.51 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.665 -0.647 . . . . 0.0 110.089 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.559 HG22 HD13 ' A' ' 15' ' ' LEU . 78.7 t -68.46 -38.24 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.303 -0.873 . . . . 0.0 111.156 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 16' ' ' LEU . 11.0 mt -61.76 -37.71 85.3 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -64.52 -35.63 81.57 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.468 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.666 HD21 ' HB2' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -75.07 -25.18 58.41 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.479 -0.763 . . . . 0.0 109.866 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -84.48 -11.2 56.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.439 -0.788 . . . . 0.0 109.94 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.18 -37.35 15.09 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 121.348 -0.845 . . . . 0.0 109.927 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 14.4 mmtp -100.71 -24.72 14.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.641 -0.662 . . . . 0.0 109.714 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.53 29.67 8.63 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.666 ' HB2' HD21 ' A' ' 22' ' ' LEU . 14.5 mt-10 -79.77 125.92 30.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.498 -1.001 . . . . 0.0 110.241 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -106.64 63.18 0.64 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.455 -0.778 . . . . 0.0 109.677 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.27 -153.17 0.51 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.519 -0.738 . . . . 0.0 110.116 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 48' ' ' THR . 0.0 OUTLIER -118.02 147.87 42.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.385 -0.822 . . . . 0.0 110.725 -179.638 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.589 HG23 HD11 ' A' ' 15' ' ' LEU . 2.9 mp -118.52 116.25 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.607 -0.683 . . . . 0.0 109.735 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.459 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . 29.2 mmtt -75.96 154.32 35.97 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.528 -0.732 . . . . 0.0 110.725 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.491 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 97.4 m -135.78 158.44 44.38 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.48 -0.762 . . . . 0.0 110.305 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -147.5 38.04 0.93 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.387 -0.821 . . . . 0.0 111.155 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 93.0 p -94.81 -132.11 0.17 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.96 -1.087 . . . . 0.0 110.774 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.4 mtt85 -132.91 -64.23 0.75 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.986 -1.071 . . . . 0.0 110.317 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 mpp_? -97.99 40.92 1.15 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.432 -0.793 . . . . 0.0 110.098 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -40.2 125.78 2.08 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.528 0.68 . . . . 0.0 112.452 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.733 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 71.1 m -128.88 155.86 44.59 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.748 ' CG2' HG12 ' A' ' 62' ' ' ILE . 5.2 mp -86.76 168.89 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.406 -0.809 . . . . 0.0 111.457 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.595 HG22 ' CG ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -136.51 171.84 8.02 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.645 -0.659 . . . . 0.0 110.167 179.469 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 42.7 Cg_endo -66.64 -32.78 37.63 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 124.239 1.652 . . . . 0.0 111.249 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -69.27 -5.51 23.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.559 -0.713 . . . . 0.0 110.711 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.617 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 1.3 mmm -91.83 -0.57 57.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.188 -0.945 . . . . 0.0 111.311 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.617 ' HA ' HG23 ' A' ' 62' ' ' ILE . 6.6 p -53.55 7.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.42 ' C ' ' CG ' ' A' ' 47' ' ' HIS . . . -148.67 29.44 1.29 Allowed Glycine 0 N--CA 1.496 2.7 0 O-C-N 119.895 -1.753 . . . . 0.0 110.33 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.42 ' CG ' ' C ' ' A' ' 46' ' ' GLY . 9.6 m-70 -148.1 155.91 42.0 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.205 -1.174 . . . . 0.0 111.193 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -101.04 90.96 4.35 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 177.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.579 HD11 ' SD ' ' A' ' 44' ' ' MET . 2.5 mp -88.84 121.05 38.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.593 -176.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.717 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.56 81.63 4.87 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.824 0.821 . . . . 0.0 109.238 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.1 m -61.41 135.3 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.963 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 33' ' ' THR . 18.5 t80 -80.21 106.96 12.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.364 -0.835 . . . . 0.0 109.497 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -71.13 -0.98 10.86 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.569 -0.707 . . . . 0.0 110.329 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.84 -22.61 8.07 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 107.693 -2.163 . . . . 0.0 107.693 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -140.21 -28.18 0.73 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.985 -0.715 . . . . 0.0 111.158 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.58 155.27 47.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.235 -0.916 . . . . 0.0 112.2 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.471 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . 19.4 m-70 -99.92 110.4 22.74 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.717 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 24.9 t -97.71 96.99 3.64 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.239 -0.913 . . . . 0.0 109.943 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.507 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.7 Cg_endo -66.68 92.41 0.3 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 O-C-N 123.906 1.477 . . . . 0.0 109.615 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.485 ' O ' HD13 ' A' ' 62' ' ' ILE . 12.9 m -103.92 125.19 58.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.613 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 2.6 t80 -72.66 103.09 3.48 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.748 HG12 ' CG2' ' A' ' 40' ' ' ILE . 1.5 mp -55.98 -61.63 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -176.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 m 65.41 174.42 0.22 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.419 ' N ' HG21 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -85.38 58.79 5.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.357 -1.464 . . . . 0.0 109.976 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -171.57 -25.94 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.94 -1.1 . . . . 0.0 113.27 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.5 mmm -89.2 -25.43 21.78 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.558 -1.339 . . . . 0.0 111.097 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.57 HG22 ' C ' ' A' ' 41' ' ' VAL . 3.3 p -67.02 163.09 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 121.331 -0.855 . . . . 0.0 112.561 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.492 ' N ' HG23 ' A' ' 67' ' ' VAL . . . 118.83 -13.57 11.59 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.756 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.59 ' CG ' ' HG3' ' A' ' 73' ' ' GLU . 19.7 m-70 -123.06 -83.56 0.66 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 119.037 1.418 . . . . 0.0 110.724 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.733 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.2 -30.93 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.671 0.748 . . . . 0.0 110.48 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.543 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 0.9 OUTLIER 174.12 -14.98 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.272 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.809 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.99 -18.46 74.54 Favored Glycine 0 N--CA 1.496 2.647 0 O-C-N 120.982 -1.074 . . . . 0.0 110.423 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.59 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 2.0 mt-10 . . . . . 0 N--CA 1.497 1.88 0 O-C-N 121.237 -1.155 . . . . 0.0 109.262 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.753 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.208 0.528 . . . . 0.0 109.958 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.4 p -102.12 109.61 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.83 . . . . 0.0 108.77 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.753 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 38.8 t70 -46.06 111.59 0.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.624 -0.673 . . . . 0.0 111.803 -178.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.403 ' HA ' HD11 ' A' ' 16' ' ' LEU . 7.7 t70 -68.3 -24.2 64.83 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -64.92 -28.38 69.49 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.853 -0.53 . . . . 0.0 109.78 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.568 ' HG ' HD13 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -77.67 -34.98 52.81 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.211 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.592 ' HA ' HG11 ' A' ' 19' ' ' VAL . 3.8 mp -62.3 -47.28 84.97 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.048 0.451 . . . . 0.0 109.902 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.44 -23.04 5.39 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.737 -0.602 . . . . 0.0 110.445 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HB2' HG22 ' A' ' 31' ' ' ILE . 8.8 mmtm -102.58 -30.84 10.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.301 -0.874 . . . . 0.0 111.045 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.592 HG11 ' HA ' ' A' ' 16' ' ' LEU . 1.4 p -78.13 -39.86 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.191 -0.943 . . . . 0.0 111.274 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.464 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 12.6 mt -63.25 -36.84 85.0 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.89 -38.88 83.5 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.271 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.536 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 3.2 mt -73.42 -24.67 60.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.119 -0.988 . . . . 0.0 110.197 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -80.71 -10.4 59.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.522 -0.736 . . . . 0.0 109.59 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.19 -35.58 23.42 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 121.498 -0.751 . . . . 0.0 109.707 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.541 ' HE3' ' HB2' ' A' ' 27' ' ' GLU . 7.4 pttt -102.3 -29.57 11.59 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.533 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.59 28.35 7.54 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.541 ' HB2' ' HE3' ' A' ' 25' ' ' LYS . 2.6 mt-10 -90.9 134.61 34.33 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.467 -1.019 . . . . 0.0 110.382 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -100.04 76.45 1.93 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.463 -0.773 . . . . 0.0 109.357 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.98 -154.55 0.54 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.51 -0.743 . . . . 0.0 110.212 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.503 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -118.99 161.1 20.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.453 -0.779 . . . . 0.0 110.763 -179.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.504 ' HB ' HG12 ' A' ' 49' ' ' ILE . 2.9 mp -132.77 112.42 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.54 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -85.69 152.69 22.88 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.55 -0.718 . . . . 0.0 111.186 -178.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.497 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 8.5 m -134.87 163.21 30.34 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.925 -0.484 . . . . 0.0 110.279 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.436 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 16.0 m-90 -146.73 37.06 0.97 Allowed 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.289 -0.882 . . . . 0.0 110.854 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.0 t -94.74 -126.63 0.12 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.077 -1.015 . . . . 0.0 110.779 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.14 -59.68 0.78 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.827 -1.171 . . . . 0.0 110.822 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -98.36 35.61 1.75 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.322 -0.861 . . . . 0.0 110.605 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.5 m -36.06 123.9 0.74 Allowed 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.31 0.576 . . . . 0.0 111.942 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 69' ' ' HIS . 27.5 m -128.32 162.27 27.46 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.546 -0.721 . . . . 0.0 110.569 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.719 ' CG2' ' HG2' ' A' ' 44' ' ' MET . 1.9 mt -66.58 165.01 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 O-C-N 121.631 -0.668 . . . . 0.0 110.861 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.646 ' O ' ' HG3' ' A' ' 44' ' ' MET . 0.1 OUTLIER -123.45 -171.41 0.22 Allowed Pre-proline 0 N--CA 1.505 2.312 0 O-C-N 121.362 -0.836 . . . . 0.0 110.14 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.547 ' CD ' ' CB ' ' A' ' 41' ' ' VAL . 57.7 Cg_endo -87.75 -31.19 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.657 1.346 . . . . 0.0 111.098 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -90.05 15.47 10.07 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.536 -0.727 . . . . 0.0 111.056 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.782 ' SD ' ' CG2' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -94.43 4.84 53.34 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.17 -0.956 . . . . 0.0 111.798 -179.695 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.637 HG21 ' HE2' ' A' ' 44' ' ' MET . 39.5 t -57.46 -2.83 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.478 ' HA3' ' CE1' ' A' ' 61' ' ' TYR . . . -150.77 34.08 0.96 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.513 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 52.7 m-70 -138.49 152.67 48.48 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.221 -1.164 . . . . 0.0 110.938 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.54 HG22 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.29 80.82 2.47 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.504 HG12 ' HB ' ' A' ' 31' ' ' ILE . 9.2 mt -78.09 117.35 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.182 -0.949 . . . . 0.0 110.915 -177.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.722 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.42 80.07 4.83 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.772 0.796 . . . . 0.0 108.99 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.8 m -57.87 127.12 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.181 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 33' ' ' THR . 14.9 t80 -75.76 105.99 7.1 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.196 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -69.61 -0.8 7.36 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.577 -0.702 . . . . 0.0 110.429 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.03 -20.71 9.73 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 107.839 -2.104 . . . . 0.0 107.839 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -140.1 -29.22 0.71 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.957 -0.731 . . . . 0.0 110.974 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.53 154.82 48.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.243 -0.911 . . . . 0.0 112.029 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.46 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 5.0 m80 -100.59 106.04 17.51 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.722 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 40.4 t -94.98 99.93 4.89 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.206 -0.934 . . . . 0.0 109.804 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.501 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.7 Cg_endo -66.54 92.39 0.29 Allowed 'Trans proline' 0 N--CA 1.49 1.304 0 O-C-N 123.904 1.476 . . . . 0.0 109.598 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 58' ' ' VAL . 94.0 t -98.39 116.59 41.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.75 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.54 ' HB2' HG22 ' A' ' 48' ' ' THR . 6.2 t80 -73.03 108.77 6.11 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.782 ' CG2' ' SD ' ' A' ' 44' ' ' MET . 2.4 mp -92.72 159.89 2.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.884 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 3.1 m -129.83 -159.81 0.99 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 177.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.481 ' HB2' HG12 ' A' ' 45' ' ' VAL . 3.2 tt0 -90.25 47.75 1.48 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.242 -1.536 . . . . 0.0 110.412 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -156.58 -34.23 0.08 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.973 -1.079 . . . . 0.0 112.675 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.611 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 71.3 mtm -85.86 5.01 34.74 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.999 -1.063 . . . . 0.0 111.546 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.554 HG21 ' N ' ' A' ' 68' ' ' GLY . 7.5 p -83.99 166.2 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 120.893 -1.129 . . . . 0.0 111.767 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.554 ' N ' HG21 ' A' ' 67' ' ' VAL . . . 106.5 -21.7 32.19 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.57 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 16.5 m-70 -112.27 -86.87 0.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.121 -1.223 . . . . 0.0 111.003 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.538 ' HD2' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER 177.61 -36.27 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 122.273 1.035 . . . . 0.0 109.278 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.538 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -178.98 -15.33 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.998 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.83 -15.3 73.7 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.611 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 1.5 mm-40 . . . . . 0 N--CA 1.497 1.885 0 O-C-N 121.44 -1.035 . . . . 0.0 108.773 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.659 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 121.316 0.579 . . . . 0.0 110.309 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.9 p -113.63 118.9 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.659 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 38.8 t70 -43.81 105.87 0.06 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.618 -0.676 . . . . 0.0 111.604 -178.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -68.04 -21.35 65.02 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -66.84 -28.41 68.33 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 122.007 -0.433 . . . . 0.0 110.49 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.555 ' HG ' ' N ' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -76.85 -37.32 55.83 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.709 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.555 ' N ' ' HG ' ' A' ' 15' ' ' LEU . 3.9 mp -60.75 -44.21 96.98 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.97 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.513 ' HA ' HD22 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -55.74 -25.07 38.75 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.196 179.141 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -102.31 -31.39 10.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.453 -0.78 . . . . 0.0 110.67 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.624 ' CG1' ' HG3' ' A' ' 43' ' ' GLU . 1.4 p -71.8 -37.3 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.287 -0.883 . . . . 0.0 111.021 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.513 HD22 ' HA ' ' A' ' 17' ' ' GLU . 4.0 pp -64.47 -28.2 69.5 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.84 -31.96 65.13 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 27' ' ' GLU . 1.4 mt -76.92 -22.08 53.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.609 -0.682 . . . . 0.0 109.582 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -84.76 -19.6 32.37 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.496 -0.753 . . . . 0.0 109.716 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.14 -39.13 17.02 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 121.504 -0.748 . . . . 0.0 109.908 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -90.71 -25.3 20.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.672 -0.643 . . . . 0.0 109.533 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.36 16.61 49.25 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.526 ' HB2' HD21 ' A' ' 22' ' ' LEU . 1.5 mt-10 -75.41 128.35 35.15 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.514 -0.991 . . . . 0.0 110.477 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.0 mtmm -115.13 50.89 0.95 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.551 -0.718 . . . . 0.0 109.513 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.7 ttp-105 -88.31 -92.2 0.11 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.57 -0.706 . . . . 0.0 110.411 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.42 ' CD1' ' HD3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -170.9 146.25 2.5 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.118 -0.989 . . . . 0.0 110.674 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.506 HD11 HG22 ' A' ' 19' ' ' VAL . 2.8 mt -115.26 119.07 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.508 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 0.1 OUTLIER -79.63 151.05 30.79 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.437 -0.789 . . . . 0.0 111.543 -178.63 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.4 m -137.6 155.3 49.34 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.601 -0.687 . . . . 0.0 110.353 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' A' ' 32' ' ' LYS . 17.5 m-90 -146.02 29.53 1.09 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.299 -0.876 . . . . 0.0 111.601 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -82.9 -98.14 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.812 -1.18 . . . . 0.0 110.592 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -174.29 -61.59 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.215 -0.928 . . . . 0.0 109.558 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.19 42.7 1.09 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.5 m -50.9 133.9 26.22 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.525 0.679 . . . . 0.0 111.923 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 20.6 m -127.25 161.54 28.31 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.684 ' CG2' HG12 ' A' ' 62' ' ' ILE . 1.1 mp -80.56 162.15 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.291 -0.88 . . . . 0.0 111.566 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.545 HG21 ' HG3' ' A' ' 44' ' ' MET . 0.0 OUTLIER -129.3 169.58 12.83 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 121.701 -0.624 . . . . 0.0 110.011 178.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.439 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 43.7 Cg_endo -67.5 -31.72 33.31 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.262 1.664 . . . . 0.0 110.918 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.624 ' HG3' ' CG1' ' A' ' 19' ' ' VAL . 2.3 pt-20 -80.16 5.69 13.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.482 -0.761 . . . . 0.0 110.926 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.659 ' HB3' HG12 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -98.12 -5.74 33.04 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.287 -0.883 . . . . 0.0 111.448 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.59 ' HA ' HG23 ' A' ' 62' ' ' ILE . 61.8 t -48.29 -6.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.516 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA3' ' CE1' ' A' ' 61' ' ' TYR . . . -144.72 38.97 1.24 Allowed Glycine 0 N--CA 1.491 2.344 0 O-C-N 120.186 -1.571 . . . . 0.0 109.221 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 49.6 m-70 -143.08 147.35 34.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.508 -0.995 . . . . 0.0 111.183 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.81 80.93 2.39 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 177.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.523 HD13 HG22 ' A' ' 19' ' ' VAL . 1.5 mt -85.19 124.1 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.391 -0.818 . . . . 0.0 111.347 -176.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.762 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -77.78 80.28 4.24 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -61.08 130.47 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.057 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 30.5 t80 -78.27 105.88 9.81 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.236 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -69.91 0.0 6.59 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.618 -0.677 . . . . 0.0 110.6 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.67 -18.87 10.65 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 107.913 -2.075 . . . . 0.0 107.913 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -140.1 -28.57 0.73 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.938 -0.742 . . . . 0.0 110.884 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -135.86 155.32 50.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.226 -0.921 . . . . 0.0 112.015 -178.353 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.423 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . 1.1 m-70 -101.57 105.43 16.39 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.762 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 21.9 t -95.35 102.29 9.42 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.217 -0.927 . . . . 0.0 110.051 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.529 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.3 Cg_endo -66.64 91.96 0.3 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.916 1.482 . . . . 0.0 109.006 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 58' ' ' VAL . 79.1 t -108.21 126.75 64.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.938 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.5 t80 -72.88 110.89 7.53 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 176.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.684 HG12 ' CG2' ' A' ' 40' ' ' ILE . 1.7 mp -62.71 -56.77 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.642 -0.661 . . . . 0.0 112.732 -177.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 3.5 m 68.79 162.39 0.21 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -177.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.504 ' N ' HG11 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -78.93 62.76 3.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.639 -1.288 . . . . 0.0 109.451 -179.398 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -167.53 -32.85 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.317 -0.864 . . . . 0.0 112.271 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.638 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 2.8 mtt -98.07 8.49 44.69 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.79 -1.194 . . . . 0.0 111.85 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.557 HG21 ' N ' ' A' ' 68' ' ' GLY . 8.2 p -90.22 162.62 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 120.757 -1.214 . . . . 0.0 112.214 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.557 ' N ' HG21 ' A' ' 67' ' ' VAL . . . 106.69 -16.82 39.96 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 178.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.549 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 16.3 m-70 -112.86 -88.44 0.54 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.12 -1.223 . . . . 0.0 110.726 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.09 -35.64 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 122.394 1.092 . . . . 0.0 109.02 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.54 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -178.74 -14.93 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.973 -179.587 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.41 -14.75 77.17 Favored Glycine 0 N--CA 1.498 2.771 0 O-C-N 120.797 -1.189 . . . . 0.0 110.281 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.638 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 1.8 mm-40 . . . . . 0 N--CA 1.496 1.858 0 O-C-N 121.356 -1.085 . . . . 0.0 108.686 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.504 ' CZ ' ' HB3' ' A' ' 35' ' ' SER . 1.7 t80 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.499 0.666 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.548 ' CG2' HG23 ' A' ' 41' ' ' VAL . 3.5 p -137.17 119.75 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.589 ' CB ' ' HB3' ' A' ' 15' ' ' LEU . 34.1 m-20 -23.62 99.97 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 CA-C-O 121.046 0.45 . . . . 0.0 112.142 -178.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.2 -26.4 63.86 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.559 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -76.07 -14.04 60.2 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 120.99 0.424 . . . . 0.0 110.148 178.64 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.589 ' HB3' ' CB ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -87.01 -35.33 18.86 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.585 ' HA ' HG13 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -70.56 -43.93 68.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.745 -0.597 . . . . 0.0 110.01 178.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.57 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -53.08 -19.73 3.05 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.8 179.408 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.472 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 17.6 mttt -106.39 -32.56 8.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.347 -0.846 . . . . 0.0 110.146 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.605 HG12 ' HE2' ' A' ' 44' ' ' MET . 0.5 OUTLIER -73.57 -40.66 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.403 -0.811 . . . . 0.0 111.153 -179.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.57 HD22 ' HA ' ' A' ' 17' ' ' GLU . 3.8 pp -60.52 -26.27 66.74 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.57 -36.24 52.27 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 27' ' ' GLU . 0.9 OUTLIER -72.22 -28.49 63.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.591 -0.693 . . . . 0.0 109.637 178.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -83.56 -11.33 57.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.581 -0.699 . . . . 0.0 109.599 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.0 -37.22 14.47 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 121.588 -0.695 . . . . 0.0 110.002 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.489 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 4.6 ptmt -96.56 -23.92 16.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.611 -0.681 . . . . 0.0 109.84 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.32 29.45 7.5 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.489 ' HG3' ' HE2' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -92.98 129.08 39.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.427 -1.043 . . . . 0.0 110.685 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -107.25 70.63 0.8 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.593 -0.692 . . . . 0.0 109.226 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.34 -152.76 0.5 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.656 -0.653 . . . . 0.0 110.006 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -114.05 155.79 25.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.421 -0.799 . . . . 0.0 110.354 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.486 HG23 ' HA ' ' A' ' 15' ' ' LEU . 5.8 mt -135.06 116.32 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.498 -0.751 . . . . 0.0 109.346 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -103.33 148.37 25.94 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.277 -0.889 . . . . 0.0 110.891 -179.45 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 56.6 m -137.91 156.78 47.53 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.579 -0.701 . . . . 0.0 110.177 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.506 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 19.9 m-90 -118.57 44.93 2.15 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.681 -0.637 . . . . 0.0 110.057 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 10' ' ' PHE . 66.1 m -83.79 -167.24 1.65 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.289 -0.882 . . . . 0.0 111.004 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -102.11 -61.88 1.33 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.436 -0.79 . . . . 0.0 110.341 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.33 41.32 1.07 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.355 -0.841 . . . . 0.0 109.636 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 63.1 m -37.75 105.44 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.643 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 44.6 m -122.35 159.7 26.92 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.684 -0.635 . . . . 0.0 109.316 178.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.819 ' CG2' HG12 ' A' ' 62' ' ' ILE . 4.8 mp -90.08 168.92 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.408 -0.807 . . . . 0.0 111.705 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.622 HG21 ' HG2' ' A' ' 44' ' ' MET . 0.1 OUTLIER -139.56 174.6 3.93 Favored Pre-proline 0 N--CA 1.505 2.306 0 O-C-N 121.79 -0.569 . . . . 0.0 109.787 179.443 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.529 ' HD2' HG13 ' A' ' 41' ' ' VAL . 42.8 Cg_endo -65.61 -33.53 45.05 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 124.116 1.588 . . . . 0.0 111.198 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.75 -12.43 23.97 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.597 -0.69 . . . . 0.0 110.578 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.622 ' HG2' HG21 ' A' ' 41' ' ' VAL . 6.2 mmt -87.09 -4.8 59.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.364 -0.835 . . . . 0.0 111.909 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.481 ' HA ' HG23 ' A' ' 62' ' ' ILE . 7.5 p -51.11 1.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.475 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.408 ' C ' ' CG ' ' A' ' 47' ' ' HIS . . . -146.27 31.01 1.58 Allowed Glycine 0 N--CA 1.495 2.62 0 O-C-N 119.918 -1.739 . . . . 0.0 110.28 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.408 ' CG ' ' C ' ' A' ' 46' ' ' GLY . 17.9 m-70 -147.88 156.55 42.82 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.217 -1.167 . . . . 0.0 111.315 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.528 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.69 88.73 3.9 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.677 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.563 HG12 ' CD1' ' A' ' 15' ' ' LEU . 2.6 mt -86.69 119.31 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.178 -0.951 . . . . 0.0 112.019 -176.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.693 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.87 86.81 5.36 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 122.15 0.976 . . . . 0.0 109.193 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.1 m -71.25 134.8 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.232 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.537 ' HB2' ' O ' ' A' ' 33' ' ' THR . 28.5 t80 -75.2 105.58 6.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.342 -0.849 . . . . 0.0 108.886 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -71.46 0.03 9.28 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.53 -0.731 . . . . 0.0 110.801 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.41 -22.48 7.84 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -140.36 -28.84 0.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 122.016 -0.697 . . . . 0.0 110.79 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.21 156.22 49.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.266 -0.896 . . . . 0.0 111.988 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 93.6 m-70 -101.83 108.31 19.76 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.693 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 22.0 t -94.3 101.5 6.66 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.308 -0.87 . . . . 0.0 110.008 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 57' ' ' HIS . 43.0 Cg_endo -68.85 94.0 0.45 Allowed 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.933 1.491 . . . . 0.0 108.96 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.471 ' O ' HD13 ' A' ' 62' ' ' ILE . 15.0 m -106.36 126.93 62.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.217 -178.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -69.5 104.32 2.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 176.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.819 HG12 ' CG2' ' A' ' 40' ' ' ILE . 1.3 mp -60.2 -53.22 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.3 p 59.6 -175.63 0.1 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -90.41 43.51 1.15 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.486 -1.384 . . . . 0.0 109.941 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -150.92 -29.11 0.2 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.948 -1.095 . . . . 0.0 113.464 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.46 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 5.9 mtt -89.29 -23.18 22.36 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.527 -1.358 . . . . 0.0 111.435 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.588 HG21 ' N ' ' A' ' 68' ' ' GLY . 2.7 p -67.01 160.14 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.077 -1.015 . . . . 0.0 112.459 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.588 ' N ' HG21 ' A' ' 67' ' ' VAL . . . 114.62 -13.56 20.48 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.869 -0.682 . . . . 0.0 111.586 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.534 ' CG ' ' HG3' ' A' ' 73' ' ' GLU . 22.2 m-70 -121.98 -83.8 0.66 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.912 1.356 . . . . 0.0 110.853 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.88 -30.98 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 121.661 0.743 . . . . 0.0 110.326 -179.597 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.566 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 1.3 pp 173.12 -14.18 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.767 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.29 -18.99 73.82 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.534 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 2.6 mt-10 . . . . . 0 N--CA 1.497 1.909 0 O-C-N 121.355 -1.085 . . . . 0.0 109.24 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.716 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.329 0.585 . . . . 0.0 110.177 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.6 p -116.01 119.08 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.716 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 5.1 t70 -44.55 103.9 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.686 -0.634 . . . . 0.0 111.161 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.86 -22.1 65.14 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.16 -29.99 63.25 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.977 -0.452 . . . . 0.0 110.253 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.71 ' HG ' HD11 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -78.25 -38.68 42.24 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.277 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.71 HD11 ' HG ' ' A' ' 15' ' ' LEU . 2.9 mp -58.92 -42.98 90.98 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.309 0.576 . . . . 0.0 109.584 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.531 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -56.01 -23.75 34.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.806 -0.558 . . . . 0.0 109.943 179.257 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.4 -29.82 12.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.497 -0.752 . . . . 0.0 110.592 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.661 HG22 HD12 ' A' ' 49' ' ' ILE . 2.3 p -73.96 -38.05 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.186 -0.946 . . . . 0.0 111.02 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.531 HD22 ' HA ' ' A' ' 17' ' ' GLU . 4.1 pp -61.75 -26.63 68.19 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -69.61 -34.06 73.55 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 3.6 mm? -74.13 -26.56 60.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.621 -0.674 . . . . 0.0 109.369 178.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -82.13 -13.44 57.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.598 -0.689 . . . . 0.0 109.674 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.37 -33.61 21.96 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.505 -0.747 . . . . 0.0 110.095 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HG3' ' HG3' ' A' ' 27' ' ' GLU . 2.1 ptmt -92.01 -17.08 25.6 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.61 -0.682 . . . . 0.0 109.714 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.37 32.43 11.93 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.488 ' HG3' ' HG3' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -114.39 128.56 56.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.527 -0.984 . . . . 0.0 110.743 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.78 80.79 2.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.597 -0.69 . . . . 0.0 109.588 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.82 -147.84 0.39 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.55 -0.719 . . . . 0.0 109.848 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -121.27 154.05 36.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 110.203 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.696 ' HB ' HD11 ' A' ' 49' ' ' ILE . 28.0 mm -118.79 154.22 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.328 -0.857 . . . . 0.0 110.057 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.461 ' HB2' ' CZ2' ' A' ' 34' ' ' TRP . 1.6 mmtp -102.76 137.09 41.43 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.667 -0.646 . . . . 0.0 110.345 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.656 HG22 ' CB ' ' A' ' 12' ' ' ASP . 9.6 m -124.45 150.28 45.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.572 -0.705 . . . . 0.0 109.806 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.572 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 1.4 m-90 -145.69 38.56 1.12 Allowed 'General case' 0 N--CA 1.51 2.563 0 O-C-N 121.067 -1.021 . . . . 0.0 112.652 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -100.57 -97.5 0.25 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.467 -1.395 . . . . 0.0 110.702 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.83 -60.02 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.094 -1.004 . . . . 0.0 109.346 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.54 35.16 2.53 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.8 m -51.48 138.9 21.16 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.529 0.68 . . . . 0.0 111.742 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.608 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 3.0 m -133.79 165.91 23.87 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.859 -0.526 . . . . 0.0 109.836 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.671 HG12 HG12 ' A' ' 62' ' ' ILE . 5.0 mp -86.2 161.49 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.199 -0.938 . . . . 0.0 110.551 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.665 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -141.1 176.23 2.59 Favored Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 121.672 -0.643 . . . . 0.0 109.686 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.665 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 38.3 Cg_endo -62.86 -28.77 75.86 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.137 1.598 . . . . 0.0 109.595 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -66.79 -10.64 49.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.847 -0.533 . . . . 0.0 110.864 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.659 ' HG2' HG22 ' A' ' 41' ' ' VAL . 1.9 ptp -140.19 44.21 1.89 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.814 -1.179 . . . . 0.0 112.324 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.78 ' CG1' ' HA ' ' A' ' 64' ' ' GLU . 3.2 t -91.49 27.96 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.819 -1.176 . . . . 0.0 110.938 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.66 24.74 0.94 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.425 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 12.6 m-70 -139.55 167.81 21.26 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.235 -1.156 . . . . 0.0 110.533 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.632 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -98.96 81.62 2.63 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 178.394 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.696 HD11 ' HB ' ' A' ' 31' ' ' ILE . 1.1 mm -79.37 112.47 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.673 -0.642 . . . . 0.0 110.929 -177.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.737 ' HB3' ' HB3' ' A' ' 57' ' ' HIS . . . -77.8 80.83 4.24 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.969 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.58 138.29 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.879 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.572 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 19.7 t80 -80.67 108.0 13.95 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.565 -0.854 . . . . 0.0 108.983 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -76.57 15.45 0.62 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.769 -0.582 . . . . 0.0 110.247 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.81 -29.3 11.03 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.0 pttt -140.57 -27.37 0.73 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.636 -0.92 . . . . 0.0 111.188 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -126.41 156.15 41.03 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.737 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 13.2 m-70 -94.9 115.82 27.94 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.708 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 46.2 t -103.81 90.64 2.99 Favored Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 121.157 -0.965 . . . . 0.0 109.337 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.541 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.8 Cg_endo -65.42 89.47 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 O-C-N 124.019 1.536 . . . . 0.0 110.301 -178.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 60' ' ' VAL . 5.3 m -94.67 110.04 23.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.268 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.632 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -69.39 95.28 0.79 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.792 -1.163 . . . . 0.0 108.222 178.514 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.671 HG12 HG12 ' A' ' 40' ' ' ILE . 2.7 mp -76.79 127.64 37.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.145 -178.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.59 ' C ' HG13 ' A' ' 45' ' ' VAL . 72.1 p -101.78 158.74 15.9 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.78 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -42.78 -19.61 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.433 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 63' ' ' THR . 10.1 p30 -121.59 29.59 7.12 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.696 -1.253 . . . . 0.0 112.641 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 18.7 mmt -126.72 -19.19 4.57 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.973 -1.079 . . . . 0.0 110.73 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.433 ' HB ' ' CG2' ' A' ' 62' ' ' ILE . 13.3 p -65.5 162.61 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.343 -0.848 . . . . 0.0 112.239 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.16 -11.07 10.78 Favored Glycine 0 N--CA 1.491 2.367 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.727 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.672 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 14.2 m-70 -113.94 -88.29 0.56 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 119.33 1.565 . . . . 0.0 111.015 -178.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.608 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.54 -32.29 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.824 0.821 . . . . 0.0 109.785 -179.531 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.549 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 1.4 pp 174.03 -11.58 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.788 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.17 -15.01 81.74 Favored Glycine 0 N--CA 1.492 2.372 0 O-C-N 120.827 -1.171 . . . . 0.0 110.418 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.672 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 12.9 mm-40 . . . . . 0 N--CA 1.495 1.785 0 O-C-N 121.252 -1.146 . . . . 0.0 109.58 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.736 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.181 0.515 . . . . 0.0 110.261 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.8 p -104.42 116.36 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.736 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 28.1 t70 -50.02 105.48 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.482 -0.761 . . . . 0.0 111.014 -178.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -64.82 -24.97 67.71 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -66.83 -31.43 72.05 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.281 0.563 . . . . 0.0 109.511 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.627 ' CD1' HG12 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -78.97 -35.42 43.08 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.504 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.613 ' HG ' ' HE1' ' A' ' 44' ' ' MET . 2.7 mp -63.18 -42.95 99.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.689 -0.632 . . . . 0.0 109.558 178.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.529 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -56.35 -22.94 34.27 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.277 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.446 ' HB2' HG22 ' A' ' 31' ' ' ILE . 12.2 mttt -99.0 -31.15 11.95 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.503 -0.748 . . . . 0.0 110.602 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.525 HG23 ' HG2' ' A' ' 44' ' ' MET . 1.8 p -73.27 -40.07 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.132 -0.98 . . . . 0.0 110.559 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.529 HD22 ' HA ' ' A' ' 17' ' ' GLU . 4.0 pp -64.14 -25.05 67.92 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -72.89 -33.11 65.84 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.439 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 2.9 mm? -73.89 -26.96 60.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.43 -0.794 . . . . 0.0 109.238 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -81.74 -14.01 57.04 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.535 -0.728 . . . . 0.0 109.842 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.28 -38.94 21.49 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.525 -0.735 . . . . 0.0 109.078 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.98 -19.81 31.5 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.266 0.555 . . . . 0.0 109.824 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.47 3.32 72.02 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -85.35 148.04 26.23 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.382 -1.07 . . . . 0.0 110.507 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -119.33 94.2 4.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.456 -0.778 . . . . 0.0 109.745 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -117.5 -157.89 0.68 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.49 -0.757 . . . . 0.0 110.45 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.0 OUTLIER -110.84 147.2 35.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.595 -0.691 . . . . 0.0 110.63 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.503 ' HB ' HG12 ' A' ' 49' ' ' ILE . 2.8 mp -121.87 117.95 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.488 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . 3.8 mppt? -82.56 159.0 22.88 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.276 -0.89 . . . . 0.0 111.21 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 17.9 m -139.74 158.51 43.99 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.576 -0.703 . . . . 0.0 110.037 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -146.93 38.77 1.0 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.367 -0.833 . . . . 0.0 111.052 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.7 m -98.05 -109.06 0.17 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.992 -1.067 . . . . 0.0 110.756 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.9 -64.73 0.19 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.912 -1.117 . . . . 0.0 110.366 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 38' ' ' SER . 1.6 mtp180 -92.54 25.63 2.96 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.405 -0.81 . . . . 0.0 110.191 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 37' ' ' ARG . 73.7 m -31.53 116.92 0.18 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.335 0.588 . . . . 0.0 112.466 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.701 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 45.1 m -124.38 159.93 29.28 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.74 -0.6 . . . . 0.0 110.476 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.599 HG21 HG13 ' A' ' 62' ' ' ILE . 5.3 mp -88.63 169.47 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.609 -0.682 . . . . 0.0 110.407 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.641 HG21 ' SD ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -140.07 172.9 5.63 Favored Pre-proline 0 N--CA 1.508 2.458 0 O-C-N 121.176 -0.952 . . . . 0.0 110.945 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 41.8 Cg_endo -66.0 -30.1 48.25 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 124.394 1.734 . . . . 0.0 111.561 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.98 5.03 10.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.497 -0.752 . . . . 0.0 110.461 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.641 ' SD ' HG21 ' A' ' 41' ' ' VAL . 23.1 mtt -111.78 -0.7 15.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 111.411 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 42' ' ' PRO . 2.1 p -41.42 -4.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.923 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 44' ' ' MET . . . -137.71 35.27 2.07 Favored Glycine 0 N--CA 1.495 2.588 0 O-C-N 119.771 -1.831 . . . . 0.0 110.47 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.439 ' CE1' ' HB3' ' A' ' 22' ' ' LEU . 26.2 m-70 -144.43 153.18 41.64 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.09 -1.241 . . . . 0.0 110.971 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -99.77 92.34 5.27 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.286 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.627 HG12 ' CD1' ' A' ' 15' ' ' LEU . 2.6 mt -88.8 120.78 38.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.097 -1.002 . . . . 0.0 111.239 -177.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.708 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -76.31 77.1 3.08 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.986 0.898 . . . . 0.0 109.09 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.0 m -56.73 132.25 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.476 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 33' ' ' THR . 19.8 t80 -77.14 104.52 7.69 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.574 -0.85 . . . . 0.0 109.006 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -70.2 0.4 6.37 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.571 -0.706 . . . . 0.0 110.421 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.31 -23.66 7.99 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.52 -28.94 0.7 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 122.051 -0.676 . . . . 0.0 111.136 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.53 155.57 45.55 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.243 -0.911 . . . . 0.0 112.159 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.467 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . 6.9 m80 -100.81 104.78 16.03 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.708 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 39.1 t -93.71 101.16 5.53 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.205 -0.934 . . . . 0.0 109.92 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.494 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.7 Cg_endo -66.23 90.19 0.26 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 O-C-N 123.909 1.479 . . . . 0.0 109.82 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 60' ' ' VAL . 34.3 m -101.8 127.67 55.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.707 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 4.6 t80 -69.72 111.88 5.8 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 177.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.686 HG21 ' HB ' ' A' ' 67' ' ' VAL . 0.4 OUTLIER -51.33 -51.34 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.833 -0.542 . . . . 0.0 111.398 -178.058 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 m 60.88 169.85 0.09 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.363 0.602 . . . . 0.0 109.538 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.424 ' N ' HG21 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -81.51 2.85 27.12 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.873 -1.142 . . . . 0.0 111.603 -179.313 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -142.51 1.88 1.39 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.83 -1.169 . . . . 0.0 113.038 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.587 ' HB2' ' O ' ' A' ' 62' ' ' ILE . 20.2 mmt -99.95 -15.06 18.45 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.435 -1.415 . . . . 0.0 110.206 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.686 ' HB ' HG21 ' A' ' 62' ' ' ILE . 13.9 p -74.37 168.73 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.252 -0.905 . . . . 0.0 112.254 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.8 -5.35 22.52 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.701 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.662 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 19.8 m-70 -127.57 -85.0 0.6 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 119.289 1.545 . . . . 0.0 110.854 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.701 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.9 -29.29 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.532 0.682 . . . . 0.0 110.088 -179.243 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.601 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 2.4 pp 171.58 -17.39 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.309 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.67 -18.76 74.26 Favored Glycine 0 N--CA 1.494 2.549 0 O-C-N 121.083 -1.01 . . . . 0.0 110.802 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.662 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 23.6 mm-40 . . . . . 0 N--CA 1.497 1.879 0 O-C-N 121.214 -1.168 . . . . 0.0 109.213 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.513 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 1.6 t80 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.592 0.71 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.635 ' CG2' HG23 ' A' ' 41' ' ' VAL . 6.6 p -134.13 123.58 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.648 ' HB3' HG22 ' A' ' 33' ' ' THR . 49.0 m-20 -29.13 99.51 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.117 0.484 . . . . 0.0 111.817 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.1 -25.04 64.22 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.73 -21.23 55.56 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 122.021 -0.424 . . . . 0.0 110.044 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.644 ' HG ' HD13 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -80.88 -37.66 29.4 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.644 HD13 ' HG ' ' A' ' 15' ' ' LEU . 3.6 mp -64.48 -42.36 95.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.716 -0.615 . . . . 0.0 109.893 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.502 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -56.24 -21.17 21.87 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.759 179.787 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.71 -26.06 11.96 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.311 -0.868 . . . . 0.0 110.335 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.607 HG12 ' CE ' ' A' ' 44' ' ' MET . 0.5 OUTLIER -76.5 -36.9 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.303 -0.873 . . . . 0.0 110.935 -179.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.502 HD22 ' HA ' ' A' ' 17' ' ' GLU . 3.8 pp -63.71 -28.7 70.07 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -33.66 68.48 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.499 HD21 ' HB2' ' A' ' 27' ' ' GLU . 1.2 mt -79.58 -27.79 41.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.665 -0.647 . . . . 0.0 109.488 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -82.44 -11.29 58.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.538 -0.726 . . . . 0.0 109.558 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.57 -40.04 21.46 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.513 -0.742 . . . . 0.0 109.978 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.534 ' CD ' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -103.99 -25.76 12.88 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.403 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.92 25.31 5.96 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.534 ' HG3' ' CD ' ' A' ' 25' ' ' LYS . 4.7 mt-10 -79.3 130.12 35.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.335 -1.097 . . . . 0.0 110.602 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.0 mtmm -107.64 65.78 0.65 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.57 -0.707 . . . . 0.0 109.125 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.72 -151.03 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.6 -0.687 . . . . 0.0 110.049 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.0 OUTLIER -120.96 145.21 47.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.854 . . . . 0.0 110.57 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.488 HG23 ' HA ' ' A' ' 15' ' ' LEU . 2.7 mp -120.4 113.16 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.496 -0.753 . . . . 0.0 109.434 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -92.76 147.65 22.69 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.311 -0.868 . . . . 0.0 110.813 -179.35 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.648 HG22 ' HB3' ' A' ' 12' ' ' ASP . 17.6 m -138.69 166.7 23.7 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.468 -0.77 . . . . 0.0 110.301 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.423 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 15.4 m-90 -139.01 39.89 2.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.711 -0.618 . . . . 0.0 109.874 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 10' ' ' PHE . 50.6 m -78.82 -142.38 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.337 -0.852 . . . . 0.0 110.654 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.32 -61.4 1.41 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.989 -1.07 . . . . 0.0 110.317 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.513 ' HB3' ' HB3' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -94.33 39.53 1.09 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.403 -0.81 . . . . 0.0 109.825 179.484 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.485 ' HB3' HG22 ' A' ' 51' ' ' VAL . 36.3 m -35.54 131.57 0.48 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.302 0.572 . . . . 0.0 112.277 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 27.9 m -150.02 162.27 40.71 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.631 -0.668 . . . . 0.0 110.401 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.61 HG22 HG12 ' A' ' 62' ' ' ILE . 1.2 mp -80.42 165.92 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.418 0 CA-C-O 121.642 0.734 . . . . 0.0 111.647 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.751 HG21 ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -140.4 179.59 1.22 Allowed Pre-proline 0 N--CA 1.503 2.183 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.605 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.638 ' HD2' ' CG1' ' A' ' 41' ' ' VAL . 48.8 Cg_endo -70.94 -33.01 12.76 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.872 1.459 . . . . 0.0 111.512 -179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -73.18 -0.14 13.42 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.451 -0.781 . . . . 0.0 110.984 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 41' ' ' VAL . 1.3 mpt? -100.8 2.99 41.7 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.304 -0.872 . . . . 0.0 111.378 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 42' ' ' PRO . 4.0 p -57.2 -0.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.64 35.1 1.04 Allowed Glycine 0 N--CA 1.493 2.495 0 O-C-N 120.42 -1.425 . . . . 0.0 109.736 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.494 ' HB2' HD12 ' A' ' 49' ' ' ILE . 45.6 m-70 -144.34 154.93 43.53 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.279 -1.13 . . . . 0.0 111.06 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.571 HG22 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.76 83.85 2.82 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.223 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.567 HG12 ' CD1' ' A' ' 15' ' ' LEU . 2.7 mp -86.26 122.61 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 111.141 -177.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.733 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.09 87.13 4.87 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.971 0.891 . . . . 0.0 109.729 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.485 HG22 ' HB3' ' A' ' 38' ' ' SER . 4.9 p -62.36 120.55 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.733 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.489 ' HB2' ' O ' ' A' ' 33' ' ' THR . 20.6 t80 -67.1 109.19 2.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -0.897 . . . . 0.0 109.65 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -78.18 10.66 2.81 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.599 -0.688 . . . . 0.0 110.604 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.58 -26.72 13.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -139.82 -28.17 0.75 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.662 -0.905 . . . . 0.0 110.429 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -130.36 153.73 48.4 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.0 0.905 . . . . 0.0 113.323 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 6.5 m80 -96.02 113.99 25.65 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.733 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 21.9 t -103.44 94.76 6.24 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.238 -0.914 . . . . 0.0 109.531 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.502 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.6 Cg_endo -66.29 89.54 0.26 Allowed 'Trans proline' 0 N--CA 1.491 1.364 0 O-C-N 123.981 1.516 . . . . 0.0 109.567 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.523 HG21 ' O ' ' A' ' 58' ' ' VAL . 93.6 t -98.34 120.6 47.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.828 -179.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.571 ' HB2' HG22 ' A' ' 48' ' ' THR . 2.5 t80 -73.65 105.07 4.81 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.61 HG12 HG22 ' A' ' 40' ' ' ILE . 2.9 mp -85.38 135.07 25.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.679 -0.638 . . . . 0.0 111.071 -178.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.3 p -98.26 -158.81 0.7 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.88 10.27 19.21 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.925 -1.11 . . . . 0.0 111.45 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -145.16 17.75 1.56 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.85 -1.156 . . . . 0.0 112.259 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 67.9 mtt -115.56 0.11 13.21 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.056 -1.028 . . . . 0.0 110.076 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.588 HG21 ' HB ' ' A' ' 40' ' ' ILE . 8.1 p -85.68 167.57 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.219 -0.926 . . . . 0.0 111.298 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.489 ' N ' HG23 ' A' ' 67' ' ' VAL . . . 115.75 -15.98 16.54 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.615 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 15.6 m-70 -118.72 -86.36 0.64 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.052 -1.263 . . . . 0.0 111.122 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.01 -33.81 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 122.165 0.983 . . . . 0.0 109.277 -179.611 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.49 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 0.5 OUTLIER 178.77 -16.13 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.834 -179.711 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.38 -14.2 79.47 Favored Glycine 0 N--CA 1.497 2.763 0 O-C-N 120.875 -1.141 . . . . 0.0 110.407 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.615 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 2.7 mm-40 . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.324 -1.103 . . . . 0.0 108.667 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.723 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.119 0.485 . . . . 0.0 109.942 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.457 ' CG2' HG12 ' A' ' 41' ' ' VAL . 14.8 p -114.33 122.04 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.383 -0.823 . . . . 0.0 108.915 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.723 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 37.5 t70 -48.53 107.85 0.15 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.64 -0.662 . . . . 0.0 111.579 -178.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.529 ' HA ' HD11 ' A' ' 16' ' ' LEU . 9.5 t70 -68.63 -22.48 64.42 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -67.06 -21.88 65.87 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.044 0.45 . . . . 0.0 110.358 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.568 ' HG ' ' N ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -83.7 -36.94 23.34 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.325 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.568 ' N ' ' HG ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -66.87 -46.5 74.8 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.427 179.291 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.512 ' HA ' HD22 ' A' ' 20' ' ' LEU . 5.3 pt-20 -52.62 -21.88 4.42 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.728 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.0 -29.21 10.08 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.366 -0.834 . . . . 0.0 110.693 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.618 HG13 ' CE ' ' A' ' 44' ' ' MET . 1.4 p -78.51 -38.7 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.096 -1.003 . . . . 0.0 111.161 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.512 HD22 ' HA ' ' A' ' 17' ' ' GLU . 3.6 pp -63.11 -24.83 68.08 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -71.84 -32.2 67.28 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.462 ' HG ' ' HB3' ' A' ' 27' ' ' GLU . 1.7 mp -76.96 -27.11 54.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.652 -0.655 . . . . 0.0 109.381 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -86.29 -14.29 44.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.556 -0.715 . . . . 0.0 109.286 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.04 -40.35 12.36 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.666 -0.646 . . . . 0.0 110.2 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.411 ' CE ' ' HG2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -93.86 -29.55 15.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.453 -0.779 . . . . 0.0 109.19 179.721 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.93 22.35 7.65 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.462 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 8.2 mm-40 -82.32 136.05 35.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.335 -1.097 . . . . 0.0 109.87 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -113.29 80.73 1.4 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.463 -0.773 . . . . 0.0 109.961 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.53 -160.66 1.0 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.353 0.597 . . . . 0.0 110.532 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -106.98 161.31 14.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.64 -0.663 . . . . 0.0 110.447 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.665 ' HB ' HG12 ' A' ' 49' ' ' ILE . 37.9 mm -116.01 164.43 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.518 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 2.1 mptt -127.68 149.99 49.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.476 HG21 ' CG ' ' A' ' 12' ' ' ASP . 22.4 m -135.21 155.16 51.14 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.361 -0.837 . . . . 0.0 111.227 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.518 ' CH2' ' HB2' ' A' ' 32' ' ' LYS . 23.2 m-90 -145.18 28.47 1.22 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.728 -0.608 . . . . 0.0 110.352 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.435 ' O ' ' HD2' ' A' ' 52' ' ' TYR . 0.4 OUTLIER -92.88 -159.32 0.67 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.065 -1.022 . . . . 0.0 110.934 -179.222 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -108.47 -56.53 2.24 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.093 -1.004 . . . . 0.0 110.55 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -94.4 33.27 1.43 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.394 -0.816 . . . . 0.0 110.189 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.9 m -39.0 126.03 1.56 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.404 0.621 . . . . 0.0 111.781 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 17.4 m -133.85 162.74 31.19 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.656 -0.653 . . . . 0.0 110.28 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.707 HG21 HG12 ' A' ' 62' ' ' ILE . 1.3 mp -79.16 164.83 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.606 -0.684 . . . . 0.0 111.872 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.657 HG22 ' CG ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -140.07 175.19 3.34 Favored Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.568 -0.708 . . . . 0.0 109.536 178.468 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.649 ' HD2' ' CG1' ' A' ' 41' ' ' VAL . 46.7 Cg_endo -69.53 -32.45 19.49 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.018 1.536 . . . . 0.0 111.864 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.54 ' HB2' ' HE3' ' A' ' 44' ' ' MET . 4.6 mm-40 -73.82 -0.08 14.75 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.346 -0.846 . . . . 0.0 110.896 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.714 ' SD ' HD12 ' A' ' 49' ' ' ILE . 3.9 mmt -95.5 -6.99 39.34 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.219 -0.925 . . . . 0.0 111.853 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.552 ' HA ' HG23 ' A' ' 62' ' ' ILE . 74.0 t -45.84 -8.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.647 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.425 ' HA3' ' CE1' ' A' ' 61' ' ' TYR . . . -143.01 34.73 1.75 Allowed Glycine 0 N--CA 1.493 2.485 0 O-C-N 120.174 -1.579 . . . . 0.0 109.726 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.422 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 30.0 m-70 -141.89 150.55 41.68 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.393 -1.063 . . . . 0.0 110.559 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.77 81.91 2.53 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.714 HD12 ' SD ' ' A' ' 44' ' ' MET . 42.1 mt -77.21 124.04 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.527 -0.733 . . . . 0.0 111.472 -177.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.75 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -81.04 76.84 7.98 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.0 m -58.85 124.45 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.316 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 32.3 t80 -74.8 105.64 5.96 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.408 -0.807 . . . . 0.0 109.091 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -68.93 -0.23 5.31 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.669 -0.644 . . . . 0.0 110.95 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.81 -18.5 9.85 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -140.03 -28.78 0.73 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.795 -0.827 . . . . 0.0 110.975 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -136.28 154.65 50.82 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.23 -0.919 . . . . 0.0 112.146 -178.21 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.456 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . 5.7 m-70 -99.12 105.5 17.6 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.75 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 38.1 t -94.36 101.58 6.89 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.098 -1.001 . . . . 0.0 109.957 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.527 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.3 Cg_endo -66.13 94.12 0.29 Allowed 'Trans proline' 0 N--CA 1.492 1.396 0 O-C-N 123.995 1.523 . . . . 0.0 108.934 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.491 ' O ' HD13 ' A' ' 62' ' ' ILE . 75.6 t -109.73 125.33 66.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.065 -177.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 2.5 t80 -70.69 110.67 5.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.707 HG12 HG21 ' A' ' 40' ' ' ILE . 1.5 mp -61.06 -59.33 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.644 -0.66 . . . . 0.0 112.406 -177.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 3.5 m 69.52 161.26 0.21 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -177.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.454 ' N ' HG11 ' A' ' 45' ' ' VAL . 7.5 tp10 -78.42 62.24 3.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.83 -1.169 . . . . 0.0 109.902 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -173.1 -27.79 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.133 -0.979 . . . . 0.0 112.607 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.41 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 4.8 mmm -97.69 6.6 47.74 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.804 -1.185 . . . . 0.0 111.608 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.502 HG23 ' N ' ' A' ' 68' ' ' GLY . 7.5 p -89.07 163.83 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 120.857 -1.152 . . . . 0.0 112.059 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.502 ' N ' HG23 ' A' ' 67' ' ' VAL . . . 109.68 -14.73 32.19 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.517 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 16.8 m-70 -117.77 -89.73 0.58 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.984 -1.303 . . . . 0.0 111.125 -179.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.611 ' HG2' ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER 177.64 -31.39 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.134 0.968 . . . . 0.0 109.232 -179.38 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.611 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 2.2 pp 177.62 -17.91 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.657 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.0 -15.68 74.36 Favored Glycine 0 N--CA 1.499 2.841 0 O-C-N 120.936 -1.103 . . . . 0.0 110.427 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.517 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 2.5 mm-40 . . . . . 0 N--CA 1.496 1.844 0 O-C-N 121.352 -1.087 . . . . 0.0 108.407 178.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.716 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 121.323 0.583 . . . . 0.0 110.165 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.408 ' CG2' HG23 ' A' ' 41' ' ' VAL . 14.5 p -102.12 109.96 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.716 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 26.2 t70 -45.63 109.17 0.16 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.516 -0.74 . . . . 0.0 111.499 -178.207 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -67.43 -23.86 65.58 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.46 -29.26 66.89 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.115 0.483 . . . . 0.0 110.097 179.284 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.671 ' HG ' HD11 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -79.95 -38.14 32.99 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.67 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.671 HD11 ' HG ' ' A' ' 15' ' ' LEU . 3.2 mp -63.33 -39.61 95.02 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.414 0.626 . . . . 0.0 109.553 178.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.49 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -55.49 -23.66 27.15 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.799 -0.563 . . . . 0.0 110.029 179.271 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -97.89 -31.82 12.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.482 -0.761 . . . . 0.0 110.499 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 16' ' ' LEU . 1.4 p -71.27 -38.16 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.317 -0.865 . . . . 0.0 110.933 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.49 HD22 ' HA ' ' A' ' 17' ' ' GLU . 3.8 pp -63.27 -26.82 68.95 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.053 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -74.47 -32.58 62.63 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.53 HD21 ' HB2' ' A' ' 27' ' ' GLU . 1.5 mt -75.14 -27.53 59.79 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -83.47 -12.41 56.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.519 -0.738 . . . . 0.0 109.463 178.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.5 -39.88 16.97 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 121.556 -0.715 . . . . 0.0 109.931 179.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.426 ' CE ' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -97.71 -26.65 14.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.509 -0.744 . . . . 0.0 109.807 179.716 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.416 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . 105.07 26.73 6.18 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.53 ' HB2' HD21 ' A' ' 22' ' ' LEU . 7.2 mt-10 -82.44 130.31 35.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.371 -1.076 . . . . 0.0 110.232 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -113.88 59.64 0.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.504 -0.747 . . . . 0.0 109.645 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.39 -136.68 0.32 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.495 -0.753 . . . . 0.0 109.877 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.566 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -132.56 153.88 50.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.95 -1.094 . . . . 0.0 110.719 -179.333 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.659 ' HB ' HD11 ' A' ' 49' ' ' ILE . 4.2 mt -127.35 120.07 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.224 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HG3' ' CZ2' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -100.35 160.03 14.66 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.529 -0.732 . . . . 0.0 111.462 -178.69 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 18.8 m -141.2 168.65 19.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.811 -0.556 . . . . 0.0 110.112 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.418 ' CZ2' ' HG3' ' A' ' 32' ' ' LYS . 17.7 m-90 -144.59 39.32 1.27 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.365 -0.834 . . . . 0.0 110.556 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.9 t -92.88 -94.31 0.15 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.175 -0.953 . . . . 0.0 110.544 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.7 ttm105 -167.17 -60.16 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.989 -1.069 . . . . 0.0 110.841 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -103.34 35.67 2.5 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.336 -0.853 . . . . 0.0 110.568 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -41.01 121.91 1.64 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.16 0.505 . . . . 0.0 111.89 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.705 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 87.8 m -120.74 158.87 26.56 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.679 -0.638 . . . . 0.0 110.293 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.704 HG23 HG12 ' A' ' 62' ' ' ILE . 4.9 mp -85.76 169.34 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.367 -0.833 . . . . 0.0 111.274 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.696 HG21 ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -138.21 179.49 1.31 Allowed Pre-proline 0 N--CA 1.502 2.14 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.097 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.615 ' HD2' ' CG1' ' A' ' 41' ' ' VAL . 44.9 Cg_endo -68.6 -31.89 25.59 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.879 1.463 . . . . 0.0 111.303 -179.277 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.87 -3.62 16.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.587 -0.696 . . . . 0.0 111.127 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.696 ' SD ' HG21 ' A' ' 41' ' ' VAL . 1.3 mpt? -93.72 0.09 56.23 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.201 -0.937 . . . . 0.0 111.925 -179.304 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.506 HG22 ' CG ' ' A' ' 64' ' ' GLU . 3.5 p -52.31 -3.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.99 33.11 1.52 Allowed Glycine 0 N--CA 1.493 2.473 0 O-C-N 120.394 -1.441 . . . . 0.0 109.668 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 38.6 m-70 -142.91 152.51 42.15 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.303 -1.116 . . . . 0.0 110.907 -179.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -99.61 83.61 2.81 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 178.361 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.659 HD11 ' HB ' ' A' ' 31' ' ' ILE . 1.1 mm -78.6 112.23 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 111.587 -177.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.673 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -76.43 79.92 3.15 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.079 0.943 . . . . 0.0 108.777 178.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.3 m -62.19 132.19 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.816 -178.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.515 ' HB2' ' O ' ' A' ' 33' ' ' THR . 26.5 t80 -77.03 103.45 6.97 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.375 -0.828 . . . . 0.0 108.876 178.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -69.71 -0.7 7.4 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.527 -0.733 . . . . 0.0 110.563 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.58 -20.12 9.56 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.761 -2.136 . . . . 0.0 107.761 -178.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -140.15 -29.73 0.7 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 122.004 -0.704 . . . . 0.0 110.752 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.89 155.94 49.83 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.295 -0.878 . . . . 0.0 112.037 -178.278 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.517 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 3.1 m80 -100.64 100.67 11.41 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.092 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.673 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 58.6 t -87.34 104.03 5.59 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.341 -0.85 . . . . 0.0 109.956 -179.041 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' A' ' 57' ' ' HIS . 42.8 Cg_endo -67.96 89.91 0.37 Allowed 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.921 1.485 . . . . 0.0 109.481 -179.336 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.5 HG21 ' O ' ' A' ' 60' ' ' VAL . 12.7 m -94.21 111.84 25.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.177 -178.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 2.4 t80 -69.96 101.25 1.73 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 118.526 -1.27 . . . . 0.0 107.598 177.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.704 HG12 HG23 ' A' ' 40' ' ' ILE . 2.7 mp -80.8 141.33 15.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 121.543 0.687 . . . . 0.0 111.338 -178.113 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.3 p -110.29 -152.09 0.49 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 177.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.506 ' CG ' HG22 ' A' ' 45' ' ' VAL . 6.9 mt-10 -87.91 -13.38 42.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.764 -1.21 . . . . 0.0 110.921 179.237 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.53 27.35 6.53 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.984 -1.072 . . . . 0.0 112.147 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.5 mmt -116.12 -29.06 6.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.06 -1.025 . . . . 0.0 110.175 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.483 HG22 ' C ' ' A' ' 41' ' ' VAL . 5.7 p -65.67 163.89 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 O-C-N 121.39 -0.819 . . . . 0.0 111.874 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.426 ' N ' HG23 ' A' ' 67' ' ' VAL . . . 123.9 -11.0 8.33 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.475 178.234 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.678 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 17.2 m-70 -124.53 -84.48 0.64 Allowed 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 119.08 1.44 . . . . 0.0 111.007 -178.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.705 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.47 -30.19 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.505 0.669 . . . . 0.0 110.273 -179.42 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.536 ' HB3' ' O ' ' A' ' 70' ' ' LYS . 0.5 OUTLIER 173.32 -16.5 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.563 -179.776 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.04 -15.62 76.47 Favored Glycine 0 N--CA 1.495 2.613 0 O-C-N 121.053 -1.029 . . . . 0.0 110.602 -179.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.678 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 22.9 mm-40 . . . . . 0 N--CA 1.496 1.843 0 O-C-N 121.141 -1.211 . . . . 0.0 109.423 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.3 m -81.13 159.03 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.461 -1.023 . . . . 0.0 110.402 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.727 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -112.69 143.32 44.1 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.533 -0.73 . . . . 0.0 109.858 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 70.4 t -105.55 117.56 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.727 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 37.1 t70 -44.45 112.71 0.45 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.403 0.621 . . . . 0.0 111.725 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.561 ' HA ' HD11 ' A' ' 16' ' ' LEU . 9.5 t70 -71.23 -21.97 62.05 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -70.11 -25.13 63.35 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.87 -0.519 . . . . 0.0 110.442 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.634 HD12 ' SD ' ' A' ' 44' ' ' MET . 0.6 OUTLIER -77.46 -37.47 51.38 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.658 ' HA ' HG11 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -62.5 -46.91 86.31 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.744 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.5 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -51.17 -23.47 3.34 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.311 179.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.465 ' HB2' HG22 ' A' ' 31' ' ' ILE . 14.3 mttm -106.06 -33.62 7.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.448 -0.782 . . . . 0.0 110.568 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.658 HG11 ' HA ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -73.3 -39.64 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.279 -0.888 . . . . 0.0 111.402 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.5 HD22 ' HA ' ' A' ' 17' ' ' GLU . 3.6 pp -63.13 -27.19 69.21 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.23 -32.67 64.88 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -77.99 -24.09 48.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.653 -0.654 . . . . 0.0 109.437 178.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -82.73 -11.63 58.16 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.392 -0.817 . . . . 0.0 109.635 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.66 -39.77 19.8 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 121.461 -0.774 . . . . 0.0 109.969 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.529 ' CD ' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -103.23 -23.37 13.62 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.459 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.414 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . 102.14 29.07 6.21 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.569 ' HB2' HD21 ' A' ' 22' ' ' LEU . 5.8 mt-10 -76.1 130.33 38.16 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.394 -1.062 . . . . 0.0 110.669 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.8 mtmm -107.3 59.68 0.62 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.569 -0.707 . . . . 0.0 109.285 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -102.88 -154.34 0.49 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.509 -0.744 . . . . 0.0 109.992 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.463 ' HB2' ' HB ' ' A' ' 48' ' ' THR . 0.0 OUTLIER -124.49 145.16 49.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.587 -0.695 . . . . 0.0 110.13 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.526 HD11 HG22 ' A' ' 19' ' ' VAL . 2.4 mp -114.65 119.83 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.615 -0.678 . . . . 0.0 109.47 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.421 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 20.5 mmtt -79.61 154.63 28.58 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.412 -0.805 . . . . 0.0 111.199 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.7 m -141.38 153.47 45.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.61 -0.681 . . . . 0.0 110.094 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.421 ' CH2' ' HB2' ' A' ' 32' ' ' LYS . 14.7 m-90 -144.49 35.01 1.17 Allowed 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.311 -0.868 . . . . 0.0 111.354 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.3 t -84.63 -96.03 0.07 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.893 -1.13 . . . . 0.0 110.586 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.6 mtm105 -171.81 -61.91 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.106 -0.996 . . . . 0.0 109.631 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.453 ' HG2' ' HD1' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -103.53 31.15 4.54 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.435 0.636 . . . . 0.0 109.399 178.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.4 m -44.74 130.9 7.08 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.439 0.637 . . . . 0.0 111.997 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 75.7 m -124.76 159.06 31.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.775 -0.578 . . . . 0.0 109.936 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.647 HG23 HG12 ' A' ' 62' ' ' ILE . 4.8 mp -79.56 169.48 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.389 -0.82 . . . . 0.0 111.237 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.567 HG22 ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -140.15 176.49 2.5 Favored Pre-proline 0 N--CA 1.5 2.056 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 43.2 Cg_endo -66.89 -29.85 40.89 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.006 1.53 . . . . 0.0 110.595 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -71.46 -3.63 22.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.444 -0.785 . . . . 0.0 111.061 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.634 ' SD ' HD12 ' A' ' 15' ' ' LEU . 1.4 mtp -98.24 7.21 46.57 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.988 -1.07 . . . . 0.0 112.143 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.629 HG23 ' HA ' ' A' ' 64' ' ' GLU . 89.6 t -57.5 -1.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.529 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.06 35.41 0.99 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.431 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 31.7 m-70 -142.48 146.34 34.66 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.41 -1.053 . . . . 0.0 111.117 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.585 HG22 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.7 83.95 2.85 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 178.023 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.564 ' HB ' ' HE1' ' A' ' 44' ' ' MET . 1.9 mt -86.97 120.63 36.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.139 -0.976 . . . . 0.0 110.924 -177.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.695 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -75.72 78.65 2.67 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.977 0.894 . . . . 0.0 109.152 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.3 m -59.9 131.11 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.534 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.455 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 26.8 t80 -78.06 105.01 8.99 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -75.09 7.91 2.97 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.317 -0.864 . . . . 0.0 111.055 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.26 -27.39 6.11 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.65 -24.9 0.77 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.821 -0.811 . . . . 0.0 111.495 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -132.65 154.49 50.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.134 -0.979 . . . . 0.0 112.244 -177.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.481 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . 0.8 OUTLIER -99.6 101.46 12.67 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.248 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.695 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 48.1 t -90.75 104.07 8.42 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.178 -0.951 . . . . 0.0 110.089 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.493 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.5 Cg_endo -66.08 87.37 0.24 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 O-C-N 123.899 1.473 . . . . 0.0 109.447 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.506 HG21 ' O ' ' A' ' 60' ' ' VAL . 15.1 m -92.72 112.59 26.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.464 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.585 ' HB2' HG22 ' A' ' 48' ' ' THR . 2.3 t80 -75.13 100.36 4.23 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.647 HG12 HG23 ' A' ' 40' ' ' ILE . 2.8 mp -81.57 135.29 25.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.564 -0.71 . . . . 0.0 111.144 -178.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.9 p -101.03 -155.47 0.52 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.629 ' HA ' HG23 ' A' ' 45' ' ' VAL . 1.3 tp10 -89.43 10.88 20.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.627 -1.295 . . . . 0.0 110.614 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.92 24.15 1.19 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.941 -1.099 . . . . 0.0 111.478 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.713 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 6.6 mmt -114.09 -27.95 7.5 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.039 -1.038 . . . . 0.0 110.216 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.528 ' HA ' ' HZ ' ' A' ' 74' ' ' PHE . 7.5 p -63.02 164.87 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 O-C-N 121.585 -0.697 . . . . 0.0 111.822 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 123.35 -14.51 8.23 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.387 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.693 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 16.5 m-70 -122.03 -85.04 0.66 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 119.034 1.417 . . . . 0.0 111.21 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.65 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.68 -30.64 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.586 0.708 . . . . 0.0 110.42 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.515 ' HB3' ' O ' ' A' ' 70' ' ' LYS . 0.4 OUTLIER 174.46 -16.0 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.706 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.55 -16.4 75.8 Favored Glycine 0 N--CA 1.497 2.704 0 O-C-N 120.954 -1.091 . . . . 0.0 110.686 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.693 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 1.1 mm-40 -86.03 -16.73 37.29 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.254 -1.145 . . . . 0.0 109.461 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.713 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 1.6 m-85 -109.39 -16.87 13.92 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.568 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -137.55 55.23 9.26 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.525 -0.734 . . . . 0.0 110.162 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 47.1 Cg_endo -85.33 50.04 2.64 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.63 1.332 . . . . 0.0 110.273 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.5 m -129.64 147.24 51.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.641 -0.662 . . . . 0.0 110.311 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.4 -175.68 3.88 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.573 -0.704 . . . . 0.0 110.308 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.7 t -66.2 -26.21 67.29 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.453 -0.779 . . . . 0.0 110.744 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.1 p90 . . . . . 0 N--CA 1.496 1.861 0 O-C-N 121.346 -0.846 . . . . 0.0 110.275 179.803 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.26 139.03 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.557 -0.966 . . . . 0.0 110.265 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.754 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -126.98 143.36 51.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.444 -0.785 . . . . 0.0 110.03 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.8 p -106.06 116.92 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.754 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 35.9 t70 -47.93 108.7 0.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.437 -0.79 . . . . 0.0 111.266 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.77 -23.88 66.13 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -70.58 -20.54 62.77 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.976 -0.453 . . . . 0.0 110.071 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.629 ' HG ' HD11 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -88.54 -35.13 17.12 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.304 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.629 HD11 ' HG ' ' A' ' 15' ' ' LEU . 4.7 mp -69.52 -38.69 77.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.72 -0.612 . . . . 0.0 110.204 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.528 ' HA ' HD22 ' A' ' 20' ' ' LEU . 3.0 pt-20 -58.29 -20.69 44.76 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.439 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.474 ' HB2' HG22 ' A' ' 31' ' ' ILE . 41.7 mtpt -100.3 -29.56 12.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.387 -0.821 . . . . 0.0 110.394 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.618 HG13 ' HG3' ' A' ' 43' ' ' GLU . 1.5 p -76.19 -37.21 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.247 -0.908 . . . . 0.0 111.141 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.528 HD22 ' HA ' ' A' ' 17' ' ' GLU . 3.7 pp -61.8 -26.58 68.19 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.02 -33.97 70.86 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.19 -25.46 42.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.694 -0.629 . . . . 0.0 109.573 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -84.31 -12.91 53.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.509 -0.744 . . . . 0.0 109.592 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.87 -39.22 13.2 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 121.509 -0.745 . . . . 0.0 110.014 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 15.3 mmtt -94.77 -29.86 14.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.578 -0.701 . . . . 0.0 109.332 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.23 25.01 6.89 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -84.63 136.13 33.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.413 -1.051 . . . . 0.0 110.091 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -113.1 77.4 1.05 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.418 -0.801 . . . . 0.0 109.623 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.93 -154.85 0.57 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.496 -0.752 . . . . 0.0 110.363 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.507 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -112.85 155.36 24.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.412 -0.805 . . . . 0.0 110.545 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.515 HG23 HD11 ' A' ' 15' ' ' LEU . 2.7 mp -129.24 113.5 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.493 -0.755 . . . . 0.0 109.338 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.503 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -66.64 154.36 40.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.521 -0.737 . . . . 0.0 111.117 -179.062 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.509 HG22 ' CB ' ' A' ' 12' ' ' ASP . 9.1 m -143.06 135.83 27.75 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.696 -0.628 . . . . 0.0 109.997 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.651 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -152.46 75.71 1.12 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.259 -0.9 . . . . 0.0 111.25 -179.713 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.403 ' HB3' ' CE2' ' A' ' 10' ' ' PHE . 0.6 OUTLIER -123.28 -82.2 0.65 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.147 -0.97 . . . . 0.0 110.052 179.061 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.41 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 5.8 ttm180 -167.97 -64.17 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.314 -0.866 . . . . 0.0 109.727 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.41 ' HD2' ' HB3' ' A' ' 36' ' ' ARG . 0.4 OUTLIER -104.25 35.11 2.8 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.57 -0.706 . . . . 0.0 109.387 179.113 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.0 m -37.9 124.92 1.17 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.406 0.622 . . . . 0.0 111.991 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 34.4 m -130.57 159.08 38.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.788 -0.57 . . . . 0.0 110.183 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.632 HG22 HG12 ' A' ' 62' ' ' ILE . 5.1 mp -83.85 168.94 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.401 -0.812 . . . . 0.0 110.909 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.603 HG21 ' CG ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -138.43 176.9 2.36 Favored Pre-proline 0 N--CA 1.501 2.112 0 O-C-N 121.743 -0.598 . . . . 0.0 109.683 179.375 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.563 ' HD2' ' CG1' ' A' ' 41' ' ' VAL . 43.4 Cg_endo -66.93 -31.34 38.19 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.005 1.529 . . . . 0.0 111.276 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.618 ' HG3' HG13 ' A' ' 19' ' ' VAL . 2.5 pt-20 -72.27 -3.08 21.56 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.313 -0.867 . . . . 0.0 111.075 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.603 ' CG ' HG21 ' A' ' 41' ' ' VAL . 18.8 mmt -97.15 10.1 40.32 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.213 -0.929 . . . . 0.0 111.748 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.591 HG23 ' HA ' ' A' ' 64' ' ' GLU . 80.3 t -61.24 0.63 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 O-C-N 120.93 -1.106 . . . . 0.0 113.508 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.38 35.53 0.96 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.462 ' HB2' HD12 ' A' ' 49' ' ' ILE . 36.4 m-70 -141.68 150.24 41.62 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.484 -1.009 . . . . 0.0 111.041 -178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.555 HG22 ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -99.77 83.7 2.79 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.585 HG12 ' CD1' ' A' ' 15' ' ' LEU . 2.4 mp -83.56 121.39 36.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.398 -0.813 . . . . 0.0 110.885 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.736 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -77.23 79.49 3.75 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.695 0.76 . . . . 0.0 109.456 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.4 ' HA ' ' HB ' ' A' ' 33' ' ' THR . 19.4 m -58.16 135.0 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.385 0.612 . . . . 0.0 110.643 -179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.651 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 30.5 t80 -75.62 106.82 7.38 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.558 -0.714 . . . . 0.0 109.31 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -77.54 4.78 10.38 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.307 -0.871 . . . . 0.0 110.734 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.64 -30.17 4.98 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.87 -26.27 0.73 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.961 -0.729 . . . . 0.0 111.578 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.8 155.42 41.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.227 -0.92 . . . . 0.0 112.345 -177.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.472 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . 1.2 m-70 -97.77 104.81 16.87 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.736 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 48.6 t -93.51 101.49 5.93 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.228 -0.92 . . . . 0.0 110.108 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.52 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.7 Cg_endo -65.77 90.32 0.24 Allowed 'Trans proline' 0 N--CA 1.494 1.513 0 O-C-N 123.892 1.469 . . . . 0.0 109.712 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.55 HG12 ' CG ' ' A' ' 74' ' ' PHE . 44.7 t -96.04 113.96 31.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.123 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.555 ' HB2' HG22 ' A' ' 48' ' ' THR . 2.4 t80 -72.9 103.93 3.88 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.632 HG12 HG22 ' A' ' 40' ' ' ILE . 2.7 mp -84.81 132.04 32.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.638 -0.664 . . . . 0.0 111.105 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.0 p -94.92 -157.2 0.55 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 177.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.591 ' HA ' HG23 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -90.12 15.42 10.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.8 -1.188 . . . . 0.0 110.883 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.79 19.72 1.01 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.875 -1.141 . . . . 0.0 112.051 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.72 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 5.3 mmt -115.58 -18.19 10.97 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.834 -1.166 . . . . 0.0 110.502 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.538 HG22 ' C ' ' A' ' 41' ' ' VAL . 5.6 p -73.94 167.15 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.316 -0.865 . . . . 0.0 111.759 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.452 ' N ' HG23 ' A' ' 67' ' ' VAL . . . 121.28 -11.97 9.75 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.164 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.66 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 18.7 m-70 -128.13 -81.42 0.59 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.944 1.372 . . . . 0.0 111.257 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.6 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.76 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 121.714 0.768 . . . . 0.0 110.126 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.548 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 0.7 OUTLIER 173.73 -16.45 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.759 -179.641 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.1 -16.11 76.73 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.002 -1.061 . . . . 0.0 110.506 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.66 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 21.3 mm-40 -83.94 -21.07 31.95 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.245 -1.15 . . . . 0.0 108.97 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.72 ' CD2' ' HB3' ' A' ' 66' ' ' MET . 14.9 m-85 -94.35 -21.87 18.7 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.56 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -134.11 56.11 17.83 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.816 -0.553 . . . . 0.0 109.716 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.56 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 46.3 Cg_endo -84.78 50.77 3.01 Favored 'Trans proline' 0 C--N 1.32 -0.968 0 O-C-N 123.587 1.309 . . . . 0.0 110.303 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.5 m -71.98 132.44 44.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.536 -0.727 . . . . 0.0 110.188 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.19 179.34 5.09 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.48 -0.762 . . . . 0.0 110.383 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 29.1 p -74.83 149.19 39.7 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.448 -0.782 . . . . 0.0 110.406 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 . . . . . 0 N--CA 1.501 2.101 0 O-C-N 121.805 -0.559 . . . . 0.0 110.681 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -106.97 -33.57 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.473 -1.016 . . . . 0.0 110.892 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.741 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -141.37 139.26 33.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.815 . . . . 0.0 110.189 -179.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 p -105.17 112.86 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.741 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 38.9 t70 -41.38 111.8 0.25 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.468 0.651 . . . . 0.0 111.913 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.567 ' HA ' HD11 ' A' ' 16' ' ' LEU . 8.4 t70 -69.75 -23.99 63.47 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -67.4 -26.66 66.55 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.928 -0.483 . . . . 0.0 110.221 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.566 ' HG ' ' N ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -79.31 -36.11 40.14 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.621 ' HA ' HG11 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -64.57 -45.55 86.57 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.688 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.82 -22.69 2.29 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.148 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.443 ' HB2' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -103.59 -36.55 7.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.579 -0.701 . . . . 0.0 110.174 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.621 HG11 ' HA ' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -70.22 -40.67 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.281 -0.887 . . . . 0.0 110.872 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.466 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 10.9 mt -62.69 -37.26 85.79 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.57 -34.69 78.84 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.766 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -77.71 -27.78 50.76 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.345 -0.847 . . . . 0.0 109.515 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -82.51 -12.07 58.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.631 -0.668 . . . . 0.0 109.82 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.86 -35.22 20.74 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 121.385 -0.822 . . . . 0.0 109.867 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.474 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 11.3 mmtt -89.3 -16.05 32.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.61 -0.681 . . . . 0.0 109.816 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.35 26.52 27.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -109.44 137.89 46.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.587 -0.949 . . . . 0.0 110.489 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -110.63 87.78 2.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.49 -0.756 . . . . 0.0 109.644 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.44 -154.34 0.54 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.472 -0.767 . . . . 0.0 110.266 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -112.02 155.43 23.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -0.806 . . . . 0.0 110.589 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.485 HD11 HG22 ' A' ' 19' ' ' VAL . 3.3 mt -130.56 122.01 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.604 -0.685 . . . . 0.0 109.74 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 34' ' ' TRP . 0.1 OUTLIER -84.68 155.63 21.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.407 -0.808 . . . . 0.0 110.882 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.454 HG22 ' OG ' ' A' ' 38' ' ' SER . 19.4 m -137.17 158.19 44.99 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.582 -0.699 . . . . 0.0 110.466 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.479 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 19.8 m-90 -145.54 30.72 1.1 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.333 -0.855 . . . . 0.0 111.726 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 p -86.33 -96.91 0.08 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.847 -1.158 . . . . 0.0 110.606 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.27 -66.34 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.097 -1.002 . . . . 0.0 110.186 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.447 ' HG2' ' CD1' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -99.73 45.24 0.99 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.67 0.747 . . . . 0.0 109.6 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.454 ' OG ' HG22 ' A' ' 33' ' ' THR . 2.2 m -50.9 138.32 19.25 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.448 0.642 . . . . 0.0 112.371 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.742 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 57.0 m -132.0 159.17 39.54 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.644 HG22 ' CG2' ' A' ' 62' ' ' ILE . 5.2 mp -89.76 168.25 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.231 -0.918 . . . . 0.0 111.276 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.574 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -140.21 174.69 3.75 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.228 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.574 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 40.9 Cg_endo -64.86 -31.53 57.01 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.995 1.524 . . . . 0.0 110.194 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -65.93 -12.42 54.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.761 -0.587 . . . . 0.0 110.631 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.586 ' HE3' HD12 ' A' ' 62' ' ' ILE . 41.4 mtp -97.84 11.29 37.81 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.278 -0.888 . . . . 0.0 110.872 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 42' ' ' PRO . 7.5 p -62.14 5.03 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.339 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.28 33.05 1.03 Allowed Glycine 0 N--CA 1.493 2.475 0 O-C-N 120.311 -1.493 . . . . 0.0 109.976 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.536 ' HB2' HD12 ' A' ' 49' ' ' ILE . 45.9 m-70 -144.07 153.21 41.95 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.153 -1.204 . . . . 0.0 111.29 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.57 HG22 ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -100.01 83.92 2.78 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 178.255 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.573 ' CD1' ' HG2' ' A' ' 44' ' ' MET . 3.1 mp -86.61 118.13 32.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 111.281 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.713 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -76.77 80.26 3.38 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.922 0.868 . . . . 0.0 109.071 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.8 m -58.56 132.05 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.285 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.413 ' HB2' ' O ' ' A' ' 33' ' ' THR . 30.4 t80 -74.33 105.8 5.67 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -76.1 13.88 0.81 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.669 -0.644 . . . . 0.0 110.535 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.71 -27.72 12.8 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.5 pttp -140.48 -27.82 0.73 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.596 -0.943 . . . . 0.0 110.84 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -130.35 155.55 46.18 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.106 0.955 . . . . 0.0 113.546 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.621 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 50.8 m-70 -96.3 111.84 23.78 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.713 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 42.1 t -101.33 95.46 4.99 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.132 -0.98 . . . . 0.0 109.455 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.521 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.3 Cg_endo -65.09 87.51 0.18 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.939 1.494 . . . . 0.0 109.787 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 60' ' ' VAL . 10.4 m -94.77 114.67 31.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.208 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.57 ' HB2' HG22 ' A' ' 48' ' ' THR . 2.1 t80 -73.4 100.56 3.24 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.644 ' CG2' HG22 ' A' ' 40' ' ' ILE . 2.6 mp -83.9 138.43 19.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.594 0.711 . . . . 0.0 111.996 -177.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.406 ' C ' HG21 ' A' ' 45' ' ' VAL . 24.8 p -104.99 -153.98 0.5 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 176.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.407 ' HB2' HG22 ' A' ' 45' ' ' VAL . 4.7 tp10 -90.43 0.5 57.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.549 -1.344 . . . . 0.0 110.978 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -126.94 -8.9 6.02 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.014 -1.054 . . . . 0.0 112.191 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.71 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 8.6 mmt -86.96 -26.23 23.94 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.805 -1.184 . . . . 0.0 110.121 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.526 HG22 ' C ' ' A' ' 41' ' ' VAL . 5.5 p -66.91 164.31 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.377 -0.827 . . . . 0.0 111.827 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.416 ' N ' HG23 ' A' ' 67' ' ' VAL . . . 120.7 -11.89 10.19 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.52 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.69 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 16.3 m-70 -121.72 -84.99 0.66 Allowed 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 119.078 1.439 . . . . 0.0 111.074 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.742 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.1 OUTLIER 178.36 -30.54 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 CA-C-O 121.601 0.715 . . . . 0.0 110.328 -179.496 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.551 ' HB3' ' O ' ' A' ' 70' ' ' LYS . 1.2 pp 173.3 -15.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.703 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.71 -17.4 76.61 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.69 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 3.6 mm-40 -84.05 -20.83 32.01 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.276 -1.132 . . . . 0.0 109.202 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.71 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 5.8 m-85 -103.61 -17.47 15.14 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.561 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -137.6 55.97 10.64 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.492 -0.755 . . . . 0.0 110.209 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 44.5 Cg_endo -86.66 48.88 1.96 Allowed 'Trans proline' 0 C--N 1.318 -1.048 0 O-C-N 123.619 1.326 . . . . 0.0 110.21 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.8 m -139.46 -56.43 0.58 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.657 -0.652 . . . . 0.0 110.209 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -96.12 -48.85 5.49 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.593 -0.692 . . . . 0.0 110.28 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.4 t -106.62 -177.14 3.28 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.601 -0.687 . . . . 0.0 110.372 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.4 t80 . . . . . 0 N--CA 1.495 1.788 0 O-C-N 121.317 -0.864 . . . . 0.0 110.139 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 p -138.1 145.73 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.485 -1.009 . . . . 0.0 110.441 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.733 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -124.75 152.41 43.86 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.497 -0.752 . . . . 0.0 109.951 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.5 p -114.43 121.02 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.733 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 30.9 t70 -48.93 102.88 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.502 -0.749 . . . . 0.0 111.043 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -63.89 -24.24 67.66 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.23 -33.86 76.25 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.617 ' HG ' HD11 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -77.39 -36.81 53.11 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.35 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.617 HD11 ' HG ' ' A' ' 15' ' ' LEU . 4.6 mp -62.38 -41.85 98.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.625 -0.672 . . . . 0.0 109.503 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.11 -23.17 19.51 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.647 -0.658 . . . . 0.0 109.993 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.442 ' HB2' HG22 ' A' ' 31' ' ' ILE . 21.4 mtmm -98.62 -33.13 11.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.431 -0.793 . . . . 0.0 110.489 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.482 HG13 ' HA ' ' A' ' 16' ' ' LEU . 1.5 p -69.73 -40.52 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.231 -0.918 . . . . 0.0 110.426 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.462 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 12.1 mt -63.22 -36.93 85.29 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 177.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.9 -34.04 72.65 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.627 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 29' ' ' ARG . 2.5 mm? -78.77 -26.99 44.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.347 -0.845 . . . . 0.0 109.435 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -81.48 -13.1 58.56 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.577 -0.702 . . . . 0.0 109.752 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.86 -35.39 24.21 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.447 -0.783 . . . . 0.0 109.702 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 17.1 mmtt -89.89 -15.09 32.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.724 -0.61 . . . . 0.0 109.826 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.55 26.25 36.32 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -111.0 144.6 39.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.539 -0.977 . . . . 0.0 110.497 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -111.27 92.99 4.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.502 -0.749 . . . . 0.0 109.611 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.412 ' HB2' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -115.84 -157.19 0.64 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.539 -0.725 . . . . 0.0 110.449 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -112.8 154.04 26.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.538 -0.726 . . . . 0.0 110.364 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.462 HD11 HG22 ' A' ' 19' ' ' VAL . 3.0 mt -131.49 121.84 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.498 -0.751 . . . . 0.0 109.873 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.39 160.02 24.18 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.287 -0.883 . . . . 0.0 110.816 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.508 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 16.5 m -137.31 158.39 44.53 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.659 -0.651 . . . . 0.0 110.181 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.434 ' CD1' ' HE1' ' A' ' 57' ' ' HIS . 20.0 m-90 -145.74 37.01 1.07 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.272 -0.893 . . . . 0.0 110.629 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.41 ' HB3' ' HE1' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -100.21 -155.45 0.51 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.168 -0.958 . . . . 0.0 110.687 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.74 -58.13 2.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.179 -0.95 . . . . 0.0 110.147 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.38 35.26 1.99 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.539 -0.726 . . . . 0.0 109.924 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.5 m -42.19 128.21 3.65 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.338 0.589 . . . . 0.0 111.839 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.654 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 23.7 m -136.94 163.46 30.65 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.674 -0.641 . . . . 0.0 110.308 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.692 HG23 HG12 ' A' ' 62' ' ' ILE . 5.1 mp -85.42 169.73 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.472 -0.768 . . . . 0.0 111.186 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.632 HG22 ' HG3' ' A' ' 44' ' ' MET . 0.1 OUTLIER -137.27 176.26 2.88 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 121.563 -0.711 . . . . 0.0 109.771 178.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.568 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 42.1 Cg_endo -66.57 -29.43 44.14 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.059 1.557 . . . . 0.0 111.334 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HG3' HG12 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -77.75 8.0 5.07 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.479 -0.763 . . . . 0.0 111.392 179.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.632 ' HG3' HG22 ' A' ' 41' ' ' VAL . 2.1 mtt -109.96 19.27 19.21 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.01 -1.056 . . . . 0.0 111.512 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.585 HG23 ' HA ' ' A' ' 64' ' ' GLU . 89.0 t -66.68 7.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 121.088 -1.007 . . . . 0.0 113.352 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.2 32.44 0.95 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 34.8 m-70 -138.78 147.36 42.49 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.277 -1.131 . . . . 0.0 111.243 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -99.63 82.0 2.57 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.604 HG12 ' CD1' ' A' ' 15' ' ' LEU . 2.6 mp -81.61 117.38 27.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.314 -0.866 . . . . 0.0 111.446 -177.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.693 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -76.67 78.01 3.32 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 122.094 0.949 . . . . 0.0 108.813 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.9 m -60.43 131.12 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.775 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.508 ' HB2' ' O ' ' A' ' 33' ' ' THR . 36.2 t80 -78.28 103.95 8.55 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -74.36 7.87 2.59 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.362 -0.836 . . . . 0.0 111.339 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.94 -27.31 5.94 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -140.71 -24.97 0.76 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.84 -0.8 . . . . 0.0 111.522 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -133.64 154.09 51.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.106 -0.996 . . . . 0.0 112.443 -177.668 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.466 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 22.3 m-70 -98.84 100.61 11.82 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.693 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 52.5 t -88.75 104.29 7.13 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.236 -0.915 . . . . 0.0 109.887 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.486 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.6 Cg_endo -66.65 88.75 0.28 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 O-C-N 123.912 1.48 . . . . 0.0 109.501 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.506 HG21 ' O ' ' A' ' 60' ' ' VAL . 13.7 m -94.31 112.44 27.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.327 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 5.9 t80 -72.9 100.0 2.82 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.692 HG12 HG23 ' A' ' 40' ' ' ILE . 2.7 mp -80.82 134.47 27.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.283 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.448 ' C ' HG11 ' A' ' 45' ' ' VAL . 1.9 m -105.19 -150.25 0.43 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 177.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.585 ' HA ' HG23 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -90.01 -3.66 57.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.341 -1.474 . . . . 0.0 111.247 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.4 24.41 4.45 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.917 -1.114 . . . . 0.0 111.44 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.627 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 22.1 mtt -114.82 -31.61 6.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.149 -0.97 . . . . 0.0 110.02 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.533 ' HA ' ' HZ ' ' A' ' 74' ' ' PHE . 6.0 p -62.07 163.29 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 O-C-N 121.453 -0.779 . . . . 0.0 111.925 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.449 ' N ' HG23 ' A' ' 67' ' ' VAL . . . 120.91 -9.55 10.42 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.323 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.678 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 17.1 m-70 -122.97 -86.29 0.65 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 119.101 1.45 . . . . 0.0 110.836 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.654 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.54 -30.43 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.495 0.664 . . . . 0.0 110.243 -179.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.534 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 1.4 pp 173.55 -14.05 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.273 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.805 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.37 -17.85 79.08 Favored Glycine 0 N--CA 1.493 2.454 0 O-C-N 120.927 -1.108 . . . . 0.0 110.627 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.678 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 16.7 mm-40 -84.68 -15.99 43.39 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.251 -1.146 . . . . 0.0 109.352 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.627 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 1.9 m-85 -109.29 -18.7 13.52 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.573 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -133.33 53.07 9.66 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.541 -0.724 . . . . 0.0 109.686 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 48.0 Cg_endo -81.77 54.87 5.26 Favored 'Trans proline' 0 C--N 1.321 -0.914 0 O-C-N 123.629 1.331 . . . . 0.0 110.2 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 11.1 t -68.74 -162.1 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.728 -0.608 . . . . 0.0 110.699 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.48 119.51 4.94 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.418 -0.801 . . . . 0.0 110.673 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.4 t -150.29 172.62 15.08 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.598 -0.689 . . . . 0.0 110.393 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 . . . . . 0 N--CA 1.5 2.074 0 O-C-N 121.667 -0.646 . . . . 0.0 110.705 179.998 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.7 t -120.19 91.33 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.417 -1.049 . . . . 0.0 109.93 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.702 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -111.72 140.17 46.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.511 -0.743 . . . . 0.0 109.746 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.552 ' HA ' ' HB ' ' A' ' 39' ' ' THR . 13.5 p -92.11 108.4 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.702 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 36.2 t70 -48.31 115.74 1.32 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.457 0.646 . . . . 0.0 111.736 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.72 -25.07 62.78 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -63.78 -27.73 69.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.862 -0.524 . . . . 0.0 110.12 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.524 ' HG ' ' N ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -78.74 -36.73 42.77 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.712 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.596 ' HA ' HG11 ' A' ' 19' ' ' VAL . 4.0 mp -62.64 -43.79 97.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.853 -0.529 . . . . 0.0 109.919 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.32 -21.31 23.49 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.666 -0.646 . . . . 0.0 110.593 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -106.27 -23.81 12.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.4 -0.812 . . . . 0.0 111.164 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.596 HG11 ' HA ' ' A' ' 16' ' ' LEU . 1.4 p -86.26 -40.94 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.983 -1.073 . . . . 0.0 111.0 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.482 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 14.1 mt -65.34 -38.16 89.28 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -62.64 -33.84 75.84 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.539 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -78.0 -25.98 48.29 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.291 -0.881 . . . . 0.0 109.456 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -81.56 -12.4 58.8 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.586 -0.696 . . . . 0.0 109.682 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.91 -37.21 27.15 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 121.446 -0.784 . . . . 0.0 109.346 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -86.05 -22.55 27.15 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.64 15.71 51.76 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -95.68 145.03 25.6 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.534 -0.98 . . . . 0.0 110.388 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -110.15 89.39 3.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.517 -0.74 . . . . 0.0 109.557 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -111.77 -155.57 0.57 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.496 -0.752 . . . . 0.0 110.365 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.483 ' HB2' ' HB ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -119.2 154.09 33.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.412 -0.805 . . . . 0.0 110.319 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.52 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 2.7 mp -129.65 121.49 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.495 -0.753 . . . . 0.0 110.18 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.516 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -99.89 153.44 19.16 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.321 -0.862 . . . . 0.0 111.23 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -140.95 166.77 23.88 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.689 -0.632 . . . . 0.0 110.072 179.209 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.469 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 13.6 m-90 -144.89 43.16 1.34 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.639 -0.663 . . . . 0.0 110.508 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.26 -83.35 0.26 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.231 -0.918 . . . . 0.0 110.605 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -179.93 -63.68 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.422 -0.799 . . . . 0.0 110.155 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -101.89 35.94 2.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.466 -0.771 . . . . 0.0 109.616 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.2 m -42.16 113.22 0.41 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.442 0.639 . . . . 0.0 111.578 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.697 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 26.2 m -107.12 159.35 16.39 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.818 -0.551 . . . . 0.0 109.554 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.648 ' CG2' ' HG3' ' A' ' 44' ' ' MET . 1.1 mp -74.47 163.76 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.479 -0.763 . . . . 0.0 111.163 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.644 ' O ' ' SD ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -121.61 179.13 1.02 Allowed Pre-proline 0 N--CA 1.507 2.407 0 O-C-N 121.648 -0.658 . . . . 0.0 109.925 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 50.4 Cg_endo -71.44 -32.49 12.3 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 124.079 1.568 . . . . 0.0 111.346 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -83.98 15.27 3.48 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.445 -0.785 . . . . 0.0 110.573 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.701 ' HG2' ' CG2' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -82.92 -15.7 50.33 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.636 -0.665 . . . . 0.0 112.125 -179.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.501 ' HB ' ' HE3' ' A' ' 44' ' ' MET . 2.4 p -58.31 6.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.41 29.26 1.07 Allowed Glycine 0 N--CA 1.491 2.335 0 O-C-N 119.917 -1.739 . . . . 0.0 110.056 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.529 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 25.4 m-70 -145.93 156.6 43.63 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.998 -1.295 . . . . 0.0 111.539 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.483 ' HB ' ' HB2' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -99.03 78.86 2.3 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 177.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.507 HG12 ' HB ' ' A' ' 31' ' ' ILE . 78.8 mt -78.18 116.79 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.526 -0.734 . . . . 0.0 111.516 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.742 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.85 85.92 5.45 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.6 m -66.77 128.81 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.026 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.46 ' HB2' ' O ' ' A' ' 33' ' ' THR . 27.0 t80 -76.73 105.77 8.0 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.449 -0.782 . . . . 0.0 108.911 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -70.29 -0.85 8.82 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.679 -0.638 . . . . 0.0 110.679 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.9 -19.64 9.49 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -140.1 -28.68 0.73 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.933 -0.745 . . . . 0.0 110.898 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.68 155.2 50.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.187 -0.946 . . . . 0.0 111.977 -178.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.509 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -101.63 111.3 23.5 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.742 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 18.0 t -98.64 94.96 2.7 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.256 -0.902 . . . . 0.0 109.743 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.53 ' HA ' ' CA ' ' A' ' 50' ' ' ALA . 43.6 Cg_endo -69.37 94.9 0.5 Allowed 'Trans proline' 0 N--CA 1.487 1.137 0 O-C-N 123.847 1.446 . . . . 0.0 109.531 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.552 HG12 ' HB3' ' A' ' 74' ' ' PHE . 48.6 t -111.93 127.89 68.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.062 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.529 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.9 t80 -72.19 102.34 3.03 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 176.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.701 ' CG2' ' HG2' ' A' ' 44' ' ' MET . 2.8 mp -65.54 -60.48 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -175.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' A' ' 62' ' ' ILE . 4.9 m 71.71 172.17 0.31 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -176.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.3 66.83 3.97 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.856 -1.152 . . . . 0.0 110.396 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -169.54 -24.17 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.398 -0.814 . . . . 0.0 112.625 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.665 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 11.0 mtt -110.15 9.12 24.01 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.613 -1.304 . . . . 0.0 112.544 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.617 ' HB ' ' HE1' ' A' ' 44' ' ' MET . 14.2 p -89.33 166.49 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 O-C-N 120.583 -1.323 . . . . 0.0 112.652 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.521 ' N ' HG21 ' A' ' 67' ' ' VAL . . . 105.17 -13.81 48.38 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.557 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 15.2 m-70 -113.43 -90.37 0.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 118.813 1.306 . . . . 0.0 110.478 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.86 -35.36 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 122.306 1.05 . . . . 0.0 109.106 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.539 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -178.67 -13.55 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.027 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.57 -15.64 80.44 Favored Glycine 0 N--CA 1.497 2.704 0 O-C-N 120.829 -1.17 . . . . 0.0 110.286 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.557 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 2.0 mm-40 -79.82 -21.39 44.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.385 -1.067 . . . . 0.0 108.567 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.665 ' CD2' ' HB3' ' A' ' 66' ' ' MET . 5.9 m-85 -99.64 -21.96 15.63 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.532 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -133.88 58.32 31.18 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.65 -0.656 . . . . 0.0 110.56 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.532 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 44.7 Cg_endo -88.35 40.4 0.56 Allowed 'Trans proline' 0 C--N 1.318 -1.047 0 O-C-N 123.556 1.292 . . . . 0.0 110.402 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.9 t -176.63 40.98 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.248 0.547 . . . . 0.0 109.989 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -141.76 -59.34 0.47 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.23 -0.919 . . . . 0.0 110.488 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 56.5 m -123.86 145.84 48.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.474 -0.766 . . . . 0.0 110.336 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.0 t80 . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.448 -0.782 . . . . 0.0 110.135 179.95 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.434 ' HB ' ' CD ' ' A' ' 37' ' ' ARG . 78.1 t -109.43 -51.05 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.507 -0.996 . . . . 0.0 110.296 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.739 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -135.16 135.78 41.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.61 -0.681 . . . . 0.0 110.293 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.463 HG13 HG12 ' A' ' 41' ' ' VAL . 77.7 t -105.14 114.48 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.739 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 1.8 t0 -44.58 106.29 0.07 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.448 0.642 . . . . 0.0 111.805 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -67.65 -23.35 65.32 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.7 t60 -67.32 -35.7 79.98 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.873 -0.517 . . . . 0.0 109.908 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.719 ' HG ' HD11 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -75.32 -38.24 60.33 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.29 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.719 HD11 ' HG ' ' A' ' 15' ' ' LEU . 2.6 mp -58.78 -43.58 90.45 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.299 0.571 . . . . 0.0 109.639 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.54 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -55.03 -25.75 32.56 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.065 179.315 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HB2' HG22 ' A' ' 31' ' ' ILE . 10.3 mmtm -97.12 -31.95 12.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.479 -0.763 . . . . 0.0 111.034 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.577 HG22 HD13 ' A' ' 49' ' ' ILE . 3.6 p -74.07 -38.03 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 120.997 -1.064 . . . . 0.0 111.271 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.54 HD22 ' HA ' ' A' ' 17' ' ' GLU . 3.6 pp -62.69 -25.03 67.95 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.75 -35.28 72.58 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.406 HD11 ' HA ' ' A' ' 22' ' ' LEU . 3.4 mm? -72.33 -27.49 62.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.623 -0.673 . . . . 0.0 109.585 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -83.17 -16.13 47.85 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.588 -0.695 . . . . 0.0 109.792 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.8 -36.99 23.12 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 121.577 -0.702 . . . . 0.0 109.57 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -88.03 -21.07 24.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.674 -0.641 . . . . 0.0 109.35 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.01 17.26 59.7 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -93.28 149.15 21.44 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.38 -1.071 . . . . 0.0 110.593 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -110.74 96.57 6.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.549 -0.72 . . . . 0.0 109.756 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 ttt85 -126.73 -155.53 0.69 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.532 -0.73 . . . . 0.0 110.353 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -116.99 155.79 28.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.5 -0.75 . . . . 0.0 110.469 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.512 ' HB ' HD12 ' A' ' 49' ' ' ILE . 3.2 mp -132.05 112.98 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.614 -0.679 . . . . 0.0 109.536 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.13 148.35 26.38 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.386 -0.821 . . . . 0.0 110.897 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 14.3 t -141.09 174.87 10.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.679 -0.638 . . . . 0.0 110.171 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.45 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 10.0 m-90 -143.8 47.13 1.45 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.145 -0.972 . . . . 0.0 111.666 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 t -88.96 -84.25 0.21 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.718 -1.239 . . . . 0.0 111.077 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.54 -88.83 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.02 -1.05 . . . . 0.0 111.36 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.547 ' HD2' ' HB3' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -97.4 52.83 1.13 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.209 -0.932 . . . . 0.0 109.975 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.499 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 0.4 OUTLIER -39.11 138.12 0.63 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.264 0.554 . . . . 0.0 112.363 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 24.4 m -129.2 159.21 36.76 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.529 -0.732 . . . . 0.0 110.133 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.682 HG22 ' SD ' ' A' ' 44' ' ' MET . 1.2 mp -78.99 159.55 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 121.541 -0.725 . . . . 0.0 111.604 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.491 HG23 ' HE2' ' A' ' 44' ' ' MET . 0.0 OUTLIER -133.64 171.23 9.46 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 42.6 Cg_endo -67.16 -31.79 35.42 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.133 1.596 . . . . 0.0 110.493 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.44 ' HG3' ' CG1' ' A' ' 19' ' ' VAL . 6.5 pt-20 -75.24 -1.97 25.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.53 -0.731 . . . . 0.0 111.025 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.682 ' SD ' HG22 ' A' ' 40' ' ' ILE . 1.4 ptp -114.98 16.7 17.11 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.897 -1.127 . . . . 0.0 110.886 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.57 ' CG1' ' HG3' ' A' ' 64' ' ' GLU . 2.6 t -68.27 6.5 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.358 -0.839 . . . . 0.0 112.782 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.77 35.79 0.92 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.518 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 54.2 m-70 -140.24 159.2 42.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.501 -0.999 . . . . 0.0 110.488 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.08 82.47 2.73 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 178.382 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.577 HD13 HG22 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -83.51 115.82 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.495 -0.753 . . . . 0.0 111.55 -176.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.735 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -77.99 81.6 4.38 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.499 ' HB ' ' HB3' ' A' ' 38' ' ' SER . 33.0 m -66.19 132.66 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.581 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 33' ' ' THR . 23.8 t80 -72.44 104.35 3.77 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -70.7 -0.23 8.39 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.51 -0.744 . . . . 0.0 110.488 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.6 -21.79 8.43 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.12 -30.0 0.69 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 122.009 -0.701 . . . . 0.0 110.633 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.89 156.47 48.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.309 -0.869 . . . . 0.0 111.737 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.433 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -102.41 101.74 12.0 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.178 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.735 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 14.6 m -91.39 105.56 13.26 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.152 -0.967 . . . . 0.0 110.335 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.501 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 43.0 Cg_endo -68.7 88.88 0.42 Allowed 'Trans proline' 0 N--CA 1.49 1.276 0 O-C-N 123.91 1.479 . . . . 0.0 109.163 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.493 HG21 ' O ' ' A' ' 58' ' ' VAL . 58.2 t -98.18 119.17 45.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.485 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 2.3 t80 -70.97 101.54 2.2 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 118.85 -1.14 . . . . 0.0 107.95 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.66 HD11 ' SD ' ' A' ' 44' ' ' MET . 3.2 mp -80.75 138.34 19.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.638 -0.664 . . . . 0.0 110.566 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.441 ' C ' HG11 ' A' ' 45' ' ' VAL . 60.8 p -98.71 -161.23 0.86 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 177.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.57 ' HG3' ' CG1' ' A' ' 45' ' ' VAL . 0.6 OUTLIER -85.29 5.79 28.98 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.823 -1.173 . . . . 0.0 111.081 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -128.57 -11.53 5.0 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.739 -1.226 . . . . 0.0 113.053 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.656 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 9.0 mtt -88.37 -5.59 58.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.519 -1.363 . . . . 0.0 110.618 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 68' ' ' GLY . 9.0 p -81.79 165.19 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.073 -1.017 . . . . 0.0 111.535 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.481 ' N ' HG23 ' A' ' 67' ' ' VAL . . . 109.05 -18.16 31.4 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.578 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 16.5 m-70 -115.89 -86.14 0.62 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -1.204 . . . . 0.0 110.695 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.37 -35.09 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 122.215 1.007 . . . . 0.0 109.291 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.554 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 0.5 OUTLIER 179.63 -16.08 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.864 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.78 -15.1 73.43 Favored Glycine 0 N--CA 1.497 2.715 0 O-C-N 120.889 -1.132 . . . . 0.0 110.458 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.578 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 1.6 mm-40 -81.45 -17.78 47.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.362 -1.081 . . . . 0.0 108.805 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.656 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 9.2 m-85 -97.03 -20.23 18.19 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.572 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -134.24 54.11 11.31 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.764 -0.585 . . . . 0.0 109.94 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.572 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 48.9 Cg_endo -85.13 50.12 2.73 Favored 'Trans proline' 0 C--N 1.32 -0.962 0 O-C-N 123.476 1.25 . . . . 0.0 110.375 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.7 m -92.91 83.48 4.76 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.55 -0.719 . . . . 0.0 110.052 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.1 mtp-105 50.57 73.77 0.26 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.743 -0.598 . . . . 0.0 110.473 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.7 t 39.04 44.19 0.88 Allowed 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 121.374 0.607 . . . . 0.0 111.592 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.325 -0.859 . . . . 0.0 110.189 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.4 t -88.74 126.39 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.511 -0.994 . . . . 0.0 109.961 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.552 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -134.23 149.8 51.0 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.657 -0.652 . . . . 0.0 109.964 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.434 HG13 HG12 ' A' ' 41' ' ' VAL . 56.0 t -110.22 124.19 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.617 ' HB2' HG22 ' A' ' 33' ' ' THR . 0.8 OUTLIER -45.1 107.14 0.09 Allowed 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.375 0.607 . . . . 0.0 111.427 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.78 -27.02 64.57 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.78 -15.81 63.62 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.943 -0.473 . . . . 0.0 110.171 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.609 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -84.36 -39.08 19.52 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.466 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.569 ' HA ' HG11 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -69.07 -43.79 73.9 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.605 -0.685 . . . . 0.0 110.714 179.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -53.93 -19.39 4.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.446 -0.784 . . . . 0.0 110.885 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HE3' HG21 ' A' ' 31' ' ' ILE . 2.1 mtmt -112.49 -33.6 6.11 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.261 -0.9 . . . . 0.0 111.134 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.628 HG13 ' CE ' ' A' ' 44' ' ' MET . 1.1 p -73.73 -39.69 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.081 -1.012 . . . . 0.0 111.591 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.498 HD13 ' HB3' ' A' ' 16' ' ' LEU . 18.1 mt -60.11 -37.88 81.33 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.07 -40.24 92.92 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.593 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.504 HD21 ' CB ' ' A' ' 27' ' ' GLU . 1.1 mt -71.92 -26.63 62.38 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.272 -0.892 . . . . 0.0 110.289 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -80.66 -10.75 59.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.558 -0.714 . . . . 0.0 109.636 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.98 -35.62 15.43 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.482 -0.761 . . . . 0.0 110.172 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.447 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -102.39 -25.89 13.48 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.547 -0.721 . . . . 0.0 109.793 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.55 29.49 12.06 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.504 ' CB ' HD21 ' A' ' 22' ' ' LEU . 5.0 mm-40 -80.14 149.37 30.58 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.446 -1.032 . . . . 0.0 110.351 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -111.8 86.0 2.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.579 -0.701 . . . . 0.0 109.953 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -136.34 -160.13 1.02 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.484 -0.76 . . . . 0.0 110.53 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -119.52 156.69 29.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.649 -0.657 . . . . 0.0 110.206 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.609 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 2.7 mp -124.79 123.39 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.37 -0.831 . . . . 0.0 109.75 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.402 ' HE3' HD12 ' A' ' 30' ' ' LEU . 1.1 mptt -98.28 151.15 20.79 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.246 -0.909 . . . . 0.0 111.137 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.617 HG22 ' HB2' ' A' ' 12' ' ' ASP . 18.4 m -136.15 162.47 32.86 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.652 -0.655 . . . . 0.0 109.584 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.428 ' CD1' ' NE2' ' A' ' 57' ' ' HIS . 27.9 m-90 -141.44 38.36 1.7 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.279 -0.888 . . . . 0.0 110.768 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.7 m -82.82 -101.23 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.208 -0.932 . . . . 0.0 110.566 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.43 -68.69 0.12 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.041 -1.037 . . . . 0.0 109.756 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.488 ' HG2' ' HD1' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -106.48 50.76 0.76 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.777 0.799 . . . . 0.0 108.857 178.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.429 ' OG ' ' HB3' ' A' ' 12' ' ' ASP . 22.4 m -47.86 111.01 0.37 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.302 0.572 . . . . 0.0 111.905 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 69' ' ' HIS . 28.7 m -105.43 155.84 18.76 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.693 -0.63 . . . . 0.0 109.597 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.607 HG22 HG12 ' A' ' 62' ' ' ILE . 4.4 mp -77.82 167.87 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.145 -0.972 . . . . 0.0 111.297 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.607 ' CG1' ' HD2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -137.5 176.73 2.53 Favored Pre-proline 0 N--CA 1.501 2.081 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.142 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.607 ' HD2' ' CG1' ' A' ' 41' ' ' VAL . 45.1 Cg_endo -68.42 -35.18 18.66 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.889 1.468 . . . . 0.0 111.335 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.504 ' HB2' ' HE3' ' A' ' 44' ' ' MET . 0.8 OUTLIER -66.0 -9.93 34.82 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.461 -0.775 . . . . 0.0 110.677 179.099 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.628 ' CE ' HG13 ' A' ' 19' ' ' VAL . 4.0 mmt -88.14 0.93 55.44 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.348 -0.845 . . . . 0.0 111.323 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 42' ' ' PRO . 5.6 p -54.98 -2.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.18 34.66 1.19 Allowed Glycine 0 N--CA 1.492 2.426 0 O-C-N 120.43 -1.419 . . . . 0.0 109.605 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.483 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 56.1 m-70 -142.54 150.94 41.09 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.304 -1.115 . . . . 0.0 111.127 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.553 HG22 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.75 81.41 2.46 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.15 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.58 HG12 ' CD1' ' A' ' 15' ' ' LEU . 3.0 mt -85.54 121.88 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 111.654 -176.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.734 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.85 82.48 5.05 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 122.102 0.953 . . . . 0.0 108.888 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.2 m -63.0 127.52 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.542 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.511 ' HB2' ' O ' ' A' ' 33' ' ' THR . 20.2 t80 -71.71 104.29 3.33 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -70.68 -1.43 11.32 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.557 -0.715 . . . . 0.0 110.553 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.29 -21.05 8.84 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -140.18 -29.75 0.69 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.882 -0.775 . . . . 0.0 110.82 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.41 155.67 49.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.332 -0.855 . . . . 0.0 111.928 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.428 ' NE2' ' CD1' ' A' ' 34' ' ' TRP . 6.0 m80 -102.51 103.99 14.38 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.734 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 28.7 t -93.55 102.78 8.28 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.3 -0.875 . . . . 0.0 110.106 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.501 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.5 Cg_endo -66.59 89.32 0.28 Allowed 'Trans proline' 0 N--CA 1.492 1.404 0 O-C-N 123.878 1.462 . . . . 0.0 109.195 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.474 ' CG1' ' CD2' ' A' ' 74' ' ' PHE . 48.1 t -97.57 118.68 44.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.201 -178.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.553 ' HB2' HG22 ' A' ' 48' ' ' THR . 2.6 t80 -73.19 103.9 4.06 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.607 HG12 HG22 ' A' ' 40' ' ' ILE . 2.7 mp -84.45 144.82 9.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.675 0.75 . . . . 0.0 111.64 -178.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.9 p -111.03 -158.71 0.65 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -90.59 15.14 11.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.588 -1.32 . . . . 0.0 110.997 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -137.95 -13.47 1.43 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.919 -1.113 . . . . 0.0 112.527 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.655 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 28.3 mmt -88.04 -24.97 23.32 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.605 -1.309 . . . . 0.0 110.327 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.549 HG23 ' C ' ' A' ' 41' ' ' VAL . 4.2 p -66.61 163.45 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.388 -0.82 . . . . 0.0 111.437 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.539 ' N ' HG21 ' A' ' 67' ' ' VAL . . . 118.17 -14.79 12.23 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.113 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.635 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 21.5 m-70 -127.21 -81.14 0.6 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.965 -1.315 . . . . 0.0 111.497 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.559 ' HD2' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER 177.42 -31.97 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.717 0.77 . . . . 0.0 110.268 -179.264 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.559 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 0.7 OUTLIER 173.82 -16.0 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.757 -179.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.53 -18.02 73.29 Favored Glycine 0 N--CA 1.496 2.639 0 O-C-N 120.946 -1.096 . . . . 0.0 110.503 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.635 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 1.3 mt-10 -84.62 -20.07 31.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.407 -1.054 . . . . 0.0 109.124 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.655 ' CD2' ' HB3' ' A' ' 66' ' ' MET . 20.8 m-85 -92.6 -20.52 20.8 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.58 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -134.73 54.49 11.59 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.747 -0.596 . . . . 0.0 109.719 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.58 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 48.7 Cg_endo -85.01 50.77 2.95 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.615 1.324 . . . . 0.0 110.337 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.1 m -72.12 127.37 32.34 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.633 -0.667 . . . . 0.0 110.101 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.0 ptt-85 -75.57 148.57 38.76 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.542 -0.724 . . . . 0.0 110.536 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.2 m -139.61 104.87 5.03 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.52 -0.738 . . . . 0.0 109.99 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.065 0 O-C-N 121.782 -0.573 . . . . 0.0 110.695 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.6 t -113.05 106.89 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.445 -1.032 . . . . 0.0 109.969 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.781 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -119.61 144.06 47.32 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.526 -0.734 . . . . 0.0 109.543 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.432 HG12 HG23 ' A' ' 41' ' ' VAL . 69.4 t -101.83 112.05 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.781 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 39.0 t70 -44.68 106.52 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.145 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -67.87 -24.2 65.21 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -66.22 -25.61 66.99 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.942 -0.474 . . . . 0.0 109.91 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.587 ' HG ' ' N ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -79.76 -38.16 33.81 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.587 ' N ' ' HG ' ' A' ' 15' ' ' LEU . 5.0 mp -62.58 -42.3 99.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.796 -0.565 . . . . 0.0 109.923 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.66 -30.76 22.98 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.136 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.57 ' HB2' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -91.77 -27.99 17.67 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.464 -0.772 . . . . 0.0 110.602 179.524 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.543 HG12 ' SD ' ' A' ' 44' ' ' MET . 93.9 t -73.62 -40.16 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.15 -0.969 . . . . 0.0 111.186 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 16' ' ' LEU . 10.9 mt -60.93 -36.43 79.29 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.18 -36.09 83.12 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.051 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.424 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 2.9 mm? -77.63 -26.57 50.65 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.258 -0.901 . . . . 0.0 109.666 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -81.96 -12.48 58.34 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.623 -0.673 . . . . 0.0 109.757 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.59 -34.53 27.65 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.417 -0.802 . . . . 0.0 109.512 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 25' ' ' LYS . 16.3 mmtt -93.11 -15.87 25.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.773 -0.579 . . . . 0.0 109.8 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.21 28.99 34.97 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -106.48 148.74 27.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.649 -0.912 . . . . 0.0 110.705 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 mtmm -113.36 90.81 3.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.586 -0.696 . . . . 0.0 109.97 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.9 ttt-85 -113.5 -158.32 0.65 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.459 -0.776 . . . . 0.0 110.305 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.0 OUTLIER -116.19 148.39 40.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.574 -0.704 . . . . 0.0 110.274 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.57 HG22 ' HB2' ' A' ' 18' ' ' LYS . 3.2 mp -121.83 118.75 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.594 -0.691 . . . . 0.0 109.552 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.502 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . 20.5 mmmt -78.9 152.93 30.89 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.453 -0.779 . . . . 0.0 111.029 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 24.1 m -139.69 153.16 47.18 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.589 -0.694 . . . . 0.0 109.778 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.426 ' CZ2' ' CB ' ' A' ' 32' ' ' LYS . 9.7 m-90 -145.3 36.44 1.1 Allowed 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.22 -0.925 . . . . 0.0 111.6 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 m -86.86 -95.97 0.08 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.764 -1.21 . . . . 0.0 110.361 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -173.99 -63.02 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.191 -0.943 . . . . 0.0 109.464 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.406 ' HG3' ' HB3' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -102.24 36.85 2.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.591 -0.693 . . . . 0.0 109.212 178.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.2 m -48.29 144.48 3.91 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.515 0.674 . . . . 0.0 111.77 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.679 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 52.3 m -133.81 160.19 38.36 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.273 0.558 . . . . 0.0 109.678 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.742 ' CG2' HG12 ' A' ' 62' ' ' ILE . 1.2 mp -83.41 164.78 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.632 -0.668 . . . . 0.0 111.846 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.638 HG21 ' CG ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -134.15 174.21 4.92 Favored Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.787 -0.57 . . . . 0.0 109.466 178.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.575 ' HD2' ' CG1' ' A' ' 41' ' ' VAL . 46.0 Cg_endo -68.92 -34.65 17.07 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 124.0 1.526 . . . . 0.0 111.581 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.518 ' HB3' HG13 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -68.42 -6.54 25.26 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.408 -0.808 . . . . 0.0 110.742 179.331 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.656 ' SD ' HD12 ' A' ' 49' ' ' ILE . 6.6 mmt -86.31 -6.29 58.99 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.365 -0.835 . . . . 0.0 111.658 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.447 ' HA ' HG23 ' A' ' 62' ' ' ILE . 6.0 p -51.51 1.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.406 ' C ' ' CG ' ' A' ' 47' ' ' HIS . . . -146.27 33.19 1.48 Allowed Glycine 0 N--CA 1.495 2.575 0 O-C-N 119.93 -1.731 . . . . 0.0 110.071 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.436 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 21.8 m-70 -147.66 153.98 40.03 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.106 -1.232 . . . . 0.0 111.181 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -99.64 88.76 3.92 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 177.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.656 HD12 ' SD ' ' A' ' 44' ' ' MET . 22.9 mt -86.24 121.94 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.565 -176.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.732 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.16 78.05 5.64 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.3 m -62.39 128.67 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.643 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 35.3 t80 -75.67 105.48 6.73 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -76.08 8.35 3.31 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.368 -0.833 . . . . 0.0 111.221 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.71 -27.11 6.06 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.49 -24.03 0.79 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.819 -0.812 . . . . 0.0 111.596 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -135.76 154.17 51.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.019 -1.051 . . . . 0.0 112.411 -177.655 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.453 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -100.19 105.2 16.77 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.732 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 23.4 t -94.1 101.26 6.04 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.146 -0.971 . . . . 0.0 109.935 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.516 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.8 Cg_endo -67.72 93.08 0.37 Allowed 'Trans proline' 0 N--CA 1.489 1.25 0 O-C-N 123.955 1.503 . . . . 0.0 109.697 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.553 ' HB ' ' CD2' ' A' ' 74' ' ' PHE . 16.4 m -109.38 129.07 64.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.829 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 2.8 t80 -71.35 105.8 3.64 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.742 HG12 ' CG2' ' A' ' 40' ' ' ILE . 1.6 mp -57.97 -63.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 3.0 m 66.3 171.33 0.24 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -176.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -83.84 58.58 4.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.372 -1.455 . . . . 0.0 109.26 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -161.25 -36.86 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.306 -0.871 . . . . 0.0 112.181 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.608 ' CB ' ' CE2' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -88.24 -15.98 34.46 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.87 -1.144 . . . . 0.0 111.146 -179.087 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.603 HG21 ' N ' ' A' ' 68' ' ' GLY . 7.5 p -73.66 161.73 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.099 -1.0 . . . . 0.0 112.138 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.603 ' N ' HG21 ' A' ' 67' ' ' VAL . . . 113.56 -19.3 19.39 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.597 ' CG ' ' HG3' ' A' ' 73' ' ' GLU . 17.0 m-70 -114.9 -84.44 0.61 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.077 -1.249 . . . . 0.0 110.483 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.679 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.19 -34.67 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 122.042 0.925 . . . . 0.0 109.846 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.514 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 0.5 OUTLIER 176.88 -14.26 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.856 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 80' ' ' TYR . . . -70.41 -15.58 72.89 Favored Glycine 0 N--CA 1.496 2.668 0 O-C-N 120.9 -1.125 . . . . 0.0 110.313 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.597 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 1.1 mt-10 -84.18 -13.56 52.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.336 -1.097 . . . . 0.0 109.037 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.671 ' HE2' ' HA ' ' A' ' 62' ' ' ILE . 4.5 m-85 -102.65 -20.17 14.52 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.567 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -135.1 52.54 7.46 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.759 -0.588 . . . . 0.0 110.263 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 48.6 Cg_endo -82.62 51.28 3.67 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 O-C-N 123.511 1.269 . . . . 0.0 110.318 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.1 t -89.58 -28.05 19.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.511 -0.743 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.0 ttm105 -136.9 68.69 1.42 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.406 -0.808 . . . . 0.0 110.089 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.1 m 52.86 67.92 0.92 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.686 -0.634 . . . . 0.0 110.2 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.485 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.477 -0.765 . . . . 0.0 110.206 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.5 m -94.35 170.81 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.567 -0.961 . . . . 0.0 110.572 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.742 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -131.98 145.48 51.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.505 -0.747 . . . . 0.0 109.888 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.456 HG23 HG12 ' A' ' 41' ' ' VAL . 7.2 p -108.8 113.98 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.742 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 38.8 t70 -41.96 109.23 0.12 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.716 -0.615 . . . . 0.0 111.682 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -68.52 -24.57 64.67 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.524 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 1.7 t-80 -65.57 -20.64 66.41 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.908 -0.495 . . . . 0.0 110.3 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HG ' ' N ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -85.32 -38.43 18.81 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.133 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.604 ' N ' ' HG ' ' A' ' 15' ' ' LEU . 4.7 mp -63.82 -43.13 97.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.83 -0.544 . . . . 0.0 110.26 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.601 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -57.31 -19.15 20.39 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.756 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.426 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 42.0 mttm -102.56 -29.02 11.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.356 -0.84 . . . . 0.0 110.657 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.661 HG23 ' SD ' ' A' ' 44' ' ' MET . 1.7 p -79.55 -36.21 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.154 -0.966 . . . . 0.0 111.479 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.601 HD22 ' HA ' ' A' ' 17' ' ' GLU . 3.8 pp -62.82 -25.66 68.36 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -34.34 63.36 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.674 HD21 ' HB2' ' A' ' 27' ' ' GLU . 1.2 mt -76.27 -27.43 56.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.796 -0.565 . . . . 0.0 109.567 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -84.16 -13.82 51.83 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.613 -0.679 . . . . 0.0 109.676 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.51 -37.94 15.35 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 121.55 -0.718 . . . . 0.0 109.955 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -97.01 -23.97 16.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.575 -0.703 . . . . 0.0 109.654 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.44 25.89 19.71 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.674 ' HB2' HD21 ' A' ' 22' ' ' LEU . 24.9 mt-10 -72.18 125.58 27.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.471 -1.017 . . . . 0.0 110.258 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.18 94.88 9.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.552 -0.717 . . . . 0.0 110.225 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.1 ttp85 -149.59 -160.93 1.24 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.519 -0.738 . . . . 0.0 110.312 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.596 ' HB2' ' HB ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -119.71 165.07 15.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.585 -0.697 . . . . 0.0 110.455 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.64 ' HB ' HG12 ' A' ' 49' ' ' ILE . 36.3 mm -112.57 159.92 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.321 -0.862 . . . . 0.0 109.026 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.48 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -125.5 153.41 43.61 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.288 -0.883 . . . . 0.0 110.839 -178.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.448 HG21 ' CG ' ' A' ' 12' ' ' ASP . 20.0 m -139.84 154.17 47.25 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.588 -0.695 . . . . 0.0 110.712 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.48 ' CH2' ' HB2' ' A' ' 32' ' ' LYS . 16.6 m-90 -146.49 34.19 0.96 Allowed 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.433 -0.792 . . . . 0.0 111.224 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.69 -93.56 0.11 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.864 -1.148 . . . . 0.0 110.989 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.5 ttp85 -170.02 -66.49 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.194 -0.941 . . . . 0.0 109.287 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.57 ' HD2' ' HB3' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -104.43 44.0 1.06 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.247 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.408 ' OG ' ' CG2' ' A' ' 33' ' ' THR . 19.5 m -56.21 153.08 9.86 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.555 0.693 . . . . 0.0 112.317 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.682 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 40.9 m -140.38 162.21 35.86 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.878 -0.514 . . . . 0.0 110.055 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.688 HG23 HG12 ' A' ' 62' ' ' ILE . 4.8 mp -81.81 170.29 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 O-C-N 121.291 -0.881 . . . . 0.0 111.094 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.659 HG21 ' CG ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -132.1 175.2 3.88 Favored Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.744 -0.597 . . . . 0.0 109.74 179.073 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.556 ' HD2' ' CG1' ' A' ' 41' ' ' VAL . 47.0 Cg_endo -70.17 -32.7 16.37 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 124.096 1.577 . . . . 0.0 111.539 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.578 ' HG3' ' CG1' ' A' ' 19' ' ' VAL . 2.0 pt-20 -72.33 -3.43 23.81 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.275 -0.891 . . . . 0.0 110.957 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.661 ' SD ' HG23 ' A' ' 19' ' ' VAL . 23.5 mmm -91.1 15.65 11.27 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.296 -0.878 . . . . 0.0 112.231 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.567 HG23 ' HA ' ' A' ' 64' ' ' GLU . 66.0 t -64.73 4.49 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 O-C-N 120.947 -1.096 . . . . 0.0 113.129 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.35 29.84 1.07 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.498 ' HB2' ' HE2' ' A' ' 44' ' ' MET . 20.0 m-70 -139.09 150.71 46.03 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.377 -1.072 . . . . 0.0 110.701 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.65 86.31 3.31 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.139 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.64 HG12 ' HB ' ' A' ' 31' ' ' ILE . 58.3 mt -72.53 117.79 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.17 -0.956 . . . . 0.0 111.298 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.651 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.91 73.99 6.66 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.2 m -56.27 126.29 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.305 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 29.0 t80 -76.93 101.99 6.19 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -74.55 9.97 1.54 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.485 -0.76 . . . . 0.0 111.065 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.67 -27.86 6.12 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.75 -25.85 0.75 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.837 -0.802 . . . . 0.0 111.602 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -130.74 153.89 48.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.149 -0.969 . . . . 0.0 112.377 -177.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.499 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 2.3 m80 -99.74 99.19 9.98 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.651 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 46.5 t -86.57 104.73 6.22 Favored Pre-proline 0 N--CA 1.501 2.102 0 O-C-N 121.215 -0.928 . . . . 0.0 109.505 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 57' ' ' HIS . 42.7 Cg_endo -67.08 90.68 0.31 Allowed 'Trans proline' 0 N--CA 1.489 1.258 0 O-C-N 123.892 1.47 . . . . 0.0 110.251 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.42 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 35.6 m -95.83 111.36 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.39 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 2.2 t80 -72.59 104.46 3.88 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.015 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.688 HG12 HG23 ' A' ' 40' ' ' ILE . 2.7 mp -85.59 127.98 39.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.578 -0.701 . . . . 0.0 111.324 -178.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.435 ' C ' HG11 ' A' ' 45' ' ' VAL . 46.3 p -92.71 -153.28 0.34 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.567 ' HA ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -87.97 8.0 28.44 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.711 -1.243 . . . . 0.0 111.196 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -147.64 21.11 1.16 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.959 -1.088 . . . . 0.0 111.775 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.693 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 7.8 mmt -107.61 -26.51 10.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.235 -0.916 . . . . 0.0 109.804 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.523 ' HA ' ' HZ ' ' A' ' 74' ' ' PHE . 6.8 p -65.36 163.7 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 121.469 -0.769 . . . . 0.0 111.691 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.436 ' N ' HG23 ' A' ' 67' ' ' VAL . . . 122.42 -10.2 9.28 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.397 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.668 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 17.4 m-70 -123.82 -86.26 0.64 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.128 1.464 . . . . 0.0 110.983 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.682 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.31 -30.29 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.556 0.693 . . . . 0.0 110.308 -179.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.524 ' HB3' ' O ' ' A' ' 70' ' ' LYS . 0.8 OUTLIER 174.27 -15.21 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.769 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.65 -18.46 78.65 Favored Glycine 0 N--CA 1.495 2.606 0 O-C-N 120.929 -1.107 . . . . 0.0 110.633 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.668 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 22.2 mm-40 -84.25 -18.64 35.8 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.22 -1.165 . . . . 0.0 109.349 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.693 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 3.7 m-85 -105.4 -16.58 14.7 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.585 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -136.45 54.2 8.9 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.639 -0.663 . . . . 0.0 109.75 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.585 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 46.5 Cg_endo -84.52 51.34 3.23 Favored 'Trans proline' 0 C--N 1.32 -0.925 0 O-C-N 123.629 1.331 . . . . 0.0 110.382 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.8 m -66.4 -44.95 81.58 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.612 -0.68 . . . . 0.0 110.255 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.68 138.79 39.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.661 -0.649 . . . . 0.0 110.202 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 86.8 m -82.77 104.64 13.16 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.443 -0.786 . . . . 0.0 110.062 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.049 0 O-C-N 121.744 -0.597 . . . . 0.0 110.665 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.7 p -80.9 151.23 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.558 -0.966 . . . . 0.0 110.387 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.756 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -129.11 134.79 48.22 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.471 -0.768 . . . . 0.0 110.075 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.46 ' HA ' ' HB ' ' A' ' 39' ' ' THR . 7.5 p -101.83 115.68 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 178.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.756 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 27.8 t70 -46.34 107.06 0.09 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.476 0.655 . . . . 0.0 111.303 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -69.6 -24.48 63.67 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -64.67 -28.45 69.61 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.809 -0.557 . . . . 0.0 109.841 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.577 ' HG ' HD13 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -77.25 -37.72 52.53 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.577 HD13 ' HG ' ' A' ' 15' ' ' LEU . 4.1 mp -60.47 -47.29 86.78 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.171 0.51 . . . . 0.0 109.736 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.1 -23.06 4.79 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.648 -0.657 . . . . 0.0 110.722 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.544 ' HB2' HG22 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -104.28 -25.27 12.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.331 -0.855 . . . . 0.0 110.679 179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.531 HG11 ' HA ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -79.81 -36.14 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.268 -0.895 . . . . 0.0 110.841 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 16' ' ' LEU . 9.2 mt -63.74 -36.53 84.17 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 178.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.93 -34.35 75.93 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.566 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.544 ' HG ' ' HB3' ' A' ' 27' ' ' GLU . 1.5 mp -79.0 -27.1 43.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.543 -0.723 . . . . 0.0 109.578 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -84.33 -11.22 56.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.567 -0.708 . . . . 0.0 109.408 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.73 -41.37 11.94 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.619 -0.676 . . . . 0.0 110.396 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -99.44 -27.06 13.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.371 -0.831 . . . . 0.0 110.076 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.455 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . 105.24 27.51 5.84 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.544 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -79.49 135.85 36.75 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.397 -1.06 . . . . 0.0 110.268 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -114.14 61.84 0.66 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.626 -0.671 . . . . 0.0 109.508 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -109.33 -154.8 0.54 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.504 -0.747 . . . . 0.0 110.187 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.514 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -117.59 156.43 28.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.453 -0.78 . . . . 0.0 110.637 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 18' ' ' LYS . 3.5 mt -127.71 114.5 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.44 153.04 25.56 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.293 -0.879 . . . . 0.0 111.203 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 15.3 t -144.75 -173.39 4.05 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.473 -0.767 . . . . 0.0 111.067 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.617 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 19.4 m-90 -139.68 39.33 2.02 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.182 -0.949 . . . . 0.0 111.633 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.01 -99.35 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.726 -1.234 . . . . 0.0 110.402 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.31 -62.41 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.935 -1.103 . . . . 0.0 109.684 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HG2' ' HD2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -106.19 38.35 2.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.541 -0.724 . . . . 0.0 109.242 178.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.506 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 1.1 m -41.5 114.97 0.57 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.335 0.588 . . . . 0.0 111.616 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 25.9 m -106.71 161.94 14.21 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.536 -0.728 . . . . 0.0 110.436 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.58 HG22 ' CG2' ' A' ' 62' ' ' ILE . 1.2 mp -83.91 168.06 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.472 -0.767 . . . . 0.0 111.904 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.618 HG22 ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -140.2 174.01 4.44 Favored Pre-proline 0 N--CA 1.501 2.109 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.301 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.507 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 42.3 Cg_endo -66.03 -30.61 47.52 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.923 1.486 . . . . 0.0 110.823 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -73.51 -4.68 35.37 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.584 -0.698 . . . . 0.0 110.948 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.618 ' SD ' HG22 ' A' ' 41' ' ' VAL . 51.4 mtp -97.27 2.53 50.91 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.115 -0.991 . . . . 0.0 111.033 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 42' ' ' PRO . 7.6 p -59.97 3.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.09 33.49 1.03 Allowed Glycine 0 N--CA 1.493 2.476 0 O-C-N 120.208 -1.558 . . . . 0.0 110.144 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.569 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 38.0 m-70 -145.51 156.34 43.65 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.219 -1.165 . . . . 0.0 111.048 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.549 HG22 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.87 86.25 3.25 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.514 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.592 ' CD1' ' HG2' ' A' ' 44' ' ' MET . 3.1 mp -91.87 117.84 36.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.18 -0.95 . . . . 0.0 111.556 -177.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.757 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.21 89.16 4.88 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 122.162 0.982 . . . . 0.0 109.311 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 38' ' ' SER . 26.2 m -66.39 127.43 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.131 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.617 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 26.1 t80 -70.01 108.49 4.07 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.174 -1.011 . . . . 0.0 108.911 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -75.92 16.57 0.4 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.666 -0.646 . . . . 0.0 110.322 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.93 -28.87 13.01 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -140.56 -26.76 0.74 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.528 -0.983 . . . . 0.0 111.14 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -127.74 156.52 42.29 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 76.8 m-70 -95.51 120.01 35.01 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.757 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 16.9 t -109.43 85.32 3.55 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.162 -0.961 . . . . 0.0 109.194 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.541 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.6 Cg_endo -67.6 85.57 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.348 0 O-C-N 123.852 1.448 . . . . 0.0 109.312 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 58' ' ' VAL . 50.5 t -99.46 123.12 51.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.844 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.549 ' HB2' HG22 ' A' ' 48' ' ' THR . 4.1 t80 -72.53 102.28 3.2 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.585 ' HB ' ' O ' ' A' ' 44' ' ' MET . 3.0 mp -80.87 140.76 16.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.843 0.83 . . . . 0.0 111.769 -177.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.5 p -105.51 -158.83 0.68 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.431 ' HB2' HG22 ' A' ' 45' ' ' VAL . 4.2 tp10 -90.55 7.43 39.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.708 -1.245 . . . . 0.0 111.244 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.423 ' ND2' ' HG3' ' A' ' 66' ' ' MET . 2.4 p-10 -127.33 -17.82 4.62 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.723 -1.235 . . . . 0.0 112.625 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.603 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 26.3 mtt -86.1 -17.95 33.69 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.625 -1.297 . . . . 0.0 110.399 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.565 HG21 ' N ' ' A' ' 68' ' ' GLY . 7.6 p -71.49 162.75 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.248 -0.908 . . . . 0.0 111.316 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.565 ' N ' HG21 ' A' ' 67' ' ' VAL . . . 114.31 -16.94 19.52 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.61 ' CG ' ' HG3' ' A' ' 73' ' ' GLU . 18.0 m-70 -120.5 -81.94 0.64 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.11 -1.229 . . . . 0.0 110.744 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.54 -34.72 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.03 0.919 . . . . 0.0 109.747 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.552 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 0.7 OUTLIER 176.37 -15.29 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.195 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.926 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.52 -16.46 71.73 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 120.985 -1.072 . . . . 0.0 110.537 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.61 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 1.2 mt-10 -83.96 -15.79 46.5 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.328 -1.101 . . . . 0.0 109.099 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.603 ' CD2' ' HB3' ' A' ' 66' ' ' MET . 9.6 m-85 -97.06 -20.35 18.09 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.58 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -134.08 53.26 9.5 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.906 -0.496 . . . . 0.0 110.045 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.58 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 49.0 Cg_endo -84.25 50.74 3.13 Favored 'Trans proline' 0 C--N 1.321 -0.913 0 O-C-N 123.443 1.233 . . . . 0.0 110.13 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -130.17 152.84 49.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.589 -0.694 . . . . 0.0 110.252 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.6 mmp_? -74.66 106.7 6.35 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.504 -0.747 . . . . 0.0 109.975 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.2 p -127.53 138.37 52.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.512 -0.743 . . . . 0.0 110.285 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.6 t80 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.565 -0.71 . . . . 0.0 110.141 -179.932 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.4 t -115.03 129.1 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.56 -0.965 . . . . 0.0 110.135 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.77 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -122.65 153.77 38.92 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.55 -0.719 . . . . 0.0 109.849 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.556 ' CG2' HG23 ' A' ' 41' ' ' VAL . 12.5 p -111.71 117.15 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.536 -0.728 . . . . 0.0 109.052 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.77 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 37.2 t70 -46.43 105.2 0.06 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.507 -0.745 . . . . 0.0 111.422 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -67.1 -23.29 65.82 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -66.46 -26.67 67.31 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.899 -0.501 . . . . 0.0 109.955 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.677 HD13 HG22 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -81.37 -39.19 25.42 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.458 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.634 HD13 ' HG ' ' A' ' 15' ' ' LEU . 5.1 mp -62.22 -41.58 98.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.843 -0.536 . . . . 0.0 109.672 178.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.8 -30.88 6.2 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.741 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 0.9 OUTLIER -90.33 -30.89 17.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.529 -0.732 . . . . 0.0 110.327 179.058 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.677 HG22 HD13 ' A' ' 15' ' ' LEU . 71.8 t -72.63 -36.05 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.264 -0.897 . . . . 0.0 111.689 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 16' ' ' LEU . 12.2 mt -61.28 -37.66 83.96 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 18' ' ' LYS . 3.0 tm-20 -63.2 -39.74 95.51 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.322 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.55 HD11 ' HA ' ' A' ' 19' ' ' VAL . 3.6 mt -74.08 -22.08 59.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.274 -0.891 . . . . 0.0 110.091 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -83.43 -12.33 56.53 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.374 -0.829 . . . . 0.0 109.585 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.49 -39.18 16.53 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.447 -0.783 . . . . 0.0 109.757 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.424 ' HE3' ' HG2' ' A' ' 21' ' ' GLU . 65.3 mttt -97.52 -32.97 11.54 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.457 0.646 . . . . 0.0 109.325 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.74 19.53 19.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.527 ' CB ' HD21 ' A' ' 22' ' ' LEU . 28.8 mt-10 -71.22 140.36 50.42 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.509 -0.995 . . . . 0.0 110.351 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -110.73 76.84 1.0 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.475 -0.766 . . . . 0.0 109.762 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.83 -155.79 0.58 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.512 -0.742 . . . . 0.0 110.418 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -115.51 167.97 10.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.568 -0.707 . . . . 0.0 110.316 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.502 HG13 HG21 ' A' ' 19' ' ' VAL . 45.3 mm -126.72 157.99 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.438 -0.789 . . . . 0.0 109.79 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -120.74 130.67 54.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.548 -0.72 . . . . 0.0 110.319 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 18.2 m -119.54 159.82 23.6 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.572 -0.705 . . . . 0.0 110.318 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 19.3 m-90 -145.02 16.57 1.56 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.314 -0.866 . . . . 0.0 111.819 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.62 -152.72 0.07 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.918 -1.114 . . . . 0.0 110.785 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.78 -61.78 1.66 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.072 -1.018 . . . . 0.0 110.067 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.473 ' HG2' ' HD1' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -100.49 43.86 1.04 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.562 -0.711 . . . . 0.0 109.854 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.1 m -50.5 134.71 23.6 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.396 0.617 . . . . 0.0 111.606 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 27.1 m -130.18 161.95 29.98 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.811 -0.555 . . . . 0.0 109.748 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.733 ' CG2' HG12 ' A' ' 62' ' ' ILE . 5.0 mp -85.97 170.28 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.375 -0.828 . . . . 0.0 111.121 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.712 HG21 ' SD ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -135.84 175.45 3.57 Favored Pre-proline 0 N--CA 1.505 2.308 0 O-C-N 121.463 -0.773 . . . . 0.0 110.049 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.618 ' HD2' ' CG1' ' A' ' 41' ' ' VAL . 47.0 Cg_endo -69.43 -34.61 15.31 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 124.024 1.539 . . . . 0.0 111.719 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.709 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 0.7 OUTLIER -71.87 0.53 8.91 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.298 -0.876 . . . . 0.0 111.171 179.62 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.712 ' SD ' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -90.15 -3.86 57.63 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.15 -0.969 . . . . 0.0 111.224 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.592 ' HA ' HG23 ' A' ' 62' ' ' ILE . 4.4 p -49.1 2.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.6 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 44' ' ' MET . . . -146.15 30.02 1.63 Allowed Glycine 0 N--CA 1.496 2.634 0 O-C-N 119.798 -1.814 . . . . 0.0 110.292 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.457 ' CE1' ' HB3' ' A' ' 22' ' ' LEU . 8.1 m-70 -147.43 155.75 42.23 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.159 -1.201 . . . . 0.0 111.059 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.98 89.35 4.03 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.07 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.555 ' CD1' ' HG3' ' A' ' 44' ' ' MET . 2.3 mp -86.64 118.16 32.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.443 -0.786 . . . . 0.0 111.752 -176.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.734 ' HB3' ' HB3' ' A' ' 57' ' ' HIS . . . -78.91 84.85 4.91 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.973 0.892 . . . . 0.0 109.106 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.547 HG21 ' HB ' ' A' ' 58' ' ' VAL . 23.0 m -61.97 129.09 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.534 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.494 ' HB2' ' O ' ' A' ' 33' ' ' THR . 26.5 t80 -78.0 106.44 9.86 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.082 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -75.01 13.76 0.63 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.702 -0.624 . . . . 0.0 110.598 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.58 -25.74 20.29 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -140.51 -25.9 0.76 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.617 -0.931 . . . . 0.0 111.24 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -131.96 151.88 51.45 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.734 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 66.5 m80 -93.13 117.48 30.12 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.733 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 21.8 t -106.91 87.46 2.95 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.079 -1.013 . . . . 0.0 109.338 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.544 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.3 Cg_endo -65.69 93.04 0.25 Allowed 'Trans proline' 0 N--CA 1.489 1.254 0 O-C-N 123.952 1.501 . . . . 0.0 109.814 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.503 ' O ' HD13 ' A' ' 62' ' ' ILE . 12.4 m -107.05 125.97 63.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.655 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 2.8 t80 -71.64 103.52 3.06 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.733 HG12 ' CG2' ' A' ' 40' ' ' ILE . 1.6 mp -56.53 -56.74 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -176.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m 64.62 178.46 0.18 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -177.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.432 ' HB3' HG22 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -86.43 48.91 1.7 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.517 -1.364 . . . . 0.0 111.102 -179.314 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -171.81 -9.09 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.889 -1.132 . . . . 0.0 113.979 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.641 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 29.3 mtt -99.63 -23.48 15.04 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.203 -1.56 . . . . 0.0 111.202 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.551 HG23 ' C ' ' A' ' 41' ' ' VAL . 2.7 p -67.76 163.48 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.489 0 O-C-N 121.284 -0.885 . . . . 0.0 112.514 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.52 ' N ' HG21 ' A' ' 67' ' ' VAL . . . 122.75 -11.33 8.89 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.956 177.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.651 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 17.7 m-70 -125.14 -83.02 0.64 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.135 1.468 . . . . 0.0 110.77 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.67 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.34 -31.22 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.588 0.708 . . . . 0.0 110.258 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.543 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 1.0 OUTLIER 173.62 -15.94 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.709 -179.839 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.02 -18.19 76.19 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.651 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 23.1 mm-40 -84.7 -19.53 32.63 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.291 -1.123 . . . . 0.0 109.184 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.641 ' CD2' ' HB3' ' A' ' 66' ' ' MET . 15.6 m-85 -98.08 -18.22 18.66 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.582 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -134.38 52.23 7.5 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.592 -0.693 . . . . 0.0 110.091 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.582 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 50.0 Cg_endo -84.6 51.58 3.28 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 O-C-N 123.509 1.268 . . . . 0.0 110.056 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 42.0 m -60.07 -49.29 78.24 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.701 -0.625 . . . . 0.0 110.459 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.01 129.27 35.32 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.56 -0.713 . . . . 0.0 110.056 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 26.4 m -144.78 -54.47 0.32 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.383 -0.823 . . . . 0.0 110.169 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 . . . . . 0 N--CA 1.496 1.83 0 O-C-N 121.499 -0.75 . . . . 0.0 110.112 -179.964 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.6 m -80.08 150.02 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.547 -0.973 . . . . 0.0 110.517 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.744 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -111.13 151.61 27.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.548 -0.72 . . . . 0.0 110.034 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.6 t -100.08 110.18 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.294 -0.879 . . . . 0.0 108.872 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.744 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 38.5 t70 -48.42 111.0 0.39 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.405 0.621 . . . . 0.0 111.306 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.35 -23.7 64.73 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -65.61 -28.58 69.22 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.92 -0.488 . . . . 0.0 110.493 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HG ' ' N ' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -77.57 -37.61 50.19 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.498 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.608 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 3.8 mp -60.96 -44.4 97.37 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 120.983 0.421 . . . . 0.0 109.946 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.554 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -53.9 -25.36 19.81 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.273 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.494 ' HE3' ' HG2' ' A' ' 17' ' ' GLU . 5.1 mtmt -101.77 -29.67 11.74 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.485 -0.759 . . . . 0.0 110.371 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.608 ' CG1' ' HA ' ' A' ' 16' ' ' LEU . 1.1 p -75.82 -35.93 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.366 -0.834 . . . . 0.0 111.37 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.554 HD22 ' HA ' ' A' ' 17' ' ' GLU . 3.8 pp -62.98 -28.68 70.26 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -71.91 -35.28 69.63 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.473 HD21 ' HB2' ' A' ' 27' ' ' GLU . 3.3 mt -73.57 -27.26 61.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.651 -0.656 . . . . 0.0 109.753 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -84.93 -17.82 36.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.596 -0.69 . . . . 0.0 109.374 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.33 -38.77 15.94 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.535 -0.728 . . . . 0.0 109.738 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.1 mttm -90.39 -26.34 19.95 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.08 15.14 49.55 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.473 ' HB2' HD21 ' A' ' 22' ' ' LEU . 20.7 mt-10 -80.95 124.93 29.54 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.382 -1.07 . . . . 0.0 110.364 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -98.87 74.15 2.02 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.574 -0.704 . . . . 0.0 109.517 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -108.15 -151.56 0.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.667 -0.645 . . . . 0.0 110.079 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -118.08 153.68 33.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 110.71 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.568 ' HB ' HD12 ' A' ' 49' ' ' ILE . 2.7 mp -127.26 119.08 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.516 -0.74 . . . . 0.0 109.186 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.525 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . 4.7 mptt -84.42 158.82 20.95 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.306 -0.871 . . . . 0.0 111.366 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 15.9 m -141.47 155.97 45.8 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.706 -0.622 . . . . 0.0 109.713 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.451 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 12.0 m-90 -145.76 36.54 1.06 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.225 -0.922 . . . . 0.0 111.404 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -91.91 -95.16 0.13 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.891 -1.131 . . . . 0.0 110.826 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.9 tpt85 -170.2 -63.5 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.084 -1.01 . . . . 0.0 110.514 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -99.27 37.52 1.55 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.267 -0.896 . . . . 0.0 110.007 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.0 m -40.91 133.74 2.08 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.473 0.654 . . . . 0.0 112.153 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 49.1 m -128.54 156.81 42.72 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.902 -0.499 . . . . 0.0 109.821 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.678 HG22 ' SD ' ' A' ' 44' ' ' MET . 1.3 mp -76.98 160.29 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.481 -0.762 . . . . 0.0 111.248 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.666 HG21 ' HG3' ' A' ' 44' ' ' MET . 0.0 OUTLIER -132.06 176.5 2.85 Favored Pre-proline 0 N--CA 1.502 2.158 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.158 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 41.7 Cg_endo -65.76 -29.5 50.88 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.906 1.477 . . . . 0.0 110.596 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -77.78 0.75 22.52 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.686 -0.634 . . . . 0.0 110.688 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.678 ' SD ' HG22 ' A' ' 40' ' ' ILE . 2.4 mtt -93.82 -11.62 30.84 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.072 -1.017 . . . . 0.0 111.644 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.539 HG21 ' N ' ' A' ' 64' ' ' GLU . 7.5 p -56.52 4.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.414 ' C ' ' CG ' ' A' ' 47' ' ' HIS . . . -150.29 29.74 1.08 Allowed Glycine 0 N--CA 1.495 2.601 0 O-C-N 119.953 -1.717 . . . . 0.0 110.088 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 21.8 m-70 -147.35 159.22 43.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.168 -1.195 . . . . 0.0 111.338 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.522 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.57 84.64 2.99 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 178.176 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.58 ' CD1' ' HG2' ' A' ' 44' ' ' MET . 1.0 OUTLIER -84.99 121.09 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.176 -0.953 . . . . 0.0 111.221 -177.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.758 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.61 84.17 4.74 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.832 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.0 m -64.83 130.08 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.4 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.468 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 30.1 t80 -75.34 107.14 7.25 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -84.34 28.01 0.66 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.461 -0.775 . . . . 0.0 110.92 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.11 -36.78 4.09 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -140.69 -20.35 0.82 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.443 -1.033 . . . . 0.0 111.721 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.468 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 2.2 mm100 -128.82 153.07 47.79 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -177.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.415 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . 2.1 m80 -98.7 108.16 20.78 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.758 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 21.8 t -100.86 95.61 4.72 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.144 -0.973 . . . . 0.0 109.469 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.536 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.0 Cg_endo -67.29 93.1 0.35 Allowed 'Trans proline' 0 N--CA 1.488 1.176 0 O-C-N 123.837 1.44 . . . . 0.0 109.423 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.577 HG12 ' CD2' ' A' ' 74' ' ' PHE . 95.9 t -110.36 126.71 67.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.828 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.0 t80 -71.96 104.72 3.61 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.642 HG12 HG22 ' A' ' 40' ' ' ILE . 2.6 mp -67.37 -50.17 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 2.9 m 65.53 178.7 0.2 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.539 ' N ' HG21 ' A' ' 45' ' ' VAL . 1.1 tm-20 -86.17 61.58 6.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.506 -1.371 . . . . 0.0 109.323 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -162.28 -34.38 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.203 -0.935 . . . . 0.0 112.271 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.675 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 10.3 mtt -99.74 9.29 43.32 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.882 -1.136 . . . . 0.0 112.11 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.472 HG21 ' N ' ' A' ' 68' ' ' GLY . 8.3 p -90.04 162.02 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 120.736 -1.227 . . . . 0.0 112.461 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.472 ' N ' HG21 ' A' ' 67' ' ' VAL . . . 105.56 -16.0 44.98 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.552 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 16.2 m-70 -112.45 -88.89 0.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.015 -1.285 . . . . 0.0 110.792 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.3 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 122.437 1.113 . . . . 0.0 109.07 -179.663 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.547 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 0.8 OUTLIER -179.64 -13.85 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.938 -179.603 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.67 -15.17 77.77 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.675 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 1.5 mm-40 -81.18 -15.55 55.44 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.36 -1.082 . . . . 0.0 108.824 178.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.644 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 4.8 m-85 -102.21 -23.07 14.06 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.541 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -131.85 56.46 23.96 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.82 -0.55 . . . . 0.0 109.542 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 46.2 Cg_endo -83.28 54.45 4.68 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.696 1.366 . . . . 0.0 109.986 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.8 t 39.5 46.36 1.43 Allowed 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 121.424 0.631 . . . . 0.0 111.682 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.87 127.2 43.67 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.365 -0.834 . . . . 0.0 109.95 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.6 m -86.82 109.86 19.56 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.41 -0.806 . . . . 0.0 110.196 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 O-C-N 121.555 -0.716 . . . . 0.0 110.165 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t 53.72 72.36 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.839 -0.801 . . . . 0.0 110.295 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.714 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -100.81 148.92 24.39 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.487 -0.758 . . . . 0.0 109.857 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.8 t -95.41 106.1 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 108.566 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.714 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 32.6 t70 -46.35 110.81 0.3 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.375 0.607 . . . . 0.0 111.404 -178.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -67.31 -23.1 65.61 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -63.56 -33.68 76.13 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.912 -0.492 . . . . 0.0 110.31 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.692 ' HG ' HD11 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -80.28 -38.1 31.49 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.692 HD11 ' HG ' ' A' ' 15' ' ' LEU . 4.0 mp -61.49 -40.8 95.88 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.61 -31.33 15.68 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.493 ' HB2' HG22 ' A' ' 31' ' ' ILE . 25.8 mmtt -89.13 -32.43 17.51 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.665 -0.647 . . . . 0.0 110.089 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.559 HG22 HD13 ' A' ' 15' ' ' LEU . 78.7 t -68.46 -38.24 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.303 -0.873 . . . . 0.0 111.156 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 16' ' ' LEU . 11.0 mt -61.76 -37.71 85.3 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -64.52 -35.63 81.57 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.468 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.666 HD21 ' HB2' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -75.07 -25.18 58.41 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.479 -0.763 . . . . 0.0 109.866 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -84.48 -11.2 56.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.439 -0.788 . . . . 0.0 109.94 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.18 -37.35 15.09 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 121.348 -0.845 . . . . 0.0 109.927 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 14.4 mmtp -100.71 -24.72 14.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.641 -0.662 . . . . 0.0 109.714 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.53 29.67 8.63 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.666 ' HB2' HD21 ' A' ' 22' ' ' LEU . 14.5 mt-10 -79.77 125.92 30.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.498 -1.001 . . . . 0.0 110.241 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -106.64 63.18 0.64 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.455 -0.778 . . . . 0.0 109.677 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.27 -153.17 0.51 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.519 -0.738 . . . . 0.0 110.116 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 48' ' ' THR . 0.0 OUTLIER -118.02 147.87 42.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.385 -0.822 . . . . 0.0 110.725 -179.638 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.589 HG23 HD11 ' A' ' 15' ' ' LEU . 2.9 mp -118.52 116.25 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.607 -0.683 . . . . 0.0 109.735 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.459 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . 29.2 mmtt -75.96 154.32 35.97 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.528 -0.732 . . . . 0.0 110.725 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.491 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 97.4 m -135.78 158.44 44.38 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.48 -0.762 . . . . 0.0 110.305 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -147.5 38.04 0.93 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.387 -0.821 . . . . 0.0 111.155 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 93.0 p -94.81 -132.11 0.17 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.96 -1.087 . . . . 0.0 110.774 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.4 mtt85 -132.91 -64.23 0.75 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.986 -1.071 . . . . 0.0 110.317 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 mpp_? -97.99 40.92 1.15 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.432 -0.793 . . . . 0.0 110.098 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -40.2 125.78 2.08 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.528 0.68 . . . . 0.0 112.452 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.733 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 71.1 m -128.88 155.86 44.59 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.748 ' CG2' HG12 ' A' ' 62' ' ' ILE . 5.2 mp -86.76 168.89 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.406 -0.809 . . . . 0.0 111.457 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.595 HG22 ' CG ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -136.51 171.84 8.02 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.645 -0.659 . . . . 0.0 110.167 179.469 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 42.7 Cg_endo -66.64 -32.78 37.63 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 124.239 1.652 . . . . 0.0 111.249 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -69.27 -5.51 23.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.559 -0.713 . . . . 0.0 110.711 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.617 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 1.3 mmm -91.83 -0.57 57.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.188 -0.945 . . . . 0.0 111.311 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.617 ' HA ' HG23 ' A' ' 62' ' ' ILE . 6.6 p -53.55 7.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.42 ' C ' ' CG ' ' A' ' 47' ' ' HIS . . . -148.67 29.44 1.29 Allowed Glycine 0 N--CA 1.496 2.7 0 O-C-N 119.895 -1.753 . . . . 0.0 110.33 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.42 ' CG ' ' C ' ' A' ' 46' ' ' GLY . 9.6 m-70 -148.1 155.91 42.0 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.205 -1.174 . . . . 0.0 111.193 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -101.04 90.96 4.35 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 177.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.579 HD11 ' SD ' ' A' ' 44' ' ' MET . 2.5 mp -88.84 121.05 38.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.593 -176.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.717 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.56 81.63 4.87 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.824 0.821 . . . . 0.0 109.238 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.1 m -61.41 135.3 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.963 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 33' ' ' THR . 18.5 t80 -80.21 106.96 12.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.364 -0.835 . . . . 0.0 109.497 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -71.13 -0.98 10.86 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.569 -0.707 . . . . 0.0 110.329 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.84 -22.61 8.07 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 107.693 -2.163 . . . . 0.0 107.693 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -140.21 -28.18 0.73 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.985 -0.715 . . . . 0.0 111.158 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.58 155.27 47.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.235 -0.916 . . . . 0.0 112.2 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.471 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . 19.4 m-70 -99.92 110.4 22.74 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.717 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 24.9 t -97.71 96.99 3.64 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.239 -0.913 . . . . 0.0 109.943 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.507 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.7 Cg_endo -66.68 92.41 0.3 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 O-C-N 123.906 1.477 . . . . 0.0 109.615 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.545 ' HB ' ' CD2' ' A' ' 74' ' ' PHE . 12.9 m -103.92 125.19 58.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.613 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 2.6 t80 -72.66 103.09 3.48 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.748 HG12 ' CG2' ' A' ' 40' ' ' ILE . 1.5 mp -55.98 -61.63 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -176.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 m 65.41 174.42 0.22 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.419 ' N ' HG21 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -85.38 58.79 5.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.357 -1.464 . . . . 0.0 109.976 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -171.57 -25.94 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.94 -1.1 . . . . 0.0 113.27 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.656 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 2.5 mmm -89.2 -25.43 21.78 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.558 -1.339 . . . . 0.0 111.097 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.57 HG22 ' C ' ' A' ' 41' ' ' VAL . 3.3 p -67.02 163.09 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 121.331 -0.855 . . . . 0.0 112.561 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.492 ' N ' HG23 ' A' ' 67' ' ' VAL . . . 118.83 -13.57 11.59 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.756 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.59 ' CG ' ' HG3' ' A' ' 73' ' ' GLU . 19.7 m-70 -123.06 -83.56 0.66 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 119.037 1.418 . . . . 0.0 110.724 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.733 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.2 -30.93 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.671 0.748 . . . . 0.0 110.48 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.543 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 0.9 OUTLIER 174.12 -14.98 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.272 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.809 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.99 -18.46 74.54 Favored Glycine 0 N--CA 1.496 2.647 0 O-C-N 120.982 -1.074 . . . . 0.0 110.423 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.59 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 2.0 mt-10 -86.41 -16.85 35.94 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.237 -1.155 . . . . 0.0 109.262 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.666 ' HE2' ' HA ' ' A' ' 62' ' ' ILE . 9.9 m-85 -101.01 -19.89 15.63 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.572 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -134.32 55.18 13.9 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.669 -0.644 . . . . 0.0 109.877 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.572 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 46.4 Cg_endo -85.02 49.89 2.7 Favored 'Trans proline' 0 C--N 1.319 -0.982 0 O-C-N 123.535 1.282 . . . . 0.0 110.178 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.6 t -76.22 -25.74 55.4 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.662 -0.649 . . . . 0.0 111.028 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -73.98 -59.46 2.71 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.341 -0.849 . . . . 0.0 110.2 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 p -143.26 -68.23 0.35 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.491 -0.756 . . . . 0.0 110.237 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 . . . . . 0 N--CA 1.496 1.849 0 O-C-N 121.377 -0.827 . . . . 0.0 110.324 -179.903 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.3 m -74.96 149.99 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.562 -0.963 . . . . 0.0 110.433 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.753 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -107.77 148.82 28.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.59 -0.694 . . . . 0.0 109.958 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.4 p -102.12 109.61 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.83 . . . . 0.0 108.77 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.753 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 38.8 t70 -46.06 111.59 0.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.624 -0.673 . . . . 0.0 111.803 -178.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.403 ' HA ' HD11 ' A' ' 16' ' ' LEU . 7.7 t70 -68.3 -24.2 64.83 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -64.92 -28.38 69.49 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.853 -0.53 . . . . 0.0 109.78 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.568 ' HG ' HD13 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -77.67 -34.98 52.81 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.211 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.592 ' HA ' HG11 ' A' ' 19' ' ' VAL . 3.8 mp -62.3 -47.28 84.97 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.048 0.451 . . . . 0.0 109.902 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.44 -23.04 5.39 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.737 -0.602 . . . . 0.0 110.445 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HB2' HG22 ' A' ' 31' ' ' ILE . 8.8 mmtm -102.58 -30.84 10.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.301 -0.874 . . . . 0.0 111.045 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.592 HG11 ' HA ' ' A' ' 16' ' ' LEU . 1.4 p -78.13 -39.86 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.191 -0.943 . . . . 0.0 111.274 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.464 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 12.6 mt -63.25 -36.84 85.0 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.89 -38.88 83.5 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.271 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.536 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 3.2 mt -73.42 -24.67 60.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.119 -0.988 . . . . 0.0 110.197 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -80.71 -10.4 59.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.522 -0.736 . . . . 0.0 109.59 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.19 -35.58 23.42 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 121.498 -0.751 . . . . 0.0 109.707 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.541 ' HE3' ' HB2' ' A' ' 27' ' ' GLU . 7.4 pttt -102.3 -29.57 11.59 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.533 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.59 28.35 7.54 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.541 ' HB2' ' HE3' ' A' ' 25' ' ' LYS . 2.6 mt-10 -90.9 134.61 34.33 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.467 -1.019 . . . . 0.0 110.382 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -100.04 76.45 1.93 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.463 -0.773 . . . . 0.0 109.357 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.98 -154.55 0.54 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.51 -0.743 . . . . 0.0 110.212 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.503 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -118.99 161.1 20.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.453 -0.779 . . . . 0.0 110.763 -179.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.504 ' HB ' HG12 ' A' ' 49' ' ' ILE . 2.9 mp -132.77 112.42 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.54 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -85.69 152.69 22.88 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.55 -0.718 . . . . 0.0 111.186 -178.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.497 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 8.5 m -134.87 163.21 30.34 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.925 -0.484 . . . . 0.0 110.279 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.436 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 16.0 m-90 -146.73 37.06 0.97 Allowed 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.289 -0.882 . . . . 0.0 110.854 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.0 t -94.74 -126.63 0.12 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.077 -1.015 . . . . 0.0 110.779 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.14 -59.68 0.78 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.827 -1.171 . . . . 0.0 110.822 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -98.36 35.61 1.75 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.322 -0.861 . . . . 0.0 110.605 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.5 m -36.06 123.9 0.74 Allowed 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.31 0.576 . . . . 0.0 111.942 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 69' ' ' HIS . 27.5 m -128.32 162.27 27.46 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.546 -0.721 . . . . 0.0 110.569 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.719 ' CG2' ' HG2' ' A' ' 44' ' ' MET . 1.9 mt -66.58 165.01 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 O-C-N 121.631 -0.668 . . . . 0.0 110.861 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.646 ' O ' ' HG3' ' A' ' 44' ' ' MET . 0.1 OUTLIER -123.45 -171.41 0.22 Allowed Pre-proline 0 N--CA 1.505 2.312 0 O-C-N 121.362 -0.836 . . . . 0.0 110.14 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.547 ' CD ' ' CB ' ' A' ' 41' ' ' VAL . 57.7 Cg_endo -87.75 -31.19 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.657 1.346 . . . . 0.0 111.098 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -90.05 15.47 10.07 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.536 -0.727 . . . . 0.0 111.056 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.782 ' SD ' ' CG2' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -94.43 4.84 53.34 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.17 -0.956 . . . . 0.0 111.798 -179.695 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.637 HG21 ' HE2' ' A' ' 44' ' ' MET . 39.5 t -57.46 -2.83 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.478 ' HA3' ' CE1' ' A' ' 61' ' ' TYR . . . -150.77 34.08 0.96 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.513 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 52.7 m-70 -138.49 152.67 48.48 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.221 -1.164 . . . . 0.0 110.938 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.54 HG22 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.29 80.82 2.47 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.504 HG12 ' HB ' ' A' ' 31' ' ' ILE . 9.2 mt -78.09 117.35 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.182 -0.949 . . . . 0.0 110.915 -177.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.722 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.42 80.07 4.83 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.772 0.796 . . . . 0.0 108.99 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.8 m -57.87 127.12 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.181 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 33' ' ' THR . 14.9 t80 -75.76 105.99 7.1 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.196 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -69.61 -0.8 7.36 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.577 -0.702 . . . . 0.0 110.429 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.03 -20.71 9.73 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 107.839 -2.104 . . . . 0.0 107.839 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -140.1 -29.22 0.71 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.957 -0.731 . . . . 0.0 110.974 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.53 154.82 48.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.243 -0.911 . . . . 0.0 112.029 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.46 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 5.0 m80 -100.59 106.04 17.51 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.722 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 40.4 t -94.98 99.93 4.89 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.206 -0.934 . . . . 0.0 109.804 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.501 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.7 Cg_endo -66.54 92.39 0.29 Allowed 'Trans proline' 0 N--CA 1.49 1.304 0 O-C-N 123.904 1.476 . . . . 0.0 109.598 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 58' ' ' VAL . 94.0 t -98.39 116.59 41.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.75 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.54 ' HB2' HG22 ' A' ' 48' ' ' THR . 6.2 t80 -73.03 108.77 6.11 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.782 ' CG2' ' SD ' ' A' ' 44' ' ' MET . 2.4 mp -92.72 159.89 2.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.884 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 3.1 m -129.83 -159.81 0.99 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 177.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.481 ' HB2' HG12 ' A' ' 45' ' ' VAL . 3.2 tt0 -90.25 47.75 1.48 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.242 -1.536 . . . . 0.0 110.412 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -156.58 -34.23 0.08 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.973 -1.079 . . . . 0.0 112.675 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.611 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 71.3 mtm -85.86 5.01 34.74 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.999 -1.063 . . . . 0.0 111.546 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.554 HG21 ' N ' ' A' ' 68' ' ' GLY . 7.5 p -83.99 166.2 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 120.893 -1.129 . . . . 0.0 111.767 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.554 ' N ' HG21 ' A' ' 67' ' ' VAL . . . 106.5 -21.7 32.19 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.57 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 16.5 m-70 -112.27 -86.87 0.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.121 -1.223 . . . . 0.0 111.003 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.538 ' HD2' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER 177.61 -36.27 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 122.273 1.035 . . . . 0.0 109.278 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.544 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -178.98 -15.33 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.998 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.83 -15.3 73.7 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.611 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 1.5 mm-40 -82.22 -16.86 48.13 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.44 -1.035 . . . . 0.0 108.773 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.544 ' CD1' ' HA ' ' A' ' 71' ' ' LEU . 7.5 m-85 -98.2 -22.3 16.24 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.547 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -134.2 56.49 19.07 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.797 -0.564 . . . . 0.0 110.39 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 47.4 Cg_endo -86.62 44.3 1.18 Allowed 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.393 1.207 . . . . 0.0 110.436 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.1 t -172.06 39.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.74 -0.6 . . . . 0.0 110.267 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.68 146.78 33.47 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.176 -0.953 . . . . 0.0 110.498 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.3 t -143.89 144.62 31.81 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.507 -0.745 . . . . 0.0 110.214 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 O-C-N 121.38 -0.825 . . . . 0.0 110.275 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.3 m -83.34 152.2 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.565 -0.962 . . . . 0.0 110.402 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.659 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.7 OUTLIER -135.45 137.93 42.69 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.413 -0.804 . . . . 0.0 110.309 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.9 p -113.63 118.9 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.659 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 38.8 t70 -43.81 105.87 0.06 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.618 -0.676 . . . . 0.0 111.604 -178.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -68.04 -21.35 65.02 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -66.84 -28.41 68.33 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 122.007 -0.433 . . . . 0.0 110.49 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.555 ' HG ' ' N ' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -76.85 -37.32 55.83 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.709 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.555 ' N ' ' HG ' ' A' ' 15' ' ' LEU . 3.9 mp -60.75 -44.21 96.98 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.97 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.513 ' HA ' HD22 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -55.74 -25.07 38.75 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.196 179.141 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -102.31 -31.39 10.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.453 -0.78 . . . . 0.0 110.67 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.624 ' CG1' ' HG3' ' A' ' 43' ' ' GLU . 1.4 p -71.8 -37.3 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.287 -0.883 . . . . 0.0 111.021 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.513 HD22 ' HA ' ' A' ' 17' ' ' GLU . 4.0 pp -64.47 -28.2 69.5 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.84 -31.96 65.13 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 27' ' ' GLU . 1.4 mt -76.92 -22.08 53.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.609 -0.682 . . . . 0.0 109.582 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -84.76 -19.6 32.37 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.496 -0.753 . . . . 0.0 109.716 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.14 -39.13 17.02 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 121.504 -0.748 . . . . 0.0 109.908 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -90.71 -25.3 20.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.672 -0.643 . . . . 0.0 109.533 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.36 16.61 49.25 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.526 ' HB2' HD21 ' A' ' 22' ' ' LEU . 1.5 mt-10 -75.41 128.35 35.15 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.514 -0.991 . . . . 0.0 110.477 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.0 mtmm -115.13 50.89 0.95 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.551 -0.718 . . . . 0.0 109.513 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.7 ttp-105 -88.31 -92.2 0.11 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.57 -0.706 . . . . 0.0 110.411 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.42 ' CD1' ' HD3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -170.9 146.25 2.5 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.118 -0.989 . . . . 0.0 110.674 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.506 HD11 HG22 ' A' ' 19' ' ' VAL . 2.8 mt -115.26 119.07 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.508 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 0.1 OUTLIER -79.63 151.05 30.79 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.437 -0.789 . . . . 0.0 111.543 -178.63 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.4 m -137.6 155.3 49.34 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.601 -0.687 . . . . 0.0 110.353 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' A' ' 32' ' ' LYS . 17.5 m-90 -146.02 29.53 1.09 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.299 -0.876 . . . . 0.0 111.601 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -82.9 -98.14 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.812 -1.18 . . . . 0.0 110.592 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -174.29 -61.59 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.215 -0.928 . . . . 0.0 109.558 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.19 42.7 1.09 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.5 m -50.9 133.9 26.22 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.525 0.679 . . . . 0.0 111.923 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 20.6 m -127.25 161.54 28.31 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.684 ' CG2' HG12 ' A' ' 62' ' ' ILE . 1.1 mp -80.56 162.15 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.291 -0.88 . . . . 0.0 111.566 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.545 HG21 ' HG3' ' A' ' 44' ' ' MET . 0.0 OUTLIER -129.3 169.58 12.83 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 121.701 -0.624 . . . . 0.0 110.011 178.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.439 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 43.7 Cg_endo -67.5 -31.72 33.31 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.262 1.664 . . . . 0.0 110.918 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.624 ' HG3' ' CG1' ' A' ' 19' ' ' VAL . 2.3 pt-20 -80.16 5.69 13.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.482 -0.761 . . . . 0.0 110.926 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.659 ' HB3' HG12 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -98.12 -5.74 33.04 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.287 -0.883 . . . . 0.0 111.448 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.59 ' HA ' HG23 ' A' ' 62' ' ' ILE . 61.8 t -48.29 -6.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.516 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA3' ' CE1' ' A' ' 61' ' ' TYR . . . -144.72 38.97 1.24 Allowed Glycine 0 N--CA 1.491 2.344 0 O-C-N 120.186 -1.571 . . . . 0.0 109.221 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 49.6 m-70 -143.08 147.35 34.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.508 -0.995 . . . . 0.0 111.183 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.81 80.93 2.39 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 177.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.523 HD13 HG22 ' A' ' 19' ' ' VAL . 1.5 mt -85.19 124.1 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.391 -0.818 . . . . 0.0 111.347 -176.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.762 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -77.78 80.28 4.24 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -61.08 130.47 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.057 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 30.5 t80 -78.27 105.88 9.81 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.236 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -69.91 0.0 6.59 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.618 -0.677 . . . . 0.0 110.6 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.67 -18.87 10.65 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 107.913 -2.075 . . . . 0.0 107.913 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -140.1 -28.57 0.73 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.938 -0.742 . . . . 0.0 110.884 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -135.86 155.32 50.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.226 -0.921 . . . . 0.0 112.015 -178.353 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.423 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . 1.1 m-70 -101.57 105.43 16.39 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.762 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 21.9 t -95.35 102.29 9.42 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.217 -0.927 . . . . 0.0 110.051 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.529 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.3 Cg_endo -66.64 91.96 0.3 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.916 1.482 . . . . 0.0 109.006 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.531 HG12 ' CD2' ' A' ' 74' ' ' PHE . 79.1 t -108.21 126.75 64.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.938 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.5 t80 -72.88 110.89 7.53 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 176.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.684 HG12 ' CG2' ' A' ' 40' ' ' ILE . 1.7 mp -62.71 -56.77 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.642 -0.661 . . . . 0.0 112.732 -177.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 3.5 m 68.79 162.39 0.21 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -177.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.504 ' N ' HG11 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -78.93 62.76 3.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.639 -1.288 . . . . 0.0 109.451 -179.398 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -167.53 -32.85 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.317 -0.864 . . . . 0.0 112.271 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.642 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 2.8 mtt -98.07 8.49 44.69 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.79 -1.194 . . . . 0.0 111.85 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.557 HG21 ' N ' ' A' ' 68' ' ' GLY . 8.2 p -90.22 162.62 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 120.757 -1.214 . . . . 0.0 112.214 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.557 ' N ' HG21 ' A' ' 67' ' ' VAL . . . 106.69 -16.82 39.96 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 178.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.549 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 16.3 m-70 -112.86 -88.44 0.54 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.12 -1.223 . . . . 0.0 110.726 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.09 -35.64 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 122.394 1.092 . . . . 0.0 109.02 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.547 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -178.74 -14.93 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.973 -179.587 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.41 -14.75 77.17 Favored Glycine 0 N--CA 1.498 2.771 0 O-C-N 120.797 -1.189 . . . . 0.0 110.281 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.638 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 1.8 mm-40 -81.02 -18.2 47.63 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.356 -1.085 . . . . 0.0 108.686 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.642 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 10.6 m-85 -96.86 -22.2 17.05 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.56 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -132.91 55.11 15.57 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.745 -0.597 . . . . 0.0 109.743 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.56 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 46.7 Cg_endo -84.11 51.46 3.38 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 O-C-N 123.639 1.336 . . . . 0.0 110.26 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.6 m -69.1 138.32 54.2 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.613 -0.679 . . . . 0.0 110.198 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -79.44 -52.31 8.22 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.534 -0.729 . . . . 0.0 110.241 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.9 p -129.36 -54.27 1.18 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.581 -0.699 . . . . 0.0 110.367 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.425 -0.797 . . . . 0.0 110.296 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.484 ' HB ' ' HD2' ' A' ' 37' ' ' ARG . 76.2 t -80.32 -40.76 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.546 -0.973 . . . . 0.0 110.361 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.504 ' CZ ' ' HB3' ' A' ' 35' ' ' SER . 1.7 t80 -155.98 156.61 34.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.476 -0.765 . . . . 0.0 110.848 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.548 ' CG2' HG23 ' A' ' 41' ' ' VAL . 3.5 p -137.17 119.75 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.589 ' CB ' ' HB3' ' A' ' 15' ' ' LEU . 34.1 m-20 -23.62 99.97 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 CA-C-O 121.046 0.45 . . . . 0.0 112.142 -178.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.2 -26.4 63.86 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.559 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -76.07 -14.04 60.2 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 120.99 0.424 . . . . 0.0 110.148 178.64 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.589 ' HB3' ' CB ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -87.01 -35.33 18.86 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.585 ' HA ' HG13 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -70.56 -43.93 68.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.745 -0.597 . . . . 0.0 110.01 178.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.57 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -53.08 -19.73 3.05 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.8 179.408 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.472 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 17.6 mttt -106.39 -32.56 8.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.347 -0.846 . . . . 0.0 110.146 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.605 HG12 ' HE2' ' A' ' 44' ' ' MET . 0.5 OUTLIER -73.57 -40.66 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.403 -0.811 . . . . 0.0 111.153 -179.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.57 HD22 ' HA ' ' A' ' 17' ' ' GLU . 3.8 pp -60.52 -26.27 66.74 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.57 -36.24 52.27 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 27' ' ' GLU . 0.9 OUTLIER -72.22 -28.49 63.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.591 -0.693 . . . . 0.0 109.637 178.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -83.56 -11.33 57.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.581 -0.699 . . . . 0.0 109.599 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.0 -37.22 14.47 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 121.588 -0.695 . . . . 0.0 110.002 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.489 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 4.6 ptmt -96.56 -23.92 16.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.611 -0.681 . . . . 0.0 109.84 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.32 29.45 7.5 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.489 ' HG3' ' HE2' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -92.98 129.08 39.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.427 -1.043 . . . . 0.0 110.685 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -107.25 70.63 0.8 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.593 -0.692 . . . . 0.0 109.226 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.34 -152.76 0.5 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.656 -0.653 . . . . 0.0 110.006 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -114.05 155.79 25.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.421 -0.799 . . . . 0.0 110.354 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.486 HG23 ' HA ' ' A' ' 15' ' ' LEU . 5.8 mt -135.06 116.32 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.498 -0.751 . . . . 0.0 109.346 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -103.33 148.37 25.94 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.277 -0.889 . . . . 0.0 110.891 -179.45 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 56.6 m -137.91 156.78 47.53 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.579 -0.701 . . . . 0.0 110.177 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.506 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 19.9 m-90 -118.57 44.93 2.15 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.681 -0.637 . . . . 0.0 110.057 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 10' ' ' PHE . 66.1 m -83.79 -167.24 1.65 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.289 -0.882 . . . . 0.0 111.004 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -102.11 -61.88 1.33 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.436 -0.79 . . . . 0.0 110.341 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.484 ' HD2' ' HB ' ' A' ' 9' ' ' VAL . 0.3 OUTLIER -92.33 41.32 1.07 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.355 -0.841 . . . . 0.0 109.636 179.355 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 63.1 m -37.75 105.44 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.643 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 44.6 m -122.35 159.7 26.92 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.684 -0.635 . . . . 0.0 109.316 178.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.819 ' CG2' HG12 ' A' ' 62' ' ' ILE . 4.8 mp -90.08 168.92 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.408 -0.807 . . . . 0.0 111.705 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.622 HG21 ' HG2' ' A' ' 44' ' ' MET . 0.1 OUTLIER -139.56 174.6 3.93 Favored Pre-proline 0 N--CA 1.505 2.306 0 O-C-N 121.79 -0.569 . . . . 0.0 109.787 179.443 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.529 ' HD2' HG13 ' A' ' 41' ' ' VAL . 42.8 Cg_endo -65.61 -33.53 45.05 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 124.116 1.588 . . . . 0.0 111.198 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.75 -12.43 23.97 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.597 -0.69 . . . . 0.0 110.578 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.622 ' HG2' HG21 ' A' ' 41' ' ' VAL . 6.2 mmt -87.09 -4.8 59.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.364 -0.835 . . . . 0.0 111.909 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.481 ' HA ' HG23 ' A' ' 62' ' ' ILE . 7.5 p -51.11 1.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.475 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.408 ' C ' ' CG ' ' A' ' 47' ' ' HIS . . . -146.27 31.01 1.58 Allowed Glycine 0 N--CA 1.495 2.62 0 O-C-N 119.918 -1.739 . . . . 0.0 110.28 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.408 ' CG ' ' C ' ' A' ' 46' ' ' GLY . 17.9 m-70 -147.88 156.55 42.82 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.217 -1.167 . . . . 0.0 111.315 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.528 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.69 88.73 3.9 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.677 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.563 HG12 ' CD1' ' A' ' 15' ' ' LEU . 2.6 mt -86.69 119.31 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.178 -0.951 . . . . 0.0 112.019 -176.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.693 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.87 86.81 5.36 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 122.15 0.976 . . . . 0.0 109.193 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.1 m -71.25 134.8 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.232 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.537 ' HB2' ' O ' ' A' ' 33' ' ' THR . 28.5 t80 -75.2 105.58 6.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.342 -0.849 . . . . 0.0 108.886 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -71.46 0.03 9.28 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.53 -0.731 . . . . 0.0 110.801 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.41 -22.48 7.84 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -140.36 -28.84 0.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 122.016 -0.697 . . . . 0.0 110.79 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.21 156.22 49.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.266 -0.896 . . . . 0.0 111.988 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 93.6 m-70 -101.83 108.31 19.76 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.693 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 22.0 t -94.3 101.5 6.66 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.308 -0.87 . . . . 0.0 110.008 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 57' ' ' HIS . 43.0 Cg_endo -68.85 94.0 0.45 Allowed 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.933 1.491 . . . . 0.0 108.96 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.636 ' HB ' ' CD2' ' A' ' 74' ' ' PHE . 15.0 m -106.36 126.93 62.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.217 -178.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -69.5 104.32 2.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 176.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.819 HG12 ' CG2' ' A' ' 40' ' ' ILE . 1.3 mp -60.2 -53.22 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.3 p 59.6 -175.63 0.1 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -90.41 43.51 1.15 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.486 -1.384 . . . . 0.0 109.941 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -150.92 -29.11 0.2 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.948 -1.095 . . . . 0.0 113.464 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.586 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 5.9 mtt -89.29 -23.18 22.36 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.527 -1.358 . . . . 0.0 111.435 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.588 HG21 ' N ' ' A' ' 68' ' ' GLY . 2.7 p -67.01 160.14 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.077 -1.015 . . . . 0.0 112.459 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.588 ' N ' HG21 ' A' ' 67' ' ' VAL . . . 114.62 -13.56 20.48 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.869 -0.682 . . . . 0.0 111.586 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.534 ' CG ' ' HG3' ' A' ' 73' ' ' GLU . 22.2 m-70 -121.98 -83.8 0.66 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.912 1.356 . . . . 0.0 110.853 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.88 -30.98 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 121.661 0.743 . . . . 0.0 110.326 -179.597 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.566 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 1.3 pp 173.12 -14.18 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.767 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.29 -18.99 73.82 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 2.6 mt-10 -86.09 -15.14 42.16 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.355 -1.085 . . . . 0.0 109.24 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.655 ' HE2' ' HA ' ' A' ' 62' ' ' ILE . 10.2 m-85 -99.85 -21.76 15.59 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.554 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -133.43 54.79 13.88 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.782 -0.574 . . . . 0.0 109.922 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 48.1 Cg_endo -83.93 51.04 3.3 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.672 1.354 . . . . 0.0 110.261 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.5 t -74.58 168.22 20.2 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.624 -0.673 . . . . 0.0 110.648 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.12 174.3 9.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.457 -0.777 . . . . 0.0 110.355 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.8 p -87.86 135.41 33.4 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.456 -0.777 . . . . 0.0 110.144 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 . . . . . 0 N--CA 1.496 1.849 0 O-C-N 121.524 -0.735 . . . . 0.0 110.217 -179.893 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.9 t -104.27 80.08 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.525 -0.985 . . . . 0.0 109.845 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.716 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -139.0 148.8 43.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.399 -0.813 . . . . 0.0 110.177 -179.798 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.6 p -116.01 119.08 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.716 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 5.1 t70 -44.55 103.9 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.686 -0.634 . . . . 0.0 111.161 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.86 -22.1 65.14 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.16 -29.99 63.25 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.977 -0.452 . . . . 0.0 110.253 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.71 ' HG ' HD11 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -78.25 -38.68 42.24 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.277 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.71 HD11 ' HG ' ' A' ' 15' ' ' LEU . 2.9 mp -58.92 -42.98 90.98 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.309 0.576 . . . . 0.0 109.584 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.531 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -56.01 -23.75 34.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.806 -0.558 . . . . 0.0 109.943 179.257 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.4 -29.82 12.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.497 -0.752 . . . . 0.0 110.592 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.661 HG22 HD12 ' A' ' 49' ' ' ILE . 2.3 p -73.96 -38.05 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.186 -0.946 . . . . 0.0 111.02 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.531 HD22 ' HA ' ' A' ' 17' ' ' GLU . 4.1 pp -61.75 -26.63 68.19 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -69.61 -34.06 73.55 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 3.6 mm? -74.13 -26.56 60.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.621 -0.674 . . . . 0.0 109.369 178.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -82.13 -13.44 57.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.598 -0.689 . . . . 0.0 109.674 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.37 -33.61 21.96 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.505 -0.747 . . . . 0.0 110.095 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HG3' ' HG3' ' A' ' 27' ' ' GLU . 2.1 ptmt -92.01 -17.08 25.6 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.61 -0.682 . . . . 0.0 109.714 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.37 32.43 11.93 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.488 ' HG3' ' HG3' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -114.39 128.56 56.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.527 -0.984 . . . . 0.0 110.743 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.78 80.79 2.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.597 -0.69 . . . . 0.0 109.588 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.82 -147.84 0.39 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.55 -0.719 . . . . 0.0 109.848 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -121.27 154.05 36.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 110.203 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.696 ' HB ' HD11 ' A' ' 49' ' ' ILE . 28.0 mm -118.79 154.22 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.328 -0.857 . . . . 0.0 110.057 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.461 ' HB2' ' CZ2' ' A' ' 34' ' ' TRP . 1.6 mmtp -102.76 137.09 41.43 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.667 -0.646 . . . . 0.0 110.345 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.656 HG22 ' CB ' ' A' ' 12' ' ' ASP . 9.6 m -124.45 150.28 45.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.572 -0.705 . . . . 0.0 109.806 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.572 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 1.4 m-90 -145.69 38.56 1.12 Allowed 'General case' 0 N--CA 1.51 2.563 0 O-C-N 121.067 -1.021 . . . . 0.0 112.652 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -100.57 -97.5 0.25 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.467 -1.395 . . . . 0.0 110.702 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.83 -60.02 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.094 -1.004 . . . . 0.0 109.346 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.54 35.16 2.53 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.8 m -51.48 138.9 21.16 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.529 0.68 . . . . 0.0 111.742 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.608 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 3.0 m -133.79 165.91 23.87 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.859 -0.526 . . . . 0.0 109.836 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.671 HG12 HG12 ' A' ' 62' ' ' ILE . 5.0 mp -86.2 161.49 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.199 -0.938 . . . . 0.0 110.551 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.665 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -141.1 176.23 2.59 Favored Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 121.672 -0.643 . . . . 0.0 109.686 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.665 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 38.3 Cg_endo -62.86 -28.77 75.86 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.137 1.598 . . . . 0.0 109.595 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -66.79 -10.64 49.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.847 -0.533 . . . . 0.0 110.864 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.659 ' HG2' HG22 ' A' ' 41' ' ' VAL . 1.9 ptp -140.19 44.21 1.89 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.814 -1.179 . . . . 0.0 112.324 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.78 ' CG1' ' HA ' ' A' ' 64' ' ' GLU . 3.2 t -91.49 27.96 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.819 -1.176 . . . . 0.0 110.938 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.66 24.74 0.94 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.425 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 12.6 m-70 -139.55 167.81 21.26 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.235 -1.156 . . . . 0.0 110.533 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.632 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -98.96 81.62 2.63 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 178.394 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.696 HD11 ' HB ' ' A' ' 31' ' ' ILE . 1.1 mm -79.37 112.47 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.673 -0.642 . . . . 0.0 110.929 -177.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.737 ' HB3' ' HB3' ' A' ' 57' ' ' HIS . . . -77.8 80.83 4.24 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.969 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.58 138.29 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.879 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.572 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 19.7 t80 -80.67 108.0 13.95 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.565 -0.854 . . . . 0.0 108.983 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -76.57 15.45 0.62 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.769 -0.582 . . . . 0.0 110.247 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.81 -29.3 11.03 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.0 pttt -140.57 -27.37 0.73 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.636 -0.92 . . . . 0.0 111.188 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -126.41 156.15 41.03 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.737 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 13.2 m-70 -94.9 115.82 27.94 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.708 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 46.2 t -103.81 90.64 2.99 Favored Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 121.157 -0.965 . . . . 0.0 109.337 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.541 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.8 Cg_endo -65.42 89.47 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 O-C-N 124.019 1.536 . . . . 0.0 110.301 -178.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 60' ' ' VAL . 5.3 m -94.67 110.04 23.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.268 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.632 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -69.39 95.28 0.79 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.792 -1.163 . . . . 0.0 108.222 178.514 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.671 HG12 HG12 ' A' ' 40' ' ' ILE . 2.7 mp -76.79 127.64 37.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.145 -178.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.59 ' C ' HG13 ' A' ' 45' ' ' VAL . 72.1 p -101.78 158.74 15.9 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.78 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -42.78 -19.61 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.433 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 63' ' ' THR . 10.1 p30 -121.59 29.59 7.12 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.696 -1.253 . . . . 0.0 112.641 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.701 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 18.7 mmt -126.72 -19.19 4.57 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.973 -1.079 . . . . 0.0 110.73 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.549 ' HA ' ' HZ ' ' A' ' 74' ' ' PHE . 13.3 p -65.5 162.61 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.343 -0.848 . . . . 0.0 112.239 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.16 -11.07 10.78 Favored Glycine 0 N--CA 1.491 2.367 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.727 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.672 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 14.2 m-70 -113.94 -88.29 0.56 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 119.33 1.565 . . . . 0.0 111.015 -178.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.608 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.54 -32.29 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.824 0.821 . . . . 0.0 109.785 -179.531 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.549 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 1.4 pp 174.03 -11.58 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.788 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.17 -15.01 81.74 Favored Glycine 0 N--CA 1.492 2.372 0 O-C-N 120.827 -1.171 . . . . 0.0 110.418 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.672 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 12.9 mm-40 -86.66 -16.44 36.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.252 -1.146 . . . . 0.0 109.58 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.701 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 0.7 OUTLIER -117.73 -18.94 9.5 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.872 -0.517 . . . . 0.0 110.095 -179.108 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.512 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -138.38 58.19 14.04 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.436 -0.79 . . . . 0.0 110.007 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.512 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 44.2 Cg_endo -84.33 51.62 3.36 Favored 'Trans proline' 0 C--N 1.316 -1.157 0 O-C-N 123.626 1.329 . . . . 0.0 110.319 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.6 t -67.84 171.56 6.45 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.672 -0.642 . . . . 0.0 110.55 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 56.71 41.09 28.75 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.615 -0.678 . . . . 0.0 110.56 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.9 t -116.79 5.83 13.12 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.277 -0.89 . . . . 0.0 111.066 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.9 p90 . . . . . 0 N--CA 1.496 1.831 0 O-C-N 121.084 -1.01 . . . . 0.0 110.269 179.902 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.83 134.92 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.546 -0.973 . . . . 0.0 110.302 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.736 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -129.08 144.51 51.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.462 -0.774 . . . . 0.0 110.261 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.8 p -104.42 116.36 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.736 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 28.1 t70 -50.02 105.48 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.482 -0.761 . . . . 0.0 111.014 -178.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -64.82 -24.97 67.71 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -66.83 -31.43 72.05 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.281 0.563 . . . . 0.0 109.511 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.627 ' CD1' HG12 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -78.97 -35.42 43.08 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.504 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.613 ' HG ' ' HE1' ' A' ' 44' ' ' MET . 2.7 mp -63.18 -42.95 99.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.689 -0.632 . . . . 0.0 109.558 178.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.529 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -56.35 -22.94 34.27 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.277 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.446 ' HB2' HG22 ' A' ' 31' ' ' ILE . 12.2 mttt -99.0 -31.15 11.95 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.503 -0.748 . . . . 0.0 110.602 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.525 HG23 ' HG2' ' A' ' 44' ' ' MET . 1.8 p -73.27 -40.07 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.132 -0.98 . . . . 0.0 110.559 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.529 HD22 ' HA ' ' A' ' 17' ' ' GLU . 4.0 pp -64.14 -25.05 67.92 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -72.89 -33.11 65.84 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.439 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 2.9 mm? -73.89 -26.96 60.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.43 -0.794 . . . . 0.0 109.238 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -81.74 -14.01 57.04 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.535 -0.728 . . . . 0.0 109.842 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.28 -38.94 21.49 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.525 -0.735 . . . . 0.0 109.078 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.98 -19.81 31.5 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.266 0.555 . . . . 0.0 109.824 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.47 3.32 72.02 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -85.35 148.04 26.23 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.382 -1.07 . . . . 0.0 110.507 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -119.33 94.2 4.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.456 -0.778 . . . . 0.0 109.745 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -117.5 -157.89 0.68 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.49 -0.757 . . . . 0.0 110.45 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.0 OUTLIER -110.84 147.2 35.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.595 -0.691 . . . . 0.0 110.63 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.503 ' HB ' HG12 ' A' ' 49' ' ' ILE . 2.8 mp -121.87 117.95 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.488 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . 3.8 mppt? -82.56 159.0 22.88 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.276 -0.89 . . . . 0.0 111.21 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 17.9 m -139.74 158.51 43.99 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.576 -0.703 . . . . 0.0 110.037 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -146.93 38.77 1.0 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.367 -0.833 . . . . 0.0 111.052 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.7 m -98.05 -109.06 0.17 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.992 -1.067 . . . . 0.0 110.756 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.9 -64.73 0.19 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.912 -1.117 . . . . 0.0 110.366 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 38' ' ' SER . 1.6 mtp180 -92.54 25.63 2.96 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.405 -0.81 . . . . 0.0 110.191 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 37' ' ' ARG . 73.7 m -31.53 116.92 0.18 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.335 0.588 . . . . 0.0 112.466 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.701 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 45.1 m -124.38 159.93 29.28 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.74 -0.6 . . . . 0.0 110.476 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.599 HG21 HG13 ' A' ' 62' ' ' ILE . 5.3 mp -88.63 169.47 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.609 -0.682 . . . . 0.0 110.407 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.641 HG21 ' SD ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -140.07 172.9 5.63 Favored Pre-proline 0 N--CA 1.508 2.458 0 O-C-N 121.176 -0.952 . . . . 0.0 110.945 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 41.8 Cg_endo -66.0 -30.1 48.25 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 124.394 1.734 . . . . 0.0 111.561 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.98 5.03 10.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.497 -0.752 . . . . 0.0 110.461 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.641 ' SD ' HG21 ' A' ' 41' ' ' VAL . 23.1 mtt -111.78 -0.7 15.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 111.411 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 42' ' ' PRO . 2.1 p -41.42 -4.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.923 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 44' ' ' MET . . . -137.71 35.27 2.07 Favored Glycine 0 N--CA 1.495 2.588 0 O-C-N 119.771 -1.831 . . . . 0.0 110.47 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.439 ' CE1' ' HB3' ' A' ' 22' ' ' LEU . 26.2 m-70 -144.43 153.18 41.64 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.09 -1.241 . . . . 0.0 110.971 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -99.77 92.34 5.27 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.286 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.627 HG12 ' CD1' ' A' ' 15' ' ' LEU . 2.6 mt -88.8 120.78 38.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.097 -1.002 . . . . 0.0 111.239 -177.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.708 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -76.31 77.1 3.08 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.986 0.898 . . . . 0.0 109.09 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.0 m -56.73 132.25 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.476 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 33' ' ' THR . 19.8 t80 -77.14 104.52 7.69 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.574 -0.85 . . . . 0.0 109.006 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -70.2 0.4 6.37 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.571 -0.706 . . . . 0.0 110.421 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.31 -23.66 7.99 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.52 -28.94 0.7 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 122.051 -0.676 . . . . 0.0 111.136 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.53 155.57 45.55 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.243 -0.911 . . . . 0.0 112.159 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.467 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . 6.9 m80 -100.81 104.78 16.03 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.708 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 39.1 t -93.71 101.16 5.53 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.205 -0.934 . . . . 0.0 109.92 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.494 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.7 Cg_endo -66.23 90.19 0.26 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 O-C-N 123.909 1.479 . . . . 0.0 109.82 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 60' ' ' VAL . 34.3 m -101.8 127.67 55.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.707 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 4.6 t80 -69.72 111.88 5.8 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 177.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.686 HG21 ' HB ' ' A' ' 67' ' ' VAL . 0.4 OUTLIER -51.33 -51.34 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.833 -0.542 . . . . 0.0 111.398 -178.058 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 m 60.88 169.85 0.09 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.363 0.602 . . . . 0.0 109.538 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.424 ' N ' HG21 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -81.51 2.85 27.12 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.873 -1.142 . . . . 0.0 111.603 -179.313 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -142.51 1.88 1.39 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.83 -1.169 . . . . 0.0 113.038 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.587 ' HB2' ' O ' ' A' ' 62' ' ' ILE . 20.2 mmt -99.95 -15.06 18.45 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.435 -1.415 . . . . 0.0 110.206 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.686 ' HB ' HG21 ' A' ' 62' ' ' ILE . 13.9 p -74.37 168.73 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.252 -0.905 . . . . 0.0 112.254 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.8 -5.35 22.52 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.701 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.662 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 19.8 m-70 -127.57 -85.0 0.6 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 119.289 1.545 . . . . 0.0 110.854 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.701 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.9 -29.29 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.532 0.682 . . . . 0.0 110.088 -179.243 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.601 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 2.4 pp 171.58 -17.39 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.309 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.67 -18.76 74.26 Favored Glycine 0 N--CA 1.494 2.549 0 O-C-N 121.083 -1.01 . . . . 0.0 110.802 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.662 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 23.6 mm-40 -84.71 -22.6 29.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.214 -1.168 . . . . 0.0 109.213 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.575 ' CD2' ' HB3' ' A' ' 66' ' ' MET . 13.8 m-85 -95.23 -21.83 18.2 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.566 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -132.89 55.18 15.97 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.556 -0.715 . . . . 0.0 109.863 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.566 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 46.5 Cg_endo -84.84 50.07 2.8 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 O-C-N 123.508 1.267 . . . . 0.0 110.302 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.7 m -112.64 41.71 1.98 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.576 -0.702 . . . . 0.0 110.15 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.3 ttm105 -154.09 143.31 21.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.308 -0.87 . . . . 0.0 110.343 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 78.0 m -93.3 -49.54 5.9 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.5 -0.75 . . . . 0.0 110.081 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.07 0 O-C-N 121.722 -0.611 . . . . 0.0 110.523 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.4 m -73.78 136.57 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.55 -0.971 . . . . 0.0 110.413 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.513 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 1.6 t80 -156.61 155.24 31.5 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.457 -0.777 . . . . 0.0 110.662 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.635 ' CG2' HG23 ' A' ' 41' ' ' VAL . 6.6 p -134.13 123.58 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.648 ' HB3' HG22 ' A' ' 33' ' ' THR . 49.0 m-20 -29.13 99.51 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.117 0.484 . . . . 0.0 111.817 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.1 -25.04 64.22 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.73 -21.23 55.56 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 122.021 -0.424 . . . . 0.0 110.044 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.644 ' HG ' HD13 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -80.88 -37.66 29.4 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.644 HD13 ' HG ' ' A' ' 15' ' ' LEU . 3.6 mp -64.48 -42.36 95.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.716 -0.615 . . . . 0.0 109.893 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.502 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -56.24 -21.17 21.87 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.759 179.787 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.71 -26.06 11.96 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.311 -0.868 . . . . 0.0 110.335 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.607 HG12 ' CE ' ' A' ' 44' ' ' MET . 0.5 OUTLIER -76.5 -36.9 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.303 -0.873 . . . . 0.0 110.935 -179.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.502 HD22 ' HA ' ' A' ' 17' ' ' GLU . 3.8 pp -63.71 -28.7 70.07 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -33.66 68.48 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.499 HD21 ' HB2' ' A' ' 27' ' ' GLU . 1.2 mt -79.58 -27.79 41.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.665 -0.647 . . . . 0.0 109.488 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -82.44 -11.29 58.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.538 -0.726 . . . . 0.0 109.558 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.57 -40.04 21.46 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.513 -0.742 . . . . 0.0 109.978 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.534 ' CD ' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -103.99 -25.76 12.88 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.403 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.92 25.31 5.96 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.534 ' HG3' ' CD ' ' A' ' 25' ' ' LYS . 4.7 mt-10 -79.3 130.12 35.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.335 -1.097 . . . . 0.0 110.602 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.0 mtmm -107.64 65.78 0.65 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.57 -0.707 . . . . 0.0 109.125 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.72 -151.03 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.6 -0.687 . . . . 0.0 110.049 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.0 OUTLIER -120.96 145.21 47.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.854 . . . . 0.0 110.57 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.488 HG23 ' HA ' ' A' ' 15' ' ' LEU . 2.7 mp -120.4 113.16 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.496 -0.753 . . . . 0.0 109.434 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -92.76 147.65 22.69 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.311 -0.868 . . . . 0.0 110.813 -179.35 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.648 HG22 ' HB3' ' A' ' 12' ' ' ASP . 17.6 m -138.69 166.7 23.7 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.468 -0.77 . . . . 0.0 110.301 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.423 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 15.4 m-90 -139.01 39.89 2.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.711 -0.618 . . . . 0.0 109.874 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 10' ' ' PHE . 50.6 m -78.82 -142.38 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.337 -0.852 . . . . 0.0 110.654 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.32 -61.4 1.41 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.989 -1.07 . . . . 0.0 110.317 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.513 ' HB3' ' HB3' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -94.33 39.53 1.09 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.403 -0.81 . . . . 0.0 109.825 179.484 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.485 ' HB3' HG22 ' A' ' 51' ' ' VAL . 36.3 m -35.54 131.57 0.48 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.302 0.572 . . . . 0.0 112.277 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 27.9 m -150.02 162.27 40.71 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.631 -0.668 . . . . 0.0 110.401 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.61 HG22 HG12 ' A' ' 62' ' ' ILE . 1.2 mp -80.42 165.92 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.418 0 CA-C-O 121.642 0.734 . . . . 0.0 111.647 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.751 HG21 ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -140.4 179.59 1.22 Allowed Pre-proline 0 N--CA 1.503 2.183 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.605 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.638 ' HD2' ' CG1' ' A' ' 41' ' ' VAL . 48.8 Cg_endo -70.94 -33.01 12.76 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.872 1.459 . . . . 0.0 111.512 -179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -73.18 -0.14 13.42 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.451 -0.781 . . . . 0.0 110.984 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 41' ' ' VAL . 1.3 mpt? -100.8 2.99 41.7 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.304 -0.872 . . . . 0.0 111.378 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 42' ' ' PRO . 4.0 p -57.2 -0.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.64 35.1 1.04 Allowed Glycine 0 N--CA 1.493 2.495 0 O-C-N 120.42 -1.425 . . . . 0.0 109.736 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.494 ' HB2' HD12 ' A' ' 49' ' ' ILE . 45.6 m-70 -144.34 154.93 43.53 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.279 -1.13 . . . . 0.0 111.06 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.571 HG22 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.76 83.85 2.82 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.223 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.567 HG12 ' CD1' ' A' ' 15' ' ' LEU . 2.7 mp -86.26 122.61 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 111.141 -177.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.733 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.09 87.13 4.87 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.971 0.891 . . . . 0.0 109.729 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.485 HG22 ' HB3' ' A' ' 38' ' ' SER . 4.9 p -62.36 120.55 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.733 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.489 ' HB2' ' O ' ' A' ' 33' ' ' THR . 20.6 t80 -67.1 109.19 2.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -0.897 . . . . 0.0 109.65 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -78.18 10.66 2.81 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.599 -0.688 . . . . 0.0 110.604 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.58 -26.72 13.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -139.82 -28.17 0.75 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.662 -0.905 . . . . 0.0 110.429 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -130.36 153.73 48.4 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.0 0.905 . . . . 0.0 113.323 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 6.5 m80 -96.02 113.99 25.65 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.733 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 21.9 t -103.44 94.76 6.24 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.238 -0.914 . . . . 0.0 109.531 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.502 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.6 Cg_endo -66.29 89.54 0.26 Allowed 'Trans proline' 0 N--CA 1.491 1.364 0 O-C-N 123.981 1.516 . . . . 0.0 109.567 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.523 HG21 ' O ' ' A' ' 58' ' ' VAL . 93.6 t -98.34 120.6 47.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.828 -179.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.571 ' HB2' HG22 ' A' ' 48' ' ' THR . 2.5 t80 -73.65 105.07 4.81 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.61 HG12 HG22 ' A' ' 40' ' ' ILE . 2.9 mp -85.38 135.07 25.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.679 -0.638 . . . . 0.0 111.071 -178.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.3 p -98.26 -158.81 0.7 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.88 10.27 19.21 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.925 -1.11 . . . . 0.0 111.45 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -145.16 17.75 1.56 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.85 -1.156 . . . . 0.0 112.259 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.694 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 67.9 mtt -115.56 0.11 13.21 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.056 -1.028 . . . . 0.0 110.076 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.588 HG21 ' HB ' ' A' ' 40' ' ' ILE . 8.1 p -85.68 167.57 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.219 -0.926 . . . . 0.0 111.298 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.489 ' N ' HG23 ' A' ' 67' ' ' VAL . . . 115.75 -15.98 16.54 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.615 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 15.6 m-70 -118.72 -86.36 0.64 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.052 -1.263 . . . . 0.0 111.122 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.01 -33.81 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 122.165 0.983 . . . . 0.0 109.277 -179.611 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.513 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 0.5 OUTLIER 178.77 -16.13 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.834 -179.711 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.38 -14.2 79.47 Favored Glycine 0 N--CA 1.497 2.763 0 O-C-N 120.875 -1.141 . . . . 0.0 110.407 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.615 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 2.7 mm-40 -78.89 -22.88 45.27 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.324 -1.103 . . . . 0.0 108.667 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.694 ' CD2' ' HB3' ' A' ' 66' ' ' MET . 5.6 m-85 -97.09 -20.77 17.78 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.58 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -132.11 54.21 13.43 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.551 -0.718 . . . . 0.0 109.92 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.58 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 48.0 Cg_endo -85.13 50.42 2.81 Favored 'Trans proline' 0 C--N 1.32 -0.962 0 O-C-N 123.546 1.287 . . . . 0.0 110.152 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.5 t -62.17 140.94 58.42 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.606 -0.684 . . . . 0.0 110.695 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 -150.62 119.0 6.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.454 -0.779 . . . . 0.0 110.175 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.8 m 63.7 166.82 0.14 Allowed 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 121.308 0.575 . . . . 0.0 110.869 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 . . . . . 0 N--CA 1.496 1.856 0 O-C-N 121.311 -0.868 . . . . 0.0 110.175 -179.928 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.1 t -111.19 -56.63 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.477 -1.013 . . . . 0.0 110.027 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.723 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -124.26 157.07 35.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.669 -0.644 . . . . 0.0 109.942 -179.768 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.457 ' CG2' HG12 ' A' ' 41' ' ' VAL . 14.8 p -114.33 122.04 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.383 -0.823 . . . . 0.0 108.915 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.723 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 37.5 t70 -48.53 107.85 0.15 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.64 -0.662 . . . . 0.0 111.579 -178.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.529 ' HA ' HD11 ' A' ' 16' ' ' LEU . 9.5 t70 -68.63 -22.48 64.42 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -67.06 -21.88 65.87 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.044 0.45 . . . . 0.0 110.358 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.568 ' HG ' ' N ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -83.7 -36.94 23.34 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.325 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.568 ' N ' ' HG ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -66.87 -46.5 74.8 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.427 179.291 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.512 ' HA ' HD22 ' A' ' 20' ' ' LEU . 5.3 pt-20 -52.62 -21.88 4.42 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.728 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.0 -29.21 10.08 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.366 -0.834 . . . . 0.0 110.693 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.618 HG13 ' CE ' ' A' ' 44' ' ' MET . 1.4 p -78.51 -38.7 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.096 -1.003 . . . . 0.0 111.161 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.512 HD22 ' HA ' ' A' ' 17' ' ' GLU . 3.6 pp -63.11 -24.83 68.08 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -71.84 -32.2 67.28 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.462 ' HG ' ' HB3' ' A' ' 27' ' ' GLU . 1.7 mp -76.96 -27.11 54.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.652 -0.655 . . . . 0.0 109.381 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -86.29 -14.29 44.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.556 -0.715 . . . . 0.0 109.286 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.04 -40.35 12.36 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.666 -0.646 . . . . 0.0 110.2 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.411 ' CE ' ' HG2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -93.86 -29.55 15.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.453 -0.779 . . . . 0.0 109.19 179.721 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.93 22.35 7.65 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.462 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 8.2 mm-40 -82.32 136.05 35.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.335 -1.097 . . . . 0.0 109.87 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -113.29 80.73 1.4 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.463 -0.773 . . . . 0.0 109.961 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.53 -160.66 1.0 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.353 0.597 . . . . 0.0 110.532 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -106.98 161.31 14.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.64 -0.663 . . . . 0.0 110.447 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.665 ' HB ' HG12 ' A' ' 49' ' ' ILE . 37.9 mm -116.01 164.43 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.518 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 2.1 mptt -127.68 149.99 49.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.476 HG21 ' CG ' ' A' ' 12' ' ' ASP . 22.4 m -135.21 155.16 51.14 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.361 -0.837 . . . . 0.0 111.227 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.518 ' CH2' ' HB2' ' A' ' 32' ' ' LYS . 23.2 m-90 -145.18 28.47 1.22 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.728 -0.608 . . . . 0.0 110.352 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.435 ' O ' ' HD2' ' A' ' 52' ' ' TYR . 0.4 OUTLIER -92.88 -159.32 0.67 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.065 -1.022 . . . . 0.0 110.934 -179.222 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -108.47 -56.53 2.24 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.093 -1.004 . . . . 0.0 110.55 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -94.4 33.27 1.43 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.394 -0.816 . . . . 0.0 110.189 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.9 m -39.0 126.03 1.56 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.404 0.621 . . . . 0.0 111.781 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 17.4 m -133.85 162.74 31.19 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.656 -0.653 . . . . 0.0 110.28 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.707 HG21 HG12 ' A' ' 62' ' ' ILE . 1.3 mp -79.16 164.83 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.606 -0.684 . . . . 0.0 111.872 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.657 HG22 ' CG ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -140.07 175.19 3.34 Favored Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.568 -0.708 . . . . 0.0 109.536 178.468 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.649 ' HD2' ' CG1' ' A' ' 41' ' ' VAL . 46.7 Cg_endo -69.53 -32.45 19.49 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.018 1.536 . . . . 0.0 111.864 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.54 ' HB2' ' HE3' ' A' ' 44' ' ' MET . 4.6 mm-40 -73.82 -0.08 14.75 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.346 -0.846 . . . . 0.0 110.896 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.714 ' SD ' HD12 ' A' ' 49' ' ' ILE . 3.9 mmt -95.5 -6.99 39.34 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.219 -0.925 . . . . 0.0 111.853 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.552 ' HA ' HG23 ' A' ' 62' ' ' ILE . 74.0 t -45.84 -8.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.647 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.425 ' HA3' ' CE1' ' A' ' 61' ' ' TYR . . . -143.01 34.73 1.75 Allowed Glycine 0 N--CA 1.493 2.485 0 O-C-N 120.174 -1.579 . . . . 0.0 109.726 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.422 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 30.0 m-70 -141.89 150.55 41.68 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.393 -1.063 . . . . 0.0 110.559 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.77 81.91 2.53 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.714 HD12 ' SD ' ' A' ' 44' ' ' MET . 42.1 mt -77.21 124.04 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.527 -0.733 . . . . 0.0 111.472 -177.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.75 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -81.04 76.84 7.98 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.0 m -58.85 124.45 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.316 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 32.3 t80 -74.8 105.64 5.96 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.408 -0.807 . . . . 0.0 109.091 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -68.93 -0.23 5.31 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.669 -0.644 . . . . 0.0 110.95 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.81 -18.5 9.85 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -140.03 -28.78 0.73 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.795 -0.827 . . . . 0.0 110.975 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -136.28 154.65 50.82 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.23 -0.919 . . . . 0.0 112.146 -178.21 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.456 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . 5.7 m-70 -99.12 105.5 17.6 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.75 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 38.1 t -94.36 101.58 6.89 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.098 -1.001 . . . . 0.0 109.957 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.527 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.3 Cg_endo -66.13 94.12 0.29 Allowed 'Trans proline' 0 N--CA 1.492 1.396 0 O-C-N 123.995 1.523 . . . . 0.0 108.934 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.501 ' CG1' ' CD2' ' A' ' 74' ' ' PHE . 75.6 t -109.73 125.33 66.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.065 -177.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 2.5 t80 -70.69 110.67 5.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.707 HG12 HG21 ' A' ' 40' ' ' ILE . 1.5 mp -61.06 -59.33 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.644 -0.66 . . . . 0.0 112.406 -177.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 3.5 m 69.52 161.26 0.21 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -177.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.454 ' N ' HG11 ' A' ' 45' ' ' VAL . 7.5 tp10 -78.42 62.24 3.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.83 -1.169 . . . . 0.0 109.902 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -173.1 -27.79 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.133 -0.979 . . . . 0.0 112.607 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.674 ' CB ' ' CE2' ' A' ' 74' ' ' PHE . 4.8 mmm -97.69 6.6 47.74 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.804 -1.185 . . . . 0.0 111.608 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.502 HG23 ' N ' ' A' ' 68' ' ' GLY . 7.5 p -89.07 163.83 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 120.857 -1.152 . . . . 0.0 112.059 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.502 ' N ' HG23 ' A' ' 67' ' ' VAL . . . 109.68 -14.73 32.19 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.517 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 16.8 m-70 -117.77 -89.73 0.58 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.984 -1.303 . . . . 0.0 111.125 -179.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.611 ' HG2' ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER 177.64 -31.39 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.134 0.968 . . . . 0.0 109.232 -179.38 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.611 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 2.2 pp 177.62 -17.91 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.657 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.0 -15.68 74.36 Favored Glycine 0 N--CA 1.499 2.841 0 O-C-N 120.936 -1.103 . . . . 0.0 110.427 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.517 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 2.5 mm-40 -78.63 -21.59 48.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.352 -1.087 . . . . 0.0 108.407 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.674 ' CE2' ' CB ' ' A' ' 66' ' ' MET . 7.4 m-85 -96.18 -23.46 16.72 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.549 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -131.06 55.66 20.34 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.687 -0.633 . . . . 0.0 110.181 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 47.0 Cg_endo -85.66 48.47 2.15 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 O-C-N 123.573 1.302 . . . . 0.0 110.203 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 85.2 m -141.67 -56.53 0.47 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.678 -0.639 . . . . 0.0 110.212 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.21 127.98 38.99 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.586 -0.696 . . . . 0.0 110.075 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.2 t -136.42 40.45 2.63 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.567 -0.708 . . . . 0.0 110.35 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 N--CA 1.5 2.061 0 O-C-N 121.538 -0.726 . . . . 0.0 110.563 179.858 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' A' ' 37' ' ' ARG . 89.0 t -116.71 -68.39 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.554 -0.968 . . . . 0.0 110.061 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.716 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -125.29 139.79 53.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.523 -0.736 . . . . 0.0 110.165 -179.843 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.408 ' CG2' HG23 ' A' ' 41' ' ' VAL . 14.5 p -102.12 109.96 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.716 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 26.2 t70 -45.63 109.17 0.16 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.516 -0.74 . . . . 0.0 111.499 -178.207 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -67.43 -23.86 65.58 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.46 -29.26 66.89 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.115 0.483 . . . . 0.0 110.097 179.284 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.671 ' HG ' HD11 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -79.95 -38.14 32.99 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.67 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.671 HD11 ' HG ' ' A' ' 15' ' ' LEU . 3.2 mp -63.33 -39.61 95.02 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.414 0.626 . . . . 0.0 109.553 178.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.49 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -55.49 -23.66 27.15 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.799 -0.563 . . . . 0.0 110.029 179.271 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -97.89 -31.82 12.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.482 -0.761 . . . . 0.0 110.499 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 16' ' ' LEU . 1.4 p -71.27 -38.16 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.317 -0.865 . . . . 0.0 110.933 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.49 HD22 ' HA ' ' A' ' 17' ' ' GLU . 3.8 pp -63.27 -26.82 68.95 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.053 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -74.47 -32.58 62.63 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.53 HD21 ' HB2' ' A' ' 27' ' ' GLU . 1.5 mt -75.14 -27.53 59.79 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -83.47 -12.41 56.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.519 -0.738 . . . . 0.0 109.463 178.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.5 -39.88 16.97 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 121.556 -0.715 . . . . 0.0 109.931 179.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.426 ' CE ' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -97.71 -26.65 14.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.509 -0.744 . . . . 0.0 109.807 179.716 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.416 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . 105.07 26.73 6.18 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.53 ' HB2' HD21 ' A' ' 22' ' ' LEU . 7.2 mt-10 -82.44 130.31 35.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.371 -1.076 . . . . 0.0 110.232 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -113.88 59.64 0.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.504 -0.747 . . . . 0.0 109.645 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.39 -136.68 0.32 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.495 -0.753 . . . . 0.0 109.877 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.566 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -132.56 153.88 50.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.95 -1.094 . . . . 0.0 110.719 -179.333 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.659 ' HB ' HD11 ' A' ' 49' ' ' ILE . 4.2 mt -127.35 120.07 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.224 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HG3' ' CZ2' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -100.35 160.03 14.66 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.529 -0.732 . . . . 0.0 111.462 -178.69 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 18.8 m -141.2 168.65 19.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.811 -0.556 . . . . 0.0 110.112 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.418 ' CZ2' ' HG3' ' A' ' 32' ' ' LYS . 17.7 m-90 -144.59 39.32 1.27 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.365 -0.834 . . . . 0.0 110.556 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.9 t -92.88 -94.31 0.15 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.175 -0.953 . . . . 0.0 110.544 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.7 ttm105 -167.17 -60.16 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.989 -1.069 . . . . 0.0 110.841 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.492 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 1.9 mpt_? -103.34 35.67 2.5 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.336 -0.853 . . . . 0.0 110.568 -179.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -41.01 121.91 1.64 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.16 0.505 . . . . 0.0 111.89 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.705 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 87.8 m -120.74 158.87 26.56 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.679 -0.638 . . . . 0.0 110.293 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.704 HG23 HG12 ' A' ' 62' ' ' ILE . 4.9 mp -85.76 169.34 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.367 -0.833 . . . . 0.0 111.274 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.696 HG21 ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -138.21 179.49 1.31 Allowed Pre-proline 0 N--CA 1.502 2.14 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.097 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.615 ' HD2' ' CG1' ' A' ' 41' ' ' VAL . 44.9 Cg_endo -68.6 -31.89 25.59 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.879 1.463 . . . . 0.0 111.303 -179.277 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.87 -3.62 16.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.587 -0.696 . . . . 0.0 111.127 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.696 ' SD ' HG21 ' A' ' 41' ' ' VAL . 1.3 mpt? -93.72 0.09 56.23 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.201 -0.937 . . . . 0.0 111.925 -179.304 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.506 HG22 ' CG ' ' A' ' 64' ' ' GLU . 3.5 p -52.31 -3.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.99 33.11 1.52 Allowed Glycine 0 N--CA 1.493 2.473 0 O-C-N 120.394 -1.441 . . . . 0.0 109.668 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 38.6 m-70 -142.91 152.51 42.15 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.303 -1.116 . . . . 0.0 110.907 -179.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -99.61 83.61 2.81 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 178.361 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.659 HD11 ' HB ' ' A' ' 31' ' ' ILE . 1.1 mm -78.6 112.23 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 111.587 -177.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.673 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -76.43 79.92 3.15 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.079 0.943 . . . . 0.0 108.777 178.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.3 m -62.19 132.19 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.816 -178.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.515 ' HB2' ' O ' ' A' ' 33' ' ' THR . 26.5 t80 -77.03 103.45 6.97 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.375 -0.828 . . . . 0.0 108.876 178.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -69.71 -0.7 7.4 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.527 -0.733 . . . . 0.0 110.563 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.58 -20.12 9.56 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.761 -2.136 . . . . 0.0 107.761 -178.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -140.15 -29.73 0.7 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 122.004 -0.704 . . . . 0.0 110.752 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.89 155.94 49.83 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.295 -0.878 . . . . 0.0 112.037 -178.278 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.517 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 3.1 m80 -100.64 100.67 11.41 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.092 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.673 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 58.6 t -87.34 104.03 5.59 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.341 -0.85 . . . . 0.0 109.956 -179.041 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' A' ' 57' ' ' HIS . 42.8 Cg_endo -67.96 89.91 0.37 Allowed 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.921 1.485 . . . . 0.0 109.481 -179.336 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.5 HG21 ' O ' ' A' ' 60' ' ' VAL . 12.7 m -94.21 111.84 25.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.177 -178.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 2.4 t80 -69.96 101.25 1.73 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 118.526 -1.27 . . . . 0.0 107.598 177.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.704 HG12 HG23 ' A' ' 40' ' ' ILE . 2.7 mp -80.8 141.33 15.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 121.543 0.687 . . . . 0.0 111.338 -178.113 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.3 p -110.29 -152.09 0.49 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 177.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.506 ' CG ' HG22 ' A' ' 45' ' ' VAL . 6.9 mt-10 -87.91 -13.38 42.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.764 -1.21 . . . . 0.0 110.921 179.237 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.53 27.35 6.53 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.984 -1.072 . . . . 0.0 112.147 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.682 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 9.5 mmt -116.12 -29.06 6.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.06 -1.025 . . . . 0.0 110.175 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.531 ' HA ' ' HZ ' ' A' ' 74' ' ' PHE . 5.7 p -65.67 163.89 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 O-C-N 121.39 -0.819 . . . . 0.0 111.874 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.426 ' N ' HG23 ' A' ' 67' ' ' VAL . . . 123.9 -11.0 8.33 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.475 178.234 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.678 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 17.2 m-70 -124.53 -84.48 0.64 Allowed 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 119.08 1.44 . . . . 0.0 111.007 -178.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.705 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.47 -30.19 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.505 0.669 . . . . 0.0 110.273 -179.42 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.536 ' HB3' ' O ' ' A' ' 70' ' ' LYS . 0.5 OUTLIER 173.32 -16.5 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.563 -179.776 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 76' ' ' PRO . . . -72.04 -15.62 76.47 Favored Glycine 0 N--CA 1.495 2.613 0 O-C-N 121.053 -1.029 . . . . 0.0 110.602 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.678 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 22.9 mm-40 -86.3 -18.82 30.99 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.141 -1.211 . . . . 0.0 109.423 178.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.682 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 4.0 m-85 -104.98 -17.89 14.36 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.537 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -139.07 58.31 12.61 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.538 -0.726 . . . . 0.0 110.02 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 43.8 Cg_endo -87.09 47.88 1.66 Allowed 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.635 1.334 . . . . 0.0 110.453 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.6 m 49.04 44.81 22.91 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.376 0.608 . . . . 0.0 110.483 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.52 143.73 20.1 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.31 -0.868 . . . . 0.0 110.237 -179.746 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -79.07 168.53 19.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.499 -0.751 . . . . 0.0 110.507 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.2 p90 . . . . . 0 N--CA 1.497 1.918 0 O-C-N 121.443 -0.786 . . . . 0.0 110.283 -179.993 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.735 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.232 0.539 . . . . 0.0 109.858 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.781 HG11 HG13 ' A' ' 41' ' ' VAL . 70.4 t -105.55 117.56 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.735 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 37.1 t70 -44.45 112.71 0.45 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.403 0.621 . . . . 0.0 111.725 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.23 -21.97 62.05 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -70.11 -25.13 63.35 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.87 -0.519 . . . . 0.0 110.442 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.943 HD13 ' CD1' ' A' ' 49' ' ' ILE . 0.6 OUTLIER -77.46 -37.47 51.38 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.746 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.838 ' HA ' HG12 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -62.5 -46.91 86.31 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.744 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.17 -23.47 3.34 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.311 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -106.06 -33.62 7.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.448 -0.782 . . . . 0.0 110.568 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.838 HG12 ' HA ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -73.3 -39.64 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.279 -0.888 . . . . 0.0 111.402 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 16' ' ' LEU . 3.6 pp -63.13 -27.19 69.21 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.23 -32.67 64.88 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.577 HD22 ' CB ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -77.99 -24.09 48.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.653 -0.654 . . . . 0.0 109.437 178.832 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -82.73 -11.63 58.16 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.392 -0.817 . . . . 0.0 109.635 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.66 -39.77 19.8 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 121.461 -0.774 . . . . 0.0 109.969 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.54 ' CD ' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -103.23 -23.37 13.62 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.459 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.407 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . 102.14 29.07 6.21 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.577 ' CB ' HD22 ' A' ' 22' ' ' LEU . 5.8 mt-10 -76.1 130.33 38.16 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.394 -1.062 . . . . 0.0 110.669 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.8 mtmm -107.3 59.68 0.62 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.569 -0.707 . . . . 0.0 109.285 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -102.88 -154.34 0.49 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.509 -0.744 . . . . 0.0 109.992 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -124.49 145.16 49.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.587 -0.695 . . . . 0.0 110.13 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.516 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 2.4 mp -114.65 119.83 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.615 -0.678 . . . . 0.0 109.47 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.531 ' CE ' HD11 ' A' ' 30' ' ' LEU . 20.5 mmtt -79.61 154.63 28.58 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.412 -0.805 . . . . 0.0 111.199 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.68 HG23 ' CG ' ' A' ' 12' ' ' ASP . 20.7 m -141.38 153.47 45.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.61 -0.681 . . . . 0.0 110.094 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.457 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 14.7 m-90 -144.49 35.01 1.17 Allowed 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.311 -0.868 . . . . 0.0 111.354 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.3 t -84.63 -96.03 0.07 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.893 -1.13 . . . . 0.0 110.586 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.6 mtm105 -171.81 -61.91 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.106 -0.996 . . . . 0.0 109.631 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.479 ' HG2' ' HD1' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -103.53 31.15 4.54 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.435 0.636 . . . . 0.0 109.399 178.853 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.438 ' OG ' HG21 ' A' ' 33' ' ' THR . 13.4 m -44.74 130.9 7.08 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.439 0.637 . . . . 0.0 111.997 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.761 HG23 ' O ' ' A' ' 69' ' ' HIS . 75.7 m -124.76 159.06 31.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.775 -0.578 . . . . 0.0 109.936 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.665 HG21 HG12 ' A' ' 62' ' ' ILE . 4.8 mp -79.56 169.48 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.389 -0.82 . . . . 0.0 111.237 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.781 HG13 HG11 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -140.15 176.49 2.5 Favored Pre-proline 0 N--CA 1.5 2.056 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.621 ' O ' HG23 ' A' ' 45' ' ' VAL . 43.2 Cg_endo -66.89 -29.85 40.89 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.006 1.53 . . . . 0.0 110.595 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -71.46 -3.63 22.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.444 -0.785 . . . . 0.0 111.061 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.817 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.4 mtp -98.24 7.21 46.57 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.988 -1.07 . . . . 0.0 112.143 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 42' ' ' PRO . 89.6 t -57.5 -1.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.529 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.06 35.41 0.99 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 21.3 m80 -142.48 146.34 34.66 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.41 -1.053 . . . . 0.0 111.117 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.817 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.7 83.95 2.85 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 178.023 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.943 ' CD1' HD13 ' A' ' 15' ' ' LEU . 1.9 mt -86.97 120.63 36.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.139 -0.976 . . . . 0.0 110.924 -177.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.737 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -75.72 78.65 2.67 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.977 0.894 . . . . 0.0 109.152 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.656 HG21 ' O ' ' A' ' 70' ' ' LYS . 31.3 m -59.9 131.11 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.534 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 26.8 t80 -78.06 105.01 8.99 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -75.09 7.91 2.97 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.317 -0.864 . . . . 0.0 111.055 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.26 -27.39 6.11 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.65 -24.9 0.77 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.821 -0.811 . . . . 0.0 111.495 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -132.65 154.49 50.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.134 -0.979 . . . . 0.0 112.244 -177.703 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.442 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 3.4 m-70 -99.6 101.46 12.67 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.737 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 48.1 t -90.75 104.07 8.42 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.178 -0.951 . . . . 0.0 110.089 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.545 ' HB3' HD12 ' A' ' 30' ' ' LEU . 40.5 Cg_endo -66.08 87.37 0.24 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 O-C-N 123.899 1.473 . . . . 0.0 109.447 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 49' ' ' ILE . 15.1 m -92.72 112.59 26.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.464 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.817 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.3 t80 -75.13 100.36 4.23 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.817 HD13 ' HB3' ' A' ' 44' ' ' MET . 2.8 mp -81.57 135.29 25.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.564 -0.71 . . . . 0.0 111.144 -178.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.432 ' C ' HG13 ' A' ' 45' ' ' VAL . 58.9 p -101.03 -155.47 0.52 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.511 ' N ' HG13 ' A' ' 45' ' ' VAL . 1.3 tp10 -89.43 10.88 20.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.627 -1.295 . . . . 0.0 110.614 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.92 24.15 1.19 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.941 -1.099 . . . . 0.0 111.478 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 6.6 mmt -114.09 -27.95 7.5 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.039 -1.038 . . . . 0.0 110.216 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.533 HG23 HG22 ' A' ' 40' ' ' ILE . 7.5 p -63.02 164.87 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 O-C-N 121.585 -0.697 . . . . 0.0 111.822 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.5 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 123.35 -14.51 8.23 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.387 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.761 ' O ' HG23 ' A' ' 39' ' ' THR . 12.5 m80 -122.03 -85.04 0.66 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 119.034 1.417 . . . . 0.0 111.21 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.683 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.68 -30.64 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.586 0.708 . . . . 0.0 110.42 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.525 ' HB3' ' O ' ' A' ' 70' ' ' LYS . 0.4 OUTLIER 174.46 -16.0 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.706 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.55 -16.4 75.8 Favored Glycine 0 N--CA 1.497 2.704 0 O-C-N 120.954 -1.091 . . . . 0.0 110.686 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.65 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 1.1 mm-40 . . . . . 0 N--CA 1.498 1.925 0 O-C-N 121.254 -1.145 . . . . 0.0 109.461 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.736 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.327 0.584 . . . . 0.0 110.03 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 11' ' ' VAL . 12.8 p -106.06 116.92 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.736 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 35.9 t70 -47.93 108.7 0.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.437 -0.79 . . . . 0.0 111.266 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.77 -23.88 66.13 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.441 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.7 OUTLIER -70.58 -20.54 62.77 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.976 -0.453 . . . . 0.0 110.071 179.081 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.849 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -88.54 -35.13 17.12 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.304 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.849 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.7 mp -69.52 -38.69 77.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.72 -0.612 . . . . 0.0 110.204 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.536 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . 3.0 pt-20 -58.29 -20.69 44.76 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.439 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -100.3 -29.56 12.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.387 -0.821 . . . . 0.0 110.394 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.047 HG21 ' SD ' ' A' ' 44' ' ' MET . 1.5 p -76.19 -37.21 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.247 -0.908 . . . . 0.0 111.141 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.536 ' CD2' ' HA ' ' A' ' 17' ' ' GLU . 3.7 pp -61.8 -26.58 68.19 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.02 -33.97 70.86 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.438 ' HA ' HD12 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -79.19 -25.46 42.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.694 -0.629 . . . . 0.0 109.573 178.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -84.31 -12.91 53.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.509 -0.744 . . . . 0.0 109.592 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.87 -39.22 13.2 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 121.509 -0.745 . . . . 0.0 110.014 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -94.77 -29.86 14.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.578 -0.701 . . . . 0.0 109.332 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.23 25.01 6.89 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.415 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 28.0 mt-10 -84.63 136.13 33.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.413 -1.051 . . . . 0.0 110.091 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -113.1 77.4 1.05 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.418 -0.801 . . . . 0.0 109.623 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.93 -154.85 0.57 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.496 -0.752 . . . . 0.0 110.363 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -112.85 155.36 24.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.412 -0.805 . . . . 0.0 110.545 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.683 HG21 ' O ' ' A' ' 15' ' ' LEU . 2.7 mp -129.24 113.5 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.493 -0.755 . . . . 0.0 109.338 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.517 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -66.64 154.36 40.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.521 -0.737 . . . . 0.0 111.117 -179.062 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.567 HG23 ' CB ' ' A' ' 12' ' ' ASP . 9.1 m -143.06 135.83 27.75 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.696 -0.628 . . . . 0.0 109.997 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.677 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -152.46 75.71 1.12 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.259 -0.9 . . . . 0.0 111.25 -179.713 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.423 ' HB3' ' CE2' ' A' ' 10' ' ' PHE . 0.6 OUTLIER -123.28 -82.2 0.65 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.147 -0.97 . . . . 0.0 110.052 179.061 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.417 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 5.8 ttm180 -167.97 -64.17 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.314 -0.866 . . . . 0.0 109.727 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.417 ' HD2' ' HB3' ' A' ' 36' ' ' ARG . 0.4 OUTLIER -104.25 35.11 2.8 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.57 -0.706 . . . . 0.0 109.387 179.113 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.477 ' OG ' HG22 ' A' ' 33' ' ' THR . 5.0 m -37.9 124.92 1.17 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.406 0.622 . . . . 0.0 111.991 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.751 HG23 ' O ' ' A' ' 69' ' ' HIS . 34.4 m -130.57 159.08 38.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.788 -0.57 . . . . 0.0 110.183 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.74 HG21 HG21 ' A' ' 62' ' ' ILE . 5.1 mp -83.85 168.94 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.401 -0.812 . . . . 0.0 110.909 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.682 HG12 ' HD2' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -138.43 176.9 2.36 Favored Pre-proline 0 N--CA 1.501 2.112 0 O-C-N 121.743 -0.598 . . . . 0.0 109.683 179.375 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.682 ' HD2' HG12 ' A' ' 41' ' ' VAL . 43.4 Cg_endo -66.93 -31.34 38.19 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.005 1.529 . . . . 0.0 111.276 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.761 ' HG3' HG11 ' A' ' 19' ' ' VAL . 2.5 pt-20 -72.27 -3.08 21.56 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.313 -0.867 . . . . 0.0 111.075 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' MET . . . . . 1.047 ' SD ' HG21 ' A' ' 19' ' ' VAL . 18.8 mmt -97.15 10.1 40.32 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.213 -0.929 . . . . 0.0 111.748 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 42' ' ' PRO . 80.3 t -61.24 0.63 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 O-C-N 120.93 -1.106 . . . . 0.0 113.508 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.38 35.53 0.96 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.543 ' HB2' HD11 ' A' ' 49' ' ' ILE . 23.3 m80 -141.68 150.24 41.62 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.484 -1.009 . . . . 0.0 111.041 -178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.699 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -99.77 83.7 2.79 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.569 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.817 ' CG2' HD13 ' A' ' 15' ' ' LEU . 2.4 mp -83.56 121.39 36.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.398 -0.813 . . . . 0.0 110.885 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.772 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -77.23 79.49 3.75 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.695 0.76 . . . . 0.0 109.456 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.44 ' HA ' ' HB ' ' A' ' 33' ' ' THR . 19.4 m -58.16 135.0 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.385 0.612 . . . . 0.0 110.643 -179.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.677 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 30.5 t80 -75.62 106.82 7.38 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.558 -0.714 . . . . 0.0 109.31 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -77.54 4.78 10.38 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.307 -0.871 . . . . 0.0 110.734 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.64 -30.17 4.98 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.87 -26.27 0.73 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.961 -0.729 . . . . 0.0 111.578 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.8 155.42 41.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.227 -0.92 . . . . 0.0 112.345 -177.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.462 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 1.2 m-70 -97.77 104.81 16.87 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.772 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 48.6 t -93.51 101.49 5.93 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.228 -0.92 . . . . 0.0 110.108 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.523 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.7 Cg_endo -65.77 90.32 0.24 Allowed 'Trans proline' 0 N--CA 1.494 1.513 0 O-C-N 123.892 1.469 . . . . 0.0 109.712 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 58' ' ' VAL . 44.7 t -96.04 113.96 31.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.123 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.699 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.4 t80 -72.9 103.93 3.88 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.74 HG21 HG21 ' A' ' 40' ' ' ILE . 2.7 mp -84.81 132.04 32.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.638 -0.664 . . . . 0.0 111.105 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.408 ' C ' HG13 ' A' ' 45' ' ' VAL . 50.0 p -94.92 -157.2 0.55 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 177.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.527 ' N ' HG13 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -90.12 15.42 10.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.8 -1.188 . . . . 0.0 110.883 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.79 19.72 1.01 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.875 -1.141 . . . . 0.0 112.051 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 5.3 mmt -115.58 -18.19 10.97 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.834 -1.166 . . . . 0.0 110.502 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.56 HG22 ' N ' ' A' ' 68' ' ' GLY . 5.6 p -73.94 167.15 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.316 -0.865 . . . . 0.0 111.759 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.56 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 121.28 -11.97 9.75 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.164 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.751 ' O ' HG23 ' A' ' 39' ' ' THR . 18.3 m80 -128.13 -81.42 0.59 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.944 1.372 . . . . 0.0 111.257 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.632 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.76 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 121.714 0.768 . . . . 0.0 110.126 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.595 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.7 OUTLIER 173.73 -16.45 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.759 -179.641 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.1 -16.11 76.73 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.002 -1.061 . . . . 0.0 110.506 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.489 ' HG3' ' ND1' ' A' ' 69' ' ' HIS . 21.3 mm-40 . . . . . 0 N--CA 1.497 1.91 0 O-C-N 121.245 -1.15 . . . . 0.0 108.97 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.728 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.258 0.551 . . . . 0.0 110.189 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.729 HG21 HG13 ' A' ' 41' ' ' VAL . 14.7 p -105.17 112.86 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.728 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 38.9 t70 -41.38 111.8 0.25 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.468 0.651 . . . . 0.0 111.913 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.75 -23.99 63.47 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -67.4 -26.66 66.55 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.928 -0.483 . . . . 0.0 110.221 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.592 HD13 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -79.31 -36.11 40.14 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.61 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.77 ' HA ' HG12 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -64.57 -45.55 86.57 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.688 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.82 -22.69 2.29 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.148 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.497 ' O ' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -103.59 -36.55 7.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.579 -0.701 . . . . 0.0 110.174 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.77 HG12 ' HA ' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -70.22 -40.67 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.281 -0.887 . . . . 0.0 110.872 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.516 HD23 ' OE1' ' A' ' 43' ' ' GLU . 10.9 mt -62.69 -37.26 85.79 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.57 -34.69 78.84 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.766 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 18' ' ' LYS . 2.4 mm? -77.71 -27.78 50.76 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.345 -0.847 . . . . 0.0 109.515 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -82.51 -12.07 58.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.631 -0.668 . . . . 0.0 109.82 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.86 -35.22 20.74 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 121.385 -0.822 . . . . 0.0 109.867 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 11.3 mmtt -89.3 -16.05 32.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.61 -0.681 . . . . 0.0 109.816 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.35 26.52 27.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.46 ' O ' HD12 ' A' ' 22' ' ' LEU . 5.2 mm-40 -109.44 137.89 46.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.587 -0.949 . . . . 0.0 110.489 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -110.63 87.78 2.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.49 -0.756 . . . . 0.0 109.644 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.44 -154.34 0.54 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.472 -0.767 . . . . 0.0 110.266 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -112.02 155.43 23.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -0.806 . . . . 0.0 110.589 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.59 ' CD1' HG23 ' A' ' 19' ' ' VAL . 3.3 mt -130.56 122.01 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.604 -0.685 . . . . 0.0 109.74 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.45 ' HB3' ' CZ2' ' A' ' 34' ' ' TRP . 0.1 OUTLIER -84.68 155.63 21.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.407 -0.808 . . . . 0.0 110.882 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.736 HG21 ' OG ' ' A' ' 38' ' ' SER . 19.4 m -137.17 158.19 44.99 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.582 -0.699 . . . . 0.0 110.466 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.45 ' CZ2' ' HB3' ' A' ' 32' ' ' LYS . 19.8 m-90 -145.54 30.72 1.1 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.333 -0.855 . . . . 0.0 111.726 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 p -86.33 -96.91 0.08 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.847 -1.158 . . . . 0.0 110.606 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.27 -66.34 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.097 -1.002 . . . . 0.0 110.186 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.474 ' HG2' ' HD1' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -99.73 45.24 0.99 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.67 0.747 . . . . 0.0 109.6 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.736 ' OG ' HG21 ' A' ' 33' ' ' THR . 2.2 m -50.9 138.32 19.25 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.448 0.642 . . . . 0.0 112.371 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.778 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 57.0 m -132.0 159.17 39.54 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.903 HG21 HG21 ' A' ' 62' ' ' ILE . 5.2 mp -89.76 168.25 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.231 -0.918 . . . . 0.0 111.276 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.729 HG13 HG21 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -140.21 174.69 3.75 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.228 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.551 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 40.9 Cg_endo -64.86 -31.53 57.01 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.995 1.524 . . . . 0.0 110.194 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.516 ' OE1' HD23 ' A' ' 20' ' ' LEU . 3.3 mm-40 -65.93 -12.42 54.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.761 -0.587 . . . . 0.0 110.631 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.69 ' HB3' HD13 ' A' ' 62' ' ' ILE . 41.4 mtp -97.84 11.29 37.81 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.278 -0.888 . . . . 0.0 110.872 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.665 HG23 ' N ' ' A' ' 64' ' ' GLU . 7.5 p -62.14 5.03 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.339 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.28 33.05 1.03 Allowed Glycine 0 N--CA 1.493 2.475 0 O-C-N 120.311 -1.493 . . . . 0.0 109.976 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.784 ' HB2' HD11 ' A' ' 49' ' ' ILE . 45.9 m-70 -144.07 153.21 41.95 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.153 -1.204 . . . . 0.0 111.29 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.741 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -100.01 83.92 2.78 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 178.255 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.784 HD11 ' HB2' ' A' ' 47' ' ' HIS . 3.1 mp -86.61 118.13 32.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 111.281 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.755 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -76.77 80.26 3.38 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.922 0.868 . . . . 0.0 109.071 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 51' ' ' VAL . 32.8 m -58.56 132.05 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.285 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.479 ' HD1' ' CD2' ' A' ' 57' ' ' HIS . 30.4 t80 -74.33 105.8 5.67 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -76.1 13.88 0.81 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.669 -0.644 . . . . 0.0 110.535 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.71 -27.72 12.8 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.5 pttp -140.48 -27.82 0.73 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.596 -0.943 . . . . 0.0 110.84 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -130.35 155.55 46.18 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.106 0.955 . . . . 0.0 113.546 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.653 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 25.7 m80 -96.3 111.84 23.78 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.755 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 42.1 t -101.33 95.46 4.99 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.132 -0.98 . . . . 0.0 109.455 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.526 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.3 Cg_endo -65.09 87.51 0.18 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.939 1.494 . . . . 0.0 109.787 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.598 HG13 HG12 ' A' ' 58' ' ' VAL . 10.4 m -94.77 114.67 31.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.208 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.741 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.1 t80 -73.4 100.56 3.24 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.903 HG21 HG21 ' A' ' 40' ' ' ILE . 2.6 mp -83.9 138.43 19.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.594 0.711 . . . . 0.0 111.996 -177.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.644 ' C ' HG23 ' A' ' 45' ' ' VAL . 24.8 p -104.99 -153.98 0.5 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 176.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.665 ' N ' HG23 ' A' ' 45' ' ' VAL . 4.7 tp10 -90.43 0.5 57.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.549 -1.344 . . . . 0.0 110.978 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -126.94 -8.9 6.02 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.014 -1.054 . . . . 0.0 112.191 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.6 mmt -86.96 -26.23 23.94 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.805 -1.184 . . . . 0.0 110.121 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.499 HG21 ' C ' ' A' ' 41' ' ' VAL . 5.5 p -66.91 164.31 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.377 -0.827 . . . . 0.0 111.827 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.497 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 120.7 -11.89 10.19 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.52 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.773 ' O ' HG23 ' A' ' 39' ' ' THR . 12.1 m80 -121.72 -84.99 0.66 Allowed 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 119.078 1.439 . . . . 0.0 111.074 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.778 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.1 OUTLIER 178.36 -30.54 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 CA-C-O 121.601 0.715 . . . . 0.0 110.328 -179.496 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.57 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 1.2 pp 173.3 -15.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.703 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.71 -17.4 76.61 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.529 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 3.6 mm-40 . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.276 -1.132 . . . . 0.0 109.202 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.716 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 121.281 0.562 . . . . 0.0 109.951 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 39' ' ' THR . 14.5 p -114.43 121.02 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.716 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 30.9 t70 -48.93 102.88 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.502 -0.749 . . . . 0.0 111.043 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -63.89 -24.24 67.66 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.23 -33.86 76.25 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.805 HD11 ' CE ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -77.39 -36.81 53.11 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.35 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.689 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.6 mp -62.38 -41.85 98.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.625 -0.672 . . . . 0.0 109.503 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.11 -23.17 19.51 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.647 -0.658 . . . . 0.0 109.993 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -98.62 -33.13 11.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.431 -0.793 . . . . 0.0 110.489 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 16' ' ' LEU . 1.5 p -69.73 -40.52 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.231 -0.918 . . . . 0.0 110.426 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.596 HD21 ' OE2' ' A' ' 43' ' ' GLU . 12.1 mt -63.22 -36.93 85.29 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 177.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.9 -34.04 72.65 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.627 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 27' ' ' GLU . 2.5 mm? -78.77 -26.99 44.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.347 -0.845 . . . . 0.0 109.435 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -81.48 -13.1 58.56 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.577 -0.702 . . . . 0.0 109.752 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.86 -35.39 24.21 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.447 -0.783 . . . . 0.0 109.702 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 17.1 mmtt -89.89 -15.09 32.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.724 -0.61 . . . . 0.0 109.826 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.55 26.25 36.32 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.439 ' O ' HD12 ' A' ' 22' ' ' LEU . 47.1 mt-10 -111.0 144.6 39.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.539 -0.977 . . . . 0.0 110.497 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -111.27 92.99 4.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.502 -0.749 . . . . 0.0 109.611 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.84 -157.19 0.64 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.539 -0.725 . . . . 0.0 110.449 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -112.8 154.04 26.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.538 -0.726 . . . . 0.0 110.364 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.573 HG21 HD12 ' A' ' 15' ' ' LEU . 3.0 mt -131.49 121.84 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.498 -0.751 . . . . 0.0 109.873 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.39 160.02 24.18 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.287 -0.883 . . . . 0.0 110.816 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.669 HG23 ' CG ' ' A' ' 12' ' ' ASP . 16.5 m -137.31 158.39 44.53 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.659 -0.651 . . . . 0.0 110.181 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.439 ' CD1' ' HE1' ' A' ' 57' ' ' HIS . 20.0 m-90 -145.74 37.01 1.07 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.272 -0.893 . . . . 0.0 110.629 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.428 ' HB3' ' HE1' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -100.21 -155.45 0.51 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.168 -0.958 . . . . 0.0 110.687 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.74 -58.13 2.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.179 -0.95 . . . . 0.0 110.147 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.38 35.26 1.99 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.539 -0.726 . . . . 0.0 109.924 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.435 ' HB3' HG21 ' A' ' 33' ' ' THR . 58.5 m -42.19 128.21 3.65 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.338 0.589 . . . . 0.0 111.839 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.713 ' O ' HG23 ' A' ' 11' ' ' VAL . 23.7 m -136.94 163.46 30.65 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.674 -0.641 . . . . 0.0 110.308 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.76 HG21 HG21 ' A' ' 62' ' ' ILE . 5.1 mp -85.42 169.73 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.472 -0.768 . . . . 0.0 111.186 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.674 HG12 ' HD2' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -137.27 176.26 2.88 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 121.563 -0.711 . . . . 0.0 109.771 178.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.674 ' HD2' HG12 ' A' ' 41' ' ' VAL . 42.1 Cg_endo -66.57 -29.43 44.14 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.059 1.557 . . . . 0.0 111.334 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.596 ' OE2' HD21 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -77.75 8.0 5.07 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.479 -0.763 . . . . 0.0 111.392 179.604 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.805 ' CE ' HD11 ' A' ' 15' ' ' LEU . 2.1 mtt -109.96 19.27 19.21 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.01 -1.056 . . . . 0.0 111.512 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.705 HG13 ' N ' ' A' ' 64' ' ' GLU . 89.0 t -66.68 7.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 121.088 -1.007 . . . . 0.0 113.352 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.2 32.44 0.95 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 34.8 m-70 -138.78 147.36 42.49 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.277 -1.131 . . . . 0.0 111.243 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.767 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -99.63 82.0 2.57 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.377 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.746 ' CG2' HD13 ' A' ' 15' ' ' LEU . 2.6 mp -81.61 117.38 27.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.314 -0.866 . . . . 0.0 111.446 -177.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.723 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -76.67 78.01 3.32 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 122.094 0.949 . . . . 0.0 108.813 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.666 HG21 ' HB3' ' A' ' 71' ' ' LEU . 32.9 m -60.43 131.12 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.775 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.515 ' HB2' ' O ' ' A' ' 33' ' ' THR . 36.2 t80 -78.28 103.95 8.55 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -74.36 7.87 2.59 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.362 -0.836 . . . . 0.0 111.339 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.94 -27.31 5.94 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -140.71 -24.97 0.76 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.84 -0.8 . . . . 0.0 111.522 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.503 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -133.64 154.09 51.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.106 -0.996 . . . . 0.0 112.443 -177.668 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.489 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 22.3 m-70 -98.84 100.61 11.82 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.723 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 52.5 t -88.75 104.29 7.13 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.236 -0.915 . . . . 0.0 109.887 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.496 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.6 Cg_endo -66.65 88.75 0.28 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 O-C-N 123.912 1.48 . . . . 0.0 109.501 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 49' ' ' ILE . 13.7 m -94.31 112.44 27.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.327 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.767 ' HB2' HG23 ' A' ' 48' ' ' THR . 5.9 t80 -72.9 100.0 2.82 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.76 HG21 HG21 ' A' ' 40' ' ' ILE . 2.7 mp -80.82 134.47 27.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.283 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.696 ' C ' HG13 ' A' ' 45' ' ' VAL . 1.9 m -105.19 -150.25 0.43 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 177.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.705 ' N ' HG13 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -90.01 -3.66 57.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.341 -1.474 . . . . 0.0 111.247 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.4 24.41 4.45 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.917 -1.114 . . . . 0.0 111.44 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.1 mtt -114.82 -31.61 6.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.149 -0.97 . . . . 0.0 110.02 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.528 ' HB ' HG21 ' A' ' 62' ' ' ILE . 6.0 p -62.07 163.29 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 O-C-N 121.453 -0.779 . . . . 0.0 111.925 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.478 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 120.91 -9.55 10.42 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.323 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.667 ' O ' HG23 ' A' ' 39' ' ' THR . 14.1 m80 -122.97 -86.29 0.65 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 119.101 1.45 . . . . 0.0 110.836 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.54 -30.43 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.495 0.664 . . . . 0.0 110.243 -179.553 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.666 ' HB3' HG21 ' A' ' 51' ' ' VAL . 1.4 pp 173.55 -14.05 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.273 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.805 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.37 -17.85 79.08 Favored Glycine 0 N--CA 1.493 2.454 0 O-C-N 120.927 -1.108 . . . . 0.0 110.627 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.507 ' HG3' ' ND1' ' A' ' 69' ' ' HIS . 16.7 mm-40 . . . . . 0 N--CA 1.497 1.905 0 O-C-N 121.251 -1.146 . . . . 0.0 109.352 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.662 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.17 0.51 . . . . 0.0 109.746 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.807 HG21 HG13 ' A' ' 41' ' ' VAL . 13.5 p -92.11 108.4 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.662 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 36.2 t70 -48.31 115.74 1.32 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.457 0.646 . . . . 0.0 111.736 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.72 -25.07 62.78 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -63.78 -27.73 69.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.862 -0.524 . . . . 0.0 110.12 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.846 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -78.74 -36.73 42.77 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.712 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.846 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.0 mp -62.64 -43.79 97.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.853 -0.529 . . . . 0.0 109.919 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.32 -21.31 23.49 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.666 -0.646 . . . . 0.0 110.593 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.599 ' O ' HD23 ' A' ' 22' ' ' LEU . 6.4 mmpt? -106.27 -23.81 12.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.4 -0.812 . . . . 0.0 111.164 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.695 HG12 ' HA ' ' A' ' 16' ' ' LEU . 1.4 p -86.26 -40.94 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.983 -1.073 . . . . 0.0 111.0 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.482 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 14.1 mt -65.34 -38.16 89.28 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -62.64 -33.84 75.84 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.539 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.599 HD23 ' O ' ' A' ' 18' ' ' LYS . 2.3 mm? -78.0 -25.98 48.29 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.291 -0.881 . . . . 0.0 109.456 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -81.56 -12.4 58.8 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.586 -0.696 . . . . 0.0 109.682 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.91 -37.21 27.15 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 121.446 -0.784 . . . . 0.0 109.346 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -86.05 -22.55 27.15 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.64 15.71 51.76 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -95.68 145.03 25.6 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.534 -0.98 . . . . 0.0 110.388 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -110.15 89.39 3.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.517 -0.74 . . . . 0.0 109.557 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.433 ' HB2' HD11 ' A' ' 22' ' ' LEU . 7.6 ttm180 -111.77 -155.57 0.57 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.496 -0.752 . . . . 0.0 110.365 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -119.2 154.09 33.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.412 -0.805 . . . . 0.0 110.319 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.588 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 2.7 mp -129.65 121.49 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.495 -0.753 . . . . 0.0 110.18 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.515 ' CD ' HD11 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -99.89 153.44 19.16 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.321 -0.862 . . . . 0.0 111.23 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.586 HG23 ' H ' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -140.95 166.77 23.88 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.689 -0.632 . . . . 0.0 110.072 179.209 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.478 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 13.6 m-90 -144.89 43.16 1.34 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.639 -0.663 . . . . 0.0 110.508 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.26 -83.35 0.26 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.231 -0.918 . . . . 0.0 110.605 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -179.93 -63.68 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.422 -0.799 . . . . 0.0 110.155 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -101.89 35.94 2.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.466 -0.771 . . . . 0.0 109.616 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.2 m -42.16 113.22 0.41 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.442 0.639 . . . . 0.0 111.578 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.875 HG23 ' O ' ' A' ' 69' ' ' HIS . 26.2 m -107.12 159.35 16.39 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.818 -0.551 . . . . 0.0 109.554 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.654 ' CG2' ' HG3' ' A' ' 44' ' ' MET . 1.1 mp -74.47 163.76 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.479 -0.763 . . . . 0.0 111.163 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.816 HG11 HD11 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -121.61 179.13 1.02 Allowed Pre-proline 0 N--CA 1.507 2.407 0 O-C-N 121.648 -0.658 . . . . 0.0 109.925 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.567 ' HD2' HG12 ' A' ' 41' ' ' VAL . 50.4 Cg_endo -71.44 -32.49 12.3 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 124.079 1.568 . . . . 0.0 111.346 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -83.98 15.27 3.48 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.445 -0.785 . . . . 0.0 110.573 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.942 ' CG ' HG21 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -82.92 -15.7 50.33 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.636 -0.665 . . . . 0.0 112.125 -179.422 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.615 HG23 ' N ' ' A' ' 64' ' ' GLU . 2.4 p -58.31 6.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.41 29.26 1.07 Allowed Glycine 0 N--CA 1.491 2.335 0 O-C-N 119.917 -1.739 . . . . 0.0 110.056 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.539 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 18.2 m80 -145.93 156.6 43.63 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.998 -1.295 . . . . 0.0 111.539 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -99.03 78.86 2.3 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 177.888 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.719 HD12 ' CD1' ' A' ' 62' ' ' ILE . 78.8 mt -78.18 116.79 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.526 -0.734 . . . . 0.0 111.516 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.773 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.85 85.92 5.45 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 51' ' ' VAL . 17.6 m -66.77 128.81 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.026 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.586 ' H ' HG23 ' A' ' 33' ' ' THR . 27.0 t80 -76.73 105.77 8.0 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.449 -0.782 . . . . 0.0 108.911 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -70.29 -0.85 8.82 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.679 -0.638 . . . . 0.0 110.679 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.9 -19.64 9.49 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -140.1 -28.68 0.73 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.933 -0.745 . . . . 0.0 110.898 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -134.68 155.2 50.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.187 -0.946 . . . . 0.0 111.977 -178.307 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.539 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -101.63 111.3 23.5 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.773 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 18.0 t -98.64 94.96 2.7 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.256 -0.902 . . . . 0.0 109.743 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 57' ' ' HIS . 43.6 Cg_endo -69.37 94.9 0.5 Allowed 'Trans proline' 0 N--CA 1.487 1.137 0 O-C-N 123.847 1.446 . . . . 0.0 109.531 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.563 ' CG2' HG12 ' A' ' 58' ' ' VAL . 48.6 t -111.93 127.89 68.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.062 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.539 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.9 t80 -72.19 102.34 3.03 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 176.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.942 HG21 ' CG ' ' A' ' 44' ' ' MET . 2.8 mp -65.54 -60.48 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -175.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 62' ' ' ILE . 4.9 m 71.71 172.17 0.31 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -176.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.615 ' N ' HG23 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -78.3 66.83 3.97 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.856 -1.152 . . . . 0.0 110.396 -179.06 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -169.54 -24.17 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.398 -0.814 . . . . 0.0 112.625 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.419 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 11.0 mtt -110.15 9.12 24.01 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.613 -1.304 . . . . 0.0 112.544 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.661 ' HB ' ' HE3' ' A' ' 44' ' ' MET . 14.2 p -89.33 166.49 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 O-C-N 120.583 -1.323 . . . . 0.0 112.652 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.523 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 105.17 -13.81 48.38 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.875 ' O ' HG23 ' A' ' 39' ' ' THR . 8.9 m80 -113.43 -90.37 0.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 118.813 1.306 . . . . 0.0 110.478 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.755 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.86 -35.36 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 122.306 1.05 . . . . 0.0 109.106 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.645 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -178.67 -13.55 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.027 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.57 -15.64 80.44 Favored Glycine 0 N--CA 1.497 2.704 0 O-C-N 120.829 -1.17 . . . . 0.0 110.286 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.495 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 2.0 mm-40 . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.385 -1.067 . . . . 0.0 108.567 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.715 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.381 0.61 . . . . 0.0 110.293 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.078 HG11 HG13 ' A' ' 41' ' ' VAL . 77.7 t -105.14 114.48 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.715 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 1.8 t0 -44.58 106.29 0.07 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.448 0.642 . . . . 0.0 111.805 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -67.65 -23.35 65.32 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.7 t60 -67.32 -35.7 79.98 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.873 -0.517 . . . . 0.0 109.908 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.735 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -75.32 -38.24 60.33 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.29 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.735 HD12 ' HG ' ' A' ' 15' ' ' LEU . 2.6 mp -58.78 -43.58 90.45 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.299 0.571 . . . . 0.0 109.639 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.506 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -55.03 -25.75 32.56 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.065 179.315 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.478 ' HB2' HG23 ' A' ' 31' ' ' ILE . 10.3 mmtm -97.12 -31.95 12.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.479 -0.763 . . . . 0.0 111.034 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.655 HG12 ' HA ' ' A' ' 16' ' ' LEU . 3.6 p -74.07 -38.03 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 120.997 -1.064 . . . . 0.0 111.271 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.506 HD21 ' HA ' ' A' ' 17' ' ' GLU . 3.6 pp -62.69 -25.03 67.95 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.75 -35.28 72.58 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 27' ' ' GLU . 3.4 mm? -72.33 -27.49 62.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.623 -0.673 . . . . 0.0 109.585 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -83.17 -16.13 47.85 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.588 -0.695 . . . . 0.0 109.792 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.8 -36.99 23.12 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 121.577 -0.702 . . . . 0.0 109.57 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -88.03 -21.07 24.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.674 -0.641 . . . . 0.0 109.35 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.01 17.26 59.7 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.494 ' O ' HD12 ' A' ' 22' ' ' LEU . 21.7 mm-40 -93.28 149.15 21.44 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.38 -1.071 . . . . 0.0 110.593 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -110.74 96.57 6.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.549 -0.72 . . . . 0.0 109.756 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.446 ' HB2' HD11 ' A' ' 22' ' ' LEU . 1.8 ttt85 -126.73 -155.53 0.69 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.532 -0.73 . . . . 0.0 110.353 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -116.99 155.79 28.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.5 -0.75 . . . . 0.0 110.469 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.652 HD13 HG23 ' A' ' 19' ' ' VAL . 3.2 mp -132.05 112.98 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.614 -0.679 . . . . 0.0 109.536 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.13 148.35 26.38 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.386 -0.821 . . . . 0.0 110.897 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 14.3 t -141.09 174.87 10.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.679 -0.638 . . . . 0.0 110.171 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.501 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 10.0 m-90 -143.8 47.13 1.45 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.145 -0.972 . . . . 0.0 111.666 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 t -88.96 -84.25 0.21 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.718 -1.239 . . . . 0.0 111.077 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.54 -88.83 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.02 -1.05 . . . . 0.0 111.36 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.539 ' HD2' ' HB3' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -97.4 52.83 1.13 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.209 -0.932 . . . . 0.0 109.975 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.525 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 0.4 OUTLIER -39.11 138.12 0.63 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.264 0.554 . . . . 0.0 112.363 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.825 HG23 ' O ' ' A' ' 69' ' ' HIS . 24.4 m -129.2 159.21 36.76 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.529 -0.732 . . . . 0.0 110.133 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.875 HG23 ' SD ' ' A' ' 44' ' ' MET . 1.2 mp -78.99 159.55 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 121.541 -0.725 . . . . 0.0 111.604 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.078 HG13 HG11 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -133.64 171.23 9.46 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.808 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 42.6 Cg_endo -67.16 -31.79 35.42 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.133 1.596 . . . . 0.0 110.493 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HG3' HG11 ' A' ' 19' ' ' VAL . 6.5 pt-20 -75.24 -1.97 25.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.53 -0.731 . . . . 0.0 111.025 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.906 ' SD ' HD13 ' A' ' 62' ' ' ILE . 1.4 ptp -114.98 16.7 17.11 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.897 -1.127 . . . . 0.0 110.886 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.615 HG13 ' CA ' ' A' ' 64' ' ' GLU . 2.6 t -68.27 6.5 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.358 -0.839 . . . . 0.0 112.782 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.77 35.79 0.92 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.539 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 54.2 m-70 -140.24 159.2 42.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.501 -0.999 . . . . 0.0 110.488 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.644 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.08 82.47 2.73 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 178.382 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.602 ' CG2' HD13 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -83.51 115.82 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.495 -0.753 . . . . 0.0 111.55 -176.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.767 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -77.99 81.6 4.38 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.561 HG22 HG23 ' A' ' 58' ' ' VAL . 33.0 m -66.19 132.66 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.581 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.501 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 23.8 t80 -72.44 104.35 3.77 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -70.7 -0.23 8.39 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.51 -0.744 . . . . 0.0 110.488 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.6 -21.79 8.43 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.12 -30.0 0.69 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 122.009 -0.701 . . . . 0.0 110.633 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.409 ' CG ' HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -133.89 156.47 48.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.309 -0.869 . . . . 0.0 111.737 -178.42 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.451 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -102.41 101.74 12.0 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.178 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.767 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 14.6 m -91.39 105.56 13.26 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.152 -0.967 . . . . 0.0 110.335 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.505 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 43.0 Cg_endo -68.7 88.88 0.42 Allowed 'Trans proline' 0 N--CA 1.49 1.276 0 O-C-N 123.91 1.479 . . . . 0.0 109.163 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 58' ' ' VAL . 58.2 t -98.18 119.17 45.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.485 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.644 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.3 t80 -70.97 101.54 2.2 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 118.85 -1.14 . . . . 0.0 107.95 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.906 HD13 ' SD ' ' A' ' 44' ' ' MET . 3.2 mp -80.75 138.34 19.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.638 -0.664 . . . . 0.0 110.566 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.445 ' C ' HG13 ' A' ' 45' ' ' VAL . 60.8 p -98.71 -161.23 0.86 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 177.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.615 ' CA ' HG13 ' A' ' 45' ' ' VAL . 0.6 OUTLIER -85.29 5.79 28.98 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.823 -1.173 . . . . 0.0 111.081 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -128.57 -11.53 5.0 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.739 -1.226 . . . . 0.0 113.053 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.625 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 9.0 mtt -88.37 -5.59 58.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.519 -1.363 . . . . 0.0 110.618 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 68' ' ' GLY . 9.0 p -81.79 165.19 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.073 -1.017 . . . . 0.0 111.535 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.498 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 109.05 -18.16 31.4 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.825 ' O ' HG23 ' A' ' 39' ' ' THR . 12.1 m80 -115.89 -86.14 0.62 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -1.204 . . . . 0.0 110.695 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.37 -35.09 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 122.215 1.007 . . . . 0.0 109.291 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER 179.63 -16.08 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.864 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.78 -15.1 73.43 Favored Glycine 0 N--CA 1.497 2.715 0 O-C-N 120.889 -1.132 . . . . 0.0 110.458 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.625 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 1.6 mm-40 . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.362 -1.081 . . . . 0.0 108.805 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 121.197 0.523 . . . . 0.0 109.964 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.0 t -110.22 124.19 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.951 ' OD1' HD23 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -45.1 107.14 0.09 Allowed 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.375 0.607 . . . . 0.0 111.427 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.78 -27.02 64.57 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.827 ' CB ' HG23 ' A' ' 33' ' ' THR . 1.0 OUTLIER -68.78 -15.81 63.62 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.943 -0.473 . . . . 0.0 110.171 178.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.088 HD11 ' SD ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -84.36 -39.08 19.52 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.466 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.84 ' HA ' HG12 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -69.07 -43.79 73.9 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.605 -0.685 . . . . 0.0 110.714 179.417 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.443 ' HG2' ' HA ' ' A' ' 14' ' ' HIS . 5.8 pt-20 -53.93 -19.39 4.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.446 -0.784 . . . . 0.0 110.885 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.563 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.1 mtmt -112.49 -33.6 6.11 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.261 -0.9 . . . . 0.0 111.134 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.885 HG21 ' SD ' ' A' ' 44' ' ' MET . 1.1 p -73.73 -39.69 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.081 -1.012 . . . . 0.0 111.591 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.457 HD11 ' HB3' ' A' ' 16' ' ' LEU . 18.1 mt -60.11 -37.88 81.33 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.07 -40.24 92.92 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.593 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.689 HD23 ' CB ' ' A' ' 27' ' ' GLU . 1.1 mt -71.92 -26.63 62.38 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.272 -0.892 . . . . 0.0 110.289 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -80.66 -10.75 59.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.558 -0.714 . . . . 0.0 109.636 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.98 -35.62 15.43 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.482 -0.761 . . . . 0.0 110.172 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.478 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -102.39 -25.89 13.48 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.547 -0.721 . . . . 0.0 109.793 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.55 29.49 12.06 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.689 ' CB ' HD23 ' A' ' 22' ' ' LEU . 5.0 mm-40 -80.14 149.37 30.58 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.446 -1.032 . . . . 0.0 110.351 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -111.8 86.0 2.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.579 -0.701 . . . . 0.0 109.953 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -136.34 -160.13 1.02 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.484 -0.76 . . . . 0.0 110.53 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.543 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -119.52 156.69 29.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.649 -0.657 . . . . 0.0 110.206 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.659 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 2.7 mp -124.79 123.39 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.37 -0.831 . . . . 0.0 109.75 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.505 ' HE3' HD11 ' A' ' 30' ' ' LEU . 1.1 mptt -98.28 151.15 20.79 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.246 -0.909 . . . . 0.0 111.137 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.949 HG21 ' HB2' ' A' ' 12' ' ' ASP . 18.4 m -136.15 162.47 32.86 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.652 -0.655 . . . . 0.0 109.584 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.428 ' CD1' ' NE2' ' A' ' 57' ' ' HIS . 27.9 m-90 -141.44 38.36 1.7 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.279 -0.888 . . . . 0.0 110.768 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.7 m -82.82 -101.23 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.208 -0.932 . . . . 0.0 110.566 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.43 -68.69 0.12 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.041 -1.037 . . . . 0.0 109.756 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.509 ' HG2' ' HD1' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -106.48 50.76 0.76 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.777 0.799 . . . . 0.0 108.857 178.761 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.445 ' OG ' ' HB3' ' A' ' 12' ' ' ASP . 22.4 m -47.86 111.01 0.37 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.302 0.572 . . . . 0.0 111.905 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 69' ' ' HIS . 28.7 m -105.43 155.84 18.76 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.693 -0.63 . . . . 0.0 109.597 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.746 HG21 HG21 ' A' ' 62' ' ' ILE . 4.4 mp -77.82 167.87 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.145 -0.972 . . . . 0.0 111.297 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.77 HG12 ' HD2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -137.5 176.73 2.53 Favored Pre-proline 0 N--CA 1.501 2.081 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.142 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.77 ' HD2' HG12 ' A' ' 41' ' ' VAL . 45.1 Cg_endo -68.42 -35.18 18.66 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.889 1.468 . . . . 0.0 111.335 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.52 ' HB2' ' CE ' ' A' ' 44' ' ' MET . 0.8 OUTLIER -66.0 -9.93 34.82 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.461 -0.775 . . . . 0.0 110.677 179.099 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' MET . . . . . 1.088 ' SD ' HD11 ' A' ' 15' ' ' LEU . 4.0 mmt -88.14 0.93 55.44 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.348 -0.845 . . . . 0.0 111.323 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.476 HG23 ' N ' ' A' ' 64' ' ' GLU . 5.6 p -54.98 -2.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.18 34.66 1.19 Allowed Glycine 0 N--CA 1.492 2.426 0 O-C-N 120.43 -1.419 . . . . 0.0 109.605 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.532 ' HB2' HD11 ' A' ' 49' ' ' ILE . 56.1 m-70 -142.54 150.94 41.09 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.304 -1.115 . . . . 0.0 111.127 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.733 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.75 81.41 2.46 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.15 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.009 HG12 HD13 ' A' ' 15' ' ' LEU . 3.0 mt -85.54 121.88 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 111.654 -176.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.76 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.85 82.48 5.05 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 122.102 0.953 . . . . 0.0 108.888 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 51' ' ' VAL . 33.2 m -63.0 127.52 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.542 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 33' ' ' THR . 20.2 t80 -71.71 104.29 3.33 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -70.68 -1.43 11.32 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.557 -0.715 . . . . 0.0 110.553 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.29 -21.05 8.84 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -140.18 -29.75 0.69 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.882 -0.775 . . . . 0.0 110.82 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.41 155.67 49.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.332 -0.855 . . . . 0.0 111.928 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.432 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 6.0 m80 -102.51 103.99 14.38 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.76 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 28.7 t -93.55 102.78 8.28 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.3 -0.875 . . . . 0.0 110.106 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.501 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.5 Cg_endo -66.59 89.32 0.28 Allowed 'Trans proline' 0 N--CA 1.492 1.404 0 O-C-N 123.878 1.462 . . . . 0.0 109.195 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 58' ' ' VAL . 48.1 t -97.57 118.68 44.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.201 -178.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.733 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.6 t80 -73.19 103.9 4.06 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.91 HD13 ' HB3' ' A' ' 44' ' ' MET . 2.7 mp -84.45 144.82 9.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.675 0.75 . . . . 0.0 111.64 -178.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.9 p -111.03 -158.71 0.65 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.476 ' N ' HG23 ' A' ' 45' ' ' VAL . 3.5 tp10 -90.59 15.14 11.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.588 -1.32 . . . . 0.0 110.997 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -137.95 -13.47 1.43 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.919 -1.113 . . . . 0.0 112.527 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 28.3 mmt -88.04 -24.97 23.32 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.605 -1.309 . . . . 0.0 110.327 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.591 HG21 ' C ' ' A' ' 41' ' ' VAL . 4.2 p -66.61 163.45 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.388 -0.82 . . . . 0.0 111.437 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.499 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 118.17 -14.79 12.23 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.113 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.782 ' O ' HG23 ' A' ' 39' ' ' THR . 24.0 m80 -127.21 -81.14 0.6 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.965 -1.315 . . . . 0.0 111.497 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.606 ' HD3' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER 177.42 -31.97 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.717 0.77 . . . . 0.0 110.268 -179.264 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.606 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.7 OUTLIER 173.82 -16.0 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.757 -179.553 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.53 -18.02 73.29 Favored Glycine 0 N--CA 1.496 2.639 0 O-C-N 120.946 -1.096 . . . . 0.0 110.503 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.61 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 1.3 mt-10 . . . . . 0 N--CA 1.497 1.903 0 O-C-N 121.407 -1.054 . . . . 0.0 109.124 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.767 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.561 HG22 ' HB ' ' A' ' 39' ' ' THR . 69.4 t -101.83 112.05 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.767 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 39.0 t70 -44.68 106.52 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.145 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -67.87 -24.2 65.21 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -66.22 -25.61 66.99 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.942 -0.474 . . . . 0.0 109.91 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.89 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -79.76 -38.16 33.81 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.89 HD12 ' HG ' ' A' ' 15' ' ' LEU . 5.0 mp -62.58 -42.3 99.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.796 -0.565 . . . . 0.0 109.923 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.66 -30.76 22.98 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.136 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.77 -27.99 17.67 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.464 -0.772 . . . . 0.0 110.602 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.908 HG21 ' SD ' ' A' ' 44' ' ' MET . 93.9 t -73.62 -40.16 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.15 -0.969 . . . . 0.0 111.186 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 16' ' ' LEU . 10.9 mt -60.93 -36.43 79.29 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.18 -36.09 83.12 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.051 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.42 HD12 ' O ' ' A' ' 27' ' ' GLU . 2.9 mm? -77.63 -26.57 50.65 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.258 -0.901 . . . . 0.0 109.666 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -81.96 -12.48 58.34 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.623 -0.673 . . . . 0.0 109.757 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.59 -34.53 27.65 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.417 -0.802 . . . . 0.0 109.512 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 16.3 mmtt -93.11 -15.87 25.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.773 -0.579 . . . . 0.0 109.8 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.21 28.99 34.97 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' O ' HD12 ' A' ' 22' ' ' LEU . 28.3 mt-10 -106.48 148.74 27.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.649 -0.912 . . . . 0.0 110.705 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 mtmm -113.36 90.81 3.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.586 -0.696 . . . . 0.0 109.97 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.412 ' HB2' HD11 ' A' ' 22' ' ' LEU . 3.9 ttt-85 -113.5 -158.32 0.65 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.459 -0.776 . . . . 0.0 110.305 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.634 HD11 ' HD3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -116.19 148.39 40.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.574 -0.704 . . . . 0.0 110.274 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.749 HD13 HG22 ' A' ' 19' ' ' VAL . 3.2 mp -121.83 118.75 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.594 -0.691 . . . . 0.0 109.552 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.634 ' HD3' HD11 ' A' ' 30' ' ' LEU . 20.5 mmmt -78.9 152.93 30.89 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.453 -0.779 . . . . 0.0 111.029 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.67 HG23 ' CG ' ' A' ' 12' ' ' ASP . 24.1 m -139.69 153.16 47.18 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.589 -0.694 . . . . 0.0 109.778 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.463 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 9.7 m-90 -145.3 36.44 1.1 Allowed 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.22 -0.925 . . . . 0.0 111.6 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 m -86.86 -95.97 0.08 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.764 -1.21 . . . . 0.0 110.361 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.413 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -173.99 -63.02 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.191 -0.943 . . . . 0.0 109.464 179.698 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.43 ' HG3' ' HB3' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -102.24 36.85 2.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.591 -0.693 . . . . 0.0 109.212 178.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.414 ' OG ' HG21 ' A' ' 33' ' ' THR . 4.2 m -48.29 144.48 3.91 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.515 0.674 . . . . 0.0 111.77 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.818 HG23 ' O ' ' A' ' 69' ' ' HIS . 52.3 m -133.81 160.19 38.36 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.273 0.558 . . . . 0.0 109.678 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.778 ' CG2' HG12 ' A' ' 62' ' ' ILE . 1.2 mp -83.41 164.78 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.632 -0.668 . . . . 0.0 111.846 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.877 HG21 HD11 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -134.15 174.21 4.92 Favored Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.787 -0.57 . . . . 0.0 109.466 178.541 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.749 ' HD2' HG12 ' A' ' 41' ' ' VAL . 46.0 Cg_endo -68.92 -34.65 17.07 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 124.0 1.526 . . . . 0.0 111.581 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.42 -6.54 25.26 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.408 -0.808 . . . . 0.0 110.742 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.908 ' SD ' HG21 ' A' ' 19' ' ' VAL . 6.6 mmt -86.31 -6.29 58.99 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.365 -0.835 . . . . 0.0 111.658 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.646 HG23 ' N ' ' A' ' 64' ' ' GLU . 6.0 p -51.51 1.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.406 ' C ' ' CG ' ' A' ' 47' ' ' HIS . . . -146.27 33.19 1.48 Allowed Glycine 0 N--CA 1.495 2.575 0 O-C-N 119.93 -1.731 . . . . 0.0 110.071 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.459 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 14.6 m80 -147.66 153.98 40.03 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.106 -1.232 . . . . 0.0 111.181 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.64 88.76 3.92 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.826 HD12 HD13 ' A' ' 62' ' ' ILE . 22.9 mt -86.24 121.94 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.565 -176.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.776 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.16 78.05 5.64 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 51' ' ' VAL . 23.3 m -62.39 128.67 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.643 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 35.3 t80 -75.67 105.48 6.73 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -76.08 8.35 3.31 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.368 -0.833 . . . . 0.0 111.221 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 36' ' ' ARG . . . 122.71 -27.11 6.06 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.49 -24.03 0.79 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.819 -0.812 . . . . 0.0 111.596 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -135.76 154.17 51.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.019 -1.051 . . . . 0.0 112.411 -177.655 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.472 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 1.1 m-70 -100.19 105.2 16.77 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.776 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 23.4 t -94.1 101.26 6.04 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.146 -0.971 . . . . 0.0 109.935 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.538 ' HB3' HD12 ' A' ' 30' ' ' LEU . 41.8 Cg_endo -67.72 93.08 0.37 Allowed 'Trans proline' 0 N--CA 1.489 1.25 0 O-C-N 123.955 1.503 . . . . 0.0 109.697 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.629 ' O ' HD12 ' A' ' 62' ' ' ILE . 16.4 m -109.38 129.07 64.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.829 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.8 t80 -71.35 105.8 3.64 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.826 HD13 HD12 ' A' ' 49' ' ' ILE . 1.6 mp -57.97 -63.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.476 ' O ' HG22 ' A' ' 62' ' ' ILE . 3.0 m 66.3 171.33 0.24 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -176.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.646 ' N ' HG23 ' A' ' 45' ' ' VAL . 2.8 tp10 -83.84 58.58 4.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.372 -1.455 . . . . 0.0 109.26 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -161.25 -36.86 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.306 -0.871 . . . . 0.0 112.181 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.547 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -88.24 -15.98 34.46 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.87 -1.144 . . . . 0.0 111.146 -179.087 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.513 HG21 ' C ' ' A' ' 41' ' ' VAL . 7.5 p -73.66 161.73 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.099 -1.0 . . . . 0.0 112.138 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.48 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 113.56 -19.3 19.39 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.818 ' O ' HG23 ' A' ' 39' ' ' THR . 14.0 m80 -114.9 -84.44 0.61 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.077 -1.249 . . . . 0.0 110.483 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.732 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.19 -34.67 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 122.042 0.925 . . . . 0.0 109.846 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.554 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.5 OUTLIER 176.88 -14.26 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.856 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.41 -15.58 72.89 Favored Glycine 0 N--CA 1.496 2.668 0 O-C-N 120.9 -1.125 . . . . 0.0 110.313 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.626 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 1.1 mt-10 . . . . . 0 N--CA 1.497 1.897 0 O-C-N 121.336 -1.097 . . . . 0.0 109.037 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.724 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.274 0.559 . . . . 0.0 109.888 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.823 HG21 HG13 ' A' ' 41' ' ' VAL . 7.2 p -108.8 113.98 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.776 ' CG ' HG23 ' A' ' 33' ' ' THR . 38.8 t70 -41.96 109.23 0.12 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.716 -0.615 . . . . 0.0 111.682 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -68.52 -24.57 64.67 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.601 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 1.7 t-80 -65.57 -20.64 66.41 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.908 -0.495 . . . . 0.0 110.3 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.954 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -85.32 -38.43 18.81 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.133 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.954 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.7 mp -63.82 -43.13 97.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.83 -0.544 . . . . 0.0 110.26 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.601 ' HG2' ' HA ' ' A' ' 14' ' ' HIS . 0.6 OUTLIER -57.31 -19.15 20.39 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.756 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.423 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 42.0 mttm -102.56 -29.02 11.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.356 -0.84 . . . . 0.0 110.657 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.004 HG21 ' SD ' ' A' ' 44' ' ' MET . 1.7 p -79.55 -36.21 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.154 -0.966 . . . . 0.0 111.479 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.555 HD21 ' HA ' ' A' ' 17' ' ' GLU . 3.8 pp -62.82 -25.66 68.36 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -34.34 63.36 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.707 HD22 ' HB2' ' A' ' 27' ' ' GLU . 1.2 mt -76.27 -27.43 56.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.796 -0.565 . . . . 0.0 109.567 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -84.16 -13.82 51.83 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.613 -0.679 . . . . 0.0 109.676 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.51 -37.94 15.35 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 121.55 -0.718 . . . . 0.0 109.955 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -97.01 -23.97 16.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.575 -0.703 . . . . 0.0 109.654 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.44 25.89 19.71 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.707 ' HB2' HD22 ' A' ' 22' ' ' LEU . 24.9 mt-10 -72.18 125.58 27.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.471 -1.017 . . . . 0.0 110.258 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.18 94.88 9.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.552 -0.717 . . . . 0.0 110.225 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.1 ttp85 -149.59 -160.93 1.24 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.519 -0.738 . . . . 0.0 110.312 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.635 ' HB2' ' HB ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -119.71 165.07 15.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.585 -0.697 . . . . 0.0 110.455 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.757 HG21 HD12 ' A' ' 15' ' ' LEU . 36.3 mm -112.57 159.92 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.321 -0.862 . . . . 0.0 109.026 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.502 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -125.5 153.41 43.61 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.288 -0.883 . . . . 0.0 110.839 -178.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.776 HG23 ' CG ' ' A' ' 12' ' ' ASP . 20.0 m -139.84 154.17 47.25 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.588 -0.695 . . . . 0.0 110.712 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.502 ' CH2' ' HB2' ' A' ' 32' ' ' LYS . 16.6 m-90 -146.49 34.19 0.96 Allowed 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.433 -0.792 . . . . 0.0 111.224 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.69 -93.56 0.11 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.864 -1.148 . . . . 0.0 110.989 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.414 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . 13.5 ttp85 -170.02 -66.49 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.194 -0.941 . . . . 0.0 109.287 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.554 ' HD2' ' HB3' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -104.43 44.0 1.06 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.247 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.541 ' CB ' HG21 ' A' ' 33' ' ' THR . 19.5 m -56.21 153.08 9.86 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.555 0.693 . . . . 0.0 112.317 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.724 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 40.9 m -140.38 162.21 35.86 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.878 -0.514 . . . . 0.0 110.055 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.716 HG21 HG12 ' A' ' 62' ' ' ILE . 4.8 mp -81.81 170.29 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 O-C-N 121.291 -0.881 . . . . 0.0 111.094 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.823 HG13 HG21 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -132.1 175.2 3.88 Favored Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.744 -0.597 . . . . 0.0 109.74 179.073 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.741 ' O ' HG23 ' A' ' 45' ' ' VAL . 47.0 Cg_endo -70.17 -32.7 16.37 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 124.096 1.577 . . . . 0.0 111.539 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.723 ' HG3' HG11 ' A' ' 19' ' ' VAL . 2.0 pt-20 -72.33 -3.43 23.81 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.275 -0.891 . . . . 0.0 110.957 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' MET . . . . . 1.004 ' SD ' HG21 ' A' ' 19' ' ' VAL . 23.5 mmm -91.1 15.65 11.27 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.296 -0.878 . . . . 0.0 112.231 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 42' ' ' PRO . 66.0 t -64.73 4.49 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 O-C-N 120.947 -1.096 . . . . 0.0 113.129 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.35 29.84 1.07 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.438 ' HB2' ' CE ' ' A' ' 44' ' ' MET . 14.7 m80 -139.09 150.71 46.03 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.377 -1.072 . . . . 0.0 110.701 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.635 ' HB ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.65 86.31 3.31 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.139 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.791 HD11 ' CG ' ' A' ' 44' ' ' MET . 58.3 mt -72.53 117.79 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.17 -0.956 . . . . 0.0 111.298 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.675 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.91 73.99 6.66 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.613 HG21 ' HB3' ' A' ' 71' ' ' LEU . 34.2 m -56.27 126.29 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.305 -177.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.522 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 29.0 t80 -76.93 101.99 6.19 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -74.55 9.97 1.54 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.485 -0.76 . . . . 0.0 111.065 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 36' ' ' ARG . . . 121.67 -27.86 6.12 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.75 -25.85 0.75 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.837 -0.802 . . . . 0.0 111.602 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.522 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -130.74 153.89 48.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.149 -0.969 . . . . 0.0 112.377 -177.616 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.521 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 6.3 m-70 -99.74 99.19 9.98 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.675 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 46.5 t -86.57 104.73 6.22 Favored Pre-proline 0 N--CA 1.501 2.102 0 O-C-N 121.215 -0.928 . . . . 0.0 109.505 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 57' ' ' HIS . 42.7 Cg_endo -67.08 90.68 0.31 Allowed 'Trans proline' 0 N--CA 1.489 1.258 0 O-C-N 123.892 1.47 . . . . 0.0 110.251 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 60' ' ' VAL . 35.6 m -95.83 111.36 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.39 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.582 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.2 t80 -72.59 104.46 3.88 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.015 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.716 HG12 HG21 ' A' ' 40' ' ' ILE . 2.7 mp -85.59 127.98 39.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.578 -0.701 . . . . 0.0 111.324 -178.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.508 ' C ' HG13 ' A' ' 45' ' ' VAL . 46.3 p -92.71 -153.28 0.34 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.565 ' N ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -87.97 8.0 28.44 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.711 -1.243 . . . . 0.0 111.196 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -147.64 21.11 1.16 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.959 -1.088 . . . . 0.0 111.775 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 7.8 mmt -107.61 -26.51 10.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.235 -0.916 . . . . 0.0 109.804 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.565 ' HB ' HG21 ' A' ' 62' ' ' ILE . 6.8 p -65.36 163.7 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 121.469 -0.769 . . . . 0.0 111.691 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.487 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 122.42 -10.2 9.28 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.397 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.717 ' O ' HG23 ' A' ' 39' ' ' THR . 14.7 m80 -123.82 -86.26 0.64 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.128 1.464 . . . . 0.0 110.983 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.724 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.31 -30.29 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.556 0.693 . . . . 0.0 110.308 -179.626 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.629 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.8 OUTLIER 174.27 -15.21 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.769 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.65 -18.46 78.65 Favored Glycine 0 N--CA 1.495 2.606 0 O-C-N 120.929 -1.107 . . . . 0.0 110.633 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.498 ' HG3' ' ND1' ' A' ' 69' ' ' HIS . 22.2 mm-40 . . . . . 0 N--CA 1.497 1.878 0 O-C-N 121.22 -1.165 . . . . 0.0 109.349 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.734 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.288 0.566 . . . . 0.0 110.075 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.967 HG21 HG13 ' A' ' 41' ' ' VAL . 7.5 p -101.83 115.68 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 178.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.734 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 27.8 t70 -46.34 107.06 0.09 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.476 0.655 . . . . 0.0 111.303 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -69.6 -24.48 63.67 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -64.67 -28.45 69.61 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.809 -0.557 . . . . 0.0 109.841 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.844 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -77.25 -37.72 52.53 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.396 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.844 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.1 mp -60.47 -47.29 86.78 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.171 0.51 . . . . 0.0 109.736 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.1 -23.06 4.79 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.648 -0.657 . . . . 0.0 110.722 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.28 -25.27 12.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.331 -0.855 . . . . 0.0 110.679 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -79.81 -36.14 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.268 -0.895 . . . . 0.0 110.841 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 16' ' ' LEU . 9.2 mt -63.74 -36.53 84.17 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 178.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.93 -34.35 75.93 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.566 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.575 ' HG ' ' HB3' ' A' ' 27' ' ' GLU . 1.5 mp -79.0 -27.1 43.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.543 -0.723 . . . . 0.0 109.578 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -84.33 -11.22 56.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.567 -0.708 . . . . 0.0 109.408 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.73 -41.37 11.94 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.619 -0.676 . . . . 0.0 110.396 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.448 ' HG3' ' N ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -99.44 -27.06 13.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.371 -0.831 . . . . 0.0 110.076 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.448 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . 105.24 27.51 5.84 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.575 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -79.49 135.85 36.75 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.397 -1.06 . . . . 0.0 110.268 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -114.14 61.84 0.66 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.626 -0.671 . . . . 0.0 109.508 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -109.33 -154.8 0.54 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.504 -0.747 . . . . 0.0 110.187 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -117.59 156.43 28.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.453 -0.78 . . . . 0.0 110.637 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.515 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 3.5 mt -127.71 114.5 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HD3' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -110.44 153.04 25.56 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.293 -0.879 . . . . 0.0 111.203 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.52 HG21 ' CG ' ' A' ' 12' ' ' ASP . 15.3 t -144.75 -173.39 4.05 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.473 -0.767 . . . . 0.0 111.067 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.662 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 19.4 m-90 -139.68 39.33 2.02 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.182 -0.949 . . . . 0.0 111.633 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.01 -99.35 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.726 -1.234 . . . . 0.0 110.402 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.31 -62.41 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.935 -1.103 . . . . 0.0 109.684 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.436 ' HG2' ' HD2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -106.19 38.35 2.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.541 -0.724 . . . . 0.0 109.242 178.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.524 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 1.1 m -41.5 114.97 0.57 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.335 0.588 . . . . 0.0 111.616 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.826 HG23 ' O ' ' A' ' 69' ' ' HIS . 25.9 m -106.71 161.94 14.21 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.536 -0.728 . . . . 0.0 110.436 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.87 HG21 HG21 ' A' ' 62' ' ' ILE . 1.2 mp -83.91 168.06 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.472 -0.767 . . . . 0.0 111.904 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.967 HG13 HG21 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -140.2 174.01 4.44 Favored Pre-proline 0 N--CA 1.501 2.109 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.301 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.513 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 42.3 Cg_endo -66.03 -30.61 47.52 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.923 1.486 . . . . 0.0 110.823 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.504 ' OE1' HD23 ' A' ' 20' ' ' LEU . 5.5 mm-40 -73.51 -4.68 35.37 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.584 -0.698 . . . . 0.0 110.948 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.681 ' HG2' HD13 ' A' ' 49' ' ' ILE . 51.4 mtp -97.27 2.53 50.91 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.115 -0.991 . . . . 0.0 111.033 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.625 HG23 ' N ' ' A' ' 64' ' ' GLU . 7.6 p -59.97 3.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.09 33.49 1.03 Allowed Glycine 0 N--CA 1.493 2.476 0 O-C-N 120.208 -1.558 . . . . 0.0 110.144 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.859 ' HB2' HD11 ' A' ' 49' ' ' ILE . 38.0 m-70 -145.51 156.34 43.65 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.219 -1.165 . . . . 0.0 111.048 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.682 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.87 86.25 3.25 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.514 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.859 HD11 ' HB2' ' A' ' 47' ' ' HIS . 3.1 mp -91.87 117.84 36.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.18 -0.95 . . . . 0.0 111.556 -177.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.788 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.21 89.16 4.88 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 122.162 0.982 . . . . 0.0 109.311 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.524 ' HB ' ' HB3' ' A' ' 38' ' ' SER . 26.2 m -66.39 127.43 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.131 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.662 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 26.1 t80 -70.01 108.49 4.07 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.174 -1.011 . . . . 0.0 108.911 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -75.92 16.57 0.4 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.666 -0.646 . . . . 0.0 110.322 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.93 -28.87 13.01 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -140.56 -26.76 0.74 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.528 -0.983 . . . . 0.0 111.14 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -127.74 156.52 42.29 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.697 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 76.8 m-70 -95.51 120.01 35.01 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.788 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 16.9 t -109.43 85.32 3.55 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.162 -0.961 . . . . 0.0 109.194 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.544 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.6 Cg_endo -67.6 85.57 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.348 0 O-C-N 123.852 1.448 . . . . 0.0 109.312 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.696 ' CG2' HG12 ' A' ' 58' ' ' VAL . 50.5 t -99.46 123.12 51.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.844 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.682 ' HB2' HG23 ' A' ' 48' ' ' THR . 4.1 t80 -72.53 102.28 3.2 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.87 HG21 HG21 ' A' ' 40' ' ' ILE . 3.0 mp -80.87 140.76 16.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.843 0.83 . . . . 0.0 111.769 -177.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.573 ' C ' HG23 ' A' ' 45' ' ' VAL . 69.5 p -105.51 -158.83 0.68 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.625 ' N ' HG23 ' A' ' 45' ' ' VAL . 4.2 tp10 -90.55 7.43 39.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.708 -1.245 . . . . 0.0 111.244 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.445 ' ND2' ' HG3' ' A' ' 66' ' ' MET . 2.4 p-10 -127.33 -17.82 4.62 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.723 -1.235 . . . . 0.0 112.625 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.536 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 26.3 mtt -86.1 -17.95 33.69 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.625 -1.297 . . . . 0.0 110.399 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.539 HG21 ' C ' ' A' ' 41' ' ' VAL . 7.6 p -71.49 162.75 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.248 -0.908 . . . . 0.0 111.316 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.481 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 114.31 -16.94 19.52 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.826 ' O ' HG23 ' A' ' 39' ' ' THR . 16.4 m80 -120.5 -81.94 0.64 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.11 -1.229 . . . . 0.0 110.744 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.54 -34.72 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.03 0.919 . . . . 0.0 109.747 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER 176.37 -15.29 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.195 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.926 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.52 -16.46 71.73 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 120.985 -1.072 . . . . 0.0 110.537 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.637 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 1.2 mt-10 . . . . . 0 N--CA 1.497 1.913 0 O-C-N 121.328 -1.101 . . . . 0.0 109.099 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.763 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 121.268 0.556 . . . . 0.0 109.849 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 39' ' ' THR . 12.5 p -111.71 117.15 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.536 -0.728 . . . . 0.0 109.052 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.801 ' CG ' HG23 ' A' ' 33' ' ' THR . 37.2 t70 -46.43 105.2 0.06 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.507 -0.745 . . . . 0.0 111.422 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -67.1 -23.29 65.82 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -66.46 -26.67 67.31 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.899 -0.501 . . . . 0.0 109.955 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.869 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -81.37 -39.19 25.42 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.458 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.869 HD12 ' HG ' ' A' ' 15' ' ' LEU . 5.1 mp -62.22 -41.58 98.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.843 -0.536 . . . . 0.0 109.672 178.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.8 -30.88 6.2 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.741 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB3' HD12 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -90.33 -30.89 17.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.529 -0.732 . . . . 0.0 110.327 179.058 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.074 HG21 ' HE3' ' A' ' 44' ' ' MET . 71.8 t -72.63 -36.05 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.264 -0.897 . . . . 0.0 111.689 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 16' ' ' LEU . 12.2 mt -61.28 -37.66 83.96 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' A' ' 18' ' ' LYS . 3.0 tm-20 -63.2 -39.74 95.51 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.322 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.71 HD23 ' HB2' ' A' ' 27' ' ' GLU . 3.6 mt -74.08 -22.08 59.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.274 -0.891 . . . . 0.0 110.091 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -83.43 -12.33 56.53 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.374 -0.829 . . . . 0.0 109.585 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.49 -39.18 16.53 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.447 -0.783 . . . . 0.0 109.757 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.429 ' HE3' ' HG2' ' A' ' 21' ' ' GLU . 65.3 mttt -97.52 -32.97 11.54 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.457 0.646 . . . . 0.0 109.325 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.74 19.53 19.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.71 ' HB2' HD23 ' A' ' 22' ' ' LEU . 28.8 mt-10 -71.22 140.36 50.42 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.509 -0.995 . . . . 0.0 110.351 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -110.73 76.84 1.0 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.475 -0.766 . . . . 0.0 109.762 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.83 -155.79 0.58 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.512 -0.742 . . . . 0.0 110.418 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.475 ' O ' HD13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -115.51 167.97 10.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.568 -0.707 . . . . 0.0 110.316 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.703 HD11 ' CD1' ' A' ' 22' ' ' LEU . 45.3 mm -126.72 157.99 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.438 -0.789 . . . . 0.0 109.79 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -120.74 130.67 54.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.548 -0.72 . . . . 0.0 110.319 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.801 HG23 ' CG ' ' A' ' 12' ' ' ASP . 18.2 m -119.54 159.82 23.6 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.572 -0.705 . . . . 0.0 110.318 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 19.3 m-90 -145.02 16.57 1.56 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.314 -0.866 . . . . 0.0 111.819 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.62 -152.72 0.07 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.918 -1.114 . . . . 0.0 110.785 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.78 -61.78 1.66 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.072 -1.018 . . . . 0.0 110.067 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.501 ' HG2' ' HD1' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -100.49 43.86 1.04 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.562 -0.711 . . . . 0.0 109.854 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.442 ' CB ' HG21 ' A' ' 33' ' ' THR . 73.1 m -50.5 134.71 23.6 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.396 0.617 . . . . 0.0 111.606 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 69' ' ' HIS . 27.1 m -130.18 161.95 29.98 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.811 -0.555 . . . . 0.0 109.748 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.767 ' CG2' HG12 ' A' ' 62' ' ' ILE . 5.0 mp -85.97 170.28 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.375 -0.828 . . . . 0.0 111.121 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.988 HG23 ' SD ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -135.84 175.45 3.57 Favored Pre-proline 0 N--CA 1.505 2.308 0 O-C-N 121.463 -0.773 . . . . 0.0 110.049 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.791 ' HD2' HG12 ' A' ' 41' ' ' VAL . 47.0 Cg_endo -69.43 -34.61 15.31 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 124.024 1.539 . . . . 0.0 111.719 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.737 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 0.7 OUTLIER -71.87 0.53 8.91 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.298 -0.876 . . . . 0.0 111.171 179.62 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' MET . . . . . 1.074 ' HE3' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -90.15 -3.86 57.63 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.15 -0.969 . . . . 0.0 111.224 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.611 HG23 ' N ' ' A' ' 64' ' ' GLU . 4.4 p -49.1 2.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.6 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 44' ' ' MET . . . -146.15 30.02 1.63 Allowed Glycine 0 N--CA 1.496 2.634 0 O-C-N 119.798 -1.814 . . . . 0.0 110.292 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.499 ' HB2' HD11 ' A' ' 49' ' ' ILE . 5.1 m80 -147.43 155.75 42.23 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.159 -1.201 . . . . 0.0 111.059 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.98 89.35 4.03 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.07 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.845 ' CD1' HD13 ' A' ' 62' ' ' ILE . 2.3 mp -86.64 118.16 32.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.443 -0.786 . . . . 0.0 111.752 -176.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.778 ' HB1' ' HB3' ' A' ' 57' ' ' HIS . . . -78.91 84.85 4.91 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.973 0.892 . . . . 0.0 109.106 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.531 HG21 ' O ' ' A' ' 70' ' ' LYS . 23.0 m -61.97 129.09 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.534 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.5 ' HB2' ' O ' ' A' ' 33' ' ' THR . 26.5 t80 -78.0 106.44 9.86 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.082 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -75.01 13.76 0.63 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.702 -0.624 . . . . 0.0 110.598 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.58 -25.74 20.29 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -140.51 -25.9 0.76 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.617 -0.931 . . . . 0.0 111.24 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -131.96 151.88 51.45 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.778 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 66.5 m80 -93.13 117.48 30.12 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.771 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 21.8 t -106.91 87.46 2.95 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.079 -1.013 . . . . 0.0 109.338 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.55 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.3 Cg_endo -65.69 93.04 0.25 Allowed 'Trans proline' 0 N--CA 1.489 1.254 0 O-C-N 123.952 1.501 . . . . 0.0 109.814 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.687 ' O ' HD12 ' A' ' 62' ' ' ILE . 12.4 m -107.05 125.97 63.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.655 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.408 ' N ' HG23 ' A' ' 48' ' ' THR . 2.8 t80 -71.64 103.52 3.06 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.845 HD13 ' CD1' ' A' ' 49' ' ' ILE . 1.6 mp -56.53 -56.74 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -176.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.536 ' O ' HG22 ' A' ' 62' ' ' ILE . 2.7 m 64.62 178.46 0.18 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -177.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.611 ' N ' HG23 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -86.43 48.91 1.7 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.517 -1.364 . . . . 0.0 111.102 -179.314 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -171.81 -9.09 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.889 -1.132 . . . . 0.0 113.979 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 29.3 mtt -99.63 -23.48 15.04 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.203 -1.56 . . . . 0.0 111.202 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.58 HG21 ' C ' ' A' ' 41' ' ' VAL . 2.7 p -67.76 163.48 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.489 0 O-C-N 121.284 -0.885 . . . . 0.0 112.514 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.501 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 122.75 -11.33 8.89 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.956 177.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.723 ' O ' HG23 ' A' ' 39' ' ' THR . 15.7 m80 -125.14 -83.02 0.64 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.135 1.468 . . . . 0.0 110.77 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.34 -31.22 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.588 0.708 . . . . 0.0 110.258 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.574 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 1.0 OUTLIER 173.62 -15.94 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.709 -179.839 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.02 -18.19 76.19 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.483 ' HG3' ' ND1' ' A' ' 69' ' ' HIS . 23.1 mm-40 . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.291 -1.123 . . . . 0.0 109.184 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.72 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 121.194 0.521 . . . . 0.0 110.034 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.864 HG11 HG13 ' A' ' 41' ' ' VAL . 92.6 t -100.08 110.18 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.294 -0.879 . . . . 0.0 108.872 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.72 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 38.5 t70 -48.42 111.0 0.39 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.405 0.621 . . . . 0.0 111.306 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.35 -23.7 64.73 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -65.61 -28.58 69.22 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.92 -0.488 . . . . 0.0 110.493 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.885 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -77.57 -37.61 50.19 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.498 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.885 HD12 ' HG ' ' A' ' 15' ' ' LEU . 3.8 mp -60.96 -44.4 97.37 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 120.983 0.421 . . . . 0.0 109.946 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.525 ' HG2' ' HE3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -53.9 -25.36 19.81 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.273 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HE3' ' HG2' ' A' ' 17' ' ' GLU . 5.1 mtmt -101.77 -29.67 11.74 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.485 -0.759 . . . . 0.0 110.371 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.781 HG12 ' HA ' ' A' ' 16' ' ' LEU . 1.1 p -75.82 -35.93 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.366 -0.834 . . . . 0.0 111.37 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 16' ' ' LEU . 3.8 pp -62.98 -28.68 70.26 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -71.91 -35.28 69.63 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.452 HD12 HD11 ' A' ' 31' ' ' ILE . 3.3 mt -73.57 -27.26 61.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.651 -0.656 . . . . 0.0 109.753 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -84.93 -17.82 36.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.596 -0.69 . . . . 0.0 109.374 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.33 -38.77 15.94 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.535 -0.728 . . . . 0.0 109.738 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.1 mttm -90.39 -26.34 19.95 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.08 15.14 49.55 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.432 ' HB2' HD22 ' A' ' 22' ' ' LEU . 20.7 mt-10 -80.95 124.93 29.54 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.382 -1.07 . . . . 0.0 110.364 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -98.87 74.15 2.02 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.574 -0.704 . . . . 0.0 109.517 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.413 ' H ' HD13 ' A' ' 22' ' ' LEU . 1.3 ttp180 -108.15 -151.56 0.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.667 -0.645 . . . . 0.0 110.079 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -118.08 153.68 33.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 110.71 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.552 HD13 HG23 ' A' ' 19' ' ' VAL . 2.7 mp -127.26 119.08 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.516 -0.74 . . . . 0.0 109.186 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.522 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 4.7 mptt -84.42 158.82 20.95 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.306 -0.871 . . . . 0.0 111.366 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.694 HG23 ' CG ' ' A' ' 12' ' ' ASP . 15.9 m -141.47 155.97 45.8 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.706 -0.622 . . . . 0.0 109.713 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.498 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 12.0 m-90 -145.76 36.54 1.06 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.225 -0.922 . . . . 0.0 111.404 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -91.91 -95.16 0.13 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.891 -1.131 . . . . 0.0 110.826 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.9 tpt85 -170.2 -63.5 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.084 -1.01 . . . . 0.0 110.514 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -99.27 37.52 1.55 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.267 -0.896 . . . . 0.0 110.007 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.585 ' OG ' HG21 ' A' ' 33' ' ' THR . 35.0 m -40.91 133.74 2.08 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.473 0.654 . . . . 0.0 112.153 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.883 HG23 ' O ' ' A' ' 69' ' ' HIS . 49.1 m -128.54 156.81 42.72 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.902 -0.499 . . . . 0.0 109.821 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.745 HG23 ' SD ' ' A' ' 44' ' ' MET . 1.3 mp -76.98 160.29 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.481 -0.762 . . . . 0.0 111.248 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.864 HG13 HG11 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -132.06 176.5 2.85 Favored Pre-proline 0 N--CA 1.502 2.158 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.158 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 41.7 Cg_endo -65.76 -29.5 50.88 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.906 1.477 . . . . 0.0 110.596 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -77.78 0.75 22.52 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.686 -0.634 . . . . 0.0 110.688 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.745 ' SD ' HG23 ' A' ' 40' ' ' ILE . 2.4 mtt -93.82 -11.62 30.84 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.072 -1.017 . . . . 0.0 111.644 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.739 HG23 ' N ' ' A' ' 64' ' ' GLU . 7.5 p -56.52 4.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.414 ' C ' ' CG ' ' A' ' 47' ' ' HIS . . . -150.29 29.74 1.08 Allowed Glycine 0 N--CA 1.495 2.601 0 O-C-N 119.953 -1.717 . . . . 0.0 110.088 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.498 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 15.1 m80 -147.35 159.22 43.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.168 -1.195 . . . . 0.0 111.338 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.57 84.64 2.99 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 178.176 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.825 ' CD1' HD13 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -84.99 121.09 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.176 -0.953 . . . . 0.0 111.221 -177.465 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.788 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.61 84.17 4.74 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.832 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 51' ' ' VAL . 19.0 m -64.83 130.08 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.4 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.503 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 30.1 t80 -75.34 107.14 7.25 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -84.34 28.01 0.66 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.461 -0.775 . . . . 0.0 110.92 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.11 -36.78 4.09 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -140.69 -20.35 0.82 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.443 -1.033 . . . . 0.0 111.721 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.503 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 10.9 mm-40 -128.82 153.07 47.79 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -177.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.446 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 2.1 m80 -98.7 108.16 20.78 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.788 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 21.8 t -100.86 95.61 4.72 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.144 -0.973 . . . . 0.0 109.469 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.537 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.0 Cg_endo -67.29 93.1 0.35 Allowed 'Trans proline' 0 N--CA 1.488 1.176 0 O-C-N 123.837 1.44 . . . . 0.0 109.423 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.58 ' CG2' HG12 ' A' ' 58' ' ' VAL . 95.9 t -110.36 126.71 67.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.828 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.0 t80 -71.96 104.72 3.61 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.646 HD13 ' HB3' ' A' ' 44' ' ' MET . 2.6 mp -67.37 -50.17 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 2.9 m 65.53 178.7 0.2 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.739 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.1 tm-20 -86.17 61.58 6.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.506 -1.371 . . . . 0.0 109.323 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -162.28 -34.38 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.203 -0.935 . . . . 0.0 112.271 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.75 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 10.3 mtt -99.74 9.29 43.32 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.882 -1.136 . . . . 0.0 112.11 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.474 HG22 ' N ' ' A' ' 68' ' ' GLY . 8.3 p -90.04 162.02 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 120.736 -1.227 . . . . 0.0 112.461 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.474 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 105.56 -16.0 44.98 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.883 ' O ' HG23 ' A' ' 39' ' ' THR . 11.6 m80 -112.45 -88.89 0.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.015 -1.285 . . . . 0.0 110.792 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.3 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 122.437 1.113 . . . . 0.0 109.07 -179.663 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.6 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.8 OUTLIER -179.64 -13.85 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.938 -179.603 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.67 -15.17 77.77 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.75 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 1.5 mm-40 . . . . . 0 N--CA 1.495 1.825 0 O-C-N 121.36 -1.082 . . . . 0.0 108.824 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.671 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.12 0.486 . . . . 0.0 109.857 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.655 HG11 HG13 ' A' ' 41' ' ' VAL . 91.8 t -95.41 106.1 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 108.566 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.671 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 32.6 t70 -46.35 110.81 0.3 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.375 0.607 . . . . 0.0 111.404 -178.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 16' ' ' LEU . 9.5 t70 -67.31 -23.1 65.61 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -63.56 -33.68 76.13 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.912 -0.492 . . . . 0.0 110.31 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.928 HD11 ' SD ' ' A' ' 44' ' ' MET . 0.3 OUTLIER -80.28 -38.1 31.49 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.834 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.0 mp -61.49 -40.8 95.88 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.61 -31.33 15.68 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -89.13 -32.43 17.51 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.665 -0.647 . . . . 0.0 110.089 178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.778 HG22 HD13 ' A' ' 31' ' ' ILE . 78.7 t -68.46 -38.24 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.303 -0.873 . . . . 0.0 111.156 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 16' ' ' LEU . 11.0 mt -61.76 -37.71 85.3 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -64.52 -35.63 81.57 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.468 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.737 HD22 ' HB2' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -75.07 -25.18 58.41 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.479 -0.763 . . . . 0.0 109.866 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -84.48 -11.2 56.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.439 -0.788 . . . . 0.0 109.94 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.18 -37.35 15.09 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 121.348 -0.845 . . . . 0.0 109.927 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -100.71 -24.72 14.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.641 -0.662 . . . . 0.0 109.714 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.53 29.67 8.63 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.737 ' HB2' HD22 ' A' ' 22' ' ' LEU . 14.5 mt-10 -79.77 125.92 30.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.498 -1.001 . . . . 0.0 110.241 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -106.64 63.18 0.64 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.455 -0.778 . . . . 0.0 109.677 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.27 -153.17 0.51 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.519 -0.738 . . . . 0.0 110.116 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.663 HD12 ' HB3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -118.02 147.87 42.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.385 -0.822 . . . . 0.0 110.725 -179.638 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.778 HD13 HG22 ' A' ' 19' ' ' VAL . 2.9 mp -118.52 116.25 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.607 -0.683 . . . . 0.0 109.735 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.618 ' HE2' HD11 ' A' ' 30' ' ' LEU . 29.2 mmtt -75.96 154.32 35.97 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.528 -0.732 . . . . 0.0 110.725 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.641 HG23 ' OD2' ' A' ' 12' ' ' ASP . 97.4 m -135.78 158.44 44.38 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.48 -0.762 . . . . 0.0 110.305 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.419 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 10.4 m-90 -147.5 38.04 0.93 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.387 -0.821 . . . . 0.0 111.155 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 93.0 p -94.81 -132.11 0.17 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.96 -1.087 . . . . 0.0 110.774 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.4 mtt85 -132.91 -64.23 0.75 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.986 -1.071 . . . . 0.0 110.317 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 mpp_? -97.99 40.92 1.15 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.432 -0.793 . . . . 0.0 110.098 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.595 ' OG ' HG21 ' A' ' 33' ' ' THR . 0.4 OUTLIER -40.2 125.78 2.08 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.528 0.68 . . . . 0.0 112.452 -179.494 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.829 HG23 ' O ' ' A' ' 69' ' ' HIS . 71.1 m -128.88 155.86 44.59 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.789 ' CG2' HG12 ' A' ' 62' ' ' ILE . 5.2 mp -86.76 168.89 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.406 -0.809 . . . . 0.0 111.457 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.904 HG23 ' HG3' ' A' ' 44' ' ' MET . 0.0 OUTLIER -136.51 171.84 8.02 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.645 -0.659 . . . . 0.0 110.167 179.469 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 42.7 Cg_endo -66.64 -32.78 37.63 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 124.239 1.652 . . . . 0.0 111.249 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.402 ' HG3' HG11 ' A' ' 19' ' ' VAL . 12.0 pt-20 -69.27 -5.51 23.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.559 -0.713 . . . . 0.0 110.711 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.928 ' SD ' HD11 ' A' ' 15' ' ' LEU . 1.3 mmm -91.83 -0.57 57.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.188 -0.945 . . . . 0.0 111.311 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.721 HG23 ' N ' ' A' ' 64' ' ' GLU . 6.6 p -53.55 7.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.42 ' C ' ' CG ' ' A' ' 47' ' ' HIS . . . -148.67 29.44 1.29 Allowed Glycine 0 N--CA 1.496 2.7 0 O-C-N 119.895 -1.753 . . . . 0.0 110.33 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.623 ' HB2' HD11 ' A' ' 49' ' ' ILE . 6.9 m80 -148.1 155.91 42.0 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.205 -1.174 . . . . 0.0 111.193 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.485 HG23 ' N ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -101.04 90.96 4.35 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 177.855 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.778 ' CD1' HD13 ' A' ' 62' ' ' ILE . 2.5 mp -88.84 121.05 38.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.593 -176.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.757 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.56 81.63 4.87 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.824 0.821 . . . . 0.0 109.238 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.1 m -61.41 135.3 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.963 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.492 ' HB2' ' O ' ' A' ' 33' ' ' THR . 18.5 t80 -80.21 106.96 12.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.364 -0.835 . . . . 0.0 109.497 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -71.13 -0.98 10.86 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.569 -0.707 . . . . 0.0 110.329 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.84 -22.61 8.07 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 107.693 -2.163 . . . . 0.0 107.693 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -140.21 -28.18 0.73 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.985 -0.715 . . . . 0.0 111.158 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.58 155.27 47.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.235 -0.916 . . . . 0.0 112.2 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.491 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 19.4 m-70 -99.92 110.4 22.74 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.757 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 24.9 t -97.71 96.99 3.64 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.239 -0.913 . . . . 0.0 109.943 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.663 ' HB3' HD12 ' A' ' 30' ' ' LEU . 41.7 Cg_endo -66.68 92.41 0.3 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 O-C-N 123.906 1.477 . . . . 0.0 109.615 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.646 ' O ' HD12 ' A' ' 62' ' ' ILE . 12.9 m -103.92 125.19 58.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.613 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.485 ' N ' HG23 ' A' ' 48' ' ' THR . 2.6 t80 -72.66 103.09 3.48 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.789 HG12 ' CG2' ' A' ' 40' ' ' ILE . 1.5 mp -55.98 -61.63 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -176.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.522 ' O ' HG22 ' A' ' 62' ' ' ILE . 2.6 m 65.41 174.42 0.22 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -176.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.721 ' N ' HG23 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -85.38 58.79 5.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.357 -1.464 . . . . 0.0 109.976 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -171.57 -25.94 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.94 -1.1 . . . . 0.0 113.27 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.5 mmm -89.2 -25.43 21.78 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.558 -1.339 . . . . 0.0 111.097 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.573 HG21 ' C ' ' A' ' 41' ' ' VAL . 3.3 p -67.02 163.09 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 121.331 -0.855 . . . . 0.0 112.561 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.509 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 118.83 -13.57 11.59 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.756 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.829 ' O ' HG23 ' A' ' 39' ' ' THR . 20.3 m80 -123.06 -83.56 0.66 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 119.037 1.418 . . . . 0.0 110.724 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.776 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.2 -30.93 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.671 0.748 . . . . 0.0 110.48 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.611 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.9 OUTLIER 174.12 -14.98 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.272 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.809 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.99 -18.46 74.54 Favored Glycine 0 N--CA 1.496 2.647 0 O-C-N 120.982 -1.074 . . . . 0.0 110.423 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.609 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 2.0 mt-10 . . . . . 0 N--CA 1.497 1.88 0 O-C-N 121.237 -1.155 . . . . 0.0 109.262 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.717 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.208 0.528 . . . . 0.0 109.958 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.788 HG21 HG13 ' A' ' 41' ' ' VAL . 14.4 p -102.12 109.61 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.83 . . . . 0.0 108.77 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.717 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 38.8 t70 -46.06 111.59 0.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.624 -0.673 . . . . 0.0 111.803 -178.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.416 ' HA ' HD13 ' A' ' 16' ' ' LEU . 7.7 t70 -68.3 -24.2 64.83 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -64.92 -28.38 69.49 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.853 -0.53 . . . . 0.0 109.78 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.772 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -77.67 -34.98 52.81 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.211 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.783 HD11 ' CG1' ' A' ' 41' ' ' VAL . 3.8 mp -62.3 -47.28 84.97 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.048 0.451 . . . . 0.0 109.902 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.44 -23.04 5.39 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.737 -0.602 . . . . 0.0 110.445 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.567 ' O ' HD12 ' A' ' 22' ' ' LEU . 8.8 mmtm -102.58 -30.84 10.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.301 -0.874 . . . . 0.0 111.045 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.712 HG12 ' HA ' ' A' ' 16' ' ' LEU . 1.4 p -78.13 -39.86 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.191 -0.943 . . . . 0.0 111.274 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.464 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 12.6 mt -63.25 -36.84 85.0 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.89 -38.88 83.5 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.271 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.581 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 3.2 mt -73.42 -24.67 60.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.119 -0.988 . . . . 0.0 110.197 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -80.71 -10.4 59.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.522 -0.736 . . . . 0.0 109.59 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.19 -35.58 23.42 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 121.498 -0.751 . . . . 0.0 109.707 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.581 ' HE3' ' HA ' ' A' ' 22' ' ' LEU . 7.4 pttt -102.3 -29.57 11.59 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.533 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.59 28.35 7.54 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.536 ' HB2' ' HE3' ' A' ' 25' ' ' LYS . 2.6 mt-10 -90.9 134.61 34.33 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.467 -1.019 . . . . 0.0 110.382 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -100.04 76.45 1.93 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.463 -0.773 . . . . 0.0 109.357 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.98 -154.55 0.54 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.51 -0.743 . . . . 0.0 110.212 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -118.99 161.1 20.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.453 -0.779 . . . . 0.0 110.763 -179.78 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.552 ' CD1' HG23 ' A' ' 19' ' ' VAL . 2.9 mp -132.77 112.42 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.535 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -85.69 152.69 22.88 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.55 -0.718 . . . . 0.0 111.186 -178.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.627 HG23 ' CG ' ' A' ' 12' ' ' ASP . 8.5 m -134.87 163.21 30.34 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.925 -0.484 . . . . 0.0 110.279 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.474 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 16.0 m-90 -146.73 37.06 0.97 Allowed 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.289 -0.882 . . . . 0.0 110.854 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.0 t -94.74 -126.63 0.12 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.077 -1.015 . . . . 0.0 110.779 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.14 -59.68 0.78 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.827 -1.171 . . . . 0.0 110.822 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -98.36 35.61 1.75 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.322 -0.861 . . . . 0.0 110.605 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.555 ' OG ' HG21 ' A' ' 33' ' ' THR . 4.5 m -36.06 123.9 0.74 Allowed 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.31 0.576 . . . . 0.0 111.942 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.839 HG23 ' O ' ' A' ' 69' ' ' HIS . 27.5 m -128.32 162.27 27.46 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.546 -0.721 . . . . 0.0 110.569 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.874 HG22 ' HG2' ' A' ' 44' ' ' MET . 1.9 mt -66.58 165.01 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 O-C-N 121.631 -0.668 . . . . 0.0 110.861 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.788 HG13 HG21 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -123.45 -171.41 0.22 Allowed Pre-proline 0 N--CA 1.505 2.312 0 O-C-N 121.362 -0.836 . . . . 0.0 110.14 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.575 ' HD3' HG12 ' A' ' 41' ' ' VAL . 57.7 Cg_endo -87.75 -31.19 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.657 1.346 . . . . 0.0 111.098 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -90.05 15.47 10.07 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.536 -0.727 . . . . 0.0 111.056 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.874 ' HG2' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -94.43 4.84 53.34 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.17 -0.956 . . . . 0.0 111.798 -179.695 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.754 HG13 ' N ' ' A' ' 64' ' ' GLU . 39.5 t -57.46 -2.83 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.477 ' HA2' ' CE1' ' A' ' 61' ' ' TYR . . . -150.77 34.08 0.96 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.533 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 37.0 m80 -138.49 152.67 48.48 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.221 -1.164 . . . . 0.0 110.938 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.727 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.29 80.82 2.47 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.946 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.621 HD12 ' CD1' ' A' ' 62' ' ' ILE . 9.2 mt -78.09 117.35 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.182 -0.949 . . . . 0.0 110.915 -177.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.755 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.42 80.07 4.83 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.772 0.796 . . . . 0.0 108.99 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 51' ' ' VAL . 31.8 m -57.87 127.12 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.181 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.502 ' HB2' ' O ' ' A' ' 33' ' ' THR . 14.9 t80 -75.76 105.99 7.1 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.196 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -69.61 -0.8 7.36 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.577 -0.702 . . . . 0.0 110.429 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.03 -20.71 9.73 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 107.839 -2.104 . . . . 0.0 107.839 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -140.1 -29.22 0.71 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.957 -0.731 . . . . 0.0 110.974 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.53 154.82 48.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.243 -0.911 . . . . 0.0 112.029 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.488 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 5.0 m80 -100.59 106.04 17.51 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.755 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 40.4 t -94.98 99.93 4.89 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.206 -0.934 . . . . 0.0 109.804 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.505 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.7 Cg_endo -66.54 92.39 0.29 Allowed 'Trans proline' 0 N--CA 1.49 1.304 0 O-C-N 123.904 1.476 . . . . 0.0 109.598 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 58' ' ' VAL . 94.0 t -98.39 116.59 41.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.75 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.727 ' HB2' HG23 ' A' ' 48' ' ' THR . 6.2 t80 -73.03 108.77 6.11 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.869 HD13 ' HB2' ' A' ' 44' ' ' MET . 2.4 mp -92.72 159.89 2.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.884 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.617 HG22 ' H ' ' A' ' 64' ' ' GLU . 3.1 m -129.83 -159.81 0.99 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 177.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.754 ' N ' HG13 ' A' ' 45' ' ' VAL . 3.2 tt0 -90.25 47.75 1.48 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.242 -1.536 . . . . 0.0 110.412 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -156.58 -34.23 0.08 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.973 -1.079 . . . . 0.0 112.675 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.662 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 71.3 mtm -85.86 5.01 34.74 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.999 -1.063 . . . . 0.0 111.546 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.553 ' HA ' HD13 ' A' ' 40' ' ' ILE . 7.5 p -83.99 166.2 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 120.893 -1.129 . . . . 0.0 111.767 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.539 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 106.5 -21.7 32.19 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.839 ' O ' HG23 ' A' ' 39' ' ' THR . 13.0 m80 -112.27 -86.87 0.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.121 -1.223 . . . . 0.0 111.003 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.619 ' HD3' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER 177.61 -36.27 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 122.273 1.035 . . . . 0.0 109.278 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.619 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -178.98 -15.33 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.998 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.83 -15.3 73.7 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.662 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 1.5 mm-40 . . . . . 0 N--CA 1.497 1.885 0 O-C-N 121.44 -1.035 . . . . 0.0 108.773 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.646 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 121.316 0.579 . . . . 0.0 110.309 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.072 HG21 HG13 ' A' ' 41' ' ' VAL . 9.9 p -113.63 118.9 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.753 ' HB3' HD23 ' A' ' 15' ' ' LEU . 38.8 t70 -43.81 105.87 0.06 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.618 -0.676 . . . . 0.0 111.604 -178.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -68.04 -21.35 65.02 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -66.84 -28.41 68.33 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 122.007 -0.433 . . . . 0.0 110.49 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.901 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -76.85 -37.32 55.83 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.709 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.901 HD12 ' HG ' ' A' ' 15' ' ' LEU . 3.9 mp -60.75 -44.21 96.98 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.97 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.412 ' HA ' HD21 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -55.74 -25.07 38.75 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.196 179.141 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -102.31 -31.39 10.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.453 -0.78 . . . . 0.0 110.67 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.756 HG12 ' HA ' ' A' ' 16' ' ' LEU . 1.4 p -71.8 -37.3 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.287 -0.883 . . . . 0.0 111.021 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.478 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.0 pp -64.47 -28.2 69.5 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.84 -31.96 65.13 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.496 HD22 ' HB2' ' A' ' 27' ' ' GLU . 1.4 mt -76.92 -22.08 53.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.609 -0.682 . . . . 0.0 109.582 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -84.76 -19.6 32.37 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.496 -0.753 . . . . 0.0 109.716 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.14 -39.13 17.02 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 121.504 -0.748 . . . . 0.0 109.908 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -90.71 -25.3 20.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.672 -0.643 . . . . 0.0 109.533 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.36 16.61 49.25 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB2' HD22 ' A' ' 22' ' ' LEU . 1.5 mt-10 -75.41 128.35 35.15 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.514 -0.991 . . . . 0.0 110.477 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.0 mtmm -115.13 50.89 0.95 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.551 -0.718 . . . . 0.0 109.513 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.7 ttp-105 -88.31 -92.2 0.11 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.57 -0.706 . . . . 0.0 110.411 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.784 HD12 ' HB3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -170.9 146.25 2.5 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.118 -0.989 . . . . 0.0 110.674 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.583 HD13 HD11 ' A' ' 49' ' ' ILE . 2.8 mt -115.26 119.07 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.727 ' HD3' HD11 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -79.63 151.05 30.79 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.437 -0.789 . . . . 0.0 111.543 -178.63 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.733 HG23 ' CG ' ' A' ' 12' ' ' ASP . 27.4 m -137.6 155.3 49.34 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.601 -0.687 . . . . 0.0 110.353 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.531 ' CH2' ' HB2' ' A' ' 32' ' ' LYS . 17.5 m-90 -146.02 29.53 1.09 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.299 -0.876 . . . . 0.0 111.601 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -82.9 -98.14 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.812 -1.18 . . . . 0.0 110.592 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -174.29 -61.59 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.215 -0.928 . . . . 0.0 109.558 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.19 42.7 1.09 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.628 ' OG ' HG21 ' A' ' 33' ' ' THR . 2.5 m -50.9 133.9 26.22 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.525 0.679 . . . . 0.0 111.923 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.849 HG23 ' O ' ' A' ' 69' ' ' HIS . 20.6 m -127.25 161.54 28.31 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.856 ' HA ' ' HE3' ' A' ' 44' ' ' MET . 1.1 mp -80.56 162.15 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.291 -0.88 . . . . 0.0 111.566 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.072 HG13 HG21 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -129.3 169.58 12.83 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 121.701 -0.624 . . . . 0.0 110.011 178.814 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.449 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 43.7 Cg_endo -67.5 -31.72 33.31 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.262 1.664 . . . . 0.0 110.918 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.697 ' HG3' HG11 ' A' ' 19' ' ' VAL . 2.3 pt-20 -80.16 5.69 13.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.482 -0.761 . . . . 0.0 110.926 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.856 ' HE3' ' HA ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -98.12 -5.74 33.04 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.287 -0.883 . . . . 0.0 111.448 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.627 HG13 ' N ' ' A' ' 64' ' ' GLU . 61.8 t -48.29 -6.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.516 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA2' ' CE1' ' A' ' 61' ' ' TYR . . . -144.72 38.97 1.24 Allowed Glycine 0 N--CA 1.491 2.344 0 O-C-N 120.186 -1.571 . . . . 0.0 109.221 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 49.6 m-70 -143.08 147.35 34.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.508 -0.995 . . . . 0.0 111.183 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.81 80.93 2.39 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 177.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.886 ' CD1' HD13 ' A' ' 15' ' ' LEU . 1.5 mt -85.19 124.1 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.391 -0.818 . . . . 0.0 111.347 -176.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.786 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -77.78 80.28 4.24 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 51' ' ' VAL . 27.2 m -61.08 130.47 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.057 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.446 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 30.5 t80 -78.27 105.88 9.81 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.236 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -69.91 0.0 6.59 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.618 -0.677 . . . . 0.0 110.6 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.67 -18.87 10.65 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 107.913 -2.075 . . . . 0.0 107.913 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -140.1 -28.57 0.73 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.938 -0.742 . . . . 0.0 110.884 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -135.86 155.32 50.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.226 -0.921 . . . . 0.0 112.015 -178.353 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.413 ' CE1' ' CD1' ' A' ' 34' ' ' TRP . 1.1 m-70 -101.57 105.43 16.39 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.786 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 21.9 t -95.35 102.29 9.42 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.217 -0.927 . . . . 0.0 110.051 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.784 ' HB3' HD12 ' A' ' 30' ' ' LEU . 40.3 Cg_endo -66.64 91.96 0.3 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.916 1.482 . . . . 0.0 109.006 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.537 HG23 HG12 ' A' ' 58' ' ' VAL . 79.1 t -108.21 126.75 64.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.938 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.5 t80 -72.88 110.89 7.53 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 176.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.717 HG12 ' CG2' ' A' ' 40' ' ' ILE . 1.7 mp -62.71 -56.77 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.642 -0.661 . . . . 0.0 112.732 -177.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 3.5 m 68.79 162.39 0.21 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -177.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.627 ' N ' HG13 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -78.93 62.76 3.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.639 -1.288 . . . . 0.0 109.451 -179.398 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -167.53 -32.85 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.317 -0.864 . . . . 0.0 112.271 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.717 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 2.8 mtt -98.07 8.49 44.69 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.79 -1.194 . . . . 0.0 111.85 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 68' ' ' GLY . 8.2 p -90.22 162.62 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 120.757 -1.214 . . . . 0.0 112.214 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.481 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 106.69 -16.82 39.96 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.849 ' O ' HG23 ' A' ' 39' ' ' THR . 11.6 m80 -112.86 -88.44 0.54 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.12 -1.223 . . . . 0.0 110.726 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.09 -35.64 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 122.394 1.092 . . . . 0.0 109.02 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.621 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -178.74 -14.93 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.973 -179.587 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.41 -14.75 77.17 Favored Glycine 0 N--CA 1.498 2.771 0 O-C-N 120.797 -1.189 . . . . 0.0 110.281 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.717 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 1.8 mm-40 . . . . . 0 N--CA 1.496 1.858 0 O-C-N 121.356 -1.085 . . . . 0.0 108.686 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.542 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 1.7 t80 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.499 0.666 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.661 HG21 HG13 ' A' ' 41' ' ' VAL . 3.5 p -137.17 119.75 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.785 ' HB2' HD23 ' A' ' 15' ' ' LEU . 34.1 m-20 -23.62 99.97 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 CA-C-O 121.046 0.45 . . . . 0.0 112.142 -178.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.2 -26.4 63.86 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.728 ' CB ' HG23 ' A' ' 33' ' ' THR . 0.1 OUTLIER -76.07 -14.04 60.2 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 120.99 0.424 . . . . 0.0 110.148 178.64 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.042 HD11 ' SD ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -87.01 -35.33 18.86 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.645 ' HA ' HG12 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -70.56 -43.93 68.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.745 -0.597 . . . . 0.0 110.01 178.858 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.64 ' HG2' ' HA ' ' A' ' 14' ' ' HIS . 0.6 OUTLIER -53.08 -19.73 3.05 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.8 179.408 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.472 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 17.6 mttt -106.39 -32.56 8.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.347 -0.846 . . . . 0.0 110.146 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.96 HG21 ' SD ' ' A' ' 44' ' ' MET . 0.5 OUTLIER -73.57 -40.66 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.403 -0.811 . . . . 0.0 111.153 -179.726 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.511 HD21 ' HA ' ' A' ' 17' ' ' GLU . 3.8 pp -60.52 -26.27 66.74 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.57 -36.24 52.27 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 27' ' ' GLU . 0.9 OUTLIER -72.22 -28.49 63.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.591 -0.693 . . . . 0.0 109.637 178.92 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -83.56 -11.33 57.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.581 -0.699 . . . . 0.0 109.599 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.0 -37.22 14.47 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 121.588 -0.695 . . . . 0.0 110.002 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.477 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 4.6 ptmt -96.56 -23.92 16.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.611 -0.681 . . . . 0.0 109.84 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.32 29.45 7.5 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.477 ' HG3' ' HE2' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -92.98 129.08 39.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.427 -1.043 . . . . 0.0 110.685 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -107.25 70.63 0.8 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.593 -0.692 . . . . 0.0 109.226 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.34 -152.76 0.5 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.656 -0.653 . . . . 0.0 110.006 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -114.05 155.79 25.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.421 -0.799 . . . . 0.0 110.354 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.567 HG21 ' O ' ' A' ' 15' ' ' LEU . 5.8 mt -135.06 116.32 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.498 -0.751 . . . . 0.0 109.346 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -103.33 148.37 25.94 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.277 -0.889 . . . . 0.0 110.891 -179.45 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.728 HG23 ' CB ' ' A' ' 14' ' ' HIS . 56.6 m -137.91 156.78 47.53 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.579 -0.701 . . . . 0.0 110.177 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.506 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 19.9 m-90 -118.57 44.93 2.15 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.681 -0.637 . . . . 0.0 110.057 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 10' ' ' PHE . 66.1 m -83.79 -167.24 1.65 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.289 -0.882 . . . . 0.0 111.004 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -102.11 -61.88 1.33 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.436 -0.79 . . . . 0.0 110.341 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.33 41.32 1.07 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.355 -0.841 . . . . 0.0 109.636 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 63.1 m -37.75 105.44 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.808 HG23 ' O ' ' A' ' 69' ' ' HIS . 44.6 m -122.35 159.7 26.92 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.684 -0.635 . . . . 0.0 109.316 178.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.866 ' CG2' HG12 ' A' ' 62' ' ' ILE . 4.8 mp -90.08 168.92 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.408 -0.807 . . . . 0.0 111.705 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.676 HG23 ' HE3' ' A' ' 44' ' ' MET . 0.1 OUTLIER -139.56 174.6 3.93 Favored Pre-proline 0 N--CA 1.505 2.306 0 O-C-N 121.79 -0.569 . . . . 0.0 109.787 179.443 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.565 ' HD2' HG12 ' A' ' 41' ' ' VAL . 42.8 Cg_endo -65.61 -33.53 45.05 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 124.116 1.588 . . . . 0.0 111.198 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.75 -12.43 23.97 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.597 -0.69 . . . . 0.0 110.578 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' MET . . . . . 1.042 ' SD ' HD11 ' A' ' 15' ' ' LEU . 6.2 mmt -87.09 -4.8 59.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.364 -0.835 . . . . 0.0 111.909 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.526 HG23 ' N ' ' A' ' 64' ' ' GLU . 7.5 p -51.11 1.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.475 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.408 ' C ' ' CG ' ' A' ' 47' ' ' HIS . . . -146.27 31.01 1.58 Allowed Glycine 0 N--CA 1.495 2.62 0 O-C-N 119.918 -1.739 . . . . 0.0 110.28 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.408 ' CG ' ' C ' ' A' ' 46' ' ' GLY . 17.9 m-70 -147.88 156.55 42.82 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.217 -1.167 . . . . 0.0 111.315 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.69 88.73 3.9 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.677 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.938 HD12 HD13 ' A' ' 62' ' ' ILE . 2.6 mt -86.69 119.31 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.178 -0.951 . . . . 0.0 112.019 -176.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.725 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.87 86.81 5.36 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 122.15 0.976 . . . . 0.0 109.193 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.1 m -71.25 134.8 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.232 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.551 ' HB2' ' O ' ' A' ' 33' ' ' THR . 28.5 t80 -75.2 105.58 6.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.342 -0.849 . . . . 0.0 108.886 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -71.46 0.03 9.28 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.53 -0.731 . . . . 0.0 110.801 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.41 -22.48 7.84 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -140.36 -28.84 0.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 122.016 -0.697 . . . . 0.0 110.79 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.21 156.22 49.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.266 -0.896 . . . . 0.0 111.988 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.526 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 93.6 m-70 -101.83 108.31 19.76 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.725 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 22.0 t -94.3 101.5 6.66 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.308 -0.87 . . . . 0.0 110.008 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.52 ' O ' HG22 ' A' ' 48' ' ' THR . 43.0 Cg_endo -68.85 94.0 0.45 Allowed 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.933 1.491 . . . . 0.0 108.96 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.687 ' O ' HD12 ' A' ' 62' ' ' ILE . 15.0 m -106.36 126.93 62.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.217 -178.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 0.5 OUTLIER -69.5 104.32 2.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 176.841 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.938 HD13 HD12 ' A' ' 49' ' ' ILE . 1.3 mp -60.2 -53.22 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.602 ' O ' HG22 ' A' ' 62' ' ' ILE . 1.3 p 59.6 -175.63 0.1 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.526 ' N ' HG23 ' A' ' 45' ' ' VAL . 3.2 tp10 -90.41 43.51 1.15 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.486 -1.384 . . . . 0.0 109.941 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -150.92 -29.11 0.2 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.948 -1.095 . . . . 0.0 113.464 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.516 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 5.9 mtt -89.29 -23.18 22.36 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.527 -1.358 . . . . 0.0 111.435 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.652 HG21 ' C ' ' A' ' 41' ' ' VAL . 2.7 p -67.01 160.14 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.077 -1.015 . . . . 0.0 112.459 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.452 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 114.62 -13.56 20.48 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.869 -0.682 . . . . 0.0 111.586 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.808 ' O ' HG23 ' A' ' 39' ' ' THR . 25.7 m80 -121.98 -83.8 0.66 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.912 1.356 . . . . 0.0 110.853 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.687 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.88 -30.98 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 121.661 0.743 . . . . 0.0 110.326 -179.597 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.597 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 1.3 pp 173.12 -14.18 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.767 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.29 -18.99 73.82 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.555 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 2.6 mt-10 . . . . . 0 N--CA 1.497 1.909 0 O-C-N 121.355 -1.085 . . . . 0.0 109.24 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.713 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.329 0.585 . . . . 0.0 110.177 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 39' ' ' THR . 13.6 p -116.01 119.08 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.969 ' HB3' HD23 ' A' ' 15' ' ' LEU . 5.1 t70 -44.55 103.9 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.686 -0.634 . . . . 0.0 111.161 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.86 -22.1 65.14 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.16 -29.99 63.25 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.977 -0.452 . . . . 0.0 110.253 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.969 HD23 ' HB3' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -78.25 -38.68 42.24 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.277 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.744 HD12 ' HG ' ' A' ' 15' ' ' LEU . 2.9 mp -58.92 -42.98 90.98 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.309 0.576 . . . . 0.0 109.584 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.571 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -56.01 -23.75 34.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.806 -0.558 . . . . 0.0 109.943 179.257 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.4 -29.82 12.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.497 -0.752 . . . . 0.0 110.592 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.691 HG21 ' CB ' ' A' ' 44' ' ' MET . 2.3 p -73.96 -38.05 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.186 -0.946 . . . . 0.0 111.02 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.571 HD21 ' HA ' ' A' ' 17' ' ' GLU . 4.1 pp -61.75 -26.63 68.19 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -69.61 -34.06 73.55 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.696 HD13 ' HD3' ' A' ' 25' ' ' LYS . 3.6 mm? -74.13 -26.56 60.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.621 -0.674 . . . . 0.0 109.369 178.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -82.13 -13.44 57.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.598 -0.689 . . . . 0.0 109.674 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.37 -33.61 21.96 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.505 -0.747 . . . . 0.0 110.095 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.696 ' HD3' HD13 ' A' ' 22' ' ' LEU . 2.1 ptmt -92.01 -17.08 25.6 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.61 -0.682 . . . . 0.0 109.714 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.37 32.43 11.93 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.505 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -114.39 128.56 56.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.527 -0.984 . . . . 0.0 110.743 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.78 80.79 2.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.597 -0.69 . . . . 0.0 109.588 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.82 -147.84 0.39 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.55 -0.719 . . . . 0.0 109.848 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.528 ' O ' HD13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -121.27 154.05 36.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 110.203 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.848 ' HB ' HD13 ' A' ' 49' ' ' ILE . 28.0 mm -118.79 154.22 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.328 -0.857 . . . . 0.0 110.057 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.509 ' HE2' HD11 ' A' ' 30' ' ' LEU . 1.6 mmtp -102.76 137.09 41.43 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.667 -0.646 . . . . 0.0 110.345 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.67 HG23 ' CB ' ' A' ' 12' ' ' ASP . 9.6 m -124.45 150.28 45.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.572 -0.705 . . . . 0.0 109.806 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.635 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 1.4 m-90 -145.69 38.56 1.12 Allowed 'General case' 0 N--CA 1.51 2.563 0 O-C-N 121.067 -1.021 . . . . 0.0 112.652 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -100.57 -97.5 0.25 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.467 -1.395 . . . . 0.0 110.702 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.4 ' HG2' ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -169.83 -60.02 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.094 -1.004 . . . . 0.0 109.346 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.54 35.16 2.53 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.8 m -51.48 138.9 21.16 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.529 0.68 . . . . 0.0 111.742 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.783 ' O ' HG23 ' A' ' 11' ' ' VAL . 3.0 m -133.79 165.91 23.87 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.859 -0.526 . . . . 0.0 109.836 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.874 HG22 HG23 ' A' ' 67' ' ' VAL . 5.0 mp -86.2 161.49 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.199 -0.938 . . . . 0.0 110.551 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.695 HG23 ' HG2' ' A' ' 44' ' ' MET . 0.0 OUTLIER -141.1 176.23 2.59 Favored Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 121.672 -0.643 . . . . 0.0 109.686 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.651 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 38.3 Cg_endo -62.86 -28.77 75.86 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.137 1.598 . . . . 0.0 109.595 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -66.79 -10.64 49.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.847 -0.533 . . . . 0.0 110.864 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.966 ' HE1' HD21 ' A' ' 15' ' ' LEU . 1.9 ptp -140.19 44.21 1.89 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.814 -1.179 . . . . 0.0 112.324 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.832 ' CG1' ' HA ' ' A' ' 64' ' ' GLU . 3.2 t -91.49 27.96 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.819 -1.176 . . . . 0.0 110.938 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.66 24.74 0.94 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 12.6 m-70 -139.55 167.81 21.26 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.235 -1.156 . . . . 0.0 110.533 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.666 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -98.96 81.62 2.63 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 178.394 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.848 HD13 ' HB ' ' A' ' 31' ' ' ILE . 1.1 mm -79.37 112.47 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.673 -0.642 . . . . 0.0 110.929 -177.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.782 ' HB1' ' HB3' ' A' ' 57' ' ' HIS . . . -77.8 80.83 4.24 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.969 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.433 HG22 ' HB ' ' A' ' 58' ' ' VAL . 33.4 m -57.58 138.29 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.879 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.635 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 19.7 t80 -80.67 108.0 13.95 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.565 -0.854 . . . . 0.0 108.983 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -76.57 15.45 0.62 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.769 -0.582 . . . . 0.0 110.247 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.4 ' HA2' ' HG2' ' A' ' 36' ' ' ARG . . . 106.81 -29.3 11.03 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.0 pttt -140.57 -27.37 0.73 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.636 -0.92 . . . . 0.0 111.188 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -126.41 156.15 41.03 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.782 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 8.1 m80 -94.9 115.82 27.94 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.745 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 46.2 t -103.81 90.64 2.99 Favored Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 121.157 -0.965 . . . . 0.0 109.337 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.549 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.8 Cg_endo -65.42 89.47 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 O-C-N 124.019 1.536 . . . . 0.0 110.301 -178.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.665 HG11 ' HA ' ' A' ' 71' ' ' LEU . 5.3 m -94.67 110.04 23.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.268 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.666 ' HB2' HG23 ' A' ' 48' ' ' THR . 0.6 OUTLIER -69.39 95.28 0.79 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.792 -1.163 . . . . 0.0 108.222 178.514 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.731 HG21 HG21 ' A' ' 40' ' ' ILE . 2.7 mp -76.79 127.64 37.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.145 -178.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.628 ' C ' HG12 ' A' ' 45' ' ' VAL . 72.1 p -101.78 158.74 15.9 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.832 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -42.78 -19.61 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.433 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 63' ' ' THR . 10.1 p30 -121.59 29.59 7.12 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.696 -1.253 . . . . 0.0 112.641 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.418 ' HB2' ' H ' ' A' ' 63' ' ' THR . 18.7 mmt -126.72 -19.19 4.57 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.973 -1.079 . . . . 0.0 110.73 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.874 HG23 HG22 ' A' ' 40' ' ' ILE . 13.3 p -65.5 162.61 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.343 -0.848 . . . . 0.0 112.239 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.457 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 120.16 -11.07 10.78 Favored Glycine 0 N--CA 1.491 2.367 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.727 178.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.634 ' O ' HG23 ' A' ' 39' ' ' THR . 6.8 m80 -113.94 -88.29 0.56 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 119.33 1.565 . . . . 0.0 111.015 -178.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.54 -32.29 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.824 0.821 . . . . 0.0 109.785 -179.531 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.665 ' HA ' HG11 ' A' ' 60' ' ' VAL . 1.4 pp 174.03 -11.58 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.788 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.17 -15.01 81.74 Favored Glycine 0 N--CA 1.492 2.372 0 O-C-N 120.827 -1.171 . . . . 0.0 110.418 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.499 ' HG3' ' ND1' ' A' ' 69' ' ' HIS . 12.9 mm-40 . . . . . 0 N--CA 1.495 1.785 0 O-C-N 121.252 -1.146 . . . . 0.0 109.58 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.702 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.181 0.515 . . . . 0.0 110.261 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.636 HG22 HD11 ' A' ' 16' ' ' LEU . 14.8 p -104.42 116.36 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.702 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 28.1 t70 -50.02 105.48 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.482 -0.761 . . . . 0.0 111.014 -178.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -64.82 -24.97 67.71 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -66.83 -31.43 72.05 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.281 0.563 . . . . 0.0 109.511 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.87 HD11 ' SD ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -78.97 -35.42 43.08 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.504 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.636 HD11 HG22 ' A' ' 11' ' ' VAL . 2.7 mp -63.18 -42.95 99.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.689 -0.632 . . . . 0.0 109.558 178.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.559 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -56.35 -22.94 34.27 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.277 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.412 ' O ' HD23 ' A' ' 22' ' ' LEU . 12.2 mttt -99.0 -31.15 11.95 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.503 -0.748 . . . . 0.0 110.602 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.665 HG21 ' HG2' ' A' ' 44' ' ' MET . 1.8 p -73.27 -40.07 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.132 -0.98 . . . . 0.0 110.559 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.559 HD21 ' HA ' ' A' ' 17' ' ' GLU . 4.0 pp -64.14 -25.05 67.92 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -72.89 -33.11 65.84 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 27' ' ' GLU . 2.9 mm? -73.89 -26.96 60.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.43 -0.794 . . . . 0.0 109.238 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -81.74 -14.01 57.04 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.535 -0.728 . . . . 0.0 109.842 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.28 -38.94 21.49 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.525 -0.735 . . . . 0.0 109.078 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.98 -19.81 31.5 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.266 0.555 . . . . 0.0 109.824 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.47 3.32 72.02 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.472 ' O ' HD12 ' A' ' 22' ' ' LEU . 39.9 mt-10 -85.35 148.04 26.23 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.382 -1.07 . . . . 0.0 110.507 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -119.33 94.2 4.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.456 -0.778 . . . . 0.0 109.745 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -117.5 -157.89 0.68 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.49 -0.757 . . . . 0.0 110.45 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.0 OUTLIER -110.84 147.2 35.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.595 -0.691 . . . . 0.0 110.63 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.555 HG21 HD12 ' A' ' 15' ' ' LEU . 2.8 mp -121.87 117.95 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 3.8 mppt? -82.56 159.0 22.88 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.276 -0.89 . . . . 0.0 111.21 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.57 HG23 ' CG ' ' A' ' 12' ' ' ASP . 17.9 m -139.74 158.51 43.99 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.576 -0.703 . . . . 0.0 110.037 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.44 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 11.4 m-90 -146.93 38.77 1.0 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.367 -0.833 . . . . 0.0 111.052 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.7 m -98.05 -109.06 0.17 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.992 -1.067 . . . . 0.0 110.756 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.9 -64.73 0.19 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.912 -1.117 . . . . 0.0 110.366 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 38' ' ' SER . 1.6 mtp180 -92.54 25.63 2.96 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.405 -0.81 . . . . 0.0 110.191 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.444 ' OG ' HG21 ' A' ' 33' ' ' THR . 73.7 m -31.53 116.92 0.18 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.335 0.588 . . . . 0.0 112.466 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.741 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 45.1 m -124.38 159.93 29.28 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.74 -0.6 . . . . 0.0 110.476 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.708 HG21 HG23 ' A' ' 62' ' ' ILE . 5.3 mp -88.63 169.47 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.609 -0.682 . . . . 0.0 110.407 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.835 HG23 ' HG3' ' A' ' 44' ' ' MET . 0.1 OUTLIER -140.07 172.9 5.63 Favored Pre-proline 0 N--CA 1.508 2.458 0 O-C-N 121.176 -0.952 . . . . 0.0 110.945 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.644 ' HD2' HG12 ' A' ' 41' ' ' VAL . 41.8 Cg_endo -66.0 -30.1 48.25 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 124.394 1.734 . . . . 0.0 111.561 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.98 5.03 10.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.497 -0.752 . . . . 0.0 110.461 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.87 ' SD ' HD11 ' A' ' 15' ' ' LEU . 23.1 mtt -111.78 -0.7 15.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 111.411 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.568 HG23 ' N ' ' A' ' 64' ' ' GLU . 2.1 p -41.42 -4.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.923 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 44' ' ' MET . . . -137.71 35.27 2.07 Favored Glycine 0 N--CA 1.495 2.588 0 O-C-N 119.771 -1.831 . . . . 0.0 110.47 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 26.2 m-70 -144.43 153.18 41.64 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.09 -1.241 . . . . 0.0 110.971 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -99.77 92.34 5.27 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.286 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.666 HD13 ' SD ' ' A' ' 44' ' ' MET . 2.6 mt -88.8 120.78 38.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.097 -1.002 . . . . 0.0 111.239 -177.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.751 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -76.31 77.1 3.08 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.986 0.898 . . . . 0.0 109.09 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.654 HG21 ' HB3' ' A' ' 71' ' ' LEU . 33.0 m -56.73 132.25 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.476 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 33' ' ' THR . 19.8 t80 -77.14 104.52 7.69 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.574 -0.85 . . . . 0.0 109.006 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -70.2 0.4 6.37 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.571 -0.706 . . . . 0.0 110.421 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.31 -23.66 7.99 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.52 -28.94 0.7 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 122.051 -0.676 . . . . 0.0 111.136 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.53 155.57 45.55 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.243 -0.911 . . . . 0.0 112.159 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.471 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 6.9 m80 -100.81 104.78 16.03 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.751 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 39.1 t -93.71 101.16 5.53 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.205 -0.934 . . . . 0.0 109.92 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.549 ' O ' HG22 ' A' ' 48' ' ' THR . 40.7 Cg_endo -66.23 90.19 0.26 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 O-C-N 123.909 1.479 . . . . 0.0 109.82 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 60' ' ' VAL . 34.3 m -101.8 127.67 55.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.707 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 4.6 t80 -69.72 111.88 5.8 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 177.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.78 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.4 OUTLIER -51.33 -51.34 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.833 -0.542 . . . . 0.0 111.398 -178.058 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 m 60.88 169.85 0.09 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.363 0.602 . . . . 0.0 109.538 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.568 ' N ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -81.51 2.85 27.12 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.873 -1.142 . . . . 0.0 111.603 -179.313 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -142.51 1.88 1.39 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.83 -1.169 . . . . 0.0 113.038 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.594 ' HB2' ' O ' ' A' ' 62' ' ' ILE . 20.2 mmt -99.95 -15.06 18.45 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.435 -1.415 . . . . 0.0 110.206 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.646 HG23 HG22 ' A' ' 40' ' ' ILE . 13.9 p -74.37 168.73 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.252 -0.905 . . . . 0.0 112.254 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.54 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 114.8 -5.35 22.52 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.701 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.733 ' O ' HG23 ' A' ' 39' ' ' THR . 21.6 m80 -127.57 -85.0 0.6 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 119.289 1.545 . . . . 0.0 110.854 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.741 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.9 -29.29 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.532 0.682 . . . . 0.0 110.088 -179.243 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.654 ' HB3' HG21 ' A' ' 51' ' ' VAL . 2.4 pp 171.58 -17.39 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.309 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.67 -18.76 74.26 Favored Glycine 0 N--CA 1.494 2.549 0 O-C-N 121.083 -1.01 . . . . 0.0 110.802 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.487 ' HG3' ' ND1' ' A' ' 69' ' ' HIS . 23.6 mm-40 . . . . . 0 N--CA 1.497 1.879 0 O-C-N 121.214 -1.168 . . . . 0.0 109.213 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.531 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 1.6 t80 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.592 0.71 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.681 HG21 HG13 ' A' ' 41' ' ' VAL . 6.6 p -134.13 123.58 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.884 ' HB2' HD23 ' A' ' 15' ' ' LEU . 49.0 m-20 -29.13 99.51 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.117 0.484 . . . . 0.0 111.817 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.1 -25.04 64.22 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.695 ' HB3' HG23 ' A' ' 33' ' ' THR . 0.2 OUTLIER -76.73 -21.23 55.56 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 122.021 -0.424 . . . . 0.0 110.044 178.936 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.884 HD23 ' HB2' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -80.88 -37.66 29.4 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.923 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.664 HD11 HG21 ' A' ' 41' ' ' VAL . 3.6 mp -64.48 -42.36 95.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.716 -0.615 . . . . 0.0 109.893 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.409 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -56.24 -21.17 21.87 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.759 179.787 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.71 -26.06 11.96 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.311 -0.868 . . . . 0.0 110.335 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.623 HG11 ' CE ' ' A' ' 44' ' ' MET . 0.5 OUTLIER -76.5 -36.9 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.303 -0.873 . . . . 0.0 110.935 -179.83 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.474 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 3.8 pp -63.71 -28.7 70.07 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -33.66 68.48 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.482 HD22 ' CB ' ' A' ' 27' ' ' GLU . 1.2 mt -79.58 -27.79 41.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.665 -0.647 . . . . 0.0 109.488 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -82.44 -11.29 58.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.538 -0.726 . . . . 0.0 109.558 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.57 -40.04 21.46 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.513 -0.742 . . . . 0.0 109.978 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.535 ' CD ' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -103.99 -25.76 12.88 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.403 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.92 25.31 5.96 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.535 ' HG3' ' CD ' ' A' ' 25' ' ' LYS . 4.7 mt-10 -79.3 130.12 35.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.335 -1.097 . . . . 0.0 110.602 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.0 mtmm -107.64 65.78 0.65 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.57 -0.707 . . . . 0.0 109.125 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.72 -151.03 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.6 -0.687 . . . . 0.0 110.049 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.0 OUTLIER -120.96 145.21 47.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.854 . . . . 0.0 110.57 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.548 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 2.7 mp -120.4 113.16 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.496 -0.753 . . . . 0.0 109.434 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -92.76 147.65 22.69 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.311 -0.868 . . . . 0.0 110.813 -179.35 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.795 HG21 ' HB3' ' A' ' 12' ' ' ASP . 17.6 m -138.69 166.7 23.7 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.468 -0.77 . . . . 0.0 110.301 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.456 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 15.4 m-90 -139.01 39.89 2.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.711 -0.618 . . . . 0.0 109.874 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 10' ' ' PHE . 50.6 m -78.82 -142.38 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.337 -0.852 . . . . 0.0 110.654 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.32 -61.4 1.41 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.989 -1.07 . . . . 0.0 110.317 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -94.33 39.53 1.09 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.403 -0.81 . . . . 0.0 109.825 179.484 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.727 ' HB3' HG23 ' A' ' 51' ' ' VAL . 36.3 m -35.54 131.57 0.48 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.302 0.572 . . . . 0.0 112.277 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.802 HG23 ' O ' ' A' ' 69' ' ' HIS . 27.9 m -150.02 162.27 40.71 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.631 -0.668 . . . . 0.0 110.401 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.689 HG21 HG21 ' A' ' 62' ' ' ILE . 1.2 mp -80.42 165.92 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.418 0 CA-C-O 121.642 0.734 . . . . 0.0 111.647 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.889 HG23 ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -140.4 179.59 1.22 Allowed Pre-proline 0 N--CA 1.503 2.183 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.605 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.75 ' HD2' HG12 ' A' ' 41' ' ' VAL . 48.8 Cg_endo -70.94 -33.01 12.76 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.872 1.459 . . . . 0.0 111.512 -179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -73.18 -0.14 13.42 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.451 -0.781 . . . . 0.0 110.984 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.889 ' SD ' HG23 ' A' ' 41' ' ' VAL . 1.3 mpt? -100.8 2.99 41.7 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.304 -0.872 . . . . 0.0 111.378 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.566 HG23 ' N ' ' A' ' 64' ' ' GLU . 4.0 p -57.2 -0.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.64 35.1 1.04 Allowed Glycine 0 N--CA 1.493 2.495 0 O-C-N 120.42 -1.425 . . . . 0.0 109.736 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.695 ' HB2' HD11 ' A' ' 49' ' ' ILE . 30.9 m80 -144.34 154.93 43.53 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.279 -1.13 . . . . 0.0 111.06 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.686 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.76 83.85 2.82 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.223 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.829 HG12 HD13 ' A' ' 15' ' ' LEU . 2.7 mp -86.26 122.61 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 111.141 -177.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.757 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.09 87.13 4.87 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.971 0.891 . . . . 0.0 109.729 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.727 HG23 ' HB3' ' A' ' 38' ' ' SER . 4.9 p -62.36 120.55 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.733 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 33' ' ' THR . 20.6 t80 -67.1 109.19 2.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -0.897 . . . . 0.0 109.65 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -78.18 10.66 2.81 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.599 -0.688 . . . . 0.0 110.604 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.58 -26.72 13.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -139.82 -28.17 0.75 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.662 -0.905 . . . . 0.0 110.429 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -130.36 153.73 48.4 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.0 0.905 . . . . 0.0 113.323 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.436 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 6.5 m80 -96.02 113.99 25.65 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.757 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 21.9 t -103.44 94.76 6.24 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.238 -0.914 . . . . 0.0 109.531 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.496 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.6 Cg_endo -66.29 89.54 0.26 Allowed 'Trans proline' 0 N--CA 1.491 1.364 0 O-C-N 123.981 1.516 . . . . 0.0 109.567 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 58' ' ' VAL . 93.6 t -98.34 120.6 47.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.828 -179.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.686 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.5 t80 -73.65 105.07 4.81 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.761 HD13 ' HB3' ' A' ' 44' ' ' MET . 2.9 mp -85.38 135.07 25.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.679 -0.638 . . . . 0.0 111.071 -178.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.438 ' C ' HG23 ' A' ' 45' ' ' VAL . 59.3 p -98.26 -158.81 0.7 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 177.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.566 ' N ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -87.88 10.27 19.21 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.925 -1.11 . . . . 0.0 111.45 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -145.16 17.75 1.56 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.85 -1.156 . . . . 0.0 112.259 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 67.9 mtt -115.56 0.11 13.21 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.056 -1.028 . . . . 0.0 110.076 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.566 HG23 ' HB ' ' A' ' 40' ' ' ILE . 8.1 p -85.68 167.57 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.219 -0.926 . . . . 0.0 111.298 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 115.75 -15.98 16.54 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.802 ' O ' HG23 ' A' ' 39' ' ' THR . 9.3 m80 -118.72 -86.36 0.64 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.052 -1.263 . . . . 0.0 111.122 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.613 ' HD3' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER 178.01 -33.81 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 122.165 0.983 . . . . 0.0 109.277 -179.611 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.613 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.5 OUTLIER 178.77 -16.13 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.834 -179.711 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.38 -14.2 79.47 Favored Glycine 0 N--CA 1.497 2.763 0 O-C-N 120.875 -1.141 . . . . 0.0 110.407 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.468 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 2.7 mm-40 . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.324 -1.103 . . . . 0.0 108.667 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.72 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.119 0.485 . . . . 0.0 109.942 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.695 HG21 HG13 ' A' ' 41' ' ' VAL . 14.8 p -114.33 122.04 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.383 -0.823 . . . . 0.0 108.915 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.789 ' CG ' HG23 ' A' ' 33' ' ' THR . 37.5 t70 -48.53 107.85 0.15 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.64 -0.662 . . . . 0.0 111.579 -178.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -68.63 -22.48 64.42 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.405 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 4.6 t-80 -67.06 -21.88 65.87 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.044 0.45 . . . . 0.0 110.358 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.052 HD13 HD13 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -83.7 -36.94 23.34 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.325 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.877 ' HA ' HG12 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -66.87 -46.5 74.8 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.427 179.291 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.419 ' HA ' HD21 ' A' ' 20' ' ' LEU . 5.3 pt-20 -52.62 -21.88 4.42 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.728 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.0 -29.21 10.08 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.366 -0.834 . . . . 0.0 110.693 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.877 HG12 ' HA ' ' A' ' 16' ' ' LEU . 1.4 p -78.51 -38.7 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.096 -1.003 . . . . 0.0 111.161 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.475 ' C ' HD12 ' A' ' 20' ' ' LEU . 3.6 pp -63.11 -24.83 68.08 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -71.84 -32.2 67.28 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' A' ' 27' ' ' GLU . 1.7 mp -76.96 -27.11 54.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.652 -0.655 . . . . 0.0 109.381 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -86.29 -14.29 44.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.556 -0.715 . . . . 0.0 109.286 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.04 -40.35 12.36 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.666 -0.646 . . . . 0.0 110.2 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.422 ' CE ' ' HG2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -93.86 -29.55 15.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.453 -0.779 . . . . 0.0 109.19 179.721 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.93 22.35 7.65 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.495 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 8.2 mm-40 -82.32 136.05 35.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.335 -1.097 . . . . 0.0 109.87 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -113.29 80.73 1.4 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.463 -0.773 . . . . 0.0 109.961 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.53 -160.66 1.0 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.353 0.597 . . . . 0.0 110.532 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -106.98 161.31 14.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.64 -0.663 . . . . 0.0 110.447 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.67 ' HB ' HG12 ' A' ' 49' ' ' ILE . 37.9 mm -116.01 164.43 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.544 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 2.1 mptt -127.68 149.99 49.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.789 HG23 ' CG ' ' A' ' 12' ' ' ASP . 22.4 m -135.21 155.16 51.14 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.361 -0.837 . . . . 0.0 111.227 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.544 ' CH2' ' HB2' ' A' ' 32' ' ' LYS . 23.2 m-90 -145.18 28.47 1.22 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.728 -0.608 . . . . 0.0 110.352 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.443 ' O ' ' HD2' ' A' ' 52' ' ' TYR . 0.4 OUTLIER -92.88 -159.32 0.67 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.065 -1.022 . . . . 0.0 110.934 -179.222 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -108.47 -56.53 2.24 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.093 -1.004 . . . . 0.0 110.55 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -94.4 33.27 1.43 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.394 -0.816 . . . . 0.0 110.189 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.403 ' OG ' HG21 ' A' ' 33' ' ' THR . 42.9 m -39.0 126.03 1.56 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.404 0.621 . . . . 0.0 111.781 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.85 HG23 ' O ' ' A' ' 69' ' ' HIS . 17.4 m -133.85 162.74 31.19 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.656 -0.653 . . . . 0.0 110.28 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.759 HG23 ' CG1' ' A' ' 62' ' ' ILE . 1.3 mp -79.16 164.83 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.606 -0.684 . . . . 0.0 111.872 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.86 HG12 ' HD2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -140.07 175.19 3.34 Favored Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.568 -0.708 . . . . 0.0 109.536 178.468 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.86 ' HD2' HG12 ' A' ' 41' ' ' VAL . 46.7 Cg_endo -69.53 -32.45 19.49 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.018 1.536 . . . . 0.0 111.864 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.533 ' HB2' ' CE ' ' A' ' 44' ' ' MET . 4.6 mm-40 -73.82 -0.08 14.75 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.346 -0.846 . . . . 0.0 110.896 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.832 ' HE1' HG11 ' A' ' 19' ' ' VAL . 3.9 mmt -95.5 -6.99 39.34 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.219 -0.925 . . . . 0.0 111.853 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.56 HG13 ' N ' ' A' ' 64' ' ' GLU . 74.0 t -45.84 -8.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.647 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.422 ' HA2' ' CE1' ' A' ' 61' ' ' TYR . . . -143.01 34.73 1.75 Allowed Glycine 0 N--CA 1.493 2.485 0 O-C-N 120.174 -1.579 . . . . 0.0 109.726 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.445 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 30.0 m-70 -141.89 150.55 41.68 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.393 -1.063 . . . . 0.0 110.559 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.77 81.91 2.53 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.773 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.052 HD13 HD13 ' A' ' 15' ' ' LEU . 42.1 mt -77.21 124.04 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.527 -0.733 . . . . 0.0 111.472 -177.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.781 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -81.04 76.84 7.98 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' ' 51' ' ' VAL . 23.0 m -58.85 124.45 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.316 -178.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 32.3 t80 -74.8 105.64 5.96 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.408 -0.807 . . . . 0.0 109.091 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -68.93 -0.23 5.31 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.669 -0.644 . . . . 0.0 110.95 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.81 -18.5 9.85 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -140.03 -28.78 0.73 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.795 -0.827 . . . . 0.0 110.975 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -136.28 154.65 50.82 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.23 -0.919 . . . . 0.0 112.146 -178.21 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.446 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 5.7 m-70 -99.12 105.5 17.6 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.781 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 38.1 t -94.36 101.58 6.89 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.098 -1.001 . . . . 0.0 109.957 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.536 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.3 Cg_endo -66.13 94.12 0.29 Allowed 'Trans proline' 0 N--CA 1.492 1.396 0 O-C-N 123.995 1.523 . . . . 0.0 108.934 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.609 HG23 HG12 ' A' ' 58' ' ' VAL . 75.6 t -109.73 125.33 66.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.065 -177.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.5 t80 -70.69 110.67 5.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.759 ' CG1' HG23 ' A' ' 40' ' ' ILE . 1.5 mp -61.06 -59.33 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.644 -0.66 . . . . 0.0 112.406 -177.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 3.5 m 69.52 161.26 0.21 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -177.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.56 ' N ' HG13 ' A' ' 45' ' ' VAL . 7.5 tp10 -78.42 62.24 3.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.83 -1.169 . . . . 0.0 109.902 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -173.1 -27.79 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.133 -0.979 . . . . 0.0 112.607 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.477 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 4.8 mmm -97.69 6.6 47.74 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.804 -1.185 . . . . 0.0 111.608 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.504 HG22 ' N ' ' A' ' 68' ' ' GLY . 7.5 p -89.07 163.83 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 120.857 -1.152 . . . . 0.0 112.059 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.504 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 109.68 -14.73 32.19 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.85 ' O ' HG23 ' A' ' 39' ' ' THR . 12.7 m80 -117.77 -89.73 0.58 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.984 -1.303 . . . . 0.0 111.125 -179.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.592 ' HG2' ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER 177.64 -31.39 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.134 0.968 . . . . 0.0 109.232 -179.38 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.592 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 2.2 pp 177.62 -17.91 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.657 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.0 -15.68 74.36 Favored Glycine 0 N--CA 1.499 2.841 0 O-C-N 120.936 -1.103 . . . . 0.0 110.427 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.477 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 2.5 mm-40 . . . . . 0 N--CA 1.496 1.844 0 O-C-N 121.352 -1.087 . . . . 0.0 108.407 178.254 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.69 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 121.323 0.583 . . . . 0.0 110.165 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 11' ' ' VAL . 14.5 p -102.12 109.96 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.694 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.786 ' HB3' HD23 ' A' ' 15' ' ' LEU . 26.2 t70 -45.63 109.17 0.16 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.516 -0.74 . . . . 0.0 111.499 -178.207 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -67.43 -23.86 65.58 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.46 -29.26 66.89 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.115 0.483 . . . . 0.0 110.097 179.284 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.841 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -79.95 -38.14 32.99 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.67 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.841 HD12 ' HG ' ' A' ' 15' ' ' LEU . 3.2 mp -63.33 -39.61 95.02 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.414 0.626 . . . . 0.0 109.553 178.281 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.53 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -55.49 -23.66 27.15 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.799 -0.563 . . . . 0.0 110.029 179.271 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -97.89 -31.82 12.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.482 -0.761 . . . . 0.0 110.499 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 16' ' ' LEU . 1.4 p -71.27 -38.16 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.317 -0.865 . . . . 0.0 110.933 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.53 HD21 ' HA ' ' A' ' 17' ' ' GLU . 3.8 pp -63.27 -26.82 68.95 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.053 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -74.47 -32.58 62.63 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.527 HD22 ' CB ' ' A' ' 27' ' ' GLU . 1.5 mt -75.14 -27.53 59.79 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.676 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -83.47 -12.41 56.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.519 -0.738 . . . . 0.0 109.463 178.238 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.5 -39.88 16.97 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 121.556 -0.715 . . . . 0.0 109.931 179.658 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.45 ' CE ' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -97.71 -26.65 14.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.509 -0.744 . . . . 0.0 109.807 179.716 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.416 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . 105.07 26.73 6.18 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.527 ' CB ' HD22 ' A' ' 22' ' ' LEU . 7.2 mt-10 -82.44 130.31 35.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.371 -1.076 . . . . 0.0 110.232 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -113.88 59.64 0.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.504 -0.747 . . . . 0.0 109.645 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.39 -136.68 0.32 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.495 -0.753 . . . . 0.0 109.877 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.571 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -132.56 153.88 50.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.95 -1.094 . . . . 0.0 110.719 -179.333 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.85 ' HB ' HD13 ' A' ' 49' ' ' ILE . 4.2 mt -127.35 120.07 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.224 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.441 ' HG3' ' CZ2' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -100.35 160.03 14.66 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.529 -0.732 . . . . 0.0 111.462 -178.69 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.584 HG21 ' OG ' ' A' ' 38' ' ' SER . 18.8 m -141.2 168.65 19.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.811 -0.556 . . . . 0.0 110.112 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.476 ' N ' HG22 ' A' ' 33' ' ' THR . 17.7 m-90 -144.59 39.32 1.27 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.365 -0.834 . . . . 0.0 110.556 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.453 ' H ' HG22 ' A' ' 33' ' ' THR . 22.9 t -92.88 -94.31 0.15 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.175 -0.953 . . . . 0.0 110.544 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.7 ttm105 -167.17 -60.16 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.989 -1.069 . . . . 0.0 110.841 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -103.34 35.67 2.5 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.336 -0.853 . . . . 0.0 110.568 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.584 ' OG ' HG21 ' A' ' 33' ' ' THR . 0.4 OUTLIER -41.01 121.91 1.64 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.16 0.505 . . . . 0.0 111.89 -179.91 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.751 HG23 ' O ' ' A' ' 69' ' ' HIS . 87.8 m -120.74 158.87 26.56 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.679 -0.638 . . . . 0.0 110.293 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.746 HG21 HG12 ' A' ' 62' ' ' ILE . 4.9 mp -85.76 169.34 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.367 -0.833 . . . . 0.0 111.274 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.97 HG23 ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -138.21 179.49 1.31 Allowed Pre-proline 0 N--CA 1.502 2.14 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.097 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.728 ' HD2' HG12 ' A' ' 41' ' ' VAL . 44.9 Cg_endo -68.6 -31.89 25.59 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.879 1.463 . . . . 0.0 111.303 -179.277 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.87 -3.62 16.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.587 -0.696 . . . . 0.0 111.127 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.97 ' SD ' HG23 ' A' ' 41' ' ' VAL . 1.3 mpt? -93.72 0.09 56.23 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.201 -0.937 . . . . 0.0 111.925 -179.304 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.486 HG21 ' CG ' ' A' ' 64' ' ' GLU . 3.5 p -52.31 -3.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.99 33.11 1.52 Allowed Glycine 0 N--CA 1.493 2.473 0 O-C-N 120.394 -1.441 . . . . 0.0 109.668 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 38.6 m-70 -142.91 152.51 42.15 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.303 -1.116 . . . . 0.0 110.907 -179.588 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.646 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -99.61 83.61 2.81 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 178.361 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.85 HD13 ' HB ' ' A' ' 31' ' ' ILE . 1.1 mm -78.6 112.23 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 111.587 -177.117 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.705 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -76.43 79.92 3.15 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.079 0.943 . . . . 0.0 108.777 178.807 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 70' ' ' LYS . 32.3 m -62.19 132.19 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.816 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.519 ' HB2' ' O ' ' A' ' 33' ' ' THR . 26.5 t80 -77.03 103.45 6.97 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.375 -0.828 . . . . 0.0 108.876 178.951 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -69.71 -0.7 7.4 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.527 -0.733 . . . . 0.0 110.563 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.58 -20.12 9.56 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.761 -2.136 . . . . 0.0 107.761 -178.558 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -140.15 -29.73 0.7 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 122.004 -0.704 . . . . 0.0 110.752 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.89 155.94 49.83 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.295 -0.878 . . . . 0.0 112.037 -178.278 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.539 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 3.1 m80 -100.64 100.67 11.41 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.092 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.705 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 58.6 t -87.34 104.03 5.59 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.341 -0.85 . . . . 0.0 109.956 -179.041 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 57' ' ' HIS . 42.8 Cg_endo -67.96 89.91 0.37 Allowed 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.921 1.485 . . . . 0.0 109.481 -179.336 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 49' ' ' ILE . 12.7 m -94.21 111.84 25.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.177 -178.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.646 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.4 t80 -69.96 101.25 1.73 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 118.526 -1.27 . . . . 0.0 107.598 177.692 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.874 HD13 ' HB3' ' A' ' 44' ' ' MET . 2.7 mp -80.8 141.33 15.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 121.543 0.687 . . . . 0.0 111.338 -178.113 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.3 p -110.29 -152.09 0.49 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 177.443 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.486 ' CG ' HG21 ' A' ' 45' ' ' VAL . 6.9 mt-10 -87.91 -13.38 42.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.764 -1.21 . . . . 0.0 110.921 179.237 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.53 27.35 6.53 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.984 -1.072 . . . . 0.0 112.147 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.5 mmt -116.12 -29.06 6.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.06 -1.025 . . . . 0.0 110.175 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 68' ' ' GLY . 5.7 p -65.67 163.89 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 O-C-N 121.39 -0.819 . . . . 0.0 111.874 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.487 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 123.9 -11.0 8.33 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.475 178.234 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.751 ' O ' HG23 ' A' ' 39' ' ' THR . 14.2 m80 -124.53 -84.48 0.64 Allowed 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 119.08 1.44 . . . . 0.0 111.007 -178.628 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.741 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.47 -30.19 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.505 0.669 . . . . 0.0 110.273 -179.42 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.636 ' HB3' HG21 ' A' ' 51' ' ' VAL . 0.5 OUTLIER 173.32 -16.5 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.563 -179.776 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.04 -15.62 76.47 Favored Glycine 0 N--CA 1.495 2.613 0 O-C-N 121.053 -1.029 . . . . 0.0 110.602 -179.668 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.508 ' HG3' ' ND1' ' A' ' 69' ' ' HIS . 22.9 mm-40 . . . . . 0 N--CA 1.496 1.843 0 O-C-N 121.141 -1.211 . . . . 0.0 109.423 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.3 m -81.13 159.03 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.461 -1.023 . . . . 0.0 110.402 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.735 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -112.69 143.32 44.1 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.533 -0.73 . . . . 0.0 109.858 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.781 HG11 HG13 ' A' ' 41' ' ' VAL . 70.4 t -105.55 117.56 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.735 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 37.1 t70 -44.45 112.71 0.45 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.403 0.621 . . . . 0.0 111.725 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.23 -21.97 62.05 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -70.11 -25.13 63.35 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.87 -0.519 . . . . 0.0 110.442 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.943 HD13 ' CD1' ' A' ' 49' ' ' ILE . 0.6 OUTLIER -77.46 -37.47 51.38 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.746 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.838 ' HA ' HG12 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -62.5 -46.91 86.31 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.744 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.17 -23.47 3.34 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.311 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -106.06 -33.62 7.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.448 -0.782 . . . . 0.0 110.568 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.838 HG12 ' HA ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -73.3 -39.64 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.279 -0.888 . . . . 0.0 111.402 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 16' ' ' LEU . 3.6 pp -63.13 -27.19 69.21 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.23 -32.67 64.88 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.577 HD22 ' CB ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -77.99 -24.09 48.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.653 -0.654 . . . . 0.0 109.437 178.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -82.73 -11.63 58.16 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.392 -0.817 . . . . 0.0 109.635 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.66 -39.77 19.8 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 121.461 -0.774 . . . . 0.0 109.969 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.54 ' CD ' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -103.23 -23.37 13.62 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.459 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.407 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . 102.14 29.07 6.21 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.577 ' CB ' HD22 ' A' ' 22' ' ' LEU . 5.8 mt-10 -76.1 130.33 38.16 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.394 -1.062 . . . . 0.0 110.669 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.8 mtmm -107.3 59.68 0.62 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.569 -0.707 . . . . 0.0 109.285 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -102.88 -154.34 0.49 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.509 -0.744 . . . . 0.0 109.992 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -124.49 145.16 49.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.587 -0.695 . . . . 0.0 110.13 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.516 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 2.4 mp -114.65 119.83 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.615 -0.678 . . . . 0.0 109.47 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.531 ' CE ' HD11 ' A' ' 30' ' ' LEU . 20.5 mmtt -79.61 154.63 28.58 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.412 -0.805 . . . . 0.0 111.199 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.68 HG23 ' CG ' ' A' ' 12' ' ' ASP . 20.7 m -141.38 153.47 45.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.61 -0.681 . . . . 0.0 110.094 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.457 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 14.7 m-90 -144.49 35.01 1.17 Allowed 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.311 -0.868 . . . . 0.0 111.354 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.3 t -84.63 -96.03 0.07 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.893 -1.13 . . . . 0.0 110.586 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.6 mtm105 -171.81 -61.91 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.106 -0.996 . . . . 0.0 109.631 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.479 ' HG2' ' HD1' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -103.53 31.15 4.54 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.435 0.636 . . . . 0.0 109.399 178.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.438 ' OG ' HG21 ' A' ' 33' ' ' THR . 13.4 m -44.74 130.9 7.08 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.439 0.637 . . . . 0.0 111.997 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.761 HG23 ' O ' ' A' ' 69' ' ' HIS . 75.7 m -124.76 159.06 31.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.775 -0.578 . . . . 0.0 109.936 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.665 HG21 HG12 ' A' ' 62' ' ' ILE . 4.8 mp -79.56 169.48 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.389 -0.82 . . . . 0.0 111.237 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.781 HG13 HG11 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -140.15 176.49 2.5 Favored Pre-proline 0 N--CA 1.5 2.056 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.621 ' O ' HG23 ' A' ' 45' ' ' VAL . 43.2 Cg_endo -66.89 -29.85 40.89 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.006 1.53 . . . . 0.0 110.595 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -71.46 -3.63 22.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.444 -0.785 . . . . 0.0 111.061 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.817 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.4 mtp -98.24 7.21 46.57 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.988 -1.07 . . . . 0.0 112.143 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 42' ' ' PRO . 89.6 t -57.5 -1.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.529 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.06 35.41 0.99 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 21.3 m80 -142.48 146.34 34.66 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.41 -1.053 . . . . 0.0 111.117 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.817 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.7 83.95 2.85 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 178.023 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.943 ' CD1' HD13 ' A' ' 15' ' ' LEU . 1.9 mt -86.97 120.63 36.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.139 -0.976 . . . . 0.0 110.924 -177.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.737 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -75.72 78.65 2.67 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.977 0.894 . . . . 0.0 109.152 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.656 HG21 ' O ' ' A' ' 70' ' ' LYS . 31.3 m -59.9 131.11 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.534 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 26.8 t80 -78.06 105.01 8.99 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -75.09 7.91 2.97 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.317 -0.864 . . . . 0.0 111.055 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.26 -27.39 6.11 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.65 -24.9 0.77 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.821 -0.811 . . . . 0.0 111.495 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -132.65 154.49 50.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.134 -0.979 . . . . 0.0 112.244 -177.703 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.442 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 3.4 m-70 -99.6 101.46 12.67 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.737 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 48.1 t -90.75 104.07 8.42 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.178 -0.951 . . . . 0.0 110.089 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.545 ' HB3' HD12 ' A' ' 30' ' ' LEU . 40.5 Cg_endo -66.08 87.37 0.24 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 O-C-N 123.899 1.473 . . . . 0.0 109.447 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 49' ' ' ILE . 15.1 m -92.72 112.59 26.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.464 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.817 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.3 t80 -75.13 100.36 4.23 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.817 HD13 ' HB3' ' A' ' 44' ' ' MET . 2.8 mp -81.57 135.29 25.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.564 -0.71 . . . . 0.0 111.144 -178.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.432 ' C ' HG13 ' A' ' 45' ' ' VAL . 58.9 p -101.03 -155.47 0.52 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.511 ' N ' HG13 ' A' ' 45' ' ' VAL . 1.3 tp10 -89.43 10.88 20.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.627 -1.295 . . . . 0.0 110.614 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.92 24.15 1.19 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.941 -1.099 . . . . 0.0 111.478 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.745 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 6.6 mmt -114.09 -27.95 7.5 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.039 -1.038 . . . . 0.0 110.216 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.539 ' HA ' ' HZ ' ' A' ' 74' ' ' PHE . 7.5 p -63.02 164.87 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 O-C-N 121.585 -0.697 . . . . 0.0 111.822 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.5 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 123.35 -14.51 8.23 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.387 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.761 ' O ' HG23 ' A' ' 39' ' ' THR . 12.5 m80 -122.03 -85.04 0.66 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 119.034 1.417 . . . . 0.0 111.21 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.683 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.68 -30.64 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.586 0.708 . . . . 0.0 110.42 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.525 ' HB3' ' O ' ' A' ' 70' ' ' LYS . 0.4 OUTLIER 174.46 -16.0 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.706 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.55 -16.4 75.8 Favored Glycine 0 N--CA 1.497 2.704 0 O-C-N 120.954 -1.091 . . . . 0.0 110.686 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.65 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 1.1 mm-40 -86.03 -16.73 37.29 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.254 -1.145 . . . . 0.0 109.461 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.745 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 1.6 m-85 -109.39 -16.87 13.92 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.575 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -137.55 55.23 9.26 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.525 -0.734 . . . . 0.0 110.162 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.575 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 47.1 Cg_endo -85.33 50.04 2.64 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.63 1.332 . . . . 0.0 110.273 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.5 m -129.64 147.24 51.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.641 -0.662 . . . . 0.0 110.311 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.4 -175.68 3.88 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.573 -0.704 . . . . 0.0 110.308 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.7 t -66.2 -26.21 67.29 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.453 -0.779 . . . . 0.0 110.744 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.1 p90 . . . . . 0 N--CA 1.496 1.861 0 O-C-N 121.346 -0.846 . . . . 0.0 110.275 179.803 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.26 139.03 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.557 -0.966 . . . . 0.0 110.265 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.736 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -126.98 143.36 51.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.444 -0.785 . . . . 0.0 110.03 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 11' ' ' VAL . 12.8 p -106.06 116.92 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.736 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 35.9 t70 -47.93 108.7 0.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.437 -0.79 . . . . 0.0 111.266 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.77 -23.88 66.13 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.441 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.7 OUTLIER -70.58 -20.54 62.77 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.976 -0.453 . . . . 0.0 110.071 179.081 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.849 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -88.54 -35.13 17.12 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.304 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.849 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.7 mp -69.52 -38.69 77.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.72 -0.612 . . . . 0.0 110.204 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.536 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . 3.0 pt-20 -58.29 -20.69 44.76 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.439 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -100.3 -29.56 12.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.387 -0.821 . . . . 0.0 110.394 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.047 HG21 ' SD ' ' A' ' 44' ' ' MET . 1.5 p -76.19 -37.21 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.247 -0.908 . . . . 0.0 111.141 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.536 ' CD2' ' HA ' ' A' ' 17' ' ' GLU . 3.7 pp -61.8 -26.58 68.19 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.02 -33.97 70.86 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.438 ' HA ' HD12 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -79.19 -25.46 42.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.694 -0.629 . . . . 0.0 109.573 178.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -84.31 -12.91 53.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.509 -0.744 . . . . 0.0 109.592 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.87 -39.22 13.2 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 121.509 -0.745 . . . . 0.0 110.014 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -94.77 -29.86 14.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.578 -0.701 . . . . 0.0 109.332 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.23 25.01 6.89 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.415 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 28.0 mt-10 -84.63 136.13 33.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.413 -1.051 . . . . 0.0 110.091 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -113.1 77.4 1.05 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.418 -0.801 . . . . 0.0 109.623 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.93 -154.85 0.57 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.496 -0.752 . . . . 0.0 110.363 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -112.85 155.36 24.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.412 -0.805 . . . . 0.0 110.545 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.683 HG21 ' O ' ' A' ' 15' ' ' LEU . 2.7 mp -129.24 113.5 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.493 -0.755 . . . . 0.0 109.338 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.517 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -66.64 154.36 40.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.521 -0.737 . . . . 0.0 111.117 -179.062 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.567 HG23 ' CB ' ' A' ' 12' ' ' ASP . 9.1 m -143.06 135.83 27.75 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.696 -0.628 . . . . 0.0 109.997 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.677 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -152.46 75.71 1.12 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.259 -0.9 . . . . 0.0 111.25 -179.713 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.423 ' HB3' ' CE2' ' A' ' 10' ' ' PHE . 0.6 OUTLIER -123.28 -82.2 0.65 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.147 -0.97 . . . . 0.0 110.052 179.061 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.417 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 5.8 ttm180 -167.97 -64.17 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.314 -0.866 . . . . 0.0 109.727 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.417 ' HD2' ' HB3' ' A' ' 36' ' ' ARG . 0.4 OUTLIER -104.25 35.11 2.8 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.57 -0.706 . . . . 0.0 109.387 179.113 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.477 ' OG ' HG22 ' A' ' 33' ' ' THR . 5.0 m -37.9 124.92 1.17 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.406 0.622 . . . . 0.0 111.991 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.751 HG23 ' O ' ' A' ' 69' ' ' HIS . 34.4 m -130.57 159.08 38.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.788 -0.57 . . . . 0.0 110.183 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.74 HG21 HG21 ' A' ' 62' ' ' ILE . 5.1 mp -83.85 168.94 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.401 -0.812 . . . . 0.0 110.909 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.682 HG12 ' HD2' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -138.43 176.9 2.36 Favored Pre-proline 0 N--CA 1.501 2.112 0 O-C-N 121.743 -0.598 . . . . 0.0 109.683 179.375 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.682 ' HD2' HG12 ' A' ' 41' ' ' VAL . 43.4 Cg_endo -66.93 -31.34 38.19 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.005 1.529 . . . . 0.0 111.276 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.761 ' HG3' HG11 ' A' ' 19' ' ' VAL . 2.5 pt-20 -72.27 -3.08 21.56 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.313 -0.867 . . . . 0.0 111.075 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . 1.047 ' SD ' HG21 ' A' ' 19' ' ' VAL . 18.8 mmt -97.15 10.1 40.32 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.213 -0.929 . . . . 0.0 111.748 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 42' ' ' PRO . 80.3 t -61.24 0.63 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 O-C-N 120.93 -1.106 . . . . 0.0 113.508 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.38 35.53 0.96 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.543 ' HB2' HD11 ' A' ' 49' ' ' ILE . 23.3 m80 -141.68 150.24 41.62 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.484 -1.009 . . . . 0.0 111.041 -178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.699 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -99.77 83.7 2.79 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.569 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.817 ' CG2' HD13 ' A' ' 15' ' ' LEU . 2.4 mp -83.56 121.39 36.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.398 -0.813 . . . . 0.0 110.885 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.772 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -77.23 79.49 3.75 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.695 0.76 . . . . 0.0 109.456 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.44 ' HA ' ' HB ' ' A' ' 33' ' ' THR . 19.4 m -58.16 135.0 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.385 0.612 . . . . 0.0 110.643 -179.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.677 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 30.5 t80 -75.62 106.82 7.38 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.558 -0.714 . . . . 0.0 109.31 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -77.54 4.78 10.38 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.307 -0.871 . . . . 0.0 110.734 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.64 -30.17 4.98 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.87 -26.27 0.73 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.961 -0.729 . . . . 0.0 111.578 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.8 155.42 41.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.227 -0.92 . . . . 0.0 112.345 -177.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.462 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 1.2 m-70 -97.77 104.81 16.87 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.772 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 48.6 t -93.51 101.49 5.93 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.228 -0.92 . . . . 0.0 110.108 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.523 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.7 Cg_endo -65.77 90.32 0.24 Allowed 'Trans proline' 0 N--CA 1.494 1.513 0 O-C-N 123.892 1.469 . . . . 0.0 109.712 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 58' ' ' VAL . 44.7 t -96.04 113.96 31.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.123 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.699 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.4 t80 -72.9 103.93 3.88 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.74 HG21 HG21 ' A' ' 40' ' ' ILE . 2.7 mp -84.81 132.04 32.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.638 -0.664 . . . . 0.0 111.105 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.408 ' C ' HG13 ' A' ' 45' ' ' VAL . 50.0 p -94.92 -157.2 0.55 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 177.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.527 ' N ' HG13 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -90.12 15.42 10.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.8 -1.188 . . . . 0.0 110.883 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.79 19.72 1.01 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.875 -1.141 . . . . 0.0 112.051 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.751 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 5.3 mmt -115.58 -18.19 10.97 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.834 -1.166 . . . . 0.0 110.502 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.56 HG22 ' N ' ' A' ' 68' ' ' GLY . 5.6 p -73.94 167.15 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.316 -0.865 . . . . 0.0 111.759 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.56 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 121.28 -11.97 9.75 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.164 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.751 ' O ' HG23 ' A' ' 39' ' ' THR . 18.3 m80 -128.13 -81.42 0.59 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.944 1.372 . . . . 0.0 111.257 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.632 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.76 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 121.714 0.768 . . . . 0.0 110.126 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.595 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.7 OUTLIER 173.73 -16.45 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.759 -179.641 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.1 -16.11 76.73 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.002 -1.061 . . . . 0.0 110.506 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.489 ' HG3' ' ND1' ' A' ' 69' ' ' HIS . 21.3 mm-40 -83.94 -21.07 31.95 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.245 -1.15 . . . . 0.0 108.97 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.751 ' CD2' ' HB3' ' A' ' 66' ' ' MET . 14.9 m-85 -94.35 -21.87 18.7 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.57 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -134.11 56.11 17.83 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.816 -0.553 . . . . 0.0 109.716 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.57 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 46.3 Cg_endo -84.78 50.77 3.01 Favored 'Trans proline' 0 C--N 1.32 -0.968 0 O-C-N 123.587 1.309 . . . . 0.0 110.303 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.5 m -71.98 132.44 44.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.536 -0.727 . . . . 0.0 110.188 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.19 179.34 5.09 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.48 -0.762 . . . . 0.0 110.383 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 29.1 p -74.83 149.19 39.7 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.448 -0.782 . . . . 0.0 110.406 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 . . . . . 0 N--CA 1.501 2.101 0 O-C-N 121.805 -0.559 . . . . 0.0 110.681 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -106.97 -33.57 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.473 -1.016 . . . . 0.0 110.892 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.728 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -141.37 139.26 33.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.815 . . . . 0.0 110.189 -179.716 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.729 HG21 HG13 ' A' ' 41' ' ' VAL . 14.7 p -105.17 112.86 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.728 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 38.9 t70 -41.38 111.8 0.25 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.468 0.651 . . . . 0.0 111.913 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.75 -23.99 63.47 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -67.4 -26.66 66.55 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.928 -0.483 . . . . 0.0 110.221 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.592 HD13 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -79.31 -36.11 40.14 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.61 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.77 ' HA ' HG12 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -64.57 -45.55 86.57 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.688 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.82 -22.69 2.29 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.148 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.497 ' O ' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -103.59 -36.55 7.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.579 -0.701 . . . . 0.0 110.174 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.77 HG12 ' HA ' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -70.22 -40.67 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.281 -0.887 . . . . 0.0 110.872 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.516 HD23 ' OE1' ' A' ' 43' ' ' GLU . 10.9 mt -62.69 -37.26 85.79 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.57 -34.69 78.84 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.766 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 18' ' ' LYS . 2.4 mm? -77.71 -27.78 50.76 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.345 -0.847 . . . . 0.0 109.515 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -82.51 -12.07 58.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.631 -0.668 . . . . 0.0 109.82 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.86 -35.22 20.74 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 121.385 -0.822 . . . . 0.0 109.867 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 11.3 mmtt -89.3 -16.05 32.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.61 -0.681 . . . . 0.0 109.816 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.35 26.52 27.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.46 ' O ' HD12 ' A' ' 22' ' ' LEU . 5.2 mm-40 -109.44 137.89 46.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.587 -0.949 . . . . 0.0 110.489 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -110.63 87.78 2.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.49 -0.756 . . . . 0.0 109.644 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.44 -154.34 0.54 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.472 -0.767 . . . . 0.0 110.266 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -112.02 155.43 23.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -0.806 . . . . 0.0 110.589 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.59 ' CD1' HG23 ' A' ' 19' ' ' VAL . 3.3 mt -130.56 122.01 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.604 -0.685 . . . . 0.0 109.74 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.45 ' HB3' ' CZ2' ' A' ' 34' ' ' TRP . 0.1 OUTLIER -84.68 155.63 21.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.407 -0.808 . . . . 0.0 110.882 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.736 HG21 ' OG ' ' A' ' 38' ' ' SER . 19.4 m -137.17 158.19 44.99 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.582 -0.699 . . . . 0.0 110.466 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.45 ' CZ2' ' HB3' ' A' ' 32' ' ' LYS . 19.8 m-90 -145.54 30.72 1.1 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.333 -0.855 . . . . 0.0 111.726 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 p -86.33 -96.91 0.08 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.847 -1.158 . . . . 0.0 110.606 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.27 -66.34 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.097 -1.002 . . . . 0.0 110.186 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.474 ' HG2' ' HD1' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -99.73 45.24 0.99 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.67 0.747 . . . . 0.0 109.6 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.736 ' OG ' HG21 ' A' ' 33' ' ' THR . 2.2 m -50.9 138.32 19.25 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.448 0.642 . . . . 0.0 112.371 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.778 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 57.0 m -132.0 159.17 39.54 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.903 HG21 HG21 ' A' ' 62' ' ' ILE . 5.2 mp -89.76 168.25 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.231 -0.918 . . . . 0.0 111.276 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.729 HG13 HG21 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -140.21 174.69 3.75 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.228 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.551 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 40.9 Cg_endo -64.86 -31.53 57.01 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.995 1.524 . . . . 0.0 110.194 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.516 ' OE1' HD23 ' A' ' 20' ' ' LEU . 3.3 mm-40 -65.93 -12.42 54.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.761 -0.587 . . . . 0.0 110.631 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.69 ' HB3' HD13 ' A' ' 62' ' ' ILE . 41.4 mtp -97.84 11.29 37.81 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.278 -0.888 . . . . 0.0 110.872 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.665 HG23 ' N ' ' A' ' 64' ' ' GLU . 7.5 p -62.14 5.03 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.339 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.28 33.05 1.03 Allowed Glycine 0 N--CA 1.493 2.475 0 O-C-N 120.311 -1.493 . . . . 0.0 109.976 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.784 ' HB2' HD11 ' A' ' 49' ' ' ILE . 45.9 m-70 -144.07 153.21 41.95 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.153 -1.204 . . . . 0.0 111.29 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.741 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -100.01 83.92 2.78 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 178.255 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.784 HD11 ' HB2' ' A' ' 47' ' ' HIS . 3.1 mp -86.61 118.13 32.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 111.281 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.755 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -76.77 80.26 3.38 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.922 0.868 . . . . 0.0 109.071 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 51' ' ' VAL . 32.8 m -58.56 132.05 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.285 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.479 ' HD1' ' CD2' ' A' ' 57' ' ' HIS . 30.4 t80 -74.33 105.8 5.67 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -76.1 13.88 0.81 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.669 -0.644 . . . . 0.0 110.535 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.71 -27.72 12.8 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.5 pttp -140.48 -27.82 0.73 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.596 -0.943 . . . . 0.0 110.84 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -130.35 155.55 46.18 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.106 0.955 . . . . 0.0 113.546 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.653 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 25.7 m80 -96.3 111.84 23.78 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.755 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 42.1 t -101.33 95.46 4.99 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.132 -0.98 . . . . 0.0 109.455 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.526 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.3 Cg_endo -65.09 87.51 0.18 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.939 1.494 . . . . 0.0 109.787 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.598 HG13 HG12 ' A' ' 58' ' ' VAL . 10.4 m -94.77 114.67 31.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.208 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.741 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.1 t80 -73.4 100.56 3.24 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.903 HG21 HG21 ' A' ' 40' ' ' ILE . 2.6 mp -83.9 138.43 19.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.594 0.711 . . . . 0.0 111.996 -177.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.644 ' C ' HG23 ' A' ' 45' ' ' VAL . 24.8 p -104.99 -153.98 0.5 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 176.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.665 ' N ' HG23 ' A' ' 45' ' ' VAL . 4.7 tp10 -90.43 0.5 57.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.549 -1.344 . . . . 0.0 110.978 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -126.94 -8.9 6.02 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.014 -1.054 . . . . 0.0 112.191 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.742 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 8.6 mmt -86.96 -26.23 23.94 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.805 -1.184 . . . . 0.0 110.121 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.499 HG21 ' C ' ' A' ' 41' ' ' VAL . 5.5 p -66.91 164.31 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.377 -0.827 . . . . 0.0 111.827 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.497 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 120.7 -11.89 10.19 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.52 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.773 ' O ' HG23 ' A' ' 39' ' ' THR . 12.1 m80 -121.72 -84.99 0.66 Allowed 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 119.078 1.439 . . . . 0.0 111.074 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.778 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.1 OUTLIER 178.36 -30.54 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 CA-C-O 121.601 0.715 . . . . 0.0 110.328 -179.496 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.57 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 1.2 pp 173.3 -15.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.703 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.71 -17.4 76.61 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.529 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 3.6 mm-40 -84.05 -20.83 32.01 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.276 -1.132 . . . . 0.0 109.202 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.742 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 5.8 m-85 -103.61 -17.47 15.14 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.564 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -137.6 55.97 10.64 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.492 -0.755 . . . . 0.0 110.209 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 44.5 Cg_endo -86.66 48.88 1.96 Allowed 'Trans proline' 0 C--N 1.318 -1.048 0 O-C-N 123.619 1.326 . . . . 0.0 110.21 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.8 m -139.46 -56.43 0.58 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.657 -0.652 . . . . 0.0 110.209 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -96.12 -48.85 5.49 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.593 -0.692 . . . . 0.0 110.28 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.4 t -106.62 -177.14 3.28 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.601 -0.687 . . . . 0.0 110.372 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.4 t80 . . . . . 0 N--CA 1.495 1.788 0 O-C-N 121.317 -0.864 . . . . 0.0 110.139 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 p -138.1 145.73 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.485 -1.009 . . . . 0.0 110.441 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.716 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -124.75 152.41 43.86 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.497 -0.752 . . . . 0.0 109.951 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 39' ' ' THR . 14.5 p -114.43 121.02 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.716 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 30.9 t70 -48.93 102.88 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.502 -0.749 . . . . 0.0 111.043 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -63.89 -24.24 67.66 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.23 -33.86 76.25 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.805 HD11 ' CE ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -77.39 -36.81 53.11 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.35 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.689 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.6 mp -62.38 -41.85 98.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.625 -0.672 . . . . 0.0 109.503 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.11 -23.17 19.51 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.647 -0.658 . . . . 0.0 109.993 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -98.62 -33.13 11.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.431 -0.793 . . . . 0.0 110.489 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 16' ' ' LEU . 1.5 p -69.73 -40.52 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.231 -0.918 . . . . 0.0 110.426 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.596 HD21 ' OE2' ' A' ' 43' ' ' GLU . 12.1 mt -63.22 -36.93 85.29 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 177.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.9 -34.04 72.65 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.627 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 27' ' ' GLU . 2.5 mm? -78.77 -26.99 44.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.347 -0.845 . . . . 0.0 109.435 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -81.48 -13.1 58.56 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.577 -0.702 . . . . 0.0 109.752 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.86 -35.39 24.21 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.447 -0.783 . . . . 0.0 109.702 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 17.1 mmtt -89.89 -15.09 32.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.724 -0.61 . . . . 0.0 109.826 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.55 26.25 36.32 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.439 ' O ' HD12 ' A' ' 22' ' ' LEU . 47.1 mt-10 -111.0 144.6 39.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.539 -0.977 . . . . 0.0 110.497 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -111.27 92.99 4.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.502 -0.749 . . . . 0.0 109.611 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.84 -157.19 0.64 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.539 -0.725 . . . . 0.0 110.449 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -112.8 154.04 26.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.538 -0.726 . . . . 0.0 110.364 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.573 HG21 HD12 ' A' ' 15' ' ' LEU . 3.0 mt -131.49 121.84 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.498 -0.751 . . . . 0.0 109.873 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.39 160.02 24.18 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.287 -0.883 . . . . 0.0 110.816 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.669 HG23 ' CG ' ' A' ' 12' ' ' ASP . 16.5 m -137.31 158.39 44.53 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.659 -0.651 . . . . 0.0 110.181 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.439 ' CD1' ' HE1' ' A' ' 57' ' ' HIS . 20.0 m-90 -145.74 37.01 1.07 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.272 -0.893 . . . . 0.0 110.629 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.428 ' HB3' ' HE1' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -100.21 -155.45 0.51 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.168 -0.958 . . . . 0.0 110.687 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.74 -58.13 2.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.179 -0.95 . . . . 0.0 110.147 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.38 35.26 1.99 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.539 -0.726 . . . . 0.0 109.924 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.435 ' HB3' HG21 ' A' ' 33' ' ' THR . 58.5 m -42.19 128.21 3.65 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.338 0.589 . . . . 0.0 111.839 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.713 ' O ' HG23 ' A' ' 11' ' ' VAL . 23.7 m -136.94 163.46 30.65 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.674 -0.641 . . . . 0.0 110.308 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.76 HG21 HG21 ' A' ' 62' ' ' ILE . 5.1 mp -85.42 169.73 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.472 -0.768 . . . . 0.0 111.186 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG12 ' HD2' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -137.27 176.26 2.88 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 121.563 -0.711 . . . . 0.0 109.771 178.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.674 ' HD2' HG12 ' A' ' 41' ' ' VAL . 42.1 Cg_endo -66.57 -29.43 44.14 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.059 1.557 . . . . 0.0 111.334 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.596 ' OE2' HD21 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -77.75 8.0 5.07 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.479 -0.763 . . . . 0.0 111.392 179.604 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.805 ' CE ' HD11 ' A' ' 15' ' ' LEU . 2.1 mtt -109.96 19.27 19.21 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.01 -1.056 . . . . 0.0 111.512 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.705 HG13 ' N ' ' A' ' 64' ' ' GLU . 89.0 t -66.68 7.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 121.088 -1.007 . . . . 0.0 113.352 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.2 32.44 0.95 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 34.8 m-70 -138.78 147.36 42.49 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.277 -1.131 . . . . 0.0 111.243 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.767 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -99.63 82.0 2.57 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.377 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.746 ' CG2' HD13 ' A' ' 15' ' ' LEU . 2.6 mp -81.61 117.38 27.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.314 -0.866 . . . . 0.0 111.446 -177.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.723 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -76.67 78.01 3.32 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 122.094 0.949 . . . . 0.0 108.813 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.666 HG21 ' HB3' ' A' ' 71' ' ' LEU . 32.9 m -60.43 131.12 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.775 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.515 ' HB2' ' O ' ' A' ' 33' ' ' THR . 36.2 t80 -78.28 103.95 8.55 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -74.36 7.87 2.59 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.362 -0.836 . . . . 0.0 111.339 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.94 -27.31 5.94 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -140.71 -24.97 0.76 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.84 -0.8 . . . . 0.0 111.522 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.503 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -133.64 154.09 51.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.106 -0.996 . . . . 0.0 112.443 -177.668 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.489 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 22.3 m-70 -98.84 100.61 11.82 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.723 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 52.5 t -88.75 104.29 7.13 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.236 -0.915 . . . . 0.0 109.887 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.496 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.6 Cg_endo -66.65 88.75 0.28 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 O-C-N 123.912 1.48 . . . . 0.0 109.501 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 49' ' ' ILE . 13.7 m -94.31 112.44 27.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.327 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.767 ' HB2' HG23 ' A' ' 48' ' ' THR . 5.9 t80 -72.9 100.0 2.82 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.76 HG21 HG21 ' A' ' 40' ' ' ILE . 2.7 mp -80.82 134.47 27.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.283 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.696 ' C ' HG13 ' A' ' 45' ' ' VAL . 1.9 m -105.19 -150.25 0.43 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 177.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.705 ' N ' HG13 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -90.01 -3.66 57.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.341 -1.474 . . . . 0.0 111.247 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.4 24.41 4.45 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.917 -1.114 . . . . 0.0 111.44 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.659 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 22.1 mtt -114.82 -31.61 6.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.149 -0.97 . . . . 0.0 110.02 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.549 ' HA ' ' HZ ' ' A' ' 74' ' ' PHE . 6.0 p -62.07 163.29 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 O-C-N 121.453 -0.779 . . . . 0.0 111.925 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.478 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 120.91 -9.55 10.42 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.323 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.667 ' O ' HG23 ' A' ' 39' ' ' THR . 14.1 m80 -122.97 -86.29 0.65 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 119.101 1.45 . . . . 0.0 110.836 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.54 -30.43 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.495 0.664 . . . . 0.0 110.243 -179.553 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.666 ' HB3' HG21 ' A' ' 51' ' ' VAL . 1.4 pp 173.55 -14.05 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.273 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.805 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.37 -17.85 79.08 Favored Glycine 0 N--CA 1.493 2.454 0 O-C-N 120.927 -1.108 . . . . 0.0 110.627 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.507 ' HG3' ' ND1' ' A' ' 69' ' ' HIS . 16.7 mm-40 -84.68 -15.99 43.39 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.251 -1.146 . . . . 0.0 109.352 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.659 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 1.9 m-85 -109.29 -18.7 13.52 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.583 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -133.33 53.07 9.66 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.541 -0.724 . . . . 0.0 109.686 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.583 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 48.0 Cg_endo -81.77 54.87 5.26 Favored 'Trans proline' 0 C--N 1.321 -0.914 0 O-C-N 123.629 1.331 . . . . 0.0 110.2 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 11.1 t -68.74 -162.1 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.728 -0.608 . . . . 0.0 110.699 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.48 119.51 4.94 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.418 -0.801 . . . . 0.0 110.673 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.4 t -150.29 172.62 15.08 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.598 -0.689 . . . . 0.0 110.393 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 . . . . . 0 N--CA 1.5 2.074 0 O-C-N 121.667 -0.646 . . . . 0.0 110.705 179.998 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.7 t -120.19 91.33 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.417 -1.049 . . . . 0.0 109.93 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.662 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -111.72 140.17 46.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.511 -0.743 . . . . 0.0 109.746 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.807 HG21 HG13 ' A' ' 41' ' ' VAL . 13.5 p -92.11 108.4 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.662 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 36.2 t70 -48.31 115.74 1.32 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.457 0.646 . . . . 0.0 111.736 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.72 -25.07 62.78 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -63.78 -27.73 69.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.862 -0.524 . . . . 0.0 110.12 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.846 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -78.74 -36.73 42.77 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.712 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.846 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.0 mp -62.64 -43.79 97.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.853 -0.529 . . . . 0.0 109.919 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.32 -21.31 23.49 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.666 -0.646 . . . . 0.0 110.593 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.599 ' O ' HD23 ' A' ' 22' ' ' LEU . 6.4 mmpt? -106.27 -23.81 12.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.4 -0.812 . . . . 0.0 111.164 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.695 HG12 ' HA ' ' A' ' 16' ' ' LEU . 1.4 p -86.26 -40.94 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.983 -1.073 . . . . 0.0 111.0 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.482 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 14.1 mt -65.34 -38.16 89.28 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -62.64 -33.84 75.84 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.539 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.599 HD23 ' O ' ' A' ' 18' ' ' LYS . 2.3 mm? -78.0 -25.98 48.29 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.291 -0.881 . . . . 0.0 109.456 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -81.56 -12.4 58.8 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.586 -0.696 . . . . 0.0 109.682 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.91 -37.21 27.15 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 121.446 -0.784 . . . . 0.0 109.346 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -86.05 -22.55 27.15 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.64 15.71 51.76 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -95.68 145.03 25.6 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.534 -0.98 . . . . 0.0 110.388 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -110.15 89.39 3.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.517 -0.74 . . . . 0.0 109.557 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.433 ' HB2' HD11 ' A' ' 22' ' ' LEU . 7.6 ttm180 -111.77 -155.57 0.57 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.496 -0.752 . . . . 0.0 110.365 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -119.2 154.09 33.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.412 -0.805 . . . . 0.0 110.319 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.588 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 2.7 mp -129.65 121.49 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.495 -0.753 . . . . 0.0 110.18 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.515 ' CD ' HD11 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -99.89 153.44 19.16 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.321 -0.862 . . . . 0.0 111.23 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.586 HG23 ' H ' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -140.95 166.77 23.88 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.689 -0.632 . . . . 0.0 110.072 179.209 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.478 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 13.6 m-90 -144.89 43.16 1.34 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.639 -0.663 . . . . 0.0 110.508 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.26 -83.35 0.26 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.231 -0.918 . . . . 0.0 110.605 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -179.93 -63.68 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.422 -0.799 . . . . 0.0 110.155 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -101.89 35.94 2.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.466 -0.771 . . . . 0.0 109.616 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.2 m -42.16 113.22 0.41 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.442 0.639 . . . . 0.0 111.578 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.875 HG23 ' O ' ' A' ' 69' ' ' HIS . 26.2 m -107.12 159.35 16.39 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.818 -0.551 . . . . 0.0 109.554 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.665 HD11 ' HE1' ' A' ' 74' ' ' PHE . 1.1 mp -74.47 163.76 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.479 -0.763 . . . . 0.0 111.163 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.816 HG11 HD11 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -121.61 179.13 1.02 Allowed Pre-proline 0 N--CA 1.507 2.407 0 O-C-N 121.648 -0.658 . . . . 0.0 109.925 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.567 ' HD2' HG12 ' A' ' 41' ' ' VAL . 50.4 Cg_endo -71.44 -32.49 12.3 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 124.079 1.568 . . . . 0.0 111.346 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -83.98 15.27 3.48 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.445 -0.785 . . . . 0.0 110.573 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.942 ' CG ' HG21 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -82.92 -15.7 50.33 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.636 -0.665 . . . . 0.0 112.125 -179.422 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.615 HG23 ' N ' ' A' ' 64' ' ' GLU . 2.4 p -58.31 6.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.41 29.26 1.07 Allowed Glycine 0 N--CA 1.491 2.335 0 O-C-N 119.917 -1.739 . . . . 0.0 110.056 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.539 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 18.2 m80 -145.93 156.6 43.63 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.998 -1.295 . . . . 0.0 111.539 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -99.03 78.86 2.3 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 177.888 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.719 HD12 ' CD1' ' A' ' 62' ' ' ILE . 78.8 mt -78.18 116.79 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.526 -0.734 . . . . 0.0 111.516 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.773 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.85 85.92 5.45 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 51' ' ' VAL . 17.6 m -66.77 128.81 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.026 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.586 ' H ' HG23 ' A' ' 33' ' ' THR . 27.0 t80 -76.73 105.77 8.0 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.449 -0.782 . . . . 0.0 108.911 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -70.29 -0.85 8.82 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.679 -0.638 . . . . 0.0 110.679 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.9 -19.64 9.49 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -140.1 -28.68 0.73 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.933 -0.745 . . . . 0.0 110.898 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -134.68 155.2 50.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.187 -0.946 . . . . 0.0 111.977 -178.307 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.539 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -101.63 111.3 23.5 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.773 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 18.0 t -98.64 94.96 2.7 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.256 -0.902 . . . . 0.0 109.743 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 57' ' ' HIS . 43.6 Cg_endo -69.37 94.9 0.5 Allowed 'Trans proline' 0 N--CA 1.487 1.137 0 O-C-N 123.847 1.446 . . . . 0.0 109.531 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.656 HG11 ' CD2' ' A' ' 74' ' ' PHE . 48.6 t -111.93 127.89 68.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.062 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.539 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.9 t80 -72.19 102.34 3.03 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 176.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.942 HG21 ' CG ' ' A' ' 44' ' ' MET . 2.8 mp -65.54 -60.48 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -175.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 62' ' ' ILE . 4.9 m 71.71 172.17 0.31 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -176.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.615 ' N ' HG23 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -78.3 66.83 3.97 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.856 -1.152 . . . . 0.0 110.396 -179.06 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -169.54 -24.17 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.398 -0.814 . . . . 0.0 112.625 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.702 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 11.0 mtt -110.15 9.12 24.01 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.613 -1.304 . . . . 0.0 112.544 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.661 ' HB ' ' HE3' ' A' ' 44' ' ' MET . 14.2 p -89.33 166.49 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 O-C-N 120.583 -1.323 . . . . 0.0 112.652 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.523 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 105.17 -13.81 48.38 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.875 ' O ' HG23 ' A' ' 39' ' ' THR . 8.9 m80 -113.43 -90.37 0.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 118.813 1.306 . . . . 0.0 110.478 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.755 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.86 -35.36 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 122.306 1.05 . . . . 0.0 109.106 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.645 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -178.67 -13.55 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.027 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.57 -15.64 80.44 Favored Glycine 0 N--CA 1.497 2.704 0 O-C-N 120.829 -1.17 . . . . 0.0 110.286 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.495 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 2.0 mm-40 -79.82 -21.39 44.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.385 -1.067 . . . . 0.0 108.567 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.702 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 5.9 m-85 -99.64 -21.96 15.63 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.533 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -133.88 58.32 31.18 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.65 -0.656 . . . . 0.0 110.56 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 44.7 Cg_endo -88.35 40.4 0.56 Allowed 'Trans proline' 0 C--N 1.318 -1.047 0 O-C-N 123.556 1.292 . . . . 0.0 110.402 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.9 t -176.63 40.98 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.248 0.547 . . . . 0.0 109.989 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -141.76 -59.34 0.47 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.23 -0.919 . . . . 0.0 110.488 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 56.5 m -123.86 145.84 48.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.474 -0.766 . . . . 0.0 110.336 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.0 t80 . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.448 -0.782 . . . . 0.0 110.135 179.95 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.441 ' HB ' ' CD ' ' A' ' 37' ' ' ARG . 78.1 t -109.43 -51.05 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.507 -0.996 . . . . 0.0 110.296 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.715 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -135.16 135.78 41.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.61 -0.681 . . . . 0.0 110.293 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.078 HG11 HG13 ' A' ' 41' ' ' VAL . 77.7 t -105.14 114.48 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.715 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 1.8 t0 -44.58 106.29 0.07 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.448 0.642 . . . . 0.0 111.805 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -67.65 -23.35 65.32 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.7 t60 -67.32 -35.7 79.98 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.873 -0.517 . . . . 0.0 109.908 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.735 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -75.32 -38.24 60.33 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.29 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.735 HD12 ' HG ' ' A' ' 15' ' ' LEU . 2.6 mp -58.78 -43.58 90.45 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.299 0.571 . . . . 0.0 109.639 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.506 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -55.03 -25.75 32.56 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.065 179.315 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.478 ' HB2' HG23 ' A' ' 31' ' ' ILE . 10.3 mmtm -97.12 -31.95 12.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.479 -0.763 . . . . 0.0 111.034 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.655 HG12 ' HA ' ' A' ' 16' ' ' LEU . 3.6 p -74.07 -38.03 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 120.997 -1.064 . . . . 0.0 111.271 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.506 HD21 ' HA ' ' A' ' 17' ' ' GLU . 3.6 pp -62.69 -25.03 67.95 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.75 -35.28 72.58 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 27' ' ' GLU . 3.4 mm? -72.33 -27.49 62.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.623 -0.673 . . . . 0.0 109.585 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -83.17 -16.13 47.85 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.588 -0.695 . . . . 0.0 109.792 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.8 -36.99 23.12 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 121.577 -0.702 . . . . 0.0 109.57 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -88.03 -21.07 24.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.674 -0.641 . . . . 0.0 109.35 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.01 17.26 59.7 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.494 ' O ' HD12 ' A' ' 22' ' ' LEU . 21.7 mm-40 -93.28 149.15 21.44 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.38 -1.071 . . . . 0.0 110.593 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -110.74 96.57 6.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.549 -0.72 . . . . 0.0 109.756 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.446 ' HB2' HD11 ' A' ' 22' ' ' LEU . 1.8 ttt85 -126.73 -155.53 0.69 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.532 -0.73 . . . . 0.0 110.353 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -116.99 155.79 28.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.5 -0.75 . . . . 0.0 110.469 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.652 HD13 HG23 ' A' ' 19' ' ' VAL . 3.2 mp -132.05 112.98 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.614 -0.679 . . . . 0.0 109.536 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.13 148.35 26.38 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.386 -0.821 . . . . 0.0 110.897 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 14.3 t -141.09 174.87 10.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.679 -0.638 . . . . 0.0 110.171 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.501 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 10.0 m-90 -143.8 47.13 1.45 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.145 -0.972 . . . . 0.0 111.666 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 t -88.96 -84.25 0.21 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.718 -1.239 . . . . 0.0 111.077 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.54 -88.83 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.02 -1.05 . . . . 0.0 111.36 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.539 ' HD2' ' HB3' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -97.4 52.83 1.13 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.209 -0.932 . . . . 0.0 109.975 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.525 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 0.4 OUTLIER -39.11 138.12 0.63 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.264 0.554 . . . . 0.0 112.363 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.825 HG23 ' O ' ' A' ' 69' ' ' HIS . 24.4 m -129.2 159.21 36.76 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.529 -0.732 . . . . 0.0 110.133 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.875 HG23 ' SD ' ' A' ' 44' ' ' MET . 1.2 mp -78.99 159.55 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 121.541 -0.725 . . . . 0.0 111.604 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.078 HG13 HG11 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -133.64 171.23 9.46 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 42.6 Cg_endo -67.16 -31.79 35.42 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.133 1.596 . . . . 0.0 110.493 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HG3' HG11 ' A' ' 19' ' ' VAL . 6.5 pt-20 -75.24 -1.97 25.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.53 -0.731 . . . . 0.0 111.025 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.906 ' SD ' HD13 ' A' ' 62' ' ' ILE . 1.4 ptp -114.98 16.7 17.11 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.897 -1.127 . . . . 0.0 110.886 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.615 HG13 ' CA ' ' A' ' 64' ' ' GLU . 2.6 t -68.27 6.5 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.358 -0.839 . . . . 0.0 112.782 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.77 35.79 0.92 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.539 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 54.2 m-70 -140.24 159.2 42.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.501 -0.999 . . . . 0.0 110.488 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.644 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.08 82.47 2.73 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 178.382 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.602 ' CG2' HD13 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -83.51 115.82 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.495 -0.753 . . . . 0.0 111.55 -176.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.767 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -77.99 81.6 4.38 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.561 HG22 HG23 ' A' ' 58' ' ' VAL . 33.0 m -66.19 132.66 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.581 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.501 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 23.8 t80 -72.44 104.35 3.77 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -70.7 -0.23 8.39 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.51 -0.744 . . . . 0.0 110.488 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.6 -21.79 8.43 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.12 -30.0 0.69 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 122.009 -0.701 . . . . 0.0 110.633 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.409 ' CG ' HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -133.89 156.47 48.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.309 -0.869 . . . . 0.0 111.737 -178.42 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.451 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -102.41 101.74 12.0 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.178 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.767 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 14.6 m -91.39 105.56 13.26 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.152 -0.967 . . . . 0.0 110.335 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.505 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 43.0 Cg_endo -68.7 88.88 0.42 Allowed 'Trans proline' 0 N--CA 1.49 1.276 0 O-C-N 123.91 1.479 . . . . 0.0 109.163 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 58' ' ' VAL . 58.2 t -98.18 119.17 45.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.485 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.644 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.3 t80 -70.97 101.54 2.2 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 118.85 -1.14 . . . . 0.0 107.95 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.906 HD13 ' SD ' ' A' ' 44' ' ' MET . 3.2 mp -80.75 138.34 19.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.638 -0.664 . . . . 0.0 110.566 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.445 ' C ' HG13 ' A' ' 45' ' ' VAL . 60.8 p -98.71 -161.23 0.86 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 177.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.615 ' CA ' HG13 ' A' ' 45' ' ' VAL . 0.6 OUTLIER -85.29 5.79 28.98 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.823 -1.173 . . . . 0.0 111.081 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -128.57 -11.53 5.0 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.739 -1.226 . . . . 0.0 113.053 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.691 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 9.0 mtt -88.37 -5.59 58.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.519 -1.363 . . . . 0.0 110.618 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 68' ' ' GLY . 9.0 p -81.79 165.19 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.073 -1.017 . . . . 0.0 111.535 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.498 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 109.05 -18.16 31.4 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.825 ' O ' HG23 ' A' ' 39' ' ' THR . 12.1 m80 -115.89 -86.14 0.62 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -1.204 . . . . 0.0 110.695 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.37 -35.09 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 122.215 1.007 . . . . 0.0 109.291 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.602 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 0.5 OUTLIER 179.63 -16.08 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.864 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.78 -15.1 73.43 Favored Glycine 0 N--CA 1.497 2.715 0 O-C-N 120.889 -1.132 . . . . 0.0 110.458 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.625 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 1.6 mm-40 -81.45 -17.78 47.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.362 -1.081 . . . . 0.0 108.805 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.691 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 9.2 m-85 -97.03 -20.23 18.19 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.578 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -134.24 54.11 11.31 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.764 -0.585 . . . . 0.0 109.94 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.578 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 48.9 Cg_endo -85.13 50.12 2.73 Favored 'Trans proline' 0 C--N 1.32 -0.962 0 O-C-N 123.476 1.25 . . . . 0.0 110.375 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.7 m -92.91 83.48 4.76 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.55 -0.719 . . . . 0.0 110.052 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.49 ' O ' HG22 ' A' ' 79' ' ' THR . 11.1 mtp-105 50.57 73.77 0.26 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.743 -0.598 . . . . 0.0 110.473 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 78' ' ' ARG . 14.7 t 39.04 44.19 0.88 Allowed 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 121.374 0.607 . . . . 0.0 111.592 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.325 -0.859 . . . . 0.0 110.189 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.4 t -88.74 126.39 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.511 -0.994 . . . . 0.0 109.961 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -134.23 149.8 51.0 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.657 -0.652 . . . . 0.0 109.964 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.0 t -110.22 124.19 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.951 ' OD1' HD23 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -45.1 107.14 0.09 Allowed 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.375 0.607 . . . . 0.0 111.427 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.78 -27.02 64.57 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.827 ' CB ' HG23 ' A' ' 33' ' ' THR . 1.0 OUTLIER -68.78 -15.81 63.62 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.943 -0.473 . . . . 0.0 110.171 178.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.088 HD11 ' SD ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -84.36 -39.08 19.52 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.466 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.84 ' HA ' HG12 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -69.07 -43.79 73.9 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.605 -0.685 . . . . 0.0 110.714 179.417 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.443 ' HG2' ' HA ' ' A' ' 14' ' ' HIS . 5.8 pt-20 -53.93 -19.39 4.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.446 -0.784 . . . . 0.0 110.885 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.563 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.1 mtmt -112.49 -33.6 6.11 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.261 -0.9 . . . . 0.0 111.134 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.885 HG21 ' SD ' ' A' ' 44' ' ' MET . 1.1 p -73.73 -39.69 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.081 -1.012 . . . . 0.0 111.591 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.457 HD11 ' HB3' ' A' ' 16' ' ' LEU . 18.1 mt -60.11 -37.88 81.33 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.07 -40.24 92.92 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.593 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.689 HD23 ' CB ' ' A' ' 27' ' ' GLU . 1.1 mt -71.92 -26.63 62.38 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.272 -0.892 . . . . 0.0 110.289 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -80.66 -10.75 59.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.558 -0.714 . . . . 0.0 109.636 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.98 -35.62 15.43 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.482 -0.761 . . . . 0.0 110.172 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.478 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -102.39 -25.89 13.48 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.547 -0.721 . . . . 0.0 109.793 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.55 29.49 12.06 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.689 ' CB ' HD23 ' A' ' 22' ' ' LEU . 5.0 mm-40 -80.14 149.37 30.58 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.446 -1.032 . . . . 0.0 110.351 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -111.8 86.0 2.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.579 -0.701 . . . . 0.0 109.953 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -136.34 -160.13 1.02 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.484 -0.76 . . . . 0.0 110.53 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.543 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -119.52 156.69 29.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.649 -0.657 . . . . 0.0 110.206 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.659 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 2.7 mp -124.79 123.39 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.37 -0.831 . . . . 0.0 109.75 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.505 ' HE3' HD11 ' A' ' 30' ' ' LEU . 1.1 mptt -98.28 151.15 20.79 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.246 -0.909 . . . . 0.0 111.137 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.949 HG21 ' HB2' ' A' ' 12' ' ' ASP . 18.4 m -136.15 162.47 32.86 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.652 -0.655 . . . . 0.0 109.584 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.428 ' CD1' ' NE2' ' A' ' 57' ' ' HIS . 27.9 m-90 -141.44 38.36 1.7 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.279 -0.888 . . . . 0.0 110.768 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.7 m -82.82 -101.23 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.208 -0.932 . . . . 0.0 110.566 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.43 -68.69 0.12 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.041 -1.037 . . . . 0.0 109.756 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.509 ' HG2' ' HD1' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -106.48 50.76 0.76 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.777 0.799 . . . . 0.0 108.857 178.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.445 ' OG ' ' HB3' ' A' ' 12' ' ' ASP . 22.4 m -47.86 111.01 0.37 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.302 0.572 . . . . 0.0 111.905 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 69' ' ' HIS . 28.7 m -105.43 155.84 18.76 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.693 -0.63 . . . . 0.0 109.597 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.746 HG21 HG21 ' A' ' 62' ' ' ILE . 4.4 mp -77.82 167.87 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.145 -0.972 . . . . 0.0 111.297 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.77 HG12 ' HD2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -137.5 176.73 2.53 Favored Pre-proline 0 N--CA 1.501 2.081 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.142 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.77 ' HD2' HG12 ' A' ' 41' ' ' VAL . 45.1 Cg_endo -68.42 -35.18 18.66 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.889 1.468 . . . . 0.0 111.335 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.52 ' HB2' ' CE ' ' A' ' 44' ' ' MET . 0.8 OUTLIER -66.0 -9.93 34.82 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.461 -0.775 . . . . 0.0 110.677 179.099 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . 1.088 ' SD ' HD11 ' A' ' 15' ' ' LEU . 4.0 mmt -88.14 0.93 55.44 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.348 -0.845 . . . . 0.0 111.323 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.476 HG23 ' N ' ' A' ' 64' ' ' GLU . 5.6 p -54.98 -2.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.18 34.66 1.19 Allowed Glycine 0 N--CA 1.492 2.426 0 O-C-N 120.43 -1.419 . . . . 0.0 109.605 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.532 ' HB2' HD11 ' A' ' 49' ' ' ILE . 56.1 m-70 -142.54 150.94 41.09 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.304 -1.115 . . . . 0.0 111.127 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.733 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.75 81.41 2.46 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.15 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.009 HG12 HD13 ' A' ' 15' ' ' LEU . 3.0 mt -85.54 121.88 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 111.654 -176.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.76 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.85 82.48 5.05 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 122.102 0.953 . . . . 0.0 108.888 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 51' ' ' VAL . 33.2 m -63.0 127.52 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.542 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 33' ' ' THR . 20.2 t80 -71.71 104.29 3.33 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -70.68 -1.43 11.32 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.557 -0.715 . . . . 0.0 110.553 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.29 -21.05 8.84 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -140.18 -29.75 0.69 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.882 -0.775 . . . . 0.0 110.82 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.41 155.67 49.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.332 -0.855 . . . . 0.0 111.928 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.432 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 6.0 m80 -102.51 103.99 14.38 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.76 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 28.7 t -93.55 102.78 8.28 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.3 -0.875 . . . . 0.0 110.106 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.501 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.5 Cg_endo -66.59 89.32 0.28 Allowed 'Trans proline' 0 N--CA 1.492 1.404 0 O-C-N 123.878 1.462 . . . . 0.0 109.195 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 58' ' ' VAL . 48.1 t -97.57 118.68 44.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.201 -178.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.733 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.6 t80 -73.19 103.9 4.06 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.91 HD13 ' HB3' ' A' ' 44' ' ' MET . 2.7 mp -84.45 144.82 9.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.675 0.75 . . . . 0.0 111.64 -178.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.9 p -111.03 -158.71 0.65 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.476 ' N ' HG23 ' A' ' 45' ' ' VAL . 3.5 tp10 -90.59 15.14 11.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.588 -1.32 . . . . 0.0 110.997 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -137.95 -13.47 1.43 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.919 -1.113 . . . . 0.0 112.527 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.682 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 28.3 mmt -88.04 -24.97 23.32 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.605 -1.309 . . . . 0.0 110.327 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.591 HG21 ' C ' ' A' ' 41' ' ' VAL . 4.2 p -66.61 163.45 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.388 -0.82 . . . . 0.0 111.437 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.499 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 118.17 -14.79 12.23 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.113 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.782 ' O ' HG23 ' A' ' 39' ' ' THR . 24.0 m80 -127.21 -81.14 0.6 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.965 -1.315 . . . . 0.0 111.497 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.606 ' HD3' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER 177.42 -31.97 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.717 0.77 . . . . 0.0 110.268 -179.264 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.606 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.7 OUTLIER 173.82 -16.0 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.757 -179.553 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.53 -18.02 73.29 Favored Glycine 0 N--CA 1.496 2.639 0 O-C-N 120.946 -1.096 . . . . 0.0 110.503 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.61 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 1.3 mt-10 -84.62 -20.07 31.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.407 -1.054 . . . . 0.0 109.124 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.682 ' CD2' ' HB3' ' A' ' 66' ' ' MET . 20.8 m-85 -92.6 -20.52 20.8 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.587 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -134.73 54.49 11.59 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.747 -0.596 . . . . 0.0 109.719 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.587 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 48.7 Cg_endo -85.01 50.77 2.95 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.615 1.324 . . . . 0.0 110.337 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.1 m -72.12 127.37 32.34 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.633 -0.667 . . . . 0.0 110.101 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.0 ptt-85 -75.57 148.57 38.76 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.542 -0.724 . . . . 0.0 110.536 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.2 m -139.61 104.87 5.03 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.52 -0.738 . . . . 0.0 109.99 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.065 0 O-C-N 121.782 -0.573 . . . . 0.0 110.695 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.6 t -113.05 106.89 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.445 -1.032 . . . . 0.0 109.969 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.767 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -119.61 144.06 47.32 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.526 -0.734 . . . . 0.0 109.543 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.561 HG22 ' HB ' ' A' ' 39' ' ' THR . 69.4 t -101.83 112.05 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.767 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 39.0 t70 -44.68 106.52 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.145 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -67.87 -24.2 65.21 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -66.22 -25.61 66.99 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.942 -0.474 . . . . 0.0 109.91 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.89 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -79.76 -38.16 33.81 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.89 HD12 ' HG ' ' A' ' 15' ' ' LEU . 5.0 mp -62.58 -42.3 99.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.796 -0.565 . . . . 0.0 109.923 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.66 -30.76 22.98 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.136 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.77 -27.99 17.67 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.464 -0.772 . . . . 0.0 110.602 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.908 HG21 ' SD ' ' A' ' 44' ' ' MET . 93.9 t -73.62 -40.16 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.15 -0.969 . . . . 0.0 111.186 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 16' ' ' LEU . 10.9 mt -60.93 -36.43 79.29 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.18 -36.09 83.12 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.051 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.42 HD12 ' O ' ' A' ' 27' ' ' GLU . 2.9 mm? -77.63 -26.57 50.65 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.258 -0.901 . . . . 0.0 109.666 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -81.96 -12.48 58.34 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.623 -0.673 . . . . 0.0 109.757 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.59 -34.53 27.65 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.417 -0.802 . . . . 0.0 109.512 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 16.3 mmtt -93.11 -15.87 25.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.773 -0.579 . . . . 0.0 109.8 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.21 28.99 34.97 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' O ' HD12 ' A' ' 22' ' ' LEU . 28.3 mt-10 -106.48 148.74 27.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.649 -0.912 . . . . 0.0 110.705 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 mtmm -113.36 90.81 3.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.586 -0.696 . . . . 0.0 109.97 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.412 ' HB2' HD11 ' A' ' 22' ' ' LEU . 3.9 ttt-85 -113.5 -158.32 0.65 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.459 -0.776 . . . . 0.0 110.305 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.634 HD11 ' HD3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -116.19 148.39 40.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.574 -0.704 . . . . 0.0 110.274 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.749 HD13 HG22 ' A' ' 19' ' ' VAL . 3.2 mp -121.83 118.75 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.594 -0.691 . . . . 0.0 109.552 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.634 ' HD3' HD11 ' A' ' 30' ' ' LEU . 20.5 mmmt -78.9 152.93 30.89 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.453 -0.779 . . . . 0.0 111.029 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.67 HG23 ' CG ' ' A' ' 12' ' ' ASP . 24.1 m -139.69 153.16 47.18 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.589 -0.694 . . . . 0.0 109.778 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.463 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 9.7 m-90 -145.3 36.44 1.1 Allowed 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.22 -0.925 . . . . 0.0 111.6 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 m -86.86 -95.97 0.08 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.764 -1.21 . . . . 0.0 110.361 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.413 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -173.99 -63.02 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.191 -0.943 . . . . 0.0 109.464 179.698 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.43 ' HG3' ' HB3' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -102.24 36.85 2.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.591 -0.693 . . . . 0.0 109.212 178.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.414 ' OG ' HG21 ' A' ' 33' ' ' THR . 4.2 m -48.29 144.48 3.91 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.515 0.674 . . . . 0.0 111.77 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.818 HG23 ' O ' ' A' ' 69' ' ' HIS . 52.3 m -133.81 160.19 38.36 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.273 0.558 . . . . 0.0 109.678 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.778 ' CG2' HG12 ' A' ' 62' ' ' ILE . 1.2 mp -83.41 164.78 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.632 -0.668 . . . . 0.0 111.846 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.877 HG21 HD11 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -134.15 174.21 4.92 Favored Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.787 -0.57 . . . . 0.0 109.466 178.541 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.749 ' HD2' HG12 ' A' ' 41' ' ' VAL . 46.0 Cg_endo -68.92 -34.65 17.07 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 124.0 1.526 . . . . 0.0 111.581 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.42 -6.54 25.26 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.408 -0.808 . . . . 0.0 110.742 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.908 ' SD ' HG21 ' A' ' 19' ' ' VAL . 6.6 mmt -86.31 -6.29 58.99 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.365 -0.835 . . . . 0.0 111.658 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.646 HG23 ' N ' ' A' ' 64' ' ' GLU . 6.0 p -51.51 1.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.406 ' C ' ' CG ' ' A' ' 47' ' ' HIS . . . -146.27 33.19 1.48 Allowed Glycine 0 N--CA 1.495 2.575 0 O-C-N 119.93 -1.731 . . . . 0.0 110.071 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.459 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 14.6 m80 -147.66 153.98 40.03 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.106 -1.232 . . . . 0.0 111.181 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.64 88.76 3.92 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.826 HD12 HD13 ' A' ' 62' ' ' ILE . 22.9 mt -86.24 121.94 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.565 -176.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.776 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.16 78.05 5.64 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 51' ' ' VAL . 23.3 m -62.39 128.67 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.643 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 35.3 t80 -75.67 105.48 6.73 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -76.08 8.35 3.31 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.368 -0.833 . . . . 0.0 111.221 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 36' ' ' ARG . . . 122.71 -27.11 6.06 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.49 -24.03 0.79 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.819 -0.812 . . . . 0.0 111.596 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -135.76 154.17 51.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.019 -1.051 . . . . 0.0 112.411 -177.655 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.472 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 1.1 m-70 -100.19 105.2 16.77 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.776 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 23.4 t -94.1 101.26 6.04 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.146 -0.971 . . . . 0.0 109.935 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.538 ' HB3' HD12 ' A' ' 30' ' ' LEU . 41.8 Cg_endo -67.72 93.08 0.37 Allowed 'Trans proline' 0 N--CA 1.489 1.25 0 O-C-N 123.955 1.503 . . . . 0.0 109.697 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.629 ' O ' HD12 ' A' ' 62' ' ' ILE . 16.4 m -109.38 129.07 64.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.829 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.8 t80 -71.35 105.8 3.64 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.826 HD13 HD12 ' A' ' 49' ' ' ILE . 1.6 mp -57.97 -63.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.476 ' O ' HG22 ' A' ' 62' ' ' ILE . 3.0 m 66.3 171.33 0.24 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -176.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.646 ' N ' HG23 ' A' ' 45' ' ' VAL . 2.8 tp10 -83.84 58.58 4.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.372 -1.455 . . . . 0.0 109.26 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -161.25 -36.86 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.306 -0.871 . . . . 0.0 112.181 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.612 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -88.24 -15.98 34.46 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.87 -1.144 . . . . 0.0 111.146 -179.087 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.513 HG21 ' C ' ' A' ' 41' ' ' VAL . 7.5 p -73.66 161.73 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.099 -1.0 . . . . 0.0 112.138 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.48 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 113.56 -19.3 19.39 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.818 ' O ' HG23 ' A' ' 39' ' ' THR . 14.0 m80 -114.9 -84.44 0.61 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.077 -1.249 . . . . 0.0 110.483 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.732 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.19 -34.67 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 122.042 0.925 . . . . 0.0 109.846 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.564 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 0.5 OUTLIER 176.88 -14.26 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.856 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 80' ' ' TYR . . . -70.41 -15.58 72.89 Favored Glycine 0 N--CA 1.496 2.668 0 O-C-N 120.9 -1.125 . . . . 0.0 110.313 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.626 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 1.1 mt-10 -84.18 -13.56 52.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.336 -1.097 . . . . 0.0 109.037 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.653 ' HE2' ' HA ' ' A' ' 62' ' ' ILE . 4.5 m-85 -102.65 -20.17 14.52 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.58 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -135.1 52.54 7.46 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.759 -0.588 . . . . 0.0 110.263 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.58 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 48.6 Cg_endo -82.62 51.28 3.67 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 O-C-N 123.511 1.269 . . . . 0.0 110.318 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.1 t -89.58 -28.05 19.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.511 -0.743 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.0 ttm105 -136.9 68.69 1.42 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.406 -0.808 . . . . 0.0 110.089 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.1 m 52.86 67.92 0.92 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.686 -0.634 . . . . 0.0 110.2 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.532 ' CE1' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.477 -0.765 . . . . 0.0 110.206 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.5 m -94.35 170.81 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.567 -0.961 . . . . 0.0 110.572 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.724 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -131.98 145.48 51.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.505 -0.747 . . . . 0.0 109.888 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.823 HG21 HG13 ' A' ' 41' ' ' VAL . 7.2 p -108.8 113.98 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.776 ' CG ' HG23 ' A' ' 33' ' ' THR . 38.8 t70 -41.96 109.23 0.12 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.716 -0.615 . . . . 0.0 111.682 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -68.52 -24.57 64.67 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.601 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 1.7 t-80 -65.57 -20.64 66.41 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.908 -0.495 . . . . 0.0 110.3 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.954 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -85.32 -38.43 18.81 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.133 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.954 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.7 mp -63.82 -43.13 97.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.83 -0.544 . . . . 0.0 110.26 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.601 ' HG2' ' HA ' ' A' ' 14' ' ' HIS . 0.6 OUTLIER -57.31 -19.15 20.39 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.756 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.423 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 42.0 mttm -102.56 -29.02 11.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.356 -0.84 . . . . 0.0 110.657 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.004 HG21 ' SD ' ' A' ' 44' ' ' MET . 1.7 p -79.55 -36.21 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.154 -0.966 . . . . 0.0 111.479 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.555 HD21 ' HA ' ' A' ' 17' ' ' GLU . 3.8 pp -62.82 -25.66 68.36 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -34.34 63.36 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.707 HD22 ' HB2' ' A' ' 27' ' ' GLU . 1.2 mt -76.27 -27.43 56.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.796 -0.565 . . . . 0.0 109.567 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -84.16 -13.82 51.83 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.613 -0.679 . . . . 0.0 109.676 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.51 -37.94 15.35 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 121.55 -0.718 . . . . 0.0 109.955 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -97.01 -23.97 16.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.575 -0.703 . . . . 0.0 109.654 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.44 25.89 19.71 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.707 ' HB2' HD22 ' A' ' 22' ' ' LEU . 24.9 mt-10 -72.18 125.58 27.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.471 -1.017 . . . . 0.0 110.258 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.18 94.88 9.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.552 -0.717 . . . . 0.0 110.225 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.1 ttp85 -149.59 -160.93 1.24 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.519 -0.738 . . . . 0.0 110.312 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.635 ' HB2' ' HB ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -119.71 165.07 15.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.585 -0.697 . . . . 0.0 110.455 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.757 HG21 HD12 ' A' ' 15' ' ' LEU . 36.3 mm -112.57 159.92 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.321 -0.862 . . . . 0.0 109.026 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.502 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -125.5 153.41 43.61 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.288 -0.883 . . . . 0.0 110.839 -178.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.776 HG23 ' CG ' ' A' ' 12' ' ' ASP . 20.0 m -139.84 154.17 47.25 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.588 -0.695 . . . . 0.0 110.712 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.502 ' CH2' ' HB2' ' A' ' 32' ' ' LYS . 16.6 m-90 -146.49 34.19 0.96 Allowed 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.433 -0.792 . . . . 0.0 111.224 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.69 -93.56 0.11 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.864 -1.148 . . . . 0.0 110.989 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.414 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . 13.5 ttp85 -170.02 -66.49 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.194 -0.941 . . . . 0.0 109.287 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.554 ' HD2' ' HB3' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -104.43 44.0 1.06 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.247 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.541 ' CB ' HG21 ' A' ' 33' ' ' THR . 19.5 m -56.21 153.08 9.86 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.555 0.693 . . . . 0.0 112.317 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.724 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 40.9 m -140.38 162.21 35.86 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.878 -0.514 . . . . 0.0 110.055 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.716 HG21 HG12 ' A' ' 62' ' ' ILE . 4.8 mp -81.81 170.29 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 O-C-N 121.291 -0.881 . . . . 0.0 111.094 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.823 HG13 HG21 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -132.1 175.2 3.88 Favored Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.744 -0.597 . . . . 0.0 109.74 179.073 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.741 ' O ' HG23 ' A' ' 45' ' ' VAL . 47.0 Cg_endo -70.17 -32.7 16.37 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 124.096 1.577 . . . . 0.0 111.539 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.723 ' HG3' HG11 ' A' ' 19' ' ' VAL . 2.0 pt-20 -72.33 -3.43 23.81 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.275 -0.891 . . . . 0.0 110.957 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . 1.004 ' SD ' HG21 ' A' ' 19' ' ' VAL . 23.5 mmm -91.1 15.65 11.27 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.296 -0.878 . . . . 0.0 112.231 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 42' ' ' PRO . 66.0 t -64.73 4.49 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 O-C-N 120.947 -1.096 . . . . 0.0 113.129 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.35 29.84 1.07 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.438 ' HB2' ' CE ' ' A' ' 44' ' ' MET . 14.7 m80 -139.09 150.71 46.03 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.377 -1.072 . . . . 0.0 110.701 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.635 ' HB ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.65 86.31 3.31 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.139 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.791 HD11 ' CG ' ' A' ' 44' ' ' MET . 58.3 mt -72.53 117.79 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.17 -0.956 . . . . 0.0 111.298 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.675 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.91 73.99 6.66 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.613 HG21 ' HB3' ' A' ' 71' ' ' LEU . 34.2 m -56.27 126.29 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.305 -177.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.522 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 29.0 t80 -76.93 101.99 6.19 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -74.55 9.97 1.54 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.485 -0.76 . . . . 0.0 111.065 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 36' ' ' ARG . . . 121.67 -27.86 6.12 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.75 -25.85 0.75 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.837 -0.802 . . . . 0.0 111.602 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.522 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -130.74 153.89 48.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.149 -0.969 . . . . 0.0 112.377 -177.616 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.521 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 6.3 m-70 -99.74 99.19 9.98 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.675 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 46.5 t -86.57 104.73 6.22 Favored Pre-proline 0 N--CA 1.501 2.102 0 O-C-N 121.215 -0.928 . . . . 0.0 109.505 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 57' ' ' HIS . 42.7 Cg_endo -67.08 90.68 0.31 Allowed 'Trans proline' 0 N--CA 1.489 1.258 0 O-C-N 123.892 1.47 . . . . 0.0 110.251 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 60' ' ' VAL . 35.6 m -95.83 111.36 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.39 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.582 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.2 t80 -72.59 104.46 3.88 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.015 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.716 HG12 HG21 ' A' ' 40' ' ' ILE . 2.7 mp -85.59 127.98 39.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.578 -0.701 . . . . 0.0 111.324 -178.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.508 ' C ' HG13 ' A' ' 45' ' ' VAL . 46.3 p -92.71 -153.28 0.34 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.565 ' N ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -87.97 8.0 28.44 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.711 -1.243 . . . . 0.0 111.196 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -147.64 21.11 1.16 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.959 -1.088 . . . . 0.0 111.775 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.725 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 7.8 mmt -107.61 -26.51 10.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.235 -0.916 . . . . 0.0 109.804 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.565 ' HB ' HG21 ' A' ' 62' ' ' ILE . 6.8 p -65.36 163.7 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 121.469 -0.769 . . . . 0.0 111.691 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.487 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 122.42 -10.2 9.28 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.397 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.717 ' O ' HG23 ' A' ' 39' ' ' THR . 14.7 m80 -123.82 -86.26 0.64 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.128 1.464 . . . . 0.0 110.983 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.724 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.31 -30.29 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.556 0.693 . . . . 0.0 110.308 -179.626 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.629 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.8 OUTLIER 174.27 -15.21 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.769 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.65 -18.46 78.65 Favored Glycine 0 N--CA 1.495 2.606 0 O-C-N 120.929 -1.107 . . . . 0.0 110.633 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.498 ' HG3' ' ND1' ' A' ' 69' ' ' HIS . 22.2 mm-40 -84.25 -18.64 35.8 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.22 -1.165 . . . . 0.0 109.349 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.725 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 3.7 m-85 -105.4 -16.58 14.7 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.596 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -136.45 54.2 8.9 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.639 -0.663 . . . . 0.0 109.75 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.596 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 46.5 Cg_endo -84.52 51.34 3.23 Favored 'Trans proline' 0 C--N 1.32 -0.925 0 O-C-N 123.629 1.331 . . . . 0.0 110.382 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.8 m -66.4 -44.95 81.58 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.612 -0.68 . . . . 0.0 110.255 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.68 138.79 39.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.661 -0.649 . . . . 0.0 110.202 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 86.8 m -82.77 104.64 13.16 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.443 -0.786 . . . . 0.0 110.062 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.049 0 O-C-N 121.744 -0.597 . . . . 0.0 110.665 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.7 p -80.9 151.23 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.558 -0.966 . . . . 0.0 110.387 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.734 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -129.11 134.79 48.22 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.471 -0.768 . . . . 0.0 110.075 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.967 HG21 HG13 ' A' ' 41' ' ' VAL . 7.5 p -101.83 115.68 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 178.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.734 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 27.8 t70 -46.34 107.06 0.09 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.476 0.655 . . . . 0.0 111.303 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -69.6 -24.48 63.67 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -64.67 -28.45 69.61 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.809 -0.557 . . . . 0.0 109.841 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.844 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -77.25 -37.72 52.53 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.396 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.844 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.1 mp -60.47 -47.29 86.78 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.171 0.51 . . . . 0.0 109.736 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.1 -23.06 4.79 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.648 -0.657 . . . . 0.0 110.722 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.28 -25.27 12.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.331 -0.855 . . . . 0.0 110.679 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -79.81 -36.14 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.268 -0.895 . . . . 0.0 110.841 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 16' ' ' LEU . 9.2 mt -63.74 -36.53 84.17 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 178.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.93 -34.35 75.93 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.566 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.575 ' HG ' ' HB3' ' A' ' 27' ' ' GLU . 1.5 mp -79.0 -27.1 43.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.543 -0.723 . . . . 0.0 109.578 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -84.33 -11.22 56.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.567 -0.708 . . . . 0.0 109.408 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.73 -41.37 11.94 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.619 -0.676 . . . . 0.0 110.396 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.448 ' HG3' ' N ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -99.44 -27.06 13.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.371 -0.831 . . . . 0.0 110.076 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.448 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . 105.24 27.51 5.84 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.575 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -79.49 135.85 36.75 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.397 -1.06 . . . . 0.0 110.268 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -114.14 61.84 0.66 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.626 -0.671 . . . . 0.0 109.508 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -109.33 -154.8 0.54 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.504 -0.747 . . . . 0.0 110.187 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -117.59 156.43 28.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.453 -0.78 . . . . 0.0 110.637 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.515 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 3.5 mt -127.71 114.5 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HD3' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -110.44 153.04 25.56 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.293 -0.879 . . . . 0.0 111.203 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.52 HG21 ' CG ' ' A' ' 12' ' ' ASP . 15.3 t -144.75 -173.39 4.05 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.473 -0.767 . . . . 0.0 111.067 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.662 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 19.4 m-90 -139.68 39.33 2.02 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.182 -0.949 . . . . 0.0 111.633 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.01 -99.35 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.726 -1.234 . . . . 0.0 110.402 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.31 -62.41 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.935 -1.103 . . . . 0.0 109.684 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.436 ' HG2' ' HD2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -106.19 38.35 2.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.541 -0.724 . . . . 0.0 109.242 178.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.524 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 1.1 m -41.5 114.97 0.57 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.335 0.588 . . . . 0.0 111.616 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.826 HG23 ' O ' ' A' ' 69' ' ' HIS . 25.9 m -106.71 161.94 14.21 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.536 -0.728 . . . . 0.0 110.436 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.87 HG21 HG21 ' A' ' 62' ' ' ILE . 1.2 mp -83.91 168.06 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.472 -0.767 . . . . 0.0 111.904 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.967 HG13 HG21 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -140.2 174.01 4.44 Favored Pre-proline 0 N--CA 1.501 2.109 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.301 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.513 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 42.3 Cg_endo -66.03 -30.61 47.52 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.923 1.486 . . . . 0.0 110.823 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.504 ' OE1' HD23 ' A' ' 20' ' ' LEU . 5.5 mm-40 -73.51 -4.68 35.37 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.584 -0.698 . . . . 0.0 110.948 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.681 ' HG2' HD13 ' A' ' 49' ' ' ILE . 51.4 mtp -97.27 2.53 50.91 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.115 -0.991 . . . . 0.0 111.033 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.625 HG23 ' N ' ' A' ' 64' ' ' GLU . 7.6 p -59.97 3.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.09 33.49 1.03 Allowed Glycine 0 N--CA 1.493 2.476 0 O-C-N 120.208 -1.558 . . . . 0.0 110.144 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.859 ' HB2' HD11 ' A' ' 49' ' ' ILE . 38.0 m-70 -145.51 156.34 43.65 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.219 -1.165 . . . . 0.0 111.048 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.682 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.87 86.25 3.25 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.514 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.859 HD11 ' HB2' ' A' ' 47' ' ' HIS . 3.1 mp -91.87 117.84 36.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.18 -0.95 . . . . 0.0 111.556 -177.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.788 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.21 89.16 4.88 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 122.162 0.982 . . . . 0.0 109.311 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.524 ' HB ' ' HB3' ' A' ' 38' ' ' SER . 26.2 m -66.39 127.43 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.131 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.662 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 26.1 t80 -70.01 108.49 4.07 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.174 -1.011 . . . . 0.0 108.911 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -75.92 16.57 0.4 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.666 -0.646 . . . . 0.0 110.322 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.93 -28.87 13.01 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -140.56 -26.76 0.74 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.528 -0.983 . . . . 0.0 111.14 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -127.74 156.52 42.29 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.697 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 76.8 m-70 -95.51 120.01 35.01 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.788 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 16.9 t -109.43 85.32 3.55 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.162 -0.961 . . . . 0.0 109.194 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.544 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.6 Cg_endo -67.6 85.57 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.348 0 O-C-N 123.852 1.448 . . . . 0.0 109.312 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.696 ' CG2' HG12 ' A' ' 58' ' ' VAL . 50.5 t -99.46 123.12 51.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.844 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.682 ' HB2' HG23 ' A' ' 48' ' ' THR . 4.1 t80 -72.53 102.28 3.2 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.87 HG21 HG21 ' A' ' 40' ' ' ILE . 3.0 mp -80.87 140.76 16.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.843 0.83 . . . . 0.0 111.769 -177.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.573 ' C ' HG23 ' A' ' 45' ' ' VAL . 69.5 p -105.51 -158.83 0.68 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.625 ' N ' HG23 ' A' ' 45' ' ' VAL . 4.2 tp10 -90.55 7.43 39.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.708 -1.245 . . . . 0.0 111.244 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.445 ' ND2' ' HG3' ' A' ' 66' ' ' MET . 2.4 p-10 -127.33 -17.82 4.62 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.723 -1.235 . . . . 0.0 112.625 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.634 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 26.3 mtt -86.1 -17.95 33.69 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.625 -1.297 . . . . 0.0 110.399 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.539 HG21 ' C ' ' A' ' 41' ' ' VAL . 7.6 p -71.49 162.75 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.248 -0.908 . . . . 0.0 111.316 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.481 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 114.31 -16.94 19.52 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.826 ' O ' HG23 ' A' ' 39' ' ' THR . 16.4 m80 -120.5 -81.94 0.64 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.11 -1.229 . . . . 0.0 110.744 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.54 -34.72 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.03 0.919 . . . . 0.0 109.747 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.597 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 0.7 OUTLIER 176.37 -15.29 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.195 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.926 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.52 -16.46 71.73 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 120.985 -1.072 . . . . 0.0 110.537 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.637 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 1.2 mt-10 -83.96 -15.79 46.5 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.328 -1.101 . . . . 0.0 109.099 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.634 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 9.6 m-85 -97.06 -20.35 18.09 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.589 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -134.08 53.26 9.5 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.906 -0.496 . . . . 0.0 110.045 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.589 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 49.0 Cg_endo -84.25 50.74 3.13 Favored 'Trans proline' 0 C--N 1.321 -0.913 0 O-C-N 123.443 1.233 . . . . 0.0 110.13 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -130.17 152.84 49.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.589 -0.694 . . . . 0.0 110.252 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.6 mmp_? -74.66 106.7 6.35 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.504 -0.747 . . . . 0.0 109.975 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.2 p -127.53 138.37 52.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.512 -0.743 . . . . 0.0 110.285 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.6 t80 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.565 -0.71 . . . . 0.0 110.141 -179.932 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.4 t -115.03 129.1 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.56 -0.965 . . . . 0.0 110.135 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.763 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -122.65 153.77 38.92 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.55 -0.719 . . . . 0.0 109.849 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 39' ' ' THR . 12.5 p -111.71 117.15 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.536 -0.728 . . . . 0.0 109.052 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.801 ' CG ' HG23 ' A' ' 33' ' ' THR . 37.2 t70 -46.43 105.2 0.06 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.507 -0.745 . . . . 0.0 111.422 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -67.1 -23.29 65.82 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -66.46 -26.67 67.31 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.899 -0.501 . . . . 0.0 109.955 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.869 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -81.37 -39.19 25.42 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.458 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.869 HD12 ' HG ' ' A' ' 15' ' ' LEU . 5.1 mp -62.22 -41.58 98.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.843 -0.536 . . . . 0.0 109.672 178.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.8 -30.88 6.2 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.741 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB3' HD12 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -90.33 -30.89 17.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.529 -0.732 . . . . 0.0 110.327 179.058 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.074 HG21 ' HE3' ' A' ' 44' ' ' MET . 71.8 t -72.63 -36.05 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.264 -0.897 . . . . 0.0 111.689 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 16' ' ' LEU . 12.2 mt -61.28 -37.66 83.96 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' A' ' 18' ' ' LYS . 3.0 tm-20 -63.2 -39.74 95.51 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.322 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.71 HD23 ' HB2' ' A' ' 27' ' ' GLU . 3.6 mt -74.08 -22.08 59.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.274 -0.891 . . . . 0.0 110.091 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -83.43 -12.33 56.53 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.374 -0.829 . . . . 0.0 109.585 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.49 -39.18 16.53 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.447 -0.783 . . . . 0.0 109.757 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.429 ' HE3' ' HG2' ' A' ' 21' ' ' GLU . 65.3 mttt -97.52 -32.97 11.54 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.457 0.646 . . . . 0.0 109.325 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.74 19.53 19.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.71 ' HB2' HD23 ' A' ' 22' ' ' LEU . 28.8 mt-10 -71.22 140.36 50.42 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.509 -0.995 . . . . 0.0 110.351 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -110.73 76.84 1.0 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.475 -0.766 . . . . 0.0 109.762 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.83 -155.79 0.58 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.512 -0.742 . . . . 0.0 110.418 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.475 ' O ' HD13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -115.51 167.97 10.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.568 -0.707 . . . . 0.0 110.316 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.703 HD11 ' CD1' ' A' ' 22' ' ' LEU . 45.3 mm -126.72 157.99 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.438 -0.789 . . . . 0.0 109.79 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -120.74 130.67 54.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.548 -0.72 . . . . 0.0 110.319 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.801 HG23 ' CG ' ' A' ' 12' ' ' ASP . 18.2 m -119.54 159.82 23.6 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.572 -0.705 . . . . 0.0 110.318 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 19.3 m-90 -145.02 16.57 1.56 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.314 -0.866 . . . . 0.0 111.819 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.62 -152.72 0.07 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.918 -1.114 . . . . 0.0 110.785 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.78 -61.78 1.66 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.072 -1.018 . . . . 0.0 110.067 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.501 ' HG2' ' HD1' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -100.49 43.86 1.04 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.562 -0.711 . . . . 0.0 109.854 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.442 ' CB ' HG21 ' A' ' 33' ' ' THR . 73.1 m -50.5 134.71 23.6 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.396 0.617 . . . . 0.0 111.606 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 69' ' ' HIS . 27.1 m -130.18 161.95 29.98 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.811 -0.555 . . . . 0.0 109.748 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.767 ' CG2' HG12 ' A' ' 62' ' ' ILE . 5.0 mp -85.97 170.28 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.375 -0.828 . . . . 0.0 111.121 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.988 HG23 ' SD ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -135.84 175.45 3.57 Favored Pre-proline 0 N--CA 1.505 2.308 0 O-C-N 121.463 -0.773 . . . . 0.0 110.049 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.791 ' HD2' HG12 ' A' ' 41' ' ' VAL . 47.0 Cg_endo -69.43 -34.61 15.31 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 124.024 1.539 . . . . 0.0 111.719 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.737 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 0.7 OUTLIER -71.87 0.53 8.91 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.298 -0.876 . . . . 0.0 111.171 179.62 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . 1.074 ' HE3' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -90.15 -3.86 57.63 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.15 -0.969 . . . . 0.0 111.224 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.611 HG23 ' N ' ' A' ' 64' ' ' GLU . 4.4 p -49.1 2.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.6 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 44' ' ' MET . . . -146.15 30.02 1.63 Allowed Glycine 0 N--CA 1.496 2.634 0 O-C-N 119.798 -1.814 . . . . 0.0 110.292 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.499 ' HB2' HD11 ' A' ' 49' ' ' ILE . 5.1 m80 -147.43 155.75 42.23 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.159 -1.201 . . . . 0.0 111.059 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.98 89.35 4.03 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.07 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.845 ' CD1' HD13 ' A' ' 62' ' ' ILE . 2.3 mp -86.64 118.16 32.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.443 -0.786 . . . . 0.0 111.752 -176.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.778 ' HB1' ' HB3' ' A' ' 57' ' ' HIS . . . -78.91 84.85 4.91 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.973 0.892 . . . . 0.0 109.106 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.531 HG21 ' O ' ' A' ' 70' ' ' LYS . 23.0 m -61.97 129.09 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.534 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.5 ' HB2' ' O ' ' A' ' 33' ' ' THR . 26.5 t80 -78.0 106.44 9.86 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.082 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -75.01 13.76 0.63 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.702 -0.624 . . . . 0.0 110.598 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.58 -25.74 20.29 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -140.51 -25.9 0.76 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.617 -0.931 . . . . 0.0 111.24 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -131.96 151.88 51.45 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.778 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 66.5 m80 -93.13 117.48 30.12 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.771 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 21.8 t -106.91 87.46 2.95 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.079 -1.013 . . . . 0.0 109.338 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.55 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.3 Cg_endo -65.69 93.04 0.25 Allowed 'Trans proline' 0 N--CA 1.489 1.254 0 O-C-N 123.952 1.501 . . . . 0.0 109.814 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.687 ' O ' HD12 ' A' ' 62' ' ' ILE . 12.4 m -107.05 125.97 63.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.655 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.408 ' N ' HG23 ' A' ' 48' ' ' THR . 2.8 t80 -71.64 103.52 3.06 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.845 HD13 ' CD1' ' A' ' 49' ' ' ILE . 1.6 mp -56.53 -56.74 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -176.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.536 ' O ' HG22 ' A' ' 62' ' ' ILE . 2.7 m 64.62 178.46 0.18 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -177.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.611 ' N ' HG23 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -86.43 48.91 1.7 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.517 -1.364 . . . . 0.0 111.102 -179.314 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -171.81 -9.09 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.889 -1.132 . . . . 0.0 113.979 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.671 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 29.3 mtt -99.63 -23.48 15.04 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.203 -1.56 . . . . 0.0 111.202 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.58 HG21 ' C ' ' A' ' 41' ' ' VAL . 2.7 p -67.76 163.48 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.489 0 O-C-N 121.284 -0.885 . . . . 0.0 112.514 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.501 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 122.75 -11.33 8.89 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.956 177.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.723 ' O ' HG23 ' A' ' 39' ' ' THR . 15.7 m80 -125.14 -83.02 0.64 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.135 1.468 . . . . 0.0 110.77 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.34 -31.22 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.588 0.708 . . . . 0.0 110.258 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.574 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 1.0 OUTLIER 173.62 -15.94 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.709 -179.839 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.02 -18.19 76.19 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.483 ' HG3' ' ND1' ' A' ' 69' ' ' HIS . 23.1 mm-40 -84.7 -19.53 32.63 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.291 -1.123 . . . . 0.0 109.184 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.674 ' HE1' HD13 ' A' ' 40' ' ' ILE . 15.6 m-85 -98.08 -18.22 18.66 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.594 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -134.38 52.23 7.5 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.592 -0.693 . . . . 0.0 110.091 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.594 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 50.0 Cg_endo -84.6 51.58 3.28 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 O-C-N 123.509 1.268 . . . . 0.0 110.056 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 42.0 m -60.07 -49.29 78.24 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.701 -0.625 . . . . 0.0 110.459 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.01 129.27 35.32 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.56 -0.713 . . . . 0.0 110.056 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 26.4 m -144.78 -54.47 0.32 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.383 -0.823 . . . . 0.0 110.169 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 . . . . . 0 N--CA 1.496 1.83 0 O-C-N 121.499 -0.75 . . . . 0.0 110.112 -179.964 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.6 m -80.08 150.02 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.547 -0.973 . . . . 0.0 110.517 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.72 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -111.13 151.61 27.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.548 -0.72 . . . . 0.0 110.034 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.864 HG11 HG13 ' A' ' 41' ' ' VAL . 92.6 t -100.08 110.18 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.294 -0.879 . . . . 0.0 108.872 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.72 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 38.5 t70 -48.42 111.0 0.39 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.405 0.621 . . . . 0.0 111.306 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.35 -23.7 64.73 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -65.61 -28.58 69.22 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.92 -0.488 . . . . 0.0 110.493 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.885 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -77.57 -37.61 50.19 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.498 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.885 HD12 ' HG ' ' A' ' 15' ' ' LEU . 3.8 mp -60.96 -44.4 97.37 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 120.983 0.421 . . . . 0.0 109.946 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.525 ' HG2' ' HE3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -53.9 -25.36 19.81 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.273 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HE3' ' HG2' ' A' ' 17' ' ' GLU . 5.1 mtmt -101.77 -29.67 11.74 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.485 -0.759 . . . . 0.0 110.371 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.781 HG12 ' HA ' ' A' ' 16' ' ' LEU . 1.1 p -75.82 -35.93 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.366 -0.834 . . . . 0.0 111.37 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 16' ' ' LEU . 3.8 pp -62.98 -28.68 70.26 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -71.91 -35.28 69.63 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.452 HD12 HD11 ' A' ' 31' ' ' ILE . 3.3 mt -73.57 -27.26 61.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.651 -0.656 . . . . 0.0 109.753 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -84.93 -17.82 36.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.596 -0.69 . . . . 0.0 109.374 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.33 -38.77 15.94 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.535 -0.728 . . . . 0.0 109.738 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.1 mttm -90.39 -26.34 19.95 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.08 15.14 49.55 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.432 ' HB2' HD22 ' A' ' 22' ' ' LEU . 20.7 mt-10 -80.95 124.93 29.54 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.382 -1.07 . . . . 0.0 110.364 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -98.87 74.15 2.02 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.574 -0.704 . . . . 0.0 109.517 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.413 ' H ' HD13 ' A' ' 22' ' ' LEU . 1.3 ttp180 -108.15 -151.56 0.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.667 -0.645 . . . . 0.0 110.079 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -118.08 153.68 33.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 110.71 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.552 HD13 HG23 ' A' ' 19' ' ' VAL . 2.7 mp -127.26 119.08 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.516 -0.74 . . . . 0.0 109.186 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.522 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 4.7 mptt -84.42 158.82 20.95 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.306 -0.871 . . . . 0.0 111.366 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.694 HG23 ' CG ' ' A' ' 12' ' ' ASP . 15.9 m -141.47 155.97 45.8 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.706 -0.622 . . . . 0.0 109.713 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.498 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 12.0 m-90 -145.76 36.54 1.06 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.225 -0.922 . . . . 0.0 111.404 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -91.91 -95.16 0.13 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.891 -1.131 . . . . 0.0 110.826 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.9 tpt85 -170.2 -63.5 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.084 -1.01 . . . . 0.0 110.514 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -99.27 37.52 1.55 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.267 -0.896 . . . . 0.0 110.007 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.585 ' OG ' HG21 ' A' ' 33' ' ' THR . 35.0 m -40.91 133.74 2.08 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.473 0.654 . . . . 0.0 112.153 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.883 HG23 ' O ' ' A' ' 69' ' ' HIS . 49.1 m -128.54 156.81 42.72 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.902 -0.499 . . . . 0.0 109.821 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.745 HG23 ' SD ' ' A' ' 44' ' ' MET . 1.3 mp -76.98 160.29 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.481 -0.762 . . . . 0.0 111.248 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.864 HG13 HG11 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -132.06 176.5 2.85 Favored Pre-proline 0 N--CA 1.502 2.158 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.158 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 41.7 Cg_endo -65.76 -29.5 50.88 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.906 1.477 . . . . 0.0 110.596 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -77.78 0.75 22.52 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.686 -0.634 . . . . 0.0 110.688 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.745 ' SD ' HG23 ' A' ' 40' ' ' ILE . 2.4 mtt -93.82 -11.62 30.84 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.072 -1.017 . . . . 0.0 111.644 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.739 HG23 ' N ' ' A' ' 64' ' ' GLU . 7.5 p -56.52 4.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.414 ' C ' ' CG ' ' A' ' 47' ' ' HIS . . . -150.29 29.74 1.08 Allowed Glycine 0 N--CA 1.495 2.601 0 O-C-N 119.953 -1.717 . . . . 0.0 110.088 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.498 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 15.1 m80 -147.35 159.22 43.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.168 -1.195 . . . . 0.0 111.338 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.57 84.64 2.99 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 178.176 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.825 ' CD1' HD13 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -84.99 121.09 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.176 -0.953 . . . . 0.0 111.221 -177.465 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.788 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.61 84.17 4.74 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.832 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 51' ' ' VAL . 19.0 m -64.83 130.08 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.4 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.503 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 30.1 t80 -75.34 107.14 7.25 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -84.34 28.01 0.66 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.461 -0.775 . . . . 0.0 110.92 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.11 -36.78 4.09 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -140.69 -20.35 0.82 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.443 -1.033 . . . . 0.0 111.721 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.503 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 10.9 mm-40 -128.82 153.07 47.79 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -177.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.446 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 2.1 m80 -98.7 108.16 20.78 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.788 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 21.8 t -100.86 95.61 4.72 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.144 -0.973 . . . . 0.0 109.469 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.537 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.0 Cg_endo -67.29 93.1 0.35 Allowed 'Trans proline' 0 N--CA 1.488 1.176 0 O-C-N 123.837 1.44 . . . . 0.0 109.423 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.672 HG11 ' CD2' ' A' ' 74' ' ' PHE . 95.9 t -110.36 126.71 67.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.828 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.0 t80 -71.96 104.72 3.61 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.646 HD13 ' HB3' ' A' ' 44' ' ' MET . 2.6 mp -67.37 -50.17 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 2.9 m 65.53 178.7 0.2 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.739 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.1 tm-20 -86.17 61.58 6.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.506 -1.371 . . . . 0.0 109.323 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -162.28 -34.38 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.203 -0.935 . . . . 0.0 112.271 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.75 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 10.3 mtt -99.74 9.29 43.32 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.882 -1.136 . . . . 0.0 112.11 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.474 HG22 ' N ' ' A' ' 68' ' ' GLY . 8.3 p -90.04 162.02 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 120.736 -1.227 . . . . 0.0 112.461 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.474 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 105.56 -16.0 44.98 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.883 ' O ' HG23 ' A' ' 39' ' ' THR . 11.6 m80 -112.45 -88.89 0.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.015 -1.285 . . . . 0.0 110.792 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.3 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 122.437 1.113 . . . . 0.0 109.07 -179.663 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.6 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.8 OUTLIER -179.64 -13.85 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.938 -179.603 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.67 -15.17 77.77 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.75 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 1.5 mm-40 -81.18 -15.55 55.44 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.36 -1.082 . . . . 0.0 108.824 178.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.678 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 4.8 m-85 -102.21 -23.07 14.06 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.555 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -131.85 56.46 23.96 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.82 -0.55 . . . . 0.0 109.542 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 46.2 Cg_endo -83.28 54.45 4.68 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.696 1.366 . . . . 0.0 109.986 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 76' ' ' PRO . 14.8 t 39.5 46.36 1.43 Allowed 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 121.424 0.631 . . . . 0.0 111.682 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.87 127.2 43.67 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.365 -0.834 . . . . 0.0 109.95 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.6 m -86.82 109.86 19.56 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.41 -0.806 . . . . 0.0 110.196 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 O-C-N 121.555 -0.716 . . . . 0.0 110.165 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t 53.72 72.36 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.839 -0.801 . . . . 0.0 110.295 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.671 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -100.81 148.92 24.39 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.487 -0.758 . . . . 0.0 109.857 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.655 HG11 HG13 ' A' ' 41' ' ' VAL . 91.8 t -95.41 106.1 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 108.566 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.671 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 32.6 t70 -46.35 110.81 0.3 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.375 0.607 . . . . 0.0 111.404 -178.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 16' ' ' LEU . 9.5 t70 -67.31 -23.1 65.61 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -63.56 -33.68 76.13 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.912 -0.492 . . . . 0.0 110.31 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.928 HD11 ' SD ' ' A' ' 44' ' ' MET . 0.3 OUTLIER -80.28 -38.1 31.49 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.834 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.0 mp -61.49 -40.8 95.88 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.61 -31.33 15.68 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -89.13 -32.43 17.51 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.665 -0.647 . . . . 0.0 110.089 178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.778 HG22 HD13 ' A' ' 31' ' ' ILE . 78.7 t -68.46 -38.24 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.303 -0.873 . . . . 0.0 111.156 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 16' ' ' LEU . 11.0 mt -61.76 -37.71 85.3 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -64.52 -35.63 81.57 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.468 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.737 HD22 ' HB2' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -75.07 -25.18 58.41 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.479 -0.763 . . . . 0.0 109.866 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -84.48 -11.2 56.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.439 -0.788 . . . . 0.0 109.94 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.18 -37.35 15.09 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 121.348 -0.845 . . . . 0.0 109.927 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -100.71 -24.72 14.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.641 -0.662 . . . . 0.0 109.714 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.53 29.67 8.63 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.737 ' HB2' HD22 ' A' ' 22' ' ' LEU . 14.5 mt-10 -79.77 125.92 30.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.498 -1.001 . . . . 0.0 110.241 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -106.64 63.18 0.64 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.455 -0.778 . . . . 0.0 109.677 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.27 -153.17 0.51 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.519 -0.738 . . . . 0.0 110.116 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.663 HD12 ' HB3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -118.02 147.87 42.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.385 -0.822 . . . . 0.0 110.725 -179.638 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.778 HD13 HG22 ' A' ' 19' ' ' VAL . 2.9 mp -118.52 116.25 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.607 -0.683 . . . . 0.0 109.735 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.618 ' HE2' HD11 ' A' ' 30' ' ' LEU . 29.2 mmtt -75.96 154.32 35.97 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.528 -0.732 . . . . 0.0 110.725 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.641 HG23 ' OD2' ' A' ' 12' ' ' ASP . 97.4 m -135.78 158.44 44.38 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.48 -0.762 . . . . 0.0 110.305 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.419 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 10.4 m-90 -147.5 38.04 0.93 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.387 -0.821 . . . . 0.0 111.155 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 93.0 p -94.81 -132.11 0.17 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.96 -1.087 . . . . 0.0 110.774 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.4 mtt85 -132.91 -64.23 0.75 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.986 -1.071 . . . . 0.0 110.317 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 mpp_? -97.99 40.92 1.15 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.432 -0.793 . . . . 0.0 110.098 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.595 ' OG ' HG21 ' A' ' 33' ' ' THR . 0.4 OUTLIER -40.2 125.78 2.08 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.528 0.68 . . . . 0.0 112.452 -179.494 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.829 HG23 ' O ' ' A' ' 69' ' ' HIS . 71.1 m -128.88 155.86 44.59 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.789 ' CG2' HG12 ' A' ' 62' ' ' ILE . 5.2 mp -86.76 168.89 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.406 -0.809 . . . . 0.0 111.457 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.904 HG23 ' HG3' ' A' ' 44' ' ' MET . 0.0 OUTLIER -136.51 171.84 8.02 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.645 -0.659 . . . . 0.0 110.167 179.469 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 42.7 Cg_endo -66.64 -32.78 37.63 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 124.239 1.652 . . . . 0.0 111.249 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.402 ' HG3' HG11 ' A' ' 19' ' ' VAL . 12.0 pt-20 -69.27 -5.51 23.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.559 -0.713 . . . . 0.0 110.711 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.928 ' SD ' HD11 ' A' ' 15' ' ' LEU . 1.3 mmm -91.83 -0.57 57.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.188 -0.945 . . . . 0.0 111.311 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.721 HG23 ' N ' ' A' ' 64' ' ' GLU . 6.6 p -53.55 7.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.42 ' C ' ' CG ' ' A' ' 47' ' ' HIS . . . -148.67 29.44 1.29 Allowed Glycine 0 N--CA 1.496 2.7 0 O-C-N 119.895 -1.753 . . . . 0.0 110.33 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.623 ' HB2' HD11 ' A' ' 49' ' ' ILE . 6.9 m80 -148.1 155.91 42.0 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.205 -1.174 . . . . 0.0 111.193 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.485 HG23 ' N ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -101.04 90.96 4.35 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 177.855 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.778 ' CD1' HD13 ' A' ' 62' ' ' ILE . 2.5 mp -88.84 121.05 38.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.593 -176.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.757 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.56 81.63 4.87 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.824 0.821 . . . . 0.0 109.238 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.1 m -61.41 135.3 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.963 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.492 ' HB2' ' O ' ' A' ' 33' ' ' THR . 18.5 t80 -80.21 106.96 12.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.364 -0.835 . . . . 0.0 109.497 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -71.13 -0.98 10.86 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.569 -0.707 . . . . 0.0 110.329 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.84 -22.61 8.07 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 107.693 -2.163 . . . . 0.0 107.693 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -140.21 -28.18 0.73 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.985 -0.715 . . . . 0.0 111.158 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.58 155.27 47.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.235 -0.916 . . . . 0.0 112.2 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.491 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 19.4 m-70 -99.92 110.4 22.74 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.757 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 24.9 t -97.71 96.99 3.64 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.239 -0.913 . . . . 0.0 109.943 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.663 ' HB3' HD12 ' A' ' 30' ' ' LEU . 41.7 Cg_endo -66.68 92.41 0.3 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 O-C-N 123.906 1.477 . . . . 0.0 109.615 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.646 ' O ' HD12 ' A' ' 62' ' ' ILE . 12.9 m -103.92 125.19 58.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.613 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.485 ' N ' HG23 ' A' ' 48' ' ' THR . 2.6 t80 -72.66 103.09 3.48 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.789 HG12 ' CG2' ' A' ' 40' ' ' ILE . 1.5 mp -55.98 -61.63 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -176.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.522 ' O ' HG22 ' A' ' 62' ' ' ILE . 2.6 m 65.41 174.42 0.22 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -176.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.721 ' N ' HG23 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -85.38 58.79 5.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.357 -1.464 . . . . 0.0 109.976 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -171.57 -25.94 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.94 -1.1 . . . . 0.0 113.27 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.689 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 2.5 mmm -89.2 -25.43 21.78 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.558 -1.339 . . . . 0.0 111.097 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.573 HG21 ' C ' ' A' ' 41' ' ' VAL . 3.3 p -67.02 163.09 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 121.331 -0.855 . . . . 0.0 112.561 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.509 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 118.83 -13.57 11.59 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.756 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.829 ' O ' HG23 ' A' ' 39' ' ' THR . 20.3 m80 -123.06 -83.56 0.66 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 119.037 1.418 . . . . 0.0 110.724 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.776 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.2 -30.93 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.671 0.748 . . . . 0.0 110.48 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.611 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.9 OUTLIER 174.12 -14.98 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.272 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.809 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.99 -18.46 74.54 Favored Glycine 0 N--CA 1.496 2.647 0 O-C-N 120.982 -1.074 . . . . 0.0 110.423 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.609 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 2.0 mt-10 -86.41 -16.85 35.94 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.237 -1.155 . . . . 0.0 109.262 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.689 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 9.9 m-85 -101.01 -19.89 15.63 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.583 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -134.32 55.18 13.9 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.669 -0.644 . . . . 0.0 109.877 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.583 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 46.4 Cg_endo -85.02 49.89 2.7 Favored 'Trans proline' 0 C--N 1.319 -0.982 0 O-C-N 123.535 1.282 . . . . 0.0 110.178 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.6 t -76.22 -25.74 55.4 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.662 -0.649 . . . . 0.0 111.028 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -73.98 -59.46 2.71 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.341 -0.849 . . . . 0.0 110.2 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 p -143.26 -68.23 0.35 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.491 -0.756 . . . . 0.0 110.237 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 . . . . . 0 N--CA 1.496 1.849 0 O-C-N 121.377 -0.827 . . . . 0.0 110.324 -179.903 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.3 m -74.96 149.99 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.562 -0.963 . . . . 0.0 110.433 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.717 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -107.77 148.82 28.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.59 -0.694 . . . . 0.0 109.958 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.788 HG21 HG13 ' A' ' 41' ' ' VAL . 14.4 p -102.12 109.61 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.83 . . . . 0.0 108.77 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.717 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 38.8 t70 -46.06 111.59 0.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.624 -0.673 . . . . 0.0 111.803 -178.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.416 ' HA ' HD13 ' A' ' 16' ' ' LEU . 7.7 t70 -68.3 -24.2 64.83 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -64.92 -28.38 69.49 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.853 -0.53 . . . . 0.0 109.78 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.772 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -77.67 -34.98 52.81 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.211 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.783 HD11 ' CG1' ' A' ' 41' ' ' VAL . 3.8 mp -62.3 -47.28 84.97 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.048 0.451 . . . . 0.0 109.902 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.44 -23.04 5.39 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.737 -0.602 . . . . 0.0 110.445 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.567 ' O ' HD12 ' A' ' 22' ' ' LEU . 8.8 mmtm -102.58 -30.84 10.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.301 -0.874 . . . . 0.0 111.045 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.712 HG12 ' HA ' ' A' ' 16' ' ' LEU . 1.4 p -78.13 -39.86 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.191 -0.943 . . . . 0.0 111.274 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.464 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 12.6 mt -63.25 -36.84 85.0 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.89 -38.88 83.5 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.271 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.581 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 3.2 mt -73.42 -24.67 60.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.119 -0.988 . . . . 0.0 110.197 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -80.71 -10.4 59.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.522 -0.736 . . . . 0.0 109.59 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.19 -35.58 23.42 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 121.498 -0.751 . . . . 0.0 109.707 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.581 ' HE3' ' HA ' ' A' ' 22' ' ' LEU . 7.4 pttt -102.3 -29.57 11.59 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.533 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.59 28.35 7.54 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.536 ' HB2' ' HE3' ' A' ' 25' ' ' LYS . 2.6 mt-10 -90.9 134.61 34.33 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.467 -1.019 . . . . 0.0 110.382 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -100.04 76.45 1.93 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.463 -0.773 . . . . 0.0 109.357 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.98 -154.55 0.54 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.51 -0.743 . . . . 0.0 110.212 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -118.99 161.1 20.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.453 -0.779 . . . . 0.0 110.763 -179.78 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.552 ' CD1' HG23 ' A' ' 19' ' ' VAL . 2.9 mp -132.77 112.42 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.535 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -85.69 152.69 22.88 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.55 -0.718 . . . . 0.0 111.186 -178.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.627 HG23 ' CG ' ' A' ' 12' ' ' ASP . 8.5 m -134.87 163.21 30.34 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.925 -0.484 . . . . 0.0 110.279 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.474 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 16.0 m-90 -146.73 37.06 0.97 Allowed 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.289 -0.882 . . . . 0.0 110.854 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.0 t -94.74 -126.63 0.12 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.077 -1.015 . . . . 0.0 110.779 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.14 -59.68 0.78 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.827 -1.171 . . . . 0.0 110.822 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -98.36 35.61 1.75 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.322 -0.861 . . . . 0.0 110.605 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.555 ' OG ' HG21 ' A' ' 33' ' ' THR . 4.5 m -36.06 123.9 0.74 Allowed 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.31 0.576 . . . . 0.0 111.942 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.839 HG23 ' O ' ' A' ' 69' ' ' HIS . 27.5 m -128.32 162.27 27.46 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.546 -0.721 . . . . 0.0 110.569 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.874 HG22 ' HG2' ' A' ' 44' ' ' MET . 1.9 mt -66.58 165.01 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 O-C-N 121.631 -0.668 . . . . 0.0 110.861 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.788 HG13 HG21 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -123.45 -171.41 0.22 Allowed Pre-proline 0 N--CA 1.505 2.312 0 O-C-N 121.362 -0.836 . . . . 0.0 110.14 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.575 ' HD3' HG12 ' A' ' 41' ' ' VAL . 57.7 Cg_endo -87.75 -31.19 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.657 1.346 . . . . 0.0 111.098 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -90.05 15.47 10.07 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.536 -0.727 . . . . 0.0 111.056 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.874 ' HG2' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -94.43 4.84 53.34 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.17 -0.956 . . . . 0.0 111.798 -179.695 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.754 HG13 ' N ' ' A' ' 64' ' ' GLU . 39.5 t -57.46 -2.83 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.477 ' HA2' ' CE1' ' A' ' 61' ' ' TYR . . . -150.77 34.08 0.96 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.533 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 37.0 m80 -138.49 152.67 48.48 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.221 -1.164 . . . . 0.0 110.938 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.727 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.29 80.82 2.47 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.621 HD12 ' CD1' ' A' ' 62' ' ' ILE . 9.2 mt -78.09 117.35 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.182 -0.949 . . . . 0.0 110.915 -177.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.755 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.42 80.07 4.83 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.772 0.796 . . . . 0.0 108.99 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 51' ' ' VAL . 31.8 m -57.87 127.12 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.181 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.502 ' HB2' ' O ' ' A' ' 33' ' ' THR . 14.9 t80 -75.76 105.99 7.1 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.196 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -69.61 -0.8 7.36 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.577 -0.702 . . . . 0.0 110.429 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.03 -20.71 9.73 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 107.839 -2.104 . . . . 0.0 107.839 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -140.1 -29.22 0.71 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.957 -0.731 . . . . 0.0 110.974 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.53 154.82 48.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.243 -0.911 . . . . 0.0 112.029 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.488 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 5.0 m80 -100.59 106.04 17.51 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.755 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 40.4 t -94.98 99.93 4.89 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.206 -0.934 . . . . 0.0 109.804 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.505 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.7 Cg_endo -66.54 92.39 0.29 Allowed 'Trans proline' 0 N--CA 1.49 1.304 0 O-C-N 123.904 1.476 . . . . 0.0 109.598 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 58' ' ' VAL . 94.0 t -98.39 116.59 41.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.75 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.727 ' HB2' HG23 ' A' ' 48' ' ' THR . 6.2 t80 -73.03 108.77 6.11 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.869 HD13 ' HB2' ' A' ' 44' ' ' MET . 2.4 mp -92.72 159.89 2.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.884 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.617 HG22 ' H ' ' A' ' 64' ' ' GLU . 3.1 m -129.83 -159.81 0.99 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 177.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.754 ' N ' HG13 ' A' ' 45' ' ' VAL . 3.2 tt0 -90.25 47.75 1.48 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.242 -1.536 . . . . 0.0 110.412 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -156.58 -34.23 0.08 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.973 -1.079 . . . . 0.0 112.675 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.662 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 71.3 mtm -85.86 5.01 34.74 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.999 -1.063 . . . . 0.0 111.546 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.553 ' HA ' HD13 ' A' ' 40' ' ' ILE . 7.5 p -83.99 166.2 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 120.893 -1.129 . . . . 0.0 111.767 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.539 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 106.5 -21.7 32.19 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.839 ' O ' HG23 ' A' ' 39' ' ' THR . 13.0 m80 -112.27 -86.87 0.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.121 -1.223 . . . . 0.0 111.003 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.619 ' HD3' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER 177.61 -36.27 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 122.273 1.035 . . . . 0.0 109.278 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.619 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -178.98 -15.33 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.998 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.83 -15.3 73.7 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.662 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 1.5 mm-40 -82.22 -16.86 48.13 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.44 -1.035 . . . . 0.0 108.773 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.592 ' CD1' ' HA ' ' A' ' 71' ' ' LEU . 7.5 m-85 -98.2 -22.3 16.24 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.553 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -134.2 56.49 19.07 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.797 -0.564 . . . . 0.0 110.39 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.553 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 47.4 Cg_endo -86.62 44.3 1.18 Allowed 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.393 1.207 . . . . 0.0 110.436 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.1 t -172.06 39.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.74 -0.6 . . . . 0.0 110.267 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.68 146.78 33.47 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.176 -0.953 . . . . 0.0 110.498 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.3 t -143.89 144.62 31.81 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.507 -0.745 . . . . 0.0 110.214 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 O-C-N 121.38 -0.825 . . . . 0.0 110.275 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.3 m -83.34 152.2 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.565 -0.962 . . . . 0.0 110.402 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.646 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.7 OUTLIER -135.45 137.93 42.69 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.413 -0.804 . . . . 0.0 110.309 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.072 HG21 HG13 ' A' ' 41' ' ' VAL . 9.9 p -113.63 118.9 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.753 ' HB3' HD23 ' A' ' 15' ' ' LEU . 38.8 t70 -43.81 105.87 0.06 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.618 -0.676 . . . . 0.0 111.604 -178.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -68.04 -21.35 65.02 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -66.84 -28.41 68.33 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 122.007 -0.433 . . . . 0.0 110.49 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.901 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -76.85 -37.32 55.83 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.709 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.901 HD12 ' HG ' ' A' ' 15' ' ' LEU . 3.9 mp -60.75 -44.21 96.98 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.97 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.412 ' HA ' HD21 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -55.74 -25.07 38.75 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.196 179.141 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -102.31 -31.39 10.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.453 -0.78 . . . . 0.0 110.67 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.756 HG12 ' HA ' ' A' ' 16' ' ' LEU . 1.4 p -71.8 -37.3 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.287 -0.883 . . . . 0.0 111.021 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.478 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.0 pp -64.47 -28.2 69.5 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.84 -31.96 65.13 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.496 HD22 ' HB2' ' A' ' 27' ' ' GLU . 1.4 mt -76.92 -22.08 53.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.609 -0.682 . . . . 0.0 109.582 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -84.76 -19.6 32.37 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.496 -0.753 . . . . 0.0 109.716 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.14 -39.13 17.02 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 121.504 -0.748 . . . . 0.0 109.908 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -90.71 -25.3 20.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.672 -0.643 . . . . 0.0 109.533 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.36 16.61 49.25 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB2' HD22 ' A' ' 22' ' ' LEU . 1.5 mt-10 -75.41 128.35 35.15 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.514 -0.991 . . . . 0.0 110.477 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.0 mtmm -115.13 50.89 0.95 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.551 -0.718 . . . . 0.0 109.513 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.7 ttp-105 -88.31 -92.2 0.11 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.57 -0.706 . . . . 0.0 110.411 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.784 HD12 ' HB3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -170.9 146.25 2.5 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.118 -0.989 . . . . 0.0 110.674 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.583 HD13 HD11 ' A' ' 49' ' ' ILE . 2.8 mt -115.26 119.07 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.727 ' HD3' HD11 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -79.63 151.05 30.79 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.437 -0.789 . . . . 0.0 111.543 -178.63 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.733 HG23 ' CG ' ' A' ' 12' ' ' ASP . 27.4 m -137.6 155.3 49.34 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.601 -0.687 . . . . 0.0 110.353 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.531 ' CH2' ' HB2' ' A' ' 32' ' ' LYS . 17.5 m-90 -146.02 29.53 1.09 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.299 -0.876 . . . . 0.0 111.601 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -82.9 -98.14 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.812 -1.18 . . . . 0.0 110.592 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -174.29 -61.59 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.215 -0.928 . . . . 0.0 109.558 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.19 42.7 1.09 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.628 ' OG ' HG21 ' A' ' 33' ' ' THR . 2.5 m -50.9 133.9 26.22 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.525 0.679 . . . . 0.0 111.923 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.849 HG23 ' O ' ' A' ' 69' ' ' HIS . 20.6 m -127.25 161.54 28.31 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.856 ' HA ' ' HE3' ' A' ' 44' ' ' MET . 1.1 mp -80.56 162.15 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.291 -0.88 . . . . 0.0 111.566 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.072 HG13 HG21 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -129.3 169.58 12.83 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 121.701 -0.624 . . . . 0.0 110.011 178.814 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.449 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 43.7 Cg_endo -67.5 -31.72 33.31 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.262 1.664 . . . . 0.0 110.918 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.697 ' HG3' HG11 ' A' ' 19' ' ' VAL . 2.3 pt-20 -80.16 5.69 13.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.482 -0.761 . . . . 0.0 110.926 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.856 ' HE3' ' HA ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -98.12 -5.74 33.04 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.287 -0.883 . . . . 0.0 111.448 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.627 HG13 ' N ' ' A' ' 64' ' ' GLU . 61.8 t -48.29 -6.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.516 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA2' ' CE1' ' A' ' 61' ' ' TYR . . . -144.72 38.97 1.24 Allowed Glycine 0 N--CA 1.491 2.344 0 O-C-N 120.186 -1.571 . . . . 0.0 109.221 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 49.6 m-70 -143.08 147.35 34.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.508 -0.995 . . . . 0.0 111.183 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.81 80.93 2.39 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 177.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.886 ' CD1' HD13 ' A' ' 15' ' ' LEU . 1.5 mt -85.19 124.1 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.391 -0.818 . . . . 0.0 111.347 -176.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.786 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -77.78 80.28 4.24 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 51' ' ' VAL . 27.2 m -61.08 130.47 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.057 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.446 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 30.5 t80 -78.27 105.88 9.81 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.236 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -69.91 0.0 6.59 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.618 -0.677 . . . . 0.0 110.6 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.67 -18.87 10.65 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 107.913 -2.075 . . . . 0.0 107.913 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -140.1 -28.57 0.73 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.938 -0.742 . . . . 0.0 110.884 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -135.86 155.32 50.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.226 -0.921 . . . . 0.0 112.015 -178.353 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.413 ' CE1' ' CD1' ' A' ' 34' ' ' TRP . 1.1 m-70 -101.57 105.43 16.39 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.786 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 21.9 t -95.35 102.29 9.42 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.217 -0.927 . . . . 0.0 110.051 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.784 ' HB3' HD12 ' A' ' 30' ' ' LEU . 40.3 Cg_endo -66.64 91.96 0.3 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.916 1.482 . . . . 0.0 109.006 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.552 HG11 ' CD2' ' A' ' 74' ' ' PHE . 79.1 t -108.21 126.75 64.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.938 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.5 t80 -72.88 110.89 7.53 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 176.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.717 HG12 ' CG2' ' A' ' 40' ' ' ILE . 1.7 mp -62.71 -56.77 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.642 -0.661 . . . . 0.0 112.732 -177.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 3.5 m 68.79 162.39 0.21 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -177.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.627 ' N ' HG13 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -78.93 62.76 3.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.639 -1.288 . . . . 0.0 109.451 -179.398 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -167.53 -32.85 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.317 -0.864 . . . . 0.0 112.271 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.717 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 2.8 mtt -98.07 8.49 44.69 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.79 -1.194 . . . . 0.0 111.85 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 68' ' ' GLY . 8.2 p -90.22 162.62 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 120.757 -1.214 . . . . 0.0 112.214 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.481 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 106.69 -16.82 39.96 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.849 ' O ' HG23 ' A' ' 39' ' ' THR . 11.6 m80 -112.86 -88.44 0.54 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.12 -1.223 . . . . 0.0 110.726 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.09 -35.64 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 122.394 1.092 . . . . 0.0 109.02 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.621 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -178.74 -14.93 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.973 -179.587 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.41 -14.75 77.17 Favored Glycine 0 N--CA 1.498 2.771 0 O-C-N 120.797 -1.189 . . . . 0.0 110.281 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.717 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 1.8 mm-40 -81.02 -18.2 47.63 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.356 -1.085 . . . . 0.0 108.686 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.677 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 10.6 m-85 -96.86 -22.2 17.05 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.567 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -132.91 55.11 15.57 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.745 -0.597 . . . . 0.0 109.743 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 46.7 Cg_endo -84.11 51.46 3.38 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 O-C-N 123.639 1.336 . . . . 0.0 110.26 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.6 m -69.1 138.32 54.2 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.613 -0.679 . . . . 0.0 110.198 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -79.44 -52.31 8.22 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.534 -0.729 . . . . 0.0 110.241 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.9 p -129.36 -54.27 1.18 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.581 -0.699 . . . . 0.0 110.367 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.425 -0.797 . . . . 0.0 110.296 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.478 ' HB ' ' HD2' ' A' ' 37' ' ' ARG . 76.2 t -80.32 -40.76 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.546 -0.973 . . . . 0.0 110.361 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.542 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 1.7 t80 -155.98 156.61 34.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.476 -0.765 . . . . 0.0 110.848 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.661 HG21 HG13 ' A' ' 41' ' ' VAL . 3.5 p -137.17 119.75 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.785 ' HB2' HD23 ' A' ' 15' ' ' LEU . 34.1 m-20 -23.62 99.97 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 CA-C-O 121.046 0.45 . . . . 0.0 112.142 -178.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.2 -26.4 63.86 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.728 ' CB ' HG23 ' A' ' 33' ' ' THR . 0.1 OUTLIER -76.07 -14.04 60.2 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 120.99 0.424 . . . . 0.0 110.148 178.64 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.042 HD11 ' SD ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -87.01 -35.33 18.86 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.645 ' HA ' HG12 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -70.56 -43.93 68.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.745 -0.597 . . . . 0.0 110.01 178.858 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.64 ' HG2' ' HA ' ' A' ' 14' ' ' HIS . 0.6 OUTLIER -53.08 -19.73 3.05 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.8 179.408 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.472 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 17.6 mttt -106.39 -32.56 8.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.347 -0.846 . . . . 0.0 110.146 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.96 HG21 ' SD ' ' A' ' 44' ' ' MET . 0.5 OUTLIER -73.57 -40.66 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.403 -0.811 . . . . 0.0 111.153 -179.726 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.511 HD21 ' HA ' ' A' ' 17' ' ' GLU . 3.8 pp -60.52 -26.27 66.74 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.57 -36.24 52.27 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 27' ' ' GLU . 0.9 OUTLIER -72.22 -28.49 63.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.591 -0.693 . . . . 0.0 109.637 178.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -83.56 -11.33 57.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.581 -0.699 . . . . 0.0 109.599 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.0 -37.22 14.47 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 121.588 -0.695 . . . . 0.0 110.002 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.477 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 4.6 ptmt -96.56 -23.92 16.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.611 -0.681 . . . . 0.0 109.84 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.32 29.45 7.5 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.477 ' HG3' ' HE2' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -92.98 129.08 39.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.427 -1.043 . . . . 0.0 110.685 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -107.25 70.63 0.8 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.593 -0.692 . . . . 0.0 109.226 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.34 -152.76 0.5 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.656 -0.653 . . . . 0.0 110.006 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -114.05 155.79 25.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.421 -0.799 . . . . 0.0 110.354 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.567 HG21 ' O ' ' A' ' 15' ' ' LEU . 5.8 mt -135.06 116.32 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.498 -0.751 . . . . 0.0 109.346 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -103.33 148.37 25.94 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.277 -0.889 . . . . 0.0 110.891 -179.45 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.728 HG23 ' CB ' ' A' ' 14' ' ' HIS . 56.6 m -137.91 156.78 47.53 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.579 -0.701 . . . . 0.0 110.177 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.506 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 19.9 m-90 -118.57 44.93 2.15 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.681 -0.637 . . . . 0.0 110.057 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 10' ' ' PHE . 66.1 m -83.79 -167.24 1.65 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.289 -0.882 . . . . 0.0 111.004 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -102.11 -61.88 1.33 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.436 -0.79 . . . . 0.0 110.341 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.478 ' HD2' ' HB ' ' A' ' 9' ' ' VAL . 0.3 OUTLIER -92.33 41.32 1.07 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.355 -0.841 . . . . 0.0 109.636 179.355 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 63.1 m -37.75 105.44 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.808 HG23 ' O ' ' A' ' 69' ' ' HIS . 44.6 m -122.35 159.7 26.92 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.684 -0.635 . . . . 0.0 109.316 178.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.866 ' CG2' HG12 ' A' ' 62' ' ' ILE . 4.8 mp -90.08 168.92 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.408 -0.807 . . . . 0.0 111.705 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.676 HG23 ' HE3' ' A' ' 44' ' ' MET . 0.1 OUTLIER -139.56 174.6 3.93 Favored Pre-proline 0 N--CA 1.505 2.306 0 O-C-N 121.79 -0.569 . . . . 0.0 109.787 179.443 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.565 ' HD2' HG12 ' A' ' 41' ' ' VAL . 42.8 Cg_endo -65.61 -33.53 45.05 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 124.116 1.588 . . . . 0.0 111.198 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.75 -12.43 23.97 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.597 -0.69 . . . . 0.0 110.578 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MET . . . . . 1.042 ' SD ' HD11 ' A' ' 15' ' ' LEU . 6.2 mmt -87.09 -4.8 59.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.364 -0.835 . . . . 0.0 111.909 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.526 HG23 ' N ' ' A' ' 64' ' ' GLU . 7.5 p -51.11 1.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.475 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.408 ' C ' ' CG ' ' A' ' 47' ' ' HIS . . . -146.27 31.01 1.58 Allowed Glycine 0 N--CA 1.495 2.62 0 O-C-N 119.918 -1.739 . . . . 0.0 110.28 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.408 ' CG ' ' C ' ' A' ' 46' ' ' GLY . 17.9 m-70 -147.88 156.55 42.82 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.217 -1.167 . . . . 0.0 111.315 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.69 88.73 3.9 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.677 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.938 HD12 HD13 ' A' ' 62' ' ' ILE . 2.6 mt -86.69 119.31 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.178 -0.951 . . . . 0.0 112.019 -176.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.725 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.87 86.81 5.36 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 122.15 0.976 . . . . 0.0 109.193 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.1 m -71.25 134.8 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.232 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.551 ' HB2' ' O ' ' A' ' 33' ' ' THR . 28.5 t80 -75.2 105.58 6.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.342 -0.849 . . . . 0.0 108.886 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -71.46 0.03 9.28 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.53 -0.731 . . . . 0.0 110.801 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.41 -22.48 7.84 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -140.36 -28.84 0.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 122.016 -0.697 . . . . 0.0 110.79 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.21 156.22 49.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.266 -0.896 . . . . 0.0 111.988 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.526 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 93.6 m-70 -101.83 108.31 19.76 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.725 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 22.0 t -94.3 101.5 6.66 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.308 -0.87 . . . . 0.0 110.008 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.52 ' O ' HG22 ' A' ' 48' ' ' THR . 43.0 Cg_endo -68.85 94.0 0.45 Allowed 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.933 1.491 . . . . 0.0 108.96 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.687 ' O ' HD12 ' A' ' 62' ' ' ILE . 15.0 m -106.36 126.93 62.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.217 -178.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 0.5 OUTLIER -69.5 104.32 2.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 176.841 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.938 HD13 HD12 ' A' ' 49' ' ' ILE . 1.3 mp -60.2 -53.22 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.602 ' O ' HG22 ' A' ' 62' ' ' ILE . 1.3 p 59.6 -175.63 0.1 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.526 ' N ' HG23 ' A' ' 45' ' ' VAL . 3.2 tp10 -90.41 43.51 1.15 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.486 -1.384 . . . . 0.0 109.941 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -150.92 -29.11 0.2 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.948 -1.095 . . . . 0.0 113.464 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.616 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 5.9 mtt -89.29 -23.18 22.36 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.527 -1.358 . . . . 0.0 111.435 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.652 HG21 ' C ' ' A' ' 41' ' ' VAL . 2.7 p -67.01 160.14 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.077 -1.015 . . . . 0.0 112.459 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.452 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 114.62 -13.56 20.48 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.869 -0.682 . . . . 0.0 111.586 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.808 ' O ' HG23 ' A' ' 39' ' ' THR . 25.7 m80 -121.98 -83.8 0.66 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.912 1.356 . . . . 0.0 110.853 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.687 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.88 -30.98 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 121.661 0.743 . . . . 0.0 110.326 -179.597 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.597 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 1.3 pp 173.12 -14.18 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.767 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.29 -18.99 73.82 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.555 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 2.6 mt-10 -86.09 -15.14 42.16 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.355 -1.085 . . . . 0.0 109.24 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.646 ' CD2' ' HB ' ' A' ' 60' ' ' VAL . 10.2 m-85 -99.85 -21.76 15.59 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.566 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -133.43 54.79 13.88 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.782 -0.574 . . . . 0.0 109.922 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.566 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 48.1 Cg_endo -83.93 51.04 3.3 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.672 1.354 . . . . 0.0 110.261 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.5 t -74.58 168.22 20.2 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.624 -0.673 . . . . 0.0 110.648 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.12 174.3 9.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.457 -0.777 . . . . 0.0 110.355 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.8 p -87.86 135.41 33.4 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.456 -0.777 . . . . 0.0 110.144 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 . . . . . 0 N--CA 1.496 1.849 0 O-C-N 121.524 -0.735 . . . . 0.0 110.217 -179.893 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.9 t -104.27 80.08 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.525 -0.985 . . . . 0.0 109.845 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.713 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -139.0 148.8 43.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.399 -0.813 . . . . 0.0 110.177 -179.798 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 39' ' ' THR . 13.6 p -116.01 119.08 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.969 ' HB3' HD23 ' A' ' 15' ' ' LEU . 5.1 t70 -44.55 103.9 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.686 -0.634 . . . . 0.0 111.161 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.86 -22.1 65.14 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.16 -29.99 63.25 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.977 -0.452 . . . . 0.0 110.253 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.969 HD23 ' HB3' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -78.25 -38.68 42.24 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.277 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.744 HD12 ' HG ' ' A' ' 15' ' ' LEU . 2.9 mp -58.92 -42.98 90.98 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.309 0.576 . . . . 0.0 109.584 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.571 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -56.01 -23.75 34.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.806 -0.558 . . . . 0.0 109.943 179.257 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.4 -29.82 12.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.497 -0.752 . . . . 0.0 110.592 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.691 HG21 ' CB ' ' A' ' 44' ' ' MET . 2.3 p -73.96 -38.05 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.186 -0.946 . . . . 0.0 111.02 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.571 HD21 ' HA ' ' A' ' 17' ' ' GLU . 4.1 pp -61.75 -26.63 68.19 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -69.61 -34.06 73.55 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.696 HD13 ' HD3' ' A' ' 25' ' ' LYS . 3.6 mm? -74.13 -26.56 60.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.621 -0.674 . . . . 0.0 109.369 178.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -82.13 -13.44 57.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.598 -0.689 . . . . 0.0 109.674 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.37 -33.61 21.96 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.505 -0.747 . . . . 0.0 110.095 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.696 ' HD3' HD13 ' A' ' 22' ' ' LEU . 2.1 ptmt -92.01 -17.08 25.6 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.61 -0.682 . . . . 0.0 109.714 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.37 32.43 11.93 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.505 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -114.39 128.56 56.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.527 -0.984 . . . . 0.0 110.743 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.78 80.79 2.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.597 -0.69 . . . . 0.0 109.588 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.82 -147.84 0.39 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.55 -0.719 . . . . 0.0 109.848 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.528 ' O ' HD13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -121.27 154.05 36.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 110.203 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.848 ' HB ' HD13 ' A' ' 49' ' ' ILE . 28.0 mm -118.79 154.22 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.328 -0.857 . . . . 0.0 110.057 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.509 ' HE2' HD11 ' A' ' 30' ' ' LEU . 1.6 mmtp -102.76 137.09 41.43 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.667 -0.646 . . . . 0.0 110.345 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.67 HG23 ' CB ' ' A' ' 12' ' ' ASP . 9.6 m -124.45 150.28 45.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.572 -0.705 . . . . 0.0 109.806 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.635 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 1.4 m-90 -145.69 38.56 1.12 Allowed 'General case' 0 N--CA 1.51 2.563 0 O-C-N 121.067 -1.021 . . . . 0.0 112.652 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -100.57 -97.5 0.25 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.467 -1.395 . . . . 0.0 110.702 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.4 ' HG2' ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -169.83 -60.02 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.094 -1.004 . . . . 0.0 109.346 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.54 35.16 2.53 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.8 m -51.48 138.9 21.16 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.529 0.68 . . . . 0.0 111.742 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.783 ' O ' HG23 ' A' ' 11' ' ' VAL . 3.0 m -133.79 165.91 23.87 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.859 -0.526 . . . . 0.0 109.836 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.874 HG22 HG23 ' A' ' 67' ' ' VAL . 5.0 mp -86.2 161.49 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.199 -0.938 . . . . 0.0 110.551 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.695 HG23 ' HG2' ' A' ' 44' ' ' MET . 0.0 OUTLIER -141.1 176.23 2.59 Favored Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 121.672 -0.643 . . . . 0.0 109.686 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.651 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 38.3 Cg_endo -62.86 -28.77 75.86 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.137 1.598 . . . . 0.0 109.595 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -66.79 -10.64 49.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.847 -0.533 . . . . 0.0 110.864 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.966 ' HE1' HD21 ' A' ' 15' ' ' LEU . 1.9 ptp -140.19 44.21 1.89 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.814 -1.179 . . . . 0.0 112.324 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.832 ' CG1' ' HA ' ' A' ' 64' ' ' GLU . 3.2 t -91.49 27.96 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.819 -1.176 . . . . 0.0 110.938 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.66 24.74 0.94 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 12.6 m-70 -139.55 167.81 21.26 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.235 -1.156 . . . . 0.0 110.533 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.666 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -98.96 81.62 2.63 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 178.394 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.848 HD13 ' HB ' ' A' ' 31' ' ' ILE . 1.1 mm -79.37 112.47 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.673 -0.642 . . . . 0.0 110.929 -177.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.782 ' HB1' ' HB3' ' A' ' 57' ' ' HIS . . . -77.8 80.83 4.24 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.969 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.433 HG22 ' HB ' ' A' ' 58' ' ' VAL . 33.4 m -57.58 138.29 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.879 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.635 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 19.7 t80 -80.67 108.0 13.95 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.565 -0.854 . . . . 0.0 108.983 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -76.57 15.45 0.62 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.769 -0.582 . . . . 0.0 110.247 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.4 ' HA2' ' HG2' ' A' ' 36' ' ' ARG . . . 106.81 -29.3 11.03 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.0 pttt -140.57 -27.37 0.73 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.636 -0.92 . . . . 0.0 111.188 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -126.41 156.15 41.03 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.782 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 8.1 m80 -94.9 115.82 27.94 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.745 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 46.2 t -103.81 90.64 2.99 Favored Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 121.157 -0.965 . . . . 0.0 109.337 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.549 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.8 Cg_endo -65.42 89.47 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 O-C-N 124.019 1.536 . . . . 0.0 110.301 -178.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.665 HG11 ' HA ' ' A' ' 71' ' ' LEU . 5.3 m -94.67 110.04 23.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.268 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.666 ' HB2' HG23 ' A' ' 48' ' ' THR . 0.6 OUTLIER -69.39 95.28 0.79 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.792 -1.163 . . . . 0.0 108.222 178.514 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.731 HG21 HG21 ' A' ' 40' ' ' ILE . 2.7 mp -76.79 127.64 37.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.145 -178.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.628 ' C ' HG12 ' A' ' 45' ' ' VAL . 72.1 p -101.78 158.74 15.9 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.832 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -42.78 -19.61 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.433 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 63' ' ' THR . 10.1 p30 -121.59 29.59 7.12 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.696 -1.253 . . . . 0.0 112.641 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.732 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 18.7 mmt -126.72 -19.19 4.57 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.973 -1.079 . . . . 0.0 110.73 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.874 HG23 HG22 ' A' ' 40' ' ' ILE . 13.3 p -65.5 162.61 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.343 -0.848 . . . . 0.0 112.239 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.457 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 120.16 -11.07 10.78 Favored Glycine 0 N--CA 1.491 2.367 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.727 178.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.634 ' O ' HG23 ' A' ' 39' ' ' THR . 6.8 m80 -113.94 -88.29 0.56 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 119.33 1.565 . . . . 0.0 111.015 -178.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.54 -32.29 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.824 0.821 . . . . 0.0 109.785 -179.531 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.665 ' HA ' HG11 ' A' ' 60' ' ' VAL . 1.4 pp 174.03 -11.58 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.788 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.17 -15.01 81.74 Favored Glycine 0 N--CA 1.492 2.372 0 O-C-N 120.827 -1.171 . . . . 0.0 110.418 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.499 ' HG3' ' ND1' ' A' ' 69' ' ' HIS . 12.9 mm-40 -86.66 -16.44 36.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.252 -1.146 . . . . 0.0 109.58 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.732 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 0.7 OUTLIER -117.73 -18.94 9.5 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.872 -0.517 . . . . 0.0 110.095 -179.108 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.514 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -138.38 58.19 14.04 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.436 -0.79 . . . . 0.0 110.007 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.514 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 44.2 Cg_endo -84.33 51.62 3.36 Favored 'Trans proline' 0 C--N 1.316 -1.157 0 O-C-N 123.626 1.329 . . . . 0.0 110.319 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.6 t -67.84 171.56 6.45 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.672 -0.642 . . . . 0.0 110.55 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 56.71 41.09 28.75 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.615 -0.678 . . . . 0.0 110.56 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.9 t -116.79 5.83 13.12 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.277 -0.89 . . . . 0.0 111.066 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.9 p90 . . . . . 0 N--CA 1.496 1.831 0 O-C-N 121.084 -1.01 . . . . 0.0 110.269 179.902 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.83 134.92 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.546 -0.973 . . . . 0.0 110.302 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.702 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -129.08 144.51 51.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.462 -0.774 . . . . 0.0 110.261 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.636 HG22 HD11 ' A' ' 16' ' ' LEU . 14.8 p -104.42 116.36 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.702 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 28.1 t70 -50.02 105.48 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.482 -0.761 . . . . 0.0 111.014 -178.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -64.82 -24.97 67.71 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -66.83 -31.43 72.05 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.281 0.563 . . . . 0.0 109.511 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.87 HD11 ' SD ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -78.97 -35.42 43.08 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.504 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.636 HD11 HG22 ' A' ' 11' ' ' VAL . 2.7 mp -63.18 -42.95 99.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.689 -0.632 . . . . 0.0 109.558 178.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.559 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -56.35 -22.94 34.27 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.277 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.412 ' O ' HD23 ' A' ' 22' ' ' LEU . 12.2 mttt -99.0 -31.15 11.95 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.503 -0.748 . . . . 0.0 110.602 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.665 HG21 ' HG2' ' A' ' 44' ' ' MET . 1.8 p -73.27 -40.07 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.132 -0.98 . . . . 0.0 110.559 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.559 HD21 ' HA ' ' A' ' 17' ' ' GLU . 4.0 pp -64.14 -25.05 67.92 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -72.89 -33.11 65.84 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 27' ' ' GLU . 2.9 mm? -73.89 -26.96 60.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.43 -0.794 . . . . 0.0 109.238 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -81.74 -14.01 57.04 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.535 -0.728 . . . . 0.0 109.842 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.28 -38.94 21.49 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.525 -0.735 . . . . 0.0 109.078 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.98 -19.81 31.5 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.266 0.555 . . . . 0.0 109.824 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.47 3.32 72.02 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.472 ' O ' HD12 ' A' ' 22' ' ' LEU . 39.9 mt-10 -85.35 148.04 26.23 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.382 -1.07 . . . . 0.0 110.507 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -119.33 94.2 4.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.456 -0.778 . . . . 0.0 109.745 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -117.5 -157.89 0.68 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.49 -0.757 . . . . 0.0 110.45 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.0 OUTLIER -110.84 147.2 35.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.595 -0.691 . . . . 0.0 110.63 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.555 HG21 HD12 ' A' ' 15' ' ' LEU . 2.8 mp -121.87 117.95 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 3.8 mppt? -82.56 159.0 22.88 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.276 -0.89 . . . . 0.0 111.21 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.57 HG23 ' CG ' ' A' ' 12' ' ' ASP . 17.9 m -139.74 158.51 43.99 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.576 -0.703 . . . . 0.0 110.037 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.44 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 11.4 m-90 -146.93 38.77 1.0 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.367 -0.833 . . . . 0.0 111.052 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.7 m -98.05 -109.06 0.17 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.992 -1.067 . . . . 0.0 110.756 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.9 -64.73 0.19 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.912 -1.117 . . . . 0.0 110.366 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 38' ' ' SER . 1.6 mtp180 -92.54 25.63 2.96 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.405 -0.81 . . . . 0.0 110.191 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.444 ' OG ' HG21 ' A' ' 33' ' ' THR . 73.7 m -31.53 116.92 0.18 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.335 0.588 . . . . 0.0 112.466 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.741 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 45.1 m -124.38 159.93 29.28 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.74 -0.6 . . . . 0.0 110.476 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.776 HD13 ' HE1' ' A' ' 74' ' ' PHE . 5.3 mp -88.63 169.47 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.609 -0.682 . . . . 0.0 110.407 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.835 HG23 ' HG3' ' A' ' 44' ' ' MET . 0.1 OUTLIER -140.07 172.9 5.63 Favored Pre-proline 0 N--CA 1.508 2.458 0 O-C-N 121.176 -0.952 . . . . 0.0 110.945 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.644 ' HD2' HG12 ' A' ' 41' ' ' VAL . 41.8 Cg_endo -66.0 -30.1 48.25 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 124.394 1.734 . . . . 0.0 111.561 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.98 5.03 10.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.497 -0.752 . . . . 0.0 110.461 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.87 ' SD ' HD11 ' A' ' 15' ' ' LEU . 23.1 mtt -111.78 -0.7 15.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 111.411 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.568 HG23 ' N ' ' A' ' 64' ' ' GLU . 2.1 p -41.42 -4.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.923 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 44' ' ' MET . . . -137.71 35.27 2.07 Favored Glycine 0 N--CA 1.495 2.588 0 O-C-N 119.771 -1.831 . . . . 0.0 110.47 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 26.2 m-70 -144.43 153.18 41.64 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.09 -1.241 . . . . 0.0 110.971 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -99.77 92.34 5.27 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.286 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.666 HD13 ' SD ' ' A' ' 44' ' ' MET . 2.6 mt -88.8 120.78 38.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.097 -1.002 . . . . 0.0 111.239 -177.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.751 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -76.31 77.1 3.08 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.986 0.898 . . . . 0.0 109.09 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.654 HG21 ' HB3' ' A' ' 71' ' ' LEU . 33.0 m -56.73 132.25 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.476 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 33' ' ' THR . 19.8 t80 -77.14 104.52 7.69 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.574 -0.85 . . . . 0.0 109.006 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -70.2 0.4 6.37 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.571 -0.706 . . . . 0.0 110.421 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.31 -23.66 7.99 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.52 -28.94 0.7 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 122.051 -0.676 . . . . 0.0 111.136 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.53 155.57 45.55 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.243 -0.911 . . . . 0.0 112.159 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.471 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 6.9 m80 -100.81 104.78 16.03 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.751 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 39.1 t -93.71 101.16 5.53 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.205 -0.934 . . . . 0.0 109.92 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.549 ' O ' HG22 ' A' ' 48' ' ' THR . 40.7 Cg_endo -66.23 90.19 0.26 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 O-C-N 123.909 1.479 . . . . 0.0 109.82 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 60' ' ' VAL . 34.3 m -101.8 127.67 55.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.707 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 4.6 t80 -69.72 111.88 5.8 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 177.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.78 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.4 OUTLIER -51.33 -51.34 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.833 -0.542 . . . . 0.0 111.398 -178.058 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 m 60.88 169.85 0.09 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.363 0.602 . . . . 0.0 109.538 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.568 ' N ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -81.51 2.85 27.12 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.873 -1.142 . . . . 0.0 111.603 -179.313 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -142.51 1.88 1.39 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.83 -1.169 . . . . 0.0 113.038 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.606 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 20.2 mmt -99.95 -15.06 18.45 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.435 -1.415 . . . . 0.0 110.206 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.646 HG23 HG22 ' A' ' 40' ' ' ILE . 13.9 p -74.37 168.73 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.252 -0.905 . . . . 0.0 112.254 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.54 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 114.8 -5.35 22.52 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.701 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.733 ' O ' HG23 ' A' ' 39' ' ' THR . 21.6 m80 -127.57 -85.0 0.6 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 119.289 1.545 . . . . 0.0 110.854 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.741 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.9 -29.29 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.532 0.682 . . . . 0.0 110.088 -179.243 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.654 ' HB3' HG21 ' A' ' 51' ' ' VAL . 2.4 pp 171.58 -17.39 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.309 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.67 -18.76 74.26 Favored Glycine 0 N--CA 1.494 2.549 0 O-C-N 121.083 -1.01 . . . . 0.0 110.802 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.487 ' HG3' ' ND1' ' A' ' 69' ' ' HIS . 23.6 mm-40 -84.71 -22.6 29.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.214 -1.168 . . . . 0.0 109.213 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.776 ' HE1' HD13 ' A' ' 40' ' ' ILE . 13.8 m-85 -95.23 -21.83 18.2 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.576 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -132.89 55.18 15.97 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.556 -0.715 . . . . 0.0 109.863 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.576 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 46.5 Cg_endo -84.84 50.07 2.8 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 O-C-N 123.508 1.267 . . . . 0.0 110.302 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.7 m -112.64 41.71 1.98 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.576 -0.702 . . . . 0.0 110.15 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.3 ttm105 -154.09 143.31 21.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.308 -0.87 . . . . 0.0 110.343 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 78.0 m -93.3 -49.54 5.9 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.5 -0.75 . . . . 0.0 110.081 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.07 0 O-C-N 121.722 -0.611 . . . . 0.0 110.523 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.4 m -73.78 136.57 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.55 -0.971 . . . . 0.0 110.413 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.531 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 1.6 t80 -156.61 155.24 31.5 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.457 -0.777 . . . . 0.0 110.662 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.681 HG21 HG13 ' A' ' 41' ' ' VAL . 6.6 p -134.13 123.58 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.884 ' HB2' HD23 ' A' ' 15' ' ' LEU . 49.0 m-20 -29.13 99.51 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.117 0.484 . . . . 0.0 111.817 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.1 -25.04 64.22 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.695 ' HB3' HG23 ' A' ' 33' ' ' THR . 0.2 OUTLIER -76.73 -21.23 55.56 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 122.021 -0.424 . . . . 0.0 110.044 178.936 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.884 HD23 ' HB2' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -80.88 -37.66 29.4 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.923 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.664 HD11 HG21 ' A' ' 41' ' ' VAL . 3.6 mp -64.48 -42.36 95.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.716 -0.615 . . . . 0.0 109.893 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.409 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -56.24 -21.17 21.87 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.759 179.787 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.71 -26.06 11.96 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.311 -0.868 . . . . 0.0 110.335 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.623 HG11 ' CE ' ' A' ' 44' ' ' MET . 0.5 OUTLIER -76.5 -36.9 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.303 -0.873 . . . . 0.0 110.935 -179.83 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.474 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 3.8 pp -63.71 -28.7 70.07 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -33.66 68.48 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.482 HD22 ' CB ' ' A' ' 27' ' ' GLU . 1.2 mt -79.58 -27.79 41.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.665 -0.647 . . . . 0.0 109.488 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -82.44 -11.29 58.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.538 -0.726 . . . . 0.0 109.558 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.57 -40.04 21.46 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.513 -0.742 . . . . 0.0 109.978 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.535 ' CD ' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -103.99 -25.76 12.88 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.403 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.92 25.31 5.96 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.535 ' HG3' ' CD ' ' A' ' 25' ' ' LYS . 4.7 mt-10 -79.3 130.12 35.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.335 -1.097 . . . . 0.0 110.602 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.0 mtmm -107.64 65.78 0.65 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.57 -0.707 . . . . 0.0 109.125 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.72 -151.03 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.6 -0.687 . . . . 0.0 110.049 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.0 OUTLIER -120.96 145.21 47.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.854 . . . . 0.0 110.57 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.548 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 2.7 mp -120.4 113.16 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.496 -0.753 . . . . 0.0 109.434 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -92.76 147.65 22.69 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.311 -0.868 . . . . 0.0 110.813 -179.35 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.795 HG21 ' HB3' ' A' ' 12' ' ' ASP . 17.6 m -138.69 166.7 23.7 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.468 -0.77 . . . . 0.0 110.301 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.456 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 15.4 m-90 -139.01 39.89 2.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.711 -0.618 . . . . 0.0 109.874 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 10' ' ' PHE . 50.6 m -78.82 -142.38 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.337 -0.852 . . . . 0.0 110.654 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.32 -61.4 1.41 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.989 -1.07 . . . . 0.0 110.317 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -94.33 39.53 1.09 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.403 -0.81 . . . . 0.0 109.825 179.484 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.727 ' HB3' HG23 ' A' ' 51' ' ' VAL . 36.3 m -35.54 131.57 0.48 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.302 0.572 . . . . 0.0 112.277 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.802 HG23 ' O ' ' A' ' 69' ' ' HIS . 27.9 m -150.02 162.27 40.71 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.631 -0.668 . . . . 0.0 110.401 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.689 HG21 HG21 ' A' ' 62' ' ' ILE . 1.2 mp -80.42 165.92 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.418 0 CA-C-O 121.642 0.734 . . . . 0.0 111.647 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.889 HG23 ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -140.4 179.59 1.22 Allowed Pre-proline 0 N--CA 1.503 2.183 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.605 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.75 ' HD2' HG12 ' A' ' 41' ' ' VAL . 48.8 Cg_endo -70.94 -33.01 12.76 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.872 1.459 . . . . 0.0 111.512 -179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -73.18 -0.14 13.42 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.451 -0.781 . . . . 0.0 110.984 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.889 ' SD ' HG23 ' A' ' 41' ' ' VAL . 1.3 mpt? -100.8 2.99 41.7 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.304 -0.872 . . . . 0.0 111.378 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.566 HG23 ' N ' ' A' ' 64' ' ' GLU . 4.0 p -57.2 -0.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.64 35.1 1.04 Allowed Glycine 0 N--CA 1.493 2.495 0 O-C-N 120.42 -1.425 . . . . 0.0 109.736 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.695 ' HB2' HD11 ' A' ' 49' ' ' ILE . 30.9 m80 -144.34 154.93 43.53 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.279 -1.13 . . . . 0.0 111.06 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.686 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.76 83.85 2.82 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.223 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.829 HG12 HD13 ' A' ' 15' ' ' LEU . 2.7 mp -86.26 122.61 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 111.141 -177.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.757 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.09 87.13 4.87 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.971 0.891 . . . . 0.0 109.729 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.727 HG23 ' HB3' ' A' ' 38' ' ' SER . 4.9 p -62.36 120.55 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.733 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 33' ' ' THR . 20.6 t80 -67.1 109.19 2.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -0.897 . . . . 0.0 109.65 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -78.18 10.66 2.81 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.599 -0.688 . . . . 0.0 110.604 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.58 -26.72 13.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -139.82 -28.17 0.75 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.662 -0.905 . . . . 0.0 110.429 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -130.36 153.73 48.4 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.0 0.905 . . . . 0.0 113.323 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.436 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 6.5 m80 -96.02 113.99 25.65 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.757 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 21.9 t -103.44 94.76 6.24 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.238 -0.914 . . . . 0.0 109.531 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.496 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.6 Cg_endo -66.29 89.54 0.26 Allowed 'Trans proline' 0 N--CA 1.491 1.364 0 O-C-N 123.981 1.516 . . . . 0.0 109.567 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 58' ' ' VAL . 93.6 t -98.34 120.6 47.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.828 -179.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.686 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.5 t80 -73.65 105.07 4.81 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.761 HD13 ' HB3' ' A' ' 44' ' ' MET . 2.9 mp -85.38 135.07 25.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.679 -0.638 . . . . 0.0 111.071 -178.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.438 ' C ' HG23 ' A' ' 45' ' ' VAL . 59.3 p -98.26 -158.81 0.7 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 177.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.566 ' N ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -87.88 10.27 19.21 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.925 -1.11 . . . . 0.0 111.45 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -145.16 17.75 1.56 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.85 -1.156 . . . . 0.0 112.259 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.728 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 67.9 mtt -115.56 0.11 13.21 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.056 -1.028 . . . . 0.0 110.076 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.566 HG23 ' HB ' ' A' ' 40' ' ' ILE . 8.1 p -85.68 167.57 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.219 -0.926 . . . . 0.0 111.298 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 115.75 -15.98 16.54 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.802 ' O ' HG23 ' A' ' 39' ' ' THR . 9.3 m80 -118.72 -86.36 0.64 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.052 -1.263 . . . . 0.0 111.122 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.613 ' HD3' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER 178.01 -33.81 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 122.165 0.983 . . . . 0.0 109.277 -179.611 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.613 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.5 OUTLIER 178.77 -16.13 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.834 -179.711 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.38 -14.2 79.47 Favored Glycine 0 N--CA 1.497 2.763 0 O-C-N 120.875 -1.141 . . . . 0.0 110.407 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.468 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 2.7 mm-40 -78.89 -22.88 45.27 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.324 -1.103 . . . . 0.0 108.667 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.728 ' CD2' ' HB3' ' A' ' 66' ' ' MET . 5.6 m-85 -97.09 -20.77 17.78 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.591 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -132.11 54.21 13.43 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.551 -0.718 . . . . 0.0 109.92 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.591 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 48.0 Cg_endo -85.13 50.42 2.81 Favored 'Trans proline' 0 C--N 1.32 -0.962 0 O-C-N 123.546 1.287 . . . . 0.0 110.152 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.5 t -62.17 140.94 58.42 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.606 -0.684 . . . . 0.0 110.695 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 -150.62 119.0 6.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.454 -0.779 . . . . 0.0 110.175 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.8 m 63.7 166.82 0.14 Allowed 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 121.308 0.575 . . . . 0.0 110.869 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 . . . . . 0 N--CA 1.496 1.856 0 O-C-N 121.311 -0.868 . . . . 0.0 110.175 -179.928 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.1 t -111.19 -56.63 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.477 -1.013 . . . . 0.0 110.027 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.72 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -124.26 157.07 35.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.669 -0.644 . . . . 0.0 109.942 -179.768 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.695 HG21 HG13 ' A' ' 41' ' ' VAL . 14.8 p -114.33 122.04 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.383 -0.823 . . . . 0.0 108.915 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.789 ' CG ' HG23 ' A' ' 33' ' ' THR . 37.5 t70 -48.53 107.85 0.15 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.64 -0.662 . . . . 0.0 111.579 -178.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -68.63 -22.48 64.42 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.405 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 4.6 t-80 -67.06 -21.88 65.87 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.044 0.45 . . . . 0.0 110.358 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.052 HD13 HD13 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -83.7 -36.94 23.34 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.325 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.877 ' HA ' HG12 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -66.87 -46.5 74.8 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.427 179.291 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.419 ' HA ' HD21 ' A' ' 20' ' ' LEU . 5.3 pt-20 -52.62 -21.88 4.42 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.728 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.0 -29.21 10.08 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.366 -0.834 . . . . 0.0 110.693 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.877 HG12 ' HA ' ' A' ' 16' ' ' LEU . 1.4 p -78.51 -38.7 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.096 -1.003 . . . . 0.0 111.161 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.475 ' C ' HD12 ' A' ' 20' ' ' LEU . 3.6 pp -63.11 -24.83 68.08 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -71.84 -32.2 67.28 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' A' ' 27' ' ' GLU . 1.7 mp -76.96 -27.11 54.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.652 -0.655 . . . . 0.0 109.381 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -86.29 -14.29 44.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.556 -0.715 . . . . 0.0 109.286 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.04 -40.35 12.36 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.666 -0.646 . . . . 0.0 110.2 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.422 ' CE ' ' HG2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -93.86 -29.55 15.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.453 -0.779 . . . . 0.0 109.19 179.721 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.93 22.35 7.65 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.495 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 8.2 mm-40 -82.32 136.05 35.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.335 -1.097 . . . . 0.0 109.87 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -113.29 80.73 1.4 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.463 -0.773 . . . . 0.0 109.961 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.53 -160.66 1.0 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.353 0.597 . . . . 0.0 110.532 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -106.98 161.31 14.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.64 -0.663 . . . . 0.0 110.447 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.67 ' HB ' HG12 ' A' ' 49' ' ' ILE . 37.9 mm -116.01 164.43 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.544 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 2.1 mptt -127.68 149.99 49.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.789 HG23 ' CG ' ' A' ' 12' ' ' ASP . 22.4 m -135.21 155.16 51.14 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.361 -0.837 . . . . 0.0 111.227 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.544 ' CH2' ' HB2' ' A' ' 32' ' ' LYS . 23.2 m-90 -145.18 28.47 1.22 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.728 -0.608 . . . . 0.0 110.352 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.443 ' O ' ' HD2' ' A' ' 52' ' ' TYR . 0.4 OUTLIER -92.88 -159.32 0.67 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.065 -1.022 . . . . 0.0 110.934 -179.222 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -108.47 -56.53 2.24 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.093 -1.004 . . . . 0.0 110.55 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -94.4 33.27 1.43 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.394 -0.816 . . . . 0.0 110.189 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.403 ' OG ' HG21 ' A' ' 33' ' ' THR . 42.9 m -39.0 126.03 1.56 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.404 0.621 . . . . 0.0 111.781 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.85 HG23 ' O ' ' A' ' 69' ' ' HIS . 17.4 m -133.85 162.74 31.19 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.656 -0.653 . . . . 0.0 110.28 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.759 HG23 ' CG1' ' A' ' 62' ' ' ILE . 1.3 mp -79.16 164.83 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.606 -0.684 . . . . 0.0 111.872 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.86 HG12 ' HD2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -140.07 175.19 3.34 Favored Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.568 -0.708 . . . . 0.0 109.536 178.468 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.86 ' HD2' HG12 ' A' ' 41' ' ' VAL . 46.7 Cg_endo -69.53 -32.45 19.49 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.018 1.536 . . . . 0.0 111.864 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.533 ' HB2' ' CE ' ' A' ' 44' ' ' MET . 4.6 mm-40 -73.82 -0.08 14.75 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.346 -0.846 . . . . 0.0 110.896 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.832 ' HE1' HG11 ' A' ' 19' ' ' VAL . 3.9 mmt -95.5 -6.99 39.34 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.219 -0.925 . . . . 0.0 111.853 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.56 HG13 ' N ' ' A' ' 64' ' ' GLU . 74.0 t -45.84 -8.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.647 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.422 ' HA2' ' CE1' ' A' ' 61' ' ' TYR . . . -143.01 34.73 1.75 Allowed Glycine 0 N--CA 1.493 2.485 0 O-C-N 120.174 -1.579 . . . . 0.0 109.726 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.445 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 30.0 m-70 -141.89 150.55 41.68 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.393 -1.063 . . . . 0.0 110.559 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.77 81.91 2.53 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.773 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.052 HD13 HD13 ' A' ' 15' ' ' LEU . 42.1 mt -77.21 124.04 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.527 -0.733 . . . . 0.0 111.472 -177.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.781 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -81.04 76.84 7.98 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' ' 51' ' ' VAL . 23.0 m -58.85 124.45 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.316 -178.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 32.3 t80 -74.8 105.64 5.96 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.408 -0.807 . . . . 0.0 109.091 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -68.93 -0.23 5.31 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.669 -0.644 . . . . 0.0 110.95 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.81 -18.5 9.85 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -140.03 -28.78 0.73 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.795 -0.827 . . . . 0.0 110.975 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -136.28 154.65 50.82 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.23 -0.919 . . . . 0.0 112.146 -178.21 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.446 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 5.7 m-70 -99.12 105.5 17.6 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.781 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 38.1 t -94.36 101.58 6.89 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.098 -1.001 . . . . 0.0 109.957 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.536 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.3 Cg_endo -66.13 94.12 0.29 Allowed 'Trans proline' 0 N--CA 1.492 1.396 0 O-C-N 123.995 1.523 . . . . 0.0 108.934 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.609 HG23 HG12 ' A' ' 58' ' ' VAL . 75.6 t -109.73 125.33 66.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.065 -177.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.5 t80 -70.69 110.67 5.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.759 ' CG1' HG23 ' A' ' 40' ' ' ILE . 1.5 mp -61.06 -59.33 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.644 -0.66 . . . . 0.0 112.406 -177.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 3.5 m 69.52 161.26 0.21 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -177.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.56 ' N ' HG13 ' A' ' 45' ' ' VAL . 7.5 tp10 -78.42 62.24 3.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.83 -1.169 . . . . 0.0 109.902 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -173.1 -27.79 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.133 -0.979 . . . . 0.0 112.607 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.674 ' CB ' ' CE2' ' A' ' 74' ' ' PHE . 4.8 mmm -97.69 6.6 47.74 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.804 -1.185 . . . . 0.0 111.608 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.504 HG22 ' N ' ' A' ' 68' ' ' GLY . 7.5 p -89.07 163.83 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 120.857 -1.152 . . . . 0.0 112.059 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.504 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 109.68 -14.73 32.19 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.85 ' O ' HG23 ' A' ' 39' ' ' THR . 12.7 m80 -117.77 -89.73 0.58 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.984 -1.303 . . . . 0.0 111.125 -179.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.592 ' HG2' ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER 177.64 -31.39 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.134 0.968 . . . . 0.0 109.232 -179.38 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.592 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 2.2 pp 177.62 -17.91 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.657 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.0 -15.68 74.36 Favored Glycine 0 N--CA 1.499 2.841 0 O-C-N 120.936 -1.103 . . . . 0.0 110.427 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.477 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 2.5 mm-40 -78.63 -21.59 48.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.352 -1.087 . . . . 0.0 108.407 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.674 ' CE2' ' CB ' ' A' ' 66' ' ' MET . 7.4 m-85 -96.18 -23.46 16.72 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.555 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -131.06 55.66 20.34 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.687 -0.633 . . . . 0.0 110.181 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 47.0 Cg_endo -85.66 48.47 2.15 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 O-C-N 123.573 1.302 . . . . 0.0 110.203 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 85.2 m -141.67 -56.53 0.47 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.678 -0.639 . . . . 0.0 110.212 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.21 127.98 38.99 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.586 -0.696 . . . . 0.0 110.075 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.2 t -136.42 40.45 2.63 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.567 -0.708 . . . . 0.0 110.35 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 N--CA 1.5 2.061 0 O-C-N 121.538 -0.726 . . . . 0.0 110.563 179.858 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 37' ' ' ARG . 89.0 t -116.71 -68.39 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.554 -0.968 . . . . 0.0 110.061 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.69 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -125.29 139.79 53.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.523 -0.736 . . . . 0.0 110.165 -179.843 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 11' ' ' VAL . 14.5 p -102.12 109.96 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.694 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.786 ' HB3' HD23 ' A' ' 15' ' ' LEU . 26.2 t70 -45.63 109.17 0.16 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.516 -0.74 . . . . 0.0 111.499 -178.207 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -67.43 -23.86 65.58 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.46 -29.26 66.89 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.115 0.483 . . . . 0.0 110.097 179.284 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.841 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -79.95 -38.14 32.99 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.67 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.841 HD12 ' HG ' ' A' ' 15' ' ' LEU . 3.2 mp -63.33 -39.61 95.02 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.414 0.626 . . . . 0.0 109.553 178.281 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.53 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -55.49 -23.66 27.15 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.799 -0.563 . . . . 0.0 110.029 179.271 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -97.89 -31.82 12.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.482 -0.761 . . . . 0.0 110.499 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 16' ' ' LEU . 1.4 p -71.27 -38.16 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.317 -0.865 . . . . 0.0 110.933 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.53 HD21 ' HA ' ' A' ' 17' ' ' GLU . 3.8 pp -63.27 -26.82 68.95 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.053 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -74.47 -32.58 62.63 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.527 HD22 ' CB ' ' A' ' 27' ' ' GLU . 1.5 mt -75.14 -27.53 59.79 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.676 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -83.47 -12.41 56.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.519 -0.738 . . . . 0.0 109.463 178.238 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.5 -39.88 16.97 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 121.556 -0.715 . . . . 0.0 109.931 179.658 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.45 ' CE ' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -97.71 -26.65 14.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.509 -0.744 . . . . 0.0 109.807 179.716 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.416 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . 105.07 26.73 6.18 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.527 ' CB ' HD22 ' A' ' 22' ' ' LEU . 7.2 mt-10 -82.44 130.31 35.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.371 -1.076 . . . . 0.0 110.232 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -113.88 59.64 0.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.504 -0.747 . . . . 0.0 109.645 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.39 -136.68 0.32 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.495 -0.753 . . . . 0.0 109.877 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.571 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -132.56 153.88 50.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.95 -1.094 . . . . 0.0 110.719 -179.333 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.85 ' HB ' HD13 ' A' ' 49' ' ' ILE . 4.2 mt -127.35 120.07 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.224 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.441 ' HG3' ' CZ2' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -100.35 160.03 14.66 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.529 -0.732 . . . . 0.0 111.462 -178.69 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.584 HG21 ' OG ' ' A' ' 38' ' ' SER . 18.8 m -141.2 168.65 19.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.811 -0.556 . . . . 0.0 110.112 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.476 ' N ' HG22 ' A' ' 33' ' ' THR . 17.7 m-90 -144.59 39.32 1.27 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.365 -0.834 . . . . 0.0 110.556 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.453 ' H ' HG22 ' A' ' 33' ' ' THR . 22.9 t -92.88 -94.31 0.15 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.175 -0.953 . . . . 0.0 110.544 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.7 ttm105 -167.17 -60.16 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.989 -1.069 . . . . 0.0 110.841 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.52 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 1.9 mpt_? -103.34 35.67 2.5 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.336 -0.853 . . . . 0.0 110.568 -179.681 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.584 ' OG ' HG21 ' A' ' 33' ' ' THR . 0.4 OUTLIER -41.01 121.91 1.64 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.16 0.505 . . . . 0.0 111.89 -179.91 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.751 HG23 ' O ' ' A' ' 69' ' ' HIS . 87.8 m -120.74 158.87 26.56 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.679 -0.638 . . . . 0.0 110.293 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.746 HG21 HG12 ' A' ' 62' ' ' ILE . 4.9 mp -85.76 169.34 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.367 -0.833 . . . . 0.0 111.274 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.97 HG23 ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -138.21 179.49 1.31 Allowed Pre-proline 0 N--CA 1.502 2.14 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.097 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.728 ' HD2' HG12 ' A' ' 41' ' ' VAL . 44.9 Cg_endo -68.6 -31.89 25.59 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.879 1.463 . . . . 0.0 111.303 -179.277 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.87 -3.62 16.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.587 -0.696 . . . . 0.0 111.127 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.97 ' SD ' HG23 ' A' ' 41' ' ' VAL . 1.3 mpt? -93.72 0.09 56.23 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.201 -0.937 . . . . 0.0 111.925 -179.304 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.486 HG21 ' CG ' ' A' ' 64' ' ' GLU . 3.5 p -52.31 -3.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.99 33.11 1.52 Allowed Glycine 0 N--CA 1.493 2.473 0 O-C-N 120.394 -1.441 . . . . 0.0 109.668 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 38.6 m-70 -142.91 152.51 42.15 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.303 -1.116 . . . . 0.0 110.907 -179.588 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.646 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -99.61 83.61 2.81 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 178.361 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.85 HD13 ' HB ' ' A' ' 31' ' ' ILE . 1.1 mm -78.6 112.23 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 111.587 -177.117 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.705 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -76.43 79.92 3.15 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.079 0.943 . . . . 0.0 108.777 178.807 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 70' ' ' LYS . 32.3 m -62.19 132.19 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.816 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.519 ' HB2' ' O ' ' A' ' 33' ' ' THR . 26.5 t80 -77.03 103.45 6.97 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.375 -0.828 . . . . 0.0 108.876 178.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -69.71 -0.7 7.4 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.527 -0.733 . . . . 0.0 110.563 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.58 -20.12 9.56 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.761 -2.136 . . . . 0.0 107.761 -178.558 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -140.15 -29.73 0.7 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 122.004 -0.704 . . . . 0.0 110.752 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.89 155.94 49.83 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.295 -0.878 . . . . 0.0 112.037 -178.278 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.539 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 3.1 m80 -100.64 100.67 11.41 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.092 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.705 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 58.6 t -87.34 104.03 5.59 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.341 -0.85 . . . . 0.0 109.956 -179.041 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 57' ' ' HIS . 42.8 Cg_endo -67.96 89.91 0.37 Allowed 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.921 1.485 . . . . 0.0 109.481 -179.336 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 49' ' ' ILE . 12.7 m -94.21 111.84 25.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.177 -178.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.646 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.4 t80 -69.96 101.25 1.73 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 118.526 -1.27 . . . . 0.0 107.598 177.692 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.874 HD13 ' HB3' ' A' ' 44' ' ' MET . 2.7 mp -80.8 141.33 15.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 121.543 0.687 . . . . 0.0 111.338 -178.113 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.3 p -110.29 -152.09 0.49 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 177.443 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.486 ' CG ' HG21 ' A' ' 45' ' ' VAL . 6.9 mt-10 -87.91 -13.38 42.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.764 -1.21 . . . . 0.0 110.921 179.237 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.53 27.35 6.53 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.984 -1.072 . . . . 0.0 112.147 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.716 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 9.5 mmt -116.12 -29.06 6.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.06 -1.025 . . . . 0.0 110.175 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.527 ' HA ' ' HZ ' ' A' ' 74' ' ' PHE . 5.7 p -65.67 163.89 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 O-C-N 121.39 -0.819 . . . . 0.0 111.874 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.487 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 123.9 -11.0 8.33 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.475 178.234 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.751 ' O ' HG23 ' A' ' 39' ' ' THR . 14.2 m80 -124.53 -84.48 0.64 Allowed 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 119.08 1.44 . . . . 0.0 111.007 -178.628 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.741 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.47 -30.19 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.505 0.669 . . . . 0.0 110.273 -179.42 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.636 ' HB3' HG21 ' A' ' 51' ' ' VAL . 0.5 OUTLIER 173.32 -16.5 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.563 -179.776 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.04 -15.62 76.47 Favored Glycine 0 N--CA 1.495 2.613 0 O-C-N 121.053 -1.029 . . . . 0.0 110.602 -179.668 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.508 ' HG3' ' ND1' ' A' ' 69' ' ' HIS . 22.9 mm-40 -86.3 -18.82 30.99 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.141 -1.211 . . . . 0.0 109.423 178.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.727 ' HE1' HD13 ' A' ' 40' ' ' ILE . 4.0 m-85 -104.98 -17.89 14.36 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.55 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.542 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -139.07 58.31 12.61 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.538 -0.726 . . . . 0.0 110.02 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.542 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 43.8 Cg_endo -87.09 47.88 1.66 Allowed 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.635 1.334 . . . . 0.0 110.453 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.6 m 49.04 44.81 22.91 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.376 0.608 . . . . 0.0 110.483 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.52 143.73 20.1 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.31 -0.868 . . . . 0.0 110.237 -179.746 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -79.07 168.53 19.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.499 -0.751 . . . . 0.0 110.507 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.2 p90 . . . . . 0 N--CA 1.497 1.918 0 O-C-N 121.443 -0.786 . . . . 0.0 110.283 -179.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.735 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.232 0.539 . . . . 0.0 109.858 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.781 HG11 HG13 ' A' ' 41' ' ' VAL . 70.4 t -105.55 117.56 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.735 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 37.1 t70 -44.45 112.71 0.45 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.403 0.621 . . . . 0.0 111.725 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.23 -21.97 62.05 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -70.11 -25.13 63.35 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.87 -0.519 . . . . 0.0 110.442 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.943 HD13 ' CD1' ' A' ' 49' ' ' ILE . 0.6 OUTLIER -77.46 -37.47 51.38 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.838 ' HA ' HG12 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -62.5 -46.91 86.31 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.744 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.17 -23.47 3.34 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.311 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -106.06 -33.62 7.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.448 -0.782 . . . . 0.0 110.568 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.838 HG12 ' HA ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -73.3 -39.64 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.279 -0.888 . . . . 0.0 111.402 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 16' ' ' LEU . 3.6 pp -63.13 -27.19 69.21 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.23 -32.67 64.88 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.577 HD22 ' CB ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -77.99 -24.09 48.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.653 -0.654 . . . . 0.0 109.437 178.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -82.73 -11.63 58.16 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.392 -0.817 . . . . 0.0 109.635 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.66 -39.77 19.8 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 121.461 -0.774 . . . . 0.0 109.969 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.54 ' CD ' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -103.23 -23.37 13.62 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.459 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.407 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . 102.14 29.07 6.21 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.577 ' CB ' HD22 ' A' ' 22' ' ' LEU . 5.8 mt-10 -76.1 130.33 38.16 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.394 -1.062 . . . . 0.0 110.669 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.8 mtmm -107.3 59.68 0.62 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.569 -0.707 . . . . 0.0 109.285 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -102.88 -154.34 0.49 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.509 -0.744 . . . . 0.0 109.992 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -124.49 145.16 49.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.587 -0.695 . . . . 0.0 110.13 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.516 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 2.4 mp -114.65 119.83 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.615 -0.678 . . . . 0.0 109.47 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.531 ' CE ' HD11 ' A' ' 30' ' ' LEU . 20.5 mmtt -79.61 154.63 28.58 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.412 -0.805 . . . . 0.0 111.199 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.68 HG23 ' CG ' ' A' ' 12' ' ' ASP . 20.7 m -141.38 153.47 45.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.61 -0.681 . . . . 0.0 110.094 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.457 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 14.7 m-90 -144.49 35.01 1.17 Allowed 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.311 -0.868 . . . . 0.0 111.354 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.3 t -84.63 -96.03 0.07 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.893 -1.13 . . . . 0.0 110.586 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.6 mtm105 -171.81 -61.91 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.106 -0.996 . . . . 0.0 109.631 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.479 ' HG2' ' HD1' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -103.53 31.15 4.54 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.435 0.636 . . . . 0.0 109.399 178.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.438 ' OG ' HG21 ' A' ' 33' ' ' THR . 13.4 m -44.74 130.9 7.08 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.439 0.637 . . . . 0.0 111.997 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.761 HG23 ' O ' ' A' ' 69' ' ' HIS . 75.7 m -124.76 159.06 31.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.775 -0.578 . . . . 0.0 109.936 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.665 HG21 HG12 ' A' ' 62' ' ' ILE . 4.8 mp -79.56 169.48 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.389 -0.82 . . . . 0.0 111.237 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.781 HG13 HG11 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -140.15 176.49 2.5 Favored Pre-proline 0 N--CA 1.5 2.056 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.621 ' O ' HG23 ' A' ' 45' ' ' VAL . 43.2 Cg_endo -66.89 -29.85 40.89 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.006 1.53 . . . . 0.0 110.595 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -71.46 -3.63 22.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.444 -0.785 . . . . 0.0 111.061 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.817 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.4 mtp -98.24 7.21 46.57 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.988 -1.07 . . . . 0.0 112.143 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 42' ' ' PRO . 89.6 t -57.5 -1.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.529 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.06 35.41 0.99 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 31.7 m-70 -142.48 146.34 34.66 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.41 -1.053 . . . . 0.0 111.117 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.817 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.7 83.95 2.85 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 178.023 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.943 ' CD1' HD13 ' A' ' 15' ' ' LEU . 1.9 mt -86.97 120.63 36.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.139 -0.976 . . . . 0.0 110.924 -177.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.737 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -75.72 78.65 2.67 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.977 0.894 . . . . 0.0 109.152 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.656 HG21 ' O ' ' A' ' 70' ' ' LYS . 31.3 m -59.9 131.11 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.534 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 26.8 t80 -78.06 105.01 8.99 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -75.09 7.91 2.97 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.317 -0.864 . . . . 0.0 111.055 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.26 -27.39 6.11 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.65 -24.9 0.77 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.821 -0.811 . . . . 0.0 111.495 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -132.65 154.49 50.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.134 -0.979 . . . . 0.0 112.244 -177.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.442 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 0.8 OUTLIER -99.6 101.46 12.67 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.248 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.737 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 48.1 t -90.75 104.07 8.42 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.178 -0.951 . . . . 0.0 110.089 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.545 ' HB3' HD12 ' A' ' 30' ' ' LEU . 40.5 Cg_endo -66.08 87.37 0.24 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 O-C-N 123.899 1.473 . . . . 0.0 109.447 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 49' ' ' ILE . 15.1 m -92.72 112.59 26.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.464 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.817 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.3 t80 -75.13 100.36 4.23 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.817 HD13 ' HB3' ' A' ' 44' ' ' MET . 2.8 mp -81.57 135.29 25.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.564 -0.71 . . . . 0.0 111.144 -178.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.432 ' C ' HG13 ' A' ' 45' ' ' VAL . 58.9 p -101.03 -155.47 0.52 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.511 ' N ' HG13 ' A' ' 45' ' ' VAL . 1.3 tp10 -89.43 10.88 20.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.627 -1.295 . . . . 0.0 110.614 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.92 24.15 1.19 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.941 -1.099 . . . . 0.0 111.478 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 6.6 mmt -114.09 -27.95 7.5 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.039 -1.038 . . . . 0.0 110.216 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.533 HG23 HG22 ' A' ' 40' ' ' ILE . 7.5 p -63.02 164.87 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 O-C-N 121.585 -0.697 . . . . 0.0 111.822 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.5 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 123.35 -14.51 8.23 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.387 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.761 ' O ' HG23 ' A' ' 39' ' ' THR . 16.5 m-70 -122.03 -85.04 0.66 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 119.034 1.417 . . . . 0.0 111.21 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.683 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.68 -30.64 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.586 0.708 . . . . 0.0 110.42 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.525 ' HB3' ' O ' ' A' ' 70' ' ' LYS . 0.4 OUTLIER 174.46 -16.0 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.706 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.55 -16.4 75.8 Favored Glycine 0 N--CA 1.497 2.704 0 O-C-N 120.954 -1.091 . . . . 0.0 110.686 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.713 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 1.1 mm-40 . . . . . 0 N--CA 1.498 1.925 0 O-C-N 121.254 -1.145 . . . . 0.0 109.461 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.736 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.327 0.584 . . . . 0.0 110.03 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 11' ' ' VAL . 12.8 p -106.06 116.92 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.736 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 35.9 t70 -47.93 108.7 0.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.437 -0.79 . . . . 0.0 111.266 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.77 -23.88 66.13 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.441 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.7 OUTLIER -70.58 -20.54 62.77 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.976 -0.453 . . . . 0.0 110.071 179.081 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.849 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -88.54 -35.13 17.12 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.304 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.849 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.7 mp -69.52 -38.69 77.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.72 -0.612 . . . . 0.0 110.204 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.536 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . 3.0 pt-20 -58.29 -20.69 44.76 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.439 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -100.3 -29.56 12.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.387 -0.821 . . . . 0.0 110.394 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.047 HG21 ' SD ' ' A' ' 44' ' ' MET . 1.5 p -76.19 -37.21 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.247 -0.908 . . . . 0.0 111.141 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.536 ' CD2' ' HA ' ' A' ' 17' ' ' GLU . 3.7 pp -61.8 -26.58 68.19 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.02 -33.97 70.86 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.438 ' HA ' HD12 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -79.19 -25.46 42.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.694 -0.629 . . . . 0.0 109.573 178.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -84.31 -12.91 53.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.509 -0.744 . . . . 0.0 109.592 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.87 -39.22 13.2 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 121.509 -0.745 . . . . 0.0 110.014 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -94.77 -29.86 14.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.578 -0.701 . . . . 0.0 109.332 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.23 25.01 6.89 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.415 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 28.0 mt-10 -84.63 136.13 33.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.413 -1.051 . . . . 0.0 110.091 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -113.1 77.4 1.05 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.418 -0.801 . . . . 0.0 109.623 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.93 -154.85 0.57 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.496 -0.752 . . . . 0.0 110.363 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -112.85 155.36 24.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.412 -0.805 . . . . 0.0 110.545 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.683 HG21 ' O ' ' A' ' 15' ' ' LEU . 2.7 mp -129.24 113.5 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.493 -0.755 . . . . 0.0 109.338 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.517 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -66.64 154.36 40.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.521 -0.737 . . . . 0.0 111.117 -179.062 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.567 HG23 ' CB ' ' A' ' 12' ' ' ASP . 9.1 m -143.06 135.83 27.75 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.696 -0.628 . . . . 0.0 109.997 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.677 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -152.46 75.71 1.12 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.259 -0.9 . . . . 0.0 111.25 -179.713 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.423 ' HB3' ' CE2' ' A' ' 10' ' ' PHE . 0.6 OUTLIER -123.28 -82.2 0.65 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.147 -0.97 . . . . 0.0 110.052 179.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.417 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 5.8 ttm180 -167.97 -64.17 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.314 -0.866 . . . . 0.0 109.727 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.417 ' HD2' ' HB3' ' A' ' 36' ' ' ARG . 0.4 OUTLIER -104.25 35.11 2.8 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.57 -0.706 . . . . 0.0 109.387 179.113 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.477 ' OG ' HG22 ' A' ' 33' ' ' THR . 5.0 m -37.9 124.92 1.17 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.406 0.622 . . . . 0.0 111.991 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.751 HG23 ' O ' ' A' ' 69' ' ' HIS . 34.4 m -130.57 159.08 38.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.788 -0.57 . . . . 0.0 110.183 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.74 HG21 HG21 ' A' ' 62' ' ' ILE . 5.1 mp -83.85 168.94 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.401 -0.812 . . . . 0.0 110.909 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.682 HG12 ' HD2' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -138.43 176.9 2.36 Favored Pre-proline 0 N--CA 1.501 2.112 0 O-C-N 121.743 -0.598 . . . . 0.0 109.683 179.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.682 ' HD2' HG12 ' A' ' 41' ' ' VAL . 43.4 Cg_endo -66.93 -31.34 38.19 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.005 1.529 . . . . 0.0 111.276 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.761 ' HG3' HG11 ' A' ' 19' ' ' VAL . 2.5 pt-20 -72.27 -3.08 21.56 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.313 -0.867 . . . . 0.0 111.075 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 1.047 ' SD ' HG21 ' A' ' 19' ' ' VAL . 18.8 mmt -97.15 10.1 40.32 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.213 -0.929 . . . . 0.0 111.748 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 42' ' ' PRO . 80.3 t -61.24 0.63 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 O-C-N 120.93 -1.106 . . . . 0.0 113.508 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.38 35.53 0.96 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.543 ' HB2' HD11 ' A' ' 49' ' ' ILE . 36.4 m-70 -141.68 150.24 41.62 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.484 -1.009 . . . . 0.0 111.041 -178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.699 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -99.77 83.7 2.79 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.817 ' CG2' HD13 ' A' ' 15' ' ' LEU . 2.4 mp -83.56 121.39 36.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.398 -0.813 . . . . 0.0 110.885 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.772 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -77.23 79.49 3.75 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.695 0.76 . . . . 0.0 109.456 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.44 ' HA ' ' HB ' ' A' ' 33' ' ' THR . 19.4 m -58.16 135.0 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.385 0.612 . . . . 0.0 110.643 -179.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.677 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 30.5 t80 -75.62 106.82 7.38 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.558 -0.714 . . . . 0.0 109.31 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -77.54 4.78 10.38 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.307 -0.871 . . . . 0.0 110.734 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.64 -30.17 4.98 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.87 -26.27 0.73 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.961 -0.729 . . . . 0.0 111.578 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.8 155.42 41.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.227 -0.92 . . . . 0.0 112.345 -177.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.462 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 1.2 m-70 -97.77 104.81 16.87 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.772 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 48.6 t -93.51 101.49 5.93 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.228 -0.92 . . . . 0.0 110.108 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.523 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.7 Cg_endo -65.77 90.32 0.24 Allowed 'Trans proline' 0 N--CA 1.494 1.513 0 O-C-N 123.892 1.469 . . . . 0.0 109.712 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 58' ' ' VAL . 44.7 t -96.04 113.96 31.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.123 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.699 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.4 t80 -72.9 103.93 3.88 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.74 HG21 HG21 ' A' ' 40' ' ' ILE . 2.7 mp -84.81 132.04 32.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.638 -0.664 . . . . 0.0 111.105 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.408 ' C ' HG13 ' A' ' 45' ' ' VAL . 50.0 p -94.92 -157.2 0.55 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 177.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.527 ' N ' HG13 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -90.12 15.42 10.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.8 -1.188 . . . . 0.0 110.883 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.79 19.72 1.01 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.875 -1.141 . . . . 0.0 112.051 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 5.3 mmt -115.58 -18.19 10.97 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.834 -1.166 . . . . 0.0 110.502 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.56 HG22 ' N ' ' A' ' 68' ' ' GLY . 5.6 p -73.94 167.15 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.316 -0.865 . . . . 0.0 111.759 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.56 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 121.28 -11.97 9.75 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.164 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.751 ' O ' HG23 ' A' ' 39' ' ' THR . 18.7 m-70 -128.13 -81.42 0.59 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.944 1.372 . . . . 0.0 111.257 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.632 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.76 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 121.714 0.768 . . . . 0.0 110.126 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.595 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.7 OUTLIER 173.73 -16.45 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.759 -179.641 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.1 -16.11 76.73 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.002 -1.061 . . . . 0.0 110.506 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.689 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 21.3 mm-40 . . . . . 0 N--CA 1.497 1.91 0 O-C-N 121.245 -1.15 . . . . 0.0 108.97 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.728 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.258 0.551 . . . . 0.0 110.189 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.729 HG21 HG13 ' A' ' 41' ' ' VAL . 14.7 p -105.17 112.86 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.728 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 38.9 t70 -41.38 111.8 0.25 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.468 0.651 . . . . 0.0 111.913 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.75 -23.99 63.47 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -67.4 -26.66 66.55 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.928 -0.483 . . . . 0.0 110.221 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.592 HD13 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -79.31 -36.11 40.14 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.77 ' HA ' HG12 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -64.57 -45.55 86.57 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.688 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.82 -22.69 2.29 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.148 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.497 ' O ' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -103.59 -36.55 7.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.579 -0.701 . . . . 0.0 110.174 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.77 HG12 ' HA ' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -70.22 -40.67 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.281 -0.887 . . . . 0.0 110.872 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.516 HD23 ' OE1' ' A' ' 43' ' ' GLU . 10.9 mt -62.69 -37.26 85.79 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.57 -34.69 78.84 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.766 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 18' ' ' LYS . 2.4 mm? -77.71 -27.78 50.76 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.345 -0.847 . . . . 0.0 109.515 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -82.51 -12.07 58.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.631 -0.668 . . . . 0.0 109.82 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.86 -35.22 20.74 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 121.385 -0.822 . . . . 0.0 109.867 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 11.3 mmtt -89.3 -16.05 32.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.61 -0.681 . . . . 0.0 109.816 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.35 26.52 27.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.46 ' O ' HD12 ' A' ' 22' ' ' LEU . 5.2 mm-40 -109.44 137.89 46.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.587 -0.949 . . . . 0.0 110.489 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -110.63 87.78 2.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.49 -0.756 . . . . 0.0 109.644 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.44 -154.34 0.54 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.472 -0.767 . . . . 0.0 110.266 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -112.02 155.43 23.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -0.806 . . . . 0.0 110.589 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.59 ' CD1' HG23 ' A' ' 19' ' ' VAL . 3.3 mt -130.56 122.01 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.604 -0.685 . . . . 0.0 109.74 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.45 ' HB3' ' CZ2' ' A' ' 34' ' ' TRP . 0.1 OUTLIER -84.68 155.63 21.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.407 -0.808 . . . . 0.0 110.882 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.736 HG21 ' OG ' ' A' ' 38' ' ' SER . 19.4 m -137.17 158.19 44.99 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.582 -0.699 . . . . 0.0 110.466 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.479 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 19.8 m-90 -145.54 30.72 1.1 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.333 -0.855 . . . . 0.0 111.726 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 p -86.33 -96.91 0.08 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.847 -1.158 . . . . 0.0 110.606 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.27 -66.34 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.097 -1.002 . . . . 0.0 110.186 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.474 ' HG2' ' HD1' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -99.73 45.24 0.99 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.67 0.747 . . . . 0.0 109.6 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.736 ' OG ' HG21 ' A' ' 33' ' ' THR . 2.2 m -50.9 138.32 19.25 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.448 0.642 . . . . 0.0 112.371 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.778 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 57.0 m -132.0 159.17 39.54 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.903 HG21 HG21 ' A' ' 62' ' ' ILE . 5.2 mp -89.76 168.25 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.231 -0.918 . . . . 0.0 111.276 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.729 HG13 HG21 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -140.21 174.69 3.75 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.228 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.551 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 40.9 Cg_endo -64.86 -31.53 57.01 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.995 1.524 . . . . 0.0 110.194 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.516 ' OE1' HD23 ' A' ' 20' ' ' LEU . 3.3 mm-40 -65.93 -12.42 54.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.761 -0.587 . . . . 0.0 110.631 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.69 ' HB3' HD13 ' A' ' 62' ' ' ILE . 41.4 mtp -97.84 11.29 37.81 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.278 -0.888 . . . . 0.0 110.872 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.665 HG23 ' N ' ' A' ' 64' ' ' GLU . 7.5 p -62.14 5.03 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.339 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.28 33.05 1.03 Allowed Glycine 0 N--CA 1.493 2.475 0 O-C-N 120.311 -1.493 . . . . 0.0 109.976 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.784 ' HB2' HD11 ' A' ' 49' ' ' ILE . 45.9 m-70 -144.07 153.21 41.95 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.153 -1.204 . . . . 0.0 111.29 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.741 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -100.01 83.92 2.78 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 178.255 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.784 HD11 ' HB2' ' A' ' 47' ' ' HIS . 3.1 mp -86.61 118.13 32.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 111.281 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.755 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -76.77 80.26 3.38 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.922 0.868 . . . . 0.0 109.071 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 51' ' ' VAL . 32.8 m -58.56 132.05 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.285 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 33' ' ' THR . 30.4 t80 -74.33 105.8 5.67 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -76.1 13.88 0.81 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.669 -0.644 . . . . 0.0 110.535 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.71 -27.72 12.8 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.5 pttp -140.48 -27.82 0.73 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.596 -0.943 . . . . 0.0 110.84 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -130.35 155.55 46.18 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.106 0.955 . . . . 0.0 113.546 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.653 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 50.8 m-70 -96.3 111.84 23.78 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.755 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 42.1 t -101.33 95.46 4.99 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.132 -0.98 . . . . 0.0 109.455 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.526 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.3 Cg_endo -65.09 87.51 0.18 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.939 1.494 . . . . 0.0 109.787 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.598 HG13 HG12 ' A' ' 58' ' ' VAL . 10.4 m -94.77 114.67 31.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.208 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.741 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.1 t80 -73.4 100.56 3.24 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.903 HG21 HG21 ' A' ' 40' ' ' ILE . 2.6 mp -83.9 138.43 19.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.594 0.711 . . . . 0.0 111.996 -177.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.644 ' C ' HG23 ' A' ' 45' ' ' VAL . 24.8 p -104.99 -153.98 0.5 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 176.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.665 ' N ' HG23 ' A' ' 45' ' ' VAL . 4.7 tp10 -90.43 0.5 57.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.549 -1.344 . . . . 0.0 110.978 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -126.94 -8.9 6.02 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.014 -1.054 . . . . 0.0 112.191 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.6 mmt -86.96 -26.23 23.94 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.805 -1.184 . . . . 0.0 110.121 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.499 HG21 ' C ' ' A' ' 41' ' ' VAL . 5.5 p -66.91 164.31 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.377 -0.827 . . . . 0.0 111.827 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.497 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 120.7 -11.89 10.19 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.52 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.773 ' O ' HG23 ' A' ' 39' ' ' THR . 16.3 m-70 -121.72 -84.99 0.66 Allowed 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 119.078 1.439 . . . . 0.0 111.074 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.778 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.1 OUTLIER 178.36 -30.54 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 CA-C-O 121.601 0.715 . . . . 0.0 110.328 -179.496 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.57 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 1.2 pp 173.3 -15.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.703 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.71 -17.4 76.61 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.714 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 3.6 mm-40 . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.276 -1.132 . . . . 0.0 109.202 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.716 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 121.281 0.562 . . . . 0.0 109.951 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 39' ' ' THR . 14.5 p -114.43 121.02 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.716 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 30.9 t70 -48.93 102.88 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.502 -0.749 . . . . 0.0 111.043 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -63.89 -24.24 67.66 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.23 -33.86 76.25 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.805 HD11 ' CE ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -77.39 -36.81 53.11 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.35 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.689 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.6 mp -62.38 -41.85 98.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.625 -0.672 . . . . 0.0 109.503 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.11 -23.17 19.51 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.647 -0.658 . . . . 0.0 109.993 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -98.62 -33.13 11.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.431 -0.793 . . . . 0.0 110.489 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 16' ' ' LEU . 1.5 p -69.73 -40.52 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.231 -0.918 . . . . 0.0 110.426 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.596 HD21 ' OE2' ' A' ' 43' ' ' GLU . 12.1 mt -63.22 -36.93 85.29 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 177.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.9 -34.04 72.65 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.627 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 27' ' ' GLU . 2.5 mm? -78.77 -26.99 44.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.347 -0.845 . . . . 0.0 109.435 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -81.48 -13.1 58.56 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.577 -0.702 . . . . 0.0 109.752 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.86 -35.39 24.21 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.447 -0.783 . . . . 0.0 109.702 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 17.1 mmtt -89.89 -15.09 32.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.724 -0.61 . . . . 0.0 109.826 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.55 26.25 36.32 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.439 ' O ' HD12 ' A' ' 22' ' ' LEU . 47.1 mt-10 -111.0 144.6 39.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.539 -0.977 . . . . 0.0 110.497 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -111.27 92.99 4.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.502 -0.749 . . . . 0.0 109.611 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.84 -157.19 0.64 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.539 -0.725 . . . . 0.0 110.449 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -112.8 154.04 26.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.538 -0.726 . . . . 0.0 110.364 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.573 HG21 HD12 ' A' ' 15' ' ' LEU . 3.0 mt -131.49 121.84 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.498 -0.751 . . . . 0.0 109.873 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.39 160.02 24.18 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.287 -0.883 . . . . 0.0 110.816 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.669 HG23 ' CG ' ' A' ' 12' ' ' ASP . 16.5 m -137.31 158.39 44.53 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.659 -0.651 . . . . 0.0 110.181 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.439 ' CD1' ' HE1' ' A' ' 57' ' ' HIS . 20.0 m-90 -145.74 37.01 1.07 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.272 -0.893 . . . . 0.0 110.629 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.428 ' HB3' ' HE1' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -100.21 -155.45 0.51 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.168 -0.958 . . . . 0.0 110.687 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.74 -58.13 2.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.179 -0.95 . . . . 0.0 110.147 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.38 35.26 1.99 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.539 -0.726 . . . . 0.0 109.924 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.435 ' HB3' HG21 ' A' ' 33' ' ' THR . 58.5 m -42.19 128.21 3.65 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.338 0.589 . . . . 0.0 111.839 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.713 ' O ' HG23 ' A' ' 11' ' ' VAL . 23.7 m -136.94 163.46 30.65 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.674 -0.641 . . . . 0.0 110.308 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.76 HG21 HG21 ' A' ' 62' ' ' ILE . 5.1 mp -85.42 169.73 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.472 -0.768 . . . . 0.0 111.186 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.674 HG12 ' HD2' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -137.27 176.26 2.88 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 121.563 -0.711 . . . . 0.0 109.771 178.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.674 ' HD2' HG12 ' A' ' 41' ' ' VAL . 42.1 Cg_endo -66.57 -29.43 44.14 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.059 1.557 . . . . 0.0 111.334 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.596 ' OE2' HD21 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -77.75 8.0 5.07 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.479 -0.763 . . . . 0.0 111.392 179.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.805 ' CE ' HD11 ' A' ' 15' ' ' LEU . 2.1 mtt -109.96 19.27 19.21 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.01 -1.056 . . . . 0.0 111.512 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.705 HG13 ' N ' ' A' ' 64' ' ' GLU . 89.0 t -66.68 7.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 121.088 -1.007 . . . . 0.0 113.352 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.2 32.44 0.95 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 34.8 m-70 -138.78 147.36 42.49 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.277 -1.131 . . . . 0.0 111.243 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.767 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -99.63 82.0 2.57 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.746 ' CG2' HD13 ' A' ' 15' ' ' LEU . 2.6 mp -81.61 117.38 27.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.314 -0.866 . . . . 0.0 111.446 -177.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.723 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -76.67 78.01 3.32 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 122.094 0.949 . . . . 0.0 108.813 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.666 HG21 ' HB3' ' A' ' 71' ' ' LEU . 32.9 m -60.43 131.12 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.775 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.515 ' HB2' ' O ' ' A' ' 33' ' ' THR . 36.2 t80 -78.28 103.95 8.55 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -74.36 7.87 2.59 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.362 -0.836 . . . . 0.0 111.339 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.94 -27.31 5.94 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -140.71 -24.97 0.76 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.84 -0.8 . . . . 0.0 111.522 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.503 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -133.64 154.09 51.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.106 -0.996 . . . . 0.0 112.443 -177.668 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.489 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 22.3 m-70 -98.84 100.61 11.82 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.723 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 52.5 t -88.75 104.29 7.13 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.236 -0.915 . . . . 0.0 109.887 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.496 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.6 Cg_endo -66.65 88.75 0.28 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 O-C-N 123.912 1.48 . . . . 0.0 109.501 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 49' ' ' ILE . 13.7 m -94.31 112.44 27.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.327 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.767 ' HB2' HG23 ' A' ' 48' ' ' THR . 5.9 t80 -72.9 100.0 2.82 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.76 HG21 HG21 ' A' ' 40' ' ' ILE . 2.7 mp -80.82 134.47 27.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.283 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.696 ' C ' HG13 ' A' ' 45' ' ' VAL . 1.9 m -105.19 -150.25 0.43 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 177.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.705 ' N ' HG13 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -90.01 -3.66 57.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.341 -1.474 . . . . 0.0 111.247 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.4 24.41 4.45 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.917 -1.114 . . . . 0.0 111.44 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.1 mtt -114.82 -31.61 6.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.149 -0.97 . . . . 0.0 110.02 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.528 ' HB ' HG21 ' A' ' 62' ' ' ILE . 6.0 p -62.07 163.29 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 O-C-N 121.453 -0.779 . . . . 0.0 111.925 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.478 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 120.91 -9.55 10.42 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.323 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.707 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 17.1 m-70 -122.97 -86.29 0.65 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 119.101 1.45 . . . . 0.0 110.836 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.54 -30.43 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.495 0.664 . . . . 0.0 110.243 -179.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.666 ' HB3' HG21 ' A' ' 51' ' ' VAL . 1.4 pp 173.55 -14.05 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.273 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.805 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.37 -17.85 79.08 Favored Glycine 0 N--CA 1.493 2.454 0 O-C-N 120.927 -1.108 . . . . 0.0 110.627 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.707 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 16.7 mm-40 . . . . . 0 N--CA 1.497 1.905 0 O-C-N 121.251 -1.146 . . . . 0.0 109.352 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.662 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.17 0.51 . . . . 0.0 109.746 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.807 HG21 HG13 ' A' ' 41' ' ' VAL . 13.5 p -92.11 108.4 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.662 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 36.2 t70 -48.31 115.74 1.32 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.457 0.646 . . . . 0.0 111.736 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.72 -25.07 62.78 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -63.78 -27.73 69.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.862 -0.524 . . . . 0.0 110.12 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.846 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -78.74 -36.73 42.77 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.712 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.846 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.0 mp -62.64 -43.79 97.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.853 -0.529 . . . . 0.0 109.919 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.32 -21.31 23.49 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.666 -0.646 . . . . 0.0 110.593 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.599 ' O ' HD23 ' A' ' 22' ' ' LEU . 6.4 mmpt? -106.27 -23.81 12.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.4 -0.812 . . . . 0.0 111.164 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.695 HG12 ' HA ' ' A' ' 16' ' ' LEU . 1.4 p -86.26 -40.94 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.983 -1.073 . . . . 0.0 111.0 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.482 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 14.1 mt -65.34 -38.16 89.28 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -62.64 -33.84 75.84 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.539 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.599 HD23 ' O ' ' A' ' 18' ' ' LYS . 2.3 mm? -78.0 -25.98 48.29 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.291 -0.881 . . . . 0.0 109.456 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.4 ' ND2' ' HB3' ' A' ' 43' ' ' GLU . 31.3 m-80 -81.56 -12.4 58.8 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.586 -0.696 . . . . 0.0 109.682 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.91 -37.21 27.15 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 121.446 -0.784 . . . . 0.0 109.346 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -86.05 -22.55 27.15 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.64 15.71 51.76 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -95.68 145.03 25.6 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.534 -0.98 . . . . 0.0 110.388 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -110.15 89.39 3.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.517 -0.74 . . . . 0.0 109.557 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.433 ' HB2' HD11 ' A' ' 22' ' ' LEU . 7.6 ttm180 -111.77 -155.57 0.57 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.496 -0.752 . . . . 0.0 110.365 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -119.2 154.09 33.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.412 -0.805 . . . . 0.0 110.319 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.588 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 2.7 mp -129.65 121.49 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.495 -0.753 . . . . 0.0 110.18 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.515 ' CD ' HD11 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -99.89 153.44 19.16 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.321 -0.862 . . . . 0.0 111.23 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.586 HG23 ' H ' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -140.95 166.77 23.88 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.689 -0.632 . . . . 0.0 110.072 179.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.478 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 13.6 m-90 -144.89 43.16 1.34 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.639 -0.663 . . . . 0.0 110.508 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.26 -83.35 0.26 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.231 -0.918 . . . . 0.0 110.605 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -179.93 -63.68 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.422 -0.799 . . . . 0.0 110.155 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -101.89 35.94 2.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.466 -0.771 . . . . 0.0 109.616 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.2 m -42.16 113.22 0.41 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.442 0.639 . . . . 0.0 111.578 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.875 HG23 ' O ' ' A' ' 69' ' ' HIS . 26.2 m -107.12 159.35 16.39 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.818 -0.551 . . . . 0.0 109.554 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.654 ' CG2' ' HG3' ' A' ' 44' ' ' MET . 1.1 mp -74.47 163.76 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.479 -0.763 . . . . 0.0 111.163 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.816 HG11 HD11 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -121.61 179.13 1.02 Allowed Pre-proline 0 N--CA 1.507 2.407 0 O-C-N 121.648 -0.658 . . . . 0.0 109.925 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.567 ' HD2' HG12 ' A' ' 41' ' ' VAL . 50.4 Cg_endo -71.44 -32.49 12.3 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 124.079 1.568 . . . . 0.0 111.346 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HB3' ' ND2' ' A' ' 23' ' ' ASN . 2.1 mm-40 -83.98 15.27 3.48 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.445 -0.785 . . . . 0.0 110.573 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.942 ' CG ' HG21 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -82.92 -15.7 50.33 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.636 -0.665 . . . . 0.0 112.125 -179.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.615 HG23 ' N ' ' A' ' 64' ' ' GLU . 2.4 p -58.31 6.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.41 29.26 1.07 Allowed Glycine 0 N--CA 1.491 2.335 0 O-C-N 119.917 -1.739 . . . . 0.0 110.056 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.539 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 25.4 m-70 -145.93 156.6 43.63 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.998 -1.295 . . . . 0.0 111.539 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -99.03 78.86 2.3 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 177.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.719 HD12 ' CD1' ' A' ' 62' ' ' ILE . 78.8 mt -78.18 116.79 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.526 -0.734 . . . . 0.0 111.516 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.773 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.85 85.92 5.45 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 51' ' ' VAL . 17.6 m -66.77 128.81 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.026 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.586 ' H ' HG23 ' A' ' 33' ' ' THR . 27.0 t80 -76.73 105.77 8.0 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.449 -0.782 . . . . 0.0 108.911 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -70.29 -0.85 8.82 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.679 -0.638 . . . . 0.0 110.679 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.9 -19.64 9.49 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -140.1 -28.68 0.73 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.933 -0.745 . . . . 0.0 110.898 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -134.68 155.2 50.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.187 -0.946 . . . . 0.0 111.977 -178.307 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.539 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -101.63 111.3 23.5 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.773 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 18.0 t -98.64 94.96 2.7 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.256 -0.902 . . . . 0.0 109.743 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 57' ' ' HIS . 43.6 Cg_endo -69.37 94.9 0.5 Allowed 'Trans proline' 0 N--CA 1.487 1.137 0 O-C-N 123.847 1.446 . . . . 0.0 109.531 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.563 ' CG2' HG12 ' A' ' 58' ' ' VAL . 48.6 t -111.93 127.89 68.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.062 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.539 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.9 t80 -72.19 102.34 3.03 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 176.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.942 HG21 ' CG ' ' A' ' 44' ' ' MET . 2.8 mp -65.54 -60.48 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -175.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 62' ' ' ILE . 4.9 m 71.71 172.17 0.31 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -176.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.615 ' N ' HG23 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -78.3 66.83 3.97 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.856 -1.152 . . . . 0.0 110.396 -179.06 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -169.54 -24.17 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.398 -0.814 . . . . 0.0 112.625 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.419 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 11.0 mtt -110.15 9.12 24.01 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.613 -1.304 . . . . 0.0 112.544 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.661 ' HB ' ' HE3' ' A' ' 44' ' ' MET . 14.2 p -89.33 166.49 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 O-C-N 120.583 -1.323 . . . . 0.0 112.652 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.523 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 105.17 -13.81 48.38 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.875 ' O ' HG23 ' A' ' 39' ' ' THR . 15.2 m-70 -113.43 -90.37 0.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 118.813 1.306 . . . . 0.0 110.478 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.755 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.86 -35.36 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 122.306 1.05 . . . . 0.0 109.106 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.645 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -178.67 -13.55 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.027 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.57 -15.64 80.44 Favored Glycine 0 N--CA 1.497 2.704 0 O-C-N 120.829 -1.17 . . . . 0.0 110.286 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.58 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 2.0 mm-40 . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.385 -1.067 . . . . 0.0 108.567 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.715 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.381 0.61 . . . . 0.0 110.293 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.078 HG11 HG13 ' A' ' 41' ' ' VAL . 77.7 t -105.14 114.48 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.715 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 1.8 t0 -44.58 106.29 0.07 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.448 0.642 . . . . 0.0 111.805 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -67.65 -23.35 65.32 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.7 t60 -67.32 -35.7 79.98 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.873 -0.517 . . . . 0.0 109.908 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.735 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -75.32 -38.24 60.33 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.29 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.735 HD12 ' HG ' ' A' ' 15' ' ' LEU . 2.6 mp -58.78 -43.58 90.45 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.299 0.571 . . . . 0.0 109.639 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.506 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -55.03 -25.75 32.56 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.065 179.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.478 ' HB2' HG23 ' A' ' 31' ' ' ILE . 10.3 mmtm -97.12 -31.95 12.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.479 -0.763 . . . . 0.0 111.034 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.655 HG12 ' HA ' ' A' ' 16' ' ' LEU . 3.6 p -74.07 -38.03 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 120.997 -1.064 . . . . 0.0 111.271 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.506 HD21 ' HA ' ' A' ' 17' ' ' GLU . 3.6 pp -62.69 -25.03 67.95 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.75 -35.28 72.58 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 27' ' ' GLU . 3.4 mm? -72.33 -27.49 62.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.623 -0.673 . . . . 0.0 109.585 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -83.17 -16.13 47.85 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.588 -0.695 . . . . 0.0 109.792 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.8 -36.99 23.12 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 121.577 -0.702 . . . . 0.0 109.57 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -88.03 -21.07 24.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.674 -0.641 . . . . 0.0 109.35 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.01 17.26 59.7 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.494 ' O ' HD12 ' A' ' 22' ' ' LEU . 21.7 mm-40 -93.28 149.15 21.44 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.38 -1.071 . . . . 0.0 110.593 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -110.74 96.57 6.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.549 -0.72 . . . . 0.0 109.756 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.446 ' HB2' HD11 ' A' ' 22' ' ' LEU . 1.8 ttt85 -126.73 -155.53 0.69 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.532 -0.73 . . . . 0.0 110.353 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -116.99 155.79 28.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.5 -0.75 . . . . 0.0 110.469 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.652 HD13 HG23 ' A' ' 19' ' ' VAL . 3.2 mp -132.05 112.98 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.614 -0.679 . . . . 0.0 109.536 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.13 148.35 26.38 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.386 -0.821 . . . . 0.0 110.897 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 14.3 t -141.09 174.87 10.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.679 -0.638 . . . . 0.0 110.171 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.501 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 10.0 m-90 -143.8 47.13 1.45 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.145 -0.972 . . . . 0.0 111.666 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 t -88.96 -84.25 0.21 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.718 -1.239 . . . . 0.0 111.077 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.54 -88.83 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.02 -1.05 . . . . 0.0 111.36 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.539 ' HD2' ' HB3' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -97.4 52.83 1.13 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.209 -0.932 . . . . 0.0 109.975 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.525 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 0.4 OUTLIER -39.11 138.12 0.63 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.264 0.554 . . . . 0.0 112.363 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.825 HG23 ' O ' ' A' ' 69' ' ' HIS . 24.4 m -129.2 159.21 36.76 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.529 -0.732 . . . . 0.0 110.133 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.875 HG23 ' SD ' ' A' ' 44' ' ' MET . 1.2 mp -78.99 159.55 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 121.541 -0.725 . . . . 0.0 111.604 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.078 HG13 HG11 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -133.64 171.23 9.46 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 42.6 Cg_endo -67.16 -31.79 35.42 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.133 1.596 . . . . 0.0 110.493 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HG3' HG11 ' A' ' 19' ' ' VAL . 6.5 pt-20 -75.24 -1.97 25.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.53 -0.731 . . . . 0.0 111.025 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.906 ' SD ' HD13 ' A' ' 62' ' ' ILE . 1.4 ptp -114.98 16.7 17.11 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.897 -1.127 . . . . 0.0 110.886 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.615 HG13 ' CA ' ' A' ' 64' ' ' GLU . 2.6 t -68.27 6.5 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.358 -0.839 . . . . 0.0 112.782 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.77 35.79 0.92 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.539 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 54.2 m-70 -140.24 159.2 42.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.501 -0.999 . . . . 0.0 110.488 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.644 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.08 82.47 2.73 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 178.382 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.602 ' CG2' HD13 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -83.51 115.82 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.495 -0.753 . . . . 0.0 111.55 -176.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.767 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -77.99 81.6 4.38 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.561 HG22 HG23 ' A' ' 58' ' ' VAL . 33.0 m -66.19 132.66 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.581 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.501 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 23.8 t80 -72.44 104.35 3.77 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -70.7 -0.23 8.39 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.51 -0.744 . . . . 0.0 110.488 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.6 -21.79 8.43 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.12 -30.0 0.69 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 122.009 -0.701 . . . . 0.0 110.633 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.409 ' CG ' HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -133.89 156.47 48.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.309 -0.869 . . . . 0.0 111.737 -178.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.451 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -102.41 101.74 12.0 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.178 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.767 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 14.6 m -91.39 105.56 13.26 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.152 -0.967 . . . . 0.0 110.335 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.505 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 43.0 Cg_endo -68.7 88.88 0.42 Allowed 'Trans proline' 0 N--CA 1.49 1.276 0 O-C-N 123.91 1.479 . . . . 0.0 109.163 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 58' ' ' VAL . 58.2 t -98.18 119.17 45.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.485 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.644 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.3 t80 -70.97 101.54 2.2 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 118.85 -1.14 . . . . 0.0 107.95 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.906 HD13 ' SD ' ' A' ' 44' ' ' MET . 3.2 mp -80.75 138.34 19.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.638 -0.664 . . . . 0.0 110.566 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.445 ' C ' HG13 ' A' ' 45' ' ' VAL . 60.8 p -98.71 -161.23 0.86 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 177.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.615 ' CA ' HG13 ' A' ' 45' ' ' VAL . 0.6 OUTLIER -85.29 5.79 28.98 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.823 -1.173 . . . . 0.0 111.081 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -128.57 -11.53 5.0 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.739 -1.226 . . . . 0.0 113.053 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.625 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 9.0 mtt -88.37 -5.59 58.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.519 -1.363 . . . . 0.0 110.618 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 68' ' ' GLY . 9.0 p -81.79 165.19 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.073 -1.017 . . . . 0.0 111.535 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.498 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 109.05 -18.16 31.4 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.825 ' O ' HG23 ' A' ' 39' ' ' THR . 16.5 m-70 -115.89 -86.14 0.62 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -1.204 . . . . 0.0 110.695 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.37 -35.09 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 122.215 1.007 . . . . 0.0 109.291 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER 179.63 -16.08 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.864 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.78 -15.1 73.43 Favored Glycine 0 N--CA 1.497 2.715 0 O-C-N 120.889 -1.132 . . . . 0.0 110.458 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.625 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 1.6 mm-40 . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.362 -1.081 . . . . 0.0 108.805 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 121.197 0.523 . . . . 0.0 109.964 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.0 t -110.22 124.19 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.951 ' OD1' HD23 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -45.1 107.14 0.09 Allowed 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.375 0.607 . . . . 0.0 111.427 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.78 -27.02 64.57 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.827 ' CB ' HG23 ' A' ' 33' ' ' THR . 1.0 OUTLIER -68.78 -15.81 63.62 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.943 -0.473 . . . . 0.0 110.171 178.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.088 HD11 ' SD ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -84.36 -39.08 19.52 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.466 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.84 ' HA ' HG12 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -69.07 -43.79 73.9 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.605 -0.685 . . . . 0.0 110.714 179.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.443 ' HG2' ' HA ' ' A' ' 14' ' ' HIS . 5.8 pt-20 -53.93 -19.39 4.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.446 -0.784 . . . . 0.0 110.885 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.563 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.1 mtmt -112.49 -33.6 6.11 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.261 -0.9 . . . . 0.0 111.134 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.885 HG21 ' SD ' ' A' ' 44' ' ' MET . 1.1 p -73.73 -39.69 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.081 -1.012 . . . . 0.0 111.591 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.457 HD11 ' HB3' ' A' ' 16' ' ' LEU . 18.1 mt -60.11 -37.88 81.33 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.07 -40.24 92.92 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.593 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.689 HD23 ' CB ' ' A' ' 27' ' ' GLU . 1.1 mt -71.92 -26.63 62.38 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.272 -0.892 . . . . 0.0 110.289 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -80.66 -10.75 59.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.558 -0.714 . . . . 0.0 109.636 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.98 -35.62 15.43 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.482 -0.761 . . . . 0.0 110.172 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.478 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -102.39 -25.89 13.48 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.547 -0.721 . . . . 0.0 109.793 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.55 29.49 12.06 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.689 ' CB ' HD23 ' A' ' 22' ' ' LEU . 5.0 mm-40 -80.14 149.37 30.58 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.446 -1.032 . . . . 0.0 110.351 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -111.8 86.0 2.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.579 -0.701 . . . . 0.0 109.953 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -136.34 -160.13 1.02 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.484 -0.76 . . . . 0.0 110.53 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.543 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -119.52 156.69 29.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.649 -0.657 . . . . 0.0 110.206 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.659 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 2.7 mp -124.79 123.39 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.37 -0.831 . . . . 0.0 109.75 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.505 ' HE3' HD11 ' A' ' 30' ' ' LEU . 1.1 mptt -98.28 151.15 20.79 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.246 -0.909 . . . . 0.0 111.137 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.949 HG21 ' HB2' ' A' ' 12' ' ' ASP . 18.4 m -136.15 162.47 32.86 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.652 -0.655 . . . . 0.0 109.584 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.428 ' CD1' ' NE2' ' A' ' 57' ' ' HIS . 27.9 m-90 -141.44 38.36 1.7 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.279 -0.888 . . . . 0.0 110.768 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.7 m -82.82 -101.23 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.208 -0.932 . . . . 0.0 110.566 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.43 -68.69 0.12 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.041 -1.037 . . . . 0.0 109.756 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.509 ' HG2' ' HD1' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -106.48 50.76 0.76 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.777 0.799 . . . . 0.0 108.857 178.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.445 ' OG ' ' HB3' ' A' ' 12' ' ' ASP . 22.4 m -47.86 111.01 0.37 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.302 0.572 . . . . 0.0 111.905 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 69' ' ' HIS . 28.7 m -105.43 155.84 18.76 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.693 -0.63 . . . . 0.0 109.597 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.746 HG21 HG21 ' A' ' 62' ' ' ILE . 4.4 mp -77.82 167.87 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.145 -0.972 . . . . 0.0 111.297 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.77 HG12 ' HD2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -137.5 176.73 2.53 Favored Pre-proline 0 N--CA 1.501 2.081 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.142 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.77 ' HD2' HG12 ' A' ' 41' ' ' VAL . 45.1 Cg_endo -68.42 -35.18 18.66 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.889 1.468 . . . . 0.0 111.335 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.52 ' HB2' ' CE ' ' A' ' 44' ' ' MET . 0.8 OUTLIER -66.0 -9.93 34.82 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.461 -0.775 . . . . 0.0 110.677 179.099 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 1.088 ' SD ' HD11 ' A' ' 15' ' ' LEU . 4.0 mmt -88.14 0.93 55.44 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.348 -0.845 . . . . 0.0 111.323 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.476 HG23 ' N ' ' A' ' 64' ' ' GLU . 5.6 p -54.98 -2.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.18 34.66 1.19 Allowed Glycine 0 N--CA 1.492 2.426 0 O-C-N 120.43 -1.419 . . . . 0.0 109.605 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.532 ' HB2' HD11 ' A' ' 49' ' ' ILE . 56.1 m-70 -142.54 150.94 41.09 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.304 -1.115 . . . . 0.0 111.127 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.733 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.75 81.41 2.46 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.15 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.009 HG12 HD13 ' A' ' 15' ' ' LEU . 3.0 mt -85.54 121.88 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 111.654 -176.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.76 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.85 82.48 5.05 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 122.102 0.953 . . . . 0.0 108.888 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 51' ' ' VAL . 33.2 m -63.0 127.52 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.542 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 33' ' ' THR . 20.2 t80 -71.71 104.29 3.33 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -70.68 -1.43 11.32 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.557 -0.715 . . . . 0.0 110.553 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.29 -21.05 8.84 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -140.18 -29.75 0.69 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.882 -0.775 . . . . 0.0 110.82 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.41 155.67 49.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.332 -0.855 . . . . 0.0 111.928 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.432 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 6.0 m80 -102.51 103.99 14.38 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.76 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 28.7 t -93.55 102.78 8.28 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.3 -0.875 . . . . 0.0 110.106 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.501 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.5 Cg_endo -66.59 89.32 0.28 Allowed 'Trans proline' 0 N--CA 1.492 1.404 0 O-C-N 123.878 1.462 . . . . 0.0 109.195 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 58' ' ' VAL . 48.1 t -97.57 118.68 44.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.201 -178.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.733 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.6 t80 -73.19 103.9 4.06 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.91 HD13 ' HB3' ' A' ' 44' ' ' MET . 2.7 mp -84.45 144.82 9.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.675 0.75 . . . . 0.0 111.64 -178.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.9 p -111.03 -158.71 0.65 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.476 ' N ' HG23 ' A' ' 45' ' ' VAL . 3.5 tp10 -90.59 15.14 11.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.588 -1.32 . . . . 0.0 110.997 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -137.95 -13.47 1.43 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.919 -1.113 . . . . 0.0 112.527 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 28.3 mmt -88.04 -24.97 23.32 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.605 -1.309 . . . . 0.0 110.327 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.591 HG21 ' C ' ' A' ' 41' ' ' VAL . 4.2 p -66.61 163.45 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.388 -0.82 . . . . 0.0 111.437 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.499 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 118.17 -14.79 12.23 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.113 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.782 ' O ' HG23 ' A' ' 39' ' ' THR . 21.5 m-70 -127.21 -81.14 0.6 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.965 -1.315 . . . . 0.0 111.497 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.606 ' HD3' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER 177.42 -31.97 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.717 0.77 . . . . 0.0 110.268 -179.264 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.606 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.7 OUTLIER 173.82 -16.0 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.757 -179.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.53 -18.02 73.29 Favored Glycine 0 N--CA 1.496 2.639 0 O-C-N 120.946 -1.096 . . . . 0.0 110.503 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.65 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 1.3 mt-10 . . . . . 0 N--CA 1.497 1.903 0 O-C-N 121.407 -1.054 . . . . 0.0 109.124 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.767 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.561 HG22 ' HB ' ' A' ' 39' ' ' THR . 69.4 t -101.83 112.05 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.767 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 39.0 t70 -44.68 106.52 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.145 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -67.87 -24.2 65.21 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -66.22 -25.61 66.99 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.942 -0.474 . . . . 0.0 109.91 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.89 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -79.76 -38.16 33.81 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.89 HD12 ' HG ' ' A' ' 15' ' ' LEU . 5.0 mp -62.58 -42.3 99.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.796 -0.565 . . . . 0.0 109.923 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.66 -30.76 22.98 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.136 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.77 -27.99 17.67 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.464 -0.772 . . . . 0.0 110.602 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.908 HG21 ' SD ' ' A' ' 44' ' ' MET . 93.9 t -73.62 -40.16 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.15 -0.969 . . . . 0.0 111.186 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 16' ' ' LEU . 10.9 mt -60.93 -36.43 79.29 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.18 -36.09 83.12 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.051 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.449 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 2.9 mm? -77.63 -26.57 50.65 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.258 -0.901 . . . . 0.0 109.666 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -81.96 -12.48 58.34 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.623 -0.673 . . . . 0.0 109.757 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.59 -34.53 27.65 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.417 -0.802 . . . . 0.0 109.512 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 16.3 mmtt -93.11 -15.87 25.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.773 -0.579 . . . . 0.0 109.8 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.21 28.99 34.97 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' O ' HD12 ' A' ' 22' ' ' LEU . 28.3 mt-10 -106.48 148.74 27.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.649 -0.912 . . . . 0.0 110.705 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 mtmm -113.36 90.81 3.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.586 -0.696 . . . . 0.0 109.97 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.412 ' HB2' HD11 ' A' ' 22' ' ' LEU . 3.9 ttt-85 -113.5 -158.32 0.65 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.459 -0.776 . . . . 0.0 110.305 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.634 HD11 ' HD3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -116.19 148.39 40.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.574 -0.704 . . . . 0.0 110.274 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.749 HD13 HG22 ' A' ' 19' ' ' VAL . 3.2 mp -121.83 118.75 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.594 -0.691 . . . . 0.0 109.552 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.634 ' HD3' HD11 ' A' ' 30' ' ' LEU . 20.5 mmmt -78.9 152.93 30.89 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.453 -0.779 . . . . 0.0 111.029 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.67 HG23 ' CG ' ' A' ' 12' ' ' ASP . 24.1 m -139.69 153.16 47.18 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.589 -0.694 . . . . 0.0 109.778 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.463 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 9.7 m-90 -145.3 36.44 1.1 Allowed 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.22 -0.925 . . . . 0.0 111.6 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 m -86.86 -95.97 0.08 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.764 -1.21 . . . . 0.0 110.361 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.413 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -173.99 -63.02 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.191 -0.943 . . . . 0.0 109.464 179.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.43 ' HG3' ' HB3' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -102.24 36.85 2.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.591 -0.693 . . . . 0.0 109.212 178.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.414 ' OG ' HG21 ' A' ' 33' ' ' THR . 4.2 m -48.29 144.48 3.91 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.515 0.674 . . . . 0.0 111.77 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.818 HG23 ' O ' ' A' ' 69' ' ' HIS . 52.3 m -133.81 160.19 38.36 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.273 0.558 . . . . 0.0 109.678 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.778 ' CG2' HG12 ' A' ' 62' ' ' ILE . 1.2 mp -83.41 164.78 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.632 -0.668 . . . . 0.0 111.846 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.877 HG21 HD11 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -134.15 174.21 4.92 Favored Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.787 -0.57 . . . . 0.0 109.466 178.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.749 ' HD2' HG12 ' A' ' 41' ' ' VAL . 46.0 Cg_endo -68.92 -34.65 17.07 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 124.0 1.526 . . . . 0.0 111.581 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.42 -6.54 25.26 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.408 -0.808 . . . . 0.0 110.742 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.908 ' SD ' HG21 ' A' ' 19' ' ' VAL . 6.6 mmt -86.31 -6.29 58.99 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.365 -0.835 . . . . 0.0 111.658 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.646 HG23 ' N ' ' A' ' 64' ' ' GLU . 6.0 p -51.51 1.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.406 ' C ' ' CG ' ' A' ' 47' ' ' HIS . . . -146.27 33.19 1.48 Allowed Glycine 0 N--CA 1.495 2.575 0 O-C-N 119.93 -1.731 . . . . 0.0 110.071 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.459 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 21.8 m-70 -147.66 153.98 40.03 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.106 -1.232 . . . . 0.0 111.181 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.64 88.76 3.92 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.826 HD12 HD13 ' A' ' 62' ' ' ILE . 22.9 mt -86.24 121.94 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.565 -176.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.776 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.16 78.05 5.64 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 51' ' ' VAL . 23.3 m -62.39 128.67 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.643 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 35.3 t80 -75.67 105.48 6.73 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -76.08 8.35 3.31 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.368 -0.833 . . . . 0.0 111.221 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 36' ' ' ARG . . . 122.71 -27.11 6.06 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.49 -24.03 0.79 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.819 -0.812 . . . . 0.0 111.596 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -135.76 154.17 51.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.019 -1.051 . . . . 0.0 112.411 -177.655 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.472 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -100.19 105.2 16.77 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.776 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 23.4 t -94.1 101.26 6.04 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.146 -0.971 . . . . 0.0 109.935 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.538 ' HB3' HD12 ' A' ' 30' ' ' LEU . 41.8 Cg_endo -67.72 93.08 0.37 Allowed 'Trans proline' 0 N--CA 1.489 1.25 0 O-C-N 123.955 1.503 . . . . 0.0 109.697 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.629 ' O ' HD12 ' A' ' 62' ' ' ILE . 16.4 m -109.38 129.07 64.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.829 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.8 t80 -71.35 105.8 3.64 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.826 HD13 HD12 ' A' ' 49' ' ' ILE . 1.6 mp -57.97 -63.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.476 ' O ' HG22 ' A' ' 62' ' ' ILE . 3.0 m 66.3 171.33 0.24 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -176.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.646 ' N ' HG23 ' A' ' 45' ' ' VAL . 2.8 tp10 -83.84 58.58 4.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.372 -1.455 . . . . 0.0 109.26 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -161.25 -36.86 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.306 -0.871 . . . . 0.0 112.181 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.547 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -88.24 -15.98 34.46 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.87 -1.144 . . . . 0.0 111.146 -179.087 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.513 HG21 ' C ' ' A' ' 41' ' ' VAL . 7.5 p -73.66 161.73 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.099 -1.0 . . . . 0.0 112.138 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.48 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 113.56 -19.3 19.39 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.818 ' O ' HG23 ' A' ' 39' ' ' THR . 17.0 m-70 -114.9 -84.44 0.61 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.077 -1.249 . . . . 0.0 110.483 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.732 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.19 -34.67 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 122.042 0.925 . . . . 0.0 109.846 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.554 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.5 OUTLIER 176.88 -14.26 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.856 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.41 -15.58 72.89 Favored Glycine 0 N--CA 1.496 2.668 0 O-C-N 120.9 -1.125 . . . . 0.0 110.313 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.626 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 1.1 mt-10 . . . . . 0 N--CA 1.497 1.897 0 O-C-N 121.336 -1.097 . . . . 0.0 109.037 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.724 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.274 0.559 . . . . 0.0 109.888 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.823 HG21 HG13 ' A' ' 41' ' ' VAL . 7.2 p -108.8 113.98 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.776 ' CG ' HG23 ' A' ' 33' ' ' THR . 38.8 t70 -41.96 109.23 0.12 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.716 -0.615 . . . . 0.0 111.682 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -68.52 -24.57 64.67 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.601 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 1.7 t-80 -65.57 -20.64 66.41 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.908 -0.495 . . . . 0.0 110.3 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.954 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -85.32 -38.43 18.81 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.133 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.954 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.7 mp -63.82 -43.13 97.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.83 -0.544 . . . . 0.0 110.26 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.601 ' HG2' ' HA ' ' A' ' 14' ' ' HIS . 0.6 OUTLIER -57.31 -19.15 20.39 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.756 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.423 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 42.0 mttm -102.56 -29.02 11.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.356 -0.84 . . . . 0.0 110.657 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.004 HG21 ' SD ' ' A' ' 44' ' ' MET . 1.7 p -79.55 -36.21 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.154 -0.966 . . . . 0.0 111.479 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.555 HD21 ' HA ' ' A' ' 17' ' ' GLU . 3.8 pp -62.82 -25.66 68.36 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -34.34 63.36 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.707 HD22 ' HB2' ' A' ' 27' ' ' GLU . 1.2 mt -76.27 -27.43 56.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.796 -0.565 . . . . 0.0 109.567 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -84.16 -13.82 51.83 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.613 -0.679 . . . . 0.0 109.676 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.51 -37.94 15.35 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 121.55 -0.718 . . . . 0.0 109.955 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -97.01 -23.97 16.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.575 -0.703 . . . . 0.0 109.654 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.44 25.89 19.71 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.707 ' HB2' HD22 ' A' ' 22' ' ' LEU . 24.9 mt-10 -72.18 125.58 27.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.471 -1.017 . . . . 0.0 110.258 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.18 94.88 9.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.552 -0.717 . . . . 0.0 110.225 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.1 ttp85 -149.59 -160.93 1.24 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.519 -0.738 . . . . 0.0 110.312 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.635 ' HB2' ' HB ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -119.71 165.07 15.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.585 -0.697 . . . . 0.0 110.455 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.757 HG21 HD12 ' A' ' 15' ' ' LEU . 36.3 mm -112.57 159.92 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.321 -0.862 . . . . 0.0 109.026 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.502 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -125.5 153.41 43.61 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.288 -0.883 . . . . 0.0 110.839 -178.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.776 HG23 ' CG ' ' A' ' 12' ' ' ASP . 20.0 m -139.84 154.17 47.25 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.588 -0.695 . . . . 0.0 110.712 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.502 ' CH2' ' HB2' ' A' ' 32' ' ' LYS . 16.6 m-90 -146.49 34.19 0.96 Allowed 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.433 -0.792 . . . . 0.0 111.224 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.69 -93.56 0.11 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.864 -1.148 . . . . 0.0 110.989 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.414 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . 13.5 ttp85 -170.02 -66.49 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.194 -0.941 . . . . 0.0 109.287 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.554 ' HD2' ' HB3' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -104.43 44.0 1.06 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.247 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.541 ' CB ' HG21 ' A' ' 33' ' ' THR . 19.5 m -56.21 153.08 9.86 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.555 0.693 . . . . 0.0 112.317 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.724 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 40.9 m -140.38 162.21 35.86 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.878 -0.514 . . . . 0.0 110.055 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.716 HG21 HG12 ' A' ' 62' ' ' ILE . 4.8 mp -81.81 170.29 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 O-C-N 121.291 -0.881 . . . . 0.0 111.094 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.823 HG13 HG21 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -132.1 175.2 3.88 Favored Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.744 -0.597 . . . . 0.0 109.74 179.073 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.741 ' O ' HG23 ' A' ' 45' ' ' VAL . 47.0 Cg_endo -70.17 -32.7 16.37 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 124.096 1.577 . . . . 0.0 111.539 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.723 ' HG3' HG11 ' A' ' 19' ' ' VAL . 2.0 pt-20 -72.33 -3.43 23.81 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.275 -0.891 . . . . 0.0 110.957 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 1.004 ' SD ' HG21 ' A' ' 19' ' ' VAL . 23.5 mmm -91.1 15.65 11.27 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.296 -0.878 . . . . 0.0 112.231 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 42' ' ' PRO . 66.0 t -64.73 4.49 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 O-C-N 120.947 -1.096 . . . . 0.0 113.129 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.35 29.84 1.07 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.438 ' HB2' ' CE ' ' A' ' 44' ' ' MET . 20.0 m-70 -139.09 150.71 46.03 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.377 -1.072 . . . . 0.0 110.701 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.635 ' HB ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.65 86.31 3.31 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.139 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.791 HD11 ' CG ' ' A' ' 44' ' ' MET . 58.3 mt -72.53 117.79 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.17 -0.956 . . . . 0.0 111.298 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.675 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.91 73.99 6.66 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.613 HG21 ' HB3' ' A' ' 71' ' ' LEU . 34.2 m -56.27 126.29 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.305 -177.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.522 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 29.0 t80 -76.93 101.99 6.19 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -74.55 9.97 1.54 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.485 -0.76 . . . . 0.0 111.065 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 36' ' ' ARG . . . 121.67 -27.86 6.12 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.75 -25.85 0.75 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.837 -0.802 . . . . 0.0 111.602 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.522 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -130.74 153.89 48.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.149 -0.969 . . . . 0.0 112.377 -177.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.521 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 2.3 m80 -99.74 99.19 9.98 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.675 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 46.5 t -86.57 104.73 6.22 Favored Pre-proline 0 N--CA 1.501 2.102 0 O-C-N 121.215 -0.928 . . . . 0.0 109.505 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 57' ' ' HIS . 42.7 Cg_endo -67.08 90.68 0.31 Allowed 'Trans proline' 0 N--CA 1.489 1.258 0 O-C-N 123.892 1.47 . . . . 0.0 110.251 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 60' ' ' VAL . 35.6 m -95.83 111.36 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.39 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.582 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.2 t80 -72.59 104.46 3.88 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.015 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.716 HG12 HG21 ' A' ' 40' ' ' ILE . 2.7 mp -85.59 127.98 39.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.578 -0.701 . . . . 0.0 111.324 -178.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.508 ' C ' HG13 ' A' ' 45' ' ' VAL . 46.3 p -92.71 -153.28 0.34 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.565 ' N ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -87.97 8.0 28.44 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.711 -1.243 . . . . 0.0 111.196 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -147.64 21.11 1.16 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.959 -1.088 . . . . 0.0 111.775 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 7.8 mmt -107.61 -26.51 10.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.235 -0.916 . . . . 0.0 109.804 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.565 ' HB ' HG21 ' A' ' 62' ' ' ILE . 6.8 p -65.36 163.7 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 121.469 -0.769 . . . . 0.0 111.691 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.487 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 122.42 -10.2 9.28 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.397 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.717 ' O ' HG23 ' A' ' 39' ' ' THR . 17.4 m-70 -123.82 -86.26 0.64 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.128 1.464 . . . . 0.0 110.983 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.724 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.31 -30.29 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.556 0.693 . . . . 0.0 110.308 -179.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.629 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.8 OUTLIER 174.27 -15.21 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.769 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.65 -18.46 78.65 Favored Glycine 0 N--CA 1.495 2.606 0 O-C-N 120.929 -1.107 . . . . 0.0 110.633 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.698 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 22.2 mm-40 . . . . . 0 N--CA 1.497 1.878 0 O-C-N 121.22 -1.165 . . . . 0.0 109.349 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.734 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.288 0.566 . . . . 0.0 110.075 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.967 HG21 HG13 ' A' ' 41' ' ' VAL . 7.5 p -101.83 115.68 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 178.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.734 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 27.8 t70 -46.34 107.06 0.09 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.476 0.655 . . . . 0.0 111.303 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -69.6 -24.48 63.67 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -64.67 -28.45 69.61 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.809 -0.557 . . . . 0.0 109.841 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.844 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -77.25 -37.72 52.53 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.844 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.1 mp -60.47 -47.29 86.78 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.171 0.51 . . . . 0.0 109.736 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.1 -23.06 4.79 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.648 -0.657 . . . . 0.0 110.722 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.28 -25.27 12.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.331 -0.855 . . . . 0.0 110.679 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -79.81 -36.14 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.268 -0.895 . . . . 0.0 110.841 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 16' ' ' LEU . 9.2 mt -63.74 -36.53 84.17 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 178.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.93 -34.35 75.93 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.566 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.575 ' HG ' ' HB3' ' A' ' 27' ' ' GLU . 1.5 mp -79.0 -27.1 43.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.543 -0.723 . . . . 0.0 109.578 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -84.33 -11.22 56.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.567 -0.708 . . . . 0.0 109.408 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.73 -41.37 11.94 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.619 -0.676 . . . . 0.0 110.396 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.448 ' HG3' ' N ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -99.44 -27.06 13.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.371 -0.831 . . . . 0.0 110.076 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.448 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . 105.24 27.51 5.84 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.575 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -79.49 135.85 36.75 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.397 -1.06 . . . . 0.0 110.268 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -114.14 61.84 0.66 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.626 -0.671 . . . . 0.0 109.508 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -109.33 -154.8 0.54 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.504 -0.747 . . . . 0.0 110.187 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -117.59 156.43 28.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.453 -0.78 . . . . 0.0 110.637 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.515 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 3.5 mt -127.71 114.5 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HD3' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -110.44 153.04 25.56 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.293 -0.879 . . . . 0.0 111.203 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.52 HG21 ' CG ' ' A' ' 12' ' ' ASP . 15.3 t -144.75 -173.39 4.05 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.473 -0.767 . . . . 0.0 111.067 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.662 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 19.4 m-90 -139.68 39.33 2.02 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.182 -0.949 . . . . 0.0 111.633 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.01 -99.35 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.726 -1.234 . . . . 0.0 110.402 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.31 -62.41 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.935 -1.103 . . . . 0.0 109.684 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.436 ' HG2' ' HD2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -106.19 38.35 2.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.541 -0.724 . . . . 0.0 109.242 178.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.524 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 1.1 m -41.5 114.97 0.57 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.335 0.588 . . . . 0.0 111.616 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.826 HG23 ' O ' ' A' ' 69' ' ' HIS . 25.9 m -106.71 161.94 14.21 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.536 -0.728 . . . . 0.0 110.436 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.87 HG21 HG21 ' A' ' 62' ' ' ILE . 1.2 mp -83.91 168.06 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.472 -0.767 . . . . 0.0 111.904 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.967 HG13 HG21 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -140.2 174.01 4.44 Favored Pre-proline 0 N--CA 1.501 2.109 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.513 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 42.3 Cg_endo -66.03 -30.61 47.52 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.923 1.486 . . . . 0.0 110.823 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.504 ' OE1' HD23 ' A' ' 20' ' ' LEU . 5.5 mm-40 -73.51 -4.68 35.37 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.584 -0.698 . . . . 0.0 110.948 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.681 ' HG2' HD13 ' A' ' 49' ' ' ILE . 51.4 mtp -97.27 2.53 50.91 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.115 -0.991 . . . . 0.0 111.033 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.625 HG23 ' N ' ' A' ' 64' ' ' GLU . 7.6 p -59.97 3.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.09 33.49 1.03 Allowed Glycine 0 N--CA 1.493 2.476 0 O-C-N 120.208 -1.558 . . . . 0.0 110.144 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.859 ' HB2' HD11 ' A' ' 49' ' ' ILE . 38.0 m-70 -145.51 156.34 43.65 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.219 -1.165 . . . . 0.0 111.048 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.682 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.87 86.25 3.25 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.514 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.859 HD11 ' HB2' ' A' ' 47' ' ' HIS . 3.1 mp -91.87 117.84 36.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.18 -0.95 . . . . 0.0 111.556 -177.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.788 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.21 89.16 4.88 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 122.162 0.982 . . . . 0.0 109.311 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.524 ' HB ' ' HB3' ' A' ' 38' ' ' SER . 26.2 m -66.39 127.43 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.131 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.662 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 26.1 t80 -70.01 108.49 4.07 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.174 -1.011 . . . . 0.0 108.911 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -75.92 16.57 0.4 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.666 -0.646 . . . . 0.0 110.322 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.93 -28.87 13.01 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -140.56 -26.76 0.74 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.528 -0.983 . . . . 0.0 111.14 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -127.74 156.52 42.29 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.697 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 76.8 m-70 -95.51 120.01 35.01 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.788 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 16.9 t -109.43 85.32 3.55 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.162 -0.961 . . . . 0.0 109.194 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.544 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.6 Cg_endo -67.6 85.57 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.348 0 O-C-N 123.852 1.448 . . . . 0.0 109.312 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.696 ' CG2' HG12 ' A' ' 58' ' ' VAL . 50.5 t -99.46 123.12 51.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.844 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.682 ' HB2' HG23 ' A' ' 48' ' ' THR . 4.1 t80 -72.53 102.28 3.2 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.87 HG21 HG21 ' A' ' 40' ' ' ILE . 3.0 mp -80.87 140.76 16.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.843 0.83 . . . . 0.0 111.769 -177.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.573 ' C ' HG23 ' A' ' 45' ' ' VAL . 69.5 p -105.51 -158.83 0.68 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.625 ' N ' HG23 ' A' ' 45' ' ' VAL . 4.2 tp10 -90.55 7.43 39.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.708 -1.245 . . . . 0.0 111.244 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.445 ' ND2' ' HG3' ' A' ' 66' ' ' MET . 2.4 p-10 -127.33 -17.82 4.62 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.723 -1.235 . . . . 0.0 112.625 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.536 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 26.3 mtt -86.1 -17.95 33.69 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.625 -1.297 . . . . 0.0 110.399 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.539 HG21 ' C ' ' A' ' 41' ' ' VAL . 7.6 p -71.49 162.75 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.248 -0.908 . . . . 0.0 111.316 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.481 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 114.31 -16.94 19.52 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.826 ' O ' HG23 ' A' ' 39' ' ' THR . 18.0 m-70 -120.5 -81.94 0.64 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.11 -1.229 . . . . 0.0 110.744 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.54 -34.72 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.03 0.919 . . . . 0.0 109.747 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER 176.37 -15.29 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.195 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.926 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.52 -16.46 71.73 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 120.985 -1.072 . . . . 0.0 110.537 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.637 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 1.2 mt-10 . . . . . 0 N--CA 1.497 1.913 0 O-C-N 121.328 -1.101 . . . . 0.0 109.099 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.763 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 121.268 0.556 . . . . 0.0 109.849 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 39' ' ' THR . 12.5 p -111.71 117.15 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.536 -0.728 . . . . 0.0 109.052 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.801 ' CG ' HG23 ' A' ' 33' ' ' THR . 37.2 t70 -46.43 105.2 0.06 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.507 -0.745 . . . . 0.0 111.422 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -67.1 -23.29 65.82 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -66.46 -26.67 67.31 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.899 -0.501 . . . . 0.0 109.955 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.869 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -81.37 -39.19 25.42 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.458 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.869 HD12 ' HG ' ' A' ' 15' ' ' LEU . 5.1 mp -62.22 -41.58 98.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.843 -0.536 . . . . 0.0 109.672 178.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.8 -30.88 6.2 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.741 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB3' HD12 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -90.33 -30.89 17.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.529 -0.732 . . . . 0.0 110.327 179.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.074 HG21 ' HE3' ' A' ' 44' ' ' MET . 71.8 t -72.63 -36.05 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.264 -0.897 . . . . 0.0 111.689 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 16' ' ' LEU . 12.2 mt -61.28 -37.66 83.96 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' A' ' 18' ' ' LYS . 3.0 tm-20 -63.2 -39.74 95.51 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.322 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.71 HD23 ' HB2' ' A' ' 27' ' ' GLU . 3.6 mt -74.08 -22.08 59.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.274 -0.891 . . . . 0.0 110.091 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -83.43 -12.33 56.53 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.374 -0.829 . . . . 0.0 109.585 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.49 -39.18 16.53 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.447 -0.783 . . . . 0.0 109.757 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.429 ' HE3' ' HG2' ' A' ' 21' ' ' GLU . 65.3 mttt -97.52 -32.97 11.54 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.457 0.646 . . . . 0.0 109.325 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.74 19.53 19.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.71 ' HB2' HD23 ' A' ' 22' ' ' LEU . 28.8 mt-10 -71.22 140.36 50.42 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.509 -0.995 . . . . 0.0 110.351 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -110.73 76.84 1.0 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.475 -0.766 . . . . 0.0 109.762 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.83 -155.79 0.58 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.512 -0.742 . . . . 0.0 110.418 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.475 ' O ' HD13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -115.51 167.97 10.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.568 -0.707 . . . . 0.0 110.316 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.703 HD11 ' CD1' ' A' ' 22' ' ' LEU . 45.3 mm -126.72 157.99 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.438 -0.789 . . . . 0.0 109.79 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -120.74 130.67 54.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.548 -0.72 . . . . 0.0 110.319 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.801 HG23 ' CG ' ' A' ' 12' ' ' ASP . 18.2 m -119.54 159.82 23.6 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.572 -0.705 . . . . 0.0 110.318 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 19.3 m-90 -145.02 16.57 1.56 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.314 -0.866 . . . . 0.0 111.819 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.62 -152.72 0.07 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.918 -1.114 . . . . 0.0 110.785 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.78 -61.78 1.66 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.072 -1.018 . . . . 0.0 110.067 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.501 ' HG2' ' HD1' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -100.49 43.86 1.04 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.562 -0.711 . . . . 0.0 109.854 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.442 ' CB ' HG21 ' A' ' 33' ' ' THR . 73.1 m -50.5 134.71 23.6 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.396 0.617 . . . . 0.0 111.606 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 69' ' ' HIS . 27.1 m -130.18 161.95 29.98 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.811 -0.555 . . . . 0.0 109.748 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.767 ' CG2' HG12 ' A' ' 62' ' ' ILE . 5.0 mp -85.97 170.28 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.375 -0.828 . . . . 0.0 111.121 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.988 HG23 ' SD ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -135.84 175.45 3.57 Favored Pre-proline 0 N--CA 1.505 2.308 0 O-C-N 121.463 -0.773 . . . . 0.0 110.049 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.791 ' HD2' HG12 ' A' ' 41' ' ' VAL . 47.0 Cg_endo -69.43 -34.61 15.31 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 124.024 1.539 . . . . 0.0 111.719 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.737 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 0.7 OUTLIER -71.87 0.53 8.91 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.298 -0.876 . . . . 0.0 111.171 179.62 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 1.074 ' HE3' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -90.15 -3.86 57.63 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.15 -0.969 . . . . 0.0 111.224 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.611 HG23 ' N ' ' A' ' 64' ' ' GLU . 4.4 p -49.1 2.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.6 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 44' ' ' MET . . . -146.15 30.02 1.63 Allowed Glycine 0 N--CA 1.496 2.634 0 O-C-N 119.798 -1.814 . . . . 0.0 110.292 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.499 ' HB2' HD11 ' A' ' 49' ' ' ILE . 8.1 m-70 -147.43 155.75 42.23 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.159 -1.201 . . . . 0.0 111.059 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.98 89.35 4.03 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.07 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.845 ' CD1' HD13 ' A' ' 62' ' ' ILE . 2.3 mp -86.64 118.16 32.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.443 -0.786 . . . . 0.0 111.752 -176.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.778 ' HB1' ' HB3' ' A' ' 57' ' ' HIS . . . -78.91 84.85 4.91 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.973 0.892 . . . . 0.0 109.106 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.531 HG21 ' O ' ' A' ' 70' ' ' LYS . 23.0 m -61.97 129.09 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.534 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.5 ' HB2' ' O ' ' A' ' 33' ' ' THR . 26.5 t80 -78.0 106.44 9.86 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.082 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -75.01 13.76 0.63 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.702 -0.624 . . . . 0.0 110.598 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.58 -25.74 20.29 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -140.51 -25.9 0.76 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.617 -0.931 . . . . 0.0 111.24 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -131.96 151.88 51.45 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.778 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 66.5 m80 -93.13 117.48 30.12 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.771 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 21.8 t -106.91 87.46 2.95 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.079 -1.013 . . . . 0.0 109.338 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.55 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.3 Cg_endo -65.69 93.04 0.25 Allowed 'Trans proline' 0 N--CA 1.489 1.254 0 O-C-N 123.952 1.501 . . . . 0.0 109.814 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.687 ' O ' HD12 ' A' ' 62' ' ' ILE . 12.4 m -107.05 125.97 63.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.655 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.408 ' N ' HG23 ' A' ' 48' ' ' THR . 2.8 t80 -71.64 103.52 3.06 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.845 HD13 ' CD1' ' A' ' 49' ' ' ILE . 1.6 mp -56.53 -56.74 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -176.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.536 ' O ' HG22 ' A' ' 62' ' ' ILE . 2.7 m 64.62 178.46 0.18 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -177.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.611 ' N ' HG23 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -86.43 48.91 1.7 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.517 -1.364 . . . . 0.0 111.102 -179.314 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -171.81 -9.09 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.889 -1.132 . . . . 0.0 113.979 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 29.3 mtt -99.63 -23.48 15.04 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.203 -1.56 . . . . 0.0 111.202 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.58 HG21 ' C ' ' A' ' 41' ' ' VAL . 2.7 p -67.76 163.48 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.489 0 O-C-N 121.284 -0.885 . . . . 0.0 112.514 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.501 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 122.75 -11.33 8.89 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.956 177.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.723 ' O ' HG23 ' A' ' 39' ' ' THR . 17.7 m-70 -125.14 -83.02 0.64 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.135 1.468 . . . . 0.0 110.77 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.34 -31.22 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.588 0.708 . . . . 0.0 110.258 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.574 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 1.0 OUTLIER 173.62 -15.94 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.709 -179.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.02 -18.19 76.19 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.681 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 23.1 mm-40 . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.291 -1.123 . . . . 0.0 109.184 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.72 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 121.194 0.521 . . . . 0.0 110.034 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.864 HG11 HG13 ' A' ' 41' ' ' VAL . 92.6 t -100.08 110.18 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.294 -0.879 . . . . 0.0 108.872 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.72 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 38.5 t70 -48.42 111.0 0.39 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.405 0.621 . . . . 0.0 111.306 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.35 -23.7 64.73 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -65.61 -28.58 69.22 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.92 -0.488 . . . . 0.0 110.493 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.885 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -77.57 -37.61 50.19 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.498 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.885 HD12 ' HG ' ' A' ' 15' ' ' LEU . 3.8 mp -60.96 -44.4 97.37 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 120.983 0.421 . . . . 0.0 109.946 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.525 ' HG2' ' HE3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -53.9 -25.36 19.81 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.273 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HE3' ' HG2' ' A' ' 17' ' ' GLU . 5.1 mtmt -101.77 -29.67 11.74 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.485 -0.759 . . . . 0.0 110.371 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.781 HG12 ' HA ' ' A' ' 16' ' ' LEU . 1.1 p -75.82 -35.93 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.366 -0.834 . . . . 0.0 111.37 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 16' ' ' LEU . 3.8 pp -62.98 -28.68 70.26 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -71.91 -35.28 69.63 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.452 HD12 HD11 ' A' ' 31' ' ' ILE . 3.3 mt -73.57 -27.26 61.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.651 -0.656 . . . . 0.0 109.753 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -84.93 -17.82 36.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.596 -0.69 . . . . 0.0 109.374 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.33 -38.77 15.94 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.535 -0.728 . . . . 0.0 109.738 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.1 mttm -90.39 -26.34 19.95 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.08 15.14 49.55 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.432 ' HB2' HD22 ' A' ' 22' ' ' LEU . 20.7 mt-10 -80.95 124.93 29.54 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.382 -1.07 . . . . 0.0 110.364 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -98.87 74.15 2.02 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.574 -0.704 . . . . 0.0 109.517 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.413 ' H ' HD13 ' A' ' 22' ' ' LEU . 1.3 ttp180 -108.15 -151.56 0.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.667 -0.645 . . . . 0.0 110.079 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -118.08 153.68 33.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 110.71 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.552 HD13 HG23 ' A' ' 19' ' ' VAL . 2.7 mp -127.26 119.08 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.516 -0.74 . . . . 0.0 109.186 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.522 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 4.7 mptt -84.42 158.82 20.95 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.306 -0.871 . . . . 0.0 111.366 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.694 HG23 ' CG ' ' A' ' 12' ' ' ASP . 15.9 m -141.47 155.97 45.8 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.706 -0.622 . . . . 0.0 109.713 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.498 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 12.0 m-90 -145.76 36.54 1.06 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.225 -0.922 . . . . 0.0 111.404 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -91.91 -95.16 0.13 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.891 -1.131 . . . . 0.0 110.826 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.9 tpt85 -170.2 -63.5 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.084 -1.01 . . . . 0.0 110.514 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -99.27 37.52 1.55 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.267 -0.896 . . . . 0.0 110.007 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.585 ' OG ' HG21 ' A' ' 33' ' ' THR . 35.0 m -40.91 133.74 2.08 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.473 0.654 . . . . 0.0 112.153 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.883 HG23 ' O ' ' A' ' 69' ' ' HIS . 49.1 m -128.54 156.81 42.72 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.902 -0.499 . . . . 0.0 109.821 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.745 HG23 ' SD ' ' A' ' 44' ' ' MET . 1.3 mp -76.98 160.29 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.481 -0.762 . . . . 0.0 111.248 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.864 HG13 HG11 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -132.06 176.5 2.85 Favored Pre-proline 0 N--CA 1.502 2.158 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.158 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 41.7 Cg_endo -65.76 -29.5 50.88 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.906 1.477 . . . . 0.0 110.596 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -77.78 0.75 22.52 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.686 -0.634 . . . . 0.0 110.688 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.745 ' SD ' HG23 ' A' ' 40' ' ' ILE . 2.4 mtt -93.82 -11.62 30.84 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.072 -1.017 . . . . 0.0 111.644 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.739 HG23 ' N ' ' A' ' 64' ' ' GLU . 7.5 p -56.52 4.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.414 ' C ' ' CG ' ' A' ' 47' ' ' HIS . . . -150.29 29.74 1.08 Allowed Glycine 0 N--CA 1.495 2.601 0 O-C-N 119.953 -1.717 . . . . 0.0 110.088 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.498 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 21.8 m-70 -147.35 159.22 43.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.168 -1.195 . . . . 0.0 111.338 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.57 84.64 2.99 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 178.176 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.825 ' CD1' HD13 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -84.99 121.09 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.176 -0.953 . . . . 0.0 111.221 -177.465 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.788 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.61 84.17 4.74 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.832 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 51' ' ' VAL . 19.0 m -64.83 130.08 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.4 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.503 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 30.1 t80 -75.34 107.14 7.25 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -84.34 28.01 0.66 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.461 -0.775 . . . . 0.0 110.92 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.11 -36.78 4.09 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -140.69 -20.35 0.82 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.443 -1.033 . . . . 0.0 111.721 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.503 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 2.2 mm100 -128.82 153.07 47.79 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -177.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.446 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 2.1 m80 -98.7 108.16 20.78 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.788 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 21.8 t -100.86 95.61 4.72 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.144 -0.973 . . . . 0.0 109.469 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.537 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.0 Cg_endo -67.29 93.1 0.35 Allowed 'Trans proline' 0 N--CA 1.488 1.176 0 O-C-N 123.837 1.44 . . . . 0.0 109.423 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.58 ' CG2' HG12 ' A' ' 58' ' ' VAL . 95.9 t -110.36 126.71 67.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.828 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.0 t80 -71.96 104.72 3.61 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.646 HD13 ' HB3' ' A' ' 44' ' ' MET . 2.6 mp -67.37 -50.17 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 2.9 m 65.53 178.7 0.2 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.739 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.1 tm-20 -86.17 61.58 6.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.506 -1.371 . . . . 0.0 109.323 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -162.28 -34.38 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.203 -0.935 . . . . 0.0 112.271 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.75 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 10.3 mtt -99.74 9.29 43.32 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.882 -1.136 . . . . 0.0 112.11 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.474 HG22 ' N ' ' A' ' 68' ' ' GLY . 8.3 p -90.04 162.02 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 120.736 -1.227 . . . . 0.0 112.461 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.474 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 105.56 -16.0 44.98 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.883 ' O ' HG23 ' A' ' 39' ' ' THR . 16.2 m-70 -112.45 -88.89 0.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.015 -1.285 . . . . 0.0 110.792 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.3 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 122.437 1.113 . . . . 0.0 109.07 -179.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.6 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.8 OUTLIER -179.64 -13.85 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.938 -179.603 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.67 -15.17 77.77 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.75 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 1.5 mm-40 . . . . . 0 N--CA 1.495 1.825 0 O-C-N 121.36 -1.082 . . . . 0.0 108.824 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.671 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.12 0.486 . . . . 0.0 109.857 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.655 HG11 HG13 ' A' ' 41' ' ' VAL . 91.8 t -95.41 106.1 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 108.566 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.671 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 32.6 t70 -46.35 110.81 0.3 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.375 0.607 . . . . 0.0 111.404 -178.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 16' ' ' LEU . 9.5 t70 -67.31 -23.1 65.61 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -63.56 -33.68 76.13 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.912 -0.492 . . . . 0.0 110.31 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.928 HD11 ' SD ' ' A' ' 44' ' ' MET . 0.3 OUTLIER -80.28 -38.1 31.49 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.834 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.0 mp -61.49 -40.8 95.88 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.61 -31.33 15.68 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -89.13 -32.43 17.51 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.665 -0.647 . . . . 0.0 110.089 178.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.778 HG22 HD13 ' A' ' 31' ' ' ILE . 78.7 t -68.46 -38.24 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.303 -0.873 . . . . 0.0 111.156 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 16' ' ' LEU . 11.0 mt -61.76 -37.71 85.3 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -64.52 -35.63 81.57 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.468 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.737 HD22 ' HB2' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -75.07 -25.18 58.41 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.479 -0.763 . . . . 0.0 109.866 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -84.48 -11.2 56.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.439 -0.788 . . . . 0.0 109.94 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.18 -37.35 15.09 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 121.348 -0.845 . . . . 0.0 109.927 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -100.71 -24.72 14.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.641 -0.662 . . . . 0.0 109.714 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.53 29.67 8.63 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.737 ' HB2' HD22 ' A' ' 22' ' ' LEU . 14.5 mt-10 -79.77 125.92 30.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.498 -1.001 . . . . 0.0 110.241 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -106.64 63.18 0.64 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.455 -0.778 . . . . 0.0 109.677 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.27 -153.17 0.51 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.519 -0.738 . . . . 0.0 110.116 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.663 HD12 ' HB3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -118.02 147.87 42.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.385 -0.822 . . . . 0.0 110.725 -179.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.778 HD13 HG22 ' A' ' 19' ' ' VAL . 2.9 mp -118.52 116.25 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.607 -0.683 . . . . 0.0 109.735 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.618 ' HE2' HD11 ' A' ' 30' ' ' LEU . 29.2 mmtt -75.96 154.32 35.97 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.528 -0.732 . . . . 0.0 110.725 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.641 HG23 ' OD2' ' A' ' 12' ' ' ASP . 97.4 m -135.78 158.44 44.38 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.48 -0.762 . . . . 0.0 110.305 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.419 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 10.4 m-90 -147.5 38.04 0.93 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.387 -0.821 . . . . 0.0 111.155 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 93.0 p -94.81 -132.11 0.17 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.96 -1.087 . . . . 0.0 110.774 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.4 mtt85 -132.91 -64.23 0.75 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.986 -1.071 . . . . 0.0 110.317 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 mpp_? -97.99 40.92 1.15 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.432 -0.793 . . . . 0.0 110.098 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.595 ' OG ' HG21 ' A' ' 33' ' ' THR . 0.4 OUTLIER -40.2 125.78 2.08 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.528 0.68 . . . . 0.0 112.452 -179.494 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.829 HG23 ' O ' ' A' ' 69' ' ' HIS . 71.1 m -128.88 155.86 44.59 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.789 ' CG2' HG12 ' A' ' 62' ' ' ILE . 5.2 mp -86.76 168.89 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.406 -0.809 . . . . 0.0 111.457 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.904 HG23 ' HG3' ' A' ' 44' ' ' MET . 0.0 OUTLIER -136.51 171.84 8.02 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.645 -0.659 . . . . 0.0 110.167 179.469 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 42.7 Cg_endo -66.64 -32.78 37.63 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 124.239 1.652 . . . . 0.0 111.249 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.402 ' HG3' HG11 ' A' ' 19' ' ' VAL . 12.0 pt-20 -69.27 -5.51 23.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.559 -0.713 . . . . 0.0 110.711 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.928 ' SD ' HD11 ' A' ' 15' ' ' LEU . 1.3 mmm -91.83 -0.57 57.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.188 -0.945 . . . . 0.0 111.311 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.721 HG23 ' N ' ' A' ' 64' ' ' GLU . 6.6 p -53.55 7.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.42 ' C ' ' CG ' ' A' ' 47' ' ' HIS . . . -148.67 29.44 1.29 Allowed Glycine 0 N--CA 1.496 2.7 0 O-C-N 119.895 -1.753 . . . . 0.0 110.33 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.623 ' HB2' HD11 ' A' ' 49' ' ' ILE . 9.6 m-70 -148.1 155.91 42.0 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.205 -1.174 . . . . 0.0 111.193 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.485 HG23 ' N ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -101.04 90.96 4.35 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 177.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.778 ' CD1' HD13 ' A' ' 62' ' ' ILE . 2.5 mp -88.84 121.05 38.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.593 -176.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.757 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.56 81.63 4.87 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.824 0.821 . . . . 0.0 109.238 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.1 m -61.41 135.3 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.963 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.492 ' HB2' ' O ' ' A' ' 33' ' ' THR . 18.5 t80 -80.21 106.96 12.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.364 -0.835 . . . . 0.0 109.497 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -71.13 -0.98 10.86 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.569 -0.707 . . . . 0.0 110.329 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.84 -22.61 8.07 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 107.693 -2.163 . . . . 0.0 107.693 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -140.21 -28.18 0.73 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.985 -0.715 . . . . 0.0 111.158 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.58 155.27 47.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.235 -0.916 . . . . 0.0 112.2 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.491 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 19.4 m-70 -99.92 110.4 22.74 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.757 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 24.9 t -97.71 96.99 3.64 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.239 -0.913 . . . . 0.0 109.943 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.663 ' HB3' HD12 ' A' ' 30' ' ' LEU . 41.7 Cg_endo -66.68 92.41 0.3 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 O-C-N 123.906 1.477 . . . . 0.0 109.615 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.646 ' O ' HD12 ' A' ' 62' ' ' ILE . 12.9 m -103.92 125.19 58.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.613 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.485 ' N ' HG23 ' A' ' 48' ' ' THR . 2.6 t80 -72.66 103.09 3.48 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.789 HG12 ' CG2' ' A' ' 40' ' ' ILE . 1.5 mp -55.98 -61.63 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -176.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.522 ' O ' HG22 ' A' ' 62' ' ' ILE . 2.6 m 65.41 174.42 0.22 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -176.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.721 ' N ' HG23 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -85.38 58.79 5.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.357 -1.464 . . . . 0.0 109.976 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -171.57 -25.94 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.94 -1.1 . . . . 0.0 113.27 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.5 mmm -89.2 -25.43 21.78 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.558 -1.339 . . . . 0.0 111.097 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.573 HG21 ' C ' ' A' ' 41' ' ' VAL . 3.3 p -67.02 163.09 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 121.331 -0.855 . . . . 0.0 112.561 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.509 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 118.83 -13.57 11.59 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.756 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.829 ' O ' HG23 ' A' ' 39' ' ' THR . 19.7 m-70 -123.06 -83.56 0.66 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 119.037 1.418 . . . . 0.0 110.724 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.776 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.2 -30.93 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.671 0.748 . . . . 0.0 110.48 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.611 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.9 OUTLIER 174.12 -14.98 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.272 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.809 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.99 -18.46 74.54 Favored Glycine 0 N--CA 1.496 2.647 0 O-C-N 120.982 -1.074 . . . . 0.0 110.423 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.609 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 2.0 mt-10 . . . . . 0 N--CA 1.497 1.88 0 O-C-N 121.237 -1.155 . . . . 0.0 109.262 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.717 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.208 0.528 . . . . 0.0 109.958 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.788 HG21 HG13 ' A' ' 41' ' ' VAL . 14.4 p -102.12 109.61 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.83 . . . . 0.0 108.77 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.717 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 38.8 t70 -46.06 111.59 0.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.624 -0.673 . . . . 0.0 111.803 -178.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.416 ' HA ' HD13 ' A' ' 16' ' ' LEU . 7.7 t70 -68.3 -24.2 64.83 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -64.92 -28.38 69.49 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.853 -0.53 . . . . 0.0 109.78 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.772 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -77.67 -34.98 52.81 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.211 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.783 HD11 ' CG1' ' A' ' 41' ' ' VAL . 3.8 mp -62.3 -47.28 84.97 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.048 0.451 . . . . 0.0 109.902 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.44 -23.04 5.39 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.737 -0.602 . . . . 0.0 110.445 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.567 ' O ' HD12 ' A' ' 22' ' ' LEU . 8.8 mmtm -102.58 -30.84 10.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.301 -0.874 . . . . 0.0 111.045 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.712 HG12 ' HA ' ' A' ' 16' ' ' LEU . 1.4 p -78.13 -39.86 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.191 -0.943 . . . . 0.0 111.274 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.464 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 12.6 mt -63.25 -36.84 85.0 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.89 -38.88 83.5 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.271 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.581 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 3.2 mt -73.42 -24.67 60.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.119 -0.988 . . . . 0.0 110.197 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -80.71 -10.4 59.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.522 -0.736 . . . . 0.0 109.59 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.19 -35.58 23.42 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 121.498 -0.751 . . . . 0.0 109.707 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.581 ' HE3' ' HA ' ' A' ' 22' ' ' LEU . 7.4 pttt -102.3 -29.57 11.59 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.533 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.59 28.35 7.54 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.536 ' HB2' ' HE3' ' A' ' 25' ' ' LYS . 2.6 mt-10 -90.9 134.61 34.33 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.467 -1.019 . . . . 0.0 110.382 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -100.04 76.45 1.93 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.463 -0.773 . . . . 0.0 109.357 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.98 -154.55 0.54 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.51 -0.743 . . . . 0.0 110.212 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -118.99 161.1 20.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.453 -0.779 . . . . 0.0 110.763 -179.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.552 ' CD1' HG23 ' A' ' 19' ' ' VAL . 2.9 mp -132.77 112.42 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.535 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -85.69 152.69 22.88 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.55 -0.718 . . . . 0.0 111.186 -178.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.627 HG23 ' CG ' ' A' ' 12' ' ' ASP . 8.5 m -134.87 163.21 30.34 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.925 -0.484 . . . . 0.0 110.279 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.474 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 16.0 m-90 -146.73 37.06 0.97 Allowed 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.289 -0.882 . . . . 0.0 110.854 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.0 t -94.74 -126.63 0.12 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.077 -1.015 . . . . 0.0 110.779 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.14 -59.68 0.78 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.827 -1.171 . . . . 0.0 110.822 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -98.36 35.61 1.75 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.322 -0.861 . . . . 0.0 110.605 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.555 ' OG ' HG21 ' A' ' 33' ' ' THR . 4.5 m -36.06 123.9 0.74 Allowed 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.31 0.576 . . . . 0.0 111.942 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.839 HG23 ' O ' ' A' ' 69' ' ' HIS . 27.5 m -128.32 162.27 27.46 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.546 -0.721 . . . . 0.0 110.569 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.874 HG22 ' HG2' ' A' ' 44' ' ' MET . 1.9 mt -66.58 165.01 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 O-C-N 121.631 -0.668 . . . . 0.0 110.861 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.788 HG13 HG21 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -123.45 -171.41 0.22 Allowed Pre-proline 0 N--CA 1.505 2.312 0 O-C-N 121.362 -0.836 . . . . 0.0 110.14 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.575 ' HD3' HG12 ' A' ' 41' ' ' VAL . 57.7 Cg_endo -87.75 -31.19 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.657 1.346 . . . . 0.0 111.098 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -90.05 15.47 10.07 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.536 -0.727 . . . . 0.0 111.056 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.874 ' HG2' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -94.43 4.84 53.34 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.17 -0.956 . . . . 0.0 111.798 -179.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.754 HG13 ' N ' ' A' ' 64' ' ' GLU . 39.5 t -57.46 -2.83 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.477 ' HA2' ' CE1' ' A' ' 61' ' ' TYR . . . -150.77 34.08 0.96 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.533 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 52.7 m-70 -138.49 152.67 48.48 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.221 -1.164 . . . . 0.0 110.938 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.727 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.29 80.82 2.47 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.621 HD12 ' CD1' ' A' ' 62' ' ' ILE . 9.2 mt -78.09 117.35 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.182 -0.949 . . . . 0.0 110.915 -177.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.755 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.42 80.07 4.83 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.772 0.796 . . . . 0.0 108.99 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 51' ' ' VAL . 31.8 m -57.87 127.12 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.181 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.502 ' HB2' ' O ' ' A' ' 33' ' ' THR . 14.9 t80 -75.76 105.99 7.1 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.196 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -69.61 -0.8 7.36 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.577 -0.702 . . . . 0.0 110.429 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.03 -20.71 9.73 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 107.839 -2.104 . . . . 0.0 107.839 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -140.1 -29.22 0.71 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.957 -0.731 . . . . 0.0 110.974 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.53 154.82 48.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.243 -0.911 . . . . 0.0 112.029 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.488 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 5.0 m80 -100.59 106.04 17.51 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.755 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 40.4 t -94.98 99.93 4.89 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.206 -0.934 . . . . 0.0 109.804 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.505 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.7 Cg_endo -66.54 92.39 0.29 Allowed 'Trans proline' 0 N--CA 1.49 1.304 0 O-C-N 123.904 1.476 . . . . 0.0 109.598 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 58' ' ' VAL . 94.0 t -98.39 116.59 41.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.75 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.727 ' HB2' HG23 ' A' ' 48' ' ' THR . 6.2 t80 -73.03 108.77 6.11 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.869 HD13 ' HB2' ' A' ' 44' ' ' MET . 2.4 mp -92.72 159.89 2.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.884 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.617 HG22 ' H ' ' A' ' 64' ' ' GLU . 3.1 m -129.83 -159.81 0.99 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 177.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.754 ' N ' HG13 ' A' ' 45' ' ' VAL . 3.2 tt0 -90.25 47.75 1.48 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.242 -1.536 . . . . 0.0 110.412 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -156.58 -34.23 0.08 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.973 -1.079 . . . . 0.0 112.675 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.662 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 71.3 mtm -85.86 5.01 34.74 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.999 -1.063 . . . . 0.0 111.546 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.553 ' HA ' HD13 ' A' ' 40' ' ' ILE . 7.5 p -83.99 166.2 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 120.893 -1.129 . . . . 0.0 111.767 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.539 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 106.5 -21.7 32.19 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.839 ' O ' HG23 ' A' ' 39' ' ' THR . 16.5 m-70 -112.27 -86.87 0.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.121 -1.223 . . . . 0.0 111.003 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.619 ' HD3' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER 177.61 -36.27 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 122.273 1.035 . . . . 0.0 109.278 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.619 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -178.98 -15.33 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.998 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.83 -15.3 73.7 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.662 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 1.5 mm-40 . . . . . 0 N--CA 1.497 1.885 0 O-C-N 121.44 -1.035 . . . . 0.0 108.773 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.646 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 121.316 0.579 . . . . 0.0 110.309 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.072 HG21 HG13 ' A' ' 41' ' ' VAL . 9.9 p -113.63 118.9 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.753 ' HB3' HD23 ' A' ' 15' ' ' LEU . 38.8 t70 -43.81 105.87 0.06 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.618 -0.676 . . . . 0.0 111.604 -178.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -68.04 -21.35 65.02 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -66.84 -28.41 68.33 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 122.007 -0.433 . . . . 0.0 110.49 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.901 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -76.85 -37.32 55.83 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.709 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.901 HD12 ' HG ' ' A' ' 15' ' ' LEU . 3.9 mp -60.75 -44.21 96.98 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.97 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.412 ' HA ' HD21 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -55.74 -25.07 38.75 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.196 179.141 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -102.31 -31.39 10.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.453 -0.78 . . . . 0.0 110.67 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.756 HG12 ' HA ' ' A' ' 16' ' ' LEU . 1.4 p -71.8 -37.3 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.287 -0.883 . . . . 0.0 111.021 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.478 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.0 pp -64.47 -28.2 69.5 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.84 -31.96 65.13 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.496 HD22 ' HB2' ' A' ' 27' ' ' GLU . 1.4 mt -76.92 -22.08 53.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.609 -0.682 . . . . 0.0 109.582 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -84.76 -19.6 32.37 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.496 -0.753 . . . . 0.0 109.716 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.14 -39.13 17.02 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 121.504 -0.748 . . . . 0.0 109.908 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -90.71 -25.3 20.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.672 -0.643 . . . . 0.0 109.533 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.36 16.61 49.25 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB2' HD22 ' A' ' 22' ' ' LEU . 1.5 mt-10 -75.41 128.35 35.15 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.514 -0.991 . . . . 0.0 110.477 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.0 mtmm -115.13 50.89 0.95 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.551 -0.718 . . . . 0.0 109.513 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.7 ttp-105 -88.31 -92.2 0.11 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.57 -0.706 . . . . 0.0 110.411 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.784 HD12 ' HB3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -170.9 146.25 2.5 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.118 -0.989 . . . . 0.0 110.674 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.583 HD13 HD11 ' A' ' 49' ' ' ILE . 2.8 mt -115.26 119.07 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.727 ' HD3' HD11 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -79.63 151.05 30.79 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.437 -0.789 . . . . 0.0 111.543 -178.63 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.733 HG23 ' CG ' ' A' ' 12' ' ' ASP . 27.4 m -137.6 155.3 49.34 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.601 -0.687 . . . . 0.0 110.353 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.531 ' CH2' ' HB2' ' A' ' 32' ' ' LYS . 17.5 m-90 -146.02 29.53 1.09 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.299 -0.876 . . . . 0.0 111.601 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -82.9 -98.14 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.812 -1.18 . . . . 0.0 110.592 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -174.29 -61.59 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.215 -0.928 . . . . 0.0 109.558 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.19 42.7 1.09 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.628 ' OG ' HG21 ' A' ' 33' ' ' THR . 2.5 m -50.9 133.9 26.22 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.525 0.679 . . . . 0.0 111.923 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.849 HG23 ' O ' ' A' ' 69' ' ' HIS . 20.6 m -127.25 161.54 28.31 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.856 ' HA ' ' HE3' ' A' ' 44' ' ' MET . 1.1 mp -80.56 162.15 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.291 -0.88 . . . . 0.0 111.566 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.072 HG13 HG21 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -129.3 169.58 12.83 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 121.701 -0.624 . . . . 0.0 110.011 178.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.449 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 43.7 Cg_endo -67.5 -31.72 33.31 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.262 1.664 . . . . 0.0 110.918 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.697 ' HG3' HG11 ' A' ' 19' ' ' VAL . 2.3 pt-20 -80.16 5.69 13.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.482 -0.761 . . . . 0.0 110.926 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.856 ' HE3' ' HA ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -98.12 -5.74 33.04 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.287 -0.883 . . . . 0.0 111.448 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.627 HG13 ' N ' ' A' ' 64' ' ' GLU . 61.8 t -48.29 -6.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.516 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA2' ' CE1' ' A' ' 61' ' ' TYR . . . -144.72 38.97 1.24 Allowed Glycine 0 N--CA 1.491 2.344 0 O-C-N 120.186 -1.571 . . . . 0.0 109.221 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 49.6 m-70 -143.08 147.35 34.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.508 -0.995 . . . . 0.0 111.183 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.81 80.93 2.39 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 177.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.886 ' CD1' HD13 ' A' ' 15' ' ' LEU . 1.5 mt -85.19 124.1 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.391 -0.818 . . . . 0.0 111.347 -176.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.786 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -77.78 80.28 4.24 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 51' ' ' VAL . 27.2 m -61.08 130.47 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.057 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.446 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 30.5 t80 -78.27 105.88 9.81 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.236 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -69.91 0.0 6.59 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.618 -0.677 . . . . 0.0 110.6 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.67 -18.87 10.65 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 107.913 -2.075 . . . . 0.0 107.913 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -140.1 -28.57 0.73 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.938 -0.742 . . . . 0.0 110.884 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -135.86 155.32 50.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.226 -0.921 . . . . 0.0 112.015 -178.353 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.413 ' CE1' ' CD1' ' A' ' 34' ' ' TRP . 1.1 m-70 -101.57 105.43 16.39 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.786 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 21.9 t -95.35 102.29 9.42 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.217 -0.927 . . . . 0.0 110.051 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.784 ' HB3' HD12 ' A' ' 30' ' ' LEU . 40.3 Cg_endo -66.64 91.96 0.3 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.916 1.482 . . . . 0.0 109.006 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.537 HG23 HG12 ' A' ' 58' ' ' VAL . 79.1 t -108.21 126.75 64.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.938 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.5 t80 -72.88 110.89 7.53 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 176.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.717 HG12 ' CG2' ' A' ' 40' ' ' ILE . 1.7 mp -62.71 -56.77 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.642 -0.661 . . . . 0.0 112.732 -177.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 3.5 m 68.79 162.39 0.21 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -177.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.627 ' N ' HG13 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -78.93 62.76 3.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.639 -1.288 . . . . 0.0 109.451 -179.398 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -167.53 -32.85 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.317 -0.864 . . . . 0.0 112.271 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.717 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 2.8 mtt -98.07 8.49 44.69 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.79 -1.194 . . . . 0.0 111.85 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 68' ' ' GLY . 8.2 p -90.22 162.62 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 120.757 -1.214 . . . . 0.0 112.214 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.481 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 106.69 -16.82 39.96 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.849 ' O ' HG23 ' A' ' 39' ' ' THR . 16.3 m-70 -112.86 -88.44 0.54 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.12 -1.223 . . . . 0.0 110.726 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.09 -35.64 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 122.394 1.092 . . . . 0.0 109.02 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.621 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -178.74 -14.93 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.973 -179.587 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.41 -14.75 77.17 Favored Glycine 0 N--CA 1.498 2.771 0 O-C-N 120.797 -1.189 . . . . 0.0 110.281 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.717 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 1.8 mm-40 . . . . . 0 N--CA 1.496 1.858 0 O-C-N 121.356 -1.085 . . . . 0.0 108.686 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.542 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 1.7 t80 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.499 0.666 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.661 HG21 HG13 ' A' ' 41' ' ' VAL . 3.5 p -137.17 119.75 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.785 ' HB2' HD23 ' A' ' 15' ' ' LEU . 34.1 m-20 -23.62 99.97 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 CA-C-O 121.046 0.45 . . . . 0.0 112.142 -178.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.2 -26.4 63.86 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.728 ' CB ' HG23 ' A' ' 33' ' ' THR . 0.1 OUTLIER -76.07 -14.04 60.2 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 120.99 0.424 . . . . 0.0 110.148 178.64 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.042 HD11 ' SD ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -87.01 -35.33 18.86 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.645 ' HA ' HG12 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -70.56 -43.93 68.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.745 -0.597 . . . . 0.0 110.01 178.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.64 ' HG2' ' HA ' ' A' ' 14' ' ' HIS . 0.6 OUTLIER -53.08 -19.73 3.05 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.8 179.408 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.472 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 17.6 mttt -106.39 -32.56 8.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.347 -0.846 . . . . 0.0 110.146 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.96 HG21 ' SD ' ' A' ' 44' ' ' MET . 0.5 OUTLIER -73.57 -40.66 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.403 -0.811 . . . . 0.0 111.153 -179.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.511 HD21 ' HA ' ' A' ' 17' ' ' GLU . 3.8 pp -60.52 -26.27 66.74 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.57 -36.24 52.27 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 27' ' ' GLU . 0.9 OUTLIER -72.22 -28.49 63.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.591 -0.693 . . . . 0.0 109.637 178.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -83.56 -11.33 57.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.581 -0.699 . . . . 0.0 109.599 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.0 -37.22 14.47 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 121.588 -0.695 . . . . 0.0 110.002 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.477 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 4.6 ptmt -96.56 -23.92 16.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.611 -0.681 . . . . 0.0 109.84 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.32 29.45 7.5 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.477 ' HG3' ' HE2' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -92.98 129.08 39.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.427 -1.043 . . . . 0.0 110.685 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -107.25 70.63 0.8 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.593 -0.692 . . . . 0.0 109.226 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.34 -152.76 0.5 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.656 -0.653 . . . . 0.0 110.006 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -114.05 155.79 25.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.421 -0.799 . . . . 0.0 110.354 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.567 HG21 ' O ' ' A' ' 15' ' ' LEU . 5.8 mt -135.06 116.32 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.498 -0.751 . . . . 0.0 109.346 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -103.33 148.37 25.94 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.277 -0.889 . . . . 0.0 110.891 -179.45 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.728 HG23 ' CB ' ' A' ' 14' ' ' HIS . 56.6 m -137.91 156.78 47.53 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.579 -0.701 . . . . 0.0 110.177 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.506 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 19.9 m-90 -118.57 44.93 2.15 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.681 -0.637 . . . . 0.0 110.057 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 10' ' ' PHE . 66.1 m -83.79 -167.24 1.65 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.289 -0.882 . . . . 0.0 111.004 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -102.11 -61.88 1.33 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.436 -0.79 . . . . 0.0 110.341 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.33 41.32 1.07 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.355 -0.841 . . . . 0.0 109.636 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 63.1 m -37.75 105.44 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.808 HG23 ' O ' ' A' ' 69' ' ' HIS . 44.6 m -122.35 159.7 26.92 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.684 -0.635 . . . . 0.0 109.316 178.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.866 ' CG2' HG12 ' A' ' 62' ' ' ILE . 4.8 mp -90.08 168.92 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.408 -0.807 . . . . 0.0 111.705 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.676 HG23 ' HE3' ' A' ' 44' ' ' MET . 0.1 OUTLIER -139.56 174.6 3.93 Favored Pre-proline 0 N--CA 1.505 2.306 0 O-C-N 121.79 -0.569 . . . . 0.0 109.787 179.443 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.565 ' HD2' HG12 ' A' ' 41' ' ' VAL . 42.8 Cg_endo -65.61 -33.53 45.05 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 124.116 1.588 . . . . 0.0 111.198 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.75 -12.43 23.97 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.597 -0.69 . . . . 0.0 110.578 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 1.042 ' SD ' HD11 ' A' ' 15' ' ' LEU . 6.2 mmt -87.09 -4.8 59.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.364 -0.835 . . . . 0.0 111.909 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.526 HG23 ' N ' ' A' ' 64' ' ' GLU . 7.5 p -51.11 1.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.475 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.408 ' C ' ' CG ' ' A' ' 47' ' ' HIS . . . -146.27 31.01 1.58 Allowed Glycine 0 N--CA 1.495 2.62 0 O-C-N 119.918 -1.739 . . . . 0.0 110.28 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.408 ' CG ' ' C ' ' A' ' 46' ' ' GLY . 17.9 m-70 -147.88 156.55 42.82 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.217 -1.167 . . . . 0.0 111.315 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.69 88.73 3.9 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.677 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.938 HD12 HD13 ' A' ' 62' ' ' ILE . 2.6 mt -86.69 119.31 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.178 -0.951 . . . . 0.0 112.019 -176.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.725 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.87 86.81 5.36 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 122.15 0.976 . . . . 0.0 109.193 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.1 m -71.25 134.8 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.232 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.551 ' HB2' ' O ' ' A' ' 33' ' ' THR . 28.5 t80 -75.2 105.58 6.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.342 -0.849 . . . . 0.0 108.886 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -71.46 0.03 9.28 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.53 -0.731 . . . . 0.0 110.801 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.41 -22.48 7.84 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -140.36 -28.84 0.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 122.016 -0.697 . . . . 0.0 110.79 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.21 156.22 49.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.266 -0.896 . . . . 0.0 111.988 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.526 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 93.6 m-70 -101.83 108.31 19.76 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.725 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 22.0 t -94.3 101.5 6.66 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.308 -0.87 . . . . 0.0 110.008 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.52 ' O ' HG22 ' A' ' 48' ' ' THR . 43.0 Cg_endo -68.85 94.0 0.45 Allowed 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.933 1.491 . . . . 0.0 108.96 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.687 ' O ' HD12 ' A' ' 62' ' ' ILE . 15.0 m -106.36 126.93 62.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.217 -178.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 0.5 OUTLIER -69.5 104.32 2.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 176.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.938 HD13 HD12 ' A' ' 49' ' ' ILE . 1.3 mp -60.2 -53.22 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.602 ' O ' HG22 ' A' ' 62' ' ' ILE . 1.3 p 59.6 -175.63 0.1 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.526 ' N ' HG23 ' A' ' 45' ' ' VAL . 3.2 tp10 -90.41 43.51 1.15 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.486 -1.384 . . . . 0.0 109.941 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -150.92 -29.11 0.2 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.948 -1.095 . . . . 0.0 113.464 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.516 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 5.9 mtt -89.29 -23.18 22.36 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.527 -1.358 . . . . 0.0 111.435 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.652 HG21 ' C ' ' A' ' 41' ' ' VAL . 2.7 p -67.01 160.14 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.077 -1.015 . . . . 0.0 112.459 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.452 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 114.62 -13.56 20.48 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.869 -0.682 . . . . 0.0 111.586 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.808 ' O ' HG23 ' A' ' 39' ' ' THR . 22.2 m-70 -121.98 -83.8 0.66 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.912 1.356 . . . . 0.0 110.853 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.687 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.88 -30.98 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 121.661 0.743 . . . . 0.0 110.326 -179.597 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.597 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 1.3 pp 173.12 -14.18 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.767 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.29 -18.99 73.82 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.555 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 2.6 mt-10 . . . . . 0 N--CA 1.497 1.909 0 O-C-N 121.355 -1.085 . . . . 0.0 109.24 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.713 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.329 0.585 . . . . 0.0 110.177 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 39' ' ' THR . 13.6 p -116.01 119.08 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.969 ' HB3' HD23 ' A' ' 15' ' ' LEU . 5.1 t70 -44.55 103.9 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.686 -0.634 . . . . 0.0 111.161 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.86 -22.1 65.14 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.16 -29.99 63.25 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.977 -0.452 . . . . 0.0 110.253 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.969 HD23 ' HB3' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -78.25 -38.68 42.24 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.277 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.744 HD12 ' HG ' ' A' ' 15' ' ' LEU . 2.9 mp -58.92 -42.98 90.98 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.309 0.576 . . . . 0.0 109.584 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.571 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -56.01 -23.75 34.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.806 -0.558 . . . . 0.0 109.943 179.257 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.4 -29.82 12.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.497 -0.752 . . . . 0.0 110.592 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.691 HG21 ' CB ' ' A' ' 44' ' ' MET . 2.3 p -73.96 -38.05 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.186 -0.946 . . . . 0.0 111.02 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.571 HD21 ' HA ' ' A' ' 17' ' ' GLU . 4.1 pp -61.75 -26.63 68.19 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -69.61 -34.06 73.55 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.696 HD13 ' HD3' ' A' ' 25' ' ' LYS . 3.6 mm? -74.13 -26.56 60.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.621 -0.674 . . . . 0.0 109.369 178.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -82.13 -13.44 57.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.598 -0.689 . . . . 0.0 109.674 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.37 -33.61 21.96 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.505 -0.747 . . . . 0.0 110.095 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.696 ' HD3' HD13 ' A' ' 22' ' ' LEU . 2.1 ptmt -92.01 -17.08 25.6 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.61 -0.682 . . . . 0.0 109.714 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.37 32.43 11.93 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.505 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -114.39 128.56 56.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.527 -0.984 . . . . 0.0 110.743 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.78 80.79 2.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.597 -0.69 . . . . 0.0 109.588 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.82 -147.84 0.39 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.55 -0.719 . . . . 0.0 109.848 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.528 ' O ' HD13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -121.27 154.05 36.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 110.203 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.848 ' HB ' HD13 ' A' ' 49' ' ' ILE . 28.0 mm -118.79 154.22 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.328 -0.857 . . . . 0.0 110.057 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.509 ' HE2' HD11 ' A' ' 30' ' ' LEU . 1.6 mmtp -102.76 137.09 41.43 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.667 -0.646 . . . . 0.0 110.345 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.67 HG23 ' CB ' ' A' ' 12' ' ' ASP . 9.6 m -124.45 150.28 45.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.572 -0.705 . . . . 0.0 109.806 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.635 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 1.4 m-90 -145.69 38.56 1.12 Allowed 'General case' 0 N--CA 1.51 2.563 0 O-C-N 121.067 -1.021 . . . . 0.0 112.652 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -100.57 -97.5 0.25 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.467 -1.395 . . . . 0.0 110.702 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.4 ' HG2' ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -169.83 -60.02 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.094 -1.004 . . . . 0.0 109.346 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.54 35.16 2.53 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.8 m -51.48 138.9 21.16 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.529 0.68 . . . . 0.0 111.742 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.783 ' O ' HG23 ' A' ' 11' ' ' VAL . 3.0 m -133.79 165.91 23.87 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.859 -0.526 . . . . 0.0 109.836 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.874 HG22 HG23 ' A' ' 67' ' ' VAL . 5.0 mp -86.2 161.49 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.199 -0.938 . . . . 0.0 110.551 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.695 HG23 ' HG2' ' A' ' 44' ' ' MET . 0.0 OUTLIER -141.1 176.23 2.59 Favored Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 121.672 -0.643 . . . . 0.0 109.686 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.651 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 38.3 Cg_endo -62.86 -28.77 75.86 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.137 1.598 . . . . 0.0 109.595 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -66.79 -10.64 49.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.847 -0.533 . . . . 0.0 110.864 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.966 ' HE1' HD21 ' A' ' 15' ' ' LEU . 1.9 ptp -140.19 44.21 1.89 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.814 -1.179 . . . . 0.0 112.324 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.832 ' CG1' ' HA ' ' A' ' 64' ' ' GLU . 3.2 t -91.49 27.96 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.819 -1.176 . . . . 0.0 110.938 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.66 24.74 0.94 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 12.6 m-70 -139.55 167.81 21.26 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.235 -1.156 . . . . 0.0 110.533 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.666 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -98.96 81.62 2.63 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 178.394 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.848 HD13 ' HB ' ' A' ' 31' ' ' ILE . 1.1 mm -79.37 112.47 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.673 -0.642 . . . . 0.0 110.929 -177.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.782 ' HB1' ' HB3' ' A' ' 57' ' ' HIS . . . -77.8 80.83 4.24 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.969 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.433 HG22 ' HB ' ' A' ' 58' ' ' VAL . 33.4 m -57.58 138.29 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.879 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.635 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 19.7 t80 -80.67 108.0 13.95 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.565 -0.854 . . . . 0.0 108.983 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -76.57 15.45 0.62 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.769 -0.582 . . . . 0.0 110.247 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.4 ' HA2' ' HG2' ' A' ' 36' ' ' ARG . . . 106.81 -29.3 11.03 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.0 pttt -140.57 -27.37 0.73 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.636 -0.92 . . . . 0.0 111.188 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -126.41 156.15 41.03 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.782 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 13.2 m-70 -94.9 115.82 27.94 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.745 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 46.2 t -103.81 90.64 2.99 Favored Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 121.157 -0.965 . . . . 0.0 109.337 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.549 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.8 Cg_endo -65.42 89.47 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 O-C-N 124.019 1.536 . . . . 0.0 110.301 -178.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.665 HG11 ' HA ' ' A' ' 71' ' ' LEU . 5.3 m -94.67 110.04 23.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.268 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.666 ' HB2' HG23 ' A' ' 48' ' ' THR . 0.6 OUTLIER -69.39 95.28 0.79 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.792 -1.163 . . . . 0.0 108.222 178.514 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.731 HG21 HG21 ' A' ' 40' ' ' ILE . 2.7 mp -76.79 127.64 37.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.145 -178.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.628 ' C ' HG12 ' A' ' 45' ' ' VAL . 72.1 p -101.78 158.74 15.9 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.832 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -42.78 -19.61 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.433 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 63' ' ' THR . 10.1 p30 -121.59 29.59 7.12 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.696 -1.253 . . . . 0.0 112.641 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.418 ' HB2' ' H ' ' A' ' 63' ' ' THR . 18.7 mmt -126.72 -19.19 4.57 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.973 -1.079 . . . . 0.0 110.73 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.874 HG23 HG22 ' A' ' 40' ' ' ILE . 13.3 p -65.5 162.61 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.343 -0.848 . . . . 0.0 112.239 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.457 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 120.16 -11.07 10.78 Favored Glycine 0 N--CA 1.491 2.367 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.727 178.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.7 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 14.2 m-70 -113.94 -88.29 0.56 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 119.33 1.565 . . . . 0.0 111.015 -178.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.54 -32.29 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.824 0.821 . . . . 0.0 109.785 -179.531 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.665 ' HA ' HG11 ' A' ' 60' ' ' VAL . 1.4 pp 174.03 -11.58 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.788 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.17 -15.01 81.74 Favored Glycine 0 N--CA 1.492 2.372 0 O-C-N 120.827 -1.171 . . . . 0.0 110.418 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.7 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 12.9 mm-40 . . . . . 0 N--CA 1.495 1.785 0 O-C-N 121.252 -1.146 . . . . 0.0 109.58 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.702 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.181 0.515 . . . . 0.0 110.261 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.636 HG22 HD11 ' A' ' 16' ' ' LEU . 14.8 p -104.42 116.36 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.702 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 28.1 t70 -50.02 105.48 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.482 -0.761 . . . . 0.0 111.014 -178.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -64.82 -24.97 67.71 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -66.83 -31.43 72.05 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.281 0.563 . . . . 0.0 109.511 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.87 HD11 ' SD ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -78.97 -35.42 43.08 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.504 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.636 HD11 HG22 ' A' ' 11' ' ' VAL . 2.7 mp -63.18 -42.95 99.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.689 -0.632 . . . . 0.0 109.558 178.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.559 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -56.35 -22.94 34.27 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.277 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.412 ' O ' HD23 ' A' ' 22' ' ' LEU . 12.2 mttt -99.0 -31.15 11.95 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.503 -0.748 . . . . 0.0 110.602 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.665 HG21 ' HG2' ' A' ' 44' ' ' MET . 1.8 p -73.27 -40.07 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.132 -0.98 . . . . 0.0 110.559 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.559 HD21 ' HA ' ' A' ' 17' ' ' GLU . 4.0 pp -64.14 -25.05 67.92 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -72.89 -33.11 65.84 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 27' ' ' GLU . 2.9 mm? -73.89 -26.96 60.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.43 -0.794 . . . . 0.0 109.238 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -81.74 -14.01 57.04 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.535 -0.728 . . . . 0.0 109.842 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.28 -38.94 21.49 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.525 -0.735 . . . . 0.0 109.078 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.98 -19.81 31.5 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.266 0.555 . . . . 0.0 109.824 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.47 3.32 72.02 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.472 ' O ' HD12 ' A' ' 22' ' ' LEU . 39.9 mt-10 -85.35 148.04 26.23 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.382 -1.07 . . . . 0.0 110.507 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -119.33 94.2 4.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.456 -0.778 . . . . 0.0 109.745 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -117.5 -157.89 0.68 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.49 -0.757 . . . . 0.0 110.45 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.0 OUTLIER -110.84 147.2 35.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.595 -0.691 . . . . 0.0 110.63 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.555 HG21 HD12 ' A' ' 15' ' ' LEU . 2.8 mp -121.87 117.95 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 3.8 mppt? -82.56 159.0 22.88 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.276 -0.89 . . . . 0.0 111.21 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.57 HG23 ' CG ' ' A' ' 12' ' ' ASP . 17.9 m -139.74 158.51 43.99 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.576 -0.703 . . . . 0.0 110.037 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.44 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 11.4 m-90 -146.93 38.77 1.0 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.367 -0.833 . . . . 0.0 111.052 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.7 m -98.05 -109.06 0.17 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.992 -1.067 . . . . 0.0 110.756 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.9 -64.73 0.19 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.912 -1.117 . . . . 0.0 110.366 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 38' ' ' SER . 1.6 mtp180 -92.54 25.63 2.96 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.405 -0.81 . . . . 0.0 110.191 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.444 ' OG ' HG21 ' A' ' 33' ' ' THR . 73.7 m -31.53 116.92 0.18 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.335 0.588 . . . . 0.0 112.466 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.741 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 45.1 m -124.38 159.93 29.28 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.74 -0.6 . . . . 0.0 110.476 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.708 HG21 HG23 ' A' ' 62' ' ' ILE . 5.3 mp -88.63 169.47 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.609 -0.682 . . . . 0.0 110.407 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.835 HG23 ' HG3' ' A' ' 44' ' ' MET . 0.1 OUTLIER -140.07 172.9 5.63 Favored Pre-proline 0 N--CA 1.508 2.458 0 O-C-N 121.176 -0.952 . . . . 0.0 110.945 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.644 ' HD2' HG12 ' A' ' 41' ' ' VAL . 41.8 Cg_endo -66.0 -30.1 48.25 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 124.394 1.734 . . . . 0.0 111.561 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.98 5.03 10.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.497 -0.752 . . . . 0.0 110.461 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.87 ' SD ' HD11 ' A' ' 15' ' ' LEU . 23.1 mtt -111.78 -0.7 15.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 111.411 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.568 HG23 ' N ' ' A' ' 64' ' ' GLU . 2.1 p -41.42 -4.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.923 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 44' ' ' MET . . . -137.71 35.27 2.07 Favored Glycine 0 N--CA 1.495 2.588 0 O-C-N 119.771 -1.831 . . . . 0.0 110.47 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 26.2 m-70 -144.43 153.18 41.64 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.09 -1.241 . . . . 0.0 110.971 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -99.77 92.34 5.27 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.286 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.666 HD13 ' SD ' ' A' ' 44' ' ' MET . 2.6 mt -88.8 120.78 38.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.097 -1.002 . . . . 0.0 111.239 -177.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.751 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -76.31 77.1 3.08 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.986 0.898 . . . . 0.0 109.09 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.654 HG21 ' HB3' ' A' ' 71' ' ' LEU . 33.0 m -56.73 132.25 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.476 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 33' ' ' THR . 19.8 t80 -77.14 104.52 7.69 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.574 -0.85 . . . . 0.0 109.006 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -70.2 0.4 6.37 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.571 -0.706 . . . . 0.0 110.421 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.31 -23.66 7.99 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.52 -28.94 0.7 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 122.051 -0.676 . . . . 0.0 111.136 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.53 155.57 45.55 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.243 -0.911 . . . . 0.0 112.159 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.471 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 6.9 m80 -100.81 104.78 16.03 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.751 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 39.1 t -93.71 101.16 5.53 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.205 -0.934 . . . . 0.0 109.92 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.549 ' O ' HG22 ' A' ' 48' ' ' THR . 40.7 Cg_endo -66.23 90.19 0.26 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 O-C-N 123.909 1.479 . . . . 0.0 109.82 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 60' ' ' VAL . 34.3 m -101.8 127.67 55.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.707 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 4.6 t80 -69.72 111.88 5.8 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 177.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.78 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.4 OUTLIER -51.33 -51.34 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.833 -0.542 . . . . 0.0 111.398 -178.058 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 m 60.88 169.85 0.09 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.363 0.602 . . . . 0.0 109.538 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.568 ' N ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -81.51 2.85 27.12 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.873 -1.142 . . . . 0.0 111.603 -179.313 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -142.51 1.88 1.39 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.83 -1.169 . . . . 0.0 113.038 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.594 ' HB2' ' O ' ' A' ' 62' ' ' ILE . 20.2 mmt -99.95 -15.06 18.45 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.435 -1.415 . . . . 0.0 110.206 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.646 HG23 HG22 ' A' ' 40' ' ' ILE . 13.9 p -74.37 168.73 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.252 -0.905 . . . . 0.0 112.254 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.54 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 114.8 -5.35 22.52 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.701 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.733 ' O ' HG23 ' A' ' 39' ' ' THR . 19.8 m-70 -127.57 -85.0 0.6 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 119.289 1.545 . . . . 0.0 110.854 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.741 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.9 -29.29 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.532 0.682 . . . . 0.0 110.088 -179.243 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.654 ' HB3' HG21 ' A' ' 51' ' ' VAL . 2.4 pp 171.58 -17.39 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.309 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.67 -18.76 74.26 Favored Glycine 0 N--CA 1.494 2.549 0 O-C-N 121.083 -1.01 . . . . 0.0 110.802 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.689 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 23.6 mm-40 . . . . . 0 N--CA 1.497 1.879 0 O-C-N 121.214 -1.168 . . . . 0.0 109.213 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.531 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 1.6 t80 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.592 0.71 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.681 HG21 HG13 ' A' ' 41' ' ' VAL . 6.6 p -134.13 123.58 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.884 ' HB2' HD23 ' A' ' 15' ' ' LEU . 49.0 m-20 -29.13 99.51 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.117 0.484 . . . . 0.0 111.817 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.1 -25.04 64.22 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.695 ' HB3' HG23 ' A' ' 33' ' ' THR . 0.2 OUTLIER -76.73 -21.23 55.56 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 122.021 -0.424 . . . . 0.0 110.044 178.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.884 HD23 ' HB2' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -80.88 -37.66 29.4 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.664 HD11 HG21 ' A' ' 41' ' ' VAL . 3.6 mp -64.48 -42.36 95.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.716 -0.615 . . . . 0.0 109.893 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.409 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -56.24 -21.17 21.87 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.759 179.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.71 -26.06 11.96 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.311 -0.868 . . . . 0.0 110.335 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.623 HG11 ' CE ' ' A' ' 44' ' ' MET . 0.5 OUTLIER -76.5 -36.9 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.303 -0.873 . . . . 0.0 110.935 -179.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.474 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 3.8 pp -63.71 -28.7 70.07 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -33.66 68.48 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.482 HD22 ' CB ' ' A' ' 27' ' ' GLU . 1.2 mt -79.58 -27.79 41.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.665 -0.647 . . . . 0.0 109.488 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -82.44 -11.29 58.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.538 -0.726 . . . . 0.0 109.558 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.57 -40.04 21.46 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.513 -0.742 . . . . 0.0 109.978 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.535 ' CD ' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -103.99 -25.76 12.88 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.403 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.92 25.31 5.96 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.535 ' HG3' ' CD ' ' A' ' 25' ' ' LYS . 4.7 mt-10 -79.3 130.12 35.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.335 -1.097 . . . . 0.0 110.602 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.0 mtmm -107.64 65.78 0.65 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.57 -0.707 . . . . 0.0 109.125 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.72 -151.03 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.6 -0.687 . . . . 0.0 110.049 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.0 OUTLIER -120.96 145.21 47.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.854 . . . . 0.0 110.57 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.548 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 2.7 mp -120.4 113.16 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.496 -0.753 . . . . 0.0 109.434 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -92.76 147.65 22.69 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.311 -0.868 . . . . 0.0 110.813 -179.35 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.795 HG21 ' HB3' ' A' ' 12' ' ' ASP . 17.6 m -138.69 166.7 23.7 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.468 -0.77 . . . . 0.0 110.301 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.456 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 15.4 m-90 -139.01 39.89 2.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.711 -0.618 . . . . 0.0 109.874 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 10' ' ' PHE . 50.6 m -78.82 -142.38 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.337 -0.852 . . . . 0.0 110.654 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.32 -61.4 1.41 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.989 -1.07 . . . . 0.0 110.317 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -94.33 39.53 1.09 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.403 -0.81 . . . . 0.0 109.825 179.484 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.727 ' HB3' HG23 ' A' ' 51' ' ' VAL . 36.3 m -35.54 131.57 0.48 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.302 0.572 . . . . 0.0 112.277 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.802 HG23 ' O ' ' A' ' 69' ' ' HIS . 27.9 m -150.02 162.27 40.71 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.631 -0.668 . . . . 0.0 110.401 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.689 HG21 HG21 ' A' ' 62' ' ' ILE . 1.2 mp -80.42 165.92 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.418 0 CA-C-O 121.642 0.734 . . . . 0.0 111.647 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.889 HG23 ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -140.4 179.59 1.22 Allowed Pre-proline 0 N--CA 1.503 2.183 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.605 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.75 ' HD2' HG12 ' A' ' 41' ' ' VAL . 48.8 Cg_endo -70.94 -33.01 12.76 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.872 1.459 . . . . 0.0 111.512 -179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -73.18 -0.14 13.42 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.451 -0.781 . . . . 0.0 110.984 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.889 ' SD ' HG23 ' A' ' 41' ' ' VAL . 1.3 mpt? -100.8 2.99 41.7 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.304 -0.872 . . . . 0.0 111.378 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.566 HG23 ' N ' ' A' ' 64' ' ' GLU . 4.0 p -57.2 -0.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.64 35.1 1.04 Allowed Glycine 0 N--CA 1.493 2.495 0 O-C-N 120.42 -1.425 . . . . 0.0 109.736 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.695 ' HB2' HD11 ' A' ' 49' ' ' ILE . 45.6 m-70 -144.34 154.93 43.53 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.279 -1.13 . . . . 0.0 111.06 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.686 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.76 83.85 2.82 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.223 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.829 HG12 HD13 ' A' ' 15' ' ' LEU . 2.7 mp -86.26 122.61 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 111.141 -177.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.757 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.09 87.13 4.87 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.971 0.891 . . . . 0.0 109.729 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.727 HG23 ' HB3' ' A' ' 38' ' ' SER . 4.9 p -62.36 120.55 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.733 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 33' ' ' THR . 20.6 t80 -67.1 109.19 2.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -0.897 . . . . 0.0 109.65 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -78.18 10.66 2.81 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.599 -0.688 . . . . 0.0 110.604 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.58 -26.72 13.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -139.82 -28.17 0.75 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.662 -0.905 . . . . 0.0 110.429 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -130.36 153.73 48.4 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.0 0.905 . . . . 0.0 113.323 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.436 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 6.5 m80 -96.02 113.99 25.65 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.757 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 21.9 t -103.44 94.76 6.24 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.238 -0.914 . . . . 0.0 109.531 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.496 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.6 Cg_endo -66.29 89.54 0.26 Allowed 'Trans proline' 0 N--CA 1.491 1.364 0 O-C-N 123.981 1.516 . . . . 0.0 109.567 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 58' ' ' VAL . 93.6 t -98.34 120.6 47.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.828 -179.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.686 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.5 t80 -73.65 105.07 4.81 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.761 HD13 ' HB3' ' A' ' 44' ' ' MET . 2.9 mp -85.38 135.07 25.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.679 -0.638 . . . . 0.0 111.071 -178.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.438 ' C ' HG23 ' A' ' 45' ' ' VAL . 59.3 p -98.26 -158.81 0.7 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 177.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.566 ' N ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -87.88 10.27 19.21 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.925 -1.11 . . . . 0.0 111.45 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -145.16 17.75 1.56 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.85 -1.156 . . . . 0.0 112.259 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 67.9 mtt -115.56 0.11 13.21 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.056 -1.028 . . . . 0.0 110.076 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.566 HG23 ' HB ' ' A' ' 40' ' ' ILE . 8.1 p -85.68 167.57 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.219 -0.926 . . . . 0.0 111.298 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 115.75 -15.98 16.54 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.802 ' O ' HG23 ' A' ' 39' ' ' THR . 15.6 m-70 -118.72 -86.36 0.64 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.052 -1.263 . . . . 0.0 111.122 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.613 ' HD3' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER 178.01 -33.81 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 122.165 0.983 . . . . 0.0 109.277 -179.611 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.613 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.5 OUTLIER 178.77 -16.13 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.834 -179.711 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.38 -14.2 79.47 Favored Glycine 0 N--CA 1.497 2.763 0 O-C-N 120.875 -1.141 . . . . 0.0 110.407 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.639 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 2.7 mm-40 . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.324 -1.103 . . . . 0.0 108.667 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.72 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.119 0.485 . . . . 0.0 109.942 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.695 HG21 HG13 ' A' ' 41' ' ' VAL . 14.8 p -114.33 122.04 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.383 -0.823 . . . . 0.0 108.915 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.789 ' CG ' HG23 ' A' ' 33' ' ' THR . 37.5 t70 -48.53 107.85 0.15 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.64 -0.662 . . . . 0.0 111.579 -178.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -68.63 -22.48 64.42 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.405 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 4.6 t-80 -67.06 -21.88 65.87 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.044 0.45 . . . . 0.0 110.358 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.052 HD13 HD13 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -83.7 -36.94 23.34 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.325 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.877 ' HA ' HG12 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -66.87 -46.5 74.8 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.427 179.291 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.419 ' HA ' HD21 ' A' ' 20' ' ' LEU . 5.3 pt-20 -52.62 -21.88 4.42 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.728 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.0 -29.21 10.08 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.366 -0.834 . . . . 0.0 110.693 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.877 HG12 ' HA ' ' A' ' 16' ' ' LEU . 1.4 p -78.51 -38.7 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.096 -1.003 . . . . 0.0 111.161 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.475 ' C ' HD12 ' A' ' 20' ' ' LEU . 3.6 pp -63.11 -24.83 68.08 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -71.84 -32.2 67.28 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' A' ' 27' ' ' GLU . 1.7 mp -76.96 -27.11 54.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.652 -0.655 . . . . 0.0 109.381 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -86.29 -14.29 44.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.556 -0.715 . . . . 0.0 109.286 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.04 -40.35 12.36 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.666 -0.646 . . . . 0.0 110.2 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.422 ' CE ' ' HG2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -93.86 -29.55 15.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.453 -0.779 . . . . 0.0 109.19 179.721 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.93 22.35 7.65 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.495 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 8.2 mm-40 -82.32 136.05 35.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.335 -1.097 . . . . 0.0 109.87 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -113.29 80.73 1.4 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.463 -0.773 . . . . 0.0 109.961 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.53 -160.66 1.0 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.353 0.597 . . . . 0.0 110.532 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -106.98 161.31 14.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.64 -0.663 . . . . 0.0 110.447 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.67 ' HB ' HG12 ' A' ' 49' ' ' ILE . 37.9 mm -116.01 164.43 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.544 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 2.1 mptt -127.68 149.99 49.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.789 HG23 ' CG ' ' A' ' 12' ' ' ASP . 22.4 m -135.21 155.16 51.14 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.361 -0.837 . . . . 0.0 111.227 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.544 ' CH2' ' HB2' ' A' ' 32' ' ' LYS . 23.2 m-90 -145.18 28.47 1.22 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.728 -0.608 . . . . 0.0 110.352 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.443 ' O ' ' HD2' ' A' ' 52' ' ' TYR . 0.4 OUTLIER -92.88 -159.32 0.67 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.065 -1.022 . . . . 0.0 110.934 -179.222 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -108.47 -56.53 2.24 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.093 -1.004 . . . . 0.0 110.55 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -94.4 33.27 1.43 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.394 -0.816 . . . . 0.0 110.189 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.403 ' OG ' HG21 ' A' ' 33' ' ' THR . 42.9 m -39.0 126.03 1.56 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.404 0.621 . . . . 0.0 111.781 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.85 HG23 ' O ' ' A' ' 69' ' ' HIS . 17.4 m -133.85 162.74 31.19 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.656 -0.653 . . . . 0.0 110.28 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.759 HG23 ' CG1' ' A' ' 62' ' ' ILE . 1.3 mp -79.16 164.83 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.606 -0.684 . . . . 0.0 111.872 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.86 HG12 ' HD2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -140.07 175.19 3.34 Favored Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.568 -0.708 . . . . 0.0 109.536 178.468 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.86 ' HD2' HG12 ' A' ' 41' ' ' VAL . 46.7 Cg_endo -69.53 -32.45 19.49 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.018 1.536 . . . . 0.0 111.864 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.533 ' HB2' ' CE ' ' A' ' 44' ' ' MET . 4.6 mm-40 -73.82 -0.08 14.75 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.346 -0.846 . . . . 0.0 110.896 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.832 ' HE1' HG11 ' A' ' 19' ' ' VAL . 3.9 mmt -95.5 -6.99 39.34 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.219 -0.925 . . . . 0.0 111.853 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.56 HG13 ' N ' ' A' ' 64' ' ' GLU . 74.0 t -45.84 -8.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.647 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.422 ' HA2' ' CE1' ' A' ' 61' ' ' TYR . . . -143.01 34.73 1.75 Allowed Glycine 0 N--CA 1.493 2.485 0 O-C-N 120.174 -1.579 . . . . 0.0 109.726 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.445 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 30.0 m-70 -141.89 150.55 41.68 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.393 -1.063 . . . . 0.0 110.559 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.77 81.91 2.53 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.052 HD13 HD13 ' A' ' 15' ' ' LEU . 42.1 mt -77.21 124.04 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.527 -0.733 . . . . 0.0 111.472 -177.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.781 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -81.04 76.84 7.98 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' ' 51' ' ' VAL . 23.0 m -58.85 124.45 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.316 -178.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 32.3 t80 -74.8 105.64 5.96 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.408 -0.807 . . . . 0.0 109.091 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -68.93 -0.23 5.31 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.669 -0.644 . . . . 0.0 110.95 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.81 -18.5 9.85 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -140.03 -28.78 0.73 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.795 -0.827 . . . . 0.0 110.975 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -136.28 154.65 50.82 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.23 -0.919 . . . . 0.0 112.146 -178.21 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.446 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 5.7 m-70 -99.12 105.5 17.6 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.781 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 38.1 t -94.36 101.58 6.89 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.098 -1.001 . . . . 0.0 109.957 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.536 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.3 Cg_endo -66.13 94.12 0.29 Allowed 'Trans proline' 0 N--CA 1.492 1.396 0 O-C-N 123.995 1.523 . . . . 0.0 108.934 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.609 HG23 HG12 ' A' ' 58' ' ' VAL . 75.6 t -109.73 125.33 66.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.065 -177.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.5 t80 -70.69 110.67 5.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.759 ' CG1' HG23 ' A' ' 40' ' ' ILE . 1.5 mp -61.06 -59.33 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.644 -0.66 . . . . 0.0 112.406 -177.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 3.5 m 69.52 161.26 0.21 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -177.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.56 ' N ' HG13 ' A' ' 45' ' ' VAL . 7.5 tp10 -78.42 62.24 3.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.83 -1.169 . . . . 0.0 109.902 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -173.1 -27.79 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.133 -0.979 . . . . 0.0 112.607 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.477 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 4.8 mmm -97.69 6.6 47.74 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.804 -1.185 . . . . 0.0 111.608 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.504 HG22 ' N ' ' A' ' 68' ' ' GLY . 7.5 p -89.07 163.83 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 120.857 -1.152 . . . . 0.0 112.059 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.504 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 109.68 -14.73 32.19 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.85 ' O ' HG23 ' A' ' 39' ' ' THR . 16.8 m-70 -117.77 -89.73 0.58 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.984 -1.303 . . . . 0.0 111.125 -179.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.592 ' HG2' ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER 177.64 -31.39 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.134 0.968 . . . . 0.0 109.232 -179.38 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.592 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 2.2 pp 177.62 -17.91 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.657 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.0 -15.68 74.36 Favored Glycine 0 N--CA 1.499 2.841 0 O-C-N 120.936 -1.103 . . . . 0.0 110.427 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.537 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 2.5 mm-40 . . . . . 0 N--CA 1.496 1.844 0 O-C-N 121.352 -1.087 . . . . 0.0 108.407 178.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.69 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 121.323 0.583 . . . . 0.0 110.165 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 11' ' ' VAL . 14.5 p -102.12 109.96 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.786 ' HB3' HD23 ' A' ' 15' ' ' LEU . 26.2 t70 -45.63 109.17 0.16 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.516 -0.74 . . . . 0.0 111.499 -178.207 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -67.43 -23.86 65.58 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.46 -29.26 66.89 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.115 0.483 . . . . 0.0 110.097 179.284 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.841 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -79.95 -38.14 32.99 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.67 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.841 HD12 ' HG ' ' A' ' 15' ' ' LEU . 3.2 mp -63.33 -39.61 95.02 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.414 0.626 . . . . 0.0 109.553 178.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.53 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -55.49 -23.66 27.15 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.799 -0.563 . . . . 0.0 110.029 179.271 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -97.89 -31.82 12.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.482 -0.761 . . . . 0.0 110.499 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 16' ' ' LEU . 1.4 p -71.27 -38.16 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.317 -0.865 . . . . 0.0 110.933 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.53 HD21 ' HA ' ' A' ' 17' ' ' GLU . 3.8 pp -63.27 -26.82 68.95 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.053 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -74.47 -32.58 62.63 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.527 HD22 ' CB ' ' A' ' 27' ' ' GLU . 1.5 mt -75.14 -27.53 59.79 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -83.47 -12.41 56.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.519 -0.738 . . . . 0.0 109.463 178.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.5 -39.88 16.97 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 121.556 -0.715 . . . . 0.0 109.931 179.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.45 ' CE ' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -97.71 -26.65 14.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.509 -0.744 . . . . 0.0 109.807 179.716 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.416 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . 105.07 26.73 6.18 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.527 ' CB ' HD22 ' A' ' 22' ' ' LEU . 7.2 mt-10 -82.44 130.31 35.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.371 -1.076 . . . . 0.0 110.232 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -113.88 59.64 0.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.504 -0.747 . . . . 0.0 109.645 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.39 -136.68 0.32 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.495 -0.753 . . . . 0.0 109.877 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.571 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -132.56 153.88 50.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.95 -1.094 . . . . 0.0 110.719 -179.333 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.85 ' HB ' HD13 ' A' ' 49' ' ' ILE . 4.2 mt -127.35 120.07 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.224 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.441 ' HG3' ' CZ2' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -100.35 160.03 14.66 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.529 -0.732 . . . . 0.0 111.462 -178.69 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.584 HG21 ' OG ' ' A' ' 38' ' ' SER . 18.8 m -141.2 168.65 19.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.811 -0.556 . . . . 0.0 110.112 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.476 ' N ' HG22 ' A' ' 33' ' ' THR . 17.7 m-90 -144.59 39.32 1.27 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.365 -0.834 . . . . 0.0 110.556 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.453 ' H ' HG22 ' A' ' 33' ' ' THR . 22.9 t -92.88 -94.31 0.15 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.175 -0.953 . . . . 0.0 110.544 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.7 ttm105 -167.17 -60.16 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.989 -1.069 . . . . 0.0 110.841 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -103.34 35.67 2.5 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.336 -0.853 . . . . 0.0 110.568 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.584 ' OG ' HG21 ' A' ' 33' ' ' THR . 0.4 OUTLIER -41.01 121.91 1.64 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.16 0.505 . . . . 0.0 111.89 -179.91 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.751 HG23 ' O ' ' A' ' 69' ' ' HIS . 87.8 m -120.74 158.87 26.56 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.679 -0.638 . . . . 0.0 110.293 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.746 HG21 HG12 ' A' ' 62' ' ' ILE . 4.9 mp -85.76 169.34 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.367 -0.833 . . . . 0.0 111.274 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.97 HG23 ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -138.21 179.49 1.31 Allowed Pre-proline 0 N--CA 1.502 2.14 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.097 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.728 ' HD2' HG12 ' A' ' 41' ' ' VAL . 44.9 Cg_endo -68.6 -31.89 25.59 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.879 1.463 . . . . 0.0 111.303 -179.277 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.87 -3.62 16.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.587 -0.696 . . . . 0.0 111.127 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.97 ' SD ' HG23 ' A' ' 41' ' ' VAL . 1.3 mpt? -93.72 0.09 56.23 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.201 -0.937 . . . . 0.0 111.925 -179.304 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.486 HG21 ' CG ' ' A' ' 64' ' ' GLU . 3.5 p -52.31 -3.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.99 33.11 1.52 Allowed Glycine 0 N--CA 1.493 2.473 0 O-C-N 120.394 -1.441 . . . . 0.0 109.668 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 38.6 m-70 -142.91 152.51 42.15 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.303 -1.116 . . . . 0.0 110.907 -179.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.646 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -99.61 83.61 2.81 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 178.361 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.85 HD13 ' HB ' ' A' ' 31' ' ' ILE . 1.1 mm -78.6 112.23 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 111.587 -177.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.705 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -76.43 79.92 3.15 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.079 0.943 . . . . 0.0 108.777 178.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 70' ' ' LYS . 32.3 m -62.19 132.19 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.816 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.519 ' HB2' ' O ' ' A' ' 33' ' ' THR . 26.5 t80 -77.03 103.45 6.97 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.375 -0.828 . . . . 0.0 108.876 178.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -69.71 -0.7 7.4 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.527 -0.733 . . . . 0.0 110.563 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.58 -20.12 9.56 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.761 -2.136 . . . . 0.0 107.761 -178.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -140.15 -29.73 0.7 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 122.004 -0.704 . . . . 0.0 110.752 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.89 155.94 49.83 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.295 -0.878 . . . . 0.0 112.037 -178.278 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.539 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 3.1 m80 -100.64 100.67 11.41 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.092 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.705 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 58.6 t -87.34 104.03 5.59 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.341 -0.85 . . . . 0.0 109.956 -179.041 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 57' ' ' HIS . 42.8 Cg_endo -67.96 89.91 0.37 Allowed 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.921 1.485 . . . . 0.0 109.481 -179.336 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 49' ' ' ILE . 12.7 m -94.21 111.84 25.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.177 -178.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.646 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.4 t80 -69.96 101.25 1.73 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 118.526 -1.27 . . . . 0.0 107.598 177.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.874 HD13 ' HB3' ' A' ' 44' ' ' MET . 2.7 mp -80.8 141.33 15.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 121.543 0.687 . . . . 0.0 111.338 -178.113 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.3 p -110.29 -152.09 0.49 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 177.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.486 ' CG ' HG21 ' A' ' 45' ' ' VAL . 6.9 mt-10 -87.91 -13.38 42.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.764 -1.21 . . . . 0.0 110.921 179.237 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.53 27.35 6.53 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.984 -1.072 . . . . 0.0 112.147 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.5 mmt -116.12 -29.06 6.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.06 -1.025 . . . . 0.0 110.175 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 68' ' ' GLY . 5.7 p -65.67 163.89 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 O-C-N 121.39 -0.819 . . . . 0.0 111.874 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.487 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 123.9 -11.0 8.33 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.475 178.234 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.751 ' O ' HG23 ' A' ' 39' ' ' THR . 17.2 m-70 -124.53 -84.48 0.64 Allowed 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 119.08 1.44 . . . . 0.0 111.007 -178.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.741 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.47 -30.19 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.505 0.669 . . . . 0.0 110.273 -179.42 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.636 ' HB3' HG21 ' A' ' 51' ' ' VAL . 0.5 OUTLIER 173.32 -16.5 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.563 -179.776 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.04 -15.62 76.47 Favored Glycine 0 N--CA 1.495 2.613 0 O-C-N 121.053 -1.029 . . . . 0.0 110.602 -179.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.708 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 22.9 mm-40 . . . . . 0 N--CA 1.496 1.843 0 O-C-N 121.141 -1.211 . . . . 0.0 109.423 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.3 m -81.13 159.03 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.461 -1.023 . . . . 0.0 110.402 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.735 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -112.69 143.32 44.1 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.533 -0.73 . . . . 0.0 109.858 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.781 HG11 HG13 ' A' ' 41' ' ' VAL . 70.4 t -105.55 117.56 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.735 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 37.1 t70 -44.45 112.71 0.45 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.403 0.621 . . . . 0.0 111.725 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.23 -21.97 62.05 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -70.11 -25.13 63.35 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.87 -0.519 . . . . 0.0 110.442 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.943 HD13 ' CD1' ' A' ' 49' ' ' ILE . 0.6 OUTLIER -77.46 -37.47 51.38 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.838 ' HA ' HG12 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -62.5 -46.91 86.31 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.744 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.17 -23.47 3.34 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.311 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -106.06 -33.62 7.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.448 -0.782 . . . . 0.0 110.568 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.838 HG12 ' HA ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -73.3 -39.64 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.279 -0.888 . . . . 0.0 111.402 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 16' ' ' LEU . 3.6 pp -63.13 -27.19 69.21 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.23 -32.67 64.88 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.577 HD22 ' CB ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -77.99 -24.09 48.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.653 -0.654 . . . . 0.0 109.437 178.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -82.73 -11.63 58.16 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.392 -0.817 . . . . 0.0 109.635 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.66 -39.77 19.8 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 121.461 -0.774 . . . . 0.0 109.969 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.54 ' CD ' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -103.23 -23.37 13.62 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.459 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.407 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . 102.14 29.07 6.21 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.577 ' CB ' HD22 ' A' ' 22' ' ' LEU . 5.8 mt-10 -76.1 130.33 38.16 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.394 -1.062 . . . . 0.0 110.669 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.8 mtmm -107.3 59.68 0.62 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.569 -0.707 . . . . 0.0 109.285 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -102.88 -154.34 0.49 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.509 -0.744 . . . . 0.0 109.992 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -124.49 145.16 49.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.587 -0.695 . . . . 0.0 110.13 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.516 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 2.4 mp -114.65 119.83 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.615 -0.678 . . . . 0.0 109.47 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.531 ' CE ' HD11 ' A' ' 30' ' ' LEU . 20.5 mmtt -79.61 154.63 28.58 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.412 -0.805 . . . . 0.0 111.199 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.68 HG23 ' CG ' ' A' ' 12' ' ' ASP . 20.7 m -141.38 153.47 45.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.61 -0.681 . . . . 0.0 110.094 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.457 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 14.7 m-90 -144.49 35.01 1.17 Allowed 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.311 -0.868 . . . . 0.0 111.354 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.3 t -84.63 -96.03 0.07 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.893 -1.13 . . . . 0.0 110.586 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.6 mtm105 -171.81 -61.91 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.106 -0.996 . . . . 0.0 109.631 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.479 ' HG2' ' HD1' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -103.53 31.15 4.54 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.435 0.636 . . . . 0.0 109.399 178.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.438 ' OG ' HG21 ' A' ' 33' ' ' THR . 13.4 m -44.74 130.9 7.08 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.439 0.637 . . . . 0.0 111.997 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.761 HG23 ' O ' ' A' ' 69' ' ' HIS . 75.7 m -124.76 159.06 31.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.775 -0.578 . . . . 0.0 109.936 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.665 HG21 HG12 ' A' ' 62' ' ' ILE . 4.8 mp -79.56 169.48 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.389 -0.82 . . . . 0.0 111.237 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.781 HG13 HG11 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -140.15 176.49 2.5 Favored Pre-proline 0 N--CA 1.5 2.056 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.621 ' O ' HG23 ' A' ' 45' ' ' VAL . 43.2 Cg_endo -66.89 -29.85 40.89 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.006 1.53 . . . . 0.0 110.595 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -71.46 -3.63 22.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.444 -0.785 . . . . 0.0 111.061 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.817 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.4 mtp -98.24 7.21 46.57 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.988 -1.07 . . . . 0.0 112.143 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 42' ' ' PRO . 89.6 t -57.5 -1.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.529 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.06 35.41 0.99 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 31.7 m-70 -142.48 146.34 34.66 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.41 -1.053 . . . . 0.0 111.117 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.817 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.7 83.95 2.85 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 178.023 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.943 ' CD1' HD13 ' A' ' 15' ' ' LEU . 1.9 mt -86.97 120.63 36.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.139 -0.976 . . . . 0.0 110.924 -177.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.737 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -75.72 78.65 2.67 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.977 0.894 . . . . 0.0 109.152 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.656 HG21 ' O ' ' A' ' 70' ' ' LYS . 31.3 m -59.9 131.11 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.534 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 26.8 t80 -78.06 105.01 8.99 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -75.09 7.91 2.97 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.317 -0.864 . . . . 0.0 111.055 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.26 -27.39 6.11 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.65 -24.9 0.77 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.821 -0.811 . . . . 0.0 111.495 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -132.65 154.49 50.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.134 -0.979 . . . . 0.0 112.244 -177.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.442 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 0.8 OUTLIER -99.6 101.46 12.67 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.248 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.737 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 48.1 t -90.75 104.07 8.42 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.178 -0.951 . . . . 0.0 110.089 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.545 ' HB3' HD12 ' A' ' 30' ' ' LEU . 40.5 Cg_endo -66.08 87.37 0.24 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 O-C-N 123.899 1.473 . . . . 0.0 109.447 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 49' ' ' ILE . 15.1 m -92.72 112.59 26.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.464 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.817 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.3 t80 -75.13 100.36 4.23 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.817 HD13 ' HB3' ' A' ' 44' ' ' MET . 2.8 mp -81.57 135.29 25.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.564 -0.71 . . . . 0.0 111.144 -178.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.432 ' C ' HG13 ' A' ' 45' ' ' VAL . 58.9 p -101.03 -155.47 0.52 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.511 ' N ' HG13 ' A' ' 45' ' ' VAL . 1.3 tp10 -89.43 10.88 20.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.627 -1.295 . . . . 0.0 110.614 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.92 24.15 1.19 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.941 -1.099 . . . . 0.0 111.478 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.745 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 6.6 mmt -114.09 -27.95 7.5 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.039 -1.038 . . . . 0.0 110.216 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.539 ' HA ' ' HZ ' ' A' ' 74' ' ' PHE . 7.5 p -63.02 164.87 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 O-C-N 121.585 -0.697 . . . . 0.0 111.822 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.5 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 123.35 -14.51 8.23 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.387 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.761 ' O ' HG23 ' A' ' 39' ' ' THR . 16.5 m-70 -122.03 -85.04 0.66 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 119.034 1.417 . . . . 0.0 111.21 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.683 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.68 -30.64 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.586 0.708 . . . . 0.0 110.42 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.525 ' HB3' ' O ' ' A' ' 70' ' ' LYS . 0.4 OUTLIER 174.46 -16.0 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.706 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.55 -16.4 75.8 Favored Glycine 0 N--CA 1.497 2.704 0 O-C-N 120.954 -1.091 . . . . 0.0 110.686 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.713 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 1.1 mm-40 -86.03 -16.73 37.29 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.254 -1.145 . . . . 0.0 109.461 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.745 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 1.6 m-85 -109.39 -16.87 13.92 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.575 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -137.55 55.23 9.26 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.525 -0.734 . . . . 0.0 110.162 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.575 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 47.1 Cg_endo -85.33 50.04 2.64 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.63 1.332 . . . . 0.0 110.273 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.5 m -129.64 147.24 51.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.641 -0.662 . . . . 0.0 110.311 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.4 -175.68 3.88 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.573 -0.704 . . . . 0.0 110.308 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.7 t -66.2 -26.21 67.29 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.453 -0.779 . . . . 0.0 110.744 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.1 p90 . . . . . 0 N--CA 1.496 1.861 0 O-C-N 121.346 -0.846 . . . . 0.0 110.275 179.803 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.26 139.03 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.557 -0.966 . . . . 0.0 110.265 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.736 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -126.98 143.36 51.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.444 -0.785 . . . . 0.0 110.03 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 11' ' ' VAL . 12.8 p -106.06 116.92 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.736 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 35.9 t70 -47.93 108.7 0.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.437 -0.79 . . . . 0.0 111.266 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.77 -23.88 66.13 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.441 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.7 OUTLIER -70.58 -20.54 62.77 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.976 -0.453 . . . . 0.0 110.071 179.081 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.849 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -88.54 -35.13 17.12 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.304 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.849 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.7 mp -69.52 -38.69 77.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.72 -0.612 . . . . 0.0 110.204 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.536 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . 3.0 pt-20 -58.29 -20.69 44.76 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.439 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -100.3 -29.56 12.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.387 -0.821 . . . . 0.0 110.394 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.047 HG21 ' SD ' ' A' ' 44' ' ' MET . 1.5 p -76.19 -37.21 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.247 -0.908 . . . . 0.0 111.141 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.536 ' CD2' ' HA ' ' A' ' 17' ' ' GLU . 3.7 pp -61.8 -26.58 68.19 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.02 -33.97 70.86 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.438 ' HA ' HD12 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -79.19 -25.46 42.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.694 -0.629 . . . . 0.0 109.573 178.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -84.31 -12.91 53.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.509 -0.744 . . . . 0.0 109.592 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.87 -39.22 13.2 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 121.509 -0.745 . . . . 0.0 110.014 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -94.77 -29.86 14.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.578 -0.701 . . . . 0.0 109.332 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.23 25.01 6.89 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.415 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 28.0 mt-10 -84.63 136.13 33.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.413 -1.051 . . . . 0.0 110.091 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -113.1 77.4 1.05 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.418 -0.801 . . . . 0.0 109.623 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.93 -154.85 0.57 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.496 -0.752 . . . . 0.0 110.363 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -112.85 155.36 24.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.412 -0.805 . . . . 0.0 110.545 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.683 HG21 ' O ' ' A' ' 15' ' ' LEU . 2.7 mp -129.24 113.5 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.493 -0.755 . . . . 0.0 109.338 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.517 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -66.64 154.36 40.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.521 -0.737 . . . . 0.0 111.117 -179.062 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.567 HG23 ' CB ' ' A' ' 12' ' ' ASP . 9.1 m -143.06 135.83 27.75 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.696 -0.628 . . . . 0.0 109.997 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.677 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -152.46 75.71 1.12 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.259 -0.9 . . . . 0.0 111.25 -179.713 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.423 ' HB3' ' CE2' ' A' ' 10' ' ' PHE . 0.6 OUTLIER -123.28 -82.2 0.65 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.147 -0.97 . . . . 0.0 110.052 179.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.417 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 5.8 ttm180 -167.97 -64.17 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.314 -0.866 . . . . 0.0 109.727 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.417 ' HD2' ' HB3' ' A' ' 36' ' ' ARG . 0.4 OUTLIER -104.25 35.11 2.8 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.57 -0.706 . . . . 0.0 109.387 179.113 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.477 ' OG ' HG22 ' A' ' 33' ' ' THR . 5.0 m -37.9 124.92 1.17 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.406 0.622 . . . . 0.0 111.991 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.751 HG23 ' O ' ' A' ' 69' ' ' HIS . 34.4 m -130.57 159.08 38.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.788 -0.57 . . . . 0.0 110.183 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.74 HG21 HG21 ' A' ' 62' ' ' ILE . 5.1 mp -83.85 168.94 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.401 -0.812 . . . . 0.0 110.909 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.682 HG12 ' HD2' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -138.43 176.9 2.36 Favored Pre-proline 0 N--CA 1.501 2.112 0 O-C-N 121.743 -0.598 . . . . 0.0 109.683 179.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.682 ' HD2' HG12 ' A' ' 41' ' ' VAL . 43.4 Cg_endo -66.93 -31.34 38.19 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.005 1.529 . . . . 0.0 111.276 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.761 ' HG3' HG11 ' A' ' 19' ' ' VAL . 2.5 pt-20 -72.27 -3.08 21.56 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.313 -0.867 . . . . 0.0 111.075 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 1.047 ' SD ' HG21 ' A' ' 19' ' ' VAL . 18.8 mmt -97.15 10.1 40.32 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.213 -0.929 . . . . 0.0 111.748 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 42' ' ' PRO . 80.3 t -61.24 0.63 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 O-C-N 120.93 -1.106 . . . . 0.0 113.508 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.38 35.53 0.96 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.543 ' HB2' HD11 ' A' ' 49' ' ' ILE . 36.4 m-70 -141.68 150.24 41.62 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.484 -1.009 . . . . 0.0 111.041 -178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.699 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -99.77 83.7 2.79 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.817 ' CG2' HD13 ' A' ' 15' ' ' LEU . 2.4 mp -83.56 121.39 36.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.398 -0.813 . . . . 0.0 110.885 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.772 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -77.23 79.49 3.75 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.695 0.76 . . . . 0.0 109.456 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.44 ' HA ' ' HB ' ' A' ' 33' ' ' THR . 19.4 m -58.16 135.0 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.385 0.612 . . . . 0.0 110.643 -179.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.677 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 30.5 t80 -75.62 106.82 7.38 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.558 -0.714 . . . . 0.0 109.31 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -77.54 4.78 10.38 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.307 -0.871 . . . . 0.0 110.734 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.64 -30.17 4.98 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.87 -26.27 0.73 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.961 -0.729 . . . . 0.0 111.578 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.8 155.42 41.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.227 -0.92 . . . . 0.0 112.345 -177.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.462 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 1.2 m-70 -97.77 104.81 16.87 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.772 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 48.6 t -93.51 101.49 5.93 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.228 -0.92 . . . . 0.0 110.108 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.523 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.7 Cg_endo -65.77 90.32 0.24 Allowed 'Trans proline' 0 N--CA 1.494 1.513 0 O-C-N 123.892 1.469 . . . . 0.0 109.712 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 58' ' ' VAL . 44.7 t -96.04 113.96 31.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.123 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.699 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.4 t80 -72.9 103.93 3.88 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.74 HG21 HG21 ' A' ' 40' ' ' ILE . 2.7 mp -84.81 132.04 32.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.638 -0.664 . . . . 0.0 111.105 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.408 ' C ' HG13 ' A' ' 45' ' ' VAL . 50.0 p -94.92 -157.2 0.55 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 177.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.527 ' N ' HG13 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -90.12 15.42 10.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.8 -1.188 . . . . 0.0 110.883 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.79 19.72 1.01 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.875 -1.141 . . . . 0.0 112.051 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.751 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 5.3 mmt -115.58 -18.19 10.97 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.834 -1.166 . . . . 0.0 110.502 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.56 HG22 ' N ' ' A' ' 68' ' ' GLY . 5.6 p -73.94 167.15 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.316 -0.865 . . . . 0.0 111.759 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.56 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 121.28 -11.97 9.75 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.164 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.751 ' O ' HG23 ' A' ' 39' ' ' THR . 18.7 m-70 -128.13 -81.42 0.59 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.944 1.372 . . . . 0.0 111.257 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.632 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.76 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 121.714 0.768 . . . . 0.0 110.126 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.595 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.7 OUTLIER 173.73 -16.45 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.759 -179.641 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.1 -16.11 76.73 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.002 -1.061 . . . . 0.0 110.506 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.689 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 21.3 mm-40 -83.94 -21.07 31.95 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.245 -1.15 . . . . 0.0 108.97 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.751 ' CD2' ' HB3' ' A' ' 66' ' ' MET . 14.9 m-85 -94.35 -21.87 18.7 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.57 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -134.11 56.11 17.83 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.816 -0.553 . . . . 0.0 109.716 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.57 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 46.3 Cg_endo -84.78 50.77 3.01 Favored 'Trans proline' 0 C--N 1.32 -0.968 0 O-C-N 123.587 1.309 . . . . 0.0 110.303 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.5 m -71.98 132.44 44.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.536 -0.727 . . . . 0.0 110.188 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.19 179.34 5.09 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.48 -0.762 . . . . 0.0 110.383 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 29.1 p -74.83 149.19 39.7 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.448 -0.782 . . . . 0.0 110.406 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 . . . . . 0 N--CA 1.501 2.101 0 O-C-N 121.805 -0.559 . . . . 0.0 110.681 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -106.97 -33.57 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.473 -1.016 . . . . 0.0 110.892 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.728 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -141.37 139.26 33.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.815 . . . . 0.0 110.189 -179.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.729 HG21 HG13 ' A' ' 41' ' ' VAL . 14.7 p -105.17 112.86 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.728 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 38.9 t70 -41.38 111.8 0.25 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.468 0.651 . . . . 0.0 111.913 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.75 -23.99 63.47 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -67.4 -26.66 66.55 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.928 -0.483 . . . . 0.0 110.221 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.592 HD13 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -79.31 -36.11 40.14 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.77 ' HA ' HG12 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -64.57 -45.55 86.57 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.688 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.82 -22.69 2.29 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.148 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.497 ' O ' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -103.59 -36.55 7.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.579 -0.701 . . . . 0.0 110.174 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.77 HG12 ' HA ' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -70.22 -40.67 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.281 -0.887 . . . . 0.0 110.872 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.516 HD23 ' OE1' ' A' ' 43' ' ' GLU . 10.9 mt -62.69 -37.26 85.79 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.57 -34.69 78.84 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.766 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 18' ' ' LYS . 2.4 mm? -77.71 -27.78 50.76 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.345 -0.847 . . . . 0.0 109.515 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -82.51 -12.07 58.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.631 -0.668 . . . . 0.0 109.82 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.86 -35.22 20.74 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 121.385 -0.822 . . . . 0.0 109.867 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 11.3 mmtt -89.3 -16.05 32.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.61 -0.681 . . . . 0.0 109.816 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.35 26.52 27.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.46 ' O ' HD12 ' A' ' 22' ' ' LEU . 5.2 mm-40 -109.44 137.89 46.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.587 -0.949 . . . . 0.0 110.489 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -110.63 87.78 2.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.49 -0.756 . . . . 0.0 109.644 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.44 -154.34 0.54 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.472 -0.767 . . . . 0.0 110.266 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -112.02 155.43 23.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -0.806 . . . . 0.0 110.589 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.59 ' CD1' HG23 ' A' ' 19' ' ' VAL . 3.3 mt -130.56 122.01 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.604 -0.685 . . . . 0.0 109.74 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.45 ' HB3' ' CZ2' ' A' ' 34' ' ' TRP . 0.1 OUTLIER -84.68 155.63 21.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.407 -0.808 . . . . 0.0 110.882 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.736 HG21 ' OG ' ' A' ' 38' ' ' SER . 19.4 m -137.17 158.19 44.99 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.582 -0.699 . . . . 0.0 110.466 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.479 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 19.8 m-90 -145.54 30.72 1.1 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.333 -0.855 . . . . 0.0 111.726 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 p -86.33 -96.91 0.08 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.847 -1.158 . . . . 0.0 110.606 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.27 -66.34 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.097 -1.002 . . . . 0.0 110.186 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.474 ' HG2' ' HD1' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -99.73 45.24 0.99 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.67 0.747 . . . . 0.0 109.6 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.736 ' OG ' HG21 ' A' ' 33' ' ' THR . 2.2 m -50.9 138.32 19.25 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.448 0.642 . . . . 0.0 112.371 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.778 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 57.0 m -132.0 159.17 39.54 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.903 HG21 HG21 ' A' ' 62' ' ' ILE . 5.2 mp -89.76 168.25 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.231 -0.918 . . . . 0.0 111.276 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.729 HG13 HG21 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -140.21 174.69 3.75 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.228 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.551 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 40.9 Cg_endo -64.86 -31.53 57.01 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.995 1.524 . . . . 0.0 110.194 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.516 ' OE1' HD23 ' A' ' 20' ' ' LEU . 3.3 mm-40 -65.93 -12.42 54.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.761 -0.587 . . . . 0.0 110.631 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.69 ' HB3' HD13 ' A' ' 62' ' ' ILE . 41.4 mtp -97.84 11.29 37.81 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.278 -0.888 . . . . 0.0 110.872 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.665 HG23 ' N ' ' A' ' 64' ' ' GLU . 7.5 p -62.14 5.03 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.339 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.28 33.05 1.03 Allowed Glycine 0 N--CA 1.493 2.475 0 O-C-N 120.311 -1.493 . . . . 0.0 109.976 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.784 ' HB2' HD11 ' A' ' 49' ' ' ILE . 45.9 m-70 -144.07 153.21 41.95 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.153 -1.204 . . . . 0.0 111.29 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.741 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -100.01 83.92 2.78 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 178.255 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.784 HD11 ' HB2' ' A' ' 47' ' ' HIS . 3.1 mp -86.61 118.13 32.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 111.281 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.755 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -76.77 80.26 3.38 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.922 0.868 . . . . 0.0 109.071 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 51' ' ' VAL . 32.8 m -58.56 132.05 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.285 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 33' ' ' THR . 30.4 t80 -74.33 105.8 5.67 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -76.1 13.88 0.81 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.669 -0.644 . . . . 0.0 110.535 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.71 -27.72 12.8 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.5 pttp -140.48 -27.82 0.73 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.596 -0.943 . . . . 0.0 110.84 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -130.35 155.55 46.18 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.106 0.955 . . . . 0.0 113.546 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.653 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 50.8 m-70 -96.3 111.84 23.78 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.755 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 42.1 t -101.33 95.46 4.99 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.132 -0.98 . . . . 0.0 109.455 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.526 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.3 Cg_endo -65.09 87.51 0.18 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.939 1.494 . . . . 0.0 109.787 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.598 HG13 HG12 ' A' ' 58' ' ' VAL . 10.4 m -94.77 114.67 31.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.208 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.741 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.1 t80 -73.4 100.56 3.24 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.903 HG21 HG21 ' A' ' 40' ' ' ILE . 2.6 mp -83.9 138.43 19.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.594 0.711 . . . . 0.0 111.996 -177.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.644 ' C ' HG23 ' A' ' 45' ' ' VAL . 24.8 p -104.99 -153.98 0.5 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 176.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.665 ' N ' HG23 ' A' ' 45' ' ' VAL . 4.7 tp10 -90.43 0.5 57.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.549 -1.344 . . . . 0.0 110.978 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -126.94 -8.9 6.02 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.014 -1.054 . . . . 0.0 112.191 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.742 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 8.6 mmt -86.96 -26.23 23.94 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.805 -1.184 . . . . 0.0 110.121 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.499 HG21 ' C ' ' A' ' 41' ' ' VAL . 5.5 p -66.91 164.31 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.377 -0.827 . . . . 0.0 111.827 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.497 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 120.7 -11.89 10.19 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.52 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.773 ' O ' HG23 ' A' ' 39' ' ' THR . 16.3 m-70 -121.72 -84.99 0.66 Allowed 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 119.078 1.439 . . . . 0.0 111.074 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.778 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.1 OUTLIER 178.36 -30.54 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 CA-C-O 121.601 0.715 . . . . 0.0 110.328 -179.496 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.57 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 1.2 pp 173.3 -15.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.703 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.71 -17.4 76.61 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.714 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 3.6 mm-40 -84.05 -20.83 32.01 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.276 -1.132 . . . . 0.0 109.202 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.742 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 5.8 m-85 -103.61 -17.47 15.14 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.564 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -137.6 55.97 10.64 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.492 -0.755 . . . . 0.0 110.209 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 44.5 Cg_endo -86.66 48.88 1.96 Allowed 'Trans proline' 0 C--N 1.318 -1.048 0 O-C-N 123.619 1.326 . . . . 0.0 110.21 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.8 m -139.46 -56.43 0.58 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.657 -0.652 . . . . 0.0 110.209 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -96.12 -48.85 5.49 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.593 -0.692 . . . . 0.0 110.28 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.4 t -106.62 -177.14 3.28 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.601 -0.687 . . . . 0.0 110.372 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.4 t80 . . . . . 0 N--CA 1.495 1.788 0 O-C-N 121.317 -0.864 . . . . 0.0 110.139 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 p -138.1 145.73 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.485 -1.009 . . . . 0.0 110.441 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.716 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -124.75 152.41 43.86 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.497 -0.752 . . . . 0.0 109.951 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 39' ' ' THR . 14.5 p -114.43 121.02 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.716 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 30.9 t70 -48.93 102.88 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.502 -0.749 . . . . 0.0 111.043 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -63.89 -24.24 67.66 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.23 -33.86 76.25 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.805 HD11 ' CE ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -77.39 -36.81 53.11 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.35 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.689 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.6 mp -62.38 -41.85 98.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.625 -0.672 . . . . 0.0 109.503 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.11 -23.17 19.51 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.647 -0.658 . . . . 0.0 109.993 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -98.62 -33.13 11.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.431 -0.793 . . . . 0.0 110.489 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 16' ' ' LEU . 1.5 p -69.73 -40.52 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.231 -0.918 . . . . 0.0 110.426 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.596 HD21 ' OE2' ' A' ' 43' ' ' GLU . 12.1 mt -63.22 -36.93 85.29 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 177.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.9 -34.04 72.65 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.627 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 27' ' ' GLU . 2.5 mm? -78.77 -26.99 44.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.347 -0.845 . . . . 0.0 109.435 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -81.48 -13.1 58.56 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.577 -0.702 . . . . 0.0 109.752 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.86 -35.39 24.21 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.447 -0.783 . . . . 0.0 109.702 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 17.1 mmtt -89.89 -15.09 32.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.724 -0.61 . . . . 0.0 109.826 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.55 26.25 36.32 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.439 ' O ' HD12 ' A' ' 22' ' ' LEU . 47.1 mt-10 -111.0 144.6 39.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.539 -0.977 . . . . 0.0 110.497 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -111.27 92.99 4.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.502 -0.749 . . . . 0.0 109.611 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.84 -157.19 0.64 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.539 -0.725 . . . . 0.0 110.449 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -112.8 154.04 26.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.538 -0.726 . . . . 0.0 110.364 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.573 HG21 HD12 ' A' ' 15' ' ' LEU . 3.0 mt -131.49 121.84 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.498 -0.751 . . . . 0.0 109.873 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.39 160.02 24.18 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.287 -0.883 . . . . 0.0 110.816 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.669 HG23 ' CG ' ' A' ' 12' ' ' ASP . 16.5 m -137.31 158.39 44.53 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.659 -0.651 . . . . 0.0 110.181 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.439 ' CD1' ' HE1' ' A' ' 57' ' ' HIS . 20.0 m-90 -145.74 37.01 1.07 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.272 -0.893 . . . . 0.0 110.629 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.428 ' HB3' ' HE1' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -100.21 -155.45 0.51 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.168 -0.958 . . . . 0.0 110.687 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.74 -58.13 2.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.179 -0.95 . . . . 0.0 110.147 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.38 35.26 1.99 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.539 -0.726 . . . . 0.0 109.924 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.435 ' HB3' HG21 ' A' ' 33' ' ' THR . 58.5 m -42.19 128.21 3.65 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.338 0.589 . . . . 0.0 111.839 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.713 ' O ' HG23 ' A' ' 11' ' ' VAL . 23.7 m -136.94 163.46 30.65 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.674 -0.641 . . . . 0.0 110.308 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.76 HG21 HG21 ' A' ' 62' ' ' ILE . 5.1 mp -85.42 169.73 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.472 -0.768 . . . . 0.0 111.186 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG12 ' HD2' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -137.27 176.26 2.88 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 121.563 -0.711 . . . . 0.0 109.771 178.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.674 ' HD2' HG12 ' A' ' 41' ' ' VAL . 42.1 Cg_endo -66.57 -29.43 44.14 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.059 1.557 . . . . 0.0 111.334 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.596 ' OE2' HD21 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -77.75 8.0 5.07 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.479 -0.763 . . . . 0.0 111.392 179.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.805 ' CE ' HD11 ' A' ' 15' ' ' LEU . 2.1 mtt -109.96 19.27 19.21 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.01 -1.056 . . . . 0.0 111.512 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.705 HG13 ' N ' ' A' ' 64' ' ' GLU . 89.0 t -66.68 7.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 121.088 -1.007 . . . . 0.0 113.352 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.2 32.44 0.95 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 34.8 m-70 -138.78 147.36 42.49 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.277 -1.131 . . . . 0.0 111.243 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.767 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -99.63 82.0 2.57 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.746 ' CG2' HD13 ' A' ' 15' ' ' LEU . 2.6 mp -81.61 117.38 27.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.314 -0.866 . . . . 0.0 111.446 -177.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.723 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -76.67 78.01 3.32 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 122.094 0.949 . . . . 0.0 108.813 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.666 HG21 ' HB3' ' A' ' 71' ' ' LEU . 32.9 m -60.43 131.12 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.775 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.515 ' HB2' ' O ' ' A' ' 33' ' ' THR . 36.2 t80 -78.28 103.95 8.55 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -74.36 7.87 2.59 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.362 -0.836 . . . . 0.0 111.339 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.94 -27.31 5.94 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -140.71 -24.97 0.76 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.84 -0.8 . . . . 0.0 111.522 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.503 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -133.64 154.09 51.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.106 -0.996 . . . . 0.0 112.443 -177.668 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.489 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 22.3 m-70 -98.84 100.61 11.82 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.723 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 52.5 t -88.75 104.29 7.13 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.236 -0.915 . . . . 0.0 109.887 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.496 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.6 Cg_endo -66.65 88.75 0.28 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 O-C-N 123.912 1.48 . . . . 0.0 109.501 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 49' ' ' ILE . 13.7 m -94.31 112.44 27.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.327 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.767 ' HB2' HG23 ' A' ' 48' ' ' THR . 5.9 t80 -72.9 100.0 2.82 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.76 HG21 HG21 ' A' ' 40' ' ' ILE . 2.7 mp -80.82 134.47 27.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.283 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.696 ' C ' HG13 ' A' ' 45' ' ' VAL . 1.9 m -105.19 -150.25 0.43 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 177.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.705 ' N ' HG13 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -90.01 -3.66 57.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.341 -1.474 . . . . 0.0 111.247 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.4 24.41 4.45 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.917 -1.114 . . . . 0.0 111.44 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.659 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 22.1 mtt -114.82 -31.61 6.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.149 -0.97 . . . . 0.0 110.02 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.549 ' HA ' ' HZ ' ' A' ' 74' ' ' PHE . 6.0 p -62.07 163.29 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 O-C-N 121.453 -0.779 . . . . 0.0 111.925 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.478 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 120.91 -9.55 10.42 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.323 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.707 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 17.1 m-70 -122.97 -86.29 0.65 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 119.101 1.45 . . . . 0.0 110.836 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.54 -30.43 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.495 0.664 . . . . 0.0 110.243 -179.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.666 ' HB3' HG21 ' A' ' 51' ' ' VAL . 1.4 pp 173.55 -14.05 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.273 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.805 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.37 -17.85 79.08 Favored Glycine 0 N--CA 1.493 2.454 0 O-C-N 120.927 -1.108 . . . . 0.0 110.627 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.707 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 16.7 mm-40 -84.68 -15.99 43.39 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.251 -1.146 . . . . 0.0 109.352 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.659 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 1.9 m-85 -109.29 -18.7 13.52 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.583 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -133.33 53.07 9.66 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.541 -0.724 . . . . 0.0 109.686 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.583 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 48.0 Cg_endo -81.77 54.87 5.26 Favored 'Trans proline' 0 C--N 1.321 -0.914 0 O-C-N 123.629 1.331 . . . . 0.0 110.2 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 11.1 t -68.74 -162.1 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.728 -0.608 . . . . 0.0 110.699 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.48 119.51 4.94 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.418 -0.801 . . . . 0.0 110.673 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.4 t -150.29 172.62 15.08 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.598 -0.689 . . . . 0.0 110.393 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 . . . . . 0 N--CA 1.5 2.074 0 O-C-N 121.667 -0.646 . . . . 0.0 110.705 179.998 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.7 t -120.19 91.33 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.417 -1.049 . . . . 0.0 109.93 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.662 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -111.72 140.17 46.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.511 -0.743 . . . . 0.0 109.746 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.807 HG21 HG13 ' A' ' 41' ' ' VAL . 13.5 p -92.11 108.4 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.662 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 36.2 t70 -48.31 115.74 1.32 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.457 0.646 . . . . 0.0 111.736 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.72 -25.07 62.78 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -63.78 -27.73 69.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.862 -0.524 . . . . 0.0 110.12 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.846 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -78.74 -36.73 42.77 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.712 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.846 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.0 mp -62.64 -43.79 97.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.853 -0.529 . . . . 0.0 109.919 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.32 -21.31 23.49 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.666 -0.646 . . . . 0.0 110.593 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.599 ' O ' HD23 ' A' ' 22' ' ' LEU . 6.4 mmpt? -106.27 -23.81 12.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.4 -0.812 . . . . 0.0 111.164 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.695 HG12 ' HA ' ' A' ' 16' ' ' LEU . 1.4 p -86.26 -40.94 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.983 -1.073 . . . . 0.0 111.0 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.482 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 14.1 mt -65.34 -38.16 89.28 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -62.64 -33.84 75.84 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.539 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.599 HD23 ' O ' ' A' ' 18' ' ' LYS . 2.3 mm? -78.0 -25.98 48.29 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.291 -0.881 . . . . 0.0 109.456 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.4 ' ND2' ' HB3' ' A' ' 43' ' ' GLU . 31.3 m-80 -81.56 -12.4 58.8 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.586 -0.696 . . . . 0.0 109.682 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.91 -37.21 27.15 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 121.446 -0.784 . . . . 0.0 109.346 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -86.05 -22.55 27.15 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.64 15.71 51.76 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -95.68 145.03 25.6 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.534 -0.98 . . . . 0.0 110.388 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -110.15 89.39 3.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.517 -0.74 . . . . 0.0 109.557 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.433 ' HB2' HD11 ' A' ' 22' ' ' LEU . 7.6 ttm180 -111.77 -155.57 0.57 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.496 -0.752 . . . . 0.0 110.365 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -119.2 154.09 33.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.412 -0.805 . . . . 0.0 110.319 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.588 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 2.7 mp -129.65 121.49 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.495 -0.753 . . . . 0.0 110.18 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.515 ' CD ' HD11 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -99.89 153.44 19.16 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.321 -0.862 . . . . 0.0 111.23 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.586 HG23 ' H ' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -140.95 166.77 23.88 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.689 -0.632 . . . . 0.0 110.072 179.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.478 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 13.6 m-90 -144.89 43.16 1.34 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.639 -0.663 . . . . 0.0 110.508 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.26 -83.35 0.26 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.231 -0.918 . . . . 0.0 110.605 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -179.93 -63.68 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.422 -0.799 . . . . 0.0 110.155 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -101.89 35.94 2.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.466 -0.771 . . . . 0.0 109.616 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.2 m -42.16 113.22 0.41 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.442 0.639 . . . . 0.0 111.578 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.875 HG23 ' O ' ' A' ' 69' ' ' HIS . 26.2 m -107.12 159.35 16.39 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.818 -0.551 . . . . 0.0 109.554 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.665 HD11 ' HE1' ' A' ' 74' ' ' PHE . 1.1 mp -74.47 163.76 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.479 -0.763 . . . . 0.0 111.163 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.816 HG11 HD11 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -121.61 179.13 1.02 Allowed Pre-proline 0 N--CA 1.507 2.407 0 O-C-N 121.648 -0.658 . . . . 0.0 109.925 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.567 ' HD2' HG12 ' A' ' 41' ' ' VAL . 50.4 Cg_endo -71.44 -32.49 12.3 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 124.079 1.568 . . . . 0.0 111.346 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HB3' ' ND2' ' A' ' 23' ' ' ASN . 2.1 mm-40 -83.98 15.27 3.48 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.445 -0.785 . . . . 0.0 110.573 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.942 ' CG ' HG21 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -82.92 -15.7 50.33 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.636 -0.665 . . . . 0.0 112.125 -179.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.615 HG23 ' N ' ' A' ' 64' ' ' GLU . 2.4 p -58.31 6.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.41 29.26 1.07 Allowed Glycine 0 N--CA 1.491 2.335 0 O-C-N 119.917 -1.739 . . . . 0.0 110.056 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.539 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 25.4 m-70 -145.93 156.6 43.63 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.998 -1.295 . . . . 0.0 111.539 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -99.03 78.86 2.3 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 177.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.719 HD12 ' CD1' ' A' ' 62' ' ' ILE . 78.8 mt -78.18 116.79 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.526 -0.734 . . . . 0.0 111.516 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.773 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.85 85.92 5.45 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 51' ' ' VAL . 17.6 m -66.77 128.81 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.026 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.586 ' H ' HG23 ' A' ' 33' ' ' THR . 27.0 t80 -76.73 105.77 8.0 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.449 -0.782 . . . . 0.0 108.911 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -70.29 -0.85 8.82 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.679 -0.638 . . . . 0.0 110.679 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.9 -19.64 9.49 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -140.1 -28.68 0.73 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.933 -0.745 . . . . 0.0 110.898 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -134.68 155.2 50.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.187 -0.946 . . . . 0.0 111.977 -178.307 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.539 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -101.63 111.3 23.5 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.773 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 18.0 t -98.64 94.96 2.7 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.256 -0.902 . . . . 0.0 109.743 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 57' ' ' HIS . 43.6 Cg_endo -69.37 94.9 0.5 Allowed 'Trans proline' 0 N--CA 1.487 1.137 0 O-C-N 123.847 1.446 . . . . 0.0 109.531 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.656 HG11 ' CD2' ' A' ' 74' ' ' PHE . 48.6 t -111.93 127.89 68.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.062 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.539 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.9 t80 -72.19 102.34 3.03 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 176.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.942 HG21 ' CG ' ' A' ' 44' ' ' MET . 2.8 mp -65.54 -60.48 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -175.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 62' ' ' ILE . 4.9 m 71.71 172.17 0.31 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -176.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.615 ' N ' HG23 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -78.3 66.83 3.97 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.856 -1.152 . . . . 0.0 110.396 -179.06 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -169.54 -24.17 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.398 -0.814 . . . . 0.0 112.625 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.702 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 11.0 mtt -110.15 9.12 24.01 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.613 -1.304 . . . . 0.0 112.544 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.661 ' HB ' ' HE3' ' A' ' 44' ' ' MET . 14.2 p -89.33 166.49 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 O-C-N 120.583 -1.323 . . . . 0.0 112.652 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.523 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 105.17 -13.81 48.38 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.875 ' O ' HG23 ' A' ' 39' ' ' THR . 15.2 m-70 -113.43 -90.37 0.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 118.813 1.306 . . . . 0.0 110.478 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.755 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.86 -35.36 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 122.306 1.05 . . . . 0.0 109.106 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.645 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -178.67 -13.55 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.027 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.57 -15.64 80.44 Favored Glycine 0 N--CA 1.497 2.704 0 O-C-N 120.829 -1.17 . . . . 0.0 110.286 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.58 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 2.0 mm-40 -79.82 -21.39 44.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.385 -1.067 . . . . 0.0 108.567 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.702 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 5.9 m-85 -99.64 -21.96 15.63 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.533 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -133.88 58.32 31.18 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.65 -0.656 . . . . 0.0 110.56 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 44.7 Cg_endo -88.35 40.4 0.56 Allowed 'Trans proline' 0 C--N 1.318 -1.047 0 O-C-N 123.556 1.292 . . . . 0.0 110.402 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.9 t -176.63 40.98 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.248 0.547 . . . . 0.0 109.989 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -141.76 -59.34 0.47 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.23 -0.919 . . . . 0.0 110.488 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 56.5 m -123.86 145.84 48.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.474 -0.766 . . . . 0.0 110.336 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.0 t80 . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.448 -0.782 . . . . 0.0 110.135 179.95 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.441 ' HB ' ' CD ' ' A' ' 37' ' ' ARG . 78.1 t -109.43 -51.05 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.507 -0.996 . . . . 0.0 110.296 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.715 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -135.16 135.78 41.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.61 -0.681 . . . . 0.0 110.293 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.078 HG11 HG13 ' A' ' 41' ' ' VAL . 77.7 t -105.14 114.48 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.715 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 1.8 t0 -44.58 106.29 0.07 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.448 0.642 . . . . 0.0 111.805 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -67.65 -23.35 65.32 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.7 t60 -67.32 -35.7 79.98 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.873 -0.517 . . . . 0.0 109.908 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.735 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -75.32 -38.24 60.33 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.29 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.735 HD12 ' HG ' ' A' ' 15' ' ' LEU . 2.6 mp -58.78 -43.58 90.45 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.299 0.571 . . . . 0.0 109.639 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.506 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -55.03 -25.75 32.56 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.065 179.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.478 ' HB2' HG23 ' A' ' 31' ' ' ILE . 10.3 mmtm -97.12 -31.95 12.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.479 -0.763 . . . . 0.0 111.034 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.655 HG12 ' HA ' ' A' ' 16' ' ' LEU . 3.6 p -74.07 -38.03 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 120.997 -1.064 . . . . 0.0 111.271 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.506 HD21 ' HA ' ' A' ' 17' ' ' GLU . 3.6 pp -62.69 -25.03 67.95 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.75 -35.28 72.58 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 27' ' ' GLU . 3.4 mm? -72.33 -27.49 62.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.623 -0.673 . . . . 0.0 109.585 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -83.17 -16.13 47.85 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.588 -0.695 . . . . 0.0 109.792 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.8 -36.99 23.12 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 121.577 -0.702 . . . . 0.0 109.57 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -88.03 -21.07 24.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.674 -0.641 . . . . 0.0 109.35 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.01 17.26 59.7 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.494 ' O ' HD12 ' A' ' 22' ' ' LEU . 21.7 mm-40 -93.28 149.15 21.44 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.38 -1.071 . . . . 0.0 110.593 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -110.74 96.57 6.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.549 -0.72 . . . . 0.0 109.756 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.446 ' HB2' HD11 ' A' ' 22' ' ' LEU . 1.8 ttt85 -126.73 -155.53 0.69 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.532 -0.73 . . . . 0.0 110.353 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -116.99 155.79 28.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.5 -0.75 . . . . 0.0 110.469 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.652 HD13 HG23 ' A' ' 19' ' ' VAL . 3.2 mp -132.05 112.98 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.614 -0.679 . . . . 0.0 109.536 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.13 148.35 26.38 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.386 -0.821 . . . . 0.0 110.897 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 52' ' ' TYR . 14.3 t -141.09 174.87 10.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.679 -0.638 . . . . 0.0 110.171 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.501 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 10.0 m-90 -143.8 47.13 1.45 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.145 -0.972 . . . . 0.0 111.666 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 t -88.96 -84.25 0.21 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.718 -1.239 . . . . 0.0 111.077 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -162.54 -88.83 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.02 -1.05 . . . . 0.0 111.36 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.539 ' HD2' ' HB3' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -97.4 52.83 1.13 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.209 -0.932 . . . . 0.0 109.975 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.525 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 0.4 OUTLIER -39.11 138.12 0.63 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.264 0.554 . . . . 0.0 112.363 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.825 HG23 ' O ' ' A' ' 69' ' ' HIS . 24.4 m -129.2 159.21 36.76 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.529 -0.732 . . . . 0.0 110.133 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.875 HG23 ' SD ' ' A' ' 44' ' ' MET . 1.2 mp -78.99 159.55 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 121.541 -0.725 . . . . 0.0 111.604 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.078 HG13 HG11 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -133.64 171.23 9.46 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 42.6 Cg_endo -67.16 -31.79 35.42 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.133 1.596 . . . . 0.0 110.493 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HG3' HG11 ' A' ' 19' ' ' VAL . 6.5 pt-20 -75.24 -1.97 25.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.53 -0.731 . . . . 0.0 111.025 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.906 ' SD ' HD13 ' A' ' 62' ' ' ILE . 1.4 ptp -114.98 16.7 17.11 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.897 -1.127 . . . . 0.0 110.886 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.615 HG13 ' CA ' ' A' ' 64' ' ' GLU . 2.6 t -68.27 6.5 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.358 -0.839 . . . . 0.0 112.782 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.77 35.79 0.92 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.539 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 54.2 m-70 -140.24 159.2 42.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.501 -0.999 . . . . 0.0 110.488 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.644 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.08 82.47 2.73 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 178.382 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.602 ' CG2' HD13 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -83.51 115.82 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.495 -0.753 . . . . 0.0 111.55 -176.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.767 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -77.99 81.6 4.38 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.561 HG22 HG23 ' A' ' 58' ' ' VAL . 33.0 m -66.19 132.66 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.581 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.501 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 23.8 t80 -72.44 104.35 3.77 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -70.7 -0.23 8.39 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.51 -0.744 . . . . 0.0 110.488 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.6 -21.79 8.43 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.12 -30.0 0.69 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 122.009 -0.701 . . . . 0.0 110.633 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.409 ' CG ' HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -133.89 156.47 48.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.309 -0.869 . . . . 0.0 111.737 -178.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.451 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -102.41 101.74 12.0 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.178 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.767 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 14.6 m -91.39 105.56 13.26 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.152 -0.967 . . . . 0.0 110.335 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.505 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 43.0 Cg_endo -68.7 88.88 0.42 Allowed 'Trans proline' 0 N--CA 1.49 1.276 0 O-C-N 123.91 1.479 . . . . 0.0 109.163 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 58' ' ' VAL . 58.2 t -98.18 119.17 45.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.485 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.644 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.3 t80 -70.97 101.54 2.2 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 118.85 -1.14 . . . . 0.0 107.95 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.906 HD13 ' SD ' ' A' ' 44' ' ' MET . 3.2 mp -80.75 138.34 19.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.638 -0.664 . . . . 0.0 110.566 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.445 ' C ' HG13 ' A' ' 45' ' ' VAL . 60.8 p -98.71 -161.23 0.86 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 177.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.615 ' CA ' HG13 ' A' ' 45' ' ' VAL . 0.6 OUTLIER -85.29 5.79 28.98 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.823 -1.173 . . . . 0.0 111.081 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -128.57 -11.53 5.0 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.739 -1.226 . . . . 0.0 113.053 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.691 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 9.0 mtt -88.37 -5.59 58.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.519 -1.363 . . . . 0.0 110.618 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 68' ' ' GLY . 9.0 p -81.79 165.19 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.073 -1.017 . . . . 0.0 111.535 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.498 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 109.05 -18.16 31.4 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.825 ' O ' HG23 ' A' ' 39' ' ' THR . 16.5 m-70 -115.89 -86.14 0.62 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -1.204 . . . . 0.0 110.695 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.37 -35.09 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 122.215 1.007 . . . . 0.0 109.291 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.602 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 0.5 OUTLIER 179.63 -16.08 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.864 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.78 -15.1 73.43 Favored Glycine 0 N--CA 1.497 2.715 0 O-C-N 120.889 -1.132 . . . . 0.0 110.458 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.625 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 1.6 mm-40 -81.45 -17.78 47.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.362 -1.081 . . . . 0.0 108.805 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.691 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 9.2 m-85 -97.03 -20.23 18.19 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.578 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -134.24 54.11 11.31 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.764 -0.585 . . . . 0.0 109.94 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.578 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 48.9 Cg_endo -85.13 50.12 2.73 Favored 'Trans proline' 0 C--N 1.32 -0.962 0 O-C-N 123.476 1.25 . . . . 0.0 110.375 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.7 m -92.91 83.48 4.76 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.55 -0.719 . . . . 0.0 110.052 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.49 ' O ' HG22 ' A' ' 79' ' ' THR . 11.1 mtp-105 50.57 73.77 0.26 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.743 -0.598 . . . . 0.0 110.473 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 78' ' ' ARG . 14.7 t 39.04 44.19 0.88 Allowed 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 121.374 0.607 . . . . 0.0 111.592 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.325 -0.859 . . . . 0.0 110.189 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.4 t -88.74 126.39 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.511 -0.994 . . . . 0.0 109.961 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -134.23 149.8 51.0 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.657 -0.652 . . . . 0.0 109.964 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.0 t -110.22 124.19 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.951 ' OD1' HD23 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -45.1 107.14 0.09 Allowed 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.375 0.607 . . . . 0.0 111.427 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.78 -27.02 64.57 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.827 ' CB ' HG23 ' A' ' 33' ' ' THR . 1.0 OUTLIER -68.78 -15.81 63.62 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.943 -0.473 . . . . 0.0 110.171 178.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.088 HD11 ' SD ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -84.36 -39.08 19.52 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.466 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.84 ' HA ' HG12 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -69.07 -43.79 73.9 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.605 -0.685 . . . . 0.0 110.714 179.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.443 ' HG2' ' HA ' ' A' ' 14' ' ' HIS . 5.8 pt-20 -53.93 -19.39 4.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.446 -0.784 . . . . 0.0 110.885 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.563 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.1 mtmt -112.49 -33.6 6.11 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.261 -0.9 . . . . 0.0 111.134 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.885 HG21 ' SD ' ' A' ' 44' ' ' MET . 1.1 p -73.73 -39.69 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.081 -1.012 . . . . 0.0 111.591 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.457 HD11 ' HB3' ' A' ' 16' ' ' LEU . 18.1 mt -60.11 -37.88 81.33 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.07 -40.24 92.92 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.593 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.689 HD23 ' CB ' ' A' ' 27' ' ' GLU . 1.1 mt -71.92 -26.63 62.38 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.272 -0.892 . . . . 0.0 110.289 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -80.66 -10.75 59.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.558 -0.714 . . . . 0.0 109.636 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.98 -35.62 15.43 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.482 -0.761 . . . . 0.0 110.172 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.478 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -102.39 -25.89 13.48 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.547 -0.721 . . . . 0.0 109.793 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.55 29.49 12.06 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.689 ' CB ' HD23 ' A' ' 22' ' ' LEU . 5.0 mm-40 -80.14 149.37 30.58 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.446 -1.032 . . . . 0.0 110.351 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -111.8 86.0 2.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.579 -0.701 . . . . 0.0 109.953 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -136.34 -160.13 1.02 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.484 -0.76 . . . . 0.0 110.53 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.543 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -119.52 156.69 29.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.649 -0.657 . . . . 0.0 110.206 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.659 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 2.7 mp -124.79 123.39 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.37 -0.831 . . . . 0.0 109.75 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.505 ' HE3' HD11 ' A' ' 30' ' ' LEU . 1.1 mptt -98.28 151.15 20.79 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.246 -0.909 . . . . 0.0 111.137 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.949 HG21 ' HB2' ' A' ' 12' ' ' ASP . 18.4 m -136.15 162.47 32.86 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.652 -0.655 . . . . 0.0 109.584 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.428 ' CD1' ' NE2' ' A' ' 57' ' ' HIS . 27.9 m-90 -141.44 38.36 1.7 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.279 -0.888 . . . . 0.0 110.768 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.7 m -82.82 -101.23 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.208 -0.932 . . . . 0.0 110.566 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.43 -68.69 0.12 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.041 -1.037 . . . . 0.0 109.756 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.509 ' HG2' ' HD1' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -106.48 50.76 0.76 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.777 0.799 . . . . 0.0 108.857 178.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.445 ' OG ' ' HB3' ' A' ' 12' ' ' ASP . 22.4 m -47.86 111.01 0.37 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.302 0.572 . . . . 0.0 111.905 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 69' ' ' HIS . 28.7 m -105.43 155.84 18.76 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.693 -0.63 . . . . 0.0 109.597 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.746 HG21 HG21 ' A' ' 62' ' ' ILE . 4.4 mp -77.82 167.87 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.145 -0.972 . . . . 0.0 111.297 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.77 HG12 ' HD2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -137.5 176.73 2.53 Favored Pre-proline 0 N--CA 1.501 2.081 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.142 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.77 ' HD2' HG12 ' A' ' 41' ' ' VAL . 45.1 Cg_endo -68.42 -35.18 18.66 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.889 1.468 . . . . 0.0 111.335 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.52 ' HB2' ' CE ' ' A' ' 44' ' ' MET . 0.8 OUTLIER -66.0 -9.93 34.82 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.461 -0.775 . . . . 0.0 110.677 179.099 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 1.088 ' SD ' HD11 ' A' ' 15' ' ' LEU . 4.0 mmt -88.14 0.93 55.44 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.348 -0.845 . . . . 0.0 111.323 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.476 HG23 ' N ' ' A' ' 64' ' ' GLU . 5.6 p -54.98 -2.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.18 34.66 1.19 Allowed Glycine 0 N--CA 1.492 2.426 0 O-C-N 120.43 -1.419 . . . . 0.0 109.605 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.532 ' HB2' HD11 ' A' ' 49' ' ' ILE . 56.1 m-70 -142.54 150.94 41.09 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.304 -1.115 . . . . 0.0 111.127 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.733 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.75 81.41 2.46 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.15 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.009 HG12 HD13 ' A' ' 15' ' ' LEU . 3.0 mt -85.54 121.88 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 111.654 -176.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.76 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.85 82.48 5.05 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 122.102 0.953 . . . . 0.0 108.888 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 51' ' ' VAL . 33.2 m -63.0 127.52 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.542 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 33' ' ' THR . 20.2 t80 -71.71 104.29 3.33 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -70.68 -1.43 11.32 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.557 -0.715 . . . . 0.0 110.553 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.29 -21.05 8.84 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -140.18 -29.75 0.69 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.882 -0.775 . . . . 0.0 110.82 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.41 155.67 49.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.332 -0.855 . . . . 0.0 111.928 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.432 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 6.0 m80 -102.51 103.99 14.38 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.76 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 28.7 t -93.55 102.78 8.28 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.3 -0.875 . . . . 0.0 110.106 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.501 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.5 Cg_endo -66.59 89.32 0.28 Allowed 'Trans proline' 0 N--CA 1.492 1.404 0 O-C-N 123.878 1.462 . . . . 0.0 109.195 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 58' ' ' VAL . 48.1 t -97.57 118.68 44.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.201 -178.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.733 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.6 t80 -73.19 103.9 4.06 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.91 HD13 ' HB3' ' A' ' 44' ' ' MET . 2.7 mp -84.45 144.82 9.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.675 0.75 . . . . 0.0 111.64 -178.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.9 p -111.03 -158.71 0.65 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.476 ' N ' HG23 ' A' ' 45' ' ' VAL . 3.5 tp10 -90.59 15.14 11.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.588 -1.32 . . . . 0.0 110.997 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -137.95 -13.47 1.43 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.919 -1.113 . . . . 0.0 112.527 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.682 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 28.3 mmt -88.04 -24.97 23.32 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.605 -1.309 . . . . 0.0 110.327 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.591 HG21 ' C ' ' A' ' 41' ' ' VAL . 4.2 p -66.61 163.45 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.388 -0.82 . . . . 0.0 111.437 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.499 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 118.17 -14.79 12.23 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.113 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.782 ' O ' HG23 ' A' ' 39' ' ' THR . 21.5 m-70 -127.21 -81.14 0.6 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.965 -1.315 . . . . 0.0 111.497 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.606 ' HD3' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER 177.42 -31.97 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.717 0.77 . . . . 0.0 110.268 -179.264 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.606 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.7 OUTLIER 173.82 -16.0 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.757 -179.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.53 -18.02 73.29 Favored Glycine 0 N--CA 1.496 2.639 0 O-C-N 120.946 -1.096 . . . . 0.0 110.503 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.65 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 1.3 mt-10 -84.62 -20.07 31.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.407 -1.054 . . . . 0.0 109.124 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.682 ' CD2' ' HB3' ' A' ' 66' ' ' MET . 20.8 m-85 -92.6 -20.52 20.8 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.587 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -134.73 54.49 11.59 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.747 -0.596 . . . . 0.0 109.719 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.587 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 48.7 Cg_endo -85.01 50.77 2.95 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.615 1.324 . . . . 0.0 110.337 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.1 m -72.12 127.37 32.34 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.633 -0.667 . . . . 0.0 110.101 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.0 ptt-85 -75.57 148.57 38.76 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.542 -0.724 . . . . 0.0 110.536 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.2 m -139.61 104.87 5.03 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.52 -0.738 . . . . 0.0 109.99 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.065 0 O-C-N 121.782 -0.573 . . . . 0.0 110.695 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.6 t -113.05 106.89 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.445 -1.032 . . . . 0.0 109.969 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.767 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -119.61 144.06 47.32 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.526 -0.734 . . . . 0.0 109.543 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.561 HG22 ' HB ' ' A' ' 39' ' ' THR . 69.4 t -101.83 112.05 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.767 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 39.0 t70 -44.68 106.52 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.145 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -67.87 -24.2 65.21 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -66.22 -25.61 66.99 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.942 -0.474 . . . . 0.0 109.91 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.89 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -79.76 -38.16 33.81 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.89 HD12 ' HG ' ' A' ' 15' ' ' LEU . 5.0 mp -62.58 -42.3 99.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.796 -0.565 . . . . 0.0 109.923 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.66 -30.76 22.98 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.136 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.77 -27.99 17.67 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.464 -0.772 . . . . 0.0 110.602 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.908 HG21 ' SD ' ' A' ' 44' ' ' MET . 93.9 t -73.62 -40.16 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.15 -0.969 . . . . 0.0 111.186 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 16' ' ' LEU . 10.9 mt -60.93 -36.43 79.29 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.18 -36.09 83.12 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.051 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.449 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 2.9 mm? -77.63 -26.57 50.65 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.258 -0.901 . . . . 0.0 109.666 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -81.96 -12.48 58.34 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.623 -0.673 . . . . 0.0 109.757 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.59 -34.53 27.65 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.417 -0.802 . . . . 0.0 109.512 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 16.3 mmtt -93.11 -15.87 25.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.773 -0.579 . . . . 0.0 109.8 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.21 28.99 34.97 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' O ' HD12 ' A' ' 22' ' ' LEU . 28.3 mt-10 -106.48 148.74 27.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.649 -0.912 . . . . 0.0 110.705 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 mtmm -113.36 90.81 3.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.586 -0.696 . . . . 0.0 109.97 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.412 ' HB2' HD11 ' A' ' 22' ' ' LEU . 3.9 ttt-85 -113.5 -158.32 0.65 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.459 -0.776 . . . . 0.0 110.305 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.634 HD11 ' HD3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -116.19 148.39 40.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.574 -0.704 . . . . 0.0 110.274 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.749 HD13 HG22 ' A' ' 19' ' ' VAL . 3.2 mp -121.83 118.75 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.594 -0.691 . . . . 0.0 109.552 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.634 ' HD3' HD11 ' A' ' 30' ' ' LEU . 20.5 mmmt -78.9 152.93 30.89 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.453 -0.779 . . . . 0.0 111.029 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.67 HG23 ' CG ' ' A' ' 12' ' ' ASP . 24.1 m -139.69 153.16 47.18 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.589 -0.694 . . . . 0.0 109.778 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.463 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 9.7 m-90 -145.3 36.44 1.1 Allowed 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.22 -0.925 . . . . 0.0 111.6 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 m -86.86 -95.97 0.08 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.764 -1.21 . . . . 0.0 110.361 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.413 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -173.99 -63.02 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.191 -0.943 . . . . 0.0 109.464 179.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.43 ' HG3' ' HB3' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -102.24 36.85 2.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.591 -0.693 . . . . 0.0 109.212 178.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.414 ' OG ' HG21 ' A' ' 33' ' ' THR . 4.2 m -48.29 144.48 3.91 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.515 0.674 . . . . 0.0 111.77 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.818 HG23 ' O ' ' A' ' 69' ' ' HIS . 52.3 m -133.81 160.19 38.36 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.273 0.558 . . . . 0.0 109.678 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.778 ' CG2' HG12 ' A' ' 62' ' ' ILE . 1.2 mp -83.41 164.78 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.632 -0.668 . . . . 0.0 111.846 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.877 HG21 HD11 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -134.15 174.21 4.92 Favored Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.787 -0.57 . . . . 0.0 109.466 178.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.749 ' HD2' HG12 ' A' ' 41' ' ' VAL . 46.0 Cg_endo -68.92 -34.65 17.07 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 124.0 1.526 . . . . 0.0 111.581 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.42 -6.54 25.26 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.408 -0.808 . . . . 0.0 110.742 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.908 ' SD ' HG21 ' A' ' 19' ' ' VAL . 6.6 mmt -86.31 -6.29 58.99 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.365 -0.835 . . . . 0.0 111.658 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.646 HG23 ' N ' ' A' ' 64' ' ' GLU . 6.0 p -51.51 1.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.406 ' C ' ' CG ' ' A' ' 47' ' ' HIS . . . -146.27 33.19 1.48 Allowed Glycine 0 N--CA 1.495 2.575 0 O-C-N 119.93 -1.731 . . . . 0.0 110.071 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.459 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 21.8 m-70 -147.66 153.98 40.03 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.106 -1.232 . . . . 0.0 111.181 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.64 88.76 3.92 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.826 HD12 HD13 ' A' ' 62' ' ' ILE . 22.9 mt -86.24 121.94 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.565 -176.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.776 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.16 78.05 5.64 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 51' ' ' VAL . 23.3 m -62.39 128.67 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.643 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 35.3 t80 -75.67 105.48 6.73 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -76.08 8.35 3.31 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.368 -0.833 . . . . 0.0 111.221 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 36' ' ' ARG . . . 122.71 -27.11 6.06 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.49 -24.03 0.79 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.819 -0.812 . . . . 0.0 111.596 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -135.76 154.17 51.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.019 -1.051 . . . . 0.0 112.411 -177.655 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.472 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -100.19 105.2 16.77 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.776 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 23.4 t -94.1 101.26 6.04 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.146 -0.971 . . . . 0.0 109.935 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.538 ' HB3' HD12 ' A' ' 30' ' ' LEU . 41.8 Cg_endo -67.72 93.08 0.37 Allowed 'Trans proline' 0 N--CA 1.489 1.25 0 O-C-N 123.955 1.503 . . . . 0.0 109.697 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.629 ' O ' HD12 ' A' ' 62' ' ' ILE . 16.4 m -109.38 129.07 64.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.829 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.8 t80 -71.35 105.8 3.64 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.826 HD13 HD12 ' A' ' 49' ' ' ILE . 1.6 mp -57.97 -63.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.476 ' O ' HG22 ' A' ' 62' ' ' ILE . 3.0 m 66.3 171.33 0.24 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -176.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.646 ' N ' HG23 ' A' ' 45' ' ' VAL . 2.8 tp10 -83.84 58.58 4.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.372 -1.455 . . . . 0.0 109.26 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -161.25 -36.86 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.306 -0.871 . . . . 0.0 112.181 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.612 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -88.24 -15.98 34.46 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.87 -1.144 . . . . 0.0 111.146 -179.087 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.513 HG21 ' C ' ' A' ' 41' ' ' VAL . 7.5 p -73.66 161.73 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.099 -1.0 . . . . 0.0 112.138 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.48 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 113.56 -19.3 19.39 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.818 ' O ' HG23 ' A' ' 39' ' ' THR . 17.0 m-70 -114.9 -84.44 0.61 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.077 -1.249 . . . . 0.0 110.483 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.732 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.19 -34.67 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 122.042 0.925 . . . . 0.0 109.846 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.564 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 0.5 OUTLIER 176.88 -14.26 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.856 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 80' ' ' TYR . . . -70.41 -15.58 72.89 Favored Glycine 0 N--CA 1.496 2.668 0 O-C-N 120.9 -1.125 . . . . 0.0 110.313 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.626 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 1.1 mt-10 -84.18 -13.56 52.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.336 -1.097 . . . . 0.0 109.037 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.653 ' HE2' ' HA ' ' A' ' 62' ' ' ILE . 4.5 m-85 -102.65 -20.17 14.52 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.58 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -135.1 52.54 7.46 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.759 -0.588 . . . . 0.0 110.263 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.58 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 48.6 Cg_endo -82.62 51.28 3.67 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 O-C-N 123.511 1.269 . . . . 0.0 110.318 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.1 t -89.58 -28.05 19.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.511 -0.743 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.0 ttm105 -136.9 68.69 1.42 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.406 -0.808 . . . . 0.0 110.089 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.1 m 52.86 67.92 0.92 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.686 -0.634 . . . . 0.0 110.2 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.532 ' CE1' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.477 -0.765 . . . . 0.0 110.206 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.5 m -94.35 170.81 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.567 -0.961 . . . . 0.0 110.572 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.724 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -131.98 145.48 51.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.505 -0.747 . . . . 0.0 109.888 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.823 HG21 HG13 ' A' ' 41' ' ' VAL . 7.2 p -108.8 113.98 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.776 ' CG ' HG23 ' A' ' 33' ' ' THR . 38.8 t70 -41.96 109.23 0.12 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.716 -0.615 . . . . 0.0 111.682 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -68.52 -24.57 64.67 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.601 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 1.7 t-80 -65.57 -20.64 66.41 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.908 -0.495 . . . . 0.0 110.3 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.954 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -85.32 -38.43 18.81 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.133 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.954 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.7 mp -63.82 -43.13 97.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.83 -0.544 . . . . 0.0 110.26 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.601 ' HG2' ' HA ' ' A' ' 14' ' ' HIS . 0.6 OUTLIER -57.31 -19.15 20.39 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.756 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.423 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 42.0 mttm -102.56 -29.02 11.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.356 -0.84 . . . . 0.0 110.657 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.004 HG21 ' SD ' ' A' ' 44' ' ' MET . 1.7 p -79.55 -36.21 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.154 -0.966 . . . . 0.0 111.479 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.555 HD21 ' HA ' ' A' ' 17' ' ' GLU . 3.8 pp -62.82 -25.66 68.36 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -34.34 63.36 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.707 HD22 ' HB2' ' A' ' 27' ' ' GLU . 1.2 mt -76.27 -27.43 56.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.796 -0.565 . . . . 0.0 109.567 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -84.16 -13.82 51.83 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.613 -0.679 . . . . 0.0 109.676 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.51 -37.94 15.35 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 121.55 -0.718 . . . . 0.0 109.955 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -97.01 -23.97 16.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.575 -0.703 . . . . 0.0 109.654 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.44 25.89 19.71 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.707 ' HB2' HD22 ' A' ' 22' ' ' LEU . 24.9 mt-10 -72.18 125.58 27.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.471 -1.017 . . . . 0.0 110.258 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.18 94.88 9.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.552 -0.717 . . . . 0.0 110.225 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.1 ttp85 -149.59 -160.93 1.24 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.519 -0.738 . . . . 0.0 110.312 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.635 ' HB2' ' HB ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -119.71 165.07 15.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.585 -0.697 . . . . 0.0 110.455 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.757 HG21 HD12 ' A' ' 15' ' ' LEU . 36.3 mm -112.57 159.92 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.321 -0.862 . . . . 0.0 109.026 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.502 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -125.5 153.41 43.61 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.288 -0.883 . . . . 0.0 110.839 -178.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.776 HG23 ' CG ' ' A' ' 12' ' ' ASP . 20.0 m -139.84 154.17 47.25 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.588 -0.695 . . . . 0.0 110.712 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.502 ' CH2' ' HB2' ' A' ' 32' ' ' LYS . 16.6 m-90 -146.49 34.19 0.96 Allowed 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.433 -0.792 . . . . 0.0 111.224 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.69 -93.56 0.11 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.864 -1.148 . . . . 0.0 110.989 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.414 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . 13.5 ttp85 -170.02 -66.49 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.194 -0.941 . . . . 0.0 109.287 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.554 ' HD2' ' HB3' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -104.43 44.0 1.06 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.247 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.541 ' CB ' HG21 ' A' ' 33' ' ' THR . 19.5 m -56.21 153.08 9.86 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.555 0.693 . . . . 0.0 112.317 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.724 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 40.9 m -140.38 162.21 35.86 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.878 -0.514 . . . . 0.0 110.055 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.716 HG21 HG12 ' A' ' 62' ' ' ILE . 4.8 mp -81.81 170.29 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 O-C-N 121.291 -0.881 . . . . 0.0 111.094 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.823 HG13 HG21 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -132.1 175.2 3.88 Favored Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.744 -0.597 . . . . 0.0 109.74 179.073 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.741 ' O ' HG23 ' A' ' 45' ' ' VAL . 47.0 Cg_endo -70.17 -32.7 16.37 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 124.096 1.577 . . . . 0.0 111.539 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.723 ' HG3' HG11 ' A' ' 19' ' ' VAL . 2.0 pt-20 -72.33 -3.43 23.81 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.275 -0.891 . . . . 0.0 110.957 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 1.004 ' SD ' HG21 ' A' ' 19' ' ' VAL . 23.5 mmm -91.1 15.65 11.27 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.296 -0.878 . . . . 0.0 112.231 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 42' ' ' PRO . 66.0 t -64.73 4.49 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 O-C-N 120.947 -1.096 . . . . 0.0 113.129 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.35 29.84 1.07 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.438 ' HB2' ' CE ' ' A' ' 44' ' ' MET . 20.0 m-70 -139.09 150.71 46.03 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.377 -1.072 . . . . 0.0 110.701 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.635 ' HB ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.65 86.31 3.31 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.139 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.791 HD11 ' CG ' ' A' ' 44' ' ' MET . 58.3 mt -72.53 117.79 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.17 -0.956 . . . . 0.0 111.298 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.675 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.91 73.99 6.66 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.613 HG21 ' HB3' ' A' ' 71' ' ' LEU . 34.2 m -56.27 126.29 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.305 -177.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.522 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 29.0 t80 -76.93 101.99 6.19 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -74.55 9.97 1.54 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.485 -0.76 . . . . 0.0 111.065 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 36' ' ' ARG . . . 121.67 -27.86 6.12 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.75 -25.85 0.75 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.837 -0.802 . . . . 0.0 111.602 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.522 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -130.74 153.89 48.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.149 -0.969 . . . . 0.0 112.377 -177.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.521 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 2.3 m80 -99.74 99.19 9.98 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.675 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 46.5 t -86.57 104.73 6.22 Favored Pre-proline 0 N--CA 1.501 2.102 0 O-C-N 121.215 -0.928 . . . . 0.0 109.505 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 57' ' ' HIS . 42.7 Cg_endo -67.08 90.68 0.31 Allowed 'Trans proline' 0 N--CA 1.489 1.258 0 O-C-N 123.892 1.47 . . . . 0.0 110.251 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 60' ' ' VAL . 35.6 m -95.83 111.36 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.39 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.582 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.2 t80 -72.59 104.46 3.88 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.015 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.716 HG12 HG21 ' A' ' 40' ' ' ILE . 2.7 mp -85.59 127.98 39.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.578 -0.701 . . . . 0.0 111.324 -178.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.508 ' C ' HG13 ' A' ' 45' ' ' VAL . 46.3 p -92.71 -153.28 0.34 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.565 ' N ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -87.97 8.0 28.44 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.711 -1.243 . . . . 0.0 111.196 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -147.64 21.11 1.16 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.959 -1.088 . . . . 0.0 111.775 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.725 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 7.8 mmt -107.61 -26.51 10.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.235 -0.916 . . . . 0.0 109.804 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.565 ' HB ' HG21 ' A' ' 62' ' ' ILE . 6.8 p -65.36 163.7 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 121.469 -0.769 . . . . 0.0 111.691 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.487 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 122.42 -10.2 9.28 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.397 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.717 ' O ' HG23 ' A' ' 39' ' ' THR . 17.4 m-70 -123.82 -86.26 0.64 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.128 1.464 . . . . 0.0 110.983 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.724 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.31 -30.29 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.556 0.693 . . . . 0.0 110.308 -179.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.629 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.8 OUTLIER 174.27 -15.21 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.769 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.65 -18.46 78.65 Favored Glycine 0 N--CA 1.495 2.606 0 O-C-N 120.929 -1.107 . . . . 0.0 110.633 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.698 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 22.2 mm-40 -84.25 -18.64 35.8 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.22 -1.165 . . . . 0.0 109.349 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.725 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 3.7 m-85 -105.4 -16.58 14.7 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.596 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -136.45 54.2 8.9 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.639 -0.663 . . . . 0.0 109.75 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.596 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 46.5 Cg_endo -84.52 51.34 3.23 Favored 'Trans proline' 0 C--N 1.32 -0.925 0 O-C-N 123.629 1.331 . . . . 0.0 110.382 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.8 m -66.4 -44.95 81.58 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.612 -0.68 . . . . 0.0 110.255 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.68 138.79 39.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.661 -0.649 . . . . 0.0 110.202 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 86.8 m -82.77 104.64 13.16 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.443 -0.786 . . . . 0.0 110.062 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.049 0 O-C-N 121.744 -0.597 . . . . 0.0 110.665 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.7 p -80.9 151.23 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.558 -0.966 . . . . 0.0 110.387 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.734 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -129.11 134.79 48.22 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.471 -0.768 . . . . 0.0 110.075 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.967 HG21 HG13 ' A' ' 41' ' ' VAL . 7.5 p -101.83 115.68 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 178.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.734 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 27.8 t70 -46.34 107.06 0.09 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.476 0.655 . . . . 0.0 111.303 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -69.6 -24.48 63.67 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -64.67 -28.45 69.61 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.809 -0.557 . . . . 0.0 109.841 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.844 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -77.25 -37.72 52.53 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.844 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.1 mp -60.47 -47.29 86.78 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.171 0.51 . . . . 0.0 109.736 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.1 -23.06 4.79 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.648 -0.657 . . . . 0.0 110.722 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.28 -25.27 12.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.331 -0.855 . . . . 0.0 110.679 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -79.81 -36.14 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.268 -0.895 . . . . 0.0 110.841 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 16' ' ' LEU . 9.2 mt -63.74 -36.53 84.17 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 178.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.93 -34.35 75.93 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.566 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.575 ' HG ' ' HB3' ' A' ' 27' ' ' GLU . 1.5 mp -79.0 -27.1 43.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.543 -0.723 . . . . 0.0 109.578 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -84.33 -11.22 56.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.567 -0.708 . . . . 0.0 109.408 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.73 -41.37 11.94 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.619 -0.676 . . . . 0.0 110.396 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.448 ' HG3' ' N ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -99.44 -27.06 13.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.371 -0.831 . . . . 0.0 110.076 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.448 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . 105.24 27.51 5.84 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.575 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -79.49 135.85 36.75 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.397 -1.06 . . . . 0.0 110.268 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -114.14 61.84 0.66 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.626 -0.671 . . . . 0.0 109.508 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -109.33 -154.8 0.54 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.504 -0.747 . . . . 0.0 110.187 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -117.59 156.43 28.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.453 -0.78 . . . . 0.0 110.637 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.515 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 3.5 mt -127.71 114.5 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HD3' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -110.44 153.04 25.56 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.293 -0.879 . . . . 0.0 111.203 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.52 HG21 ' CG ' ' A' ' 12' ' ' ASP . 15.3 t -144.75 -173.39 4.05 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.473 -0.767 . . . . 0.0 111.067 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.662 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 19.4 m-90 -139.68 39.33 2.02 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.182 -0.949 . . . . 0.0 111.633 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.01 -99.35 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.726 -1.234 . . . . 0.0 110.402 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.31 -62.41 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.935 -1.103 . . . . 0.0 109.684 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.436 ' HG2' ' HD2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -106.19 38.35 2.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.541 -0.724 . . . . 0.0 109.242 178.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.524 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 1.1 m -41.5 114.97 0.57 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.335 0.588 . . . . 0.0 111.616 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.826 HG23 ' O ' ' A' ' 69' ' ' HIS . 25.9 m -106.71 161.94 14.21 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.536 -0.728 . . . . 0.0 110.436 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.87 HG21 HG21 ' A' ' 62' ' ' ILE . 1.2 mp -83.91 168.06 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.472 -0.767 . . . . 0.0 111.904 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.967 HG13 HG21 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -140.2 174.01 4.44 Favored Pre-proline 0 N--CA 1.501 2.109 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.513 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 42.3 Cg_endo -66.03 -30.61 47.52 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.923 1.486 . . . . 0.0 110.823 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.504 ' OE1' HD23 ' A' ' 20' ' ' LEU . 5.5 mm-40 -73.51 -4.68 35.37 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.584 -0.698 . . . . 0.0 110.948 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.681 ' HG2' HD13 ' A' ' 49' ' ' ILE . 51.4 mtp -97.27 2.53 50.91 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.115 -0.991 . . . . 0.0 111.033 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.625 HG23 ' N ' ' A' ' 64' ' ' GLU . 7.6 p -59.97 3.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.09 33.49 1.03 Allowed Glycine 0 N--CA 1.493 2.476 0 O-C-N 120.208 -1.558 . . . . 0.0 110.144 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.859 ' HB2' HD11 ' A' ' 49' ' ' ILE . 38.0 m-70 -145.51 156.34 43.65 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.219 -1.165 . . . . 0.0 111.048 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.682 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.87 86.25 3.25 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.514 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.859 HD11 ' HB2' ' A' ' 47' ' ' HIS . 3.1 mp -91.87 117.84 36.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.18 -0.95 . . . . 0.0 111.556 -177.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.788 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.21 89.16 4.88 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 122.162 0.982 . . . . 0.0 109.311 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.524 ' HB ' ' HB3' ' A' ' 38' ' ' SER . 26.2 m -66.39 127.43 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.131 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.662 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 26.1 t80 -70.01 108.49 4.07 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.174 -1.011 . . . . 0.0 108.911 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -75.92 16.57 0.4 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.666 -0.646 . . . . 0.0 110.322 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.93 -28.87 13.01 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -140.56 -26.76 0.74 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.528 -0.983 . . . . 0.0 111.14 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -127.74 156.52 42.29 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.697 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 76.8 m-70 -95.51 120.01 35.01 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.788 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 16.9 t -109.43 85.32 3.55 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.162 -0.961 . . . . 0.0 109.194 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.544 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.6 Cg_endo -67.6 85.57 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.348 0 O-C-N 123.852 1.448 . . . . 0.0 109.312 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.696 ' CG2' HG12 ' A' ' 58' ' ' VAL . 50.5 t -99.46 123.12 51.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.844 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.682 ' HB2' HG23 ' A' ' 48' ' ' THR . 4.1 t80 -72.53 102.28 3.2 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.87 HG21 HG21 ' A' ' 40' ' ' ILE . 3.0 mp -80.87 140.76 16.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.843 0.83 . . . . 0.0 111.769 -177.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.573 ' C ' HG23 ' A' ' 45' ' ' VAL . 69.5 p -105.51 -158.83 0.68 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.625 ' N ' HG23 ' A' ' 45' ' ' VAL . 4.2 tp10 -90.55 7.43 39.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.708 -1.245 . . . . 0.0 111.244 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.445 ' ND2' ' HG3' ' A' ' 66' ' ' MET . 2.4 p-10 -127.33 -17.82 4.62 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.723 -1.235 . . . . 0.0 112.625 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.634 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 26.3 mtt -86.1 -17.95 33.69 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.625 -1.297 . . . . 0.0 110.399 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.539 HG21 ' C ' ' A' ' 41' ' ' VAL . 7.6 p -71.49 162.75 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.248 -0.908 . . . . 0.0 111.316 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.481 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 114.31 -16.94 19.52 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.826 ' O ' HG23 ' A' ' 39' ' ' THR . 18.0 m-70 -120.5 -81.94 0.64 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.11 -1.229 . . . . 0.0 110.744 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.54 -34.72 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.03 0.919 . . . . 0.0 109.747 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.597 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 0.7 OUTLIER 176.37 -15.29 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.195 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.926 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.52 -16.46 71.73 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 120.985 -1.072 . . . . 0.0 110.537 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.637 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 1.2 mt-10 -83.96 -15.79 46.5 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.328 -1.101 . . . . 0.0 109.099 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.634 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 9.6 m-85 -97.06 -20.35 18.09 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.589 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -134.08 53.26 9.5 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.906 -0.496 . . . . 0.0 110.045 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.589 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 49.0 Cg_endo -84.25 50.74 3.13 Favored 'Trans proline' 0 C--N 1.321 -0.913 0 O-C-N 123.443 1.233 . . . . 0.0 110.13 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -130.17 152.84 49.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.589 -0.694 . . . . 0.0 110.252 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.6 mmp_? -74.66 106.7 6.35 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.504 -0.747 . . . . 0.0 109.975 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.2 p -127.53 138.37 52.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.512 -0.743 . . . . 0.0 110.285 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.6 t80 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.565 -0.71 . . . . 0.0 110.141 -179.932 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.4 t -115.03 129.1 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.56 -0.965 . . . . 0.0 110.135 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.763 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -122.65 153.77 38.92 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.55 -0.719 . . . . 0.0 109.849 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 39' ' ' THR . 12.5 p -111.71 117.15 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.536 -0.728 . . . . 0.0 109.052 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.801 ' CG ' HG23 ' A' ' 33' ' ' THR . 37.2 t70 -46.43 105.2 0.06 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.507 -0.745 . . . . 0.0 111.422 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -67.1 -23.29 65.82 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -66.46 -26.67 67.31 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.899 -0.501 . . . . 0.0 109.955 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.869 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -81.37 -39.19 25.42 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.458 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.869 HD12 ' HG ' ' A' ' 15' ' ' LEU . 5.1 mp -62.22 -41.58 98.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.843 -0.536 . . . . 0.0 109.672 178.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.8 -30.88 6.2 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.741 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB3' HD12 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -90.33 -30.89 17.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.529 -0.732 . . . . 0.0 110.327 179.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.074 HG21 ' HE3' ' A' ' 44' ' ' MET . 71.8 t -72.63 -36.05 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.264 -0.897 . . . . 0.0 111.689 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 16' ' ' LEU . 12.2 mt -61.28 -37.66 83.96 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' A' ' 18' ' ' LYS . 3.0 tm-20 -63.2 -39.74 95.51 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.322 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.71 HD23 ' HB2' ' A' ' 27' ' ' GLU . 3.6 mt -74.08 -22.08 59.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.274 -0.891 . . . . 0.0 110.091 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -83.43 -12.33 56.53 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.374 -0.829 . . . . 0.0 109.585 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.49 -39.18 16.53 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.447 -0.783 . . . . 0.0 109.757 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.429 ' HE3' ' HG2' ' A' ' 21' ' ' GLU . 65.3 mttt -97.52 -32.97 11.54 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.457 0.646 . . . . 0.0 109.325 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.74 19.53 19.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.71 ' HB2' HD23 ' A' ' 22' ' ' LEU . 28.8 mt-10 -71.22 140.36 50.42 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.509 -0.995 . . . . 0.0 110.351 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -110.73 76.84 1.0 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.475 -0.766 . . . . 0.0 109.762 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.83 -155.79 0.58 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.512 -0.742 . . . . 0.0 110.418 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.475 ' O ' HD13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -115.51 167.97 10.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.568 -0.707 . . . . 0.0 110.316 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.703 HD11 ' CD1' ' A' ' 22' ' ' LEU . 45.3 mm -126.72 157.99 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.438 -0.789 . . . . 0.0 109.79 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -120.74 130.67 54.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.548 -0.72 . . . . 0.0 110.319 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.801 HG23 ' CG ' ' A' ' 12' ' ' ASP . 18.2 m -119.54 159.82 23.6 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.572 -0.705 . . . . 0.0 110.318 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 19.3 m-90 -145.02 16.57 1.56 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.314 -0.866 . . . . 0.0 111.819 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.62 -152.72 0.07 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.918 -1.114 . . . . 0.0 110.785 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.78 -61.78 1.66 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.072 -1.018 . . . . 0.0 110.067 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.501 ' HG2' ' HD1' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -100.49 43.86 1.04 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.562 -0.711 . . . . 0.0 109.854 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.442 ' CB ' HG21 ' A' ' 33' ' ' THR . 73.1 m -50.5 134.71 23.6 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.396 0.617 . . . . 0.0 111.606 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 69' ' ' HIS . 27.1 m -130.18 161.95 29.98 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.811 -0.555 . . . . 0.0 109.748 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.767 ' CG2' HG12 ' A' ' 62' ' ' ILE . 5.0 mp -85.97 170.28 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.375 -0.828 . . . . 0.0 111.121 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.988 HG23 ' SD ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -135.84 175.45 3.57 Favored Pre-proline 0 N--CA 1.505 2.308 0 O-C-N 121.463 -0.773 . . . . 0.0 110.049 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.791 ' HD2' HG12 ' A' ' 41' ' ' VAL . 47.0 Cg_endo -69.43 -34.61 15.31 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 124.024 1.539 . . . . 0.0 111.719 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.737 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 0.7 OUTLIER -71.87 0.53 8.91 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.298 -0.876 . . . . 0.0 111.171 179.62 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 1.074 ' HE3' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -90.15 -3.86 57.63 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.15 -0.969 . . . . 0.0 111.224 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.611 HG23 ' N ' ' A' ' 64' ' ' GLU . 4.4 p -49.1 2.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.6 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 44' ' ' MET . . . -146.15 30.02 1.63 Allowed Glycine 0 N--CA 1.496 2.634 0 O-C-N 119.798 -1.814 . . . . 0.0 110.292 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.499 ' HB2' HD11 ' A' ' 49' ' ' ILE . 8.1 m-70 -147.43 155.75 42.23 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.159 -1.201 . . . . 0.0 111.059 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.98 89.35 4.03 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.07 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.845 ' CD1' HD13 ' A' ' 62' ' ' ILE . 2.3 mp -86.64 118.16 32.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.443 -0.786 . . . . 0.0 111.752 -176.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.778 ' HB1' ' HB3' ' A' ' 57' ' ' HIS . . . -78.91 84.85 4.91 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.973 0.892 . . . . 0.0 109.106 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.531 HG21 ' O ' ' A' ' 70' ' ' LYS . 23.0 m -61.97 129.09 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.534 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.5 ' HB2' ' O ' ' A' ' 33' ' ' THR . 26.5 t80 -78.0 106.44 9.86 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.082 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -75.01 13.76 0.63 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.702 -0.624 . . . . 0.0 110.598 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.58 -25.74 20.29 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -140.51 -25.9 0.76 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.617 -0.931 . . . . 0.0 111.24 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -131.96 151.88 51.45 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.778 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 66.5 m80 -93.13 117.48 30.12 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.771 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 21.8 t -106.91 87.46 2.95 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.079 -1.013 . . . . 0.0 109.338 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.55 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.3 Cg_endo -65.69 93.04 0.25 Allowed 'Trans proline' 0 N--CA 1.489 1.254 0 O-C-N 123.952 1.501 . . . . 0.0 109.814 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.687 ' O ' HD12 ' A' ' 62' ' ' ILE . 12.4 m -107.05 125.97 63.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.655 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.408 ' N ' HG23 ' A' ' 48' ' ' THR . 2.8 t80 -71.64 103.52 3.06 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.845 HD13 ' CD1' ' A' ' 49' ' ' ILE . 1.6 mp -56.53 -56.74 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -176.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.536 ' O ' HG22 ' A' ' 62' ' ' ILE . 2.7 m 64.62 178.46 0.18 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -177.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.611 ' N ' HG23 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -86.43 48.91 1.7 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.517 -1.364 . . . . 0.0 111.102 -179.314 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -171.81 -9.09 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.889 -1.132 . . . . 0.0 113.979 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.671 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 29.3 mtt -99.63 -23.48 15.04 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.203 -1.56 . . . . 0.0 111.202 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.58 HG21 ' C ' ' A' ' 41' ' ' VAL . 2.7 p -67.76 163.48 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.489 0 O-C-N 121.284 -0.885 . . . . 0.0 112.514 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.501 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 122.75 -11.33 8.89 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.956 177.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.723 ' O ' HG23 ' A' ' 39' ' ' THR . 17.7 m-70 -125.14 -83.02 0.64 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.135 1.468 . . . . 0.0 110.77 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.34 -31.22 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.588 0.708 . . . . 0.0 110.258 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.574 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 1.0 OUTLIER 173.62 -15.94 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.709 -179.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.02 -18.19 76.19 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.681 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 23.1 mm-40 -84.7 -19.53 32.63 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.291 -1.123 . . . . 0.0 109.184 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.674 ' HE1' HD13 ' A' ' 40' ' ' ILE . 15.6 m-85 -98.08 -18.22 18.66 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.594 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -134.38 52.23 7.5 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.592 -0.693 . . . . 0.0 110.091 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.594 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 50.0 Cg_endo -84.6 51.58 3.28 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 O-C-N 123.509 1.268 . . . . 0.0 110.056 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 42.0 m -60.07 -49.29 78.24 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.701 -0.625 . . . . 0.0 110.459 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.01 129.27 35.32 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.56 -0.713 . . . . 0.0 110.056 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 26.4 m -144.78 -54.47 0.32 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.383 -0.823 . . . . 0.0 110.169 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 . . . . . 0 N--CA 1.496 1.83 0 O-C-N 121.499 -0.75 . . . . 0.0 110.112 -179.964 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.6 m -80.08 150.02 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.547 -0.973 . . . . 0.0 110.517 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.72 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -111.13 151.61 27.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.548 -0.72 . . . . 0.0 110.034 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.864 HG11 HG13 ' A' ' 41' ' ' VAL . 92.6 t -100.08 110.18 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.294 -0.879 . . . . 0.0 108.872 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.72 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 38.5 t70 -48.42 111.0 0.39 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.405 0.621 . . . . 0.0 111.306 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.35 -23.7 64.73 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -65.61 -28.58 69.22 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.92 -0.488 . . . . 0.0 110.493 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.885 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -77.57 -37.61 50.19 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.498 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.885 HD12 ' HG ' ' A' ' 15' ' ' LEU . 3.8 mp -60.96 -44.4 97.37 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 120.983 0.421 . . . . 0.0 109.946 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.525 ' HG2' ' HE3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -53.9 -25.36 19.81 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.273 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HE3' ' HG2' ' A' ' 17' ' ' GLU . 5.1 mtmt -101.77 -29.67 11.74 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.485 -0.759 . . . . 0.0 110.371 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.781 HG12 ' HA ' ' A' ' 16' ' ' LEU . 1.1 p -75.82 -35.93 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.366 -0.834 . . . . 0.0 111.37 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 16' ' ' LEU . 3.8 pp -62.98 -28.68 70.26 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -71.91 -35.28 69.63 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.452 HD12 HD11 ' A' ' 31' ' ' ILE . 3.3 mt -73.57 -27.26 61.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.651 -0.656 . . . . 0.0 109.753 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -84.93 -17.82 36.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.596 -0.69 . . . . 0.0 109.374 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.33 -38.77 15.94 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.535 -0.728 . . . . 0.0 109.738 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.1 mttm -90.39 -26.34 19.95 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.08 15.14 49.55 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.432 ' HB2' HD22 ' A' ' 22' ' ' LEU . 20.7 mt-10 -80.95 124.93 29.54 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.382 -1.07 . . . . 0.0 110.364 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -98.87 74.15 2.02 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.574 -0.704 . . . . 0.0 109.517 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.413 ' H ' HD13 ' A' ' 22' ' ' LEU . 1.3 ttp180 -108.15 -151.56 0.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.667 -0.645 . . . . 0.0 110.079 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -118.08 153.68 33.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 110.71 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.552 HD13 HG23 ' A' ' 19' ' ' VAL . 2.7 mp -127.26 119.08 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.516 -0.74 . . . . 0.0 109.186 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.522 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 4.7 mptt -84.42 158.82 20.95 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.306 -0.871 . . . . 0.0 111.366 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.694 HG23 ' CG ' ' A' ' 12' ' ' ASP . 15.9 m -141.47 155.97 45.8 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.706 -0.622 . . . . 0.0 109.713 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.498 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 12.0 m-90 -145.76 36.54 1.06 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.225 -0.922 . . . . 0.0 111.404 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -91.91 -95.16 0.13 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.891 -1.131 . . . . 0.0 110.826 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.9 tpt85 -170.2 -63.5 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.084 -1.01 . . . . 0.0 110.514 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -99.27 37.52 1.55 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.267 -0.896 . . . . 0.0 110.007 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.585 ' OG ' HG21 ' A' ' 33' ' ' THR . 35.0 m -40.91 133.74 2.08 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.473 0.654 . . . . 0.0 112.153 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.883 HG23 ' O ' ' A' ' 69' ' ' HIS . 49.1 m -128.54 156.81 42.72 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.902 -0.499 . . . . 0.0 109.821 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.745 HG23 ' SD ' ' A' ' 44' ' ' MET . 1.3 mp -76.98 160.29 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.481 -0.762 . . . . 0.0 111.248 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.864 HG13 HG11 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -132.06 176.5 2.85 Favored Pre-proline 0 N--CA 1.502 2.158 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.158 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 41.7 Cg_endo -65.76 -29.5 50.88 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.906 1.477 . . . . 0.0 110.596 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -77.78 0.75 22.52 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.686 -0.634 . . . . 0.0 110.688 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.745 ' SD ' HG23 ' A' ' 40' ' ' ILE . 2.4 mtt -93.82 -11.62 30.84 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.072 -1.017 . . . . 0.0 111.644 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.739 HG23 ' N ' ' A' ' 64' ' ' GLU . 7.5 p -56.52 4.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.414 ' C ' ' CG ' ' A' ' 47' ' ' HIS . . . -150.29 29.74 1.08 Allowed Glycine 0 N--CA 1.495 2.601 0 O-C-N 119.953 -1.717 . . . . 0.0 110.088 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.498 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 21.8 m-70 -147.35 159.22 43.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.168 -1.195 . . . . 0.0 111.338 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.57 84.64 2.99 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 178.176 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.825 ' CD1' HD13 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -84.99 121.09 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.176 -0.953 . . . . 0.0 111.221 -177.465 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.788 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.61 84.17 4.74 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.832 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 51' ' ' VAL . 19.0 m -64.83 130.08 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.4 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.503 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 30.1 t80 -75.34 107.14 7.25 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -84.34 28.01 0.66 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.461 -0.775 . . . . 0.0 110.92 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.11 -36.78 4.09 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -140.69 -20.35 0.82 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.443 -1.033 . . . . 0.0 111.721 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.503 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 2.2 mm100 -128.82 153.07 47.79 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -177.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.446 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 2.1 m80 -98.7 108.16 20.78 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.788 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 21.8 t -100.86 95.61 4.72 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.144 -0.973 . . . . 0.0 109.469 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.537 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.0 Cg_endo -67.29 93.1 0.35 Allowed 'Trans proline' 0 N--CA 1.488 1.176 0 O-C-N 123.837 1.44 . . . . 0.0 109.423 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.672 HG11 ' CD2' ' A' ' 74' ' ' PHE . 95.9 t -110.36 126.71 67.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.828 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.0 t80 -71.96 104.72 3.61 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.646 HD13 ' HB3' ' A' ' 44' ' ' MET . 2.6 mp -67.37 -50.17 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 2.9 m 65.53 178.7 0.2 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.739 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.1 tm-20 -86.17 61.58 6.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.506 -1.371 . . . . 0.0 109.323 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -162.28 -34.38 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.203 -0.935 . . . . 0.0 112.271 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.75 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 10.3 mtt -99.74 9.29 43.32 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.882 -1.136 . . . . 0.0 112.11 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.474 HG22 ' N ' ' A' ' 68' ' ' GLY . 8.3 p -90.04 162.02 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 120.736 -1.227 . . . . 0.0 112.461 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.474 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 105.56 -16.0 44.98 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.883 ' O ' HG23 ' A' ' 39' ' ' THR . 16.2 m-70 -112.45 -88.89 0.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.015 -1.285 . . . . 0.0 110.792 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.3 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 122.437 1.113 . . . . 0.0 109.07 -179.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.6 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.8 OUTLIER -179.64 -13.85 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.938 -179.603 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.67 -15.17 77.77 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.75 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 1.5 mm-40 -81.18 -15.55 55.44 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.36 -1.082 . . . . 0.0 108.824 178.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.678 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 4.8 m-85 -102.21 -23.07 14.06 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.555 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -131.85 56.46 23.96 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.82 -0.55 . . . . 0.0 109.542 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 46.2 Cg_endo -83.28 54.45 4.68 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.696 1.366 . . . . 0.0 109.986 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 76' ' ' PRO . 14.8 t 39.5 46.36 1.43 Allowed 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 121.424 0.631 . . . . 0.0 111.682 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.87 127.2 43.67 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.365 -0.834 . . . . 0.0 109.95 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.6 m -86.82 109.86 19.56 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.41 -0.806 . . . . 0.0 110.196 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 O-C-N 121.555 -0.716 . . . . 0.0 110.165 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t 53.72 72.36 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.839 -0.801 . . . . 0.0 110.295 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.671 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -100.81 148.92 24.39 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.487 -0.758 . . . . 0.0 109.857 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.655 HG11 HG13 ' A' ' 41' ' ' VAL . 91.8 t -95.41 106.1 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 108.566 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.671 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 32.6 t70 -46.35 110.81 0.3 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.375 0.607 . . . . 0.0 111.404 -178.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 16' ' ' LEU . 9.5 t70 -67.31 -23.1 65.61 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -63.56 -33.68 76.13 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.912 -0.492 . . . . 0.0 110.31 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.928 HD11 ' SD ' ' A' ' 44' ' ' MET . 0.3 OUTLIER -80.28 -38.1 31.49 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.834 HD12 ' HG ' ' A' ' 15' ' ' LEU . 4.0 mp -61.49 -40.8 95.88 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.61 -31.33 15.68 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -89.13 -32.43 17.51 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.665 -0.647 . . . . 0.0 110.089 178.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.778 HG22 HD13 ' A' ' 31' ' ' ILE . 78.7 t -68.46 -38.24 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.303 -0.873 . . . . 0.0 111.156 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 16' ' ' LEU . 11.0 mt -61.76 -37.71 85.3 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -64.52 -35.63 81.57 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.468 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.737 HD22 ' HB2' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -75.07 -25.18 58.41 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.479 -0.763 . . . . 0.0 109.866 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -84.48 -11.2 56.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.439 -0.788 . . . . 0.0 109.94 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.18 -37.35 15.09 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 121.348 -0.845 . . . . 0.0 109.927 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -100.71 -24.72 14.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.641 -0.662 . . . . 0.0 109.714 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.53 29.67 8.63 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.737 ' HB2' HD22 ' A' ' 22' ' ' LEU . 14.5 mt-10 -79.77 125.92 30.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.498 -1.001 . . . . 0.0 110.241 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -106.64 63.18 0.64 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.455 -0.778 . . . . 0.0 109.677 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.27 -153.17 0.51 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.519 -0.738 . . . . 0.0 110.116 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.663 HD12 ' HB3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -118.02 147.87 42.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.385 -0.822 . . . . 0.0 110.725 -179.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.778 HD13 HG22 ' A' ' 19' ' ' VAL . 2.9 mp -118.52 116.25 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.607 -0.683 . . . . 0.0 109.735 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.618 ' HE2' HD11 ' A' ' 30' ' ' LEU . 29.2 mmtt -75.96 154.32 35.97 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.528 -0.732 . . . . 0.0 110.725 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.641 HG23 ' OD2' ' A' ' 12' ' ' ASP . 97.4 m -135.78 158.44 44.38 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.48 -0.762 . . . . 0.0 110.305 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.419 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 10.4 m-90 -147.5 38.04 0.93 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.387 -0.821 . . . . 0.0 111.155 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 93.0 p -94.81 -132.11 0.17 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.96 -1.087 . . . . 0.0 110.774 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.4 mtt85 -132.91 -64.23 0.75 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.986 -1.071 . . . . 0.0 110.317 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 mpp_? -97.99 40.92 1.15 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.432 -0.793 . . . . 0.0 110.098 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.595 ' OG ' HG21 ' A' ' 33' ' ' THR . 0.4 OUTLIER -40.2 125.78 2.08 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.528 0.68 . . . . 0.0 112.452 -179.494 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.829 HG23 ' O ' ' A' ' 69' ' ' HIS . 71.1 m -128.88 155.86 44.59 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.789 ' CG2' HG12 ' A' ' 62' ' ' ILE . 5.2 mp -86.76 168.89 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.406 -0.809 . . . . 0.0 111.457 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.904 HG23 ' HG3' ' A' ' 44' ' ' MET . 0.0 OUTLIER -136.51 171.84 8.02 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.645 -0.659 . . . . 0.0 110.167 179.469 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 42.7 Cg_endo -66.64 -32.78 37.63 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 124.239 1.652 . . . . 0.0 111.249 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.402 ' HG3' HG11 ' A' ' 19' ' ' VAL . 12.0 pt-20 -69.27 -5.51 23.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.559 -0.713 . . . . 0.0 110.711 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.928 ' SD ' HD11 ' A' ' 15' ' ' LEU . 1.3 mmm -91.83 -0.57 57.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.188 -0.945 . . . . 0.0 111.311 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.721 HG23 ' N ' ' A' ' 64' ' ' GLU . 6.6 p -53.55 7.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.42 ' C ' ' CG ' ' A' ' 47' ' ' HIS . . . -148.67 29.44 1.29 Allowed Glycine 0 N--CA 1.496 2.7 0 O-C-N 119.895 -1.753 . . . . 0.0 110.33 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.623 ' HB2' HD11 ' A' ' 49' ' ' ILE . 9.6 m-70 -148.1 155.91 42.0 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.205 -1.174 . . . . 0.0 111.193 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.485 HG23 ' N ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -101.04 90.96 4.35 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 177.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.778 ' CD1' HD13 ' A' ' 62' ' ' ILE . 2.5 mp -88.84 121.05 38.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.593 -176.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.757 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.56 81.63 4.87 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.824 0.821 . . . . 0.0 109.238 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.1 m -61.41 135.3 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.963 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.492 ' HB2' ' O ' ' A' ' 33' ' ' THR . 18.5 t80 -80.21 106.96 12.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.364 -0.835 . . . . 0.0 109.497 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -71.13 -0.98 10.86 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.569 -0.707 . . . . 0.0 110.329 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.84 -22.61 8.07 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 107.693 -2.163 . . . . 0.0 107.693 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -140.21 -28.18 0.73 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.985 -0.715 . . . . 0.0 111.158 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.58 155.27 47.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.235 -0.916 . . . . 0.0 112.2 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.491 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 19.4 m-70 -99.92 110.4 22.74 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.757 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 24.9 t -97.71 96.99 3.64 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.239 -0.913 . . . . 0.0 109.943 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.663 ' HB3' HD12 ' A' ' 30' ' ' LEU . 41.7 Cg_endo -66.68 92.41 0.3 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 O-C-N 123.906 1.477 . . . . 0.0 109.615 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.646 ' O ' HD12 ' A' ' 62' ' ' ILE . 12.9 m -103.92 125.19 58.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.613 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.485 ' N ' HG23 ' A' ' 48' ' ' THR . 2.6 t80 -72.66 103.09 3.48 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.789 HG12 ' CG2' ' A' ' 40' ' ' ILE . 1.5 mp -55.98 -61.63 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -176.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.522 ' O ' HG22 ' A' ' 62' ' ' ILE . 2.6 m 65.41 174.42 0.22 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -176.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.721 ' N ' HG23 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -85.38 58.79 5.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.357 -1.464 . . . . 0.0 109.976 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -171.57 -25.94 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.94 -1.1 . . . . 0.0 113.27 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.689 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 2.5 mmm -89.2 -25.43 21.78 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.558 -1.339 . . . . 0.0 111.097 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.573 HG21 ' C ' ' A' ' 41' ' ' VAL . 3.3 p -67.02 163.09 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 121.331 -0.855 . . . . 0.0 112.561 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.509 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 118.83 -13.57 11.59 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.756 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.829 ' O ' HG23 ' A' ' 39' ' ' THR . 19.7 m-70 -123.06 -83.56 0.66 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 119.037 1.418 . . . . 0.0 110.724 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.776 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.2 -30.93 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.671 0.748 . . . . 0.0 110.48 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.611 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.9 OUTLIER 174.12 -14.98 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.272 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.809 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.99 -18.46 74.54 Favored Glycine 0 N--CA 1.496 2.647 0 O-C-N 120.982 -1.074 . . . . 0.0 110.423 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.609 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 2.0 mt-10 -86.41 -16.85 35.94 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.237 -1.155 . . . . 0.0 109.262 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.689 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 9.9 m-85 -101.01 -19.89 15.63 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.583 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -134.32 55.18 13.9 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.669 -0.644 . . . . 0.0 109.877 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.583 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 46.4 Cg_endo -85.02 49.89 2.7 Favored 'Trans proline' 0 C--N 1.319 -0.982 0 O-C-N 123.535 1.282 . . . . 0.0 110.178 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.6 t -76.22 -25.74 55.4 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.662 -0.649 . . . . 0.0 111.028 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -73.98 -59.46 2.71 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.341 -0.849 . . . . 0.0 110.2 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 p -143.26 -68.23 0.35 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.491 -0.756 . . . . 0.0 110.237 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 . . . . . 0 N--CA 1.496 1.849 0 O-C-N 121.377 -0.827 . . . . 0.0 110.324 -179.903 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.3 m -74.96 149.99 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.562 -0.963 . . . . 0.0 110.433 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.717 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -107.77 148.82 28.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.59 -0.694 . . . . 0.0 109.958 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.788 HG21 HG13 ' A' ' 41' ' ' VAL . 14.4 p -102.12 109.61 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.83 . . . . 0.0 108.77 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.717 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 38.8 t70 -46.06 111.59 0.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.624 -0.673 . . . . 0.0 111.803 -178.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.416 ' HA ' HD13 ' A' ' 16' ' ' LEU . 7.7 t70 -68.3 -24.2 64.83 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -64.92 -28.38 69.49 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.853 -0.53 . . . . 0.0 109.78 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.772 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -77.67 -34.98 52.81 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.211 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.783 HD11 ' CG1' ' A' ' 41' ' ' VAL . 3.8 mp -62.3 -47.28 84.97 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.048 0.451 . . . . 0.0 109.902 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.44 -23.04 5.39 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.737 -0.602 . . . . 0.0 110.445 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.567 ' O ' HD12 ' A' ' 22' ' ' LEU . 8.8 mmtm -102.58 -30.84 10.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.301 -0.874 . . . . 0.0 111.045 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.712 HG12 ' HA ' ' A' ' 16' ' ' LEU . 1.4 p -78.13 -39.86 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.191 -0.943 . . . . 0.0 111.274 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.464 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 12.6 mt -63.25 -36.84 85.0 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.89 -38.88 83.5 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.271 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.581 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 3.2 mt -73.42 -24.67 60.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.119 -0.988 . . . . 0.0 110.197 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -80.71 -10.4 59.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.522 -0.736 . . . . 0.0 109.59 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.19 -35.58 23.42 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 121.498 -0.751 . . . . 0.0 109.707 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.581 ' HE3' ' HA ' ' A' ' 22' ' ' LEU . 7.4 pttt -102.3 -29.57 11.59 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.533 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.59 28.35 7.54 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.536 ' HB2' ' HE3' ' A' ' 25' ' ' LYS . 2.6 mt-10 -90.9 134.61 34.33 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.467 -1.019 . . . . 0.0 110.382 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -100.04 76.45 1.93 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.463 -0.773 . . . . 0.0 109.357 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.98 -154.55 0.54 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.51 -0.743 . . . . 0.0 110.212 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -118.99 161.1 20.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.453 -0.779 . . . . 0.0 110.763 -179.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.552 ' CD1' HG23 ' A' ' 19' ' ' VAL . 2.9 mp -132.77 112.42 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.535 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -85.69 152.69 22.88 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.55 -0.718 . . . . 0.0 111.186 -178.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.627 HG23 ' CG ' ' A' ' 12' ' ' ASP . 8.5 m -134.87 163.21 30.34 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.925 -0.484 . . . . 0.0 110.279 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.474 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 16.0 m-90 -146.73 37.06 0.97 Allowed 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.289 -0.882 . . . . 0.0 110.854 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.0 t -94.74 -126.63 0.12 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.077 -1.015 . . . . 0.0 110.779 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.14 -59.68 0.78 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.827 -1.171 . . . . 0.0 110.822 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -98.36 35.61 1.75 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.322 -0.861 . . . . 0.0 110.605 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.555 ' OG ' HG21 ' A' ' 33' ' ' THR . 4.5 m -36.06 123.9 0.74 Allowed 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.31 0.576 . . . . 0.0 111.942 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.839 HG23 ' O ' ' A' ' 69' ' ' HIS . 27.5 m -128.32 162.27 27.46 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.546 -0.721 . . . . 0.0 110.569 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.874 HG22 ' HG2' ' A' ' 44' ' ' MET . 1.9 mt -66.58 165.01 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 O-C-N 121.631 -0.668 . . . . 0.0 110.861 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.788 HG13 HG21 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -123.45 -171.41 0.22 Allowed Pre-proline 0 N--CA 1.505 2.312 0 O-C-N 121.362 -0.836 . . . . 0.0 110.14 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.575 ' HD3' HG12 ' A' ' 41' ' ' VAL . 57.7 Cg_endo -87.75 -31.19 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.657 1.346 . . . . 0.0 111.098 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -90.05 15.47 10.07 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.536 -0.727 . . . . 0.0 111.056 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.874 ' HG2' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -94.43 4.84 53.34 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.17 -0.956 . . . . 0.0 111.798 -179.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.754 HG13 ' N ' ' A' ' 64' ' ' GLU . 39.5 t -57.46 -2.83 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.477 ' HA2' ' CE1' ' A' ' 61' ' ' TYR . . . -150.77 34.08 0.96 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.533 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 52.7 m-70 -138.49 152.67 48.48 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.221 -1.164 . . . . 0.0 110.938 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.727 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.29 80.82 2.47 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.621 HD12 ' CD1' ' A' ' 62' ' ' ILE . 9.2 mt -78.09 117.35 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.182 -0.949 . . . . 0.0 110.915 -177.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.755 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -78.42 80.07 4.83 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.772 0.796 . . . . 0.0 108.99 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 51' ' ' VAL . 31.8 m -57.87 127.12 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.181 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.502 ' HB2' ' O ' ' A' ' 33' ' ' THR . 14.9 t80 -75.76 105.99 7.1 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.196 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -69.61 -0.8 7.36 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.577 -0.702 . . . . 0.0 110.429 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.03 -20.71 9.73 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 107.839 -2.104 . . . . 0.0 107.839 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -140.1 -29.22 0.71 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.957 -0.731 . . . . 0.0 110.974 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.53 154.82 48.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.243 -0.911 . . . . 0.0 112.029 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.488 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 5.0 m80 -100.59 106.04 17.51 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.755 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 40.4 t -94.98 99.93 4.89 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.206 -0.934 . . . . 0.0 109.804 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.505 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 41.7 Cg_endo -66.54 92.39 0.29 Allowed 'Trans proline' 0 N--CA 1.49 1.304 0 O-C-N 123.904 1.476 . . . . 0.0 109.598 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 58' ' ' VAL . 94.0 t -98.39 116.59 41.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.75 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.727 ' HB2' HG23 ' A' ' 48' ' ' THR . 6.2 t80 -73.03 108.77 6.11 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.869 HD13 ' HB2' ' A' ' 44' ' ' MET . 2.4 mp -92.72 159.89 2.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.884 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.617 HG22 ' H ' ' A' ' 64' ' ' GLU . 3.1 m -129.83 -159.81 0.99 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 177.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.754 ' N ' HG13 ' A' ' 45' ' ' VAL . 3.2 tt0 -90.25 47.75 1.48 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.242 -1.536 . . . . 0.0 110.412 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -156.58 -34.23 0.08 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.973 -1.079 . . . . 0.0 112.675 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.662 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 71.3 mtm -85.86 5.01 34.74 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.999 -1.063 . . . . 0.0 111.546 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.553 ' HA ' HD13 ' A' ' 40' ' ' ILE . 7.5 p -83.99 166.2 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 120.893 -1.129 . . . . 0.0 111.767 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.539 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 106.5 -21.7 32.19 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.839 ' O ' HG23 ' A' ' 39' ' ' THR . 16.5 m-70 -112.27 -86.87 0.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.121 -1.223 . . . . 0.0 111.003 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.619 ' HD3' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER 177.61 -36.27 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 122.273 1.035 . . . . 0.0 109.278 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.619 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -178.98 -15.33 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.998 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.83 -15.3 73.7 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.662 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 1.5 mm-40 -82.22 -16.86 48.13 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.44 -1.035 . . . . 0.0 108.773 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.592 ' CD1' ' HA ' ' A' ' 71' ' ' LEU . 7.5 m-85 -98.2 -22.3 16.24 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.553 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -134.2 56.49 19.07 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.797 -0.564 . . . . 0.0 110.39 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.553 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 47.4 Cg_endo -86.62 44.3 1.18 Allowed 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.393 1.207 . . . . 0.0 110.436 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.1 t -172.06 39.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.74 -0.6 . . . . 0.0 110.267 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.68 146.78 33.47 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.176 -0.953 . . . . 0.0 110.498 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.3 t -143.89 144.62 31.81 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.507 -0.745 . . . . 0.0 110.214 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 O-C-N 121.38 -0.825 . . . . 0.0 110.275 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.3 m -83.34 152.2 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.565 -0.962 . . . . 0.0 110.402 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.646 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.7 OUTLIER -135.45 137.93 42.69 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.413 -0.804 . . . . 0.0 110.309 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.072 HG21 HG13 ' A' ' 41' ' ' VAL . 9.9 p -113.63 118.9 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.753 ' HB3' HD23 ' A' ' 15' ' ' LEU . 38.8 t70 -43.81 105.87 0.06 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.618 -0.676 . . . . 0.0 111.604 -178.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -68.04 -21.35 65.02 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -66.84 -28.41 68.33 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 122.007 -0.433 . . . . 0.0 110.49 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.901 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -76.85 -37.32 55.83 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.709 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.901 HD12 ' HG ' ' A' ' 15' ' ' LEU . 3.9 mp -60.75 -44.21 96.98 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.97 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.412 ' HA ' HD21 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -55.74 -25.07 38.75 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.196 179.141 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -102.31 -31.39 10.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.453 -0.78 . . . . 0.0 110.67 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.756 HG12 ' HA ' ' A' ' 16' ' ' LEU . 1.4 p -71.8 -37.3 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.287 -0.883 . . . . 0.0 111.021 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.478 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.0 pp -64.47 -28.2 69.5 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.84 -31.96 65.13 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.496 HD22 ' HB2' ' A' ' 27' ' ' GLU . 1.4 mt -76.92 -22.08 53.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.609 -0.682 . . . . 0.0 109.582 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -84.76 -19.6 32.37 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.496 -0.753 . . . . 0.0 109.716 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.14 -39.13 17.02 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 121.504 -0.748 . . . . 0.0 109.908 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -90.71 -25.3 20.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.672 -0.643 . . . . 0.0 109.533 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.36 16.61 49.25 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB2' HD22 ' A' ' 22' ' ' LEU . 1.5 mt-10 -75.41 128.35 35.15 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.514 -0.991 . . . . 0.0 110.477 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.0 mtmm -115.13 50.89 0.95 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.551 -0.718 . . . . 0.0 109.513 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.7 ttp-105 -88.31 -92.2 0.11 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.57 -0.706 . . . . 0.0 110.411 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.784 HD12 ' HB3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -170.9 146.25 2.5 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.118 -0.989 . . . . 0.0 110.674 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.583 HD13 HD11 ' A' ' 49' ' ' ILE . 2.8 mt -115.26 119.07 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.727 ' HD3' HD11 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -79.63 151.05 30.79 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.437 -0.789 . . . . 0.0 111.543 -178.63 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.733 HG23 ' CG ' ' A' ' 12' ' ' ASP . 27.4 m -137.6 155.3 49.34 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.601 -0.687 . . . . 0.0 110.353 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.531 ' CH2' ' HB2' ' A' ' 32' ' ' LYS . 17.5 m-90 -146.02 29.53 1.09 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.299 -0.876 . . . . 0.0 111.601 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -82.9 -98.14 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.812 -1.18 . . . . 0.0 110.592 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -174.29 -61.59 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.215 -0.928 . . . . 0.0 109.558 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.19 42.7 1.09 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.628 ' OG ' HG21 ' A' ' 33' ' ' THR . 2.5 m -50.9 133.9 26.22 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.525 0.679 . . . . 0.0 111.923 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.849 HG23 ' O ' ' A' ' 69' ' ' HIS . 20.6 m -127.25 161.54 28.31 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.856 ' HA ' ' HE3' ' A' ' 44' ' ' MET . 1.1 mp -80.56 162.15 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.291 -0.88 . . . . 0.0 111.566 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.072 HG13 HG21 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -129.3 169.58 12.83 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 121.701 -0.624 . . . . 0.0 110.011 178.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.449 ' HD2' ' CB ' ' A' ' 41' ' ' VAL . 43.7 Cg_endo -67.5 -31.72 33.31 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.262 1.664 . . . . 0.0 110.918 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.697 ' HG3' HG11 ' A' ' 19' ' ' VAL . 2.3 pt-20 -80.16 5.69 13.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.482 -0.761 . . . . 0.0 110.926 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.856 ' HE3' ' HA ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -98.12 -5.74 33.04 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.287 -0.883 . . . . 0.0 111.448 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.627 HG13 ' N ' ' A' ' 64' ' ' GLU . 61.8 t -48.29 -6.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.516 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA2' ' CE1' ' A' ' 61' ' ' TYR . . . -144.72 38.97 1.24 Allowed Glycine 0 N--CA 1.491 2.344 0 O-C-N 120.186 -1.571 . . . . 0.0 109.221 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 49.6 m-70 -143.08 147.35 34.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.508 -0.995 . . . . 0.0 111.183 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.81 80.93 2.39 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 177.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.886 ' CD1' HD13 ' A' ' 15' ' ' LEU . 1.5 mt -85.19 124.1 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.391 -0.818 . . . . 0.0 111.347 -176.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.786 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -77.78 80.28 4.24 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 51' ' ' VAL . 27.2 m -61.08 130.47 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.057 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.446 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 30.5 t80 -78.27 105.88 9.81 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.236 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -69.91 0.0 6.59 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.618 -0.677 . . . . 0.0 110.6 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.67 -18.87 10.65 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 107.913 -2.075 . . . . 0.0 107.913 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -140.1 -28.57 0.73 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.938 -0.742 . . . . 0.0 110.884 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -135.86 155.32 50.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.226 -0.921 . . . . 0.0 112.015 -178.353 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.413 ' CE1' ' CD1' ' A' ' 34' ' ' TRP . 1.1 m-70 -101.57 105.43 16.39 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.786 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 21.9 t -95.35 102.29 9.42 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.217 -0.927 . . . . 0.0 110.051 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.784 ' HB3' HD12 ' A' ' 30' ' ' LEU . 40.3 Cg_endo -66.64 91.96 0.3 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.916 1.482 . . . . 0.0 109.006 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.552 HG11 ' CD2' ' A' ' 74' ' ' PHE . 79.1 t -108.21 126.75 64.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.938 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.5 t80 -72.88 110.89 7.53 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 176.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.717 HG12 ' CG2' ' A' ' 40' ' ' ILE . 1.7 mp -62.71 -56.77 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.642 -0.661 . . . . 0.0 112.732 -177.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 3.5 m 68.79 162.39 0.21 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -177.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.627 ' N ' HG13 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -78.93 62.76 3.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.639 -1.288 . . . . 0.0 109.451 -179.398 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -167.53 -32.85 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.317 -0.864 . . . . 0.0 112.271 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.717 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 2.8 mtt -98.07 8.49 44.69 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.79 -1.194 . . . . 0.0 111.85 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 68' ' ' GLY . 8.2 p -90.22 162.62 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 120.757 -1.214 . . . . 0.0 112.214 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.481 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 106.69 -16.82 39.96 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.849 ' O ' HG23 ' A' ' 39' ' ' THR . 16.3 m-70 -112.86 -88.44 0.54 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.12 -1.223 . . . . 0.0 110.726 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.09 -35.64 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 122.394 1.092 . . . . 0.0 109.02 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.621 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -178.74 -14.93 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.973 -179.587 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.41 -14.75 77.17 Favored Glycine 0 N--CA 1.498 2.771 0 O-C-N 120.797 -1.189 . . . . 0.0 110.281 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.717 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 1.8 mm-40 -81.02 -18.2 47.63 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.356 -1.085 . . . . 0.0 108.686 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.677 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 10.6 m-85 -96.86 -22.2 17.05 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.567 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -132.91 55.11 15.57 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.745 -0.597 . . . . 0.0 109.743 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 46.7 Cg_endo -84.11 51.46 3.38 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 O-C-N 123.639 1.336 . . . . 0.0 110.26 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.6 m -69.1 138.32 54.2 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.613 -0.679 . . . . 0.0 110.198 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -79.44 -52.31 8.22 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.534 -0.729 . . . . 0.0 110.241 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.9 p -129.36 -54.27 1.18 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.581 -0.699 . . . . 0.0 110.367 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.425 -0.797 . . . . 0.0 110.296 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.478 ' HB ' ' HD2' ' A' ' 37' ' ' ARG . 76.2 t -80.32 -40.76 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.546 -0.973 . . . . 0.0 110.361 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.542 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 1.7 t80 -155.98 156.61 34.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.476 -0.765 . . . . 0.0 110.848 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.661 HG21 HG13 ' A' ' 41' ' ' VAL . 3.5 p -137.17 119.75 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.785 ' HB2' HD23 ' A' ' 15' ' ' LEU . 34.1 m-20 -23.62 99.97 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 CA-C-O 121.046 0.45 . . . . 0.0 112.142 -178.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.2 -26.4 63.86 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.728 ' CB ' HG23 ' A' ' 33' ' ' THR . 0.1 OUTLIER -76.07 -14.04 60.2 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 120.99 0.424 . . . . 0.0 110.148 178.64 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.042 HD11 ' SD ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -87.01 -35.33 18.86 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.645 ' HA ' HG12 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -70.56 -43.93 68.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.745 -0.597 . . . . 0.0 110.01 178.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.64 ' HG2' ' HA ' ' A' ' 14' ' ' HIS . 0.6 OUTLIER -53.08 -19.73 3.05 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.8 179.408 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.472 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 17.6 mttt -106.39 -32.56 8.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.347 -0.846 . . . . 0.0 110.146 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.96 HG21 ' SD ' ' A' ' 44' ' ' MET . 0.5 OUTLIER -73.57 -40.66 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.403 -0.811 . . . . 0.0 111.153 -179.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.511 HD21 ' HA ' ' A' ' 17' ' ' GLU . 3.8 pp -60.52 -26.27 66.74 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.57 -36.24 52.27 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 27' ' ' GLU . 0.9 OUTLIER -72.22 -28.49 63.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.591 -0.693 . . . . 0.0 109.637 178.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -83.56 -11.33 57.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.581 -0.699 . . . . 0.0 109.599 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.0 -37.22 14.47 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 121.588 -0.695 . . . . 0.0 110.002 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.477 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 4.6 ptmt -96.56 -23.92 16.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.611 -0.681 . . . . 0.0 109.84 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.32 29.45 7.5 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.477 ' HG3' ' HE2' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -92.98 129.08 39.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.427 -1.043 . . . . 0.0 110.685 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -107.25 70.63 0.8 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.593 -0.692 . . . . 0.0 109.226 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.34 -152.76 0.5 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.656 -0.653 . . . . 0.0 110.006 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -114.05 155.79 25.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.421 -0.799 . . . . 0.0 110.354 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.567 HG21 ' O ' ' A' ' 15' ' ' LEU . 5.8 mt -135.06 116.32 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.498 -0.751 . . . . 0.0 109.346 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -103.33 148.37 25.94 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.277 -0.889 . . . . 0.0 110.891 -179.45 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.728 HG23 ' CB ' ' A' ' 14' ' ' HIS . 56.6 m -137.91 156.78 47.53 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.579 -0.701 . . . . 0.0 110.177 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.506 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 19.9 m-90 -118.57 44.93 2.15 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.681 -0.637 . . . . 0.0 110.057 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 10' ' ' PHE . 66.1 m -83.79 -167.24 1.65 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.289 -0.882 . . . . 0.0 111.004 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -102.11 -61.88 1.33 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.436 -0.79 . . . . 0.0 110.341 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.478 ' HD2' ' HB ' ' A' ' 9' ' ' VAL . 0.3 OUTLIER -92.33 41.32 1.07 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.355 -0.841 . . . . 0.0 109.636 179.355 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 63.1 m -37.75 105.44 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.808 HG23 ' O ' ' A' ' 69' ' ' HIS . 44.6 m -122.35 159.7 26.92 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.684 -0.635 . . . . 0.0 109.316 178.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.866 ' CG2' HG12 ' A' ' 62' ' ' ILE . 4.8 mp -90.08 168.92 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.408 -0.807 . . . . 0.0 111.705 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.676 HG23 ' HE3' ' A' ' 44' ' ' MET . 0.1 OUTLIER -139.56 174.6 3.93 Favored Pre-proline 0 N--CA 1.505 2.306 0 O-C-N 121.79 -0.569 . . . . 0.0 109.787 179.443 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.565 ' HD2' HG12 ' A' ' 41' ' ' VAL . 42.8 Cg_endo -65.61 -33.53 45.05 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 124.116 1.588 . . . . 0.0 111.198 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.75 -12.43 23.97 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.597 -0.69 . . . . 0.0 110.578 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 1.042 ' SD ' HD11 ' A' ' 15' ' ' LEU . 6.2 mmt -87.09 -4.8 59.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.364 -0.835 . . . . 0.0 111.909 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.526 HG23 ' N ' ' A' ' 64' ' ' GLU . 7.5 p -51.11 1.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.475 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.408 ' C ' ' CG ' ' A' ' 47' ' ' HIS . . . -146.27 31.01 1.58 Allowed Glycine 0 N--CA 1.495 2.62 0 O-C-N 119.918 -1.739 . . . . 0.0 110.28 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.408 ' CG ' ' C ' ' A' ' 46' ' ' GLY . 17.9 m-70 -147.88 156.55 42.82 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.217 -1.167 . . . . 0.0 111.315 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.69 88.73 3.9 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.677 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.938 HD12 HD13 ' A' ' 62' ' ' ILE . 2.6 mt -86.69 119.31 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.178 -0.951 . . . . 0.0 112.019 -176.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.725 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.87 86.81 5.36 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 122.15 0.976 . . . . 0.0 109.193 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.1 m -71.25 134.8 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.232 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.551 ' HB2' ' O ' ' A' ' 33' ' ' THR . 28.5 t80 -75.2 105.58 6.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.342 -0.849 . . . . 0.0 108.886 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -71.46 0.03 9.28 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.53 -0.731 . . . . 0.0 110.801 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.41 -22.48 7.84 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -140.36 -28.84 0.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 122.016 -0.697 . . . . 0.0 110.79 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.21 156.22 49.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.266 -0.896 . . . . 0.0 111.988 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.526 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 93.6 m-70 -101.83 108.31 19.76 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.725 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 22.0 t -94.3 101.5 6.66 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.308 -0.87 . . . . 0.0 110.008 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.52 ' O ' HG22 ' A' ' 48' ' ' THR . 43.0 Cg_endo -68.85 94.0 0.45 Allowed 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.933 1.491 . . . . 0.0 108.96 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.687 ' O ' HD12 ' A' ' 62' ' ' ILE . 15.0 m -106.36 126.93 62.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.217 -178.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 0.5 OUTLIER -69.5 104.32 2.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 176.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.938 HD13 HD12 ' A' ' 49' ' ' ILE . 1.3 mp -60.2 -53.22 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.602 ' O ' HG22 ' A' ' 62' ' ' ILE . 1.3 p 59.6 -175.63 0.1 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.526 ' N ' HG23 ' A' ' 45' ' ' VAL . 3.2 tp10 -90.41 43.51 1.15 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.486 -1.384 . . . . 0.0 109.941 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -150.92 -29.11 0.2 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.948 -1.095 . . . . 0.0 113.464 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.616 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 5.9 mtt -89.29 -23.18 22.36 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.527 -1.358 . . . . 0.0 111.435 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.652 HG21 ' C ' ' A' ' 41' ' ' VAL . 2.7 p -67.01 160.14 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.077 -1.015 . . . . 0.0 112.459 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.452 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 114.62 -13.56 20.48 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.869 -0.682 . . . . 0.0 111.586 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.808 ' O ' HG23 ' A' ' 39' ' ' THR . 22.2 m-70 -121.98 -83.8 0.66 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.912 1.356 . . . . 0.0 110.853 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.687 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 177.88 -30.98 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 121.661 0.743 . . . . 0.0 110.326 -179.597 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.597 ' HG ' ' HD2' ' A' ' 70' ' ' LYS . 1.3 pp 173.12 -14.18 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.767 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.29 -18.99 73.82 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.555 ' HG3' ' CG ' ' A' ' 69' ' ' HIS . 2.6 mt-10 -86.09 -15.14 42.16 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.355 -1.085 . . . . 0.0 109.24 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.646 ' CD2' ' HB ' ' A' ' 60' ' ' VAL . 10.2 m-85 -99.85 -21.76 15.59 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.566 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -133.43 54.79 13.88 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.782 -0.574 . . . . 0.0 109.922 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.566 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 48.1 Cg_endo -83.93 51.04 3.3 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.672 1.354 . . . . 0.0 110.261 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.5 t -74.58 168.22 20.2 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.624 -0.673 . . . . 0.0 110.648 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.12 174.3 9.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.457 -0.777 . . . . 0.0 110.355 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.8 p -87.86 135.41 33.4 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.456 -0.777 . . . . 0.0 110.144 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 . . . . . 0 N--CA 1.496 1.849 0 O-C-N 121.524 -0.735 . . . . 0.0 110.217 -179.893 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.9 t -104.27 80.08 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.525 -0.985 . . . . 0.0 109.845 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.713 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -139.0 148.8 43.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.399 -0.813 . . . . 0.0 110.177 -179.798 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 39' ' ' THR . 13.6 p -116.01 119.08 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.969 ' HB3' HD23 ' A' ' 15' ' ' LEU . 5.1 t70 -44.55 103.9 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.686 -0.634 . . . . 0.0 111.161 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.86 -22.1 65.14 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.16 -29.99 63.25 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.977 -0.452 . . . . 0.0 110.253 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.969 HD23 ' HB3' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -78.25 -38.68 42.24 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.277 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.744 HD12 ' HG ' ' A' ' 15' ' ' LEU . 2.9 mp -58.92 -42.98 90.98 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.309 0.576 . . . . 0.0 109.584 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.571 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -56.01 -23.75 34.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.806 -0.558 . . . . 0.0 109.943 179.257 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.4 -29.82 12.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.497 -0.752 . . . . 0.0 110.592 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.691 HG21 ' CB ' ' A' ' 44' ' ' MET . 2.3 p -73.96 -38.05 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.186 -0.946 . . . . 0.0 111.02 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.571 HD21 ' HA ' ' A' ' 17' ' ' GLU . 4.1 pp -61.75 -26.63 68.19 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -69.61 -34.06 73.55 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.696 HD13 ' HD3' ' A' ' 25' ' ' LYS . 3.6 mm? -74.13 -26.56 60.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.621 -0.674 . . . . 0.0 109.369 178.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -82.13 -13.44 57.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.598 -0.689 . . . . 0.0 109.674 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.37 -33.61 21.96 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.505 -0.747 . . . . 0.0 110.095 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.696 ' HD3' HD13 ' A' ' 22' ' ' LEU . 2.1 ptmt -92.01 -17.08 25.6 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.61 -0.682 . . . . 0.0 109.714 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.37 32.43 11.93 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.505 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -114.39 128.56 56.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.527 -0.984 . . . . 0.0 110.743 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.78 80.79 2.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.597 -0.69 . . . . 0.0 109.588 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.82 -147.84 0.39 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.55 -0.719 . . . . 0.0 109.848 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.528 ' O ' HD13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -121.27 154.05 36.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 110.203 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.848 ' HB ' HD13 ' A' ' 49' ' ' ILE . 28.0 mm -118.79 154.22 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.328 -0.857 . . . . 0.0 110.057 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.509 ' HE2' HD11 ' A' ' 30' ' ' LEU . 1.6 mmtp -102.76 137.09 41.43 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.667 -0.646 . . . . 0.0 110.345 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.67 HG23 ' CB ' ' A' ' 12' ' ' ASP . 9.6 m -124.45 150.28 45.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.572 -0.705 . . . . 0.0 109.806 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.635 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 1.4 m-90 -145.69 38.56 1.12 Allowed 'General case' 0 N--CA 1.51 2.563 0 O-C-N 121.067 -1.021 . . . . 0.0 112.652 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -100.57 -97.5 0.25 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.467 -1.395 . . . . 0.0 110.702 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.4 ' HG2' ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -169.83 -60.02 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.094 -1.004 . . . . 0.0 109.346 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.54 35.16 2.53 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.8 m -51.48 138.9 21.16 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.529 0.68 . . . . 0.0 111.742 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.783 ' O ' HG23 ' A' ' 11' ' ' VAL . 3.0 m -133.79 165.91 23.87 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.859 -0.526 . . . . 0.0 109.836 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.874 HG22 HG23 ' A' ' 67' ' ' VAL . 5.0 mp -86.2 161.49 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.199 -0.938 . . . . 0.0 110.551 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.695 HG23 ' HG2' ' A' ' 44' ' ' MET . 0.0 OUTLIER -141.1 176.23 2.59 Favored Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 121.672 -0.643 . . . . 0.0 109.686 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.651 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 38.3 Cg_endo -62.86 -28.77 75.86 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.137 1.598 . . . . 0.0 109.595 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -66.79 -10.64 49.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.847 -0.533 . . . . 0.0 110.864 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.966 ' HE1' HD21 ' A' ' 15' ' ' LEU . 1.9 ptp -140.19 44.21 1.89 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.814 -1.179 . . . . 0.0 112.324 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.832 ' CG1' ' HA ' ' A' ' 64' ' ' GLU . 3.2 t -91.49 27.96 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.819 -1.176 . . . . 0.0 110.938 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.66 24.74 0.94 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 12.6 m-70 -139.55 167.81 21.26 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.235 -1.156 . . . . 0.0 110.533 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.666 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -98.96 81.62 2.63 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 178.394 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.848 HD13 ' HB ' ' A' ' 31' ' ' ILE . 1.1 mm -79.37 112.47 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.673 -0.642 . . . . 0.0 110.929 -177.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.782 ' HB1' ' HB3' ' A' ' 57' ' ' HIS . . . -77.8 80.83 4.24 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.969 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.433 HG22 ' HB ' ' A' ' 58' ' ' VAL . 33.4 m -57.58 138.29 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.879 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.635 ' CG ' ' HA ' ' A' ' 34' ' ' TRP . 19.7 t80 -80.67 108.0 13.95 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.565 -0.854 . . . . 0.0 108.983 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -76.57 15.45 0.62 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.769 -0.582 . . . . 0.0 110.247 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.4 ' HA2' ' HG2' ' A' ' 36' ' ' ARG . . . 106.81 -29.3 11.03 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.0 pttt -140.57 -27.37 0.73 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.636 -0.92 . . . . 0.0 111.188 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -126.41 156.15 41.03 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.782 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 13.2 m-70 -94.9 115.82 27.94 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.745 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 46.2 t -103.81 90.64 2.99 Favored Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 121.157 -0.965 . . . . 0.0 109.337 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.549 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.8 Cg_endo -65.42 89.47 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 O-C-N 124.019 1.536 . . . . 0.0 110.301 -178.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.665 HG11 ' HA ' ' A' ' 71' ' ' LEU . 5.3 m -94.67 110.04 23.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.268 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.666 ' HB2' HG23 ' A' ' 48' ' ' THR . 0.6 OUTLIER -69.39 95.28 0.79 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.792 -1.163 . . . . 0.0 108.222 178.514 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.731 HG21 HG21 ' A' ' 40' ' ' ILE . 2.7 mp -76.79 127.64 37.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.145 -178.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.628 ' C ' HG12 ' A' ' 45' ' ' VAL . 72.1 p -101.78 158.74 15.9 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.832 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -42.78 -19.61 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.433 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 63' ' ' THR . 10.1 p30 -121.59 29.59 7.12 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.696 -1.253 . . . . 0.0 112.641 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.732 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 18.7 mmt -126.72 -19.19 4.57 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.973 -1.079 . . . . 0.0 110.73 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.874 HG23 HG22 ' A' ' 40' ' ' ILE . 13.3 p -65.5 162.61 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.343 -0.848 . . . . 0.0 112.239 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.457 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 120.16 -11.07 10.78 Favored Glycine 0 N--CA 1.491 2.367 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.727 178.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.7 ' CD2' ' HG3' ' A' ' 73' ' ' GLU . 14.2 m-70 -113.94 -88.29 0.56 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 119.33 1.565 . . . . 0.0 111.015 -178.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.54 -32.29 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.824 0.821 . . . . 0.0 109.785 -179.531 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.665 ' HA ' HG11 ' A' ' 60' ' ' VAL . 1.4 pp 174.03 -11.58 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.788 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.17 -15.01 81.74 Favored Glycine 0 N--CA 1.492 2.372 0 O-C-N 120.827 -1.171 . . . . 0.0 110.418 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.7 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 12.9 mm-40 -86.66 -16.44 36.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.252 -1.146 . . . . 0.0 109.58 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.732 ' CE2' ' HB3' ' A' ' 66' ' ' MET . 0.7 OUTLIER -117.73 -18.94 9.5 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.872 -0.517 . . . . 0.0 110.095 -179.108 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.514 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -138.38 58.19 14.04 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.436 -0.79 . . . . 0.0 110.007 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.514 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 44.2 Cg_endo -84.33 51.62 3.36 Favored 'Trans proline' 0 C--N 1.316 -1.157 0 O-C-N 123.626 1.329 . . . . 0.0 110.319 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.6 t -67.84 171.56 6.45 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.672 -0.642 . . . . 0.0 110.55 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 56.71 41.09 28.75 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.615 -0.678 . . . . 0.0 110.56 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.9 t -116.79 5.83 13.12 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.277 -0.89 . . . . 0.0 111.066 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.9 p90 . . . . . 0 N--CA 1.496 1.831 0 O-C-N 121.084 -1.01 . . . . 0.0 110.269 179.902 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.83 134.92 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.546 -0.973 . . . . 0.0 110.302 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.702 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -129.08 144.51 51.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.462 -0.774 . . . . 0.0 110.261 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.636 HG22 HD11 ' A' ' 16' ' ' LEU . 14.8 p -104.42 116.36 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.702 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 28.1 t70 -50.02 105.48 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.482 -0.761 . . . . 0.0 111.014 -178.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -64.82 -24.97 67.71 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -66.83 -31.43 72.05 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.281 0.563 . . . . 0.0 109.511 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.87 HD11 ' SD ' ' A' ' 44' ' ' MET . 0.1 OUTLIER -78.97 -35.42 43.08 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.504 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.636 HD11 HG22 ' A' ' 11' ' ' VAL . 2.7 mp -63.18 -42.95 99.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.689 -0.632 . . . . 0.0 109.558 178.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.559 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -56.35 -22.94 34.27 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.277 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.412 ' O ' HD23 ' A' ' 22' ' ' LEU . 12.2 mttt -99.0 -31.15 11.95 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.503 -0.748 . . . . 0.0 110.602 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.665 HG21 ' HG2' ' A' ' 44' ' ' MET . 1.8 p -73.27 -40.07 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.132 -0.98 . . . . 0.0 110.559 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.559 HD21 ' HA ' ' A' ' 17' ' ' GLU . 4.0 pp -64.14 -25.05 67.92 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -72.89 -33.11 65.84 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 27' ' ' GLU . 2.9 mm? -73.89 -26.96 60.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.43 -0.794 . . . . 0.0 109.238 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -81.74 -14.01 57.04 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.535 -0.728 . . . . 0.0 109.842 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.28 -38.94 21.49 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.525 -0.735 . . . . 0.0 109.078 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.98 -19.81 31.5 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.266 0.555 . . . . 0.0 109.824 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.47 3.32 72.02 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.472 ' O ' HD12 ' A' ' 22' ' ' LEU . 39.9 mt-10 -85.35 148.04 26.23 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.382 -1.07 . . . . 0.0 110.507 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -119.33 94.2 4.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.456 -0.778 . . . . 0.0 109.745 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -117.5 -157.89 0.68 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.49 -0.757 . . . . 0.0 110.45 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.0 OUTLIER -110.84 147.2 35.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.595 -0.691 . . . . 0.0 110.63 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.555 HG21 HD12 ' A' ' 15' ' ' LEU . 2.8 mp -121.87 117.95 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 3.8 mppt? -82.56 159.0 22.88 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.276 -0.89 . . . . 0.0 111.21 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.57 HG23 ' CG ' ' A' ' 12' ' ' ASP . 17.9 m -139.74 158.51 43.99 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.576 -0.703 . . . . 0.0 110.037 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.44 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 11.4 m-90 -146.93 38.77 1.0 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.367 -0.833 . . . . 0.0 111.052 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.7 m -98.05 -109.06 0.17 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.992 -1.067 . . . . 0.0 110.756 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.9 -64.73 0.19 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.912 -1.117 . . . . 0.0 110.366 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 38' ' ' SER . 1.6 mtp180 -92.54 25.63 2.96 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.405 -0.81 . . . . 0.0 110.191 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.444 ' OG ' HG21 ' A' ' 33' ' ' THR . 73.7 m -31.53 116.92 0.18 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.335 0.588 . . . . 0.0 112.466 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.741 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 45.1 m -124.38 159.93 29.28 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.74 -0.6 . . . . 0.0 110.476 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.776 HD13 ' HE1' ' A' ' 74' ' ' PHE . 5.3 mp -88.63 169.47 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.609 -0.682 . . . . 0.0 110.407 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.835 HG23 ' HG3' ' A' ' 44' ' ' MET . 0.1 OUTLIER -140.07 172.9 5.63 Favored Pre-proline 0 N--CA 1.508 2.458 0 O-C-N 121.176 -0.952 . . . . 0.0 110.945 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.644 ' HD2' HG12 ' A' ' 41' ' ' VAL . 41.8 Cg_endo -66.0 -30.1 48.25 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 124.394 1.734 . . . . 0.0 111.561 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.98 5.03 10.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.497 -0.752 . . . . 0.0 110.461 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.87 ' SD ' HD11 ' A' ' 15' ' ' LEU . 23.1 mtt -111.78 -0.7 15.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 111.411 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.568 HG23 ' N ' ' A' ' 64' ' ' GLU . 2.1 p -41.42 -4.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.923 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 44' ' ' MET . . . -137.71 35.27 2.07 Favored Glycine 0 N--CA 1.495 2.588 0 O-C-N 119.771 -1.831 . . . . 0.0 110.47 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 26.2 m-70 -144.43 153.18 41.64 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.09 -1.241 . . . . 0.0 110.971 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -99.77 92.34 5.27 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.286 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.666 HD13 ' SD ' ' A' ' 44' ' ' MET . 2.6 mt -88.8 120.78 38.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.097 -1.002 . . . . 0.0 111.239 -177.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.751 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -76.31 77.1 3.08 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.986 0.898 . . . . 0.0 109.09 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.654 HG21 ' HB3' ' A' ' 71' ' ' LEU . 33.0 m -56.73 132.25 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.476 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 33' ' ' THR . 19.8 t80 -77.14 104.52 7.69 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.574 -0.85 . . . . 0.0 109.006 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -70.2 0.4 6.37 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.571 -0.706 . . . . 0.0 110.421 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.31 -23.66 7.99 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.52 -28.94 0.7 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 122.051 -0.676 . . . . 0.0 111.136 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.53 155.57 45.55 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.243 -0.911 . . . . 0.0 112.159 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.471 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 6.9 m80 -100.81 104.78 16.03 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.751 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 39.1 t -93.71 101.16 5.53 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.205 -0.934 . . . . 0.0 109.92 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.549 ' O ' HG22 ' A' ' 48' ' ' THR . 40.7 Cg_endo -66.23 90.19 0.26 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 O-C-N 123.909 1.479 . . . . 0.0 109.82 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 60' ' ' VAL . 34.3 m -101.8 127.67 55.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.707 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 4.6 t80 -69.72 111.88 5.8 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 177.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.78 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.4 OUTLIER -51.33 -51.34 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.833 -0.542 . . . . 0.0 111.398 -178.058 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 m 60.88 169.85 0.09 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.363 0.602 . . . . 0.0 109.538 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.568 ' N ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -81.51 2.85 27.12 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.873 -1.142 . . . . 0.0 111.603 -179.313 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -142.51 1.88 1.39 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.83 -1.169 . . . . 0.0 113.038 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.606 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 20.2 mmt -99.95 -15.06 18.45 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.435 -1.415 . . . . 0.0 110.206 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.646 HG23 HG22 ' A' ' 40' ' ' ILE . 13.9 p -74.37 168.73 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.252 -0.905 . . . . 0.0 112.254 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.54 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 114.8 -5.35 22.52 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.701 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.733 ' O ' HG23 ' A' ' 39' ' ' THR . 19.8 m-70 -127.57 -85.0 0.6 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 119.289 1.545 . . . . 0.0 110.854 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.741 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.9 -29.29 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.532 0.682 . . . . 0.0 110.088 -179.243 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.654 ' HB3' HG21 ' A' ' 51' ' ' VAL . 2.4 pp 171.58 -17.39 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.309 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.67 -18.76 74.26 Favored Glycine 0 N--CA 1.494 2.549 0 O-C-N 121.083 -1.01 . . . . 0.0 110.802 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.689 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 23.6 mm-40 -84.71 -22.6 29.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.214 -1.168 . . . . 0.0 109.213 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.776 ' HE1' HD13 ' A' ' 40' ' ' ILE . 13.8 m-85 -95.23 -21.83 18.2 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.576 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -132.89 55.18 15.97 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.556 -0.715 . . . . 0.0 109.863 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.576 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 46.5 Cg_endo -84.84 50.07 2.8 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 O-C-N 123.508 1.267 . . . . 0.0 110.302 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.7 m -112.64 41.71 1.98 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.576 -0.702 . . . . 0.0 110.15 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.3 ttm105 -154.09 143.31 21.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.308 -0.87 . . . . 0.0 110.343 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 78.0 m -93.3 -49.54 5.9 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.5 -0.75 . . . . 0.0 110.081 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.07 0 O-C-N 121.722 -0.611 . . . . 0.0 110.523 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.4 m -73.78 136.57 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.55 -0.971 . . . . 0.0 110.413 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.531 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 1.6 t80 -156.61 155.24 31.5 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.457 -0.777 . . . . 0.0 110.662 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.681 HG21 HG13 ' A' ' 41' ' ' VAL . 6.6 p -134.13 123.58 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.884 ' HB2' HD23 ' A' ' 15' ' ' LEU . 49.0 m-20 -29.13 99.51 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.117 0.484 . . . . 0.0 111.817 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.1 -25.04 64.22 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.695 ' HB3' HG23 ' A' ' 33' ' ' THR . 0.2 OUTLIER -76.73 -21.23 55.56 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 122.021 -0.424 . . . . 0.0 110.044 178.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.884 HD23 ' HB2' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -80.88 -37.66 29.4 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.664 HD11 HG21 ' A' ' 41' ' ' VAL . 3.6 mp -64.48 -42.36 95.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.716 -0.615 . . . . 0.0 109.893 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.409 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -56.24 -21.17 21.87 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.759 179.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.71 -26.06 11.96 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.311 -0.868 . . . . 0.0 110.335 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.623 HG11 ' CE ' ' A' ' 44' ' ' MET . 0.5 OUTLIER -76.5 -36.9 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.303 -0.873 . . . . 0.0 110.935 -179.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.474 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 3.8 pp -63.71 -28.7 70.07 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -33.66 68.48 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.482 HD22 ' CB ' ' A' ' 27' ' ' GLU . 1.2 mt -79.58 -27.79 41.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.665 -0.647 . . . . 0.0 109.488 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -82.44 -11.29 58.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.538 -0.726 . . . . 0.0 109.558 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.57 -40.04 21.46 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.513 -0.742 . . . . 0.0 109.978 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.535 ' CD ' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -103.99 -25.76 12.88 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.403 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.92 25.31 5.96 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.535 ' HG3' ' CD ' ' A' ' 25' ' ' LYS . 4.7 mt-10 -79.3 130.12 35.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.335 -1.097 . . . . 0.0 110.602 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.0 mtmm -107.64 65.78 0.65 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.57 -0.707 . . . . 0.0 109.125 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.72 -151.03 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.6 -0.687 . . . . 0.0 110.049 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.0 OUTLIER -120.96 145.21 47.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.854 . . . . 0.0 110.57 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.548 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 2.7 mp -120.4 113.16 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.496 -0.753 . . . . 0.0 109.434 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -92.76 147.65 22.69 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.311 -0.868 . . . . 0.0 110.813 -179.35 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.795 HG21 ' HB3' ' A' ' 12' ' ' ASP . 17.6 m -138.69 166.7 23.7 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.468 -0.77 . . . . 0.0 110.301 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.456 ' HA ' ' CG ' ' A' ' 52' ' ' TYR . 15.4 m-90 -139.01 39.89 2.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.711 -0.618 . . . . 0.0 109.874 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 10' ' ' PHE . 50.6 m -78.82 -142.38 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.337 -0.852 . . . . 0.0 110.654 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.32 -61.4 1.41 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.989 -1.07 . . . . 0.0 110.317 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -94.33 39.53 1.09 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.403 -0.81 . . . . 0.0 109.825 179.484 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.727 ' HB3' HG23 ' A' ' 51' ' ' VAL . 36.3 m -35.54 131.57 0.48 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.302 0.572 . . . . 0.0 112.277 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.802 HG23 ' O ' ' A' ' 69' ' ' HIS . 27.9 m -150.02 162.27 40.71 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.631 -0.668 . . . . 0.0 110.401 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.689 HG21 HG21 ' A' ' 62' ' ' ILE . 1.2 mp -80.42 165.92 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.418 0 CA-C-O 121.642 0.734 . . . . 0.0 111.647 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.889 HG23 ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -140.4 179.59 1.22 Allowed Pre-proline 0 N--CA 1.503 2.183 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.605 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.75 ' HD2' HG12 ' A' ' 41' ' ' VAL . 48.8 Cg_endo -70.94 -33.01 12.76 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.872 1.459 . . . . 0.0 111.512 -179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -73.18 -0.14 13.42 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.451 -0.781 . . . . 0.0 110.984 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.889 ' SD ' HG23 ' A' ' 41' ' ' VAL . 1.3 mpt? -100.8 2.99 41.7 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.304 -0.872 . . . . 0.0 111.378 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.566 HG23 ' N ' ' A' ' 64' ' ' GLU . 4.0 p -57.2 -0.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.64 35.1 1.04 Allowed Glycine 0 N--CA 1.493 2.495 0 O-C-N 120.42 -1.425 . . . . 0.0 109.736 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.695 ' HB2' HD11 ' A' ' 49' ' ' ILE . 45.6 m-70 -144.34 154.93 43.53 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.279 -1.13 . . . . 0.0 111.06 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.686 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -99.76 83.85 2.82 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.223 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.829 HG12 HD13 ' A' ' 15' ' ' LEU . 2.7 mp -86.26 122.61 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 111.141 -177.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.757 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -79.09 87.13 4.87 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.971 0.891 . . . . 0.0 109.729 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.727 HG23 ' HB3' ' A' ' 38' ' ' SER . 4.9 p -62.36 120.55 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.733 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 33' ' ' THR . 20.6 t80 -67.1 109.19 2.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -0.897 . . . . 0.0 109.65 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -78.18 10.66 2.81 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.599 -0.688 . . . . 0.0 110.604 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.58 -26.72 13.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -139.82 -28.17 0.75 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.662 -0.905 . . . . 0.0 110.429 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -130.36 153.73 48.4 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.0 0.905 . . . . 0.0 113.323 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.436 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 6.5 m80 -96.02 113.99 25.65 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.757 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 21.9 t -103.44 94.76 6.24 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.238 -0.914 . . . . 0.0 109.531 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.496 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.6 Cg_endo -66.29 89.54 0.26 Allowed 'Trans proline' 0 N--CA 1.491 1.364 0 O-C-N 123.981 1.516 . . . . 0.0 109.567 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 58' ' ' VAL . 93.6 t -98.34 120.6 47.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.828 -179.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.686 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.5 t80 -73.65 105.07 4.81 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.761 HD13 ' HB3' ' A' ' 44' ' ' MET . 2.9 mp -85.38 135.07 25.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.679 -0.638 . . . . 0.0 111.071 -178.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.438 ' C ' HG23 ' A' ' 45' ' ' VAL . 59.3 p -98.26 -158.81 0.7 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 177.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.566 ' N ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -87.88 10.27 19.21 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.925 -1.11 . . . . 0.0 111.45 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -145.16 17.75 1.56 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.85 -1.156 . . . . 0.0 112.259 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.728 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 67.9 mtt -115.56 0.11 13.21 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.056 -1.028 . . . . 0.0 110.076 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.566 HG23 ' HB ' ' A' ' 40' ' ' ILE . 8.1 p -85.68 167.57 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.219 -0.926 . . . . 0.0 111.298 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 115.75 -15.98 16.54 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.802 ' O ' HG23 ' A' ' 39' ' ' THR . 15.6 m-70 -118.72 -86.36 0.64 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.052 -1.263 . . . . 0.0 111.122 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.613 ' HD3' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER 178.01 -33.81 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 122.165 0.983 . . . . 0.0 109.277 -179.611 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.613 HD23 ' HD3' ' A' ' 70' ' ' LYS . 0.5 OUTLIER 178.77 -16.13 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.834 -179.711 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.38 -14.2 79.47 Favored Glycine 0 N--CA 1.497 2.763 0 O-C-N 120.875 -1.141 . . . . 0.0 110.407 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.639 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 2.7 mm-40 -78.89 -22.88 45.27 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.324 -1.103 . . . . 0.0 108.667 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.728 ' CD2' ' HB3' ' A' ' 66' ' ' MET . 5.6 m-85 -97.09 -20.77 17.78 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.591 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -132.11 54.21 13.43 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.551 -0.718 . . . . 0.0 109.92 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.591 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 48.0 Cg_endo -85.13 50.42 2.81 Favored 'Trans proline' 0 C--N 1.32 -0.962 0 O-C-N 123.546 1.287 . . . . 0.0 110.152 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.5 t -62.17 140.94 58.42 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.606 -0.684 . . . . 0.0 110.695 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 -150.62 119.0 6.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.454 -0.779 . . . . 0.0 110.175 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.8 m 63.7 166.82 0.14 Allowed 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 121.308 0.575 . . . . 0.0 110.869 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 . . . . . 0 N--CA 1.496 1.856 0 O-C-N 121.311 -0.868 . . . . 0.0 110.175 -179.928 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.1 t -111.19 -56.63 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.477 -1.013 . . . . 0.0 110.027 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.72 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -124.26 157.07 35.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.669 -0.644 . . . . 0.0 109.942 -179.768 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.695 HG21 HG13 ' A' ' 41' ' ' VAL . 14.8 p -114.33 122.04 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.383 -0.823 . . . . 0.0 108.915 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.789 ' CG ' HG23 ' A' ' 33' ' ' THR . 37.5 t70 -48.53 107.85 0.15 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.64 -0.662 . . . . 0.0 111.579 -178.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -68.63 -22.48 64.42 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.405 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 4.6 t-80 -67.06 -21.88 65.87 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.044 0.45 . . . . 0.0 110.358 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.052 HD13 HD13 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -83.7 -36.94 23.34 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.325 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.877 ' HA ' HG12 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -66.87 -46.5 74.8 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.427 179.291 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.419 ' HA ' HD21 ' A' ' 20' ' ' LEU . 5.3 pt-20 -52.62 -21.88 4.42 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.728 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.0 -29.21 10.08 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.366 -0.834 . . . . 0.0 110.693 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.877 HG12 ' HA ' ' A' ' 16' ' ' LEU . 1.4 p -78.51 -38.7 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.096 -1.003 . . . . 0.0 111.161 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.475 ' C ' HD12 ' A' ' 20' ' ' LEU . 3.6 pp -63.11 -24.83 68.08 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -71.84 -32.2 67.28 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' A' ' 27' ' ' GLU . 1.7 mp -76.96 -27.11 54.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.652 -0.655 . . . . 0.0 109.381 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -86.29 -14.29 44.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.556 -0.715 . . . . 0.0 109.286 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.04 -40.35 12.36 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.666 -0.646 . . . . 0.0 110.2 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.422 ' CE ' ' HG2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -93.86 -29.55 15.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.453 -0.779 . . . . 0.0 109.19 179.721 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.93 22.35 7.65 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.495 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 8.2 mm-40 -82.32 136.05 35.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.335 -1.097 . . . . 0.0 109.87 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -113.29 80.73 1.4 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.463 -0.773 . . . . 0.0 109.961 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.53 -160.66 1.0 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.353 0.597 . . . . 0.0 110.532 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -106.98 161.31 14.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.64 -0.663 . . . . 0.0 110.447 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.67 ' HB ' HG12 ' A' ' 49' ' ' ILE . 37.9 mm -116.01 164.43 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.544 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 2.1 mptt -127.68 149.99 49.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.789 HG23 ' CG ' ' A' ' 12' ' ' ASP . 22.4 m -135.21 155.16 51.14 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.361 -0.837 . . . . 0.0 111.227 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.544 ' CH2' ' HB2' ' A' ' 32' ' ' LYS . 23.2 m-90 -145.18 28.47 1.22 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.728 -0.608 . . . . 0.0 110.352 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.443 ' O ' ' HD2' ' A' ' 52' ' ' TYR . 0.4 OUTLIER -92.88 -159.32 0.67 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.065 -1.022 . . . . 0.0 110.934 -179.222 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -108.47 -56.53 2.24 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.093 -1.004 . . . . 0.0 110.55 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -94.4 33.27 1.43 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.394 -0.816 . . . . 0.0 110.189 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.403 ' OG ' HG21 ' A' ' 33' ' ' THR . 42.9 m -39.0 126.03 1.56 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.404 0.621 . . . . 0.0 111.781 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.85 HG23 ' O ' ' A' ' 69' ' ' HIS . 17.4 m -133.85 162.74 31.19 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.656 -0.653 . . . . 0.0 110.28 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.759 HG23 ' CG1' ' A' ' 62' ' ' ILE . 1.3 mp -79.16 164.83 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.606 -0.684 . . . . 0.0 111.872 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.86 HG12 ' HD2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -140.07 175.19 3.34 Favored Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.568 -0.708 . . . . 0.0 109.536 178.468 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.86 ' HD2' HG12 ' A' ' 41' ' ' VAL . 46.7 Cg_endo -69.53 -32.45 19.49 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.018 1.536 . . . . 0.0 111.864 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.533 ' HB2' ' CE ' ' A' ' 44' ' ' MET . 4.6 mm-40 -73.82 -0.08 14.75 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.346 -0.846 . . . . 0.0 110.896 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.832 ' HE1' HG11 ' A' ' 19' ' ' VAL . 3.9 mmt -95.5 -6.99 39.34 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.219 -0.925 . . . . 0.0 111.853 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.56 HG13 ' N ' ' A' ' 64' ' ' GLU . 74.0 t -45.84 -8.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.647 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.422 ' HA2' ' CE1' ' A' ' 61' ' ' TYR . . . -143.01 34.73 1.75 Allowed Glycine 0 N--CA 1.493 2.485 0 O-C-N 120.174 -1.579 . . . . 0.0 109.726 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.445 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 30.0 m-70 -141.89 150.55 41.68 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.393 -1.063 . . . . 0.0 110.559 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -99.77 81.91 2.53 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.052 HD13 HD13 ' A' ' 15' ' ' LEU . 42.1 mt -77.21 124.04 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.527 -0.733 . . . . 0.0 111.472 -177.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.781 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -81.04 76.84 7.98 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' ' 51' ' ' VAL . 23.0 m -58.85 124.45 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.316 -178.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 32.3 t80 -74.8 105.64 5.96 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.408 -0.807 . . . . 0.0 109.091 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -68.93 -0.23 5.31 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.669 -0.644 . . . . 0.0 110.95 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.81 -18.5 9.85 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -140.03 -28.78 0.73 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.795 -0.827 . . . . 0.0 110.975 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -136.28 154.65 50.82 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.23 -0.919 . . . . 0.0 112.146 -178.21 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.446 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 5.7 m-70 -99.12 105.5 17.6 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.781 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 38.1 t -94.36 101.58 6.89 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.098 -1.001 . . . . 0.0 109.957 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.536 ' N ' ' HA ' ' A' ' 50' ' ' ALA . 40.3 Cg_endo -66.13 94.12 0.29 Allowed 'Trans proline' 0 N--CA 1.492 1.396 0 O-C-N 123.995 1.523 . . . . 0.0 108.934 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.609 HG23 HG12 ' A' ' 58' ' ' VAL . 75.6 t -109.73 125.33 66.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.065 -177.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 2.5 t80 -70.69 110.67 5.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.759 ' CG1' HG23 ' A' ' 40' ' ' ILE . 1.5 mp -61.06 -59.33 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.644 -0.66 . . . . 0.0 112.406 -177.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 3.5 m 69.52 161.26 0.21 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -177.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.56 ' N ' HG13 ' A' ' 45' ' ' VAL . 7.5 tp10 -78.42 62.24 3.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.83 -1.169 . . . . 0.0 109.902 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -173.1 -27.79 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.133 -0.979 . . . . 0.0 112.607 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.674 ' CB ' ' CE2' ' A' ' 74' ' ' PHE . 4.8 mmm -97.69 6.6 47.74 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.804 -1.185 . . . . 0.0 111.608 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.504 HG22 ' N ' ' A' ' 68' ' ' GLY . 7.5 p -89.07 163.83 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 120.857 -1.152 . . . . 0.0 112.059 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.504 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 109.68 -14.73 32.19 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.85 ' O ' HG23 ' A' ' 39' ' ' THR . 16.8 m-70 -117.77 -89.73 0.58 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.984 -1.303 . . . . 0.0 111.125 -179.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.592 ' HG2' ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER 177.64 -31.39 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.134 0.968 . . . . 0.0 109.232 -179.38 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.592 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 2.2 pp 177.62 -17.91 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.657 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.0 -15.68 74.36 Favored Glycine 0 N--CA 1.499 2.841 0 O-C-N 120.936 -1.103 . . . . 0.0 110.427 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.537 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 2.5 mm-40 -78.63 -21.59 48.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.352 -1.087 . . . . 0.0 108.407 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.674 ' CE2' ' CB ' ' A' ' 66' ' ' MET . 7.4 m-85 -96.18 -23.46 16.72 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.555 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -131.06 55.66 20.34 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.687 -0.633 . . . . 0.0 110.181 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 47.0 Cg_endo -85.66 48.47 2.15 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 O-C-N 123.573 1.302 . . . . 0.0 110.203 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 85.2 m -141.67 -56.53 0.47 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.678 -0.639 . . . . 0.0 110.212 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.21 127.98 38.99 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.586 -0.696 . . . . 0.0 110.075 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.2 t -136.42 40.45 2.63 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.567 -0.708 . . . . 0.0 110.35 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 N--CA 1.5 2.061 0 O-C-N 121.538 -0.726 . . . . 0.0 110.563 179.858 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 37' ' ' ARG . 89.0 t -116.71 -68.39 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.554 -0.968 . . . . 0.0 110.061 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.69 ' CZ ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -125.29 139.79 53.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.523 -0.736 . . . . 0.0 110.165 -179.843 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 11' ' ' VAL . 14.5 p -102.12 109.96 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.786 ' HB3' HD23 ' A' ' 15' ' ' LEU . 26.2 t70 -45.63 109.17 0.16 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.516 -0.74 . . . . 0.0 111.499 -178.207 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -67.43 -23.86 65.58 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.46 -29.26 66.89 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.115 0.483 . . . . 0.0 110.097 179.284 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.841 ' HG ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -79.95 -38.14 32.99 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.67 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.841 HD12 ' HG ' ' A' ' 15' ' ' LEU . 3.2 mp -63.33 -39.61 95.02 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.414 0.626 . . . . 0.0 109.553 178.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.53 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -55.49 -23.66 27.15 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.799 -0.563 . . . . 0.0 110.029 179.271 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -97.89 -31.82 12.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.482 -0.761 . . . . 0.0 110.499 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 16' ' ' LEU . 1.4 p -71.27 -38.16 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.317 -0.865 . . . . 0.0 110.933 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.53 HD21 ' HA ' ' A' ' 17' ' ' GLU . 3.8 pp -63.27 -26.82 68.95 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.053 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -74.47 -32.58 62.63 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.527 HD22 ' CB ' ' A' ' 27' ' ' GLU . 1.5 mt -75.14 -27.53 59.79 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -83.47 -12.41 56.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.519 -0.738 . . . . 0.0 109.463 178.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.5 -39.88 16.97 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 121.556 -0.715 . . . . 0.0 109.931 179.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.45 ' CE ' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -97.71 -26.65 14.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.509 -0.744 . . . . 0.0 109.807 179.716 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.416 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . 105.07 26.73 6.18 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.527 ' CB ' HD22 ' A' ' 22' ' ' LEU . 7.2 mt-10 -82.44 130.31 35.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.371 -1.076 . . . . 0.0 110.232 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -113.88 59.64 0.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.504 -0.747 . . . . 0.0 109.645 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.39 -136.68 0.32 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.495 -0.753 . . . . 0.0 109.877 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.571 ' HB2' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -132.56 153.88 50.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.95 -1.094 . . . . 0.0 110.719 -179.333 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.85 ' HB ' HD13 ' A' ' 49' ' ' ILE . 4.2 mt -127.35 120.07 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.224 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.441 ' HG3' ' CZ2' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -100.35 160.03 14.66 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.529 -0.732 . . . . 0.0 111.462 -178.69 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.584 HG21 ' OG ' ' A' ' 38' ' ' SER . 18.8 m -141.2 168.65 19.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.811 -0.556 . . . . 0.0 110.112 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.476 ' N ' HG22 ' A' ' 33' ' ' THR . 17.7 m-90 -144.59 39.32 1.27 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.365 -0.834 . . . . 0.0 110.556 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.453 ' H ' HG22 ' A' ' 33' ' ' THR . 22.9 t -92.88 -94.31 0.15 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.175 -0.953 . . . . 0.0 110.544 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.7 ttm105 -167.17 -60.16 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.989 -1.069 . . . . 0.0 110.841 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.52 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 1.9 mpt_? -103.34 35.67 2.5 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.336 -0.853 . . . . 0.0 110.568 -179.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.584 ' OG ' HG21 ' A' ' 33' ' ' THR . 0.4 OUTLIER -41.01 121.91 1.64 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.16 0.505 . . . . 0.0 111.89 -179.91 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.751 HG23 ' O ' ' A' ' 69' ' ' HIS . 87.8 m -120.74 158.87 26.56 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.679 -0.638 . . . . 0.0 110.293 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.746 HG21 HG12 ' A' ' 62' ' ' ILE . 4.9 mp -85.76 169.34 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.367 -0.833 . . . . 0.0 111.274 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.97 HG23 ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -138.21 179.49 1.31 Allowed Pre-proline 0 N--CA 1.502 2.14 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.097 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.728 ' HD2' HG12 ' A' ' 41' ' ' VAL . 44.9 Cg_endo -68.6 -31.89 25.59 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.879 1.463 . . . . 0.0 111.303 -179.277 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.87 -3.62 16.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.587 -0.696 . . . . 0.0 111.127 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.97 ' SD ' HG23 ' A' ' 41' ' ' VAL . 1.3 mpt? -93.72 0.09 56.23 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.201 -0.937 . . . . 0.0 111.925 -179.304 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.486 HG21 ' CG ' ' A' ' 64' ' ' GLU . 3.5 p -52.31 -3.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.99 33.11 1.52 Allowed Glycine 0 N--CA 1.493 2.473 0 O-C-N 120.394 -1.441 . . . . 0.0 109.668 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 38.6 m-70 -142.91 152.51 42.15 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.303 -1.116 . . . . 0.0 110.907 -179.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.646 HG23 ' HB2' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -99.61 83.61 2.81 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 178.361 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.85 HD13 ' HB ' ' A' ' 31' ' ' ILE . 1.1 mm -78.6 112.23 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 111.587 -177.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.705 ' HA ' ' C ' ' A' ' 58' ' ' VAL . . . -76.43 79.92 3.15 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.079 0.943 . . . . 0.0 108.777 178.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 70' ' ' LYS . 32.3 m -62.19 132.19 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.816 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.519 ' HB2' ' O ' ' A' ' 33' ' ' THR . 26.5 t80 -77.03 103.45 6.97 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.375 -0.828 . . . . 0.0 108.876 178.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -69.71 -0.7 7.4 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.527 -0.733 . . . . 0.0 110.563 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.58 -20.12 9.56 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.761 -2.136 . . . . 0.0 107.761 -178.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -140.15 -29.73 0.7 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 122.004 -0.704 . . . . 0.0 110.752 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.89 155.94 49.83 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.295 -0.878 . . . . 0.0 112.037 -178.278 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.539 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 3.1 m80 -100.64 100.67 11.41 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.092 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.705 ' C ' ' HA ' ' A' ' 50' ' ' ALA . 58.6 t -87.34 104.03 5.59 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.341 -0.85 . . . . 0.0 109.956 -179.041 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 57' ' ' HIS . 42.8 Cg_endo -67.96 89.91 0.37 Allowed 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.921 1.485 . . . . 0.0 109.481 -179.336 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 49' ' ' ILE . 12.7 m -94.21 111.84 25.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.177 -178.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.646 ' HB2' HG23 ' A' ' 48' ' ' THR . 2.4 t80 -69.96 101.25 1.73 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 118.526 -1.27 . . . . 0.0 107.598 177.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.874 HD13 ' HB3' ' A' ' 44' ' ' MET . 2.7 mp -80.8 141.33 15.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 121.543 0.687 . . . . 0.0 111.338 -178.113 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.3 p -110.29 -152.09 0.49 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 177.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.486 ' CG ' HG21 ' A' ' 45' ' ' VAL . 6.9 mt-10 -87.91 -13.38 42.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.764 -1.21 . . . . 0.0 110.921 179.237 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.53 27.35 6.53 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.984 -1.072 . . . . 0.0 112.147 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.716 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 9.5 mmt -116.12 -29.06 6.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.06 -1.025 . . . . 0.0 110.175 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.527 ' HA ' ' HZ ' ' A' ' 74' ' ' PHE . 5.7 p -65.67 163.89 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 O-C-N 121.39 -0.819 . . . . 0.0 111.874 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.487 ' N ' HG22 ' A' ' 67' ' ' VAL . . . 123.9 -11.0 8.33 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.475 178.234 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.751 ' O ' HG23 ' A' ' 39' ' ' THR . 17.2 m-70 -124.53 -84.48 0.64 Allowed 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 119.08 1.44 . . . . 0.0 111.007 -178.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.741 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.0 OUTLIER 178.47 -30.19 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.505 0.669 . . . . 0.0 110.273 -179.42 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.636 ' HB3' HG21 ' A' ' 51' ' ' VAL . 0.5 OUTLIER 173.32 -16.5 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.563 -179.776 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.04 -15.62 76.47 Favored Glycine 0 N--CA 1.495 2.613 0 O-C-N 121.053 -1.029 . . . . 0.0 110.602 -179.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.708 ' HG3' ' CD2' ' A' ' 69' ' ' HIS . 22.9 mm-40 -86.3 -18.82 30.99 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.141 -1.211 . . . . 0.0 109.423 178.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.727 ' HE1' HD13 ' A' ' 40' ' ' ILE . 4.0 m-85 -104.98 -17.89 14.36 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.542 ' N ' ' HD3' ' A' ' 76' ' ' PRO . . . -139.07 58.31 12.61 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.538 -0.726 . . . . 0.0 110.02 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.542 ' HD3' ' N ' ' A' ' 75' ' ' ALA . 43.8 Cg_endo -87.09 47.88 1.66 Allowed 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.635 1.334 . . . . 0.0 110.453 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.6 m 49.04 44.81 22.91 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.376 0.608 . . . . 0.0 110.483 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.52 143.73 20.1 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.31 -0.868 . . . . 0.0 110.237 -179.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -79.07 168.53 19.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.499 -0.751 . . . . 0.0 110.507 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.2 p90 . . . . . 0 N--CA 1.497 1.918 0 O-C-N 121.443 -0.786 . . . . 0.0 110.283 -179.993 . . . . . . . . 0 0 . 1 stop_ save_